Patent Publication Number: US-2003228570-A1

Title: Methods of diagnosis of Hepatitis C infection, compositions and methods of screening for modulators of Hepatitis C infection

Description:
CROSS-REFERENCES TO RELATED APPLICATIONS  
     [0001] The present invention is related to U.S. S No. 60/308,188, filed Jul. 26, 2001; and U.S. S No. 60/366,782, filed Mar. 21, 2002, each of which is incorporated herein by reference. 
    
    
     
       FIELD OF THE INVENTION  
       [0002] The invention relates to the identification of nucleic acid and protein expression profiles and nucleic acids, products, and antibodies thereto that are involved in Hepatitis C infection; and to the use of such expression profiles to identify compositions relevant in the diagnosis, prognosis, and therapy of Hepatitis C infection and its secondary consequences. The invention further relates to methods for identifying and using agents and/or targets that inhibit Hepatitis C infection or the effects therefrom.  
       BACKGROUND OF THE INVENTION  
       [0003] Hepatitis C virus (HCV) infects an estimated 170 million persons worldwide and thus, represents a viral pandemic that is five times as widespread as infection with the Human immunodeficiency-1 virus (HIV-1). In the United States alone an estimated 2.7 million Americans have active HCV infections.  
       [0004] Sexual transmission of the virus is an inefficient means of infection, rather, the factors most strongly associated with infection are injection drug use and before 1990, receipt of blood transfusion. In some cases no risk factors can be identified. Fortunately, introduction in 1990 and 1992 of improved blood screening measures, based on the detection of HCV antibodies, dramatically decreased the risk of transfusion associated HCV infection.  
       [0005] HCV is a positive strand RNA virus that belongs to the family of Flavivirus. The natural targets of HCV are the hepatocytes and possibly also B lymphocytes. The genome is about 9400 nucleotides in length and encodes a single large polyprotein of about 3000 amino acids which undergoes proteolysis to form the mature viral proteins. Structural components include the core and two envelope proteins. Two of the regions of the envelope E2 protein, designated hypervariable regions 1 and 2 have an extremely high rate of mutation, believed to be the result of selective pressure by virus specific antibodies. Because the virus is highly mutable and evolves over the course of infection, therapies directed solely at targeting an immune response toward the virus can be ineffective in clearing the viral load. See, e.g., Lauer and Walker (2001) “Hepatitis C Virus Infection”  N. E. J. Med.  345:41-52.  
       [0006] In most persons who become infected with HCV, viremia persists indefinitely and is accompanied by variable degrees of hepatic inflammation and fibrosis. HCV infection is rarely diagnosed during the acute phase of infection when the possibility of viral clearance is greatest. Clinical manifestations of HCV infection usually occur between 2-26 weeks after exposure to HCV, but the majority of persons are asymptomatic. The symptoms that do sometimes accompany acute HCV infection are usually mild and, when present, consist of jaundice, malaise, and nausea. In most cases, acute infection leads to chronic infection which is typically characterized by a prolonged period in which there are no symptoms. Once chronic infection has been established, spontaneous clearance of viremia is rare.  
       [0007] Viral clearance is associated with the development and persistence of strong virus-specific responses by cytotoxic T lymphocytes and helper T cells. The relatively weak response of cytotoxic T lymphocytes in persons with chronic HCV infection while insufficient to contain viremia and genetic evolution of the virus is still sufficient to cause collateral damage through the elaboration of inflammatory cytokines in the liver. The constant low level inflammatory response leads to hepatitis in most cases of chronic infection and also to some degree of fibrosis which may, in turn, be accompanied by relatively non-specific symptoms such as fatigue. Cirrhosis develops in 15-20% of those individuals who are chronically infected with HCV and these individuals are at high risk for developing severe complications, such as hepatic carcinoma. In fact, once cirrhosis is established, the risk of hepatocellular carcinoma is approximately 1-4% per year.  
       [0008] In addition to hepatic disease, there are important extrahepatic manifestations of HCV infection. Most of these syndromes are associated with autoimmune or lymphoproliferative states and may be related to the possibility that HCV is able to replicate in lymphoid cells. For example, a higher incidence of non-Hodgkin&#39;s Lymphoma has been observed in HCV infection.  
       [0009] Clearly, a need exists for the identification of novel therapeutic targets and diagnostic markers of HCV infection. Early diagnosis improves the chances that an individual will be able to clear the virus before infection becomes chronic. But, since most infections do become chronic, it is worthwhile to pursue alternative therapies which can be directed at alleviating the continuous low level inflammatory response that accompanies HCV infection and other secondary consequences of HCV infection such as liver fibrosis, which in turn, leads ultimately to cirrhosis and hepatocellular carcinoma.  
       [0010] Advances in molecular medicine will facilitate elucidation of a role for novel proteins and compounds in disease states. Identification of therapeutic targets and diagnostic markers is essential for improving the current treatment of Hepatitis C infected patients. Accordingly, provided herein are molecular targets for therapeutic intervention in all aspects of Hepatitis C infection. Additionally, provided herein are methods that can be used in diagnosis and prognosis of Hepatitis C infection and/or it secondary consequences. Further provided are methods that can be used to screen candidate bioactive agents for the ability to modulate Hepatitis C infection and/or its secondary consequences.  
       [0011] The current therapeutic regimen for HCV infection is treatment with interferon alpha (IFN-α). See, e.g., Berkow,  The Merck Manual.  In chronic hepatitis C, interferon-α at a dosage of 3 million IU subcutaneous three times weekly initially suppresses inflammation in about 50% of patients. Responders are usually treated for 12 months, but most relapse when treatment is stopped; successful long-term disease suppression is only about 20 to 25% overall. Response depends in part on the viral load, viral genotype, and histological state of the disease. Combination therapy with interferon plus oral Ribavirin™ (1200 mg daily in 2 divided doses) may give a higher rate of sustained response. In addition to having limited efficacy, interferon is expensive, must be given by injection, produces bothersome flu-like side effects in most patients, and induces more serious side effects in a minority of cases. Treatment should be supervised by a specialist. Other antiviral and immunomodulatory drugs against HCV have been evaluated or are being studied, but none has shown much promise except the combination of interferon plus ribavirin™.  
       [0012] Thus, means to early diagnose infection, and to identify patients who are likely to respond to treatment with IFN-α would be useful. Prognosis of response to treatment will minimize the occurrence of negative side effects in those patients who will not respond, and will allow early application of alternative therapies early in the infection. The present invention provides these and many other important capabilities.  
       SUMMARY OF THE INVENTION  
       [0013] The present invention therefore provides nucleotide sequences of genes that are up- and down-regulated in Hepatitis C infected cells and in cells affected indirectly by Hepatitis C infection. Such genes are useful for diagnostic purposes, and also as targets for screening for therapeutic compounds that modulate Hepatitis C infection and/or its secondary consequences, such as hormones or antibodies. Other aspects of the invention will become apparent to the skilled artisan by the following description of the invention.  
       [0014] In one aspect, the present invention provides a method of detecting a RNA transcript associated with Hepatitis C infection, in a cell from a patient, the method comprising contacting a biological sample from the patient with a polynucleotide that selectively hybridizes to a sequence at least 80% identical to a sequence as shown in Tables 1A-15.  
       [0015] In one embodiment, the present invention provides a method of determining the level of a Hepatitis C infection associated transcript in a cell from a patient.  
       [0016] In one embodiment, the present invention provides a method of detecting a Transcript associated with Hepatitis C infection in a cell from a patient, the method comprising contacting a biological sample from the patient with a polynucleotide that selectively hybridizes to a sequence at least 80% identical to a sequence as shown in Tables 1A-15.  
       [0017] In one embodiment, the polynucleotide selectively hybridizes to a sequence at least 95% identical to a sequence as shown in Tables 1A-15.  
       [0018] In one embodiment, the biological sample is a tissue sample, e.g., a liver biopsy. In another embodiment, the biological sample comprises isolated nucleic acids, e.g., mRNA.  
       [0019] In one embodiment, the polynucleotide is labeled, e.g., with a fluorescent label.  
       [0020] In one embodiment, the polynucleotide is immobilized on a solid surface.  
       [0021] In one embodiment, the patient is undergoing a therapeutic regimen to treat Hepatitis C infection.  
       [0022] In one embodiment, the patient is a primate or human.  
       [0023] In one embodiment, the Hepatitis C associated transcript is mRNA.  
       [0024] In one embodiment, the method further comprises the step of amplifying nucleic acids before the step of contacting the biological sample with the polynucleotide.  
       [0025] In another aspect, the present invention provides a method of monitoring the efficacy of a therapeutic treatment for Hepatitis C infection and/or its secondary consequences, the method comprising steps of: (i) providing a biological sample from a patient undergoing the therapeutic treatment; and (ii) determining the level of a Transcript associated with Hepatitis C infection in the biological sample by contacting the biological sample with a polynucleotide that selectively hybridizes to a sequence at least 80% identical to a sequence as shown in Tables 1A-15, thereby monitoring the efficacy of the therapy. In a further embodiment, the patient has a drug resistant form of Hepatitis C infection.  
       [0026] In one embodiment, the method further comprises a step of: (iii) comparing the level of the RNA transcript associated with Hepatitis C infection to a level of the Transcript associated with Hepatitis C infection in a biological sample from the patient prior to, or earlier in, the therapeutic treatment.  
       [0027] Additionally, provided herein is a method of evaluating the effect of a candidate drug for treating Hepatitis C infection and/or its secondary consequences, comprising administering drug to a patient and removing a cell sample from the patient. The expression profile of the cell is then determined. This method may further comprise comparing the expression profile to an expression profile of a healthy individual or other comparison sample. In a preferred embodiment, said expression profile includes a gene of Tables 1A-15.  
       [0028] In one aspect, the present invention provides an isolated nucleic acid molecule consisting of a polynucleotide sequence as shown in Tables 1A-15.  
       [0029] In one embodiment, an expression vector or cell comprises the isolated nucleic acid.  
       [0030] In one aspect, the present invention provides an isolated polypeptide which is encoded by a nucleic acid molecule having polynucleotide sequence as shown in Tables 1A-15.  
       [0031] In another aspect, the present invention provides an antibody that specifically binds to an isolated polypeptide which is encoded by a nucleic acid molecule having polynucleotide sequence as shown in Tables 1A-15.  
       [0032] In one embodiment, the antibody is conjugated to an effector component, e.g., a fluorescent label, a radioisotope, or a cytotoxic chemical.  
       [0033] In one embodiment, the antibody is an antibody fragment. In another embodiment, the antibody is humanized.  
       [0034] In one aspect, the present invention provides a method of detecting a Hepatitis C infected cell or a cell affected secondarily by Hepatitis C infection in a biological sample from a patient, the method comprising contacting the biological sample with an antibody as described herein.  
       [0035] In another aspect, the present invention provides a method of detecting antibodies specific to Hepatitis C infection in a patient, the method comprising contacting a biological sample from the patient with a polypeptide encoded by a nucleic acid comprising a sequence from Tables 1A-15.  
       [0036] In another aspect, the present invention provides a method for identifying a compound that modulates a Hepatitis C infection-associated polypeptide, the method comprising steps of: (i) contacting the compound with a Hepatitis C infection-associated polypeptide, the polypeptide encoded by a polynucleotide that selectively hybridizes to a sequence at least 80% identical to a sequence as shown in Tables 1A-15; and (ii) determining the functional effect of the compound upon the polypeptide.  
       [0037] In one embodiment, the functional effect is a physical effect, an enzymatic effect, a physiological effect, or a chemical effect.  
       [0038] In one embodiment, the polypeptide is expressed in a eukaryotic host cell or cell membrane. In another embodiment, the polypeptide is recombinant.  
       [0039] In one embodiment, the functional effect is determined by measuring ligand binding to the polypeptide.  
       [0040] In another aspect, the present invention provides a method of inhibiting proliferation of a Hepatitis C infected or a cell secondarily affected by Hepatitis C infection to treat Hepatitis C infection in a patient, the method comprising the step of administering to the subject a therapeutically effective amount of a compound identified as described herein.  
       [0041] In one embodiment, the compound is an antibody, e.g., one or more monoclonal antibodies.  
       [0042] In another aspect, the present invention provides a drug screening assay comprising steps of: (i) administering a test compound to a mammal suffering from a Hepatitis C infection or to a cell sample isolated therefrom; (ii) comparing the level of gene expression of a polynucleotide that selectively hybridizes to a sequence at least 80% identical to a sequence as shown in Tables 1A-15 in a treated cell or mammal with the level of gene expression of the polynucleotide in a control cell sample or mammal, wherein a test compound that modulates the level of expression of the polynucleotide is a candidate for the treatment of Hepatitis C infection and/or its secondary consequences.  
       [0043] In one embodiment, the control is a mammal, e.g., primate, infected with Hepatitis C virus or a cell sample therefrom that has not been treated with the test compound. In another embodiment, the control is a normal cell or mammal.  
       [0044] In one embodiment, the test compound is administered in varying amounts or concentrations. In another embodiment, the test compound is administered for varying time periods. In another embodiment, the comparison can occur before or after addition or removal of the drug candidate.  
       [0045] In one embodiment, the levels of a plurality of polynucleotides that selectively hybridize to a sequence at least 80% identical to a sequence as shown in Tables 1A-15 are individually compared to their respective levels in a control cell sample or mammal. In a preferred embodiment the plurality of polynucleotides is from three to ten.  
       [0046] In another aspect, the present invention provides a method for treating a mammal infected with Hepatitis C virus comprising administering a compound identified by the assay described herein.  
       [0047] In another aspect, the present invention provides a pharmaceutical composition for treating a mammal, e.g., primate, infected with Hepatitis C virus, the composition comprising a compound identified by the assay described herein and a physiologically acceptable excipient.  
       [0048] In one aspect, the present invention provides a method of screening drug candidates by providing a cell expressing a gene that is up- or down-regulated as in a Hepatitis C infection. In one embodiment, a gene is selected from Tables 1A-15. The method further includes adding a drug candidate to the cell and determining the effect of the drug candidate on the expression of the expression profile gene.  
       [0049] In one embodiment, the method of screening drug candidates includes comparing the level of expression in the absence of the drug candidate to the level of expression in the presence of the drug candidate, wherein the concentration of the drug candidate can vary when present, and wherein the comparison can occur after addition or removal of the drug candidate. In a preferred embodiment, the cell expresses at least two or more expression profile genes. The profile genes may each show change, e.g., an increase or decrease.  
       [0050] Also provided is a method of evaluating the effect of a candidate drug for the treatment of Hepatitis C infection and/or its secondary consequences comprising administering the drug to a transgenic animal expressing or over-expressing the Hepatitis C infection modulatory protein, or an animal lacking the Hepatitis C infection modulatory protein, e.g., as a result of a gene knockout.  
       [0051] Moreover, provided herein is a biochip comprising one or more nucleic acid segments of Tables 1A-15, wherein the biochip comprises fewer than 1000 nucleic acid probes. Preferably, at least two nucleic acid segments are included. More preferably, at least three nucleic acid segments are included.  
       [0052] Furthermore, a method of diagnosing a disorder associated with Hepatitis C infection is provided. The method comprises determining the expression of a gene of Tables 1A-15, in a first tissue type of a first individual, and comparing the distribution to the expression of the gene from a second uninfected individual. A difference in the expression indicates that the first individual has a disorder associated with Hepatitis C infection.  
       [0053] In a further embodiment, the biochip also includes a polynucleotide sequence of a gene that is not changed, e.g., up- or down-regulated in Hepatitis C infection.  
       [0054] In one embodiment a method for screening for a bioactive agent capable of interfering with the binding of a Hepatitis C infection modulating protein (Hepatitis C infection modulatory protein) or a fragment thereof and an antibody which binds to said Hepatitis C infection modulatory protein or fragment thereof. In a preferred embodiment, the method comprises combining a Hepatitis C infection modulatory protein or fragment thereof, a candidate bioactive agent, and an antibody which binds to said Hepatitis C infection modulatory protein or fragment thereof. The method further includes determining the binding of said Hepatitis C infection modulatory protein or fragment thereof and said antibody. When there is a change in binding, an agent is identified as an interfering agent. The interfering agent can be an agonist or an antagonist. Preferably, the agent inhibits Hepatitis C infection and/or the secondary consequences of Hepatitis C infection.  
       [0055] Also provided herein are methods of modulating an immune response in an individual, e.g., primate. In one embodiment a method provided herein comprises administering to an individual a composition comprising a Hepatitis C infection modulating protein, or a fragment thereof. In another embodiment, the protein is encoded by a nucleic acid selected from those of Tables 1A-15.  
       [0056] Further provided herein are compositions capable of eliciting an immune response in an individual. In one embodiment, a composition provided herein comprises a Hepatitis C infection modulating protein, preferably encoded by a nucleic acid of Tables 1A-15, or a fragment thereof, and a pharmaceutically acceptable carrier. In another embodiment, said composition comprises a nucleic acid comprising a sequence encoding a Hepatitis C infection modulating protein, preferably selected from the nucleic acids of Tables 1A-15, and a pharmaceutically acceptable carrier.  
       [0057] Also provided are methods of neutralizing the effect of a protein associated with Hepatitis C infection and/or its secondary consequences, or a fragment thereof, comprising contacting an agent specific for said protein with said protein in an amount sufficient to effect neutralization. In another embodiment, the protein is encoded by a nucleic acid selected from those of Tables 1A-15.  
       [0058] In another aspect of the invention, a method of treating an individual infected with Hepatitis C is provided. In one embodiment, the method comprises administering to said individual, e.g., primate, an inhibitor of a Hepatitis C infection modulating protein. In another embodiment, the method comprises administering to a patient, e.g., primate, infected with Hepatitis C virus, an antibody to a Hepatitis C infection modulating protein conjugated to a therapeutic moiety. Such a therapeutic moiety can be a cytotoxic agent or a radioisotope.  
       DETAILED DESCRIPTION OF THE INVENTION  
       [0059] In accordance with the objects outlined above, the present invention provides novel methods for diagnosis and prognosis evaluation for Hepatitis C infection and/or its secondary consequences, as well as methods for screening for compositions which modulate Hepatitis C infection and/or its secondary consequences. Markers are identified which correlate with subsets of patients who respond to IFN-α treatment, or with subsets of patients who are retractile (non-responsive) to treatment with standard IFN-α treatment. Also provided are methods for treating Hepatitis C infection and/or its secondary consequences.  
       [0060] Definitions  
       [0061] The term “Hepatitis C infection polynucleotide” or “transcript associated with Hepatitis C infection” refers to nucleic acid polymorphic variants, alleles, mutants, and interspecies homologues isolated from cells involved in Hepatitis C infection and/or its secondary consequences, or those which allow for subsetting of infected patients. The cells from which the nucleic acids are isolated include cells such as hepatocytes and B lymphocytes, that are directly infected by virus, as well as cells that may be indirectly affected by the viral infection such as those cells involved in the immune and inflammatory response to Hepatitis C infection. The terms also refer to nucleic acids that: (1) have a nucleotide sequence with greater than about 60% nucleotide sequence identity, 65%, 70%, 75%, 80%, 85%, 90%, preferably 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% or greater nucleotide sequence identity, preferably over a region of over a region of at least about 25, 50, 100, 200, 500, 1000, or more nucleotides, to a nucleotide sequence of or associated with a gene of Tables 1A-15; or, (2) specifically hybridize under stringent hybridization conditions to a nucleic acid sequence, or the complement thereof, of Tables 1A-15 and conservatively modified variants thereof.  
       [0062] The term “Hepatitis C infection protein” and similar terms refer to polypeptide polymorphic variants, alleles, mutants, and interspecies homologues isolated from cells involved in Hepatitis C infection and its secondary consequences, including ones which allow for subsetting patients, e.g., into responsive or non-responsive subsets. The cells from which the polypeptides are isolated include cells such as hepatocytes and B lymphocytes, that are directly infected by virus, as well as cells that may be indirectly affected by the viral infection such as those cells involved in the immune and inflammatory response to Hepatitis C infection. The terms also refer to polypeptides that: (1) bind to antibodies, e.g., polyclonal antibodies, raised against an immunogen comprising an amino acid sequence encoded by a nucleotide sequence of or associated with a gene of Tables 1A-15, and conservatively modified variants thereof; or (2) have an amino acid sequence that has greater than about 60% amino acid sequence identity, 65%, 70%, 75%, 80%, 85%, 90%, preferably 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% or greater amino sequence identity, preferably over a region of over a region of at least about 25, 50, 100, 200, 500, 1000, or more amino acid, to an amino acid sequence encoded by a nucleotide sequence of, or associated with, a gene of Tables 1A-15.  
       [0063] A polynucleotide or polypeptide sequence is typically from a mammal including, but not limited to, primate, e.g., human; rodent, e.g., rat, mouse, hamster; cow, pig, horse, sheep, or other mammal, domestic or livestock. A “Hepatitis C infection polypeptide” and a “Hepatitis C infection polynucleotide,” include both naturally occurring or recombinant forms.  
       [0064] A “full length” Hepatitis C infection protein or nucleic acid refers to a Hepatitis C infection polypeptide or polynucleotide sequence, or a variant thereof, that contains all of the elements normally contained in one or more naturally occurring, wild type Hepatitis C infection polynucleotide or polypeptide sequences. The “full length” may be prior to, or after, various stages of post-translational processing or splicing, including alternative splicing.  
       [0065] “Biological sample” as used herein is a sample of biological tissue or fluid that contains nucleic acids or polypeptides, e.g., of a Hepatitis C infection protein, polynucleotide, or transcript. Such samples include, but are not limited to, tissue isolated from primates, e.g., humans, or rodents, e.g., mice and rats. Biological samples may also include sections of tissues such as biopsy and autopsy samples, frozen sections taken for histologic purposes, archival specimens, blood, plasma, serum, sputum, stool, tears, mucus, hair, skin, etc. Biological samples also include explants and primary and/or transformed cell cultures derived from patient tissues. A biological sample is typically obtained from a eukaryotic organism, most preferably a mammal such as a primate e.g., chimpanzee or human; cow; dog; cat; a rodent, e.g., guinea pig, rat, mouse; rabbit; or a bird; reptile; or fish.  
       [0066] “Providing a biological sample” means to obtain a biological sample for use in methods described in this invention. Most often, this will be done by removing a sample of cells from an animal, but can also be accomplished by using previously isolated cells (e.g., isolated by another person, at another time, and/or for another purpose), or by performing the methods of the invention in vivo. Archival tissues, having treatment and/or outcome history, will be particularly useful.  
       [0067] The terms “identical” or percent “identity,” in the context of two or more nucleic acids or polypeptide sequences, refer to two or more sequences or subsequences that are the same or have a specified percentage of amino acid residues or nucleotides that are the same (e.g., about 60% identity, preferably 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or higher identity over a specified region, when compared and aligned for maximum correspondence over a comparison window or designated region) as measured using a BLAST or BLAST 2.0 sequence comparison algorithms with default parameters described below, or by manual alignment and visual inspection (see, e.g., NCBI web site http://www.ncbi.nlm.nih.gov/BLAST/ or the like). Such sequences are then said to be “substantially identical.” This definition also refers to, or may be applied to, the complement of a test sequence. The definition also includes sequences that have deletions and/or additions, as well as those that have substitutions, as well as naturally occurring, e.g., polymorphic or allelic variants, and man-made variants. As described below, the preferred algorithms can account for gaps and the like. Preferably, identity exists over a region that is at least about 25 amino acids or nucleotides in length, or more preferably over a region that is 50-100 amino acids or nucleotides in length.  
       [0068] For sequence comparison, typically one sequence acts as a reference sequence, to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Preferably, default program parameters can be used, or alternative parameters can be designated. The sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters.  
       [0069] A “comparison window”, as used herein, includes reference to a segment of one of the number of contiguous positions selected from the group consisting typically of from 20 to 600, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned. Methods of alignment of sequences for comparison are well-known in the art. Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith and Waterman (1981)  Adv. Appl. Math.  2:482-489, by the homology alignment algorithm of Needleman and Wunsch (1970)  J. Mol. Biol.  48:443-453, by the search for similarity method of Pearson and Lipman (1988)  Proc. Nat&#39;l. Acad. Sci. USA  85:2444-2448, by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.), or by manual alignment and visual inspection (see, e.g., Ausubel, et al. (eds. 1995 and supplements)  Current Protocols in Molecular Biology  Lippincott.  
       [0070] Preferred examples of algorithms that are suitable for determining percent sequence identity and sequence similarity include the BLAST and BLAST 2.0 algorithms, which are described, e.g., in Altschul, et al. (1977)  Nuc. Acids Res.  25:3389-3402 and Altschul, et al. (1990)  J. Mol. Biol.  215:403-410. BLAST and BLAST 2.0 are used, with the parameters described herein, to determine percent sequence identity for nucleic acids and proteins of the invention. Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/). This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. T is referred to as the neighborhood word score threshold (Altschul, et al., supra). These initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them. The word hits are extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Cumulative scores are calculated using, e.g., for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always &gt;0) and N (penalty score for mismatching residues; always &lt;0). For amino acid sequences, a scoring matrix is used to calculate the cumulative score. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLASTN program (for nucleotide sequences) uses as defaults a wordlength (W) of 11, an expectation (E) of 10, M=5, N=−4 and a comparison of both strands. For amino acid sequences, the BLASTP program uses as defaults a wordlength of 3, and expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff and Henikoff (1989)  Proc. Nat&#39;l Acad. Sci. USA  89:10915-919) alignments (B) of 50, expectation (E) of 10, M=5, N=−4, and a comparison of both strands.  
       [0071] The BLAST algorithm also performs a statistical analysis of the similarity between two sequences. See, e.g., Karlin and Altschul (1993)  Proc. Nat&#39;l. Acad. Sci. USA  90:5873-5787. One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, a nucleic acid is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.2, more preferably less than about 0.01, and most preferably less than about 0.001. Log values may be large negative numbers, e.g., 5, 10, 20, 30, 40, 40, 70, 90, 110, 150, 170, etc.  
       [0072] An indication that two nucleic acid sequences or polypeptides are substantially identical is that the polypeptide encoded by the first nucleic acid is immunologically cross reactive with the antibodies raised against the polypeptide encoded by the second nucleic acid, as described below. Thus, a polypeptide is typically substantially identical to a second polypeptide, e.g., where the two peptides differ only by conservative substitutions. Another indication that two nucleic acid sequences are substantially identical is that the two molecules or their complements hybridize to each other under stringent conditions, as described below. Yet another indication that two nucleic acid sequences are substantially identical is that the same primers can be used to amplify the sequences.  
       [0073] A “host cell” is a naturally occurring cell or a transformed cell that contains an expression vector and supports the replication or expression of the expression vector. Host cells may be cultured cells, explants, cells in vivo, and the like. Host cells may be prokaryotic cells such as  E. coli , or eukaryotic cells such as yeast, insect, amphibian, or mammalian cells such as CHO, HeLa, and the like (see, e.g., the American Type Culture Collection catalog or web site, www.atcc.org).  
       [0074] The terms “isolated,” “purified,” or “biologically pure” refer to material that is substantially or essentially free from components that normally accompany it as found in its native state. Purity and homogeneity are typically determined using analytical chemistry techniques such as polyacrylamide gel electrophoresis or high performance liquid chromatography. A protein or nucleic acid that is the predominant species present in a preparation is substantially purified. In particular, an isolated nucleic acid is separated from some open reading frames that naturally flank the gene and encode proteins other than protein encoded by the gene. The term “purified” in some embodiments denotes that a nucleic acid or protein gives rise to essentially one band in an electrophoretic gel. Preferably, it means that the nucleic acid or protein is at least 85% pure, more preferably at least 95% pure, and most preferably at least 99% pure. “Purify” or “purification” in other embodiments means removing at least one contaminant from the composition to be purified. In this sense, purification does not require that the purified compound be homogenous, e.g., 100% pure.  
       [0075] The terms “polypeptide,” “peptide”, and “protein” are used interchangeably herein to refer to a polymer of amino acid residues. The terms apply to amino acid polymers in which one or more amino acid residue is an artificial chemical mimetic of a corresponding naturally occurring amino acid, as well as to naturally occurring amino acid polymers, those containing modified residues, and non-naturally occurring amino acid polymer.  
       [0076] The term “amino acid” refers to naturally occurring and synthetic amino acids, as well as amino acid analogs and amino acid mimetics that function similarly to the naturally occurring amino acids. Naturally occurring amino acids are those encoded by the genetic code, as well as those amino acids that are later modified, e.g., hydroxyproline, γ-carboxyglutamate, and O-phosphoserine. Amino acid analogs refers to compounds that have the same basic chemical structure as a naturally occurring amino acid, e.g., an α carbon that is bound to a hydrogen, a carboxyl group, an amino group, and an R group, e.g., homoserine, norleucine, methionine sulfoxide, methionine methyl sulfonium. Such analogs may have modified R groups (e.g., norleucine) or modified peptide backbones, but retain the same basic chemical structure as a naturally occurring amino acid. Amino acid mimetics refers to chemical compounds that have a structure that is different from the general chemical structure of an amino acid, but that functions similarly to a naturally occurring amino acid.  
       [0077] Amino acids may be referred to herein by either their commonly known three letter symbols or by the one-letter symbols recommended by the IUPAC-IUB Biochemical Nomenclature Commission. Nucleotides, likewise, may be referred to by their commonly accepted single-letter codes.  
       [0078] “Conservatively modified variants” applies to both amino acid and nucleic acid sequences. With respect to particular nucleic acid sequences, conservatively modified variants refers to those nucleic acids which encode identical or essentially identical amino acid sequences, or where the nucleic acid does not encode an amino acid sequence, to essentially identical or associated, e.g., naturally contiguous, sequences. Because of the degeneracy of the genetic code, a large number of functionally identical nucleic acids encode most proteins. For instance, the codons GCA, GCC, GCG, and GCU all encode the amino acid alanine. Thus, at every position where an alanine is specified by a codon, the codon can be altered to another of the corresponding codons described without altering the encoded polypeptide. Such nucleic acid variations are “silent variations,” which are one species of conservatively modified variations. Every nucleic acid sequence herein which encodes a polypeptide also describes silent variations of the nucleic acid. One of skill will recognize that in certain contexts each codon in a nucleic acid (except AUG, which is ordinarily the only codon for methionine, and TGG, which is ordinarily the only codon for tryptophan) can be modified to yield a functionally identical molecule. Accordingly, often silent variations of a nucleic acid which encodes a polypeptide is implicit in a described sequence with respect to the expression product, but not with respect to actual probe sequences.  
       [0079] As to amino acid sequences, one of skill will recognize that individual substitutions, deletions, or additions to a nucleic acid, peptide, polypeptide, or protein sequence which alters, adds or deletes a single amino acid or a small percentage of amino acids in the encoded sequence is a “conservatively modified variant” where the alteration results in the substitution of an amino acid with a chemically similar amino acid. Conservative substitution tables providing functionally similar amino acids are well known in the art. Such conservatively modified variants are in addition to and do not exclude polymorphic variants, interspecies homologs, and alleles of the invention. Typically conservative substitutions include for one another: 1) Alanine (A), Glycine (G); 2) Aspartic acid (D), Glutamic acid (E); 3) Asparagine (N), Glutamine (O); 4) Arginine (R), Lysine (K); 5) Isoleucine (I), Leucine (L), Methionine (M), Valine (V); 6) Phenylalanine (F), Tyrosine (Y), Tryptophan (W); 7) Serine (S), Threonine (T); and 8) Cysteine (C), Methionine (M). See, e.g., Creighton (1984) Proteins: Structure and Molecular Properties Freeman.  
       [0080] Macromolecular structures such as polypeptide structures can be described in terms of various levels of organization. For a general discussion of this organization, see, e.g., Alberts, et al. (1994)  Molecular Biology of the Cell  (3d ed.) Garland; and Cantor and Schimmel (1980)  Biophysical Chemistry Part I: The Conformation of Biological Macromolecules Freeman.  “Primary structure” refers to the amino acid sequence of a particular peptide. “Secondary structure” refers to locally ordered, three dimensional structures within a polypeptide. These structures are commonly known as domains. Domains are portions of a polypeptide that often form a compact unit of the polypeptide and are typically about 25-500 amino acids long. Typical domains are made up of sections of lesser organization such as stretches of β-sheet and α-helices. “Tertiary structure” refers to the complete three dimensional structure of a polypeptide monomer. “Quaternary structure” refers to the three dimensional structure formed, usually by the noncovalent association of independent tertiary units. Anisotropic terms are also known as energy terms.  
       [0081] “Nucleic acid” or “oligonucleotide” or “polynucleotide” or grammatical equivalents used herein means at least two nucleotides covalently linked together. Oligonucleotides are typically from about 5, 6, 7, 8, 9, 10, 12, 15, 25, 30, 40, 50 or more nucleotides in length, up to about 100 nucleotides in length. Nucleic acids and polynucleotides are a polymers of any length, including longer lengths, e.g., 200, 300, 500, 1000, 2000, 3000, 5000, 7000, 10,000, etc. A nucleic acid of the present invention will generally contain phosphodiester bonds, although in some cases, nucleic acid analogs are included that may have alternate backbones, comprising, e.g., phosphoramidate, phosphorothioate, phosphorodithioate, or O-methylphophoroamidite linkages (see Eckstein (1992)  Oligonucleotides and Analogues: A Practical Approach  Oxford Univ. Press); and peptide nucleic acid backbones and linkages. Other analog nucleic acids include those with positive backbones; non-ionic backbones, and non-ribose backbones, including those described in U.S. Pat. Nos. 5,235,033 and 5,034,506, and Chapters 6 and 7 in Sanghvi and Cook (eds. 1994)  Carbohydrate Modifications in Antisense Research  ACS Symposium Series 580. Nucleic acids containing one or more carbocyclic sugars are also included within one definition of nucleic acids. Modifications of the ribose-phosphate backbone may be done for a variety of reasons, e.g., to increase the stability and half-life of such molecules in physiological environments or as probes on a biochip. Mixtures of naturally occurring nucleic acids and analogs can be made; alternatively, mixtures of different nucleic acid analogs, and mixtures of naturally occurring nucleic acids and analogs may be made.  
       [0082] A variety of references disclose such nucleic acid analogs, including, for example, phosphoramidate (Beaucage, et al. (1993)  Tetrahedron  49:1925-1963 and references therein; Letsinger (1970)  J. Org. Chem.  35:3800-3803; Sprinzl, et al. (1977)  Eur. J. Biochem.  81:579-589; Letsinger, et al. (1986)  Nucl. Acids Res.  14:3487499; Sawai, et al. (1984) Chem. Lett. 805, Letsinger, et al. (1988)  J. Am. Chem. Soc.  110:4470-4471; and Pauwels, et al. (1986) Chemica Scripta 26:141-149), phosphorothioate (Mag, et al. (1991)  Nuc. Acids Res.  19:1437-441; and U.S. Pat. No. 5,644,048), phosphorodithioate (Brill, et al. (1989)  J. Am. Chem. Soc.  111:2321-322), O-methylphophoroamidite linkages (see Eckstein (1992)  Oligonucleotides and Analogues: A Practical Approach,  Oxford Univ. Press), and peptide nucleic acid backbones and linkages (see Egholm (1992)  J. Am. Chem. Soc.  114:1895-1897; Meier, et al. (1992)  Chem. Int. Ed. Engl.  31:1008-1010; Nielsen (1993)  Nature  365:566-568; and Carlsson, et al. (1996)  Nature  380:207). Other analog nucleic acids include those with positive backbones (Denpcy, et al. (1995)  Proc. Nat&#39;l Acad. Sci. USA  92:6097-101); non-ionic backbones (U.S. Pat. Nos. 5,386,023, 5,637,684, 5,602,240, 5,216,141, and 4,469,863; Kiedrowski, et al. (1991)  Angew. Chem. Intl. Ed. English  30:423-426; Letsinger, et al. (1988)  J. Am. Chem. Soc.  110:4470-471; Jung, et al. (1994)  Nucleoside and Nucleotide  13:1597-xxx; Chapters 2 and 3 in Sanghvi and Cook (eds. 1994)  Carbohydrate Modifications in Antisense Research  ACS Symposium Series 580; Mesmaeker, et al. (1994)  Bioorganic and Medicinal Chem. Lett.  4:395-398; Jeffs, et al. (1994)  J. Biomolecular NMR  34:17; and Horn, et al. (1996)  Tetrahedron Lett.  37:743-xxx) and non-ribose backbones, including those described in U.S. Pat. Nos. 5,235,033 and 5,034,506, and Chapters 6 and 7 in Sanghvi and Cook (eds. 1994)  Carbohydrate Modifications in Antisense Research  ACS Symposium Series 580. Nucleic acids containing one or more carbocyclic sugars are also included within one definition of nucleic acids. See Jenkins, et al. (1995)  Chem. Soc. Rev. pp  169-176. Several nucleic acid analogs are described in Rawls (page 35, Jun. 2, 1997)  C &amp; E News.  All of these references are hereby expressly incorporated by reference.  
       [0083] Particularly preferred are peptide nucleic acids (PNA) which includes peptide nucleic acid analogs. These backbones are substantially non-ionic under neutral conditions, in contrast to the highly charged phosphodiester backbone of naturally occurring nucleic acids. This results in two advantages. First, the PNA backbone exhibits improved hybridization kinetics. PNAs have larger changes in the melting temperature (Tm) for mismatched versus perfectly matched base pairs. DNA and RNA typically exhibit a 2-4° C. drop in Tm for an internal mismatch. With the non-ionic PNA backbone, the drop is closer to 7-9° C. Similarly, due to their non-ionic nature, hybridization of the bases attached to these backbones is relatively insensitive to salt concentration. In addition, PNAs are not degraded by cellular enzymes, and thus can be more stable.  
       [0084] The nucleic acids may be single stranded or double stranded, as specified, or contain portions of both double stranded or single stranded sequence. As will be appreciated by those in the art, the depiction of a single strand also defines the sequence of the complementary strand; thus the sequences described herein also provide the complement of the sequence. The nucleic acid may be DNA, both genomic and cDNA, RNA or a hybrid, where the nucleic acid may contain combinations of deoxyribo- and ribo-nucleotides, and combinations of bases, including uracil, adenine, thymine, cytosine, guanine, inosine, xanthine hypoxanthine, isocytosine, isoguanine, etc. “Transcript” typically refers to a naturally occurring RNA, e.g., a pre-mRNA, hnRNA, or mRNA. As used herein, the term “nucleoside” includes nucleotides and nucleoside and nucleotide analogs, and modified nucleosides such as amino modified nucleosides. In addition, “nucleoside” includes non-naturally occurring analog structures. Thus, e.g., the individual units of a peptide nucleic acid, each containing a base, are referred to herein as a nucleoside.  
       [0085] A “label” or a “detectable moiety” is a composition detectable by spectroscopic, photochemical, biochemical, immunochemical, chemical, physiological, or other physical means. For example, useful labels include 32 P , fluorescent dyes, electron-dense reagents, enzymes (e.g., as commonly used in an ELISA), biotin, digoxigenin, or haptens and proteins or other entities which can be made detectable, e.g., by incorporating a radiolabel into the peptide or used to detect antibodies specifically reactive with the peptide. The labels may be incorporated into the Hepatitis C infection nucleic acids, proteins, and antibodies. Many methods known for conjugating the antibody to the label may be employed. See, e.g., Hunter, et al. (1962)  Nature  144:945; David, et al. (1974)  Biochemistry  13:1014-1021; Pain, et al. (1981)  J. Immunol. Meth.  40:219-230; and Nygren (1982)  J. Histochem. and Cytochem.  30:407-412.  
       [0086] An “effector” or “effector moiety” or “effector component” is a molecule that is bound (or linked, or conjugated), either covalently, through a linker or a chemical bond, or noncovalently, through ionic, van der Waals, electrostatic, or hydrogen bonds, to an antibody. The “effector” can be a variety of molecules including, e.g., detection moieties including radioactive compounds, fluorescent compounds, an enzyme or substrate, tags such as epitope tags, a toxin; activatable moieties, a chemotherapeutic agent; a lipase; an antibiotic; or a radioisotope emitting “hard” e.g., beta radiation. The effectors may be fusion proteins, or even natural components of antibodies, e.g., Ig constant effector sequences.  
       [0087] A “labeled nucleic acid probe or oligonucleotide” is one that is bound, either covalently, through a linker or a chemical bond, or noncovalently, through ionic, van der Waals, electrostatic, or hydrogen bonds to a label such that the presence of the probe may be detected by detecting the presence of the label bound to the probe. Alternatively, method using high affinity interactions may achieve the same results where one of a pair of binding partners binds to the other, e.g., biotin, streptavidin.  
       [0088] As used herein a “nucleic acid probe or oligonucleotide” is defined as a nucleic acid capable of binding to a target nucleic acid of complementary sequence through one or more types of chemical bonds, usually through complementary base pairing, usually through hydrogen bond formation. As used herein, a probe may include natural (e.g., A, G, C, or T) or modified bases (7-deazaguanosine, inosine, etc.). In addition, the bases in a probe may be joined by a linkage other than a phosphodiester bond, so long as it does not functionally interfere with hybridization. Thus, e.g., probes may be peptide nucleic acids in which the constituent bases are joined by peptide bonds rather than phosphodiester linkages. It will be understood by one of skill in the art that probes may bind target sequences lacking complete complementarity with the probe sequence depending upon the stringency of the hybridization conditions. The probes are preferably directly labeled as with isotopes, chromophores, lumiphores, chromogens, or indirectly labeled such as with biotin to which a streptavidin complex may later bind. By assaying for the presence or absence of the probe, one can detect the presence or absence of the select sequence or subsequence. Diagnosis or prognosis may be based at the genomic level, or at the level of RNA or protein expression.  
       [0089] The term “recombinant” when used with reference, e.g., to a cell, or nucleic acid, protein, or vector, indicates that the cell, nucleic acid, protein or vector, has been modified by the introduction of a heterologous nucleic acid or protein or the alteration of a native nucleic acid or protein, or that the cell is derived from a cell so modified. Thus, e.g., recombinant cells express genes that are not found within the native (non-recombinant) form of the cell or express native genes that are otherwise abnormally expressed, under expressed or not expressed at all. By the term “recombinant nucleic acid” herein is meant nucleic acid, originally formed in vitro, in general, by the manipulation of nucleic acid, e.g., using polymerases and endonucleases, in a form not normally found in nature. In this manner, operably linkage of different sequences is achieved. Thus an isolated nucleic acid, in a linear form, or an expression vector formed in vitro by ligating DNA molecules that are not normally joined, are both considered recombinant for the purposes of this invention. It is understood that once a recombinant nucleic acid is made and reintroduced into a host cell or organism, it will replicate non-recombinantly, e.g., using the in vivo cellular machinery of the host cell rather than in vitro manipulations; however, such nucleic acids, once produced recombinantly, although subsequently replicated non-recombinantly, are still considered recombinant for the purposes of the invention. Similarly, a “recombinant protein” is a protein made using recombinant techniques, e.g., through the expression of a recombinant nucleic acid as depicted above.  
       [0090] The term “heterologous” when used with reference to portions of a nucleic acid indicates that the nucleic acid comprises two or more subsequences that are not normally found in the same relationship to each other in nature. For instance, the nucleic acid is typically recombinantly produced, having two or more sequences, e.g., from unrelated genes arranged to make a new functional nucleic acid, e.g., a promoter from one source and a coding region from another source. Similarly, a heterologous protein will often refer to two or more subsequences that are not found in the same relationship to each other in nature (e.g., a fusion protein).  
       [0091] A “promoter” is defined as an array of nucleic acid control sequences that direct transcription of a nucleic acid. As used herein, a promoter includes necessary nucleic acid sequences near the start site of transcription, such as, in the case of a polymerase II type promoter, a TATA element. A promoter also optionally includes distal enhancer or repressor elements, which can be located as much as several thousand base pairs from the start site of transcription. A “constitutive” promoter is a promoter that is active under most environmental and developmental conditions. An “inducible” promoter is a promoter that is active under environmental or developmental regulation. The term “operably linked” refers to a functional linkage between a nucleic acid expression control sequence (such as a promoter, or array of transcription factor binding sites) and a second nucleic acid sequence, wherein the expression control sequence directs transcription of the nucleic acid corresponding to the second sequence.  
       [0092] An “expression vector” is a nucleic acid construct, generated recombinantly or synthetically, with a series of specified nucleic acid elements that permit transcription of a particular nucleic acid in a host cell. The expression vector can be part of a plasmid, virus, or nucleic acid fragment. Typically, the expression vector includes a nucleic acid to be transcribed operably linked to a promoter.  
       [0093] The phrase “selectively (or specifically) hybridizes to” refers to the binding, duplexing, or hybridizing of a molecule only to a particular nucleotide sequence under stringent hybridization conditions when that sequence is present in a complex mixture (e.g., total cellular or library DNA or RNA).  
       [0094] The phrase “stringent hybridization conditions” refers to conditions under which a probe will hybridize to its target subsequence, typically in a complex mixture of nucleic acids, but to no other sequences. Stringent conditions are sequence-dependent and will be different in different circumstances. Longer sequences hybridize specifically at higher temperatures. An extensive guide to the hybridization of nucleic acids is found in “Overview of principles of hybridization and the strategy of nucleic acid assays” in Tijssen (1993)  Hybridization with Nucleic Probes  ( Laboratory Techniques in Biochemistry and Molecular Biology ) (vol. 24) Elsevier. Generally, stringent conditions are selected to be about 5-10° C. lower than the thermal melting point (T m ) for the specific sequence at a defined ionic strength pH. The T m  is the temperature (under defined ionic strength, pH, and nucleic concentration) at which 50% of the probes complementary to the target hybridize to the target sequence at equilibrium (as the target sequences are present in excess, at T m , 50% of the probes are occupied at equilibrium). Stringent conditions will be those in which the salt concentration is less than about 1.0 M sodium ion, typically about 0.01 to 1.0 M sodium ion concentration (or other salts) at pH 7.0 to 8.3 and the temperature is at least about 30° C. for short probes (e.g., 10 to 50 nucleotides) and at least about 60° C. for long probes (e.g., greater than 50 nucleotides). Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide. For selective or specific hybridization, a positive signal is at least two times background, preferably 10 times background hybridization. Exemplary stringent hybridization conditions can be as following: 50% formamide, 5×SSC, and 1% SDS, incubating at 42° C., or, 5×SSC, 1% SDS, incubating at 65° C., with wash in 0.2×SSC, and 0.1% SDS at 65° C. For PCR, a temperature of about 36° C. is typical for low stringency amplification, although annealing temperatures may vary between about 32-48° C. depending on primer length. For high stringency PCR amplification, a temperature of about 62° C. is typical, although high stringency annealing temperatures can range from about 50-65° C., depending on the primer length and specificity. Typical cycle conditions for both high and low stringency amplifications include a denaturation phase of 90-95° C. for 30-120 sec, an annealing phase lasting 30-120 sec, and an extension phase of about 72° C. for 1-2 min. Protocols and guidelines for low and high stringency amplification reactions are provided, e.g., in Innis, et al. (1990)  PCR Protocols, A Guide to Methods and Applications,  Academic Press, NY.  
       [0095] Nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical if the polypeptides which they encode are substantially identical. This occurs, e.g., when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code. In such cases, the nucleic acids typically hybridize under moderately stringent hybridization conditions. Exemplary “moderately stringent hybridization conditions” include a hybridization in a buffer of 40% formamide, 1 M NaCl, 1% SDS at 37° C., and a wash in 1×SSC at 45° C. A positive hybridization is at least twice background. Those of ordinary skill will readily recognize that alternative hybridization and wash conditions can be utilized to provide conditions of similar stringency. Additional guidelines for determining hybridization parameters are provided in numerous references, e.g., Ausubel, et al. (eds. 1991 and supplements)  Current Protocols in Molecular Biology  Lippincott.  
       [0096] The phrase “functional effects” in the context of assays for testing compounds that modulate activity of a Hepatitis C infection protein includes the determination of a parameter that is indirectly or directly under the influence of the Hepatitis C infection protein or nucleic acid, e.g., a functional, physical, or chemical effect, such as the ability to decrease Hepatitis C infection or its secondary consequences. It includes ligand binding activity; “Functional effects” include in vitro, in vivo, and ex vivo activities.  
       [0097] By “determining the functional effect” is meant assaying for a compound that modifies, e.g., increases or decreases, a parameter that is indirectly or directly under the influence of a Hepatitis C infection protein sequence, e.g., functional, enzymatic, physical, physiological, or chemical effects. Such functional effects can be measured by any means known to those skilled in the art, e.g., changes in spectroscopic characteristics (e.g., fluorescence, absorbance, refractive index), hydrodynamic (e.g., shape), chromatographic, or solubility properties for the protein, measuring inducible markers or transcriptional activation of the Hepatitis C infection protein; measuring binding activity or binding assays, e.g., binding to antibodies or other ligands, and measuring cellular proliferation. Determination of the functional effect of a compound on Hepatitis C infection and its secondary consequences can also be performed using assays known to those of skill in the art such as an in vitro assays. The functional effects can be evaluated by many means known to those skilled in the art, e.g., measurement of changes in RNA or protein levels for Hepatitis C infection-associated sequences, measurement of RNA stability, identification of downstream or reporter gene expression (CAT, luciferase, β-gal, GFP, and the like), e.g., via chemiluminescence, fluorescence, calorimetric reactions, antibody binding, inducible markers, and ligand binding assays.  
       [0098] “Inhibitors”, “activators”, and “modulators” of Hepatitis C infection polynucleotide and polypeptide sequences are used to refer to activating, inhibitory, or modulating molecules or compounds identified using in vitro and in vivo assays of polynucleotide and polypeptide sequences associated with Hepatitis C infection and/or its secondary consequences. Inhibitors are compounds that, e.g., bind to, partially or totally block activity, decrease, prevent, delay activation, inactivate, desensitize, or down regulate the activity or expression of Hepatitis C infection proteins, e.g., antagonists. Antisense nucleic acids may seem to inhibit expression and subsequent function of the protein. “Activators” are compounds that increase, open, activate, facilitate, enhance activation, sensitize, agonize, or up regulate Hepatitis C infection protein activity. Inhibitors, activators, or modulators also include genetically modified versions of Hepatitis C infection proteins, e.g., versions with altered activity, as well as naturally occurring and synthetic ligands, antagonists, agonists, antibodies, small chemical molecules, and the like. Such assays for inhibitors and activators include, e.g., expressing the Hepatitis C infection protein in vitro, in cells, or cell membranes, applying putative modulator compounds, and then determining the functional effects on activity, as described above. Activators and inhibitors of Hepatitis C infection and its secondary consequences can also be identified by incubating Hepatitis C infected cells and tissues or cells and tissues secondarily affected by Hepatitis C infection with the test compound and determining increases or decreases in the expression of 1 or more Hepatitis C infection proteins, e.g., 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 40, 50, or more Hepatitis C infection proteins, such as Hepatitis C infection proteins encoded by the sequences set out in Tables 1A-15.  
       [0099] Samples or assays comprising Hepatitis C infection proteins that are treated with a potential activator, inhibitor, or modulator are compared to control samples without the inhibitor, activator, or modulator to examine the extent of inhibition. Control samples (untreated with inhibitors) are assigned a relative protein activity value of 100%. Inhibition of a polypeptide is achieved when the activity value relative to the control is about 80%, preferably about 50%, more preferably about 25-0%. Activation of a Hepatitis C infection polypeptide is achieved when the activity value relative to the control (untreated with activators) is about 110%, more preferably 150%, more preferably 200-500% (e.g., about two to five fold higher relative to the control), more preferably about 1000-3000% higher. However, sometimes selectivity or specificity of response in the correct organs may be significant consideration relative to absolute change.  
       [0100] “Antibody” refers to a polypeptide comprising a framework region from an immunoglobulin gene or fragments thereof that specifically binds and recognizes an antigen. The recognized immunoglobulin genes include the kappa, lambda, alpha, gamma, delta, epsilon, and mu constant region genes, as well as the myriad immunoglobulin variable region genes. Light chains are classified as either kappa or lambda. Heavy chains are classified as gamma, mu, alpha, delta, or epsilon, which in turn define the immunoglobulin classes, IgG, IgM, IgA, IgD, and IgE, respectively. Typically, the antigen-binding region of an antibody or its functional equivalent will be most critical in specificity and affinity of binding. See Paul (ed. 1999)  Fundamental Immunology  (4th ed.) Raven.  
       [0101] An exemplary imrnunoglobulin (antibody) structural unit comprises a tetramer. Each tetramer is composed of two identical pairs of polypeptide chains, each pair having one “light” (about 25 kD) and one “heavy” chain (about 50-70 kD). The N-terminus of each chain defines a variable region of about 100 to 110 or more amino acids primarily responsible for antigen recognition. The terms variable light chain (V L ) and variable heavy chain (V H ) refer to these light and heavy chains respectively.  
       [0102] Antibodies exist, e.g., as intact immunoglobulins or as a number of well-characterized fragments produced by digestion with various peptidases. Thus, e.g., pepsin digests an antibody below the disulfide linkages in the hinge region to produce F(ab)′ 2 , a dimer of Fab which itself is a light chain joined to V H -C H 1 by a disulfide bond. The F(ab)′ 2  may be reduced under mild conditions to break the disulfide linkage in the hinge region, thereby converting the F(ab)′ 2  dimer into an Fab′ monomer. The Fab′ monomer is essentially Fab with part of the hinge region. See Paul (ed. 1999)  Fundamental Immunology  (4th ed.) Raven. While various antibody fragments are defined in terms of the digestion of an intact antibody, it will be appreciated that such fragments may be synthesized de novo either chemically or by using recombinant DNA methodology. Thus, the term antibody, as used herein, also includes antibody fragments either produced by the modification of whole antibodies, or those synthesized de novo using recombinant DNA methodologies (e.g., single chain Fv) or those identified using phage display libraries (see, e.g., McCafferty, et al. (1990)  Nature  348:552-554).  
       [0103] For preparation of antibodies, e.g., recombinant, monoclonal, or polyclonal antibodies, many techniques can be used. See, e.g., Kohler and Milstein (1975)  Nature  256:495-497; Kozbor, et al. (1983)  Immunology Today  4:72; Cole, et al. (1985) pp. 77-96 in Reisfeld and Sell (1985)  Monoclonal Antibodies and Cancer Therapy  Liss; Coligan (1991)  Current Protocols in Immunology  Lippincott; Harlow and Lane (1988)  Antibodies: A Laboratory Manual  CSH Press; and Goding (1986)  Monoclonal Antibodies: Principles and Practice  (2d ed.) Academic Press. Techniques for the production of single chain antibodies (U.S. Pat. No. 4,946,778) can be adapted to produce antibodies to polypeptides of this invention. Also, transgenic mice, or other organisms such as other mammals, may be used to express humanized antibodies. Alternatively, phage display technology can be used to identify antibodies and heteromeric Fab fragments that specifically bind to selected antigens. See, e.g., McCafferty, et al. (1990)  Nature  348:552-554; Marks, et al. (1992)  Biotechnology  10:779-783.  
       [0104] A “chimeric antibody” is an antibody molecule in which (a) the constant region, or a portion thereof, is altered, replaced or exchanged so that the antigen binding site (variable region) is linked to a constant region of a different or altered class, effector function and/or species, or an entirely different molecule which confers new properties to the chimeric antibody, e.g., an enzyme, toxin, hormone, growth factor, drug, etc.; or (b) the variable region, or a portion thereof, is altered, replaced or exchanged with a variable region having a different or altered antigen specificity.  
       Identification of Hepatitis C Infection-Associated Sequences  
       [0105] In one aspect, the expression levels of genes are determined in different patient samples for which diagnosis information is desired, to provide expression profiles. An expression profile of a particular sample is essentially a “fingerprint” of the state of the sample; while two states may have any particular gene similarly expressed, the evaluation of a number of genes simultaneously allows the generation of a gene expression profile that is characteristic of the state of the cell. That is, normal tissue may be distinguished from Hepatitis C infected tissue or cells or tissues and cells affected secondarily by Hepatitis C infection, by comparison with tissue or cell samples from uninfected individuals. By comparison of expression profiles derived from infected and uninfected individuals information regarding which genes are important (including both up- and down-regulation of genes) in each of these states is obtained.  
       [0106] The identification of sequences that are differentially expressed in Hepatitis C infected and non-infected individuals allows the use of this information in a number of ways. For example, a particular treatment regime may be evaluated: does a drug act to down-regulate Hepatitis C infection and/or its secondary effects, in a particular patient. Similarly, diagnosis and treatment outcomes may be done or confirmed by comparing patient samples with the known expression profiles. Furthermore, these gene expression profiles (or individual genes) allow screening of drug candidates with an eye to mimicking or altering a particular expression profile; e.g., screening can be done for drugs that suppress certain aspects of the Hepatitis C infected patient&#39;s expression profile. This may be done by making biochips comprising sets of the important Hepatitis C infection genes, which can then be used in these screens. These methods can also be done on the protein basis; that is, protein expression levels of the Hepatitis C infection proteins can be evaluated for diagnostic purposes or to screen candidate agents. In addition, the Hepatitis C infection nucleic acid sequences can be administered for gene therapy purposes, including the administration of antisense nucleic acids, or the Hepatitis C infection proteins (including antibodies and other modulators thereof) administered as therapeutic drugs.  
       [0107] Thus the present invention provides nucleic acid and protein sequences that are differentially expressed in Hepatitis C infected individuals, herein termed “Hepatitis C infection sequences.” Further, the invention provides means to distinguish subsets of infected individuals; e.g., those who will or will not respond to particular therapeutic treatment. As outlined below, Hepatitis C infection sequences include those that are up-regulated (e.g., expressed at a higher level) during the course of Hepatitis C infection, as well as those that are down-regulated (e.g., expressed at a lower level). In a preferred embodiment, the Hepatitis C infection sequences are from primates, e.g., humans; however, as will be appreciated by those in the art, Hepatitis C infection sequences from other organisms may be useful in animal models of disease and drug evaluation; thus, other Hepatitis C infection sequences are provided, from vertebrates, including mammals, including rodents (rats, mice, hamsters, guinea pigs, etc.), primates, farm animals (including sheep, goats, pigs, cows, horses, etc.), and pets (e.g., dogs, cats, etc.). Hepatitis C infection sequences from other organisms may be obtained using the techniques outlined below.  
       [0108] Hepatitis C infection sequences can include both nucleic acid and amino acid sequences. As will be appreciated by those in the art and is more fully outlined below, Hepatitis C infection nucleic acid sequences are useful in a variety of applications, including diagnostic applications, which will detect naturally occurring nucleic acids, as well as screening applications; e.g., biochips comprising nucleic acid probes or PCR microtiter plates with selected probes to the Hepatitis C infection sequences can be generated.  
       [0109] A Hepatitis C infection sequence can be initially identified by substantial nucleic acid and/or amino acid sequence homology to the Hepatitis C infection sequences outlined herein. Such homology can be based upon the overall nucleic acid or amino acid sequence, and is generally determined as outlined below, using either homology programs or hybridization conditions.  
       [0110] For identifying Hepatitis C infection-associated sequences, the screen typically includes comparing the expression of genes from different tissues, but typically liver biopsy samples, of infected versus uninfected individuals. Analysis of samples from treatment responsive and treatment non-responsive patients may also be performed. Samples obtained are applied, e.g., to biochips comprising nucleic acid probes. The samples are first microdissected, if applicable, and treated as is known in the art for the preparation of mRNA. Suitable biochips are commercially available, e.g., from Affymetrix. Gene expression profiles as described herein are generated and the data analyzed. Other means for analysis may also be performed, e.g., PCR based, protein, or antibody diagnosis.  
       [0111] In one embodiment, the genes showing changes in expression as between normal and disease states are compared. In a preferred embodiment, those genes identified during the screen of infected individuals, that are expressed in any significant amount in uninfected individuals are removed from the profile, although in some embodiments, this is not necessary. That is, when screening for drugs, it is usually preferable that the target be disease specific, to minimize possible side effects.  
       [0112] In a preferred embodiment, Hepatitis C infection sequences are those that are up-regulated during Hepatitis C infection; that is, the expression of these genes is higher in the tissues of Hepatitis C infected individuals as compared to the tissues of uninfected individuals. “Up-regulation” as used herein often means at least about a two-fold change, preferably at least about a three fold change, with at least about five-fold or higher being preferred. Unigene cluster identification numbers and accession numbers herein are for the GenBank sequence database and the sequences of the accession numbers are hereby expressly incorporated by reference. GenBank is known in the art, see, e.g., Benson, et al. (1998)  Nuc. Acids Res.  26:1-7; and http://www.ncbi.nlm.nih.gov/. Sequences are also available in other databases, e.g., European Molecular Biology Laboratory (EMBL) and DNA Database of Japan (DDBJ). In some situations, the sequences may be derived from assembly of available sequences or be predicted from genomic DNA using exon prediction algorithms, such as FGENESH. See Salamov and Solovyev (2000)  Genome Res.  10:516-522. In other situations, sequences have been derived from cloning and sequencing of isolated nucleic acids.  
       [0113] In another preferred embodiment, Hepatitis C infection sequences are those that are down-regulated in Hepatitis C infected individuals; that is, the expression of these genes is lower in tissue from individuals infected with Hepatitis C as compared to non-infected individuals. “Down-regulation” as used herein often means at least about a two-fold change, preferably at least about a three fold change, with at least about five-fold or higher being preferred.  
       [0114] In other embodiments, sequences which are diagnostic, or prognostic, of response to treatment are identified. In particular, markers which are diagnostic of either response or non-response to treatment are described.  
       [0115] Informatics  
       [0116] The ability to identify genes that are over or under expressed during Hepatitis C infection or treatment can additionally provide high-resolution, high-sensitivity datasets which can be used in the areas of diagnostics, therapeutics, drug development, pharmacogenetics, protein structure, biosensor development, and other related areas. For example, the expression profiles can be used in diagnostic or prognostic evaluation of patients suffering from liver conditions, particularly Hepatitis infections. Or as another example, subcellular toxicological information can be generated to better direct drug structure and activity correlation. See Anderson (Jun. 11-12, 1998)  Pharmaceutical Proteomics: Targets, Mechanism, and Function,  paper presented at the IBC Proteomics conference, Coronado, Calif. Subcellular toxicological information can also be utilized in a biological sensor device to predict the likely toxicological effect of chemical exposures and likely tolerable exposure thresholds (see U.S. Pat. No. 5,811,231). Similar advantages accrue from datasets relevant to other biomolecules and bioactive agents (e.g., nucleic acids, saccharides, lipids, drugs, and the like).  
       [0117] Thus, in another embodiment, the present invention provides a database that includes at least one set of assay data. The data contained in the database is acquired, e.g., using array analysis either singly or in a library format. The database can be in many forms in which data can be maintained and transmitted, but is preferably an electronic database. The electronic database of the invention can be maintained on any electronic device allowing for the storage of and access to the database, such as a personal computer, but is preferably distributed on a wide area network, such as the World Wide Web.  
       [0118] The focus of the present section on databases that include nucleic acid, and corresponding peptide, sequence data is for clarity of illustration only. It will be apparent to those of skill in the art that similar databases can be assembled for an assay data acquired using an assay of the invention.  
       [0119] The compositions and methods for identifying and/or quantitating the relative and/or absolute abundance of a variety of molecular and macromolecular species from a biological sample experiencing hepatitis C infection or its secondary consequences, e.g., the identification of Hepatitis C infection-associated sequences described herein, provide an abundance of information, which can be correlated with pathological conditions, drug testing, therapeutic monitoring, gene-disease causal linkages, identification of correlates of immunity and physiological status, subsetting of patients into particular treatment responsive or non-responsive groups, among others. Although the data generated from the assays of the invention is suited for manual review and analysis, in a preferred embodiment, prior data processing using high-speed computers is utilized.  
       [0120] An array of methods for indexing and retrieving biomolecular information is known in the art. For example, U.S. Pat. Nos. 6,023,659 and 5,966,712 disclose a relational database system for storing biomolecular sequence information in a manner that allows sequences to be catalogued and searched according to one or more protein function hierarchies. U.S. Pat. No. 5,953,727 discloses a relational database having sequence records containing information in a format that allows a collection of partial-length DNA sequences to be catalogued and searched according to association with one or more sequencing projects for obtaining full-length sequences from the collection of partial length sequences. U.S. Pat. No. 5,706,498 discloses a gene database retrieval system for making a retrieval of a gene sequence similar to a sequence data item in a gene database based on the degree of similarity between a key sequence and a target sequence. U.S. Pat. No. 5,538,897 discloses a method using mass spectroscopy fragmentation patterns of peptides to identify amino acid sequences in computer databases by comparison of predicted mass spectra with experimentally-derived mass spectra using a closeness-of-fit measure. U.S. Pat. No. 5,926,818 discloses a multi-dimensional database comprising a functionality for multi-dimensional data analysis described as on-line analytical processing (OLAP), which entails the consolidation of projected and actual data according to more than one consolidation path or dimension. U.S. Pat. No. 5,295,261 reports a hybrid database structure in which the fields of each database record are divided into two classes, navigational and informational data, with navigational fields stored in a hierarchical topological map which can be viewed as a tree structure or as the merger of two or more such tree structures. See also Mount (2001)  Bioinformatics: Sequence and Genome Analysis  CSH Press, NY; Durbin, et al. (eds. 1999)  Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids  Cambridge Univ. Press; Baxevanis and Oeullette (eds. 1998)  Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins  (2d ed.) Wiley-Liss; Rashidi and Buehler (1999)  Bioinformatics: Basic Applications in Biological Science and Medicine  CRC Press; Setubal, et al. (eds. 1997)  Introduction to Computational Molecular Biology  Brooks/Cole; Misener and Krawetz (eds. 2000)  Bioinformatics: Methods and Protocols  Humana Press; Higgins and Taylor (eds. 2000)  Bioinformatics: Sequence, Structure, and Databanks: A Practical Approach  Oxford Univ. Press; Brown (2001)  Bioinformatics: A Biologist&#39;s Guide to Biocomputing and the Internet  Eaton Pub.; Han and Kamber (2000)  Data Mining: Concepts and Techniques  Kaufmann Pub.; and Waterman (1995)  Introduction to Computational Biology: Maps, Sequences, and Genomes  Chap and Hall.  
       [0121] The present invention provides a computer database comprising a computer and software for storing in computer-retrievable form assay data records cross-tabulated, e.g., with data specifying the source of the target-containing sample from which each sequence specificity record was obtained, and perhaps patient data or response.  
       [0122] In an exemplary embodiment, at least one of the sources of target-containing sample is from a control tissue sample known to be free of pathological disorders. In a variation, at least one of the sources is a known pathological tissue specimen. In another variation, the assay records cross-tabulate one or more of the following parameters for each target species in a sample: (1) a unique identification code, which can include, e.g., a target molecular structure and/or characteristic separation coordinate (e.g., electrophoretic coordinates); (2) sample source; (3) absolute and/or relative quantity of the target species present in the sample; and (4) patient history or eventual treatment outcome.  
       [0123] The invention also provides for the storage and retrieval of a collection of target data in a computer data storage apparatus, which can include magnetic disks, optical disks, magneto-optical disks, DRAM, SRAM, SGRAM, SDRAM, RDRAM, DDR RAM, magnetic bubble memory devices, and other data storage devices, including CPU registers and on-CPU data storage arrays. Typically, the target data records are stored as a bit pattern in an array of magnetic domains on a magnetizable medium or as an array of charge states or transistor gate states, such as an array of cells in a DRAM device (e.g., each cell comprised of a transistor and a charge storage area, which may be on the transistor). In one embodiment, the invention provides such storage devices, and computer systems built therewith, comprising a bit pattern encoding a protein expression fingerprint record comprising unique identifiers for at least 10 target data records cross-tabulated with target source.  
       [0124] When the target is a peptide or nucleic acid, the invention preferably provides a method for identifying related peptide or nucleic acid sequences, comprising performing a computerized comparison between a peptide or nucleic acid sequence assay record stored in or retrieved from a computer storage device or database and at least one other sequence. The comparison can include a sequence analysis or comparison algorithm or computer program embodiment thereof (e.g., FASTA, TFASTA, GAP, BESTFIT) and/or the comparison may be of the relative amount of a peptide or nucleic acid sequence in a pool of sequences determined from a polypeptide or nucleic acid sample of a specimen.  
       [0125] The invention also preferably provides a magnetic disk, such as an IBM-compatible (DOS, Windows, Windows95/98/2000, Windows NT, OS/2) or other format (e.g., Linux, SunOS, Solaris, AIX, SCO Unix, VMS, MV, Macintosh, etc.) floppy diskette or hard (fixed, Winchester) disk drive, comprising a bit pattern encoding data from an assay of the invention in a file format suitable for retrieval and processing in a computerized sequence analysis, comparison, or relative quantitation method.  
       [0126] The invention also provides a network, comprising a plurality of computing devices linked via a data link, such as an Ethernet cable (coax or 10BaseT), telephone line, ISDN line, wireless network, optical fiber, or other suitable signal transmission medium, whereby at least one network device (e.g., computer, disk array, etc.) comprises a pattern of magnetic domains (e.g., magnetic disk) and/or charge domains (e.g., an array of DRAM cells) composing a bit pattern encoding data acquired from an assay of the invention.  
       [0127] The invention also provides a method for transmitting assay data that includes generating an electronic signal on an electronic communications device, such as a modem, ISDN terminal adapter, DSL, cable modem, ATM switch, or the like, wherein the signal includes (in native or encrypted format) a bit pattern encoding data from an assay or a database comprising a plurality of assay results obtained by the method of the invention.  
       [0128] In a preferred embodiment, the invention provides a computer system for comparing a query target to a database containing an array of data structures, such as an assay result obtained by the method of the invention, and ranking database targets based on the degree of identity and gap weight to the target data. A central processor is preferably initialized to load and execute the computer program for alignment and/or comparison of the assay results. Data for a query target is entered into the central processor via an I/O device. Execution of the computer program results in the central processor retrieving the assay data from the data file, which comprises a binary description of an assay result.  
       [0129] The target data or record and the computer program can be transferred to secondary memory, which is typically random access memory (e.g., DRAM, SRAM, SGRAM, or SDRAM). Targets are ranked according to the degree of correspondence between a selected assay characteristic (e.g., binding to a selected affinity moiety) and the same characteristic of the query target and results are output via an I/O device. For example, a central processor can be a conventional computer (e.g., Intel Pentium, PowerPC, Alpha, PA-8000, SPARC, MIPS 4400, MIPS 10000, VAX, etc.); a program can be a commercial or public domain molecular biology software package (e.g., UWGCG Sequence Analysis Software, Darwin); a data file can be an optical or magnetic disk, a data server, a memory device (e.g., DRAM, SRAM, SGRAM, SDRAM, EPROM, bubble memory, flash memory, etc.); an I/O device can be a terminal comprising a video display and a keyboard, a modem, an ISDN terminal adapter, an Ethernet port, a punched card reader, a magnetic strip reader, or other suitable I/O device.  
       [0130] The invention also preferably provides the use of a computer system, such as that described above, which comprises: (1) a computer; (2) a stored bit pattern encoding a collection of peptide sequence specificity records obtained by the methods of the invention, which may be stored in the computer; (3) a comparison target, such as a query target; and (4) a program for alignment and comparison, typically with rank-ordering of comparison results on the basis of computed similarity values.  
       [0131] Characteristics of Hepatitis C Infection-Associated Proteins  
       [0132] Hepatitis C infection proteins of the present invention may be classified as secreted proteins, transmembrane proteins, or intracellular proteins. In one embodiment, the Hepatitis C infection protein is an intracellular protein. Intracellular proteins may be found in the cytoplasm and/or in the nucleus. Intracellular proteins are involved in all aspects of cellular function and replication (including, e.g., signaling pathways); aberrant expression of such proteins often results in unregulated or disregulated cellular processes. See, e.g., Alberts, et al. (eds. 1994)  Molecular Biology of the Cell  (3d ed.) Garland. For example, many intracellular proteins have enzymatic activity such as protein kinase activity, protein phosphatase activity, protease activity, nucleotide cyclase activity, polymerase activity, and the like. Intracellular proteins also serve as docking proteins that are involved in organizing complexes of proteins, or targeting proteins to various subcellular localizations, and are involved in maintaining the structural integrity of organelles. In particular, many of the genes identified in the analysis of the present invention may result from virus infection or related physiology, e.g., immunological responses, etc.  
       [0133] An increasingly appreciated concept in characterizing proteins is the presence in the proteins of one or more motifs for which defined functions have been attributed. In addition to the highly conserved sequences found in the enzymatic domain of proteins, highly conserved sequences have been identified in proteins that are involved in protein-protein interaction. For example, Src-homology-2 (SH2) domains bind tyrosine-phosphorylated targets in a sequence dependent manner. PTB domains, which are distinct from SH2 domains, also bind tyrosine phosphorylated targets. SH3 domains bind to proline-rich targets. In addition, PH domains, tetratricopeptide repeats, and WD domains to name only a few, have been shown to mediate protein-protein interactions. Some of these may also be involved in binding to phospholipids or other second messengers. As will be appreciated by one of ordinary skill in the art, these motifs can be identified on the basis of primary sequence; thus, an analysis of the sequence of proteins may provide insight into both the enzymatic potential of the molecule and/or molecules with which the protein may associate. One useful database is Pfam (protein families), which is a large collection of multiple sequence alignments and hidden Markov models covering many common protein domains. Versions are available via the internet from Washington University in St. Louis, the Sanger Center in England, and the Karolinska Institute in Sweden. See, e.g., Bateman, et al. (2000)  Nuc. Acids Res.  28:263-266; Sonnhammer, et al. (1997)  Proteins  28:405-420; Bateman, et al. (1999)  Nuc. Acids Res.  27:260-262; and Sonnhammer, et al. (1998)  Nuc. Acids Res.  26:320-322.  
       [0134] In another embodiment, the Hepatitis C infection sequences are transmembrane proteins. Transmembrane proteins are molecules that span a phospholipid bilayer of a cell. They may have an intracellular domain, an extracellular domain, or both. The intracellular domains of such proteins may have a number of functions including those already described for intracellular proteins. For example, the intracellular domain may have enzymatic activity and/or may serve as a binding site for additional proteins. Frequently the intracellular domain of transmembrane proteins serves both roles. For example certain receptor tyrosine kinases have both protein kinase activity and SH2 domains. In addition, autophosphorylation of tyrosines on the receptor molecule itself, creates binding sites for additional SH2 domain containing proteins.  
       [0135] Transmembrane proteins may contain from one to many transmembrane domains. For example, receptor tyrosine kinases, certain cytokine receptors, receptor guanylyl cyclases, and receptor serine/threonine protein kinases contain a single transmembrane domain. However, various other proteins including channels and adenylyl cyclases contain numerous transmembrane domains. Many important cell surface receptors such as G protein coupled receptors (GPCRs) are classified as “seven transmembrane domain” proteins, as they contain 7 membrane spanning regions. Characteristics of transmembrane domains include approximately 20 consecutive hydrophobic amino acids that may be followed by charged amino acids. Therefore, upon analysis of the amino acid sequence of a particular protein, the localization and number of transmembrane domains within the protein may be predicted (see, e.g., PSORT web site http://psort.nibb.ac.jp/). Important transmembrane protein receptors include, but are not limited to, the insulin receptor, insulin-like growth factor receptor, human growth hormone receptor, glucose transporters, transferrin receptor, epidermal growth factor receptor, low density lipoprotein receptor, epidermal growth factor receptor, leptin receptor, interleukin receptors, e.g., IL-1 receptor, IL-2 receptor, and other identified cytokine receptors, and chemokine receptors.  
       [0136] The extracellular domains of transmembrane proteins are diverse; however, conserved motifs are found repeatedly among various extracellular domains. Conserved structure and/or functions have been ascribed to different extracellular motifs. Many extracellular domains are involved in binding to other molecules. In one aspect, extracellular domains are found on receptors. Factors that bind the receptor domain include circulating ligands, which may be peptides, proteins, or small molecules such as adenosine and the like. For example, growth factors such as EGF, FGF, and PDGF are circulating growth factors that bind to their cognate receptors to initiate a variety of cellular responses. Other factors include cytokines, mitogenic factors, neurotrophic factors, and the like. Extracellular domains also bind to cell-associated molecules. In this respect, they mediate cell-cell interactions. Cell-associated ligands can be tethered to the cell, e.g., via a glycosylphosphatidylinositol (GPI) anchor, or may themselves be transmembrane proteins. Extracellular domains also associate with the extracellular matrix and contribute to the maintenance of the cell structure.  
       [0137] Transmembrane proteins that are associated with Hepatitis C infection are particularly preferred in the present invention as they are readily accessible targets for immunotherapeutics, as are described herein. In addition, as outlined below, transmembrane proteins can be also useful in imaging modalities. Antibodies may be used to label such readily accessible proteins in situ. Alternatively, antibodies can also label intracellular proteins, in which case samples are typically permeablized to provide access to intracellular proteins. Diagnosis may be of biopsy samples isolated from the individual, including serum or liver samples.  
       [0138] It will also be appreciated by those in the art that a transmembrane protein can be made soluble by removing transmembrane sequences, e.g., through recombinant methods. Furthermore, transmembrane proteins that have been made soluble can be made to be secreted through recombinant means by adding an appropriate signal sequence. Alternatively, normal or pathological processes may result in the release of membrane or intracellular proteins into the serum, e.g., by proteolytic processing to release portions of a protein into a body fluid.  
       [0139] In another embodiment, the Hepatitis C infection proteins are secreted proteins; the secretion of which can be either constitutive or regulated. These proteins have a signal peptide or signal sequence that targets the molecule to the secretory pathway. Secreted proteins are involved in numerous physiological events; often by virtue of their circulating nature, they serve to transmit signals to various other cell types. The secreted protein may function in an autocrine manner (acting on the cell that secreted the factor), a paracrine manner (acting on cells in close proximity to the cell that secreted the factor), an endocrine manner (acting on cells at a distance, e.g., secretion into the blood stream), or exocrine (secretion, e.g., through a duct or to adjacent epithelial surface as sweat glands, sebaceous glands, pancreatic ducts, lacrimal glands, mammary glands, wax producing glands of the ear, etc.). Thus secreted molecules find use in modulating or altering numerous aspects of physiology. Hepatitis C infection proteins that are secreted proteins are particularly preferred in the present invention as they serve as good therapeutic targets and also as diagnostic markers, e.g., for blood, plasma, serum, or stool tests. Diagnosis may be direct for the protein, or of a response to the protein, e.g., presence of antibodies generated to the protein. Those which are enzymes may be antibody or small molecule targets. Others may be useful as vaccine targets, e.g., via CTL mechanisms.  
       [0140] Use of Hepatitis C Infection Nucleic Acids  
       [0141] As described above, a Hepatitis C infection sequence is initially identified by substantial nucleic acid and/or amino acid sequence homology or linkage to the Hepatitis C infection sequences outlined herein. Such homology can be based upon the overall nucleic acid or amino acid sequence, and is generally determined as outlined below, using either homology programs or hybridization conditions. Typically, linked sequences on a mRNA are found on the same molecule.  
       [0142] The Hepatitis C infection nucleic acid sequences of the invention, e.g., the sequences in Tables 1A-15, can be fragments of larger genes, e.g., they are nucleic acid segments. “Genes” in this context includes coding regions, non-coding regions, and mixtures of coding and non-coding regions. Accordingly, as will be appreciated by those in the art, using the sequences provided herein, extended sequences, in either direction, of the Hepatitis C infection genes can be obtained, using techniques well known in the art for cloning either longer sequences or the full length sequences; see Ausubel, et al., supra. Much can be done by informatics and many sequences can be clustered to include multiple sequences corresponding to a single gene, e.g., systems such as UniGene (see, http://www.ncbi.nlm.nih.gov/UniGene/).  
       [0143] Once the Hepatitis C infection nucleic acid is identified, it can be cloned and, if necessary, its constituent parts recombined to form the entire Hepatitis C infection nucleic acid coding regions or the entire mRNA sequence. Once isolated from its natural source, e.g., contained within a plasmid or other vector or excised therefrom as a linear nucleic acid segment, the recombinant Hepatitis C infection nucleic acid can be further used as a probe to identify and isolate other Hepatitis C infection nucleic acids, e.g., extended coding regions. It can also be used as a “precursor” nucleic acid to make modified or variant Hepatitis C infection nucleic acids and proteins.  
       [0144] The Hepatitis C infection nucleic acids of the present invention are used in several ways. In a first embodiment, nucleic acid probes to the Hepatitis C infection nucleic acids are made and attached to biochips to be used in screening and diagnostic methods, as outlined below, or for administration, e.g., for gene therapy, vaccine, and/or antisense applications. Alternatively, the Hepatitis C infection nucleic acids that include coding regions of Hepatitis C infection proteins can be put into expression vectors for the expression of Hepatitis C infection proteins, again for screening purposes, for administration to a patient, to generate a vaccine, or to generate antibodies.  
       [0145] In a preferred embodiment, nucleic acid probes to Hepatitis C infection nucleic acids (both the nucleic acid sequences outlined in the figures and/or the complements thereof) are made. The nucleic acid probes attached to the biochip are designed to be substantially complementary to the Hepatitis C infection nucleic acids, e.g., the target sequence (either the target sequence of the sample or to other probe sequences, e.g., in sandwich assays), such that hybridization of the target sequence and the probes of the present invention occurs. As outlined below, this complementarity need not be perfect; there may be any number of base pair mismatches which will interfere with hybridization between the target sequence and the single stranded nucleic acids of the present invention. However, if the number of mutations is so great that no hybridization can occur under even the least stringent of hybridization conditions, the sequence is not a complementary target sequence. Thus, by “substantially complementary” herein is meant that the probes are sufficiently complementary to the target sequences to hybridize under normal reaction conditions, particularly high stringency conditions, as outlined herein. PCR technologies may also be applicable.  
       [0146] A nucleic acid probe is generally single stranded but can be partially single and partially double stranded. The strandedness of the probe is dictated by the structure, composition, and properties of the target sequence. In general, the nucleic acid probes range from about 8-100 bases long, with from about 10-80 bases being preferred, and from about 30-50 bases being particularly preferred. That is, generally whole genes are not used. In some embodiments, much longer nucleic acids can be used, up to hundreds of bases.  
       [0147] In a preferred embodiment, more than one probe per sequence is used, with either overlapping probes or probes to different sections of the target being used. That is, two, three, four or more probes, with three being preferred, are used to build in a redundancy for a particular target. The probes can be overlapping (e.g., have some sequence in common), or separate. In some cases, PCR primers may be used to amplify signal for higher sensitivity.  
       [0148] Nucleic acids can be attached or immobilized to a solid support in a wide variety of ways. By “immobilized” and grammatical equivalents herein is meant the association or binding between the nucleic acid probe and a solid support is sufficient to be Tables 1A-15 under the conditions of binding, washing, analysis, and removal as outlined below. The binding can typically be covalent or non-covalent. By “non-covalent binding” and grammatical equivalents herein is meant one or more of electrostatic, hydrophilic, and hydrophobic interactions. Included in non-covalent binding is the covalent attachment of a molecule, such as, streptavidin to the support and the non-covalent binding of the biotinylated probe to the streptavidin. By “covalent binding” and grammatical equivalents herein is meant that the two moieties, the solid support and the probe, are attached by at least one bond, including sigma bonds, pi bonds, and coordination bonds. Covalent bonds can be formed directly between the probe and the solid support or can be formed by a cross linker or by inclusion of a specific reactive group on either the solid support or the probe or both molecules. Immobilization may also involve a combination of covalent and non-covalent interactions.  
       [0149] In general, the probes are attached to the biochip in a wide variety of ways, as will be appreciated by those in the art. As described herein, the nucleic acids can either be synthesized first, with subsequent attachment to the biochip, or can be directly synthesized on the biochip.  
       [0150] The biochip comprises a suitable solid substrate. By “substrate” or “solid support” or other grammatical equivalents herein is meant a material that can be modified to contain discrete individual sites appropriate for the attachment or association of the nucleic acid probes and is amenable to at least one detection method. As will be appreciated by those in the art, the number of possible substrates is very large, and include, but are not limited to, glass and modified or functionalized glass, plastics (including acrylics, polystyrene, and copolymers of styrene and other materials, polypropylene, polyethylene, polybutylene, polyurethanes, TeflonJ, etc.), polysaccharides, nylon or nitrocellulose, resins, silica or silica-based materials including silicon and modified silicon, carbon, metals, inorganic glasses, plastics, etc. In general, the substrates allow optical detection and preferably do not appreciably fluoresce. See WO 00/55627.  
       [0151] Generally the substrate is planar, although as will be appreciated by those in the art, other configurations of substrates may be used as well. For example, the probes may be placed on the inside surface of a tube, for flow-through sample analysis to minimize sample volume. Similarly, the substrate may be flexible, such as a flexible foam, including closed cell foams made of particular plastics.  
       [0152] In a preferred embodiment, the surface of the biochip and the probe may be derivatized with chemical functional groups for subsequent attachment of the two. Thus, e.g., the biochip is derivatized with a chemical functional group including, but not limited to, amino groups, carboxy groups, oxo groups, and thiol groups, with amino groups being particularly preferred. Using these functional groups, the probes can be attached using functional groups on the probes. For example, nucleic acids containing amino groups can be attached to surfaces comprising amino groups, e.g., using available linkers, homo-or hetero-bifunctional linkers as are well known (see 1994 Pierce Chemical Company catalog, technical section on cross-linkers, pages 155-200). In addition, in some cases, additional linkers, such as alkyl groups (including substituted and heteroalkyl groups) may be used.  
       [0153] In this embodiment, oligonucleotides are synthesized as is known in the art, and then attached to the surface of the solid support. Either the 5′ or 3′ terminus may be attached to the solid support, or attachment may be via an internal nucleoside. In another embodiment, the immobilization to the solid support may be very strong, yet non-covalent. For example, biotinylated oligonucleotides can be made, which bind to surfaces covalently coated with streptavidin, resulting in attachment.  
       [0154] In another embodiment, the immobilization to the solid support may be very strong, yet non-covalent. For example, biotinylated oligonucleotides can be made, which bind to surfaces covalently coated with streptavidin, resulting in attachment.  
       [0155] Alternatively, the oligonucleotides may be synthesized on the surface, as is known in the art. For example, photoactivation techniques utilizing photopolymerization compounds and techniques are used. In a preferred embodiment, the nucleic acids can be synthesized in situ, using well known photolithographic techniques, such as those described in WO 95/25116; WO 95/35505; U.S. Pat. Nos. 5,700,637 and 5,445,934; and references cited within, all of which are expressly incorporated by reference; these methods of attachment form the basis of the Affymetrix GeneChip™ technology. Other oligonucleotide synthetic techniques may be applied.  
       [0156] Often, amplification-based assays are performed to measure the expression level of Hepatitis C infection-associated sequences. These assays are typically performed in conjunction with reverse transcription. In such assays, a Hepatitis C infection-associated nucleic acid sequence acts as a template in an amplification reaction (e.g., Polymerase Chain Reaction, or PCR). In a quantitative amplification, the amount of amplification product will be proportional to the amount of template in the original sample. Comparison to appropriate controls provides a measure of the amount of Hepatitis C infection-associated RNA. Methods of quantitative amplification are well known to those of skill in the art. Detailed protocols for quantitative PCR are provided, e.g., in Innis, et al. (1990)  PCR Protocols: A Guide to Methods and Applications  Academic Press.  
       [0157] In some embodiments, a TaqMan based assay is used to measure expression. TaqMan based assays use a fluorogenic oligonucleotide probe that contains a 5′ fluorescent dye and a 3′ quenching agent. The probe hybridizes to a PCR product, but cannot itself be extended due to a blocking agent at the 3′ end. When the PCR product is amplified in subsequent cycles, the 5′ nuclease activity of the polymerase, e.g., AmpliTaq, results in the cleavage of the TaqMan probe. This cleavage separates the 5′ fluorescent dye and the 3′ quenching agent, thereby resulting in an increase in fluorescence as a function of amplification (see, e.g., literature provided by Perkin-Elmer, e.g., www2.perkin-elmer.com).  
       [0158] Other suitable amplification methods include, but are not limited to, ligase chain reaction (LCR) (see Wu and Wallace (1989)  Genomics  4:560-569, Landegren, et al. (1988)  Science  241:1077-1080, and Barringer, et al. (1990)  Gene  89:117-122), transcription amplification (Kwoh, et al. (1989)  Proc. Nat&#39;l Acad. Sci. USA  86:1173-1177), self-sustained sequence replication (Guatelli, et al. (1990)  Proc. Nat&#39;l Acad. Sci. USA  87:1874-1878), dot PCR, linker adapter PCR, etc.  
       [0159] Expression of Hepatitis C Infection Proteins from Nucleic Acids  
       [0160] In a preferred embodiment, Hepatitis C infection nucleic acids, e.g., encoding Hepatitis C infection proteins are used to make a variety of expression vectors to express Hepatitis C infection proteins which can then be used in screening assays, as described below. Expression vectors and recombinant DNA technology are well known (see, e.g., Ausubel, supra, and Fernandez and Hoeffler (eds. 1999)  Gene Expression Systems  Academic Press) and are used to express proteins. The expression vectors may be self-replicating extrachromosomal vectors or vectors which integrate into a host genome. Generally, these expression vectors include transcriptional and translational regulatory nucleic acid operably linked to the nucleic acid encoding the Hepatitis C infection protein. The term “control sequences” refers to DNA sequences used for the expression of an operably linked coding sequence in a particular host organism. Control sequences that are suitable for prokaryotes, e.g., include a promoter, optionally an operator sequence, and a ribosome binding site. Eukaryotic cells are known to utilize promoters, polyadenylation signals, and enhancers.  
       [0161] Nucleic acid is “operably linked” when it is placed into a functional relationship with another nucleic acid sequence. For example, DNA for a presequence or secretory leader is operably linked to DNA for a polypeptide if it is expressed as a preprotein that participates in the secretion of the polypeptide; a promoter or enhancer is operably linked to a coding sequence if it affects the transcription of the sequence; or a ribosome binding site is operably linked to a coding sequence if it is positioned so as to facilitate translation. Generally, “operably linked” means that the DNA sequences being linked are contiguous, and, in the case of a secretory leader, contiguous and in reading phase. However, enhancers do not have to be contiguous. Linking is typically accomplished by ligation at convenient restriction sites. If such sites do not exist, synthetic oligonucleotide adaptors or linkers are used in accordance with conventional practice. Transcriptional and translational regulatory nucleic acid will generally be appropriate to the host cell used to express the Hepatitis C infection protein. Numerous types of appropriate expression vectors, and suitable regulatory sequences are known in the art for a variety of host cells.  
       [0162] In general, transcriptional and translational regulatory sequences may include, but are not limited to, promoter sequences, ribosomal binding sites, transcriptional start and stop sequences, translational start and stop sequences, and enhancer or activator sequences. In a preferred embodiment, the regulatory sequences include a promoter and transcriptional start and stop sequences.  
       [0163] Promoter sequences encode either constitutive or inducible promoters. The promoters may be either naturally occurring promoters or hybrid promoters. Hybrid promoters, which combine elements of more than one promoter, are also known in the art, and are useful in the present invention.  
       [0164] In addition, an expression vector may comprise additional elements. For example, the expression vector may have two replication systems, thus allowing it to be maintained in two organisms, e.g., in mammalian or insect cells for expression and in a prokaryotic host for cloning and amplification. Furthermore, for integrating expression vectors, the expression vector contains at least one sequence homologous to the host cell genome, and preferably two homologous sequences which flank the expression construct. The integrating vector may be directed to a specific locus in the host cell by selecting the appropriate homologous sequence for inclusion in the vector. Constructs for integrating vectors are available. See, e.g., Fernandez and Hoeffler, supra; and Kitamura, et al. (1995)  Proc. Nat&#39;l Acad. Sci. USA  92:9146-9150.  
       [0165] In addition, in a preferred embodiment, the expression vector contains a selectable marker gene to allow the selection of transformed host cells. Selection genes are well known in the art and will vary with the host cell used.  
       [0166] The Hepatitis C infection proteins of the present invention may be produced by culturing a host cell transformed with an expression vector containing nucleic acid encoding a Hepatitis C infection protein, under the appropriate conditions to induce or cause expression of the Hepatitis C infection protein. Conditions appropriate for Hepatitis C infection protein expression will vary with the choice of the expression vector and the host cell, and will be easily ascertained by one skilled in the art through routine experimentation or optimization. For example, the use of constitutive promoters in the expression vector will require optimizing the growth and proliferation of the host cell, while the use of an inducible promoter requires the appropriate growth conditions for induction. In addition, in some embodiments, the timing of the harvest is important. For example, the baculoviral systems used in insect cell expression are lytic viruses, and thus harvest time selection can be crucial for product yield. Alternatively, cells may be identified which naturally express relevant genes at high levels.  
       [0167] Appropriate host cells include yeast, bacteria, archaebacteria, fungi, and insect and animal cells, including mammalian cells. Of particular interest are  Saccharomyces cerevisiae  and other yeasts,  E. coli, Bacillus subtilis , Sf9 cells, C 129 cells, 293 cells, Neurospora, BHK, CHO, COS, HeLa cells, HUVEC (human umbilical vein endothelial cells), THP1 cells (a macrophage cell line), and various other human cells and cell lines.  
       [0168] In a preferred embodiment, the Hepatitis C infection proteins are expressed in mammalian cells. Mammalian expression systems are also known in the art, and include retroviral and adenoviral systems. One expression vector system is a retroviral vector system such as is generally described in PCT/US97/01019 and PCT/US97/01048, both of which are hereby expressly incorporated by reference. Of particular use as mammalian promoters are the promoters from mammalian viral genes, since the viral genes are often highly expressed and have a broad host range. Examples include the SV40 early promoter, mouse mammary tumor virus LTR promoter, adenovirus major late promoter, herpes simplex virus promoter, and the CMV promoter (see, e.g., Fernandez and Hoeffler, supra). Typically, transcription termination and polyadenylation sequences recognized by mammalian cells are regulatory regions located 3′ to the translation stop codon and thus, together with the promoter elements, flank the coding sequence. Examples of transcription terminator and polyadenylation signals include those derived form SV40.  
       [0169] Methods of introducing exogenous nucleic acid into mammalian hosts, as well as other hosts, is well known in the art, and will vary with the host cell used. Techniques include dextran-mediated transfection, calcium phosphate precipitation, polybrene mediated transfection, protoplast fusion, electroporation, viral infection, encapsulation of the polynucleotide(s) in liposomes, and direct microinjection of the DNA into nuclei.  
       [0170] In a preferred embodiment, Hepatitis C infection proteins are expressed in bacterial systems. Promoters from bacteriophage may also be used. In addition, synthetic promoters and hybrid promoters are also useful; e.g., the tac promoter is a hybrid of the trp and lac promoter sequences. Furthermore, a bacterial promoter can include naturally occurring promoters of non-bacterial origin that have the ability to bind bacterial RNA polymerase and initiate transcription. In addition to a functioning promoter sequence, an efficient ribosome binding site is desirable. The expression vector may also include a signal peptide sequence that provides for secretion of the Hepatitis C infection protein in bacteria. The protein is either secreted into the growth media (gram-positive bacteria) or into the periplasmic space, located between the inner and outer membrane of the cell (gram-negative bacteria). The bacterial expression vector may also include a selectable marker gene to allow for the selection of bacterial strains that have been transformed. Suitable selection genes include genes which render the bacteria resistant to drugs, e.g., ampicillin, chloramphenicol, erythromycin, kanamycin, neomycin, and tetracycline. Selectable markers also include biosynthetic genes, such as those in the histidine, tryptophan, and leucine biosynthetic pathways. These components are assembled into expression vectors. Expression vectors for bacteria are well known in the art, and include vectors for  Bacillus subtilis, E. coli, Streptococcus cremoris,  and  Streptococcus lividans,  among others (e.g., Fernandez and Hoeffler, supra). The bacterial expression vectors are transformed into bacterial host cells using techniques such as calcium chloride treatment, electroporation, and others.  
       [0171] In one embodiment, Hepatitis C infection proteins are produced in insect cells, e.g., expression vectors for the transformation of insect cells, and, in particular, baculovirus-based expression vectors.  
       [0172] In a preferred embodiment, Hepatitis C infection protein is produced in yeast cells. Yeast expression systems include expression vectors for  Saccharomyces cerevisiae, Candida albicans  and  C. maltosa, Hansenula polymorpha, Kluyveromyces fragilis  and  K. lactis, Pichia guillerimondii  and  P. pastoris, Schizosaccharomyces pombe , and  Yarrowia lipolytica.    
       [0173] The Hepatitis C infection protein may also be made as a fusion protein, e.g., for the creation of monoclonal antibodies, if the desired epitope is small, the Hepatitis C infection protein may be fused to a carrier protein to form an immunogen. Alternatively, the Hepatitis C infection protein may be made as a fusion protein to increase expression, or for other reasons. For example, when the Hepatitis C infection protein is a Hepatitis C infection peptide, the nucleic acid encoding the peptide may be linked to other nucleic acid for expression purposes. Fusion with detection epitope tags can be made, e.g., with FLAG, His6, myc, HA, etc.  
       [0174] In a preferred embodiment, the Hepatitis C infection protein is purified or isolated after expression. Hepatitis C infection proteins may be isolated or purified in a variety of ways depending on what other components are present in the sample. Standard purification methods include electrophoretic, molecular, immunological, and chromatographic techniques, including ion exchange, hydrophobic, affinity, reverse-phase HPLC chromatography, affinity label, and chromatofocusing. For example, the Hepatitis C infection protein may be purified using a standard anti-Hepatitis C infection protein antibody column. Ultrafiltration and diafiltration techniques, in conjunction with protein concentration, are also useful. For general guidance in suitable purification techniques, see, e.g., Scopes (1993)  Protein Purification  Springer-Verlag, NY. The degree of purification necessary will vary depending on the use of the Hepatitis C infection protein. In some instances no purification will be necessary.  
       [0175] Once expressed and purified if necessary, the Hepatitis C infection proteins and nucleic acids are useful in a number of applications. They may be used as immunoselection reagents, as vaccine reagents, as screening agents, etc.  
       Variants of Hepatitis C Infection Proteins  
       [0176] In one embodiment, the proteins expressed as a result of Hepatitis C infection are derivative or variant proteins as compared to the wild-type sequence. That is, as outlined more fully below, the derivative Hepatitis C infection peptide will often contain at least one amino acid substitution, deletion or insertion, with amino acid substitutions being particularly preferred. The amino acid substitution, insertion or deletion may occur at virtually any residue within the Hepatitis C infection peptide.  
       [0177] Also included within one embodiment of Hepatitis C infection proteins of the present invention are amino acid sequence variants. These variants typically fall into one or more of three classes: substitutional, insertional or deletional variants. These variants ordinarily are prepared by site specific mutagenesis of nucleotides in the DNA encoding the Hepatitis C infection protein, using cassette or PCR mutagenesis or other techniques well known in the art, to produce DNA encoding the variant, and thereafter expressing the DNA in recombinant cell culture as outlined above. However, variant Hepatitis C infection protein fragments having up to about 100-150 residues may be prepared by in vitro synthesis using established techniques. Amino acid sequence variants are characterized by the predetermined nature of the variation, a feature that sets them apart from naturally occurring allelic or interspecies variation of the Hepatitis C infection protein amino acid sequence. The variants typically exhibit the same qualitative biological activity as the naturally occurring analogue, although variants can also be selected which have modified characteristics as will be more fully outlined below.  
       [0178] While the site or region for introducing an amino acid sequence variation is generally predetermined, the mutation per se need not be predetermined. For example, in order to optimize the performance of a mutation at a given site, random mutagenesis may be conducted at the target codon or region and the expressed Hepatitis C infection variants screened for the optimal combination of desired activity. Techniques for making substitution mutations at predetermined sites in DNA having a known sequence are well known, e.g., M13 primer mutagenesis and PCR mutagenesis. Screening of the mutants is done using assays of Hepatitis C infection protein activities.  
       [0179] Amino acid substitutions are typically of single residues; insertions usually will be on the order of from about 1-20 amino acids, although considerably larger insertions may be tolerated. Deletions range from about 1-20 residues, although in some cases deletions may be much larger.  
       [0180] Substitutions, deletions, insertions or combinations thereof may be used to arrive at a final derivative. Generally these changes are done on a few amino acids to minimize the alteration of the molecule. However, larger changes may be tolerated in certain circumstances. When small alterations in the characteristics of the Hepatitis C infection protein are desired, substitutions are generally made in accordance with the amino acid substitution relationships provided in the definition section.  
       [0181] The variants typically exhibit the same qualitative biological activity and will elicit the same immune response as the naturally-occurring analog, although variants also are selected to modify the characteristics of the Hepatitis C infection proteins as needed. Alternatively, the variant may be designed such that the biological activity of the Hepatitis C infection protein is altered. For example, glycosylation sites may be altered or removed.  
       [0182] Substantial changes in function or immunological identity are made by selecting substitutions that are less conservative than those described above. For example, substitutions may be made which more significantly affect: the structure of the polypeptide backbone in the area of the alteration, e.g., the alpha-helical or beta-sheet structure; the charge or hydrophobicity of the molecule at the target site; or the bulk of the side chain. The substitutions which in general are expected to produce the greatest changes in the polypeptide&#39;s properties are those in which (a) a hydrophilic sidechain, e.g., serine or threonine, is substituted for (or by) a hydrophobic sidechain, e.g., leucine, isoleucine, phenylalanine, valine, or alanine; (b) a cysteine or proline is substituted for (or by) another residue; (c) a residue having an electropositive side chain, e.g., lysine, arginine, or histidine, is substituted for (or by) an electronegative side chain, e.g., glutamic or aspartic acid; (d) a residue having a bulky side chain, e.g., phenylalanine, is substituted for (or by) one not having a side chain, e.g., glycine; or (e) a proline residue is incorporated or substituted, which changes the degree of rotational freedom of the peptidyl bond.  
       [0183] Covalent modifications of Hepatitis C infection polypeptides are included within the scope of this invention. One type of covalent modification includes reacting targeted amino acid residues of a Hepatitis C infection polypeptide with an organic derivatizing agent that is capable of reacting with selected side chains or the N-or C-terminal residues of a Hepatitis C infection polypeptide. Derivatization with bifunctional agents is useful, e.g., for crosslinking Hepatitis C infection polypeptides to a water-insoluble support matrix or surface for use in the method for purifying anti-Hepatitis C infection polypeptide antibodies or screening assays, as is more fully described below. Commonly used crosslinking agents include, e.g., 1,1-bis(diazoacetyl)-2-phenylethane, glutaraldehyde, N-hydroxysuccinimide esters, e.g., esters with 4-azidosalicylic acid, homobifunctional imidoesters, including disuccinimidyl esters such as 3,3′-dithiobis(succinimidylpropionate), bifunctional maleimides such as bis-N-maleimido-1,8-octane and agents such as methyl-3-((p-azidophenyl)dithio)propioimidate.  
       [0184] Other modifications include deamidation of glutaminyl and asparaginyl residues to the corresponding glutamyl and aspartyl residues, respectively, hydroxylation of proline and lysine, phosphorylation of hydroxyl groups of serinyl, threonyl or tyrosyl residues, methylation of the amino groups of the lysine, arginine, and histidine side chains (e.g., pp. 79-86, Creighton (1992)  Proteins: Structure and Molecular Properties  Freeman), acetylation of the N-terminal amine, and amidation of a C-terminal carboxyl group.  
       [0185] Another type of covalent modification of the Hepatitis C infection polypeptide included within the scope of this invention comprises altering the native glycosylation pattern of the polypeptide. “Altering the native glycosylation pattern” is intended for purposes herein to mean deleting one or more carbohydrate moieties found in native sequence Hepatitis C infection polypeptide, and/or adding one or more glycosylation sites that are not present in the native sequence Hepatitis C infection polypeptide. Glycosylation patterns can be altered in many ways. Different cell types may be used to express Hepatitis C infection-associated sequences to exhibit different glycosylation patterns.  
       [0186] Addition of glycosylation sites to Hepatitis C infection polypeptides may also be accomplished by altering the amino acid sequence thereof. The alteration may be made, e.g., by the addition of, or substitution by, one or more serine or threonine residues to the native sequence Hepatitis C infection polypeptide (for O-linked glycosylation sites). The Hepatitis C infection amino acid sequence may optionally be altered through changes at the DNA level, particularly by mutating the DNA encoding the Hepatitis C infection polypeptide at preselected bases such that codons are generated that will translate into the desired amino acids.  
       [0187] Another means of increasing the number of carbohydrate moieties on the Hepatitis C infection polypeptide is by chemical or enzymatic coupling of glycosides to the polypeptide. See, e.g., WO 87/05330; and pp. 259-306 in Aplin and Wriston (1981)  CRC Crit. Rev.    
       [0188] Biochem.  
       [0189] Removal of carbohydrate moieties present on the Hepatitis C infection polypeptide may be accomplished chemically or enzymatically or by mutational substitution of codons encoding for amino acid residues that serve as targets for glycosylation. Chemical deglycosylation techniques are applicable. See, e.g., Sojar and Bahl (1987)  Arch. Biochem. Biophys.  259:52-57; and Edge, et al. (1981)  Anal. Biochem.  118:131-137. Enzymatic cleavage of carbohydrate moieties on polypeptides can be achieved by the use of a variety of endo- and exo-glycosidases. See, e.g., Thotakura, et al. (1987)  Meth. Enzymol.  138:350-359.  
       [0190] Another type of covalent modification of Hepatitis C infection comprises linking the Hepatitis C infection polypeptide to one of a variety of nonproteinaceous polymers, e.g., polyethylene glycol, polypropylene glycol, or polyoxyalkylenes, in the manner set forth in U.S. Pat. Nos. 4,640,835; 4,496,689; 4,301,144; 4,670,417; 4,791,192; or 4,179,337.  
       [0191] Hepatitis C infection polypeptides of the present invention may also be modified in a way to form chimeric molecules comprising a Hepatitis C infection polypeptide fused to another heterologous polypeptide or amino acid sequence. In one embodiment, such a chimeric molecule comprises a fusion of a Hepatitis C infection polypeptide with a tag polypeptide which provides an epitope to which an anti-tag antibody can selectively bind. The epitope tag is generally placed at the amino-or carboxyl-terminus of the Hepatitis C infection polypeptide. The presence of such epitope-tagged forms of a Hepatitis C infection polypeptide can be detected using an antibody against the tag polypeptide. Also, provision of the epitope tag enables the Hepatitis C infection polypeptide to be readily purified by affinity purification using an anti-tag antibody or another type of affinity matrix that binds to the epitope tag. In an alternative embodiment, the chimeric molecule may comprise a fusion of a Hepatitis C infection polypeptide with an immunoglobulin or a particular region of an immunoglobulin. For a bivalent form of the chimeric molecule, such a fusion could be to the Fe region of an IgG molecule.  
       [0192] Various tag polypeptides and their respective antibodies are available. Examples include poly-histidine (poly-his) or poly-histidine-glycine (poly-his-gly) tags; HIS6, and metal chelation tags, the flu HA tag polypeptide and its antibody 12CA5 (Field, et al. (1988)  Mol. Cell. Biol.  8:2159-2165); the c-myc tag and the 8F9, 3C7, 6E10, G4, B7, and 9E10 antibodies thereto (Evan, et al. (1985)  Mol. Cell. Biol.  5:3610-3616); and the Herpes Simplex virus glycoprotein D (gD) tag and its antibody (Paborsky, et al. (1990)  Protein Engineering  3:547-553). Other tag polypeptides include the Flag-peptide (Hopp, et al. (1988)  BioTechnology  6:1204-1210); the KT3 epitope peptide (Martin, et al. (1992) Science 255:192-194); tubulin epitope peptide (Skinner, et al. (1991)  J. Biol. Chem.  266:15163-15166); and the T7 gene 10 protein peptide tag (Lutz-Freyermuth, et al. (1990)  Proc. Nat&#39;l Acad. Sci. USA  87:6393-6397).  
       [0193] Also included are other Hepatitis C infection proteins of the family, and Hepatitis C infection proteins from other organisms, which are cloned and expressed as outlined below. Thus, probe or degenerate polymerase chain reaction (PCR) primer sequences may be used to find other related Hepatitis C infection proteins from humans or other organisms. As will be appreciated by those in the art, particularly useful probe and/or PCR primer sequences include the unique areas of the Hepatitis C infection nucleic acid sequence. As is generally known in the art, preferred PCR primers are from about 15-35 nucleotides in length, with from about 20-30 being preferred, and may contain inosine as needed. The conditions for the PCR reaction are well known. See, e.g., Innis, PCR Protocols, supra.  
       [0194] In addition, as is outlined herein, Hepatitis C proteins can be made that are longer than those encoded by the nucleic acids of the Tables, e.g., by the elucidation of extended sequences, the addition of epitope or purification tags, the addition of other fusion sequences, etc.  
       [0195] Hepatitis C proteins may also be identified as being encoded by Hepatitis C nucleic acids. Thus, Heptatitis C proteins are encoded by nucleic acids that will hybridize to the sequences of the sequence listings, or their complements, as outlined herein.  
       [0196] Antibodies to Hepatitis C Infection Proteins  
       [0197] In a preferred embodiment, when the Hepatitis C infection protein is to be used to generate antibodies, e.g., for immunotherapy or immunodiagnosis, the Hepatitis C infection protein should share at least one epitope or determinant with the full length protein. By “epitope” or “determinant” herein is typically meant a portion of a protein which will generate and/or bind an antibody or T-cell receptor in the context of MHC. Thus, in most instances, antibodies made to a smaller Hepatitis C infection protein will be able to bind to the full-length protein, particularly linear epitopes. In a preferred embodiment, the epitope is unique; that is, antibodies generated to a unique epitope show little or no cross-reactivity.  
       [0198] Methods of preparing polyclonal antibodies are known to the skilled artisan (e.g., Coligan, supra; and Harlow and Lane, supra). Polyclonal antibodies can be raised in a mammal, e.g., by one or more injections of an immunizing agent and, if desired, an adjuvant. Typically, the immunizing agent and/or adjuvant will be injected in the mammal by multiple subcutaneous or intraperitoneal injections. The immunizing agent may include a protein encoded by a nucleic acid of the figures or fragment thereof or a fusion protein thereof. It may be useful to conjugate the immunizing agent to a protein known to be immunogenic in the mammal being immunized. Examples of such immunogenic proteins include but are not limited to keyhole limpet hemocyanin, serum albumin, bovine thyroglobulin, and soybean trypsin inhibitor. Examples of adjuvants which may be employed include Freund&#39;s complete adjuvant and MPL-TDM adjuvant (monophosphoryl Lipid A, synthetic trehalose dicorynomycolate). The immunization protocol may be selected by one skilled in the art without undue experimentation.  
       [0199] The antibodies may, alternatively, be monoclonal antibodies. Monoclonal antibodies may be prepared using hybridoma methods, such as those described by Kohler and Milstein (1975)  Nature  256:495-497. In a hybridoma method, a mouse, hamster, or other appropriate host animal, is typically immunized with an immunizing agent to elicit lymphocytes that produce or are capable of producing antibodies that will specifically bind to the immunizing agent. Alternatively, the lymphocytes may be immunized in vitro. The immunizing agent will typically include a polypeptide encoded by a nucleic acid of Tables 1A-15 or fragment thereof, or a fusion protein thereof. Generally, either peripheral blood lymphocytes (“PBLs”) are used if cells of human origin are desired, or spleen cells or lymph node cells are used if non-human mammalian sources are desired. The lymphocytes are then fused with an immortalized cell line using a suitable fusing agent, such as polyethylene glycol, to form a hybridoma cell (e.g., pp. 59-103 in Goding (1986)  Monoclonal Antibodies: Principles and Practice  Academic Press). Immortalized cell lines are usually transformed mammalian cells, particularly myeloma cells of rodent, bovine, primate, and human origin. Usually, rat or mouse myeloma cell lines are employed. The hybridoma cells may be cultured in a suitable culture medium that preferably contains one or more substances that inhibit the growth or survival of the unfused, immortalized cells. For example, if the parental cells lack the enzyme hypoxanthine guanine phosphoribosyl transferase (HGPRT or HPRT), the culture medium for the hybridomas typically will include hypoxanthine, aminopterin, and thymidine (“HAT medium”), which substances prevent the growth of HGPRT-deficient cells.  
       [0200] In one embodiment, the antibodies are bispecific antibodies. Bispecific antibodies are monoclonal, preferably human or humanized, antibodies that have binding specificities for at least two different antigens or that have binding specificities for two epitopes on the same antigen. In one embodiment, one of the binding specificities is for a protein encoded by a nucleic acid Tables 1A-15 or a fragment thereof, the other one is for another antigen, and preferably for a cell-surface protein or receptor or receptor subunit, preferably one that is tumor specific. Alternatively, tetramer-type technology may create multivalent reagents.  
       [0201] In a preferred embodiment, the antibodies to Hepatitis C infection protein are capable of reducing or eliminating a biological function of a Hepatitis C infection protein, as is described below. That is, the addition of anti-Hepatitis C infection protein antibodies (either polyclonal or preferably monoclonal or oligoclonal) to Hepatitis C infected cells or tissues or cells and tissues secondarily affected by Hepatitis C infection, may reduce or eliminate the Hepatitis C infection and/or its secondary consequences. Generally, at least about 25% decrease in activity, growth, size, or the like is preferred, with at least about 50% being particularly preferred and about 95-100% decrease being especially preferred.  
       [0202] In a preferred embodiment the antibodies to the Hepatitis C infection proteins are humanized antibodies (e.g., Xenerex Biosciences, Medarex, Inc., Abgenix, Inc., Protein Design Labs, Inc.). Humanized forms of non-human (e.g., murine) antibodies are chimeric molecules of immunoglobulins, immunoglobulin chains, or fragments thereof (such as Fv, Fab, Fab′, F(ab′) 2  or other antigen-binding subsequences of antibodies) which contain minimal sequence derived from non-human immunoglobulin. Humanized antibodies include human immunoglobulins (recipient antibody) in which residues from a complementary determining region (CDR) of the recipient are replaced by residues from a CDR of a non-human species (donor antibody) such as mouse, rat or rabbit having the desired specificity, affinity and capacity. In some instances, Fv framework residues of the human immunoglobulin are replaced by corresponding non-human residues. Humanized antibodies may also comprise residues which are found neither in the recipient antibody nor in the imported CDR or framework sequences. In general, a humanized antibody will comprise substantially all of at least one, and typically two, variable domains, in which all or substantially all of the CDR regions correspond to those of a non-human immunoglobulin and all or substantially all of the framework (FR) regions are those of a human immunoglobulin consensus sequence. The humanized antibody optimally also will typically comprise at least a portion of an immunoglobulin constant region (Fc), typically that of a human immunoglobulin (Jones, et al. (1986)  Nature  321:522-525; Riechmann, et al. (1988)  Nature  332:323-329; and Presta (1992)  Curr. Op. Struct. Biol.  2:593-596). Humanization can be essentially performed following the method of Winter and co-workers (Jones, et al. (1986)  Nature  321:522-525; Riechmann, et al. (1988)  Nature  332:323-327; Verhoeyen, et al. (1988)  Science  239:1534-1536), by substituting rodent CDRs or CDR sequences for corresponding sequences of a human antibody. Accordingly, such humanized antibodies are chimeric antibodies (U.S. Pat. No. 4,816,567), wherein substantially less than an intact human variable domain has been substituted by corresponding sequence from a non-human species.  
       [0203] Human-like antibodies can also be produced using phage display libraries (Hoogenboom and Winter (1992)  J. Mol. Biol.  227:381-388; Marks, et al. (1991)  J. Mol. Biol.  222:581-597) or human monoclonal antibodies (e.g., p. 77, Cole, et al. in Reisfeld and Sell (1985)  Monoclonal Antibodies and Cancer Therapy  Liss; and Boemer, et al. (1991)  J. Immunol.  147:86-95). Similarly, human antibodies can be made by introducing human immunoglobulin loci into transgenic animals, e.g., mice in which the endogenous immunoglobulin genes have been partially or completely inactivated. Upon challenge, human antibody production is observed, which closely resembles that seen in humans in nearly all respects, including gene rearrangement, assembly, and antibody repertoire. This approach is described, e.g., in U.S. Pat. Nos. 5,545,807; 5,545,806; 5,569,825; 5,625,126; 5,633,425; 5,661,016, and in the following scientific publications: Marks, et al. (1992)  Bio/Technology  10:779-783; Lonberg, et al. (1994)  Nature  368:856-859; Morrison (1994)  Nature  368:812-13; Fishwild, et al. (1996)  Nature Biotechnology  14:845-851; Neuberger (1996)  Nature Biotechnology  14:826; and Lonberg and Huszar (1995)  Intern. Rev. Immunol.  13:65-93.  
       [0204] By immunotherapy is meant treatment of Hepatitis C infection and its secondary consequences with an antibody raised against Hepatitis C infection proteins. As used herein, immunotherapy can be passive or active. Passive immunotherapy as defined herein is the passive transfer of antibody to a recipient (patient). Active immunization is the induction of antibody and/or T-cell responses in a recipient (patient). Induction of an immune response is the result of providing the recipient with an antigen to which antibodies are raised. As appreciated by one of ordinary skill in the art, the antigen may be provided by injecting a polypeptide against which antibodies are desired to be raised into a recipient, or contacting the recipient with a nucleic acid capable of expressing the antigen and under conditions for expression of the antigen, leading to an immune response.  
       [0205] In a preferred embodiment the Hepatitis C infection proteins against which antibodies are raised are secreted proteins as described above. Without being bound by theory, antibodies used for treatment will typically bind and prevent the secreted protein from binding to its receptor, thereby inactivating the secreted Hepatitis C infection protein, e.g., in autocrine signaling.  
       [0206] In another preferred embodiment, the Hepatitis C infection protein to which antibodies are raised is a transmembrane protein. Without being bound by theory, antibodies used for treatment may bind the extracellular domain of the Hepatitis C infection protein and prevent it from binding to other proteins, such as circulating ligands or cell-associated molecules. The antibody may cause down-regulation of the transmembrane Hepatitis C infection protein. As will be appreciated by one of ordinary skill in the art, the antibody may be a competitive, non-competitive or uncompetitive inhibitor of protein binding to the extracellular domain of the Hepatitis C infection protein. The antibody is also an antagonist of the Hepatitis C infection protein. Further, the antibody prevents activation of the transmembrane Hepatitis C infection protein. The antibody may also be used to target or sensitize the cell to cytotoxic agents, including, but not limited to TNF-α, TNF-β, IL-1, INF-γ and IL-2, or chemotherapeutic agents including 5FU, vinblastine, actinomycin D, cisplatin, methotrexate, and the like. In some instances the antibody belongs to a sub-type that activates serum complement when complexed with the transmembrane protein thereby mediating cytotoxicity or antigen-dependent cytotoxicity (ADCC). Thus, Hepatitis C infection and its secondary consequences is treated by administering to a patient antibodies directed against the transmembrane Hepatitis C infection protein. Antibody-labeling may activate a co-toxin, localize a toxin payload, or otherwise provide means to locally ablate cells.  
       [0207] In another preferred embodiment, the antibody is conjugated to an effector moiety. The effector moiety can be a labeling moiety, e.g., a radioactive or fluorescent label, or a therapeutic moiety. In one aspect the therapeutic moiety is a small molecule that modulates the activity of the Hepatitis C infection protein. In another aspect the therapeutic moiety modulates the activity of molecules associated with or in close proximity to the Hepatitis C infection protein. The therapeutic moiety may inhibit enzymatic activity such as protease or collagenase or protein kinase activity associated with Hepatitis C infection and its secondary consequences. The effector may activate an endogenous physiological or immunological response.  
       [0208] In a preferred embodiment, the therapeutic moiety can also be a cytotoxic agent. In this method, targeting the cytotoxic agent to tissue or cells that are either directly infected with Hepatitis C or which are affected secondarily by the Hepatitis C infection, results in a reduction in the number of afflicted cells, thereby reducing symptoms associated with Hepatitis C infection and its secondary consequences. Cytotoxic agents are numerous and varied and include, but are not limited to, cytotoxic drugs or toxins or active fragments of such toxins. Suitable toxins and their corresponding fragments include diphtheria A chain, exotoxin A chain, ricin A chain, abrin A chain, curcin, crotin, saporin, maytansins, aurostatin, phenomycin, enomycin, and the like. Cytotoxic agents also include radiochemicals made by conjugating radioisotopes to antibodies raised against Hepatitis C infection proteins, or binding of a radionuclide to a chelating agent that has been covalently attached to the antibody. Targeting the therapeutic moiety to transmembrane Hepatitis C infection proteins not only serves to increase the local concentration of therapeutic moiety in the afflicted area, but also serves to reduce deleterious side effects that may be associated with the therapeutic moiety.  
       [0209] In another preferred embodiment, the Hepatitis C infection protein against which the antibodies are raised is an intracellular protein. In this case, the antibody may be conjugated to a protein which facilitates entry into the cell. In one case, the antibody enters the cell by endocytosis. In another embodiment, a nucleic acid encoding the antibody is administered to the individual or cell. Moreover, wherein the Hepatitis C infection protein can be targeted within a cell, e.g., the nucleus, an antibody thereto contains a signal for that target localization, e.g., a nuclear localization signal.  
       [0210] The antibodies to Hepatitis C afflicted cells and tissues of the invention specifically bind to Hepatitis C infection proteins. By “specifically bind” herein is meant that the antibodies bind to the protein with a K d  of at least about 0.1 mM, more usually at least about 1 μM, preferably at least about 0.1 μM or better, and most preferably, 0.01 μM or better. Selectivity of binding is also important.  
       [0211] Detection of Hepatitis C Infection Sequences for Diagnostic and Therapeutic Applications  
       [0212] In one aspect, the RNA expression levels of genes are determined for different cellular states in the Hepatitis C infection phenotype. Expression levels of genes in tissue from uninfected individuals and in Hepatitis C infected or affected tissue are evaluated to provide expression profiles. An expression profile of a particular cell state or point of development is essentially a “fingerprint” of the state. While two states may have any particular gene similarly expressed, the evaluation of a number of genes simultaneously allows the generation of a gene expression profile that is reflective of the state of the cell. By comparing expression profiles of cells in different states, information regarding which genes are important (including both up- and down-regulation of genes) in each of these states is obtained. Then, diagnosis may be performed or confirmed to determine whether a tissue sample has the gene expression profile of normal or cancerous tissue. This will provide for molecular diagnosis of related conditions.  
       [0213] “Differential expression,” or grammatical equivalents as used herein, refers to qualitative or quantitative differences in the temporal and/or cellular gene expression patterns within and among cells and tissue. Thus, a differentially expressed gene can qualitatively have its expression altered, including an activation or inactivation, in, e.g., normal versus Hepatitis C infected tissue. Genes may be turned on or turned off in a particular state, relative to another state thus permitting comparison of two or more states. A qualitatively regulated gene will exhibit an expression pattern within a state or cell type which is detectable by standard techniques. Some genes will be expressed in one state or cell type, but not in both. Alternatively, the difference in expression may be quantitative, e.g., in that expression is increased or decreased; e.g., gene expression is either upregulated, resulting in an increased amount of transcript, or downregulated, resulting in a decreased amount of transcript. The degree to which expression differs need only be large enough to quantify via standard characterization techniques as outlined below, such as by use of Affymetrix GeneChip™ expression arrays. See, Lockhart (1996)  Nature Biotechnology  14:1675-1680. Other techniques include, but are not limited to, quantitative reverse transcriptase PCR, northern analysis, and RNase protection. As outlined above, preferably the change in expression (e.g., upregulation or downregulation) is at least about 50%, more preferably at least about 100%, more preferably at least about 150%, more preferably at least about 200%, with from 300 to at least 1000% being especially preferred.  
       [0214] Evaluation may be at the gene transcript, or the protein level. The amount of gene expression may be monitored using nucleic acid probes to the DNA or RNA equivalent of the gene transcript, and the quantification of gene expression levels, or, alternatively, the final gene product itself (protein) can be monitored, e.g., with antibodies to the Hepatitis C infection protein and standard immunoassays (ELISAs, etc.) or other techniques, including mass spectroscopy assays, 2D gel electrophoresis assays, etc. Proteins corresponding to Hepatitis C infection genes, e.g., those identified as being important in a Hepatitis C infection phenotype, can be evaluated in a diagnostic test for Hepatitis C infection and/or its secondary consequences, and certainly subsetting into responsive or non-responsive to specific treatment. In a preferred embodiment, gene expression monitoring is performed simultaneously on a number of genes. Multiple protein expression monitoring can be performed as well. Similarly, these assays may be performed on an individual basis as well.  
       [0215] In this embodiment, the Hepatitis C infection nucleic acid probes are attached to biochips as outlined herein for the detection and quantification of Hepatitis C infection sequences in a particular cell. The assays are further described below in the example. PCR techniques can be used to provide greater sensitivity.  
       [0216] In a preferred embodiment nucleic acids encoding the Hepatitis C infection protein are detected. Although DNA or RNA encoding the Hepatitis C infection protein may be detected, of particular interest are methods wherein an mRNA encoding a Hepatitis C infection protein is detected. Probes to detect mRNA can be a nucleotide/deoxynucleotide probe that is complementary to and hybridizes with the mRNA and includes, but is not limited to, oligonucleotides, cDNA or RNA. Probes also should contain a detectable label, as defined herein. In one method the mRNA is detected after immobilizing the nucleic acid to be examined on a solid support such as nylon membranes and hybridizing the probe with the sample. Following washing to remove non-specifically bound probe, the label is detected. In another method detection of the mRNA is performed in situ. In this method permeabilized cells or tissue samples are contacted with a detectably labeled nucleic acid probe for sufficient time to allow the probe to hybridize with target mRNA. Following washing to remove the non-specifically bound probe, the label is detected. For example a digoxygenin labeled riboprobe (RNA probe) that is complementary to the mRNA encoding a Hepatitis C infection protein is detected by binding the digoxygenin with an anti-digoxygenin secondary antibody and developed with nitro blue tetrazolium and 5-bromo-4-chloro-3-indoyl phosphate.  
       [0217] In a preferred embodiment, various proteins from the three classes of proteins as described herein (secreted, transmembrane or intracellular proteins) are used in diagnostic assays. The Hepatitis C infection proteins, antibodies, nucleic acids, modified proteins, and cells containing Hepatitis C infection sequences are used in diagnostic assays. This can be performed on an individual gene or corresponding polypeptide level. In a preferred embodiment, the expression profiles are used, preferably in conjunction with high throughput screening techniques to allow monitoring for expression profile genes and/or corresponding polypeptides.  
       [0218] As described and defined herein, Hepatitis C infection proteins, including intracellular, transmembrane, or secreted proteins, find use as markers of Hepatitis C infection or treatment response. Detection of these proteins in putative Hepatitis C infected tissue as well as in tissues that are affected secondarily by Hepatitis C infection, allows for detection or diagnosis of Hepatitis C infection and/or its secondary consequences. In one embodiment, antibodies are used to detect Hepatitis C infection proteins. A preferred method separates proteins from a sample by electrophoresis on a gel (typically a denaturing and reducing protein gel, but may be another type of gel, including isoelectric focusing gels and the like). Following separation of proteins, the Hepatitis C infection protein is detected, e.g., by immunoblotting with antibodies raised against the Hepatitis C infection protein. Methods of immunoblotting are well known to those of ordinary skill in the art.  
       [0219] In another preferred method, antibodies to the Hepatitis C infection protein find use in in situ imaging techniques, e.g., in histology (e.g., Asai, et al. (eds. 1993)  Methods in Cell Biology: Antibodies in Cell Biology  (vol. 37) Academic Press). In this method cells are contacted with from one to many antibodies to the Hepatitis C infection protein(s). Following washing to remove non-specific antibody binding, the presence of the antibody or antibodies is detected. In one embodiment the antibody is detected by incubating with a secondary antibody that contains a detectable label. In another method the primary antibody to the Hepatitis C infection protein(s) contains a detectable label, e.g., an enzyme marker that can act on a substrate. In another preferred embodiment each of multiple primary antibodies contains a distinct and detectable label. This method finds particular use in simultaneous screening for a plurality of Hepatitis C infection proteins. Many other histological and/or imaging techniques are also provided by the invention.  
       [0220] In a preferred embodiment the label is detected in a fluorometer which has the ability to detect and distinguish emissions of different wavelengths. In addition, a fluorescence activated cell sorter (FACS) can be used in the method.  
       [0221] In another preferred embodiment, antibodies find use in diagnosing Hepatitis C infection from blood, urine, sputum, serum, plasma, stool, and other samples. Such samples, therefore, are useful as samples to be probed or tested for the presence of Hepatitis C infection proteins. Antibodies can be used to detect a Hepatitis C infection protein by previously described immunoassay techniques including ELISA, immunoblotting (western blotting), immunoprecipitation, BIACORE technology and the like. Alternatively, the presence of antibodies may indicate an immune response against an endogenous infection.  
       [0222] In a preferred embodiment, in situ hybridization of labeled Hepatitis C infection nucleic acid probes to tissue arrays is done. For example, arrays of tissue samples, including Hepatitis C infection tissue and/or normal tissue, are made. In situ hybridization (see, e.g., Ausubel, supra) is then performed. When comparing the fingerprints between an individual and a standard, the skilled artisan can make a diagnosis, a prognosis, or a prediction based on the findings. It is further understood that the genes which indicate the diagnosis may differ from those which indicate the prognosis and molecular profiling of the condition of the cells may lead to distinctions between responsive or refractory conditions or may be predictive of outcomes.  
       [0223] In a preferred embodiment, the Hepatitis C infection proteins, antibodies, nucleic acids, modified proteins, and cells containing sequences associated with Hepatitis C infection and/or its secondary consequences are used in prognosis assays. As above, gene expression profiles can be generated that correlate to Hepatitis C infection and/or its secondary consequences, in terms of long term prognosis. Again, this may be done on either a protein or gene level, with the use of genes being preferred. As above, Hepatitis C infection probes may be attached to biochips for the detection and quantification of Hepatitis C infection sequences in a tissue or patient. The assays proceed as outlined above for diagnosis. PCR methods may provide more sensitive and accurate quantification.  
       [0224] Assays for Therapeutic Compounds  
       [0225] In a preferred embodiment members of the proteins, nucleic acids, and antibodies as described herein are used in drug screening assays. The Hepatitis C infection proteins, antibodies, nucleic acids, modified proteins, and cells containing Hepatitis C infection sequences are used in drug screening assays or by evaluating the effect of drug candidates on a “gene expression profile” or expression profile of polypeptides. In a preferred embodiment, the expression profiles are used, preferably in conjunction with high throughput screening techniques to allow monitoring for expression profile genes after treatment with a candidate agent. See, e.g., Zlokarnik, et al. (1998)  Science  279:84-88; and Heid (1996)  Genome Res.  6:986-994.  
       [0226] In a preferred embodiment, the Hepatitis C infection proteins, antibodies, nucleic acids, modified proteins, and cells containing the native or modified Hepatitis C infection proteins are used in screening assays. That is, the present invention provides novel methods for screening for compositions which modulate the Hepatitis C infection phenotype or an identified physiological function of a Hepatitis C infection protein. As above, this can be done on an individual gene level or by evaluating the effect of drug candidates on a “gene expression profile”. In a preferred embodiment, the expression profiles are used, preferably in conjunction with high throughput screening techniques to allow monitoring for expression profile genes after treatment with a candidate agent, see Zlokarnik, supra.  
       [0227] Having identified the differentially expressed genes herein, a variety of assays may be executed. In a preferred embodiment, assays may be run on an individual gene or protein level. That is, having identified a particular gene as up regulated during Hepatitis C infection, test compounds can be screened for the ability to modulate gene expression or for binding to the Hepatitis C infection protein. “Modulation” thus includes both an increase and a decrease in gene expression. The preferred amount of modulation will depend on the original change of the gene expression in normal versus tissue experiencing Hepatitis C infection and its secondary consequences, with changes of at least about 10%, preferably about 50%, more preferably about 100-300%, and in some embodiments about 300-1000% or greater. Thus, if a gene exhibits a 4-fold increase in tissue experiencing hepatitis C infection or its secondary consequences compared to normal tissue, a decrease of about four-fold is often desired; similarly, a 10-fold decrease in tissue experiencing Hepatitis C infection or its secondary consequences compared to normal tissue often provides a target value of a 10-fold increase in expression to be induced by the test compound.  
       [0228] The amount of gene expression may be monitored using nucleic acid probes and the quantification of gene expression levels, or, alternatively, the gene product itself can be monitored, e.g., through the use of antibodies to the Hepatitis C infection protein and standard immunoassays. Proteomics and separation techniques may also allow quantification of expression.  
       [0229] In a preferred embodiment, gene expression or protein monitoring of a number of entities, e.g., an expression profile, is monitored simultaneously. Such profiles will typically involve a plurality of those entities described herein.  
       [0230] In this embodiment, the Hepatitis C infection nucleic acid probes are attached to biochips as outlined herein for the detection and quantification of Hepatitis C infection sequences in a particular cell. Alternatively, PCR may be used. Thus, a series, e.g., of microtiter plate, may be used with dispensed primers in desired wells. A PCR reaction can then be performed and analyzed for each well.  
       [0231] Modulators of Testicular Cancer  
       [0232] Expression monitoring can be performed to identify compounds that modify the expression of one or more Hepatitis C infection-associated sequences, e.g., a polynucleotide sequence set out in Tables 1A-15. Generally, in a preferred embodiment, a test modulator is added to the cells prior to analysis. Moreover, screens are also provided to identify agents that modulate Hepatitis C infection and its secondary consequences, modulate Hepatitis C infection proteins, bind to a Hepatitis C infection protein, or interfere with the binding of a Hepatitis C infection protein and an antibody or other binding partner.  
       [0233] The term “test compound” or “drug candidate” or “modulator” or grammatical equivalents as used herein describes any molecule, e.g., protein, oligopeptide, small organic molecule, polysaccharide, polynucleotide, etc., to be tested for the capacity to directly or indirectly alter the Hepatitis C infection phenotype (direct or indirect) or the expression of a Hepatitis C infection sequence, e.g., a nucleic acid or protein sequence. In preferred embodiments, modulators alter expression profiles, or expression profile nucleic acids or proteins provided herein. In one embodiment, the modulator suppresses a Hepatitis C infection phenotype, e.g., to a normal tissue fingerprint. In another embodiment, a modulator induced a Hepatitis C infection phenotype. Generally, a plurality of assay mixtures are run in parallel with different agent concentrations to obtain a differential response to the various concentrations. Typically, one of these concentrations serves as a negative control, e.g., at zero concentration or below the level of detection.  
       [0234] Drug candidates encompass numerous chemical classes, though typically they are organic molecules, preferably small organic compounds having a molecular weight of more than 100 and less than about 2,500 daltons. Preferred small molecules are less than 2000, or less than 1500 or less than 1000 or less than 500 D. Candidate agents comprise functional groups necessary for structural interaction with proteins, particularly hydrogen bonding, and typically include at least an amine, carbonyl, hydroxyl or carboxyl group, preferably at least two of the functional chemical groups. The candidate agents often comprise cyclical carbon or heterocyclic structures and/or aromatic or polyaromatic structures substituted with one or more of the above functional groups. Candidate agents are also found among biomolecules including peptides, saccharides, fatty acids, steroids, purines, pyrimidines, derivatives, structural analogs, or combinations thereof. Particularly preferred are peptides or orally active compounds.  
       [0235] In one aspect, a modulator will neutralize the effect of a Hepatitis C infection protein. By “neutralize” is meant that activity of a protein is inhibited or blocked with a consequent effect on the cell.  
       [0236] In certain embodiments, combinatorial libraries of potential modulators will be screened for an ability to bind to a Hepatitis C infection polypeptide or to modulate activity. Conventionally, new chemical entities with useful properties are generated by identifying a chemical compound (called a “lead compound”) with some desirable property or activity, e.g., inhibiting activity, creating variants of the lead compound, and evaluating the property and activity of those variant compounds. Often, high throughput screening (HTS) methods are employed for such an analysis.  
       [0237] In one preferred embodiment, high throughput screening methods involve providing a library containing a large number of potential therapeutic compounds (candidate compounds). Such “combinatorial chemical libraries” are then screened in one or more assays to identify those library members (particular chemical species or subclasses) that display a desired characteristic activity. The compounds thus identified can serve as conventional “lead compounds” or can themselves be used as potential or actual therapeutics.  
       [0238] A combinatorial chemical library is a collection of diverse chemical compounds generated by either chemical synthesis or biological synthesis by combining a number of chemical “building blocks” such as reagents. For example, a linear combinatorial chemical library, such as a polypeptide (e.g., mutein) library, is formed by combining a set of chemical building blocks called amino acids in every possible way for a given compound length (e.g., the number of amino acids in a polypeptide compound). Millions of chemical compounds can be synthesized through such combinatorial mixing of chemical building blocks. See Gallop, et al. (1994)  J. Med. Chem.  37:1233-1251.  
       [0239] Preparation and screening of combinatorial chemical libraries is well known. Such combinatorial chemical libraries include, but are not limited to, peptide libraries (see, e.g., U.S. Pat. No. 5,010,175, Furka (1991)  Pept. Prot. Res.  37:487-493, Houghton, et al. (1991)  Nature  354:84-88), peptoids (PCT Publication No WO 91/19735), encoded peptides (PCT Publication WO 93/20242), random bio-oligomers (PCT Publication WO 92/00091), benzodiazepines (U.S. Pat. No. 5,288,514), diversomers such as hydantoins, benzodiazepines and dipeptides (Hobbs, et al. (1993)  Proc. Nat&#39;l Acad. Sci. USA  90:6909-6913, vinylogous polypeptides (Hagihara, et al. (1992)  J. Amer. Chem. Soc.  114:6568-xxx), nonpeptidal peptidomimetics with a Beta-D-Glucose scaffolding (Hirschmann, et al. (1992)  J. Amer. Chem. Soc.  114:9217-9218), analogous organic syntheses of small compound libraries (Chen, et al. (1994)  J. Amer. Chem. Soc.  116:2661-xxx), oligocarbamates (Cho, et al. (1993)  Science  261:1303-1305), and/or peptidyl phosphonates (Campbell, et al. (1994)  J. Org. Chem.  59:658-xxx). See, generally, Gordon, et al. (1994)  J. Med. Chem.  37:1385-1401, nucleic acid libraries (see, e.g., Stratagene, Corp.), peptide nucleic acid libraries (see, e.g., U.S. Pat. No. 5,539,083), antibody libraries (see, e.g., Vaughn, et al. (1996)  Nature Biotechnology  14(3):309-314, and PCT/US96/10287), carbohydrate libraries (see, e.g., Liang, et al. (1996)  Science  274:1520-1522, and U.S. Pat. No. 5,593,853), and small organic molecule libraries (see, e.g., benzodiazepines, page 33 Baum (Jan. 18, 1993)  C &amp; ENews;  isoprenoids, U.S. Pat. No. 5,569,588; thiazolidinones and metathiazanones, U.S. Pat. No. 5,549,974; pyrrolidines, U.S. Pat. Nos. 5,525,735 and 5,519,134; morpholino compounds, U.S. Pat. No. 5,506,337; benzodiazepines, U.S. Pat. No. 5,288,514; and the like).  
       [0240] Devices for the preparation of combinatorial libraries are commercially available (see, e.g., 357 MPS, 390 MPS, Advanced Chem Tech, Louisville Ky., Symphony, Rainin, Woburn, Mass., 433A Applied Biosystems, Foster City, Calif., 9050 Plus, Millipore, Bedford, Mass.).  
       [0241] A number of well known robotic systems have also been developed for solution phase chemistries. These systems include automated workstations like the automated synthesis apparatus developed by Takeda Chemical Industries, LTD. (Osaka, Japan) and many robotic systems utilizing robotic arms (Zymate II, Zymark Corporation, Hopkinton, Mass.; Orca, Hewlett-Packard, Palo Alto, Calif.), which mimic the manual synthetic operations performed by a chemist. The above devices are suitable for use with the present invention. The nature and implementation of modifications to these devices (if any) so that they can operate as discussed herein will be apparent to persons skilled in the relevant art. In addition, numerous combinatorial libraries are themselves commercially available. See, e.g., ComGenex, Princeton, N.J.; Asinex, Moscow, Ru; Tripos, Inc., St. Louis, Mo.; ChemStar, Ltd, Moscow, RU; 3D Pharmaceuticals, Exton, Pa.; Martek Biosciences, Columbia, Md.; etc.  
       [0242] Assays to identify modulators are amenable to high throughput screening. Preferred assays thus detect enhancement or inhibition of Hepatitis C infection gene transcription, inhibition or enhancement of polypeptide expression, and inhibition or enhancement of polypeptide activity.  
       [0243] High throughput assays for the presence, absence, quantification, or other properties of particular nucleic acids or protein products are well known to those of skill in the art. Similarly, binding assays and reporter gene assays are similarly well known. Thus, e.g., U.S. Pat. No. 5,559,410 discloses high throughput screening methods for proteins, U.S. Pat. No. 5,585,639 discloses high throughput screening methods for nucleic acid binding (e.g., in arrays), while U.S. Pat. Nos. 5,576,220 and 5,541,061 disclose high throughput methods of screening for ligand/antibody binding.  
       [0244] In addition, high throughput screening systems are commercially available (see, e.g., Zymark Corp., Hopkinton, Mass.; Air Technical Industries, Mentor, Ohio; Beckman Instruments, Inc., Fullerton, Calif.; Precision Systems, Inc., Natick, Mass., etc.). These systems typically automate entire procedures, including sample and reagent pipetting, liquid dispensing, timed incubations, and final readings of the microplate in detector(s) appropriate for the assay. These configurable systems provide high throughput and rapid start up as well as a high degree of flexibility and customization. The manufacturers of such systems provide detailed protocols for various high throughput systems. Thus, e.g., Zymark Corp. provides technical bulletins describing screening systems for detecting the modulation of gene transcription, ligand binding, and the like.  
       [0245] In one embodiment, modulators are proteins, often naturally occurring proteins or fragments of naturally occurring proteins. Thus, e.g., cellular extracts containing proteins, or random or directed digests of proteinaceous cellular extracts, may be used. In this way libraries of proteins may be made for screening in the methods of the invention. Particularly preferred in this embodiment are libraries of bacterial, fungal, viral, and mammalian proteins, with the latter being preferred, and human proteins being especially preferred. Particularly useful test compound will be directed to the class of proteins to which the target belongs, e.g., substrates for enzymes or ligands and receptors.  
       [0246] In a preferred embodiment, modulators are peptides of from about 5-30 amino acids, with from about 5-20 amino acids being preferred, and from about 7-15 being particularly preferred. The peptides may be digests of naturally occurring proteins as is outlined above, random peptides, or “biased” random peptides. By “randomized” or grammatical equivalents herein is meant that each nucleic acid and peptide consists of essentially random nucleotides and amino acids, respectively. Since generally these random peptides (or nucleic acids, discussed below) are chemically synthesized, they may incorporate nucleotide or amino acid variations. The synthetic process can be designed to generate randomized proteins or nucleic acids, to allow the formation of the possible combinations over the length of the sequence, thus forming a library of randomized candidate bioactive proteinaceous agents.  
       [0247] In one embodiment, the library is randomized, with few or no sequence preferences or constants at any position. In a preferred embodiment, the library is biased. That is, some positions within the sequence are either held constant, or are selected from a limited number of possibilities. For example, in a preferred embodiment, the nucleotides or amino acid residues are randomized within a defined class, e.g., of hydrophobic amino acids, hydrophilic residues, sterically biased (either small or large) residues, towards the creation of nucleic acid binding domains, the creation of cysteines, for cross-linking, prolines for SH-3 domains, serines, threonines, tyrosines, or histidines for phosphorylation sites, etc., or to purines, etc.  
       [0248] Modulators of Hepatitis C infection and its secondary consequences can also be nucleic acids, as defined above.  
       [0249] As described above generally for proteins, nucleic acid modulating agents may be naturally occurring nucleic acids, random nucleic acids, or “biased” random nucleic acids. For example, digests of prokaryotic or eukaryotic genomes may be used as is outlined above for proteins.  
       [0250] In a preferred embodiment, the candidate compounds are organic chemical moieties, a wide variety of which are available in the literature.  
       [0251] After a candidate agent has been added and the cells allowed to incubate for some period of time, the sample containing a target sequence to be analyzed is added to the biochip. If required, the target sequence is prepared using known techniques. For example, the sample may be treated to lyse the cells, using known lysis buffers, electroporation, etc., with purification and/or amplification such as PCR performed as appropriate. For example, an in vitro transcription with labels covalently attached to the nucleotides is performed. Generally, the nucleic acids are labeled with biotin-FITC or PE, or with cy3 or cy5.  
       [0252] In a preferred embodiment, the target sequence is labeled with, e.g., a fluorescent, a chemiluminescent, a chemical, or a radioactive signal, to provide a means of detecting the target sequence&#39;s specific binding to a probe. The label also can be an enzyme, such as, alkaline phosphatase or horseradish peroxidase, which when provided with an appropriate substrate produces a product that can be detected. Alternatively, the label can be a labeled compound or small molecule, such as an enzyme inhibitor, that binds but is not catalyzed or altered by the enzyme. The label also can be a moiety or compound, such as, an epitope tag or biotin which specifically binds to streptavidin. For the example of biotin, the streptavidin is labeled as described above, thereby, providing a detectable signal for the bound target sequence. Unbound labeled streptavidin is typically removed prior to analysis.  
       [0253] These assays can be direct hybridization assays or can comprise “sandwich assays”, which include the use of multiple probes, as is generally outlined in U.S. Pat. Nos. 5,681,702, 5,597,909, 5,545,730, 5,594,117, 5,591,584, 5,571,670, 5,580,731, 5,571,670, 5,591,584, 5,624,802, 5,635,352, 5,594,118, 5,359,100, 5,124,246 and 5,681,697, all of which are hereby incorporated by reference. In this embodiment, in general, the target nucleic acid is prepared as outlined above, and then added to the biochip comprising a plurality of nucleic acid probes, under conditions that allow the formation of a hybridization complex.  
       [0254] A variety of hybridization conditions may be used in the present invention, including high, moderate, and low stringency conditions as outlined above. The assays are generally run under stringency conditions which allows formation of the label probe hybridization complex only in the presence of target. Stringency can be controlled by altering a step parameter that is a thermodynamic variable, including, but not limited to, temperature, formamide concentration, salt concentration, chaotropic salt concentration pH, organic solvent concentration, etc.  
       [0255] These parameters may also be used to control non-specific binding, as is generally outlined in U.S. Pat. No. 5,681,697. Thus it may be desirable to perform certain steps at higher stringency conditions to reduce non-specific binding.  
       [0256] The reactions outlined herein may be accomplished in many ways. Components of the reaction may be added simultaneously, or sequentially, in different orders, with preferred embodiments outlined below. In addition, the reaction may include a variety of other reagents. These include salts, buffers, neutral proteins, e.g., albumin, detergents, etc., which may be used to facilitate optimal hybridization and detection, and/or reduce non-specific or background interactions. Reagents that otherwise improve the efficiency of the assay, such as protease inhibitors, nuclease inhibitors, anti-microbial agents, etc., may also be used as appropriate, depending on the sample preparation methods and purity of the target.  
       [0257] The assay data are analyzed to determine the expression levels, and changes in expression levels as between states, of individual genes, forming a gene expression profile.  
       [0258] Screens are performed to identify modulators of the Hepatitis C infection phenotype. In one embodiment, screening is performed to identify modulators that can induce or suppress a particular expression profile, thus preferably generating the associated phenotype. In another embodiment, e.g., for diagnostic applications, having identified differentially expressed genes important in a particular state, screens can be performed to identify modulators that alter expression of individual genes. In an another embodiment, screening is performed to identify modulators that alter a biological function of the expression product of a differentially expressed gene. Again, having identified the importance of a gene in a particular state, screens are performed to identify agents that bind and/or modulate the biological activity of the gene product.  
       [0259] In addition screens can be done for genes that are induced in response to a candidate agent. After identifying a modulator based upon its ability to suppress an expression pattern associated with Hepatitis C infection, leading to a normal expression pattern, or to modulate a single Hepatitis C infection gene expression profile so as to mimic the expression of the gene from normal tissue, a screen as described above can be performed to identify genes that are specifically modulated in response to the agent. Comparing expression profiles between normal tissue and agent treated tissue experiencing Hepatitis C infection or its secondary consequences reveals genes that are not expressed in normal tissue or in tissue experiencing Hepatitis C infection or its secondary consequences, but are expressed in agent treated tissue. These agent-specific sequences can be identified and used by methods described herein for Hepatitis C infection genes or proteins. In particular these sequences and the proteins they encode find use in marking or identifying agent treated cells. In addition, antibodies can be raised against the agent induced proteins and used to target novel therapeutics to the treated sample of tissue experiencing Hepatitis C infection or its secondary consequences.  
       [0260] Thus, in one embodiment, a test compound is administered to a population of cells, that have an associated Hepatitis C infection expression profile. By “administration” or “contacting” herein is meant that the candidate agent is added to the cells in such a manner as to allow the agent to act upon the cell, whether by uptake and intracellular action, or by action at the cell surface. In some embodiments, nucleic acid encoding a proteinaceous candidate agent (e.g., a peptide) may be put into a viral construct such as an adenoviral or retroviral construct, and added to the cell, such that expression of the peptide agent is accomplished, e.g., PCT US97/01019. Regulatable gene therapy systems can also be used.  
       [0261] Once the test compound has been administered to the cells, the cells can be washed if desired and are allowed to incubate under preferably physiological conditions for some period of time. The cells are then harvested and a new gene expression profile is generated, as outlined herein.  
       [0262] Thus, e.g., the tissue experiencing Hepatitis C infection or it secondary consequences may be screened for agents that modulate, e.g., induce or suppress the Hepatitis C infection phenotype. A change in at least one gene, preferably many, of the expression profile indicates that the agent has an effect on Hepatitis C infection. By defining such a signature for the Hepatitis C infection phenotype, screens for new drugs that alter the phenotype can be devised. With this approach, the drug target need not be known and need not be represented in the original expression screening platform, nor does the level of transcript for the target protein need to change.  
       [0263] In a preferred embodiment, as outlined above, screens may be done on individual genes and gene products (proteins). That is, having identified a particular differentially expressed gene as important in a particular state, screening of modulators of either the expression of the gene or the gene product itself can be done. The gene products of differentially expressed genes are sometimes referred to herein as “Hepatitis C infection proteins” or a “Hepatitis C infection modulatory protein”. The Hepatitis C infection modulatory protein may be a fragment, or alternatively, be the full length protein to the fragment encoded by the nucleic acids of the Tables. Preferably, the Hepatitis C infection modulatory protein is a fragment. In a preferred embodiment, the Hepatitis C infection amino acid sequence which is used to determine sequence identity or similarity is encoded by a nucleic acid of Tables 1A-15. In another embodiment, the sequences are naturally occurring allelic variants of a protein encoded by a nucleic acid of Tables 1A-15. In another embodiment, the sequences are sequence variants as further described herein.  
       [0264] Preferably, the Hepatitis C infection modulatory protein is a fragment of about 14-24 amino acids long. More preferably the fragment is a soluble fragment. Preferably, the fragment includes a non-transmembrane region. In a preferred embodiment, the fragment has an N-terminal Cys to aid in solubility. In one embodiment, the C-terminus of the fragment is kept as a free acid and the N-terminus is a free amine to aid in coupling, e.g., to cysteine.  
       [0265] In one embodiment the Hepatitis C infection proteins are conjugated to an immunogenic agent as discussed herein. In one embodiment the Hepatitis C infection protein is conjugated to BSA.  
       [0266] Measurements of Hepatitis C infection polypeptide activity, or the Hepatitis C infection phenotype can be performed using a variety of assays. For example, the effects of the test compounds upon the function of the Hepatitis C infection polypeptides can be measured by examining parameters described above. A suitable physiological change that affects activity can be used to assess the influence of a test compound on the polypeptides of this invention. When the functional consequences are determined using intact cells or animals, one can also measure a variety of effects such as, changes in intracellular second messengers such as cGMP. In the assays of the invention, mammalian Hepatitis C infection polypeptide is typically used, e.g., mouse, preferably human.  
       [0267] Assays to identify compounds with modulating activity can be performed in vitro. For example, a Hepatitis C infection polypeptide is first contacted with a potential modulator and incubated for a suitable amount of time, e.g., from 0.5 to 48 hours. In one embodiment, the Hepatitis C infection polypeptide levels are determined in vitro by measuring the level of protein or mRNA. The level of protein is measured, e.g., using immunoassays such as western blotting, ELISA, and the like with an antibody that selectively binds to the Hepatitis C infection polypeptide or a fragment thereof. For measurement of mRNA, amplification, e.g., using PCR, LCR, or hybridization assays, e.g., northern hybridization, RNAse protection, or dot blotting, are preferred. The level of protein or mRNA is detected using directly or indirectly labeled detection agents, e.g., fluorescently or radioactively labeled nucleic acids, radioactively or enzymatically labeled antibodies, and the like, as described herein.  
       [0268] Alternatively, a reporter gene system can be devised using the Hepatitis C infection protein promoter operably linked to a reporter gene such as luciferase, green fluorescent protein, CAT, or β-gal. The reporter construct is typically transfected into a cell. After treatment with a potential modulator, the amount of reporter gene transcription, translation, or activity is measured according to standard techniques.  
       [0269] In a preferred embodiment, as outlined above, screens may be done on individual genes and gene products (proteins). That is, having identified a particular differentially expressed gene as important in a particular state, screening of modulators of the expression of the gene or the gene product itself can be done. The gene products of differentially expressed genes are sometimes referred to herein as “Hepatitis C infection proteins.” The Hepatitis C infection protein may be a fragment, or alternatively, be the full length protein to a fragment shown herein.  
       [0270] In one embodiment, screening for modulators of expression of specific genes is performed. Typically, the expression of only one or a few genes are evaluated. In another embodiment, screens are designed to first find compounds that bind to differentially expressed proteins. These compounds are then evaluated for the ability to modulate differentially expressed activity. Moreover, once initial candidate compounds are identified, variants can be further screened to better evaluate structure activity relationships.  
       [0271] In a preferred embodiment, binding assays are done. In general, purified or isolated gene product is used; that is, the gene products of one or more differentially expressed nucleic acids are made. For example, antibodies are generated to the protein gene products, and standard immunoassays are run to determine the amount of protein present. Alternatively, cells comprising the Hepatitis C infection proteins can be used in the assays.  
       [0272] Thus, in a preferred embodiment, the methods comprise combining a Hepatitis C infection protein and a candidate compound, and determining the binding of the compound to the Hepatitis C infection protein. Preferred embodiments utilize the human Hepatitis C infection protein, although other mammalian proteins may also be used, e.g., for the development of animal models of human disease. In some embodiments, as outlined herein, variant or derivative Hepatitis C infection proteins may be used.  
       [0273] Generally, in a preferred embodiment of the methods herein, the Hepatitis C infection protein or the candidate agent is non-diffusably bound to an insoluble support having isolated sample receiving areas (e.g., a microtiter plate, an array, etc.). The insoluble supports may be made of any composition to which the compositions can be bound, is readily separated from soluble material, and is otherwise compatible with the overall method of screening. The surface of such supports may be solid or porous and of any convenient shape. Examples of suitable insoluble supports include microtiter plates, arrays, membranes, and beads. These are typically made of glass, plastic (e.g., polystyrene), polysaccharides, nylon, or nitrocellulose, teflon™, etc. Microtiter plates and arrays are especially convenient because a large number of assays can be carried out simultaneously, using small amounts of reagents and samples. The particular manner of binding of the composition is not crucial so long as it is compatible with the reagents and overall methods of the invention, maintains the activity of the composition and is nondiffusable. Preferred methods of binding include the use of antibodies (which do not sterically block either the ligand binding site or activation sequence when the protein is bound to the support), direct binding to “sticky” or ionic supports, chemical crosslinking, the synthesis of the protein or agent on the surface, etc. Following binding of the protein or agent, excess unbound material is removed by washing. The sample receiving areas may then be blocked through incubation with bovine serum albumin (BSA), casein, or other innocuous protein or other moiety.  
       [0274] In a preferred embodiment, the Hepatitis C infection protein is bound to the support, and a test compound is added to the assay. Alternatively, the candidate agent is bound to the support and the Hepatitis C infection protein is added. Novel binding agents include specific antibodies, non-natural binding agents identified in screens of chemical libraries, peptide analogs, etc. Of particular interest are screening assays for agents that have a low toxicity for human cells. A wide variety of assays may be used for this purpose, including labeled in vitro protein-protein binding assays, electrophoretic mobility shift assays, immunoassays for protein binding, functional assays (phosphorylation assays, etc.), and the like.  
       [0275] The determination of the binding of the test modulating compound to the Hepatitis C infection protein may be done in a number of ways. In a preferred embodiment, the compound is labeled, and binding determined directly, e.g., by attaching all or a portion of the Hepatitis C infection protein to a solid support, adding a labeled candidate agent (e.g., a fluorescent label), washing off excess reagent, and determining whether the label is present on the solid support. Various blocking and washing steps may be utilized as appropriate.  
       [0276] In some embodiments, just one of the components is labeled, e.g., the proteins (or proteinaceous candidate compounds) can be labeled. Alternatively, more than one component can be labeled with different labels, e.g.,  125 I for the proteins and a fluorophor for the compound. Proximity reagents, e.g., quenching or energy transfer reagents are also useful.  
       [0277] In one embodiment, the binding of the test compound is determined by competitive binding assay. The competitor is a binding moiety known to bind to the target molecule (e.g., a Hepatitis C infection protein), such as an antibody, peptide, binding partner, ligand, etc. Under certain circumstances, there may be competitive binding between the compound and the binding moiety, with the binding moiety displacing the compound. In one embodiment, the test compound is labeled. Either the compound, or the competitor, or both, is added first to the protein for a time sufficient to allow binding, if present. Incubations may be performed at a temperature which facilitates optimal activity, typically between 4-40° C. Incubation periods are typically optimized, e.g., to facilitate rapid high throughput screening. Typically between 0.1 and 1 hour will be sufficient. Excess reagent is generally removed or washed away. The second component is then added, and the presence or absence of the labeled component is followed, to indicate binding.  
       [0278] In a preferred embodiment, the competitor is added first, followed by the test compound. Displacement of the competitor is an indication that the test compound is binding to the Hepatitis C infection protein and thus is capable of binding to, and potentially modulating, the activity of the Hepatitis C infection protein. In this embodiment, either component can be labeled. Thus, e.g., if the competitor is labeled, the presence of label in the wash solution indicates displacement by the agent. Alternatively, if the test compound is labeled, the presence of the label on the support indicates displacement.  
       [0279] In an alternative embodiment, the test compound is added first, with incubation and washing, followed by the competitor. The absence of binding by the competitor may indicate that the test compound is bound to the Hepatitis C infection protein with a higher affinity. Thus, if the test compound is labeled, the presence of the label on the support, coupled with a lack of competitor binding, may indicate that the test compound is capable of binding to the Hepatitis C infection protein.  
       [0280] In a preferred embodiment, the methods comprise differential screening to identify agents that are capable of modulating the activity of the Hepatitis C infection proteins. In this embodiment, the methods comprise combining a Hepatitis C infection protein and a competitor in a first sample. A second sample comprises a test compound, a Hepatitis C infection protein, and a competitor. The binding of the competitor is determined for both samples, and a change, or difference in binding between the two samples indicates the presence of an agent capable of binding to the Hepatitis C infection protein and potentially modulating its activity. That is, if the binding of the competitor is different in the second sample relative to the first sample, the agent is capable of binding to the Hepatitis C infection protein.  
       [0281] Alternatively, differential screening is used to identify drug candidates that bind to the native Hepatitis C infection protein, but cannot bind to modified Hepatitis C infection proteins. The structure of the Hepatitis C infection protein may be modeled, and used in rational drug design to synthesize agents that interact with that site. Drug candidates that affect the activity of a Hepatitis C infection protein are also identified by screening drugs for the ability to either enhance or reduce the activity of the protein.  
       [0282] Positive controls and negative controls may be used in the assays. Preferably control and test samples are performed in at least triplicate to obtain statistically significant results. Incubation of all samples is for a time sufficient for the binding of the agent to the protein. Following incubation, samples are washed free of non-specifically bound material and the amount of bound, generally labeled agent determined. For example, where a radiolabel is employed, the samples may be counted in a scintillation counter to determine the amount of bound compound.  
       [0283] A variety of other reagents may be included in the screening assays. These include reagents like salts, neutral proteins, e.g., albumin, detergents, etc., which may be used to facilitate optimal protein-protein binding and/or reduce non-specific or background interactions. Also reagents that otherwise improve the efficiency of the assay, such as protease inhibitors, nuclease inhibitors, anti-microbial agents, etc., may be used. The mixture of components may be added in an order that provides for the requisite binding.  
       [0284] In a preferred embodiment, the invention provides methods for screening for a compound capable of modulating the activity of a Hepatitis C infection protein. The methods comprise adding a test compound, as defined above, to a cell comprising Hepatitis C infection proteins. Many cell types may be used. The cells may contain a recombinant nucleic acid that encodes a Hepatitis C infection protein. In a preferred embodiment, a library of candidate agents are tested on a plurality of cells. In one aspect, the assays are evaluated in the presence or absence or previous or subsequent exposure of physiological signals, e.g., hormones, antibodies, peptides, antigens, cytokines, growth factors, action potentials, pharmacological agents including chemotherapeutics, radiation, carcinogenics, or other cells (e.g., cell-cell contacts). In another example, the determinations are determined at different stages of the cell cycle process.  
       [0285] In this way, compounds that modulate Hepatitis C infection agents are identified.  
       [0286] Compounds with pharmacological activity are able to enhance or interfere with the activity of the Hepatitis C infection protein. Once identified, similar structures are evaluated to identify critical structural feature of the compound.  
       [0287] In one embodiment, a method of inhibiting the consequences of Hepatitis C infection is provided. The method comprises administration of an inhibitor of processes that occur as a secondary consequence of Hepatitis C infection. In a further embodiment, methods of treating cells or tissues infected with Hepatitis C are provided. The method comprises administration of a inhibitor of Hepatitis C infection.  
       [0288] In one embodiment, a Hepatitis C infection inhibitor is an antibody as discussed above. In another embodiment, the Hepatitis C infection inhibitor is an antisense molecule.  
       [0289] Polynucleotide Modulators of Hepatitis C Infection and/or its Secondary Consequences Antisense Polynucleotides  
       [0290] In certain embodiments, the activity of a Hepatitis C infection-associated protein is down-regulated, or entirely inhibited, by the use of antisense polynucleotide, e.g., a nucleic acid complementary to, and which can preferably hybridize specifically to, a coding mRNA nucleic acid sequence, e.g., a Hepatitis C infection protein mRNA, or a subsequence thereof. Binding of the antisense polynucleotide to the mRNA reduces the translation and/or stability of the mRNA.  
       [0291] In the context of this invention, antisense polynucleotides can comprise naturally-occurring nucleotides, or synthetic species formed from naturally-occurring subunits or their close homologs. Antisense polynucleotides may also have altered sugar moieties or inter-sugar linkages. Exemplary among these are the phosphorothioate and other sulfur containing species which are known for use in the art. Analogs are comprehended by this invention so long as they function effectively to hybridize with the Hepatitis C infection protein mRNA. See, e.g., Isis Pharmaceuticals, Carlsbad, Calif.; Sequitor, Inc., Natick, Mass.  
       [0292] Such antisense polynucleotides can readily be synthesized using recombinant means, or can be synthesized in vitro. Equipment for such synthesis is sold by several vendors, including Applied Biosystems. The preparation of other oligonucleotides such as phosphorothioates and alkylated derivatives is also well known.  
       [0293] Antisense molecules as used herein include antisense or sense oligonucleotides. Sense oligonucleotides can, e.g., be employed to block transcription by binding to the anti-sense strand. The antisense and sense oligonucleotide comprise a single-stranded nucleic acid sequence (either RNA or DNA) capable of binding to target mRNA (sense) or DNA (antisense) sequences for Hepatitis C infection molecules. A preferred antisense molecule is for a Hepatitis C infection sequences in Tables 1A-15, or for a ligand or activator thereof. Antisense or sense oligonucleotides, according to the present invention, comprise a fragment generally at least about 14 nucleotides, preferably from about 14 to 30 nucleotides. The ability to derive an antisense or a sense oligonucleotide, based upon a cDNA sequence encoding a given protein is described in, e.g., Stein and Cohen (1988)  Cancer Res.  48:2659—2668; and van der Krol, et al. (1988)  BioTechniques  6:958-976).  
       [0294] RNA interference is a mechanism to suppress gene expression in a sequence specific manner. See, e.g., Brumelkamp, et al. (2002)  Sciencexpress  (Mar. 21, 2002); Sharp (1999)  Genes Dev.  13:139-141; and Cathew (2001)  Curr. Op. Cell Biol.  13:244-248. In mammalian cells, short, e.g., 21 nt, double stranded small interfering RNAs (siRNA) have been shown to be effective at inducing an RNAi response. See, e.g., Elbashir, et al. (2001)  Nature  411:494-498. The mechanism may be used to downregulate expression levels of identified genes, e.g., treatment of or validation of relevance to disease.  
       [0295] Ribozymes  
       [0296] In addition to antisense polynucleotides, ribozymes can be used to target and inhibit transcription of Hepatitis C infection-associated nucleotide sequences. A ribozyme is an RNA molecule that catalytically cleaves other RNA molecules. Different kinds of ribozymes have been described, including group I ribozymes, hammerhead ribozymes, hairpin ribozymes, RNase P, and axhead ribozymes. See, e.g., Castanotto, et al. (1994)  Adv. in Pharmacology  25:289-317.  
       [0297] General features of hairpin ribozymes are described, e.g., in Hampel, et al. (1990)  Nuc. Acids Res.  18:299-304; European Patent Publication No. 0 360 257; U.S. Pat. No. 5,254,678. Methods of preparation are available. See, e.g., WO 94/26877; Yu, et al. (1993)  Proc. Nat&#39;l Acad. Sci. USA  90:6340-6344; Yamada, et al. (1994)  Human Gene Therapy  1:39-45; Leavitt, et al. (1995)  Proc. Nat&#39;l Acad. Sci. USA  92:699-703; Leavitt, et al. (1994)  Human Gene Therapy  5:1151-120; and Yamada, et al. (1994)  Virology  205: 121-126.  
       [0298] Polynucleotide modulators of Hepatitis C infection may be introduced into a cell containing the target nucleotide sequence by formation of a conjugate with a ligand binding molecule, as described in WO 91/04753. Suitable ligand binding molecules include, but are not limited to, cell surface receptors, growth factors, other cytokines, or other ligands that bind to cell surface receptors. Preferably, conjugation of the ligand binding molecule does not substantially interfere with the ability of the ligand binding molecule to bind to its corresponding molecule or receptor, or block entry of the sense or antisense oligonucleotide or its conjugated version into the cell. Alternatively, a polynucleotide modulator of Hepatitis C infection may be introduced into a cell containing the target nucleic acid sequence, e.g., by formation of an polynucleotide-lipid complex, as described in WO 90/10448. It is understood that the use of antisense molecules or knock out and knock in models may also be used in screening assays as discussed above, in addition to methods of treatment.  
       [0299] Thus, in one embodiment, methods of modulating Hepatitis C infection in cells or organisms are provided. In one embodiment, the methods comprise administering to a cell an anti-Hepatitis C infection antibody that reduces or eliminates the biological activity of an endogenous Hepatitis C infection protein. Alternatively, the methods comprise administering to a cell or organism a recombinant nucleic acid encoding a Hepatitis C infection protein. This may be accomplished in any number of ways. In a preferred embodiment, e.g., when the Hepatitis C infection sequence is down-regulated during the course of Hepatitis C infection, such state may be reversed by increasing the amount of Hepatitis C infection associated gene product in the cell. This can be accomplished, e.g., by overexpressing the endogenous Hepatitis C infection gene or administering a gene encoding the Hepatitis C infection sequence, using known gene-therapy techniques. In a preferred embodiment, the gene therapy techniques include the incorporation of the exogenous gene using enhanced homologous recombination (EHR), e.g., as described in PCT/US93/03868, hereby incorporated by reference in its entirety. Alternatively, e.g., when the Hepatitis C infection sequence is up-regulated during Hepatitis C infection, the activity of the endogenous Hepatitis C infection gene is decreased, e.g., by the administration of a Hepatitis C infection antisense nucleic acid.  
       [0300] In one embodiment, the Hepatitis C infection proteins of the present invention may be used to generate polyclonal and monoclonal antibodies to proteins associated with Hepatitis C infection. Similarly, the Hepatitis C infection proteins can be coupled, using standard technology, to affinity chromatography columns. These columns may then be used to purify Hepatitis C infection antibodies useful for production, diagnostic, or therapeutic purposes. In a preferred embodiment, the antibodies are generated to epitopes unique to a Hepatitis C infection protein; that is, the antibodies show little or no cross-reactivity to other proteins, such as related family members. The Hepatitis C infection antibodies may be coupled to standard affinity chromatography columns and used to purify proteins associated with Hepatitis C infection. The antibodies may also be used as blocking polypeptides, as outlined above, since they will specifically bind to the Hepatitis C infection protein.  
       [0301] Methods of Identifying Variant Hepatitis C Infection-Associated Sequences  
       [0302] Without being bound by theory, expression of various Hepatitis C infection sequences is correlated with Hepatitis C infection. Accordingly, disorders based on mutant or variant Hepatitis C infection genes may be determined. In one embodiment, the invention provides methods for identifying cells containing variant Hepatitis C infection genes, e.g., determining all or part of the sequence of at least one endogenous Hepatitis C infection genes in a cell. This may be accomplished using many sequencing techniques. In a preferred embodiment, the invention provides methods of identifying the Hepatitis C infection genotype of an individual, e.g., determining all or part of the sequence of at least one Hepatitis C infection gene of the individual. This is generally done in at least one tissue of the individual, and may include the evaluation of a number of tissues or different samples of the same tissue. The method may include comparing the sequence of the sequenced Hepatitis C infection gene to a known Hepatitis C infection gene, e.g., a wild-type gene.  
       [0303] The sequence of all or part of a Hepatitis C infection gene can then be compared to the sequence of a known Hepatitis C infection gene to determine if any differences exist. This can be done using, e.g., known homology programs, such as Bestfit, etc. In a preferred embodiment, the presence of a difference in the sequence between the Hepatitis C infection gene of the patient and the known Hepatitis C infection gene correlates with a disease state or a propensity for a disease state, or susceptibility to effective treatment, as outlined herein.  
       [0304] In a preferred embodiment, the Hepatitis C infection genes are used as probes to determine the number of copies of the Hepatitis C infection gene in the genome.  
       [0305] In another preferred embodiment, the Hepatitis C infection genes are used as probes to determine the chromosomal localization of the Hepatitis C infection genes. Information such as chromosomal localization finds use in providing a diagnosis or prognosis in particular when chromosomal abnormalities such as translocations, and the like are identified in the Hepatitis C infection gene locus.  
       [0306] Administration of Pharmaceutical and Vaccine Compositions  
       [0307] In one embodiment, a therapeutically effective dose of a Hepatitis C infection protein or modulator thereof, is administered to a patient. By “therapeutically effective dose” herein is meant a dose that produces effects for which it is administered. The exact dose will depend on the purpose of the treatment, and will be ascertainable by one skilled in the art using known techniques. See, e.g., Ansel, et al. (1999)  Pharmaceutical Dosage Forms and Drug Delivery  Lippincott; Lieberman (1992)  Pharmaceutical Dosage Forms  (vols. 1-3) Dekker, ISBN 0824770846, 082476918X, 0824712692, 0824716981; Lloyd (1999)  The Art, Science and Technology of Pharmaceutical Compounding  Amer. Pharmaceut. Assn.; and Pickar (1998)  Dosage Calculations  Thomson. Adjustments for testicular cancer degradation, systemic versus localized delivery, and rate of new protease synthesis, as well as the age, body weight, general health, sex, diet, time of administration, drug interaction, and the severity of the condition may be necessary.  
       [0308] A “patient” for the purposes of the present invention includes both humans and other animals, particularly mammals. Thus the methods are applicable to both human therapy and veterinary applications. In the preferred embodiment the patient is a mammal, preferably a primate, and in the most preferred embodiment the patient is human.  
       [0309] The administration of the Hepatitis C infection proteins and modulators thereof of the present invention can be done in a variety of ways as discussed above, including, but not limited to, orally, subcutaneously, intravenously, intranasally, transdermally, intraperitoneally, intramuscularly, intrapulmonary, vaginally, rectally, or intraocularly. In some instances, e.g., in the treatment of wounds and inflammation, the Hepatitis C infection proteins and modulators may be directly applied as a solution or spray.  
       [0310] The pharmaceutical compositions of the present invention comprise a Hepatitis C infection protein in a form suitable for administration to a patient. In the preferred embodiment, the pharmaceutical compositions are in a water soluble form, such as being present as pharmaceutically acceptable salts, which is meant to include both acid and base addition salts. “Pharmaceutically acceptable acid addition salt” refers to those salts that retain the biological effectiveness of the free bases and that are not biologically or otherwise unuseable, formed with inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, and the like, and organic acids such as acetic acid, propionic acid, glycolic acid, pyruvic acid, oxalic acid, maleic acid, malonic acid, succinic acid, fumaric acid, tartaric acid, citric acid, benzoic acid, cinnamic acid, mandelic acid, methanesulfonic acid, ethanesulfonic acid, p-toluenesulfonic acid, salicylic acid, and the like. “Pharmaceutically acceptable base addition salts” include those derived from inorganic bases such as sodium, potassium, lithium, ammonium, calcium, magnesium, iron, zinc, copper, manganese, aluminum salts, and the like. Particularly preferred are the ammonium, potassium, sodium, calcium, and magnesium salts. Salts derived from pharmaceutically acceptable organic non-toxic bases include salts of primary, secondary, and tertiary amines, substituted amines including naturally occurring substituted amines, cyclic amines and basic ion exchange resins, such as isopropylamine, trimethylamine, diethylamine, triethylamine, tripropylamine, and ethanolamine.  
       [0311] The pharmaceutical compositions may also include one or more of the following: carrier proteins such as serum albumin; buffers; fillers such as microcrystalline cellulose, lactose, corn and other starches; binding agents; sweeteners and other flavoring agents; coloring agents; and polyethylene glycol.  
       [0312] The pharmaceutical compositions can be administered in a variety of unit dosage forms depending upon the method of administration. For example, unit dosage forms suitable for oral administration include, but are not limited to, powder, tablets, pills, capsules and lozenges. It is recognized that Hepatitis C infection protein modulators (e.g., antibodies, antisense constructs, ribozymes, small organic molecules, etc.) when administered orally, should be protected from digestion. This is typically accomplished either by complexing the molecule(s) with a composition to render it resistant to acidic and enzymatic hydrolysis, or by packaging the molecule(s) in an appropriately resistant carrier, such as a liposome or a protection barrier. Means of protecting agents from digestion are available.  
       [0313] The compositions for administration will commonly comprise a Hepatitis C infection protein modulator dissolved in a pharmaceutically acceptable carrier, preferably an aqueous carrier. A variety of aqueous carriers can be used, e.g., buffered saline and the like. These solutions are sterile and generally free of undesirable matter. These compositions may be sterilized by conventional, well known sterilization techniques. The compositions may contain pharmaceutically acceptable auxiliary substances as required to approximate physiological conditions such as pH adjusting and buffering agents, toxicity adjusting agents and the like, e.g., sodium acetate, sodium chloride, potassium chloride, calcium chloride, sodium lactate and the like. The concentration of active agent in these formulations can vary widely, and will be selected primarily based on fluid volumes, viscosities, body weight, and the like in accordance with the particular mode of administration selected and the patient&#39;s needs. See, e.g., (1980)  Remington&#39;s Pharmaceutical Science  (18th ed.) Mack; and Hardman and Limbird (eds. 2001)  Goodman and Gilman: The Pharmacological Basis of Therapeutics  (10th ed.) McGraw-Hill.  
       [0314] Thus, a typical pharmaceutical composition for intravenous administration would be about 0.1 to 10 mg per patient per day. Dosages from 0.1 up to about 100 mg per patient per day may be used, particularly when the drug is administered to a secluded site and not into the blood stream, such as into a body cavity or into a lumen of an organ. Substantially higher dosages are possible in topical administration. Actual methods for preparing parenterally administrable compositions will be known or apparent. See, e.g.,  Remington&#39;s Pharmaceutical Science  and  Goodman and Gilman: The Pharmacological Basis of Therapeutics,  supra.  
       [0315] The compositions containing modulators of Hepatitis C infection proteins can be administered for therapeutic or prophylactic treatments. In therapeutic applications, compositions are administered to a patient suffering from infection in an amount sufficient to cure or at least partially arrest the disease and its complications. An amount adequate to accomplish this is defined as a “therapeutically effective dose.” Amounts effective for this use will depend upon the severity of the disease and the general state of the patient&#39;s health. Single or multiple administrations of the compositions may be administered depending on the dosage and frequency as required and tolerated by the patient. The composition should provide a sufficient quantity of the agents of this invention to effectively treat the patient. An amount of modulator that is capable of preventing or slowing the development of disease progression in a mammal is referred to as a “prophylactically effective dose.” The particular dose required for a prophylactic treatment will depend upon the medical condition and history of the mammal, the particular strains being prevented, as well as other factors such as age, weight, gender, administration route, efficiency, etc. Such prophylactic treatments may be used, e.g., in a mammal who has previously had infection to prevent a recurrence of the infection, or in a mammal who is suspected of having a significant likelihood of developing progression. Vaccine strategies may be used, in either a DNA vaccine form, or protein vaccine.  
       [0316] It will be appreciated that the present Hepatitis C infection protein-modulating compounds can be administered alone or in combination with additional Hepatitis C infection modulating compounds or with other therapeutic agent, e.g., other anti-viral agents or treatments.  
       [0317] In numerous embodiments, one or more nucleic acids, e.g., polynucleotides comprising nucleic acid sequences set forth in Tables 1A-15, such as antisense polynucleotides or ribozymes, will be introduced into cells, in vitro or in vivo. The present invention provides methods, reagents, vectors, and cells useful for expression of Hepatitis C infection-associated polypeptides and nucleic acids using in vitro (cell-free), ex vivo or in vivo (cell or organism-based) recombinant expression systems.  
       [0318] The particular procedure used to introduce the nucleic acids into a host cell for expression of a protein or nucleic acid is application specific. Many procedures for introducing foreign nucleotide sequences into host cells may be used. These include the use of calcium phosphate transfection, spheroplasts, electroporation, liposomes, microinjection, plasma vectors, viral vectors and any of the other well known methods for introducing cloned genomic DNA, cDNA, synthetic DNA or other foreign genetic material into a host cell. See, e.g., Berger and Kimmel (1987)  Guide to Molecular Cloning Techniques  from  Methods in Enzymology  (vol. 152) Academic Press; Ausubel, et al. (eds. 1999 and supplements)  Current Protocols  Lippincott; and Sambrook, et al. (2001)  Molecular Cloning: A Laboratory Manual  (3d ed., Vol. 1-3) CSH Press.  
       [0319] In a preferred embodiment, Hepatitis C infection proteins and modulators are administered as therapeutic agents, and can be formulated as outlined above. Similarly, Hepatitis C infection genes (including both the full-length sequence, partial sequences, or regulatory sequences of the Hepatitis C infection coding regions) can be administered in a gene therapy application. These Hepatitis C infection genes can include inhibitory applications, e.g., inhibitory RNA, gene therapy (e.g., for incorporation into the genome), or antisense compositions.  
       [0320] Hepatitis C infection polypeptides and polynucleotides can also be administered as vaccine compositions to stimulate HTL, CTL, and antibody responses. Such vaccine compositions can include, e.g., lipidated peptides (see, e.g., Vitiello, et al. (1995)  J. Clin. Invest.  95:341-349), peptide compositions encapsulated in poly(DL-lactide-co-glycolide) (“PLG”) microspheres (see, e.g., Eldridge, et al. (1991)  Molec. Immunol.  28:287-294; Alonso, et al. (1994)  Vaccine  12:299-306; Jones, et al. (1995)  Vaccine  13:675-681), peptide compositions contained in immune stimulating complexes (ISCOMS) (see, e.g., Takahashi, et al. (1990)  Nature  344:873-875; Hu, et al. (1998)  Clin. Exp. Immunol.  113:235-243), multiple antigen peptide systems (MAPs) (see, e.g., Tam (1988)  Proc. Nat&#39;l Acad. Sci. USA  85:5409-5413; Tam (1996)  J. Immunol. Meth.  196:17-32), peptides formulated as multivalent peptides; peptides for use in ballistic delivery systems, typically crystallized peptides, viral delivery vectors (Perkus, et al., p. 379, in Kaufmann (ed. 1996)  Concepts in Vaccine Development  de Gruyter; Chakrabarti, et al. (1986)  Nature  320:535-537; Hu, et al. (1986)  Nature  320:537-540; Kieny, et al. (1986)  Bio/Technology  4:790-795; Top, et al. (1971)  J. Infect. Dis.  124:148-154; Chanda, et al. (1990)  Virology  175:535-547), particles of viral or synthetic origin (see, e.g., Kofler, et al. (1996)  J. Immunol. Meth.  192:25-35; Eldridge, et al. (1993)  Sem. Hematol.  30:16-24; Falo, et al. (1995)  Nature Med.  1:649-653), adjuvants (Warren, et al. (1986)  Ann. Rev. Immunol.  4:369-388; Gupta, et al. (1993)  Vaccine  11:293-306), liposomes (Reddy, et al. (1992)  J. Immunol.  148:1585-1589; Rock (1996)  Immunol. Today  17:131-137), or naked or particle absorbed cDNA (Ulmer, et al. (1993)  Science  259:1745-1749; Robinson, et al. (1993)  Vaccine  11:957-960; Shiver, et al., p 423, in Kaufmann (ed. 1996)  Concepts in Vaccine Development  de Gruyter; Cease and Berzofsky (1994)  Ann. Rev. Immunol.  12:923-989; and Eldridge, et al. (1993)  Sem. Hematol.  30:16-24). Toxin-targeted delivery technologies, also known as receptor mediated targeting, such as those of Avant Immunotherapeutics, Inc. (Needham, Mass.) may also be used.  
       [0321] Vaccine compositions often include adjuvants. Many adjuvants contain a substance designed to protect the antigen from rapid catabolism, such as aluminum hydroxide or mineral oil, and a stimulator of immune responses, such as lipid A,  Bortadella pertussis  or  Mycobacterium tuberculosis  derived proteins. Certain adjuvants are commercially available as, e.g., Freund&#39;s Incomplete Adjuvant and Complete Adjuvant (Difco Laboratories, Detroit, Mich.); Merck Adjuvant 65 (Merck and Company, Inc., Rahway, N.J.); AS-2 (SmithKline Beecham, Philadelphia, Pa.); aluminum salts such as aluminum hydroxide gel (alum) or aluminum phosphate; salts of calcium, iron or zinc; an insoluble suspension of acylated tyrosine; acylated sugars; cationically or anionically derivatized polysaccharides; polyphosphazenes; biodegradable microspheres; monophosphoryl lipid A and quil A. Cytokines, such as GM-CSF, interleukin-2, -7, -12, and other like growth factors, may also be used as adjuvants.  
       [0322] Vaccines can be administered as nucleic acid compositions wherein DNA or RNA encoding one or more of the polypeptides, or a fragment thereof, is administered to a patient. This approach is described, for instance, in Wolff, et al.,  Science  247:1465 (1990) as well as U.S. Pat. Nos. 5,580,859; 5,589,466; 5,804,566; 5,739,118; 5,736,524; 5,679,647; WO 98/04720; and in more detail below. Examples of DNA-based delivery technologies include “naked DNA”, facilitated (bupivicaine, polymers, peptide-mediated) delivery, cationic lipid complexes, and particle-mediated (“gene gun”) or pressure-mediated delivery (see, e.g., U.S. Pat. No. 5,922,687).  
       [0323] For therapeutic or prophylactic immunization purposes, the peptides of the invention can be expressed by viral or bacterial vectors. Examples of expression vectors include attenuated viral hosts, such as vaccinia or fowlpox. This approach involves the use of vaccinia virus, e.g., as a vector to express nucleotide sequences that encode Hepatitis C infection polypeptides or polypeptide fragments. Upon introduction into a host, the recombinant vaccinia virus expresses the immunogenic peptide, and thereby elicits an immune response. Vaccinia vectors and methods useful in immunization protocols are described in, e.g., U.S. Pat. No. 4,722,848. Another vector is BCG (Bacille Calmette Guerin). See Stover, et al. (1991)  Nature  351:456-460. A wide variety of other vectors are available for therapeutic administration or immunization, e.g., adeno and adeno-associated virus vectors, retroviral vectors,  Salmonella typhi  vectors, detoxified anthrax toxin vectors, and the like. See, e.g., Shata, et al. (2000)  Mol. Med. Today  6:66-71; Shedlock, et al. (2000)  J. Leukoc. Biol.  68:793-806; and Hipp, et al. (2000)  In Vivo  14:571-85).  
       [0324] Methods for the use of genes as DNA vaccines are well known, and include placing a Hepatitis C infection gene or portion of a Hepatitis C infection gene under the control of a regulatable promoter or a tissue-specific promoter for expression in a Hepatitis C infection patient. The Hepatitis C infection gene used for DNA vaccines can encode full-length Hepatitis C infection proteins, but more preferably encodes portions of the Hepatitis C infection proteins including peptides derived from the Hepatitis C infection protein. In one embodiment, a patient is immunized with a DNA vaccine comprising a plurality of nucleotide sequences derived from a Hepatitis C infection gene. For example, Hepatitis C infection-associated genes or sequence encoding subfragments of a Hepatitis C infection protein are introduced into expression vectors and tested for their immunogenicity in the context of Class I MHC and an ability to generate cytotoxic T cell responses. This procedure provides for production of cytotoxic T cell responses against cells which present antigen, including intracellular epitopes.  
       [0325] In a preferred embodiment, the DNA vaccines include a gene encoding an adjuvant or accessory molecule with the DNA vaccine. Such adjuvant molecules may include cytokines that increase the immunogenic response to the Hepatitis C infection polypeptide encoded by the DNA vaccine. Additional or alternative adjuvants are available.  
       [0326] In another preferred embodiment Hepatitis C infection genes find use in generating animal models of Hepatitis C infection. When the Hepatitis C infection gene identified is repressed or diminished in cancer tissue, gene therapy technology, e.g., wherein antisense RNA directed to the Hepatitis C infection gene will also diminish or repress expression of the gene. Animal models of Hepatitis C infection find use in screening for modulators of a Hepatitis C infection-associated sequence or modulators of Hepatitis C infection. Similarly, transgenic animal technology including gene knockout technology, e.g., as a result of homologous recombination with an appropriate gene targeting vector, will result in the absence or increased expression of the Hepatitis C infection protein. When desired, tissue-specific expression or knockout of the Hepatitis C infection protein may be necessary.  
       [0327] It is also possible that the Hepatitis C infection protein is overexpressed during Hepatitis C infection. As such, transgenic animals can be generated that overexpress the Hepatitis C infection protein. Depending on the desired expression level, promoters of various strengths can be employed to express the transgene. Also, the number of copies of the integrated transgene can be determined and compared for a determination of the expression level of the transgene. Animals generated by such methods find use as animal models of Hepatitis C infection and are additionally useful in screening for modulators to treat Hepatitis C infection and/or its secondary consequences.  
       [0328] Kits for Use in Diagnostic and/or Prognostic Applications  
       [0329] For use in diagnostic, research, and therapeutic applications suggested above, kits are also provided by the invention. In the diagnostic and research applications such kits may include some of the following: assay reagents, buffers, Hepatitis C infection-specific nucleic acids or antibodies, hybridization probes and/or primers, antisense polynucleotides, ribozymes, dominant negative Hepatitis C infection polypeptides or polynucleotides, small molecules inhibitors of Hepatitis C infection-associated sequences etc. A therapeutic product may include sterile saline or another pharmaceutically acceptable emulsion and suspension base.  
       [0330] In addition, the kits may include instructional materials containing directions (e.g., protocols) for the practice of the methods of this invention. While the instructional materials typically comprise written or printed materials they are not limited to such. Any medium capable of storing such instructions and communicating them to an end user is contemplated by this invention. Such media include, but are not limited to electronic storage media (e.g., magnetic discs, tapes, cartridges, chips), optical media (e.g., CD ROM), and the like. Such media may include addresses to internet sites that provide such instructional materials.  
       [0331] The present invention also provides for kits for screening for modulators of Hepatitis C infection-associated sequences. Such kits can be prepared from readily available materials and reagents. For example, such kits can comprise one or more of the following materials: a Hepatitis C infection-associated polypeptide or polynucleotide, reaction tubes, and instructions for testing Hepatitis C infection-associated activity. Optionally, the kit contains biologically active Hepatitis C infection protein. A wide variety of kits and components can be prepared according to the present invention, depending upon the intended user of the kit and the particular needs of the user. Diagnosis would typically involve evaluation of a plurality of genes or products. The genes will be selected based on correlations with important parameters in disease which may be identified in historical or outcome data.  
       [0332] It is understood that the examples described above in no way serve to limit the true scope of this invention, but rather are presented for illustrative purposes. All publications, sequences of accession numbers, and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference.  
     
    
    
     EXAMPLES  
     Example 1  
     Gene Chip Analyses  
     [0333] Molecular profiles of various normal and testicular cancer tissues were determined and analyzed using gene chips. RNA was isolated and gene chip analysis was performed as described (Glynne, et al. (2000)  Nature  403:672-676; Zhao, et al. (2000)  Genes Dev.  14:981-993).  
     [0334] Tables 1B-14B list the accession numbers for those Pkey&#39;s lacking UnigeneID&#39;s for tables 1A-14A. For each probeset is listed the gene cluster number from which nucleotides were designed. Gene clusters were compiled using sequences derived from Genbank ESTs and mRNAs. These sequences were clustered based on sequence similarity using Clustering and Alignment Tools (DoubleTwist, Oakland Calif.). Genbank accession numbers for sequences comprising each cluster are listed in the “Accession” column.  
     [0335] Tables 1C-14C list genomic positioning for Pkeys lacking Unigene ID&#39;s and accession numbers in tables 1A-14A. For each predicted exon is listed genomic sequence source used for prediction. Nucleotide locations of each predicted exon are also listed.  
               TABLE 1A                          589 GENES UPREGULATED IN HEPATITIS C [see 60/308, 188]                                 Pkey   ExAccn   UnigeneID   Title   R1                                         428227   AA321649   Hs. 2248   INTERFERON-GAMMA INDUCED PROTEIN PRECURSOR (G   32       426711   AA383471   Hs. 180669   conserved gene amplified in osteosarcoma   20       408063   BE086548   Hs. 42346   calcineurin-binding protein calsarcin-1   19       422746   NM_004484   Hs. 119651   glypican 3   18       418318   U47732   Hs. 84072   transmembrane 4 superfamily member 3   11       414052   AW578849   Hs. 283552   ESTs, Weakly similar to unnamed protein produ   11       453319   AI985369   Hs. 20117   ESTs   10       424878   H57111   Hs. 221132   ESTs   10       426793   X89887   Hs. 172350   HIR (histone cell cycle regulation defective,   10       434210   AA665612   Hs. 120874   ESTs   9       449613   N63808   Hs. 34299   ESTs   8       421904   BE143533   Hs. 109309   hypothetical protein FLJ20035   8       427283   AL119796   Hs. 174185   ectonucleotide pyrophosphatase/phosphodiester   8       416206   AW206248   Hs. 111092     Homo sapiens  cDNA: FLJ22332 fis, clone HRC057   8       408096   BE250162   Hs. 83765   dihydrofolate reductase   8       447541   AK000288   Hs. 18800   hypothetical protein FLJ20281   8       414812   X72755   Hs. 77367   monokine induced by gamma interferon   8       436169   AA888311   Hs. 17602     Homo sapiens  cDNA FLJ12381 fis, clone MAMMA10   7       409231   AA446644   Hs. 692   GA733-2; epithelial glycoprotein (EGP) (KSA)   7       418216   AA662240   Hs. 283099   AF15q14 protein   7       432094   AI658580   Hs. 61426   ESTs   7       425053   AF046024   Hs. 154320   ubiquitin-activating enzyme E1C (homologous t   7       417621   AV654694   Hs. 82316   interferon-induced, hepatitis C-associated mi   7       414004   AA737033   Hs. 7155   ESTs, Weakly similar to 2115357A TYKi protein   7       426052   N49068   Hs. 93966   ESTs   7       435102   AW899053   Hs. 76917   F-box only protein 8   7       417788   AI436699   Hs. 84928   nuclear transcription factor Y, beta   7       445757   AW449065   Hs. 13264   KIAA0856 protein   7       456619   AV647917   Hs. 107153   inhibitor of growth family, member 1-like   7       419743   AW408762   Hs. 127478   ESTs   7       414737   AI160386   Hs. 125087   ESTs   7       428708   NM_014897   Hs. 190386   KIAA0924 protein   7       449718   AA459480   Hs23956   hypothetical protein FLJ20502   6       448402   BE244226   Hs. 21094   RAB18, member RAS oncogene family   6       434733   AI334367   Hs. 159337   ESTs   6       425266   J00077   Hs. 155421   alpha-fetoprotein   6       432706   NM_013230   Hs. 286124   CD24   6       407204   R41933   Hs. 140237   ESTs, Weakly similar to AF119917 13 PRO1722 [   6       409401   AI201895   Hs. 181309   proteasome (prosome, macropain) subunit, alph   6       424626   AA344308   Hs. 128427   ESTs   6       443547   AW271273   Hs. 23767   ESTs   6       409068   AW236991   Hs. 102495   ESTs   6       422173   BE385828   Hs. 250619   phorbolin-like protein MDS019   6       425815   R94023   Hs. 94560   ESTs   6       448111   AA053486   Hs. 20315   interferon-induced protein with tetratricopep   6       430594   AK000790   Hs. 246885   hypothetical protein FLJ20783   6       432435   BE218886   Hs. 282070   ESTs   6       449245   AI636539   Hs. 224296   ESTs   6       400719   NM_004055   Hs. 6133   calpain 5   6       442961   BE614474   Hs. 289074     Homo sapiens  cDNA FLJ13986 fis, clone Y79AA10   6       409153   W03754   Hs. 50813   hypothetical protein FLJ20022   6       422553   AI697720   Hs. 171455   ESTs   6       442432   BE093589   Hs. 38178     Homo sapiens  cDNA: FLJ23468 fis, clone HSI116   6       437086   AW291411   Hs. 192531   ESTs, Weakly similar to AF244088 1 zinc finge   6       401598   AA172106   Hs. 110950   Rag C protein   6       438523   H66220   Hs. 278177   ESTs   6       437267   AW511443   Hs. 258110   ESTs   6       408035   NM_006242   Hs. 42215   protein phosphatase 1, regulatory subunit 6   5       433401   AF039698   Hs. 284217   serologically defined colon cancer antigen 33   5       410541   AA065003   Hs. 64179   hypothetical protein   5       455743   BE073754       gb: RC0-BT0561-210100-032-d07 BT0561 Homo sapi   5       429167   BE465867   Hs. 197751   KIAA0666 protein   5       429490   AI971131   Hs. 293684   ESTs, Weakly similar to alternatively spliced   5       434263   N34895   Hs. 44648   ESTs   5       441046   W01538   Hs. 126742   ESTs   5       452327   AK000196   Hs. 29052   hypothetical protein FLJ20189   5       416504   T85831   Hs. 16004   ESTs   5       432723   D29677   Hs. 3085   KIAA0054 gene product; Helicase   5       423588   W18186   Hs. 117688   ESTs, Weakly similar to ALU5_HUMAN ALU SUBFAM       432960   AW150945   Hs. 144758   ESTs   5       403041   c21p3_565   predicted exon       433001   AF217513   Hs. 279905   clone HQ0310 PRO0310p1   5       419407   AW410377   Hs. 41502     Homo sapiens  cDNA: FLJ21276 fis, clone COL018   5       411252   AB018549   Hs. 69328   MD-2 protein   5       444670   H58373   Hs. 37494   ESTs   5       445525   BE149866   Hs. 14831   ESTs   5       414646   AA353776   Hs. 901   CD48 antigen (B-cell membrane protein)   5       429747   M87507   Hs. 2490   caspase 1, apoptosis-related cysteine proteus   5       434666   AF151103   Hs. 112259   T cell receptor gamma locus   5       413541   BE147036       gb: QV4-HT0222-091199-024-e10 HT0222 Homo sapi   5       424737   BE301883   Hs. 152707   glioblastoma amplified sequence   5       426780   BE242284   Hs. 172199   adenylate cyclase 7   5       441562   AW578981   Hs. 52184   hypothetical protein FLJ20618   5       446459   AI680731   Hs. 170399   ESTs   5       409342   AU077058   Hs. 54089   BRCA1 associated RING domain 1   5       410577   X91911   Hs. 64639   glioma pathogenesis-related protein   5       428250   AW809208   Hs. 183297   DKFZP566F2124 protein   5       450447   AF212223   Hs. 25010   hypothetical protein P15-2   5       430261   AA305127   Hs. 237225   ribosomal protein S5 pseudogene 1   5       433312   AI241331   Hs. 131765   ESTs   5       442366   AA115629   Hs. 118531   ESTs   5       427846   AW499770   Hs. 180948   KIAA0729 protein   5       454075   R43826   Hs. 16313   ESTs   5       425324   M89470   Hs. 155644   paired box gene 2   5       410527   AW851066       gb: IL3-CT0220-150200-070-B02 CT0220 Homo sapi   5       456439   AA251242   Hs. 103238   ESTs   5       434948   AI498469   Hs. 12622   ESTs, Highly similar to AF161436 1 HSPC318 [H   5       436488   BE620909   Hs. 261023   hypothetical protein FLJ20958   5       411466   AW847669       gb: IL3-CT0213-280100-056-G10 CT0213 Homo sapi   5       432378   AI493046   Hs. 146133   ESTs   5       402526   c1p1_17942   predicted exon       420433   NM_007016   Hs. 97627   protein similar to E.coli yhdg and R. capsula   5       441595   AW206035   Hs. 192123   ESTs   5       430008   AW085625   Hs. 186838   ESTs; Weakly similar to similar to zinc finge   5       434924   AA443164   Hs. 23259   hypothetical protein FLJ13433   5       419003   T78640   Hs. 268595   ESTs   5       435126   AI393666   Hs. 42315     Homo sapiens  cDNA FLJ13036 fis, clone NT2RP30   5       447513   AW955776       gb: EST367846 MAGE resequences, MAGD Homo sapi   5       423258   L13460   Hs. 1644   cytochrome P450, subfamily VIIA (cholesterol   5       417308   H60720   Hs. 81892   KIAA0101 gene product   4       442760   BE075297   Hs. 10067   ESTs, Weakly similar to WASP-family protein   4       444758   AL044878   Hs. 11899   3-hydroxy-3-methylglutaryl-Coenzyme A reducta   4       448752   AA593867   Hs. 170890     Homo sapiens  cDNA: FLJ21129 fis, clone CAS062   4       424623   AW963062   Hs. 165809   ESTs   4       431982   AW419296   Hs. 105754   ESTs   4       441028   AI333660   Hs. 17558   ESTs   4       402811   c1p3_2372       predicted exon   4       416839   H94900   Hs. 17882   ESTs   4       421029   AW057782   Hs. 293053   ESTs   4       417301   AI478158   Hs. 164478   hypothetical protein FLJ21939 similar to 5-az   4       430778   D90337   Hs. 247916   natriuretic peptide precursor C   4       443380   AI792478   Hs. 135377   ESTs   4       447183   AI554733   Hs. 173182   ESTs   4       456383   AI148037       gb: qg61e01.r1 Soares_testis_NHT  Homo sapiens     4       458239   BE439877   Hs. 283389   ESTs   4       407190   AA600135       gb: ae50c06.s1 Stratagene lung carcinoma 93721   4       425583   AF077346   Hs. 158315   interleukin 18 receptor accessory protein   4       439593   BE073597   Hs. 124863   ESTs   4       430200   BE613337   Hs. 234896   geminin   4       456299   R93374   Hs. 14173   ESTs   4       421939   BE169531   Hs. 109727   TAK1-binding protein 2; KIAA0733 protein   4       437282   AI810593   Hs. 16587   ESTs   4       410315   AI638871   Hs. 17625   ESTs   4       408380   AF123050   Hs. 44532   diubiquitin   4       442993   BE018682   Hs. 44343   ESTs   4       450560   BE383204       gb: 601298758F1 NIH_MGC_19  Homo sapiens  cDNA c   4       407444   AF229803       gb:  Homo sapiens  endozepine-like protein type   4       408558   AW015759   Hs. 235709   ESTs   4       431214   AA294921   Hs. 250811   v-ral simian leukemia viral oncogene homolog   4       441887   AW967865   Hs. 92145   ESTs   4       413871   W17187   Hs. 75598   heterogeneous nuclear ribonucleoprotein A2/B1   4       422363   T55979   Hs. 115474   replication factor C (activator 1) 3 (38 kD)   4       439175   AF086021   Hs. 271113   ESTs   4       419375   W27916       gb: 39f6 Humun retina cDNA randomly primed sub   4       424430   AI769467   Hs. 96769   ESTs   4       435571   AF212225   Hs. 283693   BM022 protein   4       425100   AF051850   Hs. 154567   supervillin   4       410430   AW732554       gb: bb08b10.y1 NIH_MGC_14  Homo sapiens  cDNA cl   4       430273   AI311127   Hs. 125522   ESTs   4       449052   AW029507   Hs. 161102   ESTs   4       454750   AW866285       gb: QV4-SN0024-080400-167-a09 SN0024 Homo sapi   4       429732   U20158   Hs. 2488   lymphocyte cytosolic protein 2 (SH2 domain-co   4       403747   c4p1_4301       predicted exon   4       418724   AA460597   Hs. 87784   hypothetical protein dJ102H19.4   4       414899   AW975433   Hs. 36288   ESTs   4       433112   AA973801   Hs. 144553   ESTs, Weakly similar to unnamed protein produ   4       439971   W32474   Hs. 7942   hypothetical protein FLJ20080   4       421170   BE217797   Hs. 126052   ESTs   4       443454   AI057494   Hs. 133421   ESTs   4       443885   H91806   Hs. 15284   ESTs   4       446648   AL137521   Hs. 15797     Homo sapiens  mRNA; cDNA DKFZp434D0218 (from c   4       456182   H85328   Hs. 239045   ESTs   4       431318   AA502700   Hs. 293147   ESTs   4       453950   AA156998   Hs. 211568   eukaryotic translation initiation factor 4 ga   4       411857   AW879403       gb: PM0-OT0019-150300-002-d01 OT0019 Homo sapi   4       409205   AI952884   Hs. 14832   ESTs, Moderately similar to unnamed protein p   4       411083   N41340   Hs. 68318   hypothetical protein FLJ20344   4       428035   AA482027   Hs. 142569   ESTs   4       435703   AW630133   Hs. 83313   GK003 protein   4       413786   AW613780   Hs. 13500   ESTs   4       434375   BE277910   Hs. 3833   3′-phosphoadenosine 5′-phosphosulfate synthas   4       448478   AI523218   Hs. 203456   ESTs   4       451192   AA019551   Hs. 60687   ESTs, Moderately similar to KIAA0544 protein   4       457235   L20433   Hs. 211588   POU domain, class 4, transcription factor 1   4       425491   AA883316   Hs. 255221   ESTs   4       430820   AF194815   Hs. 248012   immunoglobulin lambda variable 4-3   4       432572   AI660840   Hs. 191202   ESTs, Weakly similar to ALUE_HUMAN !!!! ALU C   4       457250   AA811987   Hs. 125779   ESTs   4       406367   ph2_15338       predicted exon   4       455960   BE165256       gb: QV1-HT0473-130300-106-f04 HT0473 Homo sapi   4       429503   AA394183   Hs. 26873   ESTs   4       419286   AA236005   Hs. 221303   ESTs   4       453555   N23574   Hs. 123649   ESTs, Moderately similar to ALU7_HUMAN ALU SU   4       423165   AI937547   Hs. 124915   Human DNA sequence from clone 380A1 on chromo   4       402230   c19p1_5271   predicted exon   DAL8       451356   AA748418   Hs. 164577   ESTs   4       409712   AA167385   Hs. 13583   ESTs   4       442281   N34742   Hs. 170065     Homo sapiens  cDNA FLJ13492 fis, clone PLACE10   4       434941   AW073202   Hs. 18368   DKFZP564B0769 protein   4       424145   AW802763   Hs. 193124   ESTs   4       430665   BE350122   Hs. 157367   ESTs   4       442878   AI868648   Hs. 22315   ESTs   4       457307   AI311127   Hs. 125522   ESTs   4       414522   AW518944   Hs. 76325     Homo sapiens  cDNA: FLJ23125 fis, clone LNG082   4       421650   AA781795   Hs. 122587   ESTs   4       426416   AW612744   Hs. 169824   killer cell lectin-like receptor subfamily B,   4       458836   AI568607   Hs. 182112   ESTs   4       424113   AI743880   Hs. 12876   ESTs   4       418549   AA927177   Hs. 86041   CGG triplet repeat binding protein 1   4       442297   NM_006202   Hs. 89901   phosphodiesterase 4A, cAMP-specific (dunce (D   4       419046   T81816   Hs. 193723   ESTs   4       429025   AI399910   Hs. 4842   ESTs   4       433230   AW136134   Hs. 220277   ESTs   4       452744   AI267652   Hs. 30504     Homo sapiens  mRNA; cDNA DKFZp434E082 (from cl   4       446488   AB037782   Hs. 15119   KIAA1361 protein   4       422052   AA302744   Hs. 104518   ESTs   4       430299   W28673   Hs. 106747   serine carboxypeptidase 1 precursor protein   4       442431   BE349856       gb: ht05a12.x1 NCI_CGAP_Kid13  Homo sapiens  cDN   4       411653   AF070578   Hs. 71168     Homo sapiens  clone 24674 mRNA sequence   4       440384   AA884275   Hs. 137052   ESTs   4       443542   AI927065   Hs. 146040   ESTs   4       443638   AW028696   Hs. 145679   ESTs   4       431910   AK000142   Hs. 272192     Homo sapiens  mRNA tor KIAA1590 protein, parti   4       440381   AA917808   Hs. 190495   ESTs   4       407272   X98958       gb:  H. sapiens  rearranged Ig heavy chain (clone   4       417173   U61397   Hs. 81424   ubiquitin-like 1 (sentrin)   4       417675   AI808607   Hs. 3781   similar to murine leucine-rich repeat protein   4       446552   AW470827   Hs. 156241   ESTs   4       450697   AW152166   Hs. 182113   ESTs   4       411960   R77776   Hs. 18103   ESTs   4       418637   T86737   Hs. 193536   ESTs   4       444065   AW449415   Hs. 10260     Homo sapiens  cDNA FLJ11341 fis, clone PLACE10   4       409038   T97490   Hs. 50002   small inducible cytokine subfamily A (Cys-Cys   3       418205   L21715   Hs. 83760   troponin I, skeletal, fast   3       435177   AI018174   Hs. 42936   ESTs   3       436027   AI864053   Hs. 39972   ESTs, Weakly similar to I38588 reverse transc   3       452420   BE564871   Hs. 29463   centrin, EF-hand protein, 3 (CDC31 yeast homo   3       423839   AA985505   Hs. 127217   ESTs   3       435163   AA668884   Hs. 19155   ESTs   3       449704   AK000733   Hs. 23900   GTPase activating protein   3       433854   AA610649       gb: np95c03.s1 NCI_CGAP_Thy1  Homo sapiens  cDNA   3       414821   M63835   Hs. 77424   Fc fragment of IgG, high affinity Ia, recepto   3       431300   AA502346       gb: ne26b03.s1 NCI_CGAP_Co3  Homo sapiens  cDNA   3       407469   D55640       gb: Human monocyte PABL (pseudoautosomal bound   3       450515   AW304226   Hs. 7298   biphenyl hydrolase-like (serine hydrolase; br   3       430750   AI650360   Hs. 100256   ESTs   3       410833   AW806900       gb: QV4-ST0023-160400-172-d02 ST0023 Homo sapi   3       426062   N57014   Hs. 44013   ESTs   3       432945   AL043683   Hs. 271357   ESTs, Weakly similar to unnamed protein produ   3       455708   BE069326       gb: QV3-BT0381-170100-060-g03 BT0381 Homo sapi   3       443240   R02419   Hs. 15338   ESTs   3       451429   AA525993   Hs. 173699   ESTs, Weakly similar to ALU1_HUMAN ALU SUBFAM   3       435812   AA700439   Hs. 188490   ESTs   3       453799   N32080   Hs. 271700   ESTs   3       406970   M29994       gb: Human alpha-I spectrin gene, exon 12.   3       425195   AA352026       gb: EST59954 Infant brain  Homo sapiens  cDNA 5′   3       428180   AI129767   Hs. 182874     Homo sapiens  cDNA: FLJ21929 fis, clone HEP042   3       430753   AI432401   Hs. 2659   fibrinogen-like 2   3       445800   AA126419   Hs. 301632   ESTs   3       439680   AW245741   Hs. 58461   ESTs, Weakly similar to Unknown gene product   3       444858   AI199738   Hs. 208275   ESTs, Weakly similar to unnamed protein produ   3       422879   AI241409   Hs. 188092   ESTs   3       444888   AI651039   Hs. 148559   ESTs   3       407897   AA812234   Hs. 270134   hypothetical protein FLJ20280   3       409512   AW979187   Hs. 293591   ESTs, Weakly similar to hypothetical protein   3       419843   AA749220   Hs. 177708   ESTs   3       436053   AI057224   Hs. 15443   ESTs   3       420968   AW968775   Hs. 259760   ESTs   3       457707   AW974642       gb: EST386746 MAGE resequences, MAGM Homo sapi   3       442679   R53718   Hs. 107882   hypothetical protein FLJ10659   3       434016   AF113698   Hs. 283774   clone FLB7343   3       450330   AW500775   Hs. 24817   hypothetical protein FLJ20136   3       454271   AW293271   Hs. 255179   ESTs   3       430382   AA477908   Hs. 282267   ESTs   3       458389   H70284   Hs. 160152   ESTs, Weakly similar to FETA_HUMAN ALPHA-FETO   3       413670   AB000115   Hs. 75470   hypothetical protein, expressed in osteoblast   3       451253   H48299   Hs. 26126   claudin 10   3       442805   AI201229   Hs. 131262   ESTs   3       436260   BE172762   Hs. 292710   ESTs, Weakly similar to ALU5_HUMAN ALU SUBFAM   3       410099   AA081630   Hs. 169387   KIAA0036 gene product   3       430552   AA176374   Hs. 243886   nuclear autoantigenic sperm protein (histone-   3       452548   AL050321   Hs. 29846   Human DNA sequence from clone 717M23 on chrom   3       418183   NM_001772   Hs. 83731   CD33 antigen (gp67)   3       457470   AB040973   Hs. 272385   G protein-coupled receptor 72   3       419135   R61448   Hs. 106728   ESTs, Weakly similar to KIAA1353 protein [H.s   3       448219   AA228092   Hs. 119569   ESTs, Weakly similar to growth factor recepto   3       413605   BE152644       gb: CM1-HT0329-250200-128-f09 HT0329 Homo sapi   3       435106   AA100847   Hs. 193380   ESTs, Highly similar to AF174600 1 F-box prot   3       410850   AW362867   Hs. 288699     Homo sapiens  cDNA: FLJ21425 fis, clone COL041   3       444665   BE613126   Hs. 47783   ESTs, Weakly similar to T12540 hypothetical p   3       454000   AA040620   Hs. 109144   ESTs   3       451644   N23235   Hs. 30567   ESTs   3       445594   AW058463   Hs. 12940   zinc-fingers and homeoboxes 1   3       407696   AI697340   Hs. 76549   ATPase, Na+/K+ transporting, alpha 1 polypept   3       432606   NM_002104   Hs. 3066   granzyme K (serine protease, granzyme 3; tryp   3       435511   AA683336   Hs. 189046   ESTs   3       410324   AW292539   Hs. 30177   ESTs   3       429556   AW139399   Hs. 98988   ESTs   3       446751   AA766998   Hs. 85874   ESTs, Weakly similar to predicted using Genef   3       406038   Y14443   Hs. 88219   zinc finger protein 200   3       440621   AW296024   Hs. 150434   ESTs   3       444342   NM_014398   Hs. 10887   similar to lysosome-associated membrane glyco   3       445715   AB012958   Hs. 13137   UV radiation resistance associated gene   3       417933   X02308   Hs. 82962   thymidylate synthetase   3       430929   AA489166   Hs. 156933   ESTs   3       400617   AF151064   Hs. 36069   hypothetical protein   3       402643   c1p1_28109   predicted exon       410173   AA706017   Hs. 119944   ESTs   3       445664   AW968638   Hs. 237691   ESTs   3       437830   AB020658   Hs. 5867   KIAA0851 protein   3       404287   c6p3_5616       predicted exon   3       407366   AF026942       gb:  Homo sapiens  cig33 mRNA, partial sequence.   3       417771   AA804698   Hs. 82547   retinoic acid receptor responder (tazarotene   3       447645   AW897321   Hs. 159699   ESTs   3       454038   X06374   Hs. 37040   platelet-derived growth factor alpha polypept   3       442316   Z75331   Hs. 8217     Homo sapiens  cDNA: FLJ23025 fis, clone LNG017   3       433586   T85301       gb: yd78d06.s1 Soares fetal liver spleen 1NFLS   3       408622   AA056060   Hs. 202577   EST cluster (not in UniGene)   3       428249   AA130914   Hs. 183291   zinc finger protein 268   3       448019   AW947164   Hs. 195641   ESTs   3       417228   AL134324   Hs. 7312   ESTs   3       430219   X99209   Hs. 235887   HMT1 (hnRNP methyltransferase,  S. cerevisiae )   3       411060   NM_006074   Hs. 295978   stimulated trans-acting factor (50 kDa)   3       406805   AI686003   Hs. 296031   ESTs   3       426159   Z44524   Hs. 167456     Homo sapiens  mRNA full length insert cDNA clo   3       432134   AI816782   Hs. 122583     Homo sapiens  cDNA: FLJ21934 fis, clone HEP043   3       454314   AW364844       gb: QV3-DT0044-221299-045-c03 DT0044 Homo sapi   3       441975   AW173248   Hs. 250139   ESTs   3       450937   R49131   Hs. 26267   ATP-dependant interferon response protein 1   3       433529   AA598547   Hs. 222405   ESTs   3       454024   AA993527   Hs. 16281   hypothetical protein FLJ23403   3       459352   AW810383   Hs. 206828   ESTs   3       444454   BE018316   Hs. 11183   sorting nexin 2   3       448760   AA313825   Hs. 21941   ESTs   3       456328   T41368       gb: ph1d1_19/1TV Outward Alu-primed hncDNA lib   3       416803   T79239   Hs. 168541     Homo sapiens  mRNA full length insert cDNA clo   3       418875   W19971   Hs. 233459   ESTs   3       432718   AA563943   Hs. 244371   ESTs   3       456236   AF045229   Hs. 82280   regulator of G-protein signalling 10   3       402725   c1p1_6627       predicted exon   3       408989   AW361666   Hs. 49500   KIAA0746 protein   3       430478   NM_014349   Hs. 241535   TNF-inducible protein CG12-1   3       436424   AA716190   Hs. 39056   ESTs   3       404345   AA730407   Hs. 159156   protocadherin 11   3       442049   AA310393   Hs. 299263   ESTs   3       454119   BE549773   Hs. 40510   uncoupling protein 4   3       417282   AA195203   Hs. 479   RAB5C, member RAS oncogene family   3       452436   BE077546   Hs. 31447   ESTs   3       410706   AI732404   Hs. 68846   ESTs   3       405246   cNp1_8370       predicted exon   3       430857   AW804964   Hs. 248069   Human BAC clone CTB-7J15 from 7q31   3       435403   AA779987   Hs. 269658   ESTs   3       447982   H22953   Hs. 137551   ESTs   3       432680   T47364   Hs. 278613   interferon, alpha-inducible protein 27   3       452774   AA047374   Hs. 103388   ESTs, Weakly similar to I38022 hypothetical p   3       417052   NM_000712   Hs. 81029   biliverdin reductase A   3       448959   AI610343   Hs. 186355   ESTs   3       420299   AI056871   Hs. 15276   ESTs   3       409703   NM_006187   Hs. 56009   2′-5′oligoadenylate synthetase 3   3       454413   AI653672   Hs. 40092   ESTs   3       437175   AW968078   Hs. 87773   protein kinase, cAMP-dependent, catalytic, be   3       437456   AL047045   Hs. 60293     Homo sapiens  clone 122482 unknown mRNA   3       453408   AI804732   Hs. 295963   ESTs   3       436563   AJ239450   Hs. 157874   ESTs   3       448901   AK001021   Hs. 22505   hypothetical protein FLJ10159   3       439649   T64781   Hs. 6618     Homo sapiens  cDNA FLJ20782 fis, clone COL0384   3       453887   BE564037   Hs. 36237   CGI-34 protein   3       407756   AA116021   Hs. 38260   ubiquitin specific protease 18   3       444222   AW580955   Hs. 146236   ESTs   3       416670   N69267   Hs. 26073   ESTs, Moderately similar to HG14_HUMAN NONHIS   3       418230   AI917753   Hs. 126639   ESTs   3       431049   AA846576   Hs. 103267   hypothetical protein FLJ22548 similar to gene   3       417787   R14948   Hs. 23883   ESTs   3       421165   AA284420       gb: zs59c08.r1 NCI_CGAP_GCB1  Homo sapiens  cDNA   3       433297   AV658581   Hs. 282633   ESTs   3       445044   AL137728   Hs. 12258     Homo sapiens  mRNA; cDNA DKFZp434B0920 (from c   3       418945   BE246762   Hs. 89499   arachidonate 5-lipoxygenase   3       423706   U95218   Hs. 131924   G protein-coupled receptor 65   3       422630   AA313606   Hs. 125509   hypothetical protein FLJ10648   3       416389   AA180072   Hs. 149846   integrin, beta 5   3       432954   AI076345   Hs. 214199   ESTs, Weakly similar to ALUB_HUMAN !!!! ALU C   3       435688   H72286   Hs. 128387   ESTs   3       447453   AW608645   Hs. 158946   ESTs   3       454278   AF217525   Hs. 49002   Down syndrome cell adhesion molecule   3       432485   N90866   Hs. 276770   CDW52 antigen (CAMPATH-1 antigen)   3       442584   AW976853   Hs. 172843   ESTs   3       426110   NM_002913   Hs. 166563   replication factor C (activator 1) 1 (145 kD)   3       450433   AW444538   Hs. 231863   ESTs   3       404085   c6p1_11412   predicted exon       444743   AA045648   Hs. 11817   nudix (nucleoside diphosphate linked moiety X   3       416503   H98502   Hs. 269853   ESTs   3       421727   Y13153   Hs. 107318   kynurenine 3-monooxygenase (kynurenine 3-hydr   3       458082   AW978811   Hs. 168213   ESTs, Weakly similar to ALU1_HUMAN ALU SUBFAM   3       437374   AL359571   Hs. 12772   KIAA1565 protein   3       428079   AA421020   Hs. 208919   ESTs   3       451079   AI827988   Hs. 240728   ESTs   3       408212   AA297567   Hs. 43728   hypothetical protein   3       417793   AW405434   Hs. 82575   small nuclear ribonucleoprotein polypeptide B   3       430697   AA484207   Hs. 211867   ESTs   3       453828   AW970960   Hs. 293821   ESTs   3       416784   AA334592   Hs. 79914   lumican   3       445823   AI478563   Hs. 145519   ESTs   3       419586   AI088485   Hs. 144759   ESTs   3       440857   AA907808   Hs. 135556   ESTs   3       455065   AW854352       gb: RC3-CT0255-200100-024-g10 CT0255 Homo sapi   3       450607   AL050373   Hs. 25213   hypothetical protein   3       442445   AA082665   Hs. 209561   ESTs, Weakly similar to C05E11.1 gene product   3       437868   F05965   Hs. 134441   ESTs   3       441664   AW748420   Hs. 6236     Homo sapiens  cDNA: FLJ21487 fis, clone COL054   3       409461   AA382169   Hs. 54483   N-myc (and STAT) interactor   3       409977   AW805510   Hs. 97056   hypothetical protein FLJ21634   3       446266   AI417271   Hs. 163949   ESTs   3       429623   NM_005308   Hs. 211569   G protein-coupled receptor kinase 5   3       447540   AL135716   Hs. 263780   ESTs   3       441021   AW578716   Hs. 7644   H1 histone family, member 2   3       448766   AI473827   Hs. 31793   ESTs   3       413278   BE563085   Hs. 833   interferon-stimulated protein, 15 kDa   3       450293   N36754   Hs. 171118     Homo sapiens  mRNA for FLJ00026 protein, parti   3       421908   AW935200   Hs. 243852   ESTs, Weakly similar to ALU5_HUMAN ALU SUBFAM   3       414915   NM_002462   Hs. 76391   myxovirus (influenza) resistance 1, homolog o   3       414489   AI620677   Hs. 154191   ESTs   3       433637   AW024214   Hs. 135405   ESTs   3       446428   AW082270   Hs. 210617   ESTs, Weakly similar to ALU4_HUMAN ALU SUBFAM   2       424528   AW073971   Hs. 238954   ESTs, Weakly similar to KIAA1204 protein [H.s   2       419034   NM_002110   Hs. 89555   hemopoietic cell kinase   2       419138   U48508   Hs. 89631   ryanodine receptor 1 (skeletal)   2       405031   H25530   Hs. 50868   solute carrier family 22 (organic cation tran   2       438459   T49300   Hs. 35304     Homo sapiens  cDNA FLJ13655 fis, clone PLACE10   2       429752   H52348   Hs. 36636   ESTs   2       418827   BE327311   Hs. 47166   EST; HT021 mRNA   2       423855   AA331761   Hs. 254859   ESTs   2       442989   BE567710       gb: 601340367F1 NIH_MGC_53  Homo sapiens  cDNA c   2       438493   AI130740   Hs. 6241   phosphoinositide-3-kinase, regulatory subunit   2       420338   AA825595   Hs. 88269   ESTs, Highly similar to GPRI_HUMAN PROBABLE G   2       432610   BE246615   Hs. 278507   histidyl-tRNA synthetase-like   2       431629   AU077025   Hs. 265827   interferon, alpha-inducible protein (clone IF   2       458752   AW292842   Hs. 255128   ESTs   2       405955   ph0_1394       predicted exon   2       430320   BE245290   Hs. 239218   uncharacterized hypothalamus protein HCDASE   2       441892   AB028981   Hs. 8021   KIAA1058 protein   2       424030   AB015046   Hs. 137580   xylulokinase ( H. influenzae ) homolog   2       407347   AA829847   Hs. 167347   ESTs, Weakly similar to ALU8_HUMAN ALU SUBFAM   2       416517   AA775987   Hs. 79357   proteasome (prosome, macropain) 26S subunit,   2       415000   AW025529   Hs. 239812   ESTs, Weakly similar to CALM_HUMAN CALMODULIN   2       451652   AA018968   Hs. 133536   ESTs   2       435497   AW021655   Hs. 194441   ESTs   2       448554   NM_016169   Hs. 21431   suppressor of fused   2       408405   AK001332   Hs. 44672   hypothetical protein FLJ10470   2       447769   AW873704   Hs. 48764   ESTs   2       447514   AI809314   Hs. 208501   ESTs   2       430291   AV660345   Hs. 238126   CGI-49 protein   2       426108   AA622037   Hs. 166468   programmed cell death 5   2       410240   AL157424   Hs. 61289   synaptojanin 2   2       415579   AA165232   Hs. 222069   ESTs   2       418838   AW385224   Hs. 35198   ESTs   2       427528   AU077143   Hs. 179565   minichromosome maintenance deficient (S. cere   2       452696   AI826645   Hs. 211534   ESTs   2       459252   AF043467   Hs. 32893   neurexophilin 2   2       408360   AI806090   Hs. 44344   hypothetical protein FLJ20534   2       414511   AA148725   Hs. 12969   hypothetical protein   2       422938   NM_001809   Hs. 1594   centromere protein A (17 kD)   2       452670   AF068227   Hs. 30213   ceroid-lipofuscinosis, neuronal 5   2       407332   AI801565   Hs. 200113     Homo sapiens  cDNA FLJ11379 fis, clone HEMBA10   2       402107   c18p1_7398   predicted exon       413048   M93221   Hs. 75182   mannose receptor, C type 1   2       431863   AA188185   Hs. 271871   Spindlin   2       416450   AA180467   Hs. 142556   ESTs   2       419369   W28557       gb: 48d8 Human retina cDNA randomly primed sub   2       447023   AA356764   Hs. 17109   integral membrane protein 2A   2       449420   AI654852   Hs. 196562   ESTs, Highly similar to TS24 MOUSE PROTEIN TS   2       418721   NM_002731   Hs. 87773   protein kinase, cAMP-dependent, catalytic, be   2       441941   AI953261   Hs. 169813   ESTs   2       408393   AW015318   Hs. 23165   ESTs   2       450746   D82673   Hs. 169921   general transcription factor II, i, pseudogen   2       452598   AI831594   Hs. 68647   ESTs, Weakly similar to ALU7_HUMAN ALU SUBFAM   2       427719   AI393122   Hs. 134726   ESTs   2       452852   AK001972   Hs. 30822   hypothetical protein FLJ11110   2       440266   AA088809   Hs. 19525   hypothetical protein FLJ22794   2       423613   AF036035   Hs. 129910   hyaluronoglucosaminidase 3   2       443601   AI078554   Hs. 15682   ESTs   2       432005   AA524190   Hs. 120777   ESTs, Weakly similar to ELL2_HUMAN RNA POLYME   2       427794   AA709186   Hs. 111973   ESTs   2       417831   H16423   Hs. 82685   CD47 antigen (Rh-related antigen, integrin-as   2       435981   H74319   Hs. 188620   ESTs   2       408077   AL133574   Hs. 42458     Homo sapiens  mRNA; cDNA DKFZp586C1817 (from c   2       426312   AF026939   Hs. 181874   interferon-induced protein with tetratricopep   2       440561   AA471379   Hs. 7277   peroxisomal biogenesis factor 3   2       407748   AL079409   Hs. 38176   KIAA0606 protein; SCN Circadian Oscillatory P   2       407213   T16206   Hs. 237164   ESTs, Highly similar to LDHH_HUMAN L-LACTATE   2       449204   AB000099   Hs. 23251   Down syndrome critical region gene 4   2       433364   AI075407   Hs. 296083   ESTs   2       419216   AU076718   Hs. 164021   small inducible cytokine subfamily B (Cys-X-C   2       425987   AW015005   Hs. 165662   KIAA0675 gene product   2       401263   AB033113   Hs. 50187   KIAA1287 protein   2       452194   AI694413   Hs. 298262   ESTs, Weakly similar to dJ88J8.1 [ H. sapiens ]   2       415668   AW957684   Hs. 77324   eukaryotic translation termination factor 1   2       401069   c11p3_633       predicted exon   2       416475   T70298       gb: yd26g02.s1 Soares fetal liver spleen 1NFLS   2       443303   U67319   Hs. 9216   caspase 7, apoptosis-related cysteine proteas   2       423095   S75989   Hs. 123639   solute carrier family 6 (neurotransmitter tra   2       437575   AW954355   Hs. 36529   ESTs   2       458679   AW975460   Hs. 143563   ESTs   2       446506   AI123118   Hs. 15159   transmembrane proteolipid   2       409132   AJ224538   Hs. 50732   protein kinase, AMP-activated, beta 2 non-cat   2       425508   AA991551   Hs. 97013   ESTs   2       419644   AU076951   Hs. 91797   retinoblastoma-binding protein 1   2       427639   AW444530   Hs. 105362   ESTs   2       427209   H06509   Hs. 92423   KIAA1566 protein   2       423235   AW410698       gb: fh07h04.x1 NIH_MGC_17  Homo sapiens  cDNA cl   2       434961   AW974956       gb: EST387061 MAGE resequences, MAGN Homo sapi   2       437594   AA761431   Hs. 283318   ESTs   2       407687   AK002011   Hs. 37558   hypothetical protein FLJ11149   2       443119   AA312264   Hs. 7980   ESTs, Moderately similar to ALU4_HUMAN ALU SU   2       446591   H44186   Hs. 15456   PDZ domain containing 1   2       442160   AI337127   Hs. 156325   ESTs   2       406475   ph2_23228       predicted exon   2       448965   AF092134   Hs. 22679   CGI-24 protein   2       424243   AI949359   Hs. 301837   ESTs, Highly similar to cis Golgi-localized c   2       442048   AA974603       gb: op34f05.s1 Soares_NFL_T_GBC_S1 Homo sapien   2       412530   AA766268   Hs. 266273     Homo sapiens  cDNA FLJ13346 fis, clone OVARC10   2       447922   Z92910   Hs. 20019   hemochromatosis   2       415277   R44607   Hs. 22672   ESTs   2       450770   AA019924   Hs. 28803   ESTs   2       446946   AI878932   Hs. 317   topoisomerase (DNA) I   2       448569   BE382657   Hs. 21486   signal transducer and activator of transcript   2       427581   NM_014788   Hs. 179703   KIAA0129 gene product   2       407645   AW062509       gb: MR0-CT0069-120899-001-b12 CT0069 Homo sapi   2       408179   AL042465   Hs. 43445   poly(A)-specific ribonuclease (deadenylation   2       402716   c1p1_6479       predicted exon   2       447474   AW614220   Hs. 189402   ESTs   2       452705   H49805   Hs. 246005   ESTs   2       436643   AA757626   Hs. 10941   ESTs, Weakly similar to IPP1_HUMAN PROTEIN PH   2       451625   R56793   Hs. 106576   ESTs   2       448233   AI478114   Hs. 190615   ESTs   2       427094   AB025254   Hs. 283761   tudor repeat associator with PCTAIRE 2   2       438011   BE466173   Hs. 145696   splicing factor (CC1.3)   2       430024   AI808780   Hs. 227730   integrin, alpha 6   2       424840   D79987   Hs. 153479   extra spindle poles,  S. cerevisiae , homolog o   2       447547   NM_007229   Hs. 18842   protein kinase C and casein kinase substrate   2       418259   AA215404   Hs. 137289   ESTs   2       449119   AI631195   Hs. 232193   ESTs   2       417377   NM_016603   Hs. 82035   GAP-like protein   2       415535   T65331       gb: yc74e08.r1 Soares infant brain 1NIB Homo s   2       455225   AW996689       gb: QV3-BN0046-150400-151-g09 BN0046 Homo sapi   2       404015   c5p1_9512       predicted exon   2       419515   S81944   Hs. 90791   gamma-aminobutyric acid (GABA) A receptor, al   2       438874   H02780       gb: yj41a11.r1 Soares placenta Nb2HP Homo sapi   2       457625   T10073       gb: seq1293 b4HB3MA Cot8-HAP-Ft  Homo sapiens  c   2       444151   AW972917   Hs. 128749   alpha-methylacyl-CoA racemase   2       408072   BE005566   Hs. 16773     Homo sapiens  clone TCCCIA00427 mRNA sequence   2       423568   NM_005256   Hs. 129818   growth arrest-specific 2   2       455514   AW983871       gb: RC1-HN0003-220300-021-h07 HN0003 Homo sapi   2       454167   AW176543       gb: MR0-CT0062-200899-002-b04 CT0062 Homo sapi   2       414792   BE314949   Hs. 235775   ESTs   2       453779   N35187   Hs. 43388   ESTs   2       422932   AI191813       gb: qd47f06.x1 Soares_fetal_heart_NbHH19W Homo   2       421257   BE298539   Hs. 15536   ESTs, Weakly similar to CNBP_HUMAN CELLULAR N   2       408411   C15118   Hs. 251967     Homo sapiens  clone 785627 unknown mRNA   2       408587   AW238039   Hs. 253909   ESTs   2       405545   cNp3_24204   predicted exon       408683   R58665   Hs. 46847   TRAF and TNF receptor-associated protein   2       405392   cNp3_16759   predicted exon       437613   R19892   Hs. 10267   MIL1 protein   2       439645   BE091801   Hs. 27167   ESTs   2       457498   AI732230   Hs. 191737   ESTs   2       449567   AI990790   Hs. 188614   ESTs   2       418791   AA935633   Hs. 194628   ESTs   2       437838   AI307229   Hs. 184304   ESTs   2       447735   AA775268   Hs. 6127     Homo sapiens  cDNA: FLJ23020 fis, clone LNG009   2       416240   NM_001981   Hs. 301245     Homo sapiens  clone 23743 mRNA sequence   2       424321   W74048   Hs. 1765   lymphocyte-specific protein tyrosine kinase   2       452664   AA398859   Hs. 18397     Homo sapiens  cDNA: FLJ23221 fis, clone ADSU01   2       433370   AI084343   Hs. 122310   ESTs   2       439559   AW364675   Hs. 173921   ESTs   2       413129   AF292100   Hs. 104613   RP42 homolog   2       445786   AW629819   Hs. 144502     Homo sapiens  cDNA: FLJ22055 fis, clone HEP096   2       453469   AB014533   Hs. 33010   KIAA0633 protein   2       458020   AW515443   Hs. 249495   heterogeneous nuclear ribonucleoprotein A1   2       412019   AA485890   Hs. 69330     Homo sapiens  cDNA FLJ13835 fis, clone THYRO10   2       448873   NM_003677   Hs. 22393   density-regulated protein   2       409549   AB029015   Hs. 54886   phospholipase C, epsilon 2   2       450669   AL138077   Hs. 16157   hypothetical protein FLJ12707   2       433017   Y15067   Hs. 279914   zinc finger protein 232   2       435726   BE535787   Hs. 113170   ESTs   2       434568   AA584069   Hs. 222027   ESTs   2       402524   c1p1_17748   predicted exon       428388   AA729827   Hs. 101265     Homo sapiens  cDNA: FLJ22593 fis, clone HSI032   2       453085   AW954243   Hs. 170218   KIAA0251 protein   2       449082   BE387561   Hs. 22981   DKFZP586M1523 protein   2       422459   K02100   Hs. 117050   ornithine carbamoyltransferase   2       430007   NM_014892   Hs. 227602   KIAA1116 protein   2       421494   AI763322   Hs. 152104   ESTs   2       422241   Y00062   Hs. 170121   protein tyrosine phosphatase, receptor type,   2       401445   c14p3_4294   predicted exon       414747   U30872   Hs. 77204   centromere protein F (350/400 kD, mitosin)   2       416980   AA381133   Hs. 80684   high-mobility group (nonhistone chromosomal)   2       419270   NM_005232   Hs. 89839   EphA1   2       447164   AF026941   Hs. 17518     Homo sapiens  cig5 mRNA, partial sequence   2       452576   AB023177   Hs. 29900   KIAA960 protein   2                                                          
 
     [0336]                       TABLE 1B                       Pkey   CAT Number   Accession                                            455743   1496056_1   BE073795 BE073756 BE073796 BE073754 BE073752 BE073755 BE073733 BE073753 BE073704               BE073695 BE073791       413541   1519670_1   BE147036 BE146951 BE146976 BE146966 BE146958 BE146955       410527   1030469_1   AW851066 AW851076 AW851065 AW752861 BF511007 AW851140 AW851166 AW999129 AW850779               AW850786       411466   1085200_1   AW847669 AW847667 AW847668 BE145799       447513   450115_1   AW955776 AW264910 AI401003 AI382588 D20260 N74904 H57056 R26462 AV735490       456383   250410_1   AA236756 AA287178 AI148037       450560   50855_1   NM_024331 BC003071 BM012414 BE315221 BG750119 BE272198 AL449476 BE886722 AI360302               BG002949 BM454474 AL449598 BM012506               BE383204 AA010225 AL449685 AL449684 BF742320 T06328       419375   2390505_1   W27916 W26506       410430   5482_6   BG120564 BG705653 BF846503 BF995692 BE311644       454750   1070828_1   AW866285 AW866541 AW819153 AW819000 AW819014       411857   1112533_1   AW867707 AW879403       455960   1554632_1   BE165256 BE165247 BE165239 BE165233 BE165264 BE165262 BE165261 BE165252 BE165251               BE165245 BE165203 BE165201 BE165242               BE165206 BE165175 BE165232 BE165184 BE165197 BE165194 BE165193 BE165246 BE165240 BE165186               BE165237 BE165180       442431   MH1944_19   AW886349 AI818145 BE463452 BF002624 AI360447 AI634842 AI362712 BE349856 W74084 AW014214               W72374 AA995742 R80905 R80906       433854   899720_1   BG675161 H59558 AI699484 AA610649 AI937812       431300   1529181_1   BE159863 AA502346 AU186097 R86267 H71358       410833   1061214_1   AW806900 BF373960 BF373956 AW866317 AW866524 AW866625 BF373959 AW866592       455708   1493321_1   BE069290 BE069352 BE069326       425195   12922_3   BG197420 BG219369 BG182827 AA352026       457707   114453_1   AA640546 AW974642 AA649509 AA649527       413605   1523960_1   BE152811 BE152651 BE152644 BE152659 BE152810 BE152714 BE152707 BE152643 BE152660 BE152669               BE152711 BE152808 BE152782               BE152678 BE152682 BE152813 BE152778 BF350474 BE152776 BE152781 BE152774 BF350475 BE152712               BE152706 BE152668 BE152814               BE152671 BE152652 BE152760 BE152767 BE152775 BE152815 BE152715 BE152681 BE152771 BE152661               BE152780 BE152763 BE152666               BE152708 BE152665 BE152664 BE152677 BE152662 BE152768 BE152709 BE152679 BE152667 BE152673               BE152676 BE152656 BE152769               BE152816 BE152809 BE152672 BE152653 BE152716 BE152762       433586   32908_1   BC011194 AW517087 AA601054 T85512       454314   773174_1   AW364844 AW364847 AW937534 AW937593 AW937659       456328   2306193_1   T41294 T41304 T41368 T41369       421165   50467_2   BG620396 AA428945 H89283 AA831889 AI039537 BG573209 AA284420 AI267186 H97302       455065   1094993_1   AW854352 AW854461 AW854311 AW854340       442989   1768039_1   BE567710 R02368       419369   856237_1   W28557 BG619281 W26273       416475   1972665_1   R02750 H58072 T70298 BF367306 R02749 T80873       423235   7447_1   BC016162 AK054907 BC008564 BC011232 AL533635 BF508705 AA521407 AA521325 AI400703               AI439041 BF726761 AI440391 AW451413               AI127908 BE463710 AI076067 AI380502 AI249172 AI475513 AI932260 AA598632 AW503511 BF111247               AA516001 AI435214 AW295486               AI251854 BI963232 AI242565 AI247008 AI621262 AI766708 AJ401189 NM_032595 AI523759 AW028349               AW302139 AI808223 AI475761               BE895415 BI912507 AA323578 BF951255 BF947949 AA323535 BF947948 BF448737 BF515503 BF109903               AI969706 AI356745 BF476688               AI475690 AW082861 AI056581 AI521266 AA889737 BM461771 BM129164 BI909136 BF874611 BE909797               BI755397 BI052380 BF973595               BI052420 BI012504 BF806956 BI052419 AA444012 BF848781 BF091592 AA884981       434961   121331_1   AA781075 AA654944 AW974956       442048   750422_1   AW340495 AI984319 AA974603       407645   579939_1   AW062509 AW845614 BE140931 AW845635       415535   1875630_1   T65331 F11774 F11773       455225   1113920_1   AW868687 AW996453 AW996689 AW996380 BE085650 BE085595       438874   52147_1   AF075017 R66779 R22463 H02780       457625   433710_1   H14872 T10073 AV723827 AA604786       455514   1243022_1   AW983860 BE090302 AW983845 AW983853 AW983871 AW983867 AW983852       454167   1048866_1   AW176543 AW806978 BE141056 AW806985 AW178964 AW845681       422932   9154_11   H83343 AW954934 AA417867 AA319212                                            
     [0337]                           TABLE 1C                          402811   6523646   Plus   101679-101844       403747   7658395   Minus   20493-20621       406367   9256126   Minus   58313-58489       404287   2326514   Plus   53134-53281       402725   8979991   Plus   107231-107383       405246   7249293   Minus   82725-82884       405955   6758797   Plus   39940-40092       401069   3927852   Minus   45682-45831       406475   9797684   Plus   125417-125563, 128052-128180       402716   8969253   Minus   84065-84242       404015   8655948   Minus   587821-588222                                                    
     [0338]               TABLE 2A                          ABOUT 535 GENES DOWNREGULATED IN HEPATITIS C [see 60/308, 188]                                 Pkey   ExAccn   UnigeneID   Title   Ratio                                         450912   AW939251   Hs. 25647   v-fos FBJ murine osteosarcoma viral onco   2       447078   AW885727   Hs. 301570   ESTs   2       442941   AU076728   Hs. 8867   cysteine-rich, angiogenic inducer, 61   2       419564   U08989   Hs. 91139   solute carrier family 1 (neuronal/epithe   2       447771   BE505004   Hs. 280838   ESTs   2       444286   AI625304   Hs. 190312   ESTs   2       436711   AW452601   Hs. 189907   ESTs   2       434078   AW880709   Hs. 283683   EST   2       442570   AI001834   Hs. 130264   ESTs   2       453270   AI971439   Hs. 233461   ESTs   2       410140   AL134435   Hs. 27872   ESTs   2       404839   cAp3_4046           2       418138   AA213626   Hs. 136204   EST   2       444541   AI161257   Hs. 167252   ESTs   2       408098   R61857   Hs. 120981   ESTs   2       400959   c11p1_3967           2       403397   c3p1_11672           2       440948   AW188311   Hs. 128619   ESTs   2       444648   AI221297   Hs. 147778   ESTs, Weakly similar to KIAA0454 protein   2       404723   c9p1_8723           2       451400   BE160479       gb: QV1-HT0413-210200-081-g05 HT0413 Homo   2       432228   AA335178   Hs. 274124   Human DNA sequence from clone 1018D12 on   2       415328   Z44310       gb: HSC1XF011 normalized infant brain cDN   2       445967   D59597   Hs. 118821   CGI-62 protein   2       444776   AI191980   Hs. 145430   ESTs   2       447875   R22029   Hs. 13905   ESTs   2       408834   AW276241       gb: xr08f06.x1 NCI_CGAP_Lu28  Homo sapiens     2       458099   AW263124   Hs. 34782   ESTs   2       440634   AA921767   Hs. 132447   ESTs   2       442786   H50733   Hs. 256261   ESTs   2       415477   NM_002228   Hs. 78465   v-jun avian sarcoma virus 17 oncogene ho   2       407516   X64974       gb:  H. sapiens  mRNA HTPCRH02 for olfactory   2       455806   BE141094       gb: MR0-HT0075-121199-004-e05 HT0075 Homo   2       421370   AA287904   Hs. 269669   ESTs    2       430737   AW364181   Hs. 208763   ESTs   2       404398   c7p3_782           2       418998   F13215   Hs. 287849   ESTs   2       426566   AF131836   Hs. 170453   tropomodulin   2       445225   AI216555   Hs. 202398   ESTs   2       455181   AW863568       gb: MR3-SN0010-240300-102-c10 SN0010 Homo   2       457752   AI821270   Hs. 116930   ESTs   2       405475   cNp3_19914           2       423167   AA770464       gb: ah89g09.s1 Soares_NFL_T_GBC_S1 Homo s   2       414559   AV656184   Hs. 76452   C-reactive protein, pentraxin-related   2       459263   L25475       gb: HUM21ES116 ClonTech HL 1065a Home sap   2       455175   AW993247       gb: RC2-BN0033-180200-014-h09 BN0033 Homo   2       454448   AW750209       gb: RC5-BT0562-260100-011-H03 BT0562 Homo   2       417566   T81449   Hs. 191199   ESTs   2       404498   c8p1_4579           2       418501   BE079398   Hs. 5921     Homo sapiens  cDNA: FLJ21592 fis, clone C   2       409113   AA074897       gb: zm85a05.r1 Stratagene ovarian cancer   2       401074   c11p3_815           2       456304   AI820973   Hs. 188706   ESTs   2       459689   AA584858       ESTs   2       423669   AA329417   Hs. 272321     Homo sapiens  cDNA FLJ12571 fis, clone NT   2       441884   AW172630   Hs. 144884   ESTs   2       441837   AA361743   Hs. 179881   core-binding factor, beta subunit   2       400371   U80740   Hs. 278692   trinucleotide repeat containing 8   2       439034   AF075083       gb:  Homo sapiens  full length insert cDNA   2       439075   AF085933   Hs. 292620   ESTs   2       415350   R13218       gb: yf74c05.r1 Soares infant brain 1NIB H   2       427668   AA298760   Hs. 180191     Homo sapiens  mRNA; cDNA DKFZp434L0217 (f   2       457103   AI421187   Hs. 189192   ESTs   2       433970   AA721401   Hs. 301908   ESTs   2       442314   AI311854   Hs. 129220   ESTs   2       435332   AA678019   Hs. 187994   ESTs   2       451740   R63962   Hs. 269210   ESTs   2       458198   AI286100   Hs. 192739   ESTs   2       428959   AF100779   Hs. 194680   WNT1 inducible signaling pathway protein   2       445211   BE045601   Hs. 118248   ESTs, Weakly similar to YC18_HUMAN HYPOT   2       459695   AA381579       ESTs   2       411355   AW838479   Hs. 22692   ESTs   2       401887   c17p1_704           2       406285   AW068311   Hs. 82582   integrin, beta-like 1 (with EGF-like rep   2       439201   AW503578   Hs. 209406   ESTs, Weakly similar to Z140_HUMAN ZINC   2       407760   T79084   Hs. 184407   ESTs   2       451886   T63790   Hs. 293720     Homo sapiens  cDNA: FLJ22804 fis, clone K   2       423657   AL045128   Hs. 1691   glucan (1,4-alpha-), branching enzyme 1   2       426529   AF090100   Hs. 170241     Homo sapiens  clone IMAGE 23915   2       440728   AW086077   Hs. 153272     Homo sapiens  cDNA: FLJ22715 fis, clone H   2       445061   AI253094   Hs. 145227   ESTs   2       421013   M62397   Hs. 1345   mutated in colorectal cancers   2       430873   AW269813   Hs. 154395   ESTs   2       407850   AW086230   Hs. 244912   ESTs   2       426077   AA448328   Hs. 115527   ESTs   2       419927   R53365   Hs. 20001   ESTs   2       433945   AI024718   Hs. 112873   ESTs   2       434554   R13594   Hs. 301529   ESTs   2       418625   AW948578   Hs. 136211   ESTs   2       453523   NM_012118   Hs. 258586   CCR4-like (carbon catabolite repression   2       455195   AW864370       gb: PM4-SN0016-100500-004-h09 SN0016 Homo   2       406547   ph2_5308           2       416510   H60055   Hs. 169833   single-stranded-DNA-binding protein   2       415737   AA167626   Hs. 118743   ESTs   2       431895   H60210   Hs. 272003   hemoglobin, zeta   2       402468   c1p1_13012           2       454042   H22570   Hs. 172572   hypothetical protein FLJ20093   2       401943   NM_012434   Hs. 117865   solute carrier family 17 (anion/sugar tr   2       412065   R82597   Hs. 176648   ESTs   2       444601   AV650521   Hs. 282449   ESTs   2       438247   AI018016   Hs. 131222   ESTs   2       441224   AU076964   Hs. 7753   calumenin   2       449463   AI657038   Hs. 196109   ESTs   2       451029   AA852097   Hs. 25829   ras-related protein   2       419728   L36861   Hs. 92858   guanylate cyctase activator 1A (retina)   2       436763   AI168278   Hs. 128713   ESTs   2       411861   AW867875       gb: MR0-SN0040-050500-003-f11 SN0040 Homo   2       449278   AI637876   Hs. 224372   ESTs   2       456576   AA287443       gb: zs52c10.r1 NCI_CGAP_GCB1  Homo sapiens     2       432240   AI694767   Hs. 129179   ESTs   2       447788   AI424822   Hs. 161430   ESTs   2       405278   cNp3_1070           2       408332   H91230   Hs. 234794     Homo sapiens  mRNA; cDNA DKFZp564B083 (fr   2       454442   AW816134       gb: MR3-ST0220-290100-016-e04 ST0220 Homo   2       454520   AW803371       gb: IL2-UM0079-090300-049-B06 UM0079 Homo   2       437103   AW139408   Hs. 152940   ESTs   2       458254   BE091969   Hs. 127742   ESTs   2       415075   L27479   Hs. 77889   Friedreich ataxia region gene X123   2       450577   AW612816   Hs. 202057   ESTs   2       414564   AA164803   Hs. 71994   ESTs   2       459349   AW749381       gb: QV3-BT0381-170100-060-c02 BT0381 Homo   2       450581   AF081513   Hs. 25195   endometrial bleeding associated factor   2       445239   AI217375   Hs. 170023   ESTs, Weakly similar to collagen alpha 3   2       421227   R78581   Hs. 266308   ESTs, Weakly similar to AF216312 1 type   2       432675   AI791855   Hs. 105884   ESTs   2       451831   NM_001674   Hs. 460   activating transcription factor 3   2       455104   BE064863       gb: RC1-BT0313-110300-015-f06 BT0313 Homo   2       441445   AI221959   Hs. 187937   ESTs   2       405456   cNp3_18813           2       452747   BE153855   Hs. 61460   Ig superfamily receptor LNIR precursor   2       449438   AA927317   Hs. 176719   ESTs   2       437662   AA765387   Hs. 145095   ESTs   2       443258   AF169301   Hs. 9098   sulfate transporter 1   2       448670   AW296257   Hs. 230507   ESTs   2       425426   AB021641   Hs. 157203     Homo sapiens  GIOT-1 mRNA for gonadotropi   2       446438   AI299876   Hs. 150061   ESTs   2       457005   AJ007421   Hs. 300698   ESTs, Highly similar to spalt-like zinc   2       407473   L10404       gb:  Homo sapiens  DNA binding protein for   2       404319   c7p1_2230           2       429836   AW117452   Hs. 99489   ESTs   2       416461   AA180526   Hs. 216797   ESTs   2       435185   AA669490   Hs. 289109   dimethylarginine dimethylaminohydrolase   2       403600   c3p1_6888           2       401775   c17p1_11738           2       424200   AA337221       gb: EST41944 Endometrial tumor Homo sapie   2       405532   cNp3_23494           2       424404   AA340151   Hs. 104650   hypothetical protein FLJ10292   2       427168   AA398821   Hs. 97548   ESTs   2       430071   AA355986   Hs. 232068   transcription factor 8 (represses interl   2       423290   AA324130       gb: EST27023 Cerebellum II  Homo sapiens  c   2       429295   AA682377   Hs. 99216   ESTs, Moderately similar to ALU8_HUMAN A   2       445571   AI378000   Hs. 158489   ESTs, Weakly similar to b3418.1 [H.sapie   2       432459   AW291917   Hs. 174387   ESTs   2       424584   H10692   Hs. 13310   ESTs   2       401411   c14p3_2875           2       429932   AI095005   Hs. 135174   ESTs   2       449305   AI638293       gb: tt09b07.x1 NCI_CGAP_GC6  Homo sapiens     2       413257   BE075035       gb: PM3-BT0584-260300-002-g05 BT0584 Homo   2       436062   AK000027   Hs. 98633   ESTs   2       430692   X80240       gb:  H. sapiens  endogenous retrovirus HERV-   2       403212   c2p1_2196           2       424686   AA345504       gb: EST51529 Gall bladder II  Homo sapiens     2       413272   AA127923   Hs. 293256   ESTs   2       411658   AW855598       gb: CM1-CT0278-031199-032-e08 CT0278 Homo   2       459721   AI299050       gb: qn14d12.x1 NCI_CGAP_Lu5  Homo sapiens     2       404834   cAp3_3862           2       442484   AF075360       gb: AF075360 Human fetal liver cDNA libra   2       411689   AW857121       gb: RC1-CT0302-040400-017-a12 CT0302 Homo   2       407707   AW294785   Hs. 143895     Homo sapiens  cDNA: FLJ21140 fis, clone C   2       433430   AI863735   Hs. 186755   ESTs   2       401866   c17p1_5127           2       400352   AF227133   Hs. 272389     Homo sapiens  candidate taste receptor T2   2       444862   AI209158   Hs. 143929   ESTs   2       401558   c15p1_539           2       405698   cNp3_9135           2       427731   AA411750   Hs. 20943   ESTs   2       411486   N85785   Hs. 181165   eukaryotic translation elongation factor   2       438557   AW364104   Hs. 143509     Homo sapiens  cDNA: FLJ21924 fis, clone H   2       411902   AW875344       gb: RC1-PT0009-220300-013-f06 PT0009 Homo   2       444573   AW043590   Hs. 225023   ESTs   2       420355   AW968263   Hs. 123126   ESTs   2       418225   AA747676       gb: nx85g05.s1 NCI_CGAP_GCB1  Homo sapiens     2       404974   cNp1_15731           3       410993   BE138999   Hs. 278868   ESTs   3       410900   AW810169       gb: MR4-ST0124-040500-007-h07 ST0124 Homo   3       445626   AI400253   Hs. 156240   ESTs   3       449986   AW864502       gb: PM4-SN0016-120400-004-b12 SN0016 Homo   3       413088   BE064962       gb: RC1-BT0313-130400-016-c02 BT0313 Homo   3       441747   BE467749   Hs. 144029   ESTs, Highly similar to SOX1_HUMAN SOX-1   3       448156   AI472886       gb: tj75d01.x1 Soares_NSF_F8_9W_OT_PA_P_S   3       418298   AA256014   Hs. 86682     Homo sapiens  cDNA: FLJ21578 fis, clone C   3       404196   c6p3_1867           3       452528   AA742457   Hs. 291479   ESTs   3       451540   AI801860   Hs. 208837   ESTs   3       436893   AA736815   Hs. 149225   ESTs   3       401758   c17p1_10881           3       435633   AI248152   Hs. 270047   ESTs   3       409955   U60665   Hs. 57692   testis specific basic protein   3       440600   AI807691   Hs. 126351   ESTs   3       401946   c17p3_245           3       429668   AA626142   Hs. 179991   ESTs, Weakly similar to KPCE_HUMAN PROTE   3       424562   AI420859   Hs. 150557   basic transcription element binding prot   3       402627   c1p1_26870           3       400400   AF144054   Hs. 283886     Homo sapiens  apoptosis related protein A   3       413813   M96956   Hs. 75561   teratocarcinoma-derived growth factor 1   3       433851   AA610436   Hs. 196461   ESTs   3       432217   AI864415   Hs. 162157   ESTs, Moderately similar to B34087 hypot   3       454573   BE146471       gb: QV0-HT0216-011199-043-c09 HT0216 Homo   3       432304   AA932186   Hs. 164214   ESTs   3       458072   AI890347   Hs. 271923   EST   3       443633   AL031290   Hs. 9654   similar to pregnancy-associated plasma p   3       454697   AW813728   Hs. 15036   ESTs, Highly similar to AF161358 1 HSPC0   3       415877   R45135   Hs. 21026   ESTs   3       458943   AW249181   Hs. 19954   ESTs, Weakly similar to cDNA EST yk386e1   3       431775   AW205945   Hs. 27008   phosphatidylinositol glycan, class L   3       433391   T77201       gb: yc95c09.r1 Soares infant brain 1NIB H   3       411929   AA098880   Hs. 69297   ESTs   3       443728   AI083876   Hs. 148383   ESTs   3       449637   AA001964       gb: ze49e02.r1 Soares retina N2b4HR Homo   3       436857   AA732647       gb: nz89d01.s1 NCI_CGAP_GCB1  Homo sapiens     3       406562   ph2_6297           3       411484   AW848117       gb: IL3-CT0214-301299-048-D04 CT0214 Homo   3       456549   AA283740   Hs. 89211   ESTs   3       443751   AI285839   Hs. 153324   ESTs   3       428515   AF030339   Hs. 286229   plexin C1   3       415727   BE501389   Hs. 20848   ESTs, Weakly similar to U5 snRNP-specifi   3       453493   AL039478       gb: DKFZp434P0510_s1 434 (synonym: htes3)   3       429505   AW820035   Hs. 204290     Homo sapiens  mRNA; cDNA DKFZp586N2119 (f   3       432741   AI732358   Hs. 185118   ESTs   3       408766   AA057270       gb: zk70c03.r1 Soares_pregnant_uterus_NbH   3       455036   AW851630       gb: MR2-CT0222-211099-002-h06 CT0222 Homo   3       421036   AA810560       gb: oa71h06.s1 NCI_CGAP_GCB1  Homo sapiens     3       416584   N63864   Hs. 205554   ESTs   3       420125   AA255739   Hs. 283332   ESTs   3       434137   AA907734   Hs. 124895   ESTs   3       402747   c1p1_7488           3       457508   AA542909   Hs. 162214   ESTs   3       444927   AW016637   Hs. 199425   ESTs   3       408443   N33937   Hs. 10336   ESTs   3       408033   AW138045   Hs. 242256   ESTs   3       425560   AA359368   Hs. 165998   DKFZP564M2423 protein   3       444531   BE158822   Hs. 282469   ESTs   3       455404   BE175503       gb: RC5-HT0580-050400-021-B01 HT0580 Homo   3       458786   AI457098   Hs. 280848   ESTs   3       447034   N49580   Hs. 46630   ESTs   3       434286   AF123758   Hs. 127675   ceroid-lipofuscinosis, neuronal 8 (epile   3       400488   c10p1_1764           3       453502   AL039786       gb: DKFZp434A0912_r1 434 (synonym: htes3)   3       406225   ph0_8239           3       424554   AA747563   Hs. 131799   ESTs, Weakly similar to ALU8_HUMAN ALU S   3       409854   AW501833       gb: UI-HF-BR0p-ajo-d-01-0-UI.r1 NIH_MGC_5   3       453006   AI362575   Hs. 167133   ESTs   3       406531   ph2_4560           3       451333   AK000914   Hs. 26244   hypothetical protein FLJ10052   3       419882   AA687313   Hs. 190043   ESTs   3       432073   AW661883   Hs. 259353   ESTs   3       426420   BE383808   Hs. 169829   KIAA1180 protein   3       437089   AA844539   Hs. 240855   ESTs   3       422638   AI474074   Hs. 172070   ESTs, Weakly similar to cAMP-specific cy   3       454754   AW819191       gb: CM1-ST0283-071299-061-d08 ST0283 Homo   3       429768   AA805719   Hs. 192154   ESTs   3       445224   BE254241   Hs. 288885     Homo sapiens  cDNA FLJ14246 fis, clone OV   3       450684   AA872605   Hs. 25333   interleukin 1 receptor, type II   3       435211   AI248618   Hs. 193586   ESTs   3       419392   W28573       gb: 51f10 Human retina cDNA randomly prim   3       427624   AA406245   Hs. 24895   ESTs   3       454803   AW860148       gb: RC0-CT0379-290100-032-b10 CT0379 Homo   3       427419   NM_000200   Hs. 177888   histatin 3   3       439884   H42671       gb: yp13h12.r1 Soares breast 3NbHBst Homo   3       407438   AF227133       gb:  Homo sapiens  candidate taste receptor   3       427700   AA262294   Hs. 180383   dual specificity phosphatase 6   3       408602   AA055833   Hs. 58152   ESTs, Weakly similar to anagen-specific   3       405548   cNp3_24436           3       453916   AW974874   Hs. 75212   omithine decarboxylase 1   3       425611   AF012270   Hs. 158338   retinal pigment epithelium-derived rhodo   3       459238   AF053551   Hs. 31584   metaxin 2   3       454816   AW833258       gb: RC2-TT0007-131099-011-b10_1 TT0007 Ho   3       443184   AI638728   Hs. 131973   ESTs   3       407986   U32659   Hs. 41724   interleukin 17 (cytotoxic T-lymphocyte-a   3       405510   cNp3_22634           3       435118   AA665576   Hs. 116581   ESTs   3       414041   AW974100   Hs. 293265   ESTs   3       450508   R37408   Hs. 101654   ESTs   3       417699   T91491   Hs. 119670   ESTs   3       438160   AA779332   Hs. 122671   ESTs   3       423792   AW135866   Hs. 245854   ESTs   3       437208   AA236599       gb: zs42c10.r1 Soares_NhHMPu_S1 Homo sapi   3       412234   AW902641       gb: QV3-NN1024-100500-181-d08 NN1024 Homo   3       409937   AI804584   Hs. 57672   leucine rich repeat (in FLII) interactin   3       410158   AA082030       gb: zn26h08.r1  Stratagene neuroepithelium     3       408448   BE467627   Hs. 285574   ESTs   3       435308   N28276   Hs. 117087   ESTs   3       459472   AA568933       gb: nm23c07.s1 NCI_CGAP_Co10  Homo sapiens     3       430826   U10061   Hs. 248019   POU domain, class 4, transcription facto   3       403003   c21p3_2293           3       404499   c8p1_4589           3       407530   X68790       gb:  H. sapiens  bactericidal BPl′gene for a   3       456280   D63477   Hs. 84087   KIAA0143 protein   3       446418   AI301117   Hs. 150182   ESTs   3       420535   AA280095   Hs. 88689   ESTs   3       410815   AW805974       gb: QV1-UM0106-130400-152-b10 UM0106 Homo   3       447925   AW292271   Hs. 250718   ESTs   3       441769   R62241   Hs. 172780   ESTs   3       439889   AA848093   Hs. 192993   ESTs   3       431525   AA506656   Hs. 6185   KIAA1557 protein   3       414294   BE270795   Hs. 268864   ESTs   3       451300   AA017066   Hs. 237686   EST   3       410204   AJ243425   Hs. 738   early growth response 1   3       413939   AL047051   Hs. 199961   ESTs   3       425925   AF176813   Hs. 163045   soluble adenylyl cyclase   3       418088   R49517   Hs. 268703   ESTs   3       436681   AI288242       gb: ql80b03.x1 Soares_NhHMPu_S1 Homo sapi   3       453565   BE298808   Hs. 33363   DKFZP434N093 protein   3       420568   F09247   Hs. 167399   protocadherin alpha 5   3       444564   AI167877   Hs. 143716   ESTs   3       436317   AL096777       gb: Novel human gene mapping to chomosome   3       441299   AA927914   Hs. 223718   ESTs   3       443338   R99575       gb: yq72c01.s1 Soares fetal liver spleen   3       410286   AI739159   Hs. 61898   DKFZP586N2124 protein   3       416659   W22048       gb: 61A12 Human retina cDNA Tsp509I-cleav   3       435070   AI821270   Hs. 116930   ESTs   3       449877   BE408252   Hs. 301008   ESTs   3       401945   c17p3_241           3       452102   U04343   Hs. 27954   CD86 antigen (CD28 antigen ligand 2, B7-   3       454292   N57559   Hs. 82273   hypothetical protein   3       402718   c1p1_6495           3       441453   AW176106   Hs. 285459   ESTs, Weakly similar to unknown [ D. melan     3       428785   AI015953   Hs. 125265   ESTs   3       414650   AA150435   Hs. 72063   ESTs   3       411173   R81571       gb: yj02h10.r1 Soares placenta Nb2HP Homo   3       446112   AV656599   Hs. 282636   ESTs   3       404439   c8p1_195           3       412281   AI810054   Hs. 14119   ESTs   3       432965   AW974144   Hs. 133860   ESTs   3       404632   c9p1_2941           3       459031   AA017571   Hs. 159398   ESTs   3       436195   AA774834   Hs. 75761   SFRS protein kinase 1   3       428788   AF082283   Hs. 193516   B-cell CLL/lymphoma 10   3       431512   BE270734   Hs. 2795   lactate dehydrogenase A   3       424536   AW965002   Hs. 47232   ESTs   3       443982   AI222998   Hs. 134962   ESTs   3       415120   N64464   Hs. 34950   ESTs   3       441555   AI651563   Hs. 178912   ESTs   3       419932   AA281594       gb: zt03a01.r1 NCI_CGAP_GCB1  Homo sapiens     3       422860   S67798   Hs. 121494   sperm adhesion molecule 1 (PH-20 hyaluro   3       453125   AW779544   Hs. 115497     Homo sapiens  cDNA: FLJ22655 fis, clone H   3       448306   AI480270       gb: tm26d07.x1 Soares_NFL_T_GBC_S1 Homo s   3       406284   AW068311   Hs. 82582   integrin, beta-like 1 (with EGF-like rep   3       454289   AL137554   Hs. 49927     Homo sapiens  mRNA; cDNA DKFZp434H1720 (f   3       403283   c2p1_4629           3       439541   AW970853       gb: EST382936 MAGE resequences, MAGK Homo   4       431124   AF284221   Hs. 59506   doublesex and mab-3 related transcriptio   4       435701   AW236397   Hs. 63131     Homo sapiens  cDNA FLJ13155 fis, clone NT   4       441577   AI422096       gb: tf57h05.x1 NCI_CGAP_Brn23 Homo sapien   4       429258   AA448765       gb: zx10e09.r1 Soares_total_fetus_Nb2HF8 —     4       432407   AA221036   Hs. 285026   HERV-H LTR-associating 1   4       422017   NM_003877   Hs. 110776   STAT induced STAT inhibitor-2   4       405591   cNp3_27585           4       439824   AW303556   Hs. 124515   ESTs   4       456370   AA234938   Hs. 87384   ESTs   4       413539   BE146879       gb: QV4-HT0222-261099-014-c11 HT0222 Homo   4       409894   BE081731       gb: QV2-BT0635-220400-158-e04 BT0635 Homo   4       440344   AA928516   Hs. 190575   ESTs   4       445180   BE217929   Hs. 147470   ESTs   4       421089   AB037771   Hs. 101799   KIAA1350 protein   4       414118   AI659167   Hs. 75968   thymosin, beta 4, X chromosome   4       405863   ph0_11166           4       432877   AW974111   Hs. 292477   ESTs   4       453043   AW136440   Hs. 224277   ESTs   4       443725   AW245680   Hs. 9701   growth arrest and DNA-damage-inducible,   4       411810   AW947513       gb: RC0-MT0002-140300-011-e04 MT0002 Homo   4       457807   N89812   Hs. 138809   Human clone 23564 mRNA sequence   4       444559   W04370   Hs. 282795   ESTs   4       401027   c11p1_812           4       402134   c19p1_1058           4       459646   AW883968       gb: QV3-OT0063-290300-135-c04 OT0063 Homo   4       420954   AA282074   Hs. 301753     Homo sapiens  cDNA FLJ11614 fis, clone HE   4       425431   T62818   Hs. 257482   ESTs   4       446104   AI571189   Hs. 55977     Homo sapiens  cDNA: FLJ20985 fis, clone C   4       410178   AA082211   Hs. 233936   myosin, light polypeptide, regulatory, n   4       441861   AA970039   Hs. 200940   ESTs   4       459045   N69101   Hs. 32703   ESTs   4       452948   AW368451   Hs. 188665   ESTs, Weakly similar to sodium-hydrogen   4       456375   AF147766   Hs. 199647     Homo sapiens  cDNA FLJ12993 fis, clone NT   4       454365   AW966728   Hs. 54642   methionine adenosyltransferase II, beta   4       435864   AL036499   Hs. 188491   ESTs   4       428799   AI478619   Hs. 104677   ESTs   4       444268   AI139642   Hs. 143239   ESTs   4       457674   AF119908   Hs. 235516   hypothetical protein PRO2955   4       434628   H47495   Hs. 13810   ESTs   4       459726   AI904506         Homo sapiens  cDNA: FLJ21802 fis, clone H   4       438524   AI824326   Hs. 22305   ESTs   4       411280   N50617       EST cluster (not in UniGene)   4       431317   AA502682       gb: ng23d01.s1 NCI_CGAP_Ov2  Homo sapiens     4       454148   AW732837   Hs. 42390   nasopharyngeal carcinoma susceptibility   4       431723   AW058350   Hs. 16762     Homo sapiens  mRNA; cDNA DKFZp564B2062 (f   4       418922   AW956580   Hs. 42699   Thrombospondin-1 (Hs. 87409)   4       426653   AA530892   Hs. 171695   dual specificity phosphatase 1   4       458032   AW979141   Hs. 293917     Homo sapiens  cDNA FLJ11774 fis, clone HE   4       412429   AV650262   Hs. 75765   GRO2 oncogene   4       421568   W85858   Hs. 99804   ESTs, Weakly similar to ALU1_HUMAN ALU S   4       413919   BE180590       gb: RC3-HT0625-130400-021-d12 HT0625 Homo   4       413576   BE149684       gb: RC1-HT0256-280300-017-d10 HT0256 Homo   4       454204   AW816498       gb: QV0-ST0236-171299-075-b02 ST0236 Homo   4       433712   AF090887       gb:  Homo sapiens  clone HQ0085   4       445832   AI261545       gb: qz30a07.x1 NCI_CGAP_Kid11 Homo sapien   4       404432   c8p1_1658           4       432745   AI821926   Hs. 269507   ESTs   4       405763   cXp3_1388           4       416843   D45467   Hs. 58606   ESTs   4       427608   BE148596   Hs. 179779   ribosomal protein L37   4       450594   N31036       gb: yx51g04.r1 Soares melanocyte 2NbHM Ho   4       427366   AA885108   Hs. 223806     Homo sapiens  cDNA: FLJ23157 fis, clone L   4       445772   AI733941   Hs. 145493   ESTs, Weakly similar to ALU7_HUMAN ALU S   4       404485   c8p1_4167           4       442621   AI004333   Hs. 130553   ESTs, Weakly similar to ALUA_HUMAN !!!!   4       410255   AA234006   Hs. 190488   hypothetical protein FLJ10120   4       421358   AA806749   Hs. 290346   ESTs   4       416708   H78836       gb: yu09a06.r1 Soares fetal liver spleen   4       453434   AJ271378   Hs. 140951   ESTs   4       426946   AA393595   Hs. 97446   ESTs   4       446087   AI298072   Hs. 149441   ESTs   4       453816   AL135405       gb: DKFZp762K1015_r1 762 (synonym: hmel2)   4       448588   AI970276   Hs. 156905   ESTs   4       450775   AA902384   Hs. 110248   ESTs   4       416107   AA173846   Hs. 79015   antigen identified by monoclonal antibod   4       422766   AA334108   Hs. 159572   heparan sulfate (glucosamine) 3-O-sulfot   4       454991   AW850163       gb: IL3-CT0219-271099-022-D02 CT0219 Homo   4       407528   X64990       gb:  H. sapiens  mRNA HTPCRX16 for olfactory   4       441910   AI150328   Hs. 226402   ESTs, Weakly similar to mitochondrial ci   4       450438   AI696071   Hs. 253800   ESTs   4       430251   AA609246   Hs. 181451   ESTs   4       440358   AW296778   Hs. 300357   ESTs, Highly similar to dJ416F21.2 [H.sa   4       409236   BE539805       gb: 601061906F1 NIH_MGC_10  Homo sapiens  c   4       449335   AW150717   Hs. 296176   STAT induced STAT inhibitor 3   4       404099   c6p1_1419           4       418214   AA215293   Hs. 156004   ESTs   4       406108   ph0_2356           4       441492   AI149998   Hs. 146346   ESTs   4       458867   AW995393       gb: QV0-BN0042-170300-163-g12 BN0042 Homo   4       447283   BE061049   Hs. 258396   ESTs   4       401514   AF147186       gb: AF147186  Homo sapiens  library (Schere   4       428263   AA424811   Hs. 152155   ESTs   4       434970   AW272262   Hs. 250468   ESTs   4       440882   AI205777   Hs. 129538   ESTs   4       405099   cNp1_23324           4       458960   BE383204       gb: 601298758F1 NIH_MGC_19  Homo sapiens  c   4       453611   BE009728       gb: PM0-BN0173-120400-001-f09 BN0173 Homo   4       447605   AW504937   Hs. 211169   ESTs   4       436819   AA731746   Hs. 120232   ESTs   4       419134   T89863   Hs. 221771   ESTs   4       403159   c2p1_1584           4       456973   AA375710   Hs. 102746   ESTs   4       401454   c14p3_4909           4       412625   AA114946   Hs. 261314   ESTs   4       417551   AI816291   Hs. 82273   hypothetical protein   4       440962   AI989961   Hs. 233477   ESTs, Moderately similar to A Chain A, S   4       423291   NM_004129   Hs. 126590   guanylate cyclase 1, soluble, beta 2   5       417977   AA210787   Hs. 243748   ESTs   5       456667   AW665591   Hs. 114658   ESTs   5       402337   c19p3_4189           5       451838   AW005866   Hs. 193969   ESTs   5       406346   ph2_13138           5       404121   c6p1_3615           5       446698   AW451812   Hs. 202503   ESTs   5       444988   AF272830   Hs. 12229     Homo sapiens  cDNA FLJ11324 fis, clone PL   5       418443   NM_005239   Hs. 85146   v-ets avian erythroblastosis virus E26 o   5       457993   AI799102   Hs. 292732   ESTs, Weakly similar to Gab2 [ H. sapiens ]   5       446546   BE167687   Hs. 156628   ESTs   5       435917   AA702143   Hs. 190365   ESTs   5       413496   BE144841       gb: CM0-HT0181-181099-075-f10 HT0181 Homo   5       403661   c3p3_219           5       421177   AW070211   Hs. 102415     Homo sapiens  mRNA; cDNA DKFZp586N0121 (f   5       459660   M79082       ESTs   5       411708   AW857808       gb: RC4-CT0322-261299-011-c02 CT0322 Homo   5       411962   AA099050       gb: zk85d12.r1 Soares_pregnant_uterus_NbH   5       426087   M61877   Hs. 1985   spectrin. alpha, erythrocytic 1 (ellipto   5       416188   BE157260   Hs. 79070   v-myc avian myelocytomatosis viral oncog   5       458410   H20380   Hs. 200250   ESTs, Weakly similar to neuronal thread   5       405387   cNp3_16477           5       457873   AA736920   Hs. 288518   ESTs   5       453511   AL031224   Hs. 33102   transcription factor AP-2 beta (activati   5       438863   R38002       gb: yh97g12.r1 Soares placenta Nb2HP Homo   5       458467   AW747996   Hs. 160999   ESTs   5       447844   AI433873   Hs. 35085   ESTs   5       438675   AA813725   Hs. 213568   ESTs   5       439170   AA332365   Hs. 165539   ESTs   5       410483   BE163567       gb: QV3-HT0460-230200-101-b08 HT0460 Homo   5       401276   c13p1_293           5       430725   AA485056   Hs. 173692   ESTs   5       449834   AL161980   Hs. 24022     Homo sapiens  mRNA; cDNA DKFZp761H1023 (f   5       400827   c11p1_19707           5       425534   AA995635   Hs. 7589   ESTs   5       416493   H60593   Hs. 124990   ESTs   5       434977   AI734233   Hs. 226142   ESTs, Weakly similar to ALU7_HUMAN ALU S   5       456466   AA700127   Hs. 190504   ESTs   5       458489   AI142274   Hs. 145423   ESTs   5       433232   AI658621   Hs. 127769   ESTs   5       420270   AA257990       gb: zs35h07.r1 NcI_CGAP_GCB1  Homo sapiens     5       454410   AW812744       gb: RC3-ST0186-181099-012-c09 ST0186 Homo   5       420431   AB007131   Hs. 97624   heat shock transcription factor 2 bindin   5       400844   c11p1_20936           5       435517   AA928626   Hs. 130177   ESTs   5       412996   BE046224       gb: hn38c12.x2 NCI_CGAP_RDF2  Homo sapiens     5       420475   AW408407   Hs. 187018   ESTs   5       421126   M74587   Hs. 102122   insulin-like growth factor binding prote   5       430269   BE221682   Hs. 178364   ESTs   5       425673   R70318       gb: yj81a09.r1 Soares breast 2NbHBst Homo   5       435057   AW291345   Hs. 254970   ESTs   5       405667   cNp3_6851           5       402527   c1p1_18184           6       459407   N92114       gb: za22h11.r1 Soares fetal liver spleen   6       454302   AA306105   Hs. 50785   SEC22, vesicle trafficking protein (S. c   6       426436   AA378512   Hs. 287639     Homo sapiens  cDNA FLJ14334 fis, clone PL   6       412791   AI131192   Hs. 143199   ESTs   6       441189   AW450266   Hs. 257276   ESTs   6       456013   T92048       gb: yd54g12.s1 Soares fetal liver spleen   6       441698   BE299588   Hs. 28465     Homo sapiens  cDNA: FLJ21869 fis, clone H   6       438597   AA811662   Hs. 171497   ESTs   6       456592   R91600       gb: yq10c02.r1 Soares fetal liver spleen   6       402312   c19p3_3548           6       418912   NM_000685   Hs. 89472   angiotensin receptor 1   6       440700   AW952281   Hs. 296184   ESTs, Highly similar to GB01_HUMAN GUANI   6       424128   AW966163       gb: EST378236 MAGE resequences, MAGI Homo   7       419711   C02621   Hs. 159282   ESTs   7       444851   AL117425   Hs. 301413     Homo sapiens  cDNA FLJ11516 fis, clone HE   7       414137   BE220829   Hs. 50652   ESTs, Moderately similar toALU1_HUMAN A   7       401438   c14p3_401           7       457656   AA625087   Hs. 224405   ESTs   7       434402   AA745143   Hs. 212498   ESTs   7       413574   BE149158   Hs. 129998     Homo sapiens  cDNA FLJ14267 fis, clone PL   8       447317   BE312948   Hs. 18104   hypothetical protein FLJ11274   8       444698   AI188139   Hs. 147050   ESTs   12       430758   T91568   Hs. 270616   ESTs, Moderately similar to A34087 hypot   12       452049   BE268289   Hs. 27693   CGI-124 protein   19                                                            
     [0339]                       TABLE 2B                          451400   1103195_1   BE069211 BE160479 BE160478 AI793147 AW861059       415328   1870242_1   Z44310 R55952 F05790       408834   717496_1   AW276241 BE167263 BE167259       455806   1515155_1   BE141094 BE141097 BE141263 BE141118 BE141253 BE141256 BE141225 BE141092 BE141124 BE141248 BE141254               BE141262 BE141093               BE141115 BE141259 BE141255 BE141226 BE141213 BE141222 BE141128 BE141129 BE141211 BE141157               BE141257 BE141258 BE141250               BE141116 BE141208 BE141227 BE141096 BE141112 BE141261 BE141121 BE141120 BE141300 BE141111               BE141117 BE141131 BE141212               BE141223 BE141090       455181   1106814_1   BE161696 AW863568 BE161629 BE161824       423167   879906_1   BG995664 AA322711 D79268 AA770464       459263   2049982_1   AJ003496 AJ003505 L25475       455175   1103799_1   AW993247 AW861464       454448   1028414_1   BE073941 BE073901 AW750209       409113   49403_1   AF319957 AA113914 AA131489 AA113889 AA075684 AA071047 AA126078 AA126283 AA075895 AA074583               AA070580 AA131372 AA079230               AA148748 AA120938 AA079200 AA122355 AA075041 AA071086 AA071110 AA074485 AA076151 AA070940 AA071308               AA070627 AA076622               AA079623 AA078802 AA079143 AA085188 AA079434 AA075968 AA071453 AA074159 AA076131 AA079401 AA115163               AA079329 AA069053               AA101144 AA070053 AA071087 AA102076 AA071310 AA122204 AA079659 AA063317 AA148628 AA078803 AA121103               AA076187 AA078931               AA070156 AA074198 AA070928 AA127089 AA083070 AA079280 AA134725 AA126185 AA076056 AA078833 AA084710               AA079117 AA084027               AA075042 AA129030 AA068994 AA069817 AA074897 AA079208 AA085044 AA081472 AA069220 AA071430 AA085118               AA083166 AA079450               AA074563 AA065051 AA100188 AA115929 AA064871 AA129031       459689   1272662_1   AA347192       439034   52270_1   AF075083 H52291 H52528       415350   1870780_1   T80268 R18726 Z44987 F12665 F11445 F11572 F06404 T74313 R13218 R13622       459695   817414_1   AW963571 AA381579 BG547915 H69131       455195   1107903_1   AW864319 AW864370 AW864504       411861   223814_1   BE067343 AW867875 BE067301 BE067347 BE067303 BE067304 BF851070 BE067350 BE067305 BE067306               BE067302 AW938147       456576   267535_1   AA287443 AI478347 AA419385 BE084078       454442   44916_2   AL529783 BF804681 BI858809 AW748795 AW816134 BE063456 BI911312 BG615273 AA347409       454520   825_6   BC020822 AW803378 AW803435 AW803371 BI518461 AV762185 AA298048 BI521095 AV764359 AV760834               BG548457 BI911189       459349   1027822_1   AW749381 H93337       455104   1096744_1   BF330730 BF350539 BE153665 BE065062 BE064650 BE064863 BF330763 BE153820 BE064737 BE155079               BE064651 AW856751 AW856622               BE064691 BE153674 BE153698 BE064730 BE153536       424200   890908_1   AW966196 AA337221 AA336756       423290   7964_7   AJ295991 AU138209 AV649543 BG195745 BG208133 AI458145 AW183395 AV649405 BF950906 AW962011               AW902934 AA324130 BI753806       449305   1066708_1   AW813561 AI638293       413257   1497012_1   BE075035 BE074999 BE075006 BE075008 BE075005 BE075032 BE075037       430692   60836_7   AI133594 AI064750 AW328184       424686   1228447_1   AW963243 AA345251 AA345504       411658   1095903_1   AW855645 AW855615 AW855610 BE148763 BE148764 BG951004 BG950922 BG950984 BG950998 BG950924               BG950921 BG951005 BG950995               BG950988 BG950919 AW855605 AW855608 BG950991 AW855598 AW855601 AW855596 BG950985       459721   36709_2   BE256910 AI299050 BG471673       442484   3699_10   AI110863 AF075362 AI110861 AF075360       411689   1097490_1   AW857121 AW861238 AW857123       411902   1141058_1   AW875344 AW875287 AW875285 AW875286 BF361295 AW875402 AW875400       418225   1239780_1   AW976061 AA747676 AA214595       410900   1063481_1   AW810169 AW809654 AW809839 AW810090 AW809703 AW809891 BF374636 BF374628 BF374725 AW810616               AW809733 BF374640 BF374623               AW810564       449986   2292_10   AK055879 AW007836 AA873089 N74374 AV720071 AA702706 AW055276 BE672779 AW864502 AI678780 AW864369               AI052145 T40984 N74426       413088   1489839_1   BE064856 BE064853 BE064960 BE064962 BE064857 BE064977 BE064860 BE064850 BE064815 BE064816               BE064806 BE064818 BE064796               BE064804 BE064668 BE064810 BE064979 BE064957 BE064819 BE064975 BE065059       448156   515877_1   BI495496 AW023207 BI495497 AI472886 AW023239       454573   22511_7   AW833609 AW833743 BI035140 AW821469 AW821541 AW821488 AW821531 AW821384 AW821625 AW821547               AW821549 AW821513               AW821577 BI034572 BI034365       433391   16854_1   AF038194 BG431979 BF987851 R52301 T77201       449637   34908_4   AL558074 BI914921 AV747407 AV749215 AA001964       436857   448721_1   AA732647 BE009028 BE008970       411484   1085933_1   AW848117 AW848128 AW848278 AW848401 AW848405 AW848281 AW848763       453493   470764_1   AL039478 AW970882       408766   106215_1   BG028106 BE155008 BE155007 AA057270 AA058715       455036   1091116_1   AW851708 AW851735 AW851703 AW851630 AW851712 AW851723       421036   264886_1   AW977543 AA282918       455404   703567_1   BE175503 BE175583 AW936409 AW936404       453502   1668_5   AF332192 NM_032491 BG772831 BG772873 BI460034 BI560011 BG723202 BG701021 BG720172 BI826825               BI464806 BG723004 BI559763               BI460842 BG773364 BI460208 BF377004 AL042201 BE855589 BE857075 AL044045 AA906504 AA961631               AW899993 AA885061 AW900006               AI652619 AI002078 AA983818 BG152590 BE763010 Z38801 F04136 F02320 H17003 BE762943 AI191585 N66165               BE762995 Z40423 AL039786               BI559354 BI562672 BG718512 BG720380 BI458642 BG772693 BI561299 BI459216 BF933814 R13208 Z42633 F07285               H10144 Z42852 F07873               R35183 H17002 F07362 BI459457 AL041856 BG724404 BG718143 BG701878 R50843 H10145 R40295 AW592045               BE935655 BG771671       409854   916262_1   AW502145 AW501833 AW502581       454754   1070974_1   AW819177 AW819242 AW819191 AW819175 AW819252 AW819244 AW819265 AW819269 AW819190               AW819268 AW819183 AW819246               AW819194 AW819249 AW819186 AW819180 AW819188 BE158470 AW819251 BE152602 AW819263       419392   215562_2   W28573 W27418       454803   1072913_1   BI468492 AW862380 AW860148 AW821887 AW821863 AW821894 AW821870 AW862378 AW862351       439884   10759_1   AB051476 BG289143 AV753375 AW051603 AW294678 AI435358 AI357776 AI091413 AI435427 AI367010 AI538999               AI039731 N67220 AW119213               BE326750 AI369016 T16459 R55315 AW296026 AI553628 AI537645 AI923565 BE910660 AW237341 H42671               H09709 AA847991 AA355842               BM454895 Z46035 AW195056 D63011 AI765593 BF999411 R55417 N91158 H88285 H99837 H49679 D61792               H52824 AW603615 R33635               D29082       454816   1073598_1   AW833298 AW833294 AW833272 AW833271 AW833274 AW833308 AW833275 AW833296 AW833295               AW833258 AW833306       437208   28382_1   AL110259 AA236599       412234   1160035_1   AW902569 AW902557 AW902654 AW902641 AW902650 AW902741 AW902644       410158   114375_1   BI256712 BF327164 AW936396 AW936458 AW936418 BF380035 BF368137       459472   1095076_1   AW854431 AA568933       410815   3326_23   AW805981 AW805974 AW806135 AW805972       436681   6833_1   AK021878 AU119692 AW502159 AU145969 AI393268 BE939969 AI288242 AI051978 BE677884 AI436745               AI935582 AI686473 AW861386               AA725270 BE940025 BF829279       436317   3614_2   AL096777 BM457842 AU116901 NM_021946 AK021424 AU158712 BE328021 BF765194 BF804830 BE621537 AA968672       443338   2262575_1   R99575 AI052252 R99681       416659   290122_1   W22048 W19418 H72518 BF908045       411173   881247_1   AW962014 AA324277 BI022237 AA091723 R81571       419932   3433_3   BI766402 AI365043 AA251996 N46090 AA281594       448306   50570_1   AK057289 AL601840 AL602227 BE247000 AA417150 BM150327 BM151615 BE247403 BE245780 AI480270               BE246663 BE245079 H54482               AI004637 T97117 AU157626 BE243570 AA781826 AA418396 H82937       439541   1235485_1   AW970853 N22817 AA837349       441577   17241_1   AK055721 AA399241 AI204074 AW269179 AI150462 AI422096 AA938959 AA024620 AA024498 AI751426       429258   121944_1   BG250865 AA448765 AA658293 C04967 BG988507 BG746352 C03045       413539   1519622_1   BE146879 BE146914 BE146918       409894   919627_1   AW503629 AW861738 BE081731 BE081969       411810   1107901_1   AW947513 AW864536 AW864318       459646   154497_1   AW470813 H44995 AW883968 BF746199 BF746344 BF746274 BF511374       459726   15924_1   NM_024644 AK025455 BC011350 AI240194 AA576870 AW295198 AW262665 AA968435 AA815311 AW769847               AA100496 AI796246 BI257802               AI968266 BF447872 AW341239 BE674505 AI183838 BF221583 Z40969 N64168 AI904509 AI904506 BG610839               BG107618 BG108325 BE784665               BE389806 BE390268 BF000100 AW444473 BF194857 BE843654 AW449497 BE093686 AL523620 AW402647               BI753888 BI913225 BM040984               Z45254 BF794833 BI915966 BI831226 AL523619 BG991161 BG957808 BE895148 BG469054       411280   1610_5   BF527858 AV713798 N50617 N47321 BF871615 R54159 BF741988 BF741990 BF741989 AW860545 AW835317       431317   997174_1   AW970601 AW613399 AA503435 AA502682 N91138       413919   1565718_1   BE180590 BE180585 BE180594       413576   417218_1   BG535869 BM263801 AV703254 T39786 BM263489 BE149684 T39845       454204   646158_1   AW816498 BF374419 BF374408 BF374405 AW808977 AW808605 BF334681 BF348941 BF348944 AW178676 BF374412               AW178486 BF374427               BF374429 BF348942 BF374428 BF348955 BF348940 BF348943 BF374416 BF374424 BF374431 BF374430 AW808524               BF374413 BF374418               BF334708 BF374389 BF334685 BF374473 BF374392 BF374397 BF374395 BF374407 BF374417 BF374420 BF374414               BF374422 BF374421               BF374522 BF349306 AW808532 BF374399 BF374393 BF374398 BF374394 BF374396 AW178485 BF374391               AW808816 BF374516 AW178483               AW808515 AW808791 BF374390 BF374415 AW808514 AW808379 BF374423 BF374426 BF348949 AW809007       433712   77122_3   AF090887 AI110655 AF063529       445832   437253_1   BF116098 AI261545 AW875247 N59134 AW875371       450594   82197_1   N31036 N42915 F07753 AA010329       416708   309677_1   R07686 T95204 T95230 H78836 BF932909       453816   9500_19   BG107738 BE149281 AL135405 AW891435       454991   1088900_1   AW850659 AW850532 AW850667 BE143543 AW850163 BF367228 AW850661       409236   777089_1   BE539805 BE536062 AW368376       458867   1246993_1   AW995393 AJ403118       458960   50855_1   NM_024331 BC003071 BM012414 BE315221 BG750119 BE272198 AL449476 BE886722 AI360302 BG002949               BM454474 AL449598 BM012506               BE383204 AA010225 AL449685 AL449684 BF742320 T06328       453611   1477969_1   AL045316 BF009728       413496   1517996_1   BE144708 BE144844 BE144705 BE144828 BE144815 BE144701 BE144841 BF144823 BE144836       459660   25501_86   BE072622 M79082       411708   1098544_1   AW857808 AW857817 AW857833 AW857837 AW857873       411962   2307710_1   AA099050 AA099526 T47733       438863   52130_1   AF075004 BF109017 R38002 R38003 F22027       410483   1028391_1   BE073747 AW750178 BE163567 BE073739 BE073748 BE073780 BE163491 BE163495 BE073763 BE073671               BE073689 BE073769       420270   258327_1   AW816460 AA257990 AI416981 AW500873       454410   6852_9   AW812744 AW581974 BG985054 AW812725       412996   1343199_1   BE046224 BE046730 BE046302       425673   727129_1   BG697146 AA361514 AW957439 AW298175 BI495720 R70319 AA579358 AI798179 AI633067 BG743245               AW403725 T49604 R70318       459407   1990083_1   H82757 N92114       456013   46281_8   BC015430 BG033733 T92048       456592   268841_1   AA291455 R91600 T87079       424128   890041_1   AW966163 AA335983 AA335973 AA336011 AA335668                                            
     [0340]                           TABLE 2C                       Pkey   Ref   strand   Nt_position                                                404839   7109502   Minus   11386-11689       400959   7705148   Minus   129453-130097       403397   9438368   Minus   84481-84655       404723   9884767   Minus   22795-22968       404398   9802820   Minus   17421-17497, 26796-26954,                   30866-30974       405475   1931025   Plus   1548-1702       404498   8151654   Plus   13292-13497       401074   3687273   Plus   72667-72812       401887   7229981   Plus   93973-94120       406547   7711513   Minus   172780-174358       402468   9797107   Minus   23969-24933       405278   6139075   Minus   3863-3965, 4823-4891, 5439-5529,                   6043-6170       405456   7656676   Plus   150052-150208       404319   9211467   Plus   54436-54608       403600   8101279   Minus   3680-3838       401775   9966311   Minus   110228-110340       405532   9755485   Minus   37485-39417       401411   7799787   Minus   144144-144329       403212   7630897   Minus   156037-156210       404834   6911603   Minus   37948-38226       401866   8018106   Plus   73126-73623       401558   7139678   Plus   103510-104090       405698   4165331   Plus   54114-54225       404974   3241949   Minus   12524-13612       404196   3805917   Minus   67928-68109       401758   9910067   Minus   146471-147987       401946   4914397   Plus   85670-85752, 86415-86571,                   87635-87796, 8791       402627   9931216   Plus   12136-12272, 16487-16628,                   17654-17798, 1849       406562   7711584   Plus   37316-37426       402747   9212492   Minus   7105-7357       400488   8919452   Plus   97365-98784       406225   7417725   Minus   9581-10055       406531   7711474   Minus   20515-20648, 22519-22601       405548   1532158   Plus   11552-11686       405510   7630909   Minus   101028-101174       403003   5441423   Minus   79403-79560, 79712-80021       404499   8151657   Plus   19376-19909       401945   4914397   Plus   83342-83809       402718   8969253   Plus   102033-102302, 103219-103485       404439   7139680   Plus   55316-55585       404632   9796668   Plus   45096-45229       403283   8076905   Minus   71124-71996       405591   6960456   Plus   146384-146641, 147035-147160       405863   7657810   Plus   49410-49620       401027   7230983   Minus   70407-70554, 71060-71160       402134   7704979   Minus   108621-109936       404432   7407979   Minus   123536-123660       405763   5931935   Plus   274920-275019, 276641-276802       404485   8096921   Plus   75166-75264, 124036-124232       404099   8076888   Minus   127375-127477       406108   7107999   Plus   89468-89674       401514   7622355   Plus   93224-93292, 94913-95065,                   95163-95334       405099   8074292   Minus   114365-114514, 128635-128831       403159   7408087   Plus   2775-2977       401454   9186923   Minus   114659-114832       402337   6957691   Plus   4116-4286, 16811-16973,                   17107-17256, 19715-       406346   9255974   Plus   104359-104542       404121   9796219   Plus   59256-59401       403661   8705027   Minus   30268-30482       405387   6587915   Minus   3769-3833, 5708-5895       401276   8954274   Minus   15919-16096       400827   8570385   Plus   143937-144450       400844   9188605   Plus   24746-24872, 25035-25204       405667   4726099   Plus   5798-5914       402527   9800806   Plus   4722-4916, 17858-18037,                   19964-20140, 24423-       402312   7341442   Plus   143645-143727, 147428-147514       401438   4885691   Minus   72461-72605                                                    
     [0341] Tables 3A to 6C [see 60/366,782].  
     [0342] Table 3A lists about 1389 genes up-regulated in Hepatitis C positive liver tissues compared to Hepatitis C negative liver tissues. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the Wicoxon rank-sum test p-value between the 2 groups was less than 0.10, the ratio of the “weighted average” of Hepatitis C positive liver tissues to the “weighted average” of Hepatitis C negative liver tissues was equal to or above 2.0, and that the differences between the same 2 groups was equal to or above 30.0. The “weighted average” of the Hepatitis C positive liver tissues was set to the trimean of various different Hepatitis C positive liver tissues. The “weighted average” of the Hepatitis C negative liver tissues was set to the either 10 or the trimean of various different Hepatitis C negative liver tissues, whichever value was greater to eliminate ratios with a denominator of zero or less.  
               TABLE 3A                          ABOUT 1389 GENES UP-REGULATED IN HEPATITIS C POSITIVE LIVER TISSUES       COMPARED TO HEPATITIS C NEGATIVE LIVER TISSUES                                         Pkey   ExAccn   UnigeneID   Unigene Title   R1   R2   R3                                                 428227   AA321649   Hs. 2248   small inducible cytokine subfamily B (Cy   5.544E−08   25.27   278.25       414004   AA737033   Hs. 7155   ESTs, Moderately similar to 2115357A TYK   1.131E−07   24.52   252.25       417621   AV654694   Hs. 82316   interferon-induced, hepatitis C-associat   8.497E−08   23.13   243       422746   NM_004484   Hs. 119651   glypican 3   8.647E−07   22.55   255.75       426711   AA383471   Hs. 343800   conserved gene amplified in osteosarcoma   5.544E−08   20.97   224.5       433854   AA610649   Hs. 333239   ESTs   1.322E−05   19.88   191       424090   X99699   Hs. 139262   XIAP associated factor-1   9.289E−06   17.80   190       448111   AA053486   Hs. 20315   interferon-induced protein with tetratri   2.262E−07   15.74   224.75       451652   AA018968   Hs. 133536   ESTs   1.321E−05   15.05   149.25       427283   AL119796   Hs. 174185   ectonucleotide pyrophosphatase/phosphodi   1.646E−06   14.90   189.75       418216   AA662240   Hs. 283099   AF15q14 protein   1.494E−07   14.17   153.25       432094   AI658580   Hs. 61426     Homo sapiens  mesenchymal stem cell prote   1.322E−05   13.72   128.25       425787   AA363867   Hs. 155029   ESTs   5.734E−06   13.57   151.75       430200   BE613337   Hs. 234896   geminin   1.492E−07   13.25   122.5       446094   AK001760   Hs. 13801   KIAA1685 protein   5.391E−06   12.90   138.5       413670   AB000115   Hs. 75470   hypothetical protein, expressed in osteo   3.643E−07   12.25   211       450937   R49131   Hs. 26267   ATP-dependant interferon response protei   8.647E−07   12.07   117       442048   AA974603       gb: op34f05.s1 Soares_NFL_T_GBC_S1 Homo s   1.481E−05   11.92   115       408393   AW015318   Hs. 23165   ESTs   2.127E−06   11.82   130.75       415443   T07353   Hs. 7948   ESTs   2.129E−04   11.80   115.75       417308   H60720   Hs. 81892   KIAA0101 gene product   6.467E−06   11.70   118.75       416206   AW206248   Hs. 111092   hypothetical protein FLJ22332   5.441E−07   11.35   135.25       432378   AI493046   Hs. 146133   ESTs   1.450E−06   11.13   107.5       445823   AI478563   Hs. 145519   FKSG87 protein   3.961E−06   11.00   101.25       447973   AB011169   Hs. 20141   similar to  S. cerevisiae  SSM4   2.487E−05   10.97   99.75       409153   W03754   Hs. 50813   hypothetical protein FLJ20022   2.972E−07   10.72   118.75       414052   AW578849   Hs. 283552   ESTs, Weakly similar to unnamed protein   8.090E−07   10.45   142.25       409231   AA446644   Hs. 692   GA733-2 antigen; epithelial glycoprotein   1.871E−05   10.30   130.75       407347   AA829847       gb: od40d07.s1 NCI_CGAP_GCB1  Homo sapiens     2.904E−06   10.05   93       403790           NM_001334*:  Homo sapiens  cathepsin O (CTS   1.765E−03   9.65   103.25       450293   N36754   Hs. 171118   hypothetical protein FLJ00026   7.923E−05   9.56   117.75       421057   T58283         Homo sapiens  cDNA: FLJ22063 fis, clone H   2.601E−03   9.27   85       428065   AI634046   Hs. 157313   ESTs   6.525E−04   9.22   93.25       418318   U47732   Hs. 84072   transmembrane 4 superfamily member 3   9.302E−05   9.21   115       451752   AB032997   Hs. 26966   KIAA1171 protein   6.383E−08   9.20   112.75       444665   BE613126   Hs. 47783   B aggressive lymphoma gene   1.641E−06   9.17   82.25       435812   AA700439   Hs. 188490   ESTs   2.485E−05   9.13   101.75       418143   AA283057   Hs. 266957   hypothetical protein FLJ14281   2.732E−04   9.00   82.5       435665   AI248952   Hs. 12320   ESTs   9.212E−07   8.85   103       421282   AA286914   Hs. 183299   ESTs   3.862E−04   8.67   102.5       426793   X89887   Hs. 172350   HIR (histone cell cycle regulation defec   1.083E−03   8.63   86.25       407644   D16815   Hs. 37288   nuclear receptor subfamily 1, group D, m   2.737E−04   8.56   115.25       422546   AB007969   Hs. 301478   KIAA0500 protein   2.408E−06   8.52   81.25       429490   AI971131   Hs. 23889   ESTs, Weakly similar to ALU7_HUMAN ALU S   2.951E−05   8.50   117       442994   AI026718   Hs. 16954   ESTs   5.152E−04   8.47   93.25       416224   NM_02902   Hs. 79088   reticulocalbin 2, EF-hand calcium bindin   7.048E−07   8.45   90.75       405102           C15001220*: gi|4469558|gb|AAD21311.1|(AF   1.038E−03   8.20   84.5       444314   AI140497       gb: ow76b09.s1 Soares_fetal_liver_spleen —     4.679E−04   8.10   81.25       426818   AA554827   Hs. 340046   DKFZp434A0131 protein   1.358E−03   8.02   86.5       417933   X02308   Hs. 82962   thymidylate synthetase   6.228E−04   7.95   73       432954   AI076345   Hs. 214199   ESTs   1.567E−04   7.88   76.5       449541   AA730673   Hs. 188634   ESTs   3.295E−05   7.85   70       410315   AI638871   Hs. 17625     Homo sapiens  cDNA: FLJ22524 fis, clone H   1.985E−06   7.80   86       446619   AU076643   Hs. 313   secreted phosphoprotein 1 (osteopontin,   3.481E−03   7.80   83.25       433586   T85301   Hs. 194397   gb: yd78d06.s1 Soares fetal liver spleen   1.417E−03   7.80   75       436995   AI160015   Hs. 118112   ESTs   3.858E−04   7.80   71       437374   AL359571   Hs. 44054   ninein (GSK3B interacting protein)   9.840E−06   7.70   77       421904   BE143533   Hs. 109309   hypothetical protein FLJ20035   2.972E−07   7.67   130.5       442679   R53718   Hs. 107882   hypothetical protein FLJ10659   1.048E−06   7.65   113       433401   AF039698   Hs. 284217   serologically defined colon cancer antig   1.113E−06   7.55   83       435571   AF212225   Hs. 283693   mitochondrial ribosomal protein L1   1.315E−05   7.55   79.25       419175   AW270037   Hs. 179507   KIAA0779 protein   7.276E−06   7.50   65       407930   AA045847   Hs. 188361     Homo sapiens  cDNA FLJ12807 fis, clone NT   5.420E−05   7.47   92.25       434263   N34895   Hs. 44648   ESTs   2.099E−03   7.47   67.5       448481   W15284   Hs. 74832   ESTs   7.876E−04   7.45   66.25       449935   AA004798   Hs. 108311   ESTs, Weakly similar to T00351 hypotheti   7.510E−05   7.38   79       407949   W21874   Hs. 247057   ESTs, Weakly similar to 2109260A B cell   7.276E−06   7.34   126.75       435102   AW899053   Hs. 76917   F-box only protein 8   6.222E−04   7.32   75.25       418452   BE379749   Hs. 85201   C-type (calcium dependent, carbohydrate-   2.417E−07   7.32   99.5       425053   AF046024   Hs. 154320   ubiquitin-activating enzyme E1C (homolog   7.505E−05   7.30   73.75       436090   AI640635   Hs. 332879   EST   6.091E−03   7.29   81.75       458725   AW970192   Hs. 171942   ras responsive element binding protein 1   6.048E−05   7.25   92.25       446488   AB037782   Hs. 15119   KIAA1361 protein   2.738E−04   7.25   88.25       449718   AA459480   Hs. 23956   hypothetical protein FLJ20502   1.994E−06   7.17   86       418840   AI821614   Hs. 185831   ESTs   5.649E−03   7.10   72.75       408063   BE086548   Hs. 42346   calcineurin-binding protein calsarcin-1   4.354E−05   7.05   100.5       436024   AI800041   Hs. 190555   ESTs   4.030E−04   7.02   72.75       447574   AF162666   Hs. 18895   tousled-like kinase 1   3.903E−05   6.97   88.75       447809   AW207605   Hs. 164230   ESTs, Highly similar to JC7266 3′,5′-cyc   1.547E−06   6.97   87       424878   H57111   Hs. 221132   ESTs   2.240E−04   6.95   105.25       450016   AA249590   Hs. 100748   ESTs, Weakly similar to A28996 prolinE-r   8.224E−06   6.90   63.75       452744   AI267652   Hs. 246107     Homo sapiens  mRNA; cDNA DKFZp434E082 (fr   1.969E−07   6.82   237       433230   AW136134   Hs. 220277   ESTs   1.176E−05   6.80   99.75       409052   AW898179   Hs. 50123   zinc finger protein 189   3.075E−03   6.80   59.75       434280   BE005398       gb: CM1-BN0116-150400-189-h02 BN0116 Homo   1.650E−04   6.79   81       419586   AI088485   Hs. 144759   ESTs, Weakly similar to I38022 hypotheti   5.435E−07   6.77   76.25       422506   R20909   Hs. 300741   sorcin   1.488E−02   6.77   70.75       424941   AA128376   Hs. 153884   ATP binding protein associated with cell   5.724E−05   6.77   62       411605   AW006831   Hs. 145409   ESTs   2.596E−03   6.76   89.25       433208   AW002834   Hs. 24095   ESTs   7.123E−03   6.75   65.5       433730   AK002135   Hs. 3542   hypothetical protein FLJ11273   9.472E−04   6.72   86.5       445929   AI089660   Hs. 323401   dpy-30-like protein   1.828E−04   6.72   74.75       448694   AA478756   Hs. 194477   E3 ubiquitin ligase SMURF2   1.210E−04   6.71   88.5       446667   BE161878   Hs. 224805   ESTs   4.102E−03   6.70   64.25       452973   H88409   Hs. 93788   ESTs   9.463E−04   6.70   63.25       405268           ENSP00000223174*: KIAA0783 PROTEIN.   1.274E−04   6.70   60       423732   AF058056   Hs. 132183   solute carrier family 16 (monocarboxylic   4.464E−04   6.67   64       431214   AA294921   Hs. 348024   v-ral simian leukemia viral oncogene horn   2.707E−03   6.67   65.25       419407   AW410377   Hs. 41502   hypothetical protein FLJ21276   2.125E−06   6.60   103.75       422040   AA172106   Hs. 110950   Rag C protein   1.652E−04   6.58   60       443547   AW271273   Hs. 23767   hypothetical protein FLJ12666   2.117E−06   6.57   95       446493   AK001389   Hs. 15144   hypothetical protein DKFZp564O043   2.734E−04   6.55   80.25       416475   T70298       gb: yd26g02.s1 Soares fetal liver spleen   1.091E−04   6.55   73       447541   AK000288   Hs. 18800   hypothetical protein FLJ20281   2.282E−03   6.55   63.75       441976   AA428403   Hs. 106131   ESTs   1.082E−04   6.55   62.75       434375   BE277910   Hs. 3833   3′-phosphoadenosine 5′-phosphosulfate sy   4.776E−06   6.52   80       408096   BE250162   Hs. 83765   dihydrofolate reductase   3.206E−03   6.52   71.25       453887   BE564037   Hs. 36237   hypothetical protein   5.688E−05   6.52   62.75       419550   D50918   Hs. 90998   KIAA0128 protein; septin 2   3.397E−07   6.50   71       416133   NM_001683   Hs. 89512   ATPase, Ca transporting, plasma membrane   3.206E−03   6.45   60.5       442993   BE018682   Hs. 166196   ATPase, Class I, type 8B, member 1   6.863E−06   6.40   77.5       413645   AA130992       gb: zo15e02.s1 Stratagene colon (937204)   4.820E−03   6.36   60.25       445525   BE149866   Hs. 14831     Homo sapiens , Similar to zinc finger pro   1.120E−06   6.35   74.5       431183   NM_006855   Hs. 250696   KDEL (Lys-Asp-Glu-Leu) endoplasmic relic   8.296E−03   6.35   61.5       434474   AL042936   Hs. 211571   holocytocbrome c synthase (cytochrome c   6.345E−03   6.32   56       435029   AF167706   Hs. 19280   cysteine-rich motor neuron 1   5.425E−03   6.32   53.5       409512   AW979187   Hs. 293591   melanoma differentiation associated prot   7.934E−08   6.27   221.5       426925   NM_001196   Hs. 315689     Homo sapiens  cDNA: FLJ22373 fis. clone H   8363E−05   6.25   68.25       418476   AA648431   Hs. 37883   hypothetical protein PNAS-131   9.290E−05   6.25   65       421097   AI280112   Hs. 125232     Homo sapiens  cDNA FLJ13266 fis, clone OV   1.543E−02   6.25   53.5       414405   AI362533   Hs. 306117   KIAA0306 protein   5.377E−06   6.23   68       451788   BE242857   Hs. 27021   hypothetical protein FLJ11159   3.020E−04   6.22   62       408753   AI337192   Hs. 47438   SH3 domain binding glutamic acid-rich pr   1.764E−03   6.22   54       442045   C05768   Hs. 8078     Homo sapiens  clone FBD3 Cri-du-chat crit   2.024E−04   6.19   67.5       414183   AW957446   Hs. 301711   ESTs   2.024E−04   6.17   74.5       425073   W39609   Hs. 22003   solute carrier family 6 (neurotransmitte   1.838E−03   6.17   54.5       426110   NM_002913   Hs. 166563   replication factor C (activator 1)1(14   8.722E−06   6.13   65       435511   AA683336   Hs. 189046   ESTs   3.204E−03   6.11   56.25       407218   AA095473   Hs. 28505   ubiquitin-conjugating enzyme E2H (homolo   6.093E−03   6.10   66.25       422173   BE385828   Hs. 250619   phorbolin-like protein MDS019   2.582E−07   6.05   104.5       443852   AI679966   Hs. 150603   ESTs   1.692E−03   6.02   71.25       445813   Z42023   Hs. 106576   alaninE-glyoxylate aminotransferase 2-li   4.050E−04   6.02   66       413922   AI535895   Hs. 221024   ESTs   3.628E−03   6.00   78.75       440624   AF017987   Hs. 7306   secreted frizzled-related protein 1   2.595E−03   6.00   60       426458   D83032   Hs. 169984   nuclear protein   2.601E−03   6.00   57.25       418791   AA935633   Hs. 194628   ESTs   4.684E−04   5.99   89.75       437629   AW574774   Hs. 121692   ESTs   1.485E−04   5.98   51       447164   AF026941   Hs. 17518     Homo sapiens  cig5 mRNA, partial sequence   2.959E−07   5.97   145.25       424699   AW206227   Hs. 287727   hypothetical protein FLJ23132   6.525E−04   5.97   54.25       443035   Z45822   Hs. 8906     Homo sapiens  clone 24889 mRNA sequence   1.271E−04   5.97   50.75       452827   AI571835   Hs. 55468   ESTs   9.250E−06   5.96   103       431604   AF175265   Hs. 264190   vacuolar protein sorting 35 (yeast homol   2.024E−04   5.95   62.75       445943   AW898533   Hs. 181574   ESTs   3.331E−04   5.95   60.75       451122   AA015767   Hs. 84522   ESTs   4.624E−03   5.95   53       425167   AA351629   Hs. 225567   ESTs   2.237E−04   5.93   53       411252   AB018549   Hs. 69328   MD-2 protein   8.196E−06   5.92   103.75       423598   BE247600   Hs. 155538   ESTs   6.835E−04   5.92   51       431736   AI912234   Hs. 3297   ribosomal protein S27a   3.326E−04   5.91   83.5       410361   BE391804   Hs. 62661   guanylate binding protein 1, interferon-   5.384E−04   5.88   86       417228   AL134324   Hs. 7312   ESTs   2.953E−05   5.88   63       415938   BE383507   Hs. 78921   A kinase (PRKA) anchor protein 1   2.218E−05   5.83   77.25       427484   N32859   Hs. 37288   nuclear receptor subfamily 1. group D, m   5.068E−06   5.82   114       443291   AA325633   Hs. 136102   KIAA0853 protein   3.022E−04   5.82   78.5       424308   AW975531   Hs. 154443   minichramosome maintenance deficient (S.   4.611E−05   5.82   60       430261   AA305127   Hs. 237225   hypothetical protein HT023   7.140E−04   5.82   58.5       447735   AA775268   Hs. 6127     Homo sapiens  cDNA: FLJ23020 fis, clone L   5.114E−05   5.82   48.75       419644   AU076951   Hs. 91797   retinoblastoma-binding protein 1   9.265E−06   5.80   70.75       456619   AV647917   Hs. 107153   inhibitor of growth family, member 1-lik   2.219E−05   5.80   67.25       414812   X72755   Hs. 77367   monokine induced by gamma interferon   3.893E 07   5.78   181.75       418876   AA740616       gb: ny97f11.s1 NCI_CGAP_GCB1  Homo sapiens     1.042E−05   5.75   77.5       408360   AI806090   Hs. 44344   hypothetical protein FLJ20534   1.103E−05   5.75   59.25       418224   AL036057   Hs. 83795   interferon regulatory factor 2   1.482E−04   5.75   58.25       456236   AF045229   Hs. 82280   regulator of G-protein signalling 10   3.860E−04   5.72   54.25       449609   BE246434   Hs. 289026   guanine nucleotide binding protein (G pr   3.658E−04   5.72   49       448554   NM_016169   Hs. 21431   suppressor of fused   7.897E−05   5.72   49       445529   H14421   Hs. 180513   ATP-binding cassette, sub-family A (ABC1   7.515E−05   5.70   61.75       434210   AA665612   Hs. 90093   ESTs   1.287E−07   5.67   99.5       410577   X91911   Hs. 64639   glioma pathogenesis-related protein   1.113E−06   5.67   95       400517   AF242388       lengsin   9.250E−06   5.67   73.5       438011   BE466173   Hs. 145696   splicing factor (CC1.3)   8.617E−04   5.67   64.25       456439   AA251242   Hs. 103238   ESTs   2.830E−03   5.67   48       421594   R45689   Hs. 21889     Homo sapiens  cDNA FLJ12978 fis, clone NT   3.342E−03   5.65   48.75       408214   AL120445   Hs. 77823   hypothetical protein FLJ21343   4.253E−04   5.60   58       441028   AI333660   Hs. 17558     Homo sapiens  cDNA FLJ14446 fis, clone HE   8.358E−05   5.59   58.5       421650   AA781795   Hs. 122587   ESTs   3.287E−06   5.57   95.75       433037   NM_014158   Hs. 279938   HSPC067 protein   9.795E−05   5.57   69.75       409277   T05558   Hs. 156880   ESTs   1.084E−03   5.57   62.5       428172   U09367   Hs. 182828   zinc finger protein 136 (clone pHZ-20)   1.490E−04   5.57   48.5       424915   R42755   Hs. 23096   ESTs   1.565E−04   5.54   46.5       431863   AA188185   Hs. 289043   spindlin   9.265E−06   5.53   148.5       457130   NM_005651   Hs. 183671   tryptophan 2,3-dioxygenase   3.622E−03   5.52   79       431122   AI267593   Hs. 250535     Homo sapiens  mRNA; cDNA DKFZp434N2412 (f   3.670E−04   5.52   47.25       413509   BE145419       gb: IL5-HT0198-291099-009-E01 HT0198 Homo   7.118E−03   5.52   46.75       412802   U41518   Hs. 74602   aquaporin 1 (channel-forming integral pr   1.275E−04   5.50   95.5       416309   R84694   Hs. 79194   cAMP responsive element binding protein   4.750E−06   5.50   60.5       437730   AW071087   Hs. 239176   insulin-like growth factor 1 receptor   7.833E−04   5.50   48.5       410867   X63556   Hs. 750   fibrillin 1 (Marfan syndrome)   1.438E−02   5.50   48.25       431586   AW971100   Hs. 293189   ESTs   3.341E−03   5.47   55.75       420520   AK001978   Hs. 98510   similar to rab11-binding protein   2.701E−03   5.47   55.25       421633   AF121860   Hs. 106260   sorting nexin 10   1.201E−02   5.47   52.5       437175   AW968078   Hs. 87773   protein kinase, cAMP-dependent, catalyti   1.735E−04   5.46   62.5       428467   AK002121   Hs. 184465   hypothetical protein FLJ11259   5.146E−04   5.45   46.75       443441   AW291196   Hs. 92195   ESTs   3.555E−02   5.45   50.5       424243   AI949359   Hs. 339739   ESTs, Highly similar to cis Golgi-locali   5.416E−05   5.45   49.75       415660   AI909007   Hs. 78563   ubiquitin-conjugating enzyme E2G 1 (homo   1.596E−02   5.45   48       439008   AF075072   Hs. 167535   ESTs, Weakly similar to ALU1_HUMAN ALU S   1.297E−03   5.45   47       420789   AI670057   Hs. 199882   ESTs   4.814E−03   5.45   46.75       432388   X15218   Hs. 2969   v-ski avian sarcoma viral oncogene homol   2.734E−04   5.43   46.5       439375   AA689526   Hs. 344249   steroid dehydrogenase homolog   2.219E−05   542   64.75       413010   AA393273   Hs. 75133   transcription factor 6-like 1 (mitochond   1.846E−03   5.42   46.5       448901   AK001021   Hs. 22505   hypothetical protein FLJ10159   1.989E−06   5.40   76.75       429747   M87507   Hs. 2490   caspase 1, apoptosis-related cysteine pr   9.219E−06   5.40   69.5       453742   AB037744   Hs. 34892   KIAA1323 protein   7.173E−04   5.40   55.5       405141   Y14443       zinc finger protein 200   1.159E−02   5.40   44.5       450206   AI796450   Hs. 201600   ESTs   2.735E−04   5.38   47       422553   AI697720   Hs. 171455   ESTs, Weakly similar to T31613 hypotheti   6.857E−06   5.35   84       408048   NM_007203   Hs. 42322   A kinase (PRKA) anchor protein 2   1.240E−03   5.35   58.75       420338   AA825595   Hs. 88269     Homo sapiens , clone MGC: 17339, mRNA, com   2.123E−06   5.32   49.5       414279   AW021691       GCN5 (general control of ammo-acid synt   1.544E−02   5.30   56       449429   AA054224   Hs. 59847   ESTs   3.076E−03   5.30   52       417688   R09170   Hs. 284350   ESTs   1.487E−04   5.30   43.25       434421   AI915927   Hs. 34771   ESTs   4.454E−04   5.30   65.5       439301   AA833784   Hs. 252888   ESTs   1.085E−03   5.27   74.5       433505   AW504027   Hs. 15301     Homo sapiens  cDNA FLJ12596 fis, clone NT   6.228E−04   5.27   51.25       430556   AW967807   Hs. 13797   ESTs   1.295E−03   5.26   72.5       414737   AI160386   Hs. 125087   ESTs   2.395E−06   5.25   108.25       439971   W32474   Hs. 301746   RAP2A, member of RAS oncogene family   1.753E−06   5.25   86.75       450697   AW152166   Hs. 182113   ESTs   8.621E−04   5.25   68       419490   NM_006144   Hs. 90708   granzyme A (granzyme 1, cytotoxic T-lymp   3.208E−03   5.25   55.5       433001   AF217513   Hs. 279905   clone HQ0310PRO0310p1   1.345E−04   5.23   87.75       432441   AW292425   Hs. 163484   ESTs   2.471E−04   5.22   76       449618   AI076459   Hs. 15978   KIAA1272 protein   9.832E−02   5.22   46.75       433437   U20536   Hs. 3280   caspase 6, apoptosis-related cysteine pr   1.649E−06   5.20   92.5       450916   AA011597   Hs. 177398   ESTs   7.511E−04   5.20   94.5       427699   AW965076   Hs. 180378   hypothetical protein 669   1.928E−03   5.20   53.25       421535   AB002359   Hs. 105478   phosphoribosylformylglycinamidinesyntha   6.512E−04   5.20   44.25       410511   AA743475   Hs. 285655   ESTs   2.947E−03   5.20   43       448760   AA313825   Hs. 21941   AD036 protein   2.628E−05   5.19   66       452327   AK000196   Hs. 29052   hypothetical protein FLJ20189   5.424E−05   5.17   58.25       449365   AW968261   Hs. 118913   ESTs, Moderately similar to T46371 hypot   4.097E−03   5.17   53.75       413007   BE046662       gb: hn42f02.x1 NCI_CGAP_RDF2  Homo sapiens     4.681E−04   5.17   44.5       414522   AW518944   Hs. 76325   step II splicing factor SLU7   4.684E−04   5.16   139.25       451081   AI078645   Hs. 431   murine leukemia viral (bmi-1) oncogene h   2.490E−03   5.15   49.25       437834   AA769294   Hs. 283854   gb: nz36g03.s1 NCI_CGAP_GCB1  Homo sapiens     3.307E−04   5.13   55.5       458965   AA010319   Hs. 60389   ESTs   3.856E−04   5.13   41.75       442878   AI868648   Hs. 22315   ESTs   3.672E−04   5.10   58.75       410337   M83822   Hs. 62354   cell division cycle 4-like   1.652E−04   5.10   55.75       422267   AB033044   Hs. 114012   KIAA1218 protein   1.405E−04   5.10   47.25       438865   H64256   Hs. 167619   ESTs, Moderately similar to ALUC_HUMAN!   3.034E−02   5.10   42.5       438914   N93892   Hs. 10727   ESTs   5.630E−03   5.10   43       407204   R41933   Hs. 140237   ESTs, Weakly similar to ALU1_HUMAN ALU S   1.663E−05   5.07   61.5       431049   AA846576   Hs. 103267   hypothetical protein FLJ22548 similar to   7.687E−06   5.07   55.5       417355   D13168   Hs. 82002   endothelin receptor type B   5.142E−02   5.07   45.25       419522   AI682428   Hs. 157728   ESTs   8.292E−05   5.05   48.25       433697   AA600357   Hs. 239489   TIA1 cytotoxic granule-associated RNA-bi   5.421E−03   5.02   48.25       428420   AL096858   Hs. 184245   KIAA0929 protein Msx2 interacting nuclea   7.583E−07   5.01   128.25       434658   AI624436   Hs. 310286   ESTs   6.092E−06   5.00   113.25       430268   AK000737   Hs. 237480   hypothetical protein FLJ20730   1.480E−03   5.00   50.75       426052   N49068   Hs. 93966   ESTs   7.107E−05   5.00   47.25       450086   AW016343   Hs. 233301   ESTs   2.491E−03   5.00   47       430512   AF182294   Hs. 241578   U6 snRNA-associated Sm-like protein LSm8   1.038E−02   5.00   44.5       456034   AW450979       gb: UI-H-BI3-ata-a-12-0-Ul.s1 NCI_CGAP_Su   9.642E−03   5.00   40.75       432606   NM_002104   Hs. 3066   granzyme K (serine protease, granzyme 3;   2.094E−05   4.99   146.5       431620   AA126109   Hs. 264981   2′-5′-oligoadenylate synthetase 2 (69-71   7.389E−08   4.98   241.75       440043   BE277457   Hs. 30661   hypothetical protein MGC4606   1.297E−03   4.97   43.25       427008   Z45258   Hs. 286013   short coiled-coil protein   2.785E−05   4.97   68.5       443884   N20617   Hs. 194397   leptin receptor   4.448E−03   4.95   74.25       444670   H58373   Hs. 332938   hypothetical protein MGC5370   3.017E−04   4.95   65       424852   AI222779   Hs. 144848   ESTs   6.341E−03   4.95   48       450747   AI064821   Hs. 318535   ESTs, Highly similar to 1818357A EWS gen   3.670E−02   4.95   45       411360   AK001601   Hs. 69594   high-mobility group 20A   5.639E−03   4.95   45       407366   AF026942   Hs. 271530   gb:  Homo sapiens  cig33 mRNA, partial sequ   8.647E−07   4.92   115.5       422150   AI867118   Hs. 279607   calpastatin   1.437E−02   4.92   42       419135   R61448   Hs. 106728   ESTs, Weakly similar to KIAA1353 protein   5.724E−06   4.92   115.75       414646   AA353776   Hs. 901   CD48 antigen (B-cell membrane protein)   2.413E−06   4.90   87.5       450447   AF212223   Hs. 25010   hypothetical protein P15-2   4.456E−04   4.90   54       434158   T86534   Hs. 14372   ESTs   2.190E−03   4.90   46.75       420151   AA255931   Hs. 186704   ESTs   2.209E−05   4.90   46.75       408831   AF090114   Hs. 48433   endocrine regulator   1.732E−04   4.90   41.25       449500   AW956345   Hs. 12926   ESTs   2.839E−02   4.90   40.75       418662   AI801098   Hs. 151500   ESTs   1.716E−02   4.88   49.25       416050   U51903   Hs. 78993   IQ motif containing GTPase activating pr   2.108E−02   4.88   43       451338   AW612322   Hs. 19131   transcription factor Dp-2 (E2F dimerizat   2.730E−04   4.86   40.5       449523   NM_000579   Hs. 54443   chemokine (C-C motif) receptor 5   1.871E−05   4.85   59.5       423857   N48902   Hs. 133481     Homo sapiens  mRNA; cDNA DKFZp564O0862 (f   1.764E−03   4.82   58.75       427384   T82854       gb: yd42a09.r1 Soares fetal liver spleen   2.180E−02   4.82   43.75       451273   NM_014811   Hs. 26163   KIAA0649 gene product   9.414E−04   4.82   38.25       456508   AA502764   Hs. 123469   ESTs, Weakly similar to AF208855 1 BM-01   1.298E−03   4.81   55.25       457584   AA147979   Hs. 285005   mitochondrial import receptor Tom22   5.139E−05   4.80   57       443998   AI620661   Hs. 296276   ESTs   2.290E−03   4.77   77       454075   R43826   Hs. 16313   Kruppel-like zinc finger protein GLIS2   2.100E−03   4.77   58.5       407609   R43159   Hs. 238432   ESTs   9.450E−04   4.77   54.75       424683   N87519   Hs. 27196   ESTs   1.650E−04   4.77   52.5       452820   N46161   Hs. 35274   ESTs   2.103E−03   4.77   46.75       441866   BE464341   Hs. 21201   nectin 3; DKFZP566B0846 protein   3.134E−02   4.77   40.5       429966   BE081342   Hs. 283037   HSPC039 protein   5.784E−02   4.77   39       449613   N63808   Hs. 34299   ESTs   2.725E−06   4.75   102       409703   NM_006187   Hs. 56009   2′-5′-oligoadenylate synthetase 3 (100 k   5.544E−08   4.75   441       439334   AI148976   Hs. 112062   ESTs   3.154E−04   4.74   40.25       410382   AW664971   Hs. 259546   ESTs   1.207E−04   4.72   57.75       434926   BE543269   Hs. 50252   mitochondrial ribosomal protein L32   1.733E−04   4.72   57       433198   AA992841   Hs. 27263   KIAA1458 protein   1.339E−02   4.72   44       435970   H75410   Hs. 54452   zinc finger protein, subfamily 1 A, 1 (Ik   5.395E−04   4.70   46.25       416647   BE297139   Hs. 79411   replication protein A2 (32 kD)   3.670E−04   4.68   66.25       409038   T97490   Hs. 50002   small inducible cytokine subfamily A (Cy   2.243E−04   4.68   193       429952   AF080158   Hs. 226573   inhibitor of kappa light polypeptide gen   3.684E−05   4.67   67.5       413048   M93221   Hs. 75182   mannose receptor, C type 1   7.864E−04   4.67   52.25       425068   AL048716   Hs. 154387   KIAA0103 gene product   2.843E−02   4.67   40.75       450401   AW959281   Hs. 8184   ESTs   1.547E−03   4.67   39.75       402727           NM_025065:  Homo sapiens  hypothetical prot   1.118E−02   4.67   55       449209   BE616830   Hs. 294145   ESTs   3.170E−04   4.66   58.5       432600   AI821085       gb: ns95a12.y5 NCI_CGAP_Pr3  Homo sapiens     2.022E−04   4.65   84.25       441892   AB028981   Hs. 8021   KIAA1058 protein   1.867E−05   4.65   55.5       407284   AI539227   Hs. 214039   hypothetical protein FLJ23556   8.131E−02   4.65   51.75       450516   AA902656   Hs. 21943   NIF3 (Ngg1 interacting factor 3,  S. pombe      3.658E−04   4.65   49       426728   NM_007118   Hs. 171957   triple functional domain (PTPRF interact   6.500E−02   4.64   41       449909   AA004681   Hs. 59432   ESTs   1.767E−03   4.63   37.25       409401   AI201895   Hs. 181309   proteasome (prosome, macropain) subunit,   4.052E−04   4.63   61       450669   AL138077   Hs. 16157   hypothetical protein FLJ12707   7.864E−04   4.63   36.25       408405   AK001332   Hs. 44672   hypothetical protein FLJ10470   3.393E−07   4.61   115.5       451079   AI827988   Hs. 240728   ESTs, Moderately similar to PC4259 ferri   8.821E−05   4.60   60.5       408108   AI580492   Hs. 42743   hypothetical protein   5.663E−04   4.60   47.75       453555   N23574   Hs. 123649   ESTs, Moderately similar to ALU7_HUMAN A   2.764E−05   4.60   40.25       437967   BE277414   Hs. 5947   mel transforming oncogene (derived from   8.298E−03   4.59   71.75       435260   H64245   Hs. 34458   ESTs   2.194E−03   4.59   36.75       425100   AF051850   Hs. 154567   supervillin   5.865E−03   4.58   38.5       447023   AA356764   Hs. 17109   integral membrane protein 2A   6.056E−05   4.57   92       408705   AA312135   Hs. 46967   HSPCO34 protein   1.044E−06   4.57   62.5       424626   AA344308   Hs. 128427     Homo sapiens  BAC clone RP11-335J18 from   1.399E−05   4.57   61.25       413786   AW613780   Hs. 13500   ESTs   1.966E−07   4.57   60       432572   AI660840   Hs. 191202   ESTs, Weakly similar to ALUE_HUMAN !!!!   7.522E−04   4.55   80.75       446927   AW503484   Hs. 16533   myosin phosphatase, target subunit 1   1.596E−02   4.55   42.25       417052   NM_000712   Hs. 81029   biliverdin reductase A   5.081E−06   4.55   110       437456   AL047045   Hs. 60293     Homo sapiens  clone 122482 unknown mRNA   2.477E−04   4.54   74.25       411590   T96183       gb: ye09f07.s1 Stratagene lung (937210) H   3.777E−03   4.53   46.75       401091   F07783       decay accelerating factor for complement   9.445E−04   4.52   56       423250   BE061916   Hs. 125849   chromosome 8 open reading frame 2   1.077E−02   4.52   49.75       429732   U20158   Hs. 2488   lymphocyte cytosolic protein 2 (SH2 doma   1.292E−02   4.52   36.25       409549   AB029015   Hs. 54886   phospholipase C, epsilon 2   3.841E−04   4.52   45.75       409461   AA382169   Hs. 54483   N-myc (and STAT) interactor   1.490E−07   4.50   197       451253   H48299   Hs. 26126   claudin 10   9.284E−05   4.50   92.75       443119   AA312264   Hs. 7980   hypothetical protein MGC12966   2.021E−04   4.50   43       423954   AW753164   Hs. 288604   KIAA1632 protein   1.241E−03   4.48   36.5       433226   AW503733   Hs. 9414   KIAA1488 protein   4.251E−04   4.47   68.25       429276   AF056085   Hs. 198612   G protein-coupled receptor 51   2.232E−04   4.47   64.75       419743   AW408762   Hs. 5957     Homo sapiens  clone 24416 mRNA sequence   8.609E−03   4.47   43.75       432967   AA572949   Hs. 207566   ESTs   5.637E−04   4.47   41.75       417973   NM_004490   Hs. 83070   growth factor receptor-bound protein 14   1.339E−02   4.47   40.75       417954   AI633943   Hs. 26613   ESTs, Weakly similar to no similarities   3.787E−02   4.47   39.25       421654   AW163267   Hs. 106469   suppressor of var1 ( S. cerevisiae ) 3-like   2.178E−02   4.47   39.25       445776   NM_001310   Hs. 13313   cAMP responsive element binding protein-   1.339E−02   4.47   35.5       430008   AW085625   Hs. 186838   ESTs, Weakly similar to Z295_HUMAN ZINC   3.203E−03   4.47   55.5       421215   AI868634   Hs. 246358   ESTs, Weakly similar to T3225tt hypotheti   1.662E−05   4.46   71.75       430293   AI416988   Hs. 238272   inositol 1,4,5-triphosphate receptor, ty   1.149E−04   4.45   104.5       428342   AI739168         Homo sapiens  cDNA FLJ13458 fis, clone PL   1.107E−05   4.45   85.5       446839   BE091926   Hs. 16244   mitotic spindle coiled-coil related prot   2.947E−03   4.45   53       434941   AW073202   Hs. 334825     Homo sapiens  cDNA FLJ14752 fis, clone NT   8.634E−04   4.45   50.75       421181   NM_005574   Hs. 184585   LIM domain only 2 (rhombotin-like 1)   1.845E−03   4.45   39.25       421508   NM_004833   Hs. 105115   absent in melanoma 2   7.103E−05   4.43   51.5       441652   BE467811   Hs. 7471   BBP-like protein 1   9.630E−03   4.43   43.75       429105   D87077   Hs. 196275   KIAA0240 protein   2.412E−02   4.42   34.5       439223   AW238299   Hs. 250618   UL16 binding protein 2   1.083E−03   4.42   41       446770   AV660309   Hs. 154986   ESTs, Weakly similar to PLLP_HUMAN PLASM   7.916E−02   4.42   45.25       436535   AW295687   Hs. 254420   ESTs   1.169E−05   4.40   59.5       413243   AA769266   Hs. 193657   ESTs   2.945E−03   4.40   52.25       408461   AB037756   Hs. 45207   hypothetical protein KIAA1335   6.091E−03   4.40   36.75       432873   AW837268   Hs. 279639     Homo sapiens  mRNA; cDNA DKFZp586M2022 (f   1.928E−03   4.40   34.25       416701   R94977   Hs. 35416   PRO0132 protein   1.928E−03   4.39   51.75       450746   D82673   Hs. 278589   general transcription factor II. i   7.536E−07   4.39   133.75       432435   BE218886   Hs. 282070   ESTs   9.808E−05   4.38   90.75       421685   AF189723   Hs. 106778   ATPase, Ca transporting, type 2C, member   5.412E−04   4.38   45.5       419951   AI653415   Hs. 195789   ESTs   9.022E−04   4.38   44.75       424960   BE245380   Hs. 153952   5′ nucleotidase (CD73)   2.841E−02   4.38   40.25       410099   AA081630       KIAA0036 gene product   2.038E−02   4.38   35.25       422879   AI241409   Hs. 188092   ESTs   2.021E−04   4.35   65.75       438769   AA830684   Hs. 163426   ESTs   1.419E−03   4.35   64.75       443084   AI827639   Hs. 125539   ESTs   8.228E−04   4.35   62.75       417363   AW129357   Hs. 329700   ESTs   3.627E−03   4.35   51       408162   AA993833   Hs. 118527   ESTs   8.270E−03   4.35   33.5       421379   Y15221   Hs. 103982   small inducible cytokine subfamily B (Cy   3.401E−07   4.34   115.25       414462   BE622743   Hs. 301064   arfaptin 1   1.299E−03   4.34   59.25       410245   C17908   Hs. 194125   ESTs   6.345E−03   4.32   44       434666   AF151103   Hs. 112259   T cell receptor gamma locus   1.146E−04   4.30   52.25       431328   AA502999   Hs. 291591   ESTs   1.211E−04   4.30   46       452939   R35348   Hs. 24970   ESTs, Weakly similar to B34323 GTP-bindi   5.213E−03   4.30   36.25       426030   BE243933   Hs. 108642   zinc finger protein 22 (KOX 15)   2.037E−02   4.30   38.75       417819   AI253112   Hs. 133540   ESTs   5.295E−02   4.30   36.25       429922   Z97630   Hs. 226117   H1 histone family, member 0   2332E−02   4.29   48.5       428255   AI627478   Hs. 187670   ESTs   5.672E−04   4.28   44.25       407690   R47799   Hs. 266957   hypothetical protein FLJ14281   2.107E−07   4.27   93.75       447887   AA114050   Hs. 19949   caspase 8, apoptosis-related cysteine pr   2.465E−04   4.27   50       446751   AA766998   Hs. 79126   Human DNA sequence from clone RP11-16L21   6.861E−03   4.27   45.75       432610   BE246615   Hs. 278507   histidyl-tRNA synthetase-like   8.625E−04   4.27   38.5       434198   AF119849   Hs. 283028   hypothetical protein PRO1598   1.417E−03   4.27   35.75       425387   AB037864   Hs. 156051   KIAA1443 protein   3.843E−04   4.27   35.75       407309   AA526438   Hs. 281680   peroxisomal trans 2-enoyl CoA reductase;   3.682E−05   4.27   41.75       429588   AI080271   Hs. 134533   ESTs   1.693E−03   4.27   48.25       434987   AW975114   Hs. 293273   ESTs   1.297E−03   4.25   79       432195   AJ243669   Hs. 8127   KIAA0144 gene product   7.510E−05   4.25   58       433847   AA610266       ESTs   2.477E−04   4.25   43       428720   T90468   Hs. 178154   ESTs   1.083E−03   4.25   39.5       419110   AA234171   Hs. 187626   ESTs   1.410E−04   4.25   35.75       411656   AW855576       gb: CM4-CT0278-221099-027-d01 CT0278 Homo   2.011E−03   4.25   32.5       448071   BE621584   Hs. 6983     Homo sapiens  cDNA: FLJ22646 fis, clone H   6.035E−05   4.23   46       447513   AW955776   Hs. 313500   ESTs, Moderately similar to ALU7_HUMAN A   1.118E−06   4.22   84.75       440201   AL359588   Hs. 7041   hypothetical protein DKFZp7628226   1.841E−03   4.22   42.75       425272   AA354138   Hs. 47209   ESTs, Weakly similar to C35826 hypotheti   2.599E−03   4.22   38.25       453793   AK002178   Hs. 35225   hypothetical protein FLJ11316   7.404E−03   4.22   35       440193   AW902312   Hs. 7037     Homo sapiens  clone 24923 mRNA sequence   3.909E−02   4.22   33.5       442061   AA774284   Hs. 285728   abl-interactor 12 (SH3-containing protei   8.228E−04   4.20   38.25       402507           Target Exon   5.392E−04   4.20   35.5       430569   AF241254   Hs. 178098   angiotensin I converting enzyme (peptidy   5.621E−02   4.20   35.5       454067   AA041455   Hs. 209312   ESTs   2.602E−04   4.18   44.5       431966   AB037903   Hs. 272257     Homo sapiens  truncated AKR mRNA for trun   1.246E−02   4.18   40.5       452032   BE244005   Hs. 27610   retinoic acid- and interferon inducible   1.737E−04   4.17   70.25       402964           NM_022095*:  Homo sapiens  hypothetical C2H   1.134E−03   4.17   45.75       436860   H12751   Hs. 5327   PRO1914protein   7.165E−04   4.17   70.5       435513   AW404075   Hs. 42785   DC11 protein   1.156E−02   4.15   43.75       447094   X65232   Hs. 17364   zinc finger protein 79 (pT7)   4.674E−04   4.15   31.75       453394   AW960474   Hs. 40289   ESTs   1.483E−05   4.13   78.25       408392   U28831   Hs. 44566   KIAA1641 protein   8.228E−04   4.13   61.25       417601   NM_014735   Hs. 82292   KIAA0215 gene product   2.475E−04   4.13   45       406423           C19000229*: gi|6753826|ref|NP_034311.1|f   7.487E−02   4.13   31.25       435126   AI393666   Hs. 42315   p10-binding protein   1.967E−02   4.12   33.5       416987   D86957   Hs. 80712   KIAA0202 protein   1.298E−03   4.10   62.75       433556   W56321   Hs. 111460   calcium/calmodulin-dependent protein kin   1.084E−04   4.10   52.75       414449   AA557660   Hs. 76152   decorin   1.970E−02   4.10   46.5       420000   AB036063   Hs. 94262   p53-inducible ribonucleotide reductase s   5.963E−02   4.10   38.5       418720   AI381687   Hs. 39526   ESTs   1.038E−02   4.10   38       427205   Z45791   Hs. 173946   hypothetical protein FLJ10486   2.178E−02   4.10   33       410541   AA065003   Hs. 64179   syntenin-2 protein   1.038E−03   4.09   82       411400   AA311919   Hs. 69851   nucleolar protein family A, member 1 (H/   9.789E−05   4.08   54.75       422541   NM_005131   Hs. 1540   nuclear matrix protein p84   2.284E−03   4.08   37.75       419943   AA252111   Hs. 15200   ESTs   2.874E−04   4.08   60.75       419195   AW291165   Hs. 25447   ESTs   1.135E−03   4.07   51.5       424939   AK000059   Hs. 153881     Homo sapiens  NY-REN-62 antigen mRNA, par   5.299E−02   4.06   39.75       419590   AF005043   Hs. 91390   poly (ADP-ribose) glycohydrolase   9.272E−05   4.05   42       430468   NM_004673   Hs. 241519   angiopoietin-like 1   3.204E−03   4.05   68.5       406038   Y14443       zinc finger protein 200   1.546E−03   4.05   67.75       430522   N75750   Hs. 242271   KIAA0471 gene product   1.768E−03   4.05   41.25       424848   AI263231   Hs. 327090   EST   4.440E−03   4.05   61.75       452695   AW780199   Hs. 30327   mitogen-activated protein kinase-activat   1.480E−03   4.04   34.25       451593   AF151879   Hs. 26706   CGI-121 protein   8.336E−05   4.02   65.5       408548   AA055449   Hs. 63187   ESTs, Weakly similar to ALUC_HUMAN !!!!   1.620E−03   4.02   38.75       402439           C1002445*: gi|4506787|ref|NP_003861.1|IQ   3.342E−02   4.02   32.75       442202   BE272862   Hs. 106534   hypothetical protein FLJ22625   1.565E−04   4.00   64.5       433233   AB040927   Hs. 301804   KIAA1494 protein   2.389E−03   4.00   43.5       407992   AW418811       gb: ha21a06.x1 NCI_CGAP_Kid12 Homo sapien   7.959E−03   4.00   38.25       450222   U75308   Hs. 24644   TATA box binding protein (TBP)-associate   5.152E−04   3.99   66.5       432676   AI187366       gb: qf29c01.x1 Soares_testis_NHT Homo sap   7.934E−05   3.98   49.25       427209   H06509   Hs. 92423   KIAA1566 protein   3.731E−06   3.98   126       416999   AW195747   Hs. 21122   hypothetical protein FLJ11830 similar to   1.088E−04   3.97   56.5       442485   BE092285   Hs. 29724   hypothetical protein FLJ13187   4.100E−03   3.97   52.5       425395   NM_014102   Hs. 156243   PRO1848 protein   1.922E−04   3.97   44.75       424238   AA337401   Hs. 137635   ESTs   7.396E−03   3.97   36.75       400417   X72475   Hs. 156110   Target   1.903E−02   3.97   34.75       415323   BE269352   Hs. 949   neutrophil cytosolic factor 2 (65 kD, chr   7.689E−03   3.96   49.5       433017   Y15067   Hs. 279914   zinc finger protein 232   3.665E−05   3.95   31       444985   AI677737   Hs. 28329   hypothetical protein FLJ14005   7.496E−04   3.95   90.75       426108   AA622037   Hs. 166468   programmed cell death 5   3.032E−02   3.95   43.5       441889   AI090455   Hs. 268371   hypothetical protein FLJ20274   1.001E−02   3.95   38.5       443970   AI280341   Hs. 166571   ESTs   6.136E−02   3.95   37.75       449001   AI619957       ESTs   7.682E−03   3.93   33       427213   AW007211       hypothetical protein FLJ 12876   2.601E−03   3.92   73.75       449964   AW001741   Hs. 24243   hypothetical protein FLJ10706   3.843E−04   3.92   44.5       421443   BE550141   Hs. 156148   hypothetical protein FLJ13231   3.019E−04   3.92   42.25       411412   AJ001388   Hs. 69997   zinc finger protein 238   1.899E−02   3.92   32       449832   AA694264   Hs. 60049   ESTs   1.599E 02   3.92   38       419737   H24185   Hs. 92918   hypothetical protein   6.528E−04   3.90   45.5       436165   AI373544   Hs. 331328   intermediate filament protein syncoilin   7.106E−03   3.90   42.75       437862   AW978107   Hs. 5884     Homo sapiens  mRNA; cDNA DKFZp586C0224 (f   1.187E−03   3.90   40.5       425210   AA054679   Hs. 155150   ribonuclease P(14 kD)   4.090E−03   3.90   31.25       442287   AW952703   Hs. 8182   synaptic nuclei expressed gene 1b   1.187E−03   3.88   55.5       439559   AW364675   Hs. 173921   ESTs, Weakly similar to 2109260A B cell   1.642E−04   3.88   58.25       450427   AK001436   Hs. 24994   CGI-53 protein   5.957E−02   3.88   32.25       421919   AJ224901   Hs. 109526   zinc finger protein 198   1.925E−04   3.87   85.25       443601   AI078554   Hs. 15682   ESTs   3.122E−05   3.86   79.5       449509   AA001615   Hs. 84561   ESTs   7.111E−03   3.85   36.25       456107   AA160000   Hs. 137396   ESTs, Weakly similar to JC5238 galactosy   1.035E−02   3.85   30.25       422550   BE297626   Hs. 296049   microfibrillar-associated protein 4   2.574E−02   3.85   51.25       408683   R58665   Hs. 46847   TRAF and TNF receptor-associated protein   4.448E−07   3.85   106       426860   U04953   Hs. 172801   isoleucine-tRNA synthetase   4.619E−03   3.84   45.5       438459   T49300   Hs. 35304     Homo sapiens  cDNA FLJ13655 fis. clone PL   2.088E−05   3.83   80.75       431266   AW149321   Hs. 105411   ESTs   1.090E−04   3.83   99.75       418304   AA215702       gb: zr97g10.r1 NCI_CGAP_GCB1  Homo sapiens     7.169E−04   3.82   48       435354   AA678267   Hs. 117115   ESTs   1.968E−02   3.82   36.75       403575           Target Exon   6.831E−04   3.82   30.5       442961   BE614474   Hs. 289074   F-box only protein 22   1.321E−05   3.82   76.25       412651   AA115333   Hs. 107968   ESTs   5.809E−07   3.81   128.75       448965   AF092134   Hs. 22679   CGI-24 protein   1.871E−05   3.81   60.5       450056   BE047394   Hs. 8208   ESTs, Weakly similar to S71512 hypotheti   7.505E−05   3.81   71       428330   L22524   Hs. 2256   matrix metalloproleinase 7 (matrilysin,   5.871E−03   3.81   77.25       428234   U93553   Hs. 183123   nuclear receptor subfamily 5, group A, m   5.142E−02   3.81   33       441646   AB023169   Hs. 7935   KIAA0952 protein   1.968E−02   3.80   38.25       402847           C1000826*: gi|12314084|emb|CAC05321.1|(A   1.156E−02   3.80   31.75       446207   AW968535   Hs. 14328   hypothetical protein FLJ20071   1.489E−02   3.80   34.25       414658   X58528   Hs. 76781   ATP-binding cassette, sub-family D (ALD)   2.011E−03   3.80   61.5       421965   AA301100   Hs. 346482   gb: EST14128 Testis tumor  Homo sapiens  cD   1.663E−05   3.79   87.25       414219   W20010   Hs. 75823   ALL1-fused gene from chromosome 1q   2.180E−02   3.78   35.5       436385   BE551618   Hs. 144097   ESTs   7.990E−03   3.77   56       432689   AB018320       Arg/Abl-interacting protein ArgBP2   6.099E−03   3.77   42.25       423450   AJ290445   Hs. 128759   KIAA0524 protein   2.602E−04   3.77   32.75       429031   BE002237   Hs. 239666     Homo sapiens  cDNA FLJ13495 fis, clone PL   3.071E−03   3.77   31       434526   AW085147   Hs. 152779   ESTs   4.278E−02   3.77   30.75       416039   AA376989   Hs. 78989   alcohol dehydrogenase 5 (class III), chi   3.175E−04   3.77   72.75       414915   NM_002462   Hs. 76391   myxovirus (influenza) resistance 1, homo   7.398E−08   3.77   628.75       424003   BE274717   Hs. 137506     Homo sapiens , clone IMAGE: 3605104, mRNA,   5.008E−03   3.75   46       432409   AA806538   Hs. 130732   KIAA1575 protein   1.775E−02   3.75   36.75       415736   AA827082   Hs. 291872   ESTs   5.845E−03   3.75   36       423932   T95633   Hs. 189703   ESTs   7.687E−03   3.74   52.75       434733   AI334367   Hs. 159337   ESTs   1.341E−04   3.72   55.5       420926   AA830402   Hs. 221216   ESTs   2.037E−02   3.72   48       453070   AK001465   Hs. 31575   SEC63, endoplasmic reticulum translocon   1.339E−02   3.72   47.75       426310   NM_000909   Hs. 169266   neuropeptide Y receptor Y1   7.692E−03   3.72   44.25       453753   BE252983   Hs. 35086   ubiquitin specific protease 1   8.588E−03   3.72   41       430016   NM_004736   Hs. 227656   xenotropic and polytropic retrovirus rec   1.598E−02   3.72   37.5       401016           ENSP00000227126: NAALADASE II PROTEIN.   6.847E−03   3.72   35.5       447892   AI435848   Hs. 172978   ESTs   1.246E−02   3.72   34.25       425397   J04088   Hs. 156346   topoisomerase (DNA) II alpha (170 kD)   1.599E−02   3.72   31       407756   AA116021   Hs. 38260   ubiquitin specific protease 18   1.600E−07   3.72   269.75       431392   AI371223   Hs. 288671     Homo sapiens  cDNA FLJ11997 fis, clone HE   1.300E−03   3.72   60.5       451658   AW195351   Hs. 250520   ESTs, Moderately similar to I38022 hypot   6.060E−05   3.72   62.5       451406   AI694320   Hs. 6295   ESTs, Weakly similar to T17248 hypotheti   9.882E−04   3.71   56.25       408216   AA741038   Hs. 6670   ESTs   1.084E−03   3.70   58.75       417848   AA206581   Hs. 86041   ESTs, Weakly similar to JC5314 CDC28/cdc   7.162E−04   3.70   59.75       434924   AA443164   Hs. 23259   hypothetical protein FLJ13433   1.321E−05   3.70   54       442085   AA975688   Hs. 159955   ESTs   3.339E−03   3.70   44.75       444363   AI142827   Hs. 143656   ESTs   2.723E−04   3.70   44       433891   AA613792       gb: no97h03.s1 NCI_CGAP_Pr2  Homo sapiens     4.811E−03   3.70   41       425423   NM_005897   Hs. 157180   intracisternal A particle-promoted polyp   1.915E−04   3.70   36.75       409493   AA386192   Hs. 193482     Homo sapiens  cDNA FLJ11903 fis, clone HE   1.776E−02   3.70   34       451730   AF095687   Hs. 26937   brain and nasopharyngeal carcinoma susce   3.129E−02   3.70   34       419511   AA429750   Hs. 75113   general transcription factor IIIA   5.637E−03   3.70   30       452664   AA398859   Hs. 18397   hypothetical protein FLJ23221   8.629E−07   3.69   124.5       430478   NM_014349   Hs. 241535   apolipoprotein L, 3   5.537E−08   3.69   387       421406   AF179897   Hs. 104105   Meis (mouse) homolog 2   5.643E−03   3.68   51.5       429686   AI871613   Hs. 28538     Homo sapiens  cDNA: FLJ21086 fis, clone C   2.193E−03   3.67   48.75       429680   AL035754   Hs. 2474   toll-like receptor 1   6.219E−04   3.67   38.25       423494   AW504365   Hs. 24143   Wiskott-Aldrich syndrome protein interac   3.203E−03   3.67   35.75       444545   AW995346   Hs. 146910   ESTs   1.899E−02   3.67   30.75       433907   AW296107   Hs. 152686   ESTs   5.660E−04   3.67   63.5       437650   AA814338   Hs. 292297   ESTs   7.118E−03   3.67   38.75       452279   AA286844   Hs. 61260   hypothetical protein FLJ13164   7.283E−02   3.65   36.5       444969   AI203334   Hs. 160628   ESTs   9.976E−03   3.65   37.75       431560   BE244135   Hs. 260238   hypothetical protein FLJ 10842   2.942E−03   3.65   37.5       425757   AA363171       gb: EST72986 Ovary II  Homo sapiens  cDNA 5   1.341E−04   3.65   33       433464   N92481       gb: zb12g02.s1Soares_fetal_lung_NbHL19W   8.945E−03   3.65   30.25       446111   W56338   Hs. 13880   CGI-143 protein   2.290E−03   3.65   35.75       446506   AI123118   Hs. 15159   chemokine-like factor, alternatively spl   3.386E−07   3.63   131       436503   AJ277750   Hs. 183924   ubiquitin associated and SH3 domain cont   4.097E−03   3.63   33.5       451938   AI354355   Hs. 16697   down-regulator of transcription 1, TBP-b   1.921E−04   3.63   69.75       421114   AW975051   Hs. 293156   ESTs, Weakly similar to I78885 serine/th   4.444E−03   3.63   68.25       449720   AA311152   Hs. 288708   hypothetical protein FLJ21562   4.468E−06   3.63   63.75       443373   AI792868   Hs. 135365   ESTs   4.099E−03   3.63   49       417148   AA359896   Hs. 293885   hypothetical protein FLJ14902   1.837E−02   3.63   49       457231   AI472022   Hs. 301959   proline synthetase co-transcribed (bacte   3.450E−02   3.63   32.75       408380   AF123050   Hs. 44532   diubiquitin   4.434E−07   3.62   217.25       425692   D90041   Hs. 155956   N-acetyltransferase 1 (arylamine N-acety   1.760E−05   3.60   66.5       443968   AA287702   Hs. 10031   KIAA0955 protein   8.945E−03   3.60   58.25       428250   AW809208   Hs. 183297   DKFZP566F2124 protein   5.932E−04   3.60   54       407946   AA226495   Hs. 154292   ESTs   1.903E−04   3.60   53       412828   AL133396   Hs. 74621   prion protein (p27-30) (Creutzfeld-Jakob   4.990E−02   3.60   50.25       418699   BE539639   Hs. 173030   ESTs, Weakly similar to ALU8_HUMAN ALU S   4.813E−03   3.60   43.5       431416   AA532718   Hs. 178604   ESTs   8.139E−02   3.60   37       425345   AU077297   Hs. 155894   protein tyrosine phosphatase, non-recept   3.773E−03   3.60   36.75       422303   AW410382   Hs. 27556   hypothetical protein FLJ22405   5.301E−02   3.60   36.75       456760   AW961251   Hs. 127828   guanine nucleotide binding protein (G pr   1.084E−03   3.60   33       434936   AI285970   Hs. 183817   ESTs   6.881E−02   3.59   56.25       448192   R43915   Hs. 4958   ESTs   4.440E−03   3.58   31       408618   AK000637   Hs. 46624   HSPC043 protein   7.694E−03   3.58   43.25       427051   BE178110   Hs. 173374     Homo sapiens  cDNA FLJ10500 fis, clone NT   1.201E−02   3.58   40       430024   AI808780   Hs. 227730   integrin, alpha 6   7.913E−05   3.57   68.75       424881   AL119690   Hs. 153618   HCGVIII-1 protein   2.010E−03   3.57   40.25       408438   AB011180   Hs. 100960   KIAA0608 protein   1.076E−02   3.57   38       427471   AA403131   Hs. 266782   KIAA1826 protein   2.494E−03   3.57   34       432769   AA620814   Hs. 144959   ESTs   4.558E−02   3.57   31.25       426181   AA371422   Hs. 334371   hypothetical protein MGC13096   7.162E−04   3.57   34.75       439195   H89360       gb: yw28d08.s1 Morton Fetal Cochlea Homo   4.621E−03   3.57   41.75       444020   R92962   Hs. 35052   ESTs   1.970E−02   3.57   48.75       419908   AW971327   Hs. 293315   ESTs   9.289E−03   3.56   32       427581   NM_014788   Hs. 179703   KIAA0129 gene product   1.489E−07   3.55   117.5       419440   AB020689   Hs. 90419   KIAA0882 protein   2.478E−04   3.55   57.75       409342   AU077058   Hs. 54089   BRCA1 associated RING domain 1   6.528E−04   3.55   47.25       410054   AL120050   Hs. 58220     Homo sapiens  cDNA: FLJ23005 fis, clone L   1.076E−02   3.55   38       437133   AB018319   Hs. 5460   KIAA0776 protein   1.774E−02   3.55   35.25       423886   AA332098       gb: EST36256 Embryo, 8 week I Homo sapien   1.116E−02   3.55   33       432540   AI821517   Hs. 105866   ESTs   3.620E−03   3.54   43.25       402737           Target Exon   4.105E−05   3.54   38.75       421977   W94197   Hs. 110165   ribosomal protein L26 homolog   6.855E−02   3.54   40       418222   AI675881   Hs. 86538   ESTs   2.592E−03   3.53   40.5       418793   AW382987   Hs. 88474   prostaglandin-endoperoxide synthase 1 (p   8.283E−03   3.53   34.75       417301   AI478158   Hs. 164478   hypothetical protein FLJ21939 similar to   1.083E−03   3.52   51       412863   AA121673   Hs. 59757   zinc finger protein 281   2.250E−02   3.52   45.25       439763   AA845366   Hs. 184075   ESTs, Weakly similar to ALU1_HUMAN ALU S   1.033E−03   3.52   42.25       403809           NM_024743*:  Homo sapiens  hypothetical pro   1.490E−02   3.52   41.75       421684   BE281591   Hs. 106768   hypothetical protein FLJ10511   1.117E−02   3.52   41.75       436271   AW449686   Hs. 129828   ESTs   1.563E−04   3.52   37.25       445240   AI217385   Hs. 147574   ESTs   1.599E−02   3.52   34.5       432834   F06459   Hs. 289113   cytochrome b5 reductase 1 (B5R.1)   9.286E−03   3.52   31.75       426780   BE242284   Hs. 172199   adenylate cyclase 7   2.871E−04   3.50   55.75       430750   AI650360   Hs. 100256   ESTs   1.615E−03   3.50   39.5       429301   AA449416   Hs. 31395   ESTs   6.828E−04   3.50   35       418196   AI745649   Hs. 26549   KIAA1708 protein   4.422E−02   3.50   34.5       421951   BE327432   Hs. 109804   H1 histone family, member X   2.485E−03   3.50   33.5       419825   AI754011   Hs. 7326   ESTs   6.101E−03   3.50   31.25       443303   U67319   Hs. 9216   caspase 7, apoptosis-related cysteine pr   4.604E−05   3.49   92.25       451119   AA805417   Hs. 64753   ESTs   4.088E−03   3.49   34.25       431315   AW972227   Hs. 163986     Homo sapiens  cDNA: FLJ22765 fis, clone K   2.951E−05   3.49   159.25       408731   R85652         Homo sapiens  mRNA; cDNA DKFZp434F1928 (f   3.690E−05   3.49   75.25       422423   AF283777   Hs. 116481   CD72 antigen   1.000E−02   3.48   39       437664   AW977714   Hs. 294139   ESTs, Moderately similar to ALU1_HUMAN A   2.497E−03   3.47   74.25       448219   AA228092       KIAA1681 protein   9.459E−04   3.47   56.5       408784   AW971350   Hs. 63386   ESTs   2.938E−05   3.47   46       417562   AW888754   Hs. 134126   crystallin, gamma S   1.926E−03   3.47   33.5       414821   M63835   Hs. 77424   Fc fragment of IgG, high affinity la, re   1.246E−02   3.47   36.5       408088   AW157022   Hs. 343551   hypothetical protein FLJ 22584   4.114E−05   3.46   32       417008   AA191708   Hs. 325825     Homo sapiens  cDNA FLJ20848 fis, clone AD   2.243E−04   3.46   64.5       446238   T95143   Hs. 14511   SCO (cytochrome oxidase deficient, yeast   7.107E−05   3.45   87       446162   AI631319   Hs. 63841   hypothetical protein DKFZp434E2318   2.013E−03   3.45   41.25       453686   AL110326   Hs. 304679   ESTs, Moderately similar to Z195_HUMAN Z   1.270E−04   3.45   41.25       443242   BE243910   Hs. 9082   nucleoporin p54   6.587E−03   3.45   36       409939   AA463437   Hs. 11556     Homo sapiens  cDNA FLJ12566 fis, clone NT   6.384E−05   3.45   71       418584   NM_004606   Hs. 1179   TATA box binding protein (TBP)-associate   1.241E−03   3.44   37.25       413129   AF292100   Hs. 104613   RP42 homolog   1.033E−04   3.44   106.75       416980   AA381133   Hs. 80684   high-mobility group (nonhistone chromoso   4.270E−03   3.42   67.75       450850   AA648886   Hs. 151999   ESTs   8.248E−04   3.42   55.25       426494   AL119528   Hs. 170098   KIAA0372 gene product   6.836E−03   3.42   45.5       417244   T57053   Hs. 10136   ESTs   2.711E−03   3.42   33.5       413392   AW021404   Hs. 13021   ESTs   2.827E−03   3.42   33       427722   AK000123   Hs. 180479   hypothetical protein FLJ20116   3.233E−02   3.42   32.75       441466   AW673081   Hs. 54828   ESTs   5.005E−03   3.42   32       412675   AA460716   Hs. 9788   hypothetical protein MGC10924 similar to   1.489E−02   3.41   415       439653   AW021103   Hs. 6631   hypothetical protein FLJ20373   2.954E−03   3.40   46.25       418259   AA215404       ESTs   2.628E−05   3.40   84       423032   AI684746   Hs. 119274   RAS p21 protein activator (GTPase activa   1.413E−04   3.40   71       452167   N75238   Hs. 13075     Homo sapiens  cDNA: FLJ23013 fis, clone L   4.444E−03   3.40   37       408989   AW361666   Hs. 49500   KIAA0746 protein   1.662E−05   3.40   99.5       446934   AK001943   Hs. 16577   F-box only protein 3   1.768E−03   3.38   64.25       420664   AI681270   Hs. 99824   BCE-1 protein   7.518E−04   3.38   61.5       444430   AI611153   Hs. 6093     Homo sapiens  cDNA: FLJ22783 fis, clone K   1.246E−02   3.38   45.25       437410   AW023340   Hs. 14880   ESTs   7.959E−03   3.38   43.25       426979   AF161472   Hs. 173074   DKFZP564O1863 protein   7.985E−03   3.38   40.75       422316   N75612   Hs. 301497   arginyltransferase 1   5.639E−03   3.38   35.75       421743   T35958   Hs. 107614   DKFZP564I1171 protein   2.346E−05   3.36   40.75       418721   NM_002731   Hs. 87773   protein kinase, cAMP-dependent, catalyti   3.687E−05   3.36   62       431742   NM_016652   Hs. 268281   crooked neck protein (crn)   4.093E−03   3.36   42.5       422473   U94780   Hs. 117242   meningioma expressed antigen 6 (coiled-c   1.417E−03   3.36   39.5       452194   AI694413   Hs. 332649   olfactory receptor, family 2, subfamily   6.214E−07   3.36   357.25       436372   AW972301   Hs. 310286   ESTs   8.217E−06   3.36   150.25       444454   BE018316   Hs. 11183   sorting nexin 2   3.489E−05   3.35   52.75       439717   W94472   Hs. 59529   ESTs, Moderately similar to ALU1_HUMAN A   5.865E−03   3.35   42.25       412634   U55984   Hs. 289088   heat shock 90 kD protein 1, alpha   5.358E−06   3.35   39       419970   AW612022   Hs. 94812   ESTs   3.201E−03   3.35   35.75       447514   AI809314   Hs. 208501   ESTs, Weakly similar to B34087 hypotheti   4.558E−02   3.35   32       444013   T08531   Hs. 44404     Homo sapiens  PRO1488 mRNA, complete cds   7.116E−03   3.35   31.75       445718   H79791   Hs. 15227   ESTs   9.273E−06   3.35   156.75       437025   AW296618   Hs. 120637   ESTs   5.623E−02   3.35   30.5       425462   AI491852   Hs. 46783     Homo sapiens  cDNA: FLJ22382 fis, clone H   1.657E−02   3.34   31       440726   AL050333   Hs. 7387   DKFZP564B116 protein   3.209E−03   3.34   74.25       417377   NM_016603   Hs. 82035   potential nuclear protein C5ORF5; GAP li   3.731E−06   3.34   66       452548   AL050321   Hs. 301532   CRP2 binding protein   1.919E−04   3.33   54.25       442853   AW021276   Hs. 17121   ESTs   7.401E−03   3.33   31.5       444745   AF117754   Hs. 11861   thyroid hormone receptor-associated prot   2.599E−04   3.33   90.75       438543   AA810141   Hs. 192182   ESTs   8.798E−05   3.32   59.75       447188   H65423   Hs. 17631   hypothetical protein DKFZp434E2135   5.209E−03   3.32   59.25       454064   AI130731   Hs. 57967   ESTs   7.687E−03   3.32   32.25       433269   AI343543   Hs. 126890   ESTs   3.168E−04   3.32   31.75       407813   AL120247   Hs. 40109   KIAA0872 protein   1.105E−05   3.32   66.25       452696   AI826645   Hs. 211534   ESTs   6.450E−06   3.32   55.75       430007   NM_014892   Hs. 227602   KIAA1116 protein   5.941E−04   3.32   59.75       457247   AA458605       KIAA1681 protein   7.702E−02   3.30   32.25       431451   AA761378   Hs. 192013   ESTs   5.298E−02   3.30   39.5       442160   AI337127   Hs. 156325   ESTs   7.713E−06   3.30   67.75       420962   NM_005904   Hs. 100602   MAD (mothers against decapentaplegic, Dr   9.242E−06   3.30   126.25       419284   AW820869   Hs. 215658   ESTs, Moderately similar to ZN91_HUMAN Z   5.450E−02   3.29   39.5       441297   AW403084   Hs. 7766   ubiquitin-conjugating enzyme E2E 1 (homo   7.876E−04   3.29   52       444030   AW021254   Hs. 135055   ESTs   2.194E−03   3.27   53.5       427675   AW138190   Hs. 180248   zinc finger protein 124 (HZF-16)   5.121E−05   3.27   45       408558   AW015759   Hs. 235709     Homo sapiens  mRNA; cDNA DKFZp667B0711 (f   4.420E−02   3.27   37.5       418945   BE246762   Hs. 89499   arachidonale 5-lipoxygenase   1.143E−04   3.27   37       445733   BE295568   Hs. 13225   UDP-Gal: betaGlcNAc beta 1,4-galactosylt   6.592E−03   3.27   37.5       436139   AA765786   Hs. 120936   ESTs   1.033E−04   3.26   62.25       443405   AF031463   Hs. 9302   phosducin-like   1.145E−04   3.26   53.75       432841   M93425   Hs. 62   protein tyrosine phosphatase, non-recept   3.344E−03   3.26   48.5       449188   AW072939   Hs. 347187   myotubularin related protein 1   1.757E−05   3.25   59.75       441077   AI241273   H5.15312   ESTs   9.823E−07   3.25   76       442297   NM_006202   Hs. 89901   phosphodiesterase 4A, cAMP-specific (dun   1.296E−03   3.25   36.5       449439   AB029001   Hs. 23585   KIAA1078 protein   2.409E−02   3.25   33       417665   AW852858   Hs. 22862   ESTs   1.001E−02   3.25   32.75       420174   AI824144   Hs. 23912   ESTs   2.221E−05   3.25   47.75       430929   AA489166   Hs. 156933   ESTs   3.501E−04   3.22   55.5       453128   AW026516   Hs. 31791   acylphosphatase 2, muscle type   3.777E−03   3.22   46       422932   AI191813   Hs. 308220   ESTs   1.480E−03   3.22   35.25       428004   AA449563   Hs. 151393   glutamate-cysteine ligase, catalytic sub   4.844E−02   3.21   38.75       426221   AB007881   Hs. 110613   KIAA0421 protein   6.525E−04   3.21   58.5       426312   AF026939   Hs. 181874   interferon-induced protein with tetratri   1.127E−07   3.20   172.5       417678   X06560   Hs. 82396   2′,5′-oligoadenylate synthetase 1 (40-46   1.973E−07   3.20   195.5       436854   AA749167   Hs. 173911   ESTs   2.285E−03   3.20   42       418180   BE618087   Hs. 83724   hypothetical protein MGC5466   5.144E−02   3.19   31.25       414895   AW894856   Hs. 116278     Homo sapiens  cDNA FLJ13571 fis, clone PL   9.877E−04   3.19   46.5       407765   AW076027   Hs. 257711   ESTs, Moderately similar to ALU8_HUMAN A   5.639E−03   3.18   57.75       448914   AI927656   Hs. 196459   ESTs   1.966E−02   3.17   45.25       447371   AA334274   Hs. 18368   DKFZP564B0769 protein   4.444E−03   3.17   41.75       439680   AW245741   Hs. 58461   ESTs, Weakly similar to A35659 krueppel-   1.036E−03   3.17   33.25       431188   W05656   Hs. 169755   ESTs   5.217E−03   3.17   32.5       446177   AK001902   Hs. 14202   hypothetical protein FLJ11040   6.019E−05   3.17   56.5       415914   AA306033   Hs. 78915   GA-binding protein transcription factor,   3.910E−02   3.17   38       408761   AA057264   Hs. 238936   ESTs, Weakly similar to (defline not ava   2.233E−04   3.17   48.25       408050   BE280478   Hs. 182695   hypothetical protein MGC3243   3.934E−03   3.16   33       444342   NM_014398   Hs. 10887   similar to lysosome-associated membrane   1.048E−07   3.15   116.75       441879   AI521936   Hs. 107149   novel protein similar to archaeal, yeast   2.630E−05   3.15   72.25       436169   AA888311   Hs. 17602     Homo sapiens  cDNA FLJ12381 fis, clone MA   5.121E−05   3.15   68.5       426506   AW935187   Hs. 170162   KIAA1357 protein   5.124E−05   3.15   66.25       410390   AA876905   Hs. 125286   ESTs   4.447E−03   3.15   63.5       410614   AI091195   Hs. 65029   growth arrest-specific 1   3.559E−02   3.15   43.25       407821   AA346172   Hs. 195614   ESTs   7.489E−04   3.15   35       433364   AI075407   Hs. 296083   ESTs, Moderately similar to I54374 gene   5.558E−08   3.15   474.5       408145   AF182316   Hs. 234680   fer-1 ( C. elegans )-like 3 (myoferlin)   6.880E−02   3.14   49.25       411060   NM_006074   Hs. 318501     Homo sapiens  mRNA full length insert cDN   9.799E−08   3.14   238.75       421272   AA704157       ESTs   1.921E−04   3.14   46       442739   NM_007274   Hs. 8679   cytosolic acyl coenzyme A thioester hydr   6.515E−04   3.14   42.25       438021   AV653790   Hs. 324275   WW domain-containing protein 1   7.183E−04   3.13   120.25       418027   AB037807   Hs. 83293   hypothetical protein   2.632E−05   3.13   71.5       443015   R33261   Hs. 6614   ESTs, Weakly similar to A43932 mucin 2 p   1.540E−02   3.13   36.75       450374   AA397540   Hs. 60293     Homo sapiens  clone 122482 unknown mRNA   2.842E−02   3.13   32.75       430068   AA464964       gb: zx80f10.s1 Soares ovary tumor NbHOT H   4.601E−05   3.12   47.75       452699   AW295390   Hs. 213062   ESTs   1.843E−03   3.11   52.25       453822   NM_014116   Hs. 35416   PRO0132 protein   7.490E−02   3.11   39       426647   AA243464   Hs. 294101   pre-B-cell leukemia transcription factor   1.084E−03   3.10   52       434629   AA789081   Hs. 4029   glioma-amplified sequence-41   1.135E−03   3.10   50.75       432680   T47364   Hs. 278613   interferon, alpha-inducible protein 27   5.551E−08   3.10   1337.75       403738           C4000675*: gi|3426332|gb|AAC32272.1|(AF0   1.571E−05   3.10   108       418627   AL079835   Hs. 86858   ribosomal protein S6 kinase, 70 kD, polyp   5.652E−04   3.09   35.5       457701   AW855466   Hs. 271866   ESTs, Weakly similar to ALU1_HUMAN ALU S   5.944E−04   3.08   55.75       458368   BE504731   Hs. 138827   ESTs   8.248E−04   3.08   64.5       449656   AA002008   Hs. 188633   ESTs   1.552E−03   3.07   72.5       448362   AA641767   Hs. 21015   hypothetical protein DKFZp564L0864 simil   1.117E−02   3.07   43.5       425815   R94023   Hs. 94560   ESTs, Moderately similar to I38022 hypot   2.127E−04   3.07   38.5       410851   AW612147   Hs. 32058     Homo sapiens  C1orf19 mRNA, partial cds   4.627E−03   3.07   35.5       420258   AA477514   Hs. 96247   translin-associated factor X   1.387E−02   3.07   30.5       452253   AA928891   Hs. 28608     Homo sapiens  cDNA: FLJ22115 fis, clone H   2.231E−04   3.07   42.5       417317   AW296584   Hs. 293782   ESTs   4.476E−06   3.07   78       408212   AA297567   Hs. 43728   hypothetical protein   3.326E−04   3.07   47       413278   BE563085   Hs. 833   interferon-stimulated protein, 15 kDa   5.558E−08   3.06   867.25       419257   X53461   Hs. 89781   upstream binding transcription factor, R   3.687E−05   3.05   59       424637   NM_015057   Hs. 151411   KIAA0916 protein   1.355E−06   3.05   82       414948   C15240   Hs. 182155   ESTs   2.485E−05   3.05   45.5       418677   S83308   Hs. 87224   SRY (sex determining region Y)-box 5   1.000E−02   3.05   41.25       419465   AW500239   Hs. 21187     Homo sapiens  cDNA: FLJ23068 fis, clone L   1.338E−02   3.05   35.75       443787   AV646505   Hs. 122155   ESTs   2.599E−03   3.05   31.25       438980   AW502384       gb: UI-HF-BR0p-aka-f-12-0-UI.r1NIH_MGC_5   2.102E−03   3.03   59       440668   AI989538   Hs. 191074   ESTs   1.187E−03   3.03   55.25       407687   AK002011   Hs. 37558   hypothetical protein FLJ11149   7.848E−04   3.03   37.5       409977   AW805510   Hs. 97056   hypothetical protein FLJ21634   2.218E−05   3.02   74       448030   N30714   Hs. 325960   membrane-spanning 4-domains, subfamily A   2.032E−02   3.02   50.5       407705   AB023139   Hs. 37892   KIAA0922 protein   1.408E−04   3.02   49.75       450205   AI219748   Hs. 11356   ESTs   6.495E−02   3.02   47.75       437086   AW291411   Hs. 192531   ESTs, Weakly similar to S00754 zinc fing   1.827E−04   3.02   46       411960   R77776   Hs. 18103   ESTs   1.416E−03   3.02   37.25       418757   AI864193   Hs. 169728   hypothetical protein FLJ13150   6.852E−04   3.02   41.5       434045   AI065133   Hs. 152316   hypothetical protein PRO0971   4.461E−04   3.02   46.5       414617   AI339520   Hs. 288817   ESTs, Moderately similar to N Chain N, M   1.487E−05   3.02   183.25       431709   AF220185   Hs. 267923   uncharacterized hypothalamus protein HT0   2.596E−04   3.01   42.75       431341   AA307211   Hs. 251531   proteasome (prosome, macropain) subunit,   2.126E−04   3.01   60.25       409884   AI904455   Hs. 142684   hypothetical protein DKFZp667O116   3.020E−04   3.00   68       422231   AA443512   Hs. 101383   ESTs   4.601E−05   3.00   65       418460   M26315   Hs. 85258   CD8 antigen, alpha polypeptide (p32)   1.147E−04   3.00   63       446851   AW007332   Hs. 10450     Homo sapiens  cDNA: FLJ22063 fis, clone H   8.341E−05   3.00   49       411127   AA668995   Hs. 218329   hypothetical protein   4.090E−03   3.00   35.5       432474   AA584042       gb: nn65e09.s1 NCI_CGAP_Lar1  Homo sapiens     1.596E−02   3.00   34.75       451171   AA248829   Hs. 112921   gb: jj6059.seq.F Human fetal heart, Lambd   9.877E−04   3.00   33.5       418182   AW016405   Hs. 16648   ESTs   1.239E−03   3.00   33       414033   AL079707   Hs. 207443   hypothetical protein MGC10848   1.930E−03   3.00   31.5       431542   H63010   Hs. 5740   ESTs   1.117E−02   3.00   31       414493   AL133921   Hs. 76272   retinoblastoma-binding protein 2   1.662E−05   2.99   90.25       428418   AI368826   Hs. 30654   ESTs   1.321E−05   2.99   85.75       431629   AU077025   Hs. 265827   interferon, alpha-inducible protein (clo   8.507E−08   2.99   674.75       439658   AA332057   Hs. 6639   hypothetical protein MGC15440   7.495E−05   2.99   47.75       425332   AA633306   Hs. 127279   ESTs   6.333E−03   2.99   40.25       410678   BE540516   Hs. 293732   hypothetical protein MGC3195   7.522E−04   2.98   54       452420   BE564871   Hs. 29463   centrin, EF-hand protein, 3 (CDC31 yeast   4.480E−06   2.97   69.75       451572   AA018556   Hs. 268691   ESTs, Moderately similar to ALU2_HUMAN A   2.219E−05   2.97   52.5       411190   AA306342   Hs. 69171   protein kinase C-like 2   8.296E−03   2.97   46       444437   AI377961   Hs. 44041   ESTs   6.592E−03   2.97   34       425548   AA890023   Hs. 1906   prolactin receptor   5.657E−04   2.97   39       413568   AA130381   Hs. 180257   ESTs   2.938E−05   2.97   45.25       419925   AA159850   Hs. 93765   lipoma HMGIC fusion partner   3.790E−02   2.97   42.75       446215   AW821329   Hs. 14368   SH3 domain binding glutamic acid-rich pr   2.391E−03   2.96   50       425907   AA365752   Hs. 155965   ESTs   3.236E−02   2.96   36.25       418679   D38552   Hs. 1191   KIAA0073 protein   4.611E−03   2.96   35.25       439776   AL360140   Hs. 176005     Homo sapiens  mRNA full length insert cDN   2.008E−03   2.96   33.75       446006   NM_004403   Hs. 13530   deafness, autosomal dominant 5   5.005E−03   2.96   43.5       434822   AW076088   Hs. 4187   hypothetical protein 24636   3.115E−05   2.95   82       437275   AW976035   Hs. 292396   ESTs, Weakly similar to A47582 B-cell gr   1.084E−03   2.95   49.75       439601   AB029032   Hs. 6606   KIAA1109 protein   4.808E−03   2.95   36.25       403707           Target Exon   9.630E−03   2.95   33.75       437613   R19892   Hs. 10267   MIL1 protein   2.942E−03   2.95   30.5       458455   AV648310   Hs. 213488   ESTs   2.098E−03   2.95   46.25       450256   AA286887   Hs. 24724   MFH-amplified sequences with leucine-ric   3.687E−05   2.94   101       442053   R35343   Hs. 24968   Human DNA sequence from clone RP1-233G16   1.689E−03   2.94   50       448569   BE382657   Hs. 21486   signal transducer and activator of trans   5.551E−08   2.94   419.75       414792   BE314949   Hs. 87128   hypothetical protein FLJ23309   1.177E−06   2.93   86.25       427794   AA709186   Hs. 99070   ESTs   1.290E−02   2.93   45.25       446552   AW470827   Hs. 156241   ESTs   1.086E−04   2.92   92.5       441969   AI733386   Hs. 129194   ESTs, Weakly similar to ALU1_HUMAN ALU S   1.821E−04   2.92   65.75       451644   N23235   Hs. 30567   ESTs, Weakly similar to B34087 hypotheti   2.212E−05   2.92   52.25       423129   L44396   Hs. 124106     Homo sapiens  cDNA FLJ11941 fis, clone HE   2.600E−03   2.92   46.75       418522   AA605038   Hs. 7149     Homo sapiens  cDNA: FLJ21950 fis, clone H   4.043E−04   2.92   42       426279   AI648520   Hs. 169084   tubby like protein 3   1.598E−02   2.92   35.75       409444   H47933   Hs. 33983   ESTs, Weakly similar to ALU6_HUMAN ALU S   5.389E−04   2.92   33.5       445939   BE018658   Hs. 141003     Homo sapiens  cDNA: FLJ21691 fis, clone C   4.991E−02   2.92   32       417788   AI436699   Hs. 84928   nuclear transcription factor Y, beta   1.116E−02   2.92   30       415023   AA932146   Hs. 133494     Homo sapiens  clone TCCCIA00164 mRNA sequ   4.037E−04   2.92   38       452866   R26969   Hs. 268016     Homo sapiens  cDNA: FLJ21243 fis, clone C   1.845E−03   2.92   50.5       457000   NM_006750   Hs. 172278   syntrophin, beta 2 (dystrophin-associate   5.420E−03   2.92   30.25       423568   NM_005256   Hs. 129818   growth arrest-specific 2   2.024E−04   2.92   84       454000   AA040620   Hs. 5672   hypothetical protein AF140225   1.078E−02   2.92   75.25       409600   AJ011679   Hs. 55099   rab6 GTPase activating protein (GAP and   2.212E−05   2.91   56       432451   AW972771   Hs. 292471   ESTs, Weakly similar to ALU1_HUMAN ALU S   3.668E−02   2.91   38.75       419126   AI810144   Hs. 135276   ESTs   6.101E−03   2.91   35.75       428974   AA442693   Hs. 272006   ESTs, Weakly similar to I38022 hypotheti   7.753E−06   2.90   100       440945   AW505345   Hs. 7540   f-box and leucine-rich repeat protein 3A   5.624E−02   2.90   53.25       439024   R96696   Hs. 35598   ESTs   2.750E−02   2.90   91.25       426126   AL118747   Hs. 26691   ESTs   3.163E−04   2.90   57       428738   NM_000380   Hs. 192803   xeroderma pigmentosum, complementation g   3.499E−04   2.90   56.25       403743           C1002604: gi|8393668|ref|NP_058989.1|kin   7.116E−03   2.90   49.25       437108   AA434054   Hs. 80624   hypothetical protein MGC2560   5.406E−03   2.90   47.5       407816   AW500857   Hs. 40137   anaphase-promoting complex 1; meiotic ch   1.969E−02   2.90   47.5       420683   AA830168   Hs. 271305   ESTs   1.481E−03   2.90   42.75       414429   R51494   Hs. 71818   ESTs   1.903E−02   2.90   37.25       426590   AA617830   Hs. 28310   ESTs   3.777E−03   2.90   34.75       408138   AA535740   Hs. 170263   tumor protein p53-binding protein, 1   7.123E−03   2.90   32.75       437151   AA745618       BANP homolog, SMAR1 homolog   6.130E−02   2.89   35.5       418729   AB028449   Hs. 87889   helicase-moi   1.032E−04   2.89   65.25       447002   BE242866   Hs. 16933   HepA-related protein   9.175E−07   2.88   51.25       451582   AI963026   Hs. 289958   ESTs, Weakly similar to putative p150 [H   9.642E−03   2.88   49.25       456804   AI421645   Hs. 139851   caveolin 2   3.448E−02   2.88   50.5       428695   AI355647   Hs. 189999   purinergic receptor (family A group 5)   6.035E−05   2.88   42.5       418248   NM_005000   Hs. 83916   NM_005000*:  Homo sapiens  NADH dehydrogena   3.032E−02   2.86   48       427547   BE047653   Hs. 119183   ESTs, Weakly similar to ZN91_HUMAN ZINC   1.034E−03   2.86   47       409509   AL036923   Hs. 322710   ESTs   9.289E−03   2.86   52.5       421718   AL117574         Homo sapiens  mRNA; cDNA DKFZp434L2221 (f   3.120E−05   2.85   60.75       419438   AA406400   Hs. 12482   glyceronephosphate O-acyltransferase   7.982E−03   2.85   38       412019   AA485890   Hs. 69330     Homo sapiens  cDNA FLJ13835 fis, clone TH   3.895E−05   2.85   65.75       427704   AW971063   Hs. 292882   ESTs   4.162E−02   2.85   78.25       422607   Z45471   Hs. 118684   stromal cell-derived factor 2   1.086E−04   2.85   65.25       403330           Target Exon   3.674E−04   2.85   74.5       430280   AA361258   Hs. 237868   interleukin 7 receptor   2.353E−04   2.85   80.75       436100   AA704806   Hs. 143842   ESTs, Weakly similar to 2004399A chromos   3.034E−02   2.85   54.5       453041   AI680737   Hs. 289068     Homo sapiens  cDNA FLJ11918 fis, clone HE   5.421E−03   2.84   53       408527   AL135018   Hs. 33074     Homo sapiens , clone IMAGE: 3606519, mRNA,   8.617E−03   2.83   42.5       429503   AA394183   Hs. 26873   ESTs   1.693E−03   2.82   42.25       445564   AB028957   Hs. 12896   KIAA1034 protein   5.859E−03   2.82   41.5       401197           ENSP00000229263*: HSPC213.   3.234E−02   2.82   40.5       409205   AI952884   Hs. 14832   ESTs, Moderately similar to unnamed prot   3.937E−03   2.82   38.5       443280   AA299688   Hs. 24183   ESTs   2.494E−03   2.82   41.5       408411   C15118   Hs. 322482   hypothetical protein DKFZp566J2046   1.546E−06   2.82   115       417831   H16423   Hs. 82685   CD47 antigen (Rh-related antigen, integr   3.330E−04   2.81   58.5       433483   AI926520   Hs. 31016   putative DNA binding protein   1.902E−02   2.81   33       433902   AW292820   Hs. 144906   ESTs   6.835E−04   2.81   49.25       409132   AJ224538   Hs. 50732   protein kinase, AMP-activated, beta 2 no   3.408E−07   2.81   137.25       431976   AA719001   Hs. 291065   ESTs   8.638E−04   2.80   43.25       425836   AW955696   Hs. 90960   ESTs   9.808E−06   2.80   57.5       439773   AI051313   Hs. 143315   ESTs   3.918E−03   2.80   37       427399   NM_014883   Hs. 177664   KIAA0914 gene product   1.085E−03   2.80   84.5       420985   X94703       RAB28, member RAS oncogene family   1.925E−03   2.79   39       410800   BE280421   Hs. 94499   ESTs   2.227E−04   2.79   56       418549   AA927177   Hs. 86041   CGG triplet repeat binding protein 1   4.244E−04   2.79   53.75       420339   AW968259   Hs. 186647   ESTs   1.399E−05   2.79   73       443352   H70284   Hs. 160152   ESTs, Weakly similar to FPHU alpha-fetop   1.186E−03   2.79   40.75       417018   M16038   Hs. 80887   v-yes-1 Yamaguchi sarcoma viral related   1.542E−02   2.79   59.5       423067   AA321355   Hs. 285401   colony stimulating factor 2 receptor, be   2.710E−03   2.79   34       458971   AL119206   Hs. 126257   ESTs, Weakly similar to ALU1_HUMAN ALU S   4.816E−03   2.79   77.25       438493   AI130740   Hs. 6241   phosphoinositide-3-kinase, regulatory su   4.492E−06   2.79   149.5       424755   AB033094   Hs. 152925   KIAA1268 protein   3.619E−07   2.78   83       436562   H71937   Hs. 322904   ESTs, Weakly similar to I38022 hypotheti   4.099E−03   2.78   95       421662   NM_014141   Hs. 106552   cell recognition molecule Caspr2   1.133E−03   2.78   38.25       408190   AB032963   Hs. 43577   ATPase, Class I, type 8B, member 2   7.488E−02   2.77   37.25       434500   AF143877   Hs. 215047     Homo sapiens  clone IMAGE: 113431 mRNA seq   1.159E−02   2.77   34.5       445044   AL137728   Hs. 12258     Homo sapiens  mRNA; cDNA DKFZp434B0920 (f   5.012E−03   2.77   43.25       429312   AL133572   Hs. 199009   protein containing CXXC domain 2   2.948E−03   2.76   34.75       445106   T10219   Hs. 12329   KIAA0697 protein   3.330E−04   2.76   61       450919   AA011616   Hs. 269877   ESTs   4.466E−04   2.75   50       435767   H73505   Hs. 117874   ESTs   7.701E−02   2.75   61.75       435872   AA701357   Hs. 192759   ESTs   8.827E−05   2.75   128.25       434521   NM_002267   Hs. 3886   karyopherin alpha 3 (importin alpha 4)   6.838E−04   2.75   74       432134   AI816782   Hs. 122583   hypothetical protein FLJ21934   6.838E−04   2.75   59.75       452057   AW952005   Hs. 14928   hypothetical protein FLJ12903   2.353E−04   2.75   45.25       424381   AA285249   Hs. 146329   protein kinase Chk2   1.969E−02   2.75   44.75       434963   AW974957   Hs. 288719     Homo sapiens  cDNA FLJ12142 fis, clone MA   4.260E−03   2.75   43.75       411352   NM_002890   Hs. 758   RAS p21 protein activator (GTPase activa   1.037E−03   2.75   43       426416   AW612744   Hs. 169824   killer cell lectin-like receptor subfami   6.555E−03   2.75   41       449259   AW452058   Hs. 257519   ESTs   5.652E−04   2.75   40.25       436184   BE154067   Hs. 136660   ESTs, Weakly similar to ZN91_HUMAN ZINC   9.624E−03   2.75   40.25       439605   AF086431   Hs. 22380   ESTs   5.206E−03   2.75   34.75       404676           Target Exon   2.577E−02   2.75   30.75       443154   H04360   Hs. 24283   ESTs, Moderately similar to reduced expr   2.599E−03   2.75   48.5       440538   W76332   Hs. 79107   mitogen-activated protein kinase 14   4.096E−03   2.74   31.75       413823   AI341417   Hs. 29406   ESTs   3.893E−07   2.74   78.25       413880   AI660842   Hs. 110915   interleukin 22 receptor   5.412E−05   2.73   63.25       409005   AW299806   Hs. 297256   ESTs   6.345E−03   2.73   37.25       423706   U95218   Hs. 131924   G protein-coupled receptor 65   7.848E−04   2.73   40.25       433745   AF075320   Hs. 28980   hypothetical protein FLJ14540   4.629E−03   2.73   38.5       459436   AA323121       gb: EST25881 Cerebellum II  Homo sapiens  c   1.298E−03   2.73   41.5       415668   AW957684   Hs. 306814   hypothetical protein FLJ21889   2.664E−02   2.73   65.25       439462   AL133026   Hs. 6567     Homo sapiens  mRNA; cDNA DKFZp436C136 (fr   2.006E−03   2.72   34       436741   AA860163   Hs. 291319   ESTs   8.293E−03   2.72   33.5       422722   H74219   Hs. 269772   ESTs   9.896E−04   2.72   40       447030   AW444659   Hs. 232184   ESTs   5.005E−03   2.71   30.75       446217   AI651594   Hs. 99709   ESTs   1.714E−07   2.70   116.25       413838   AV661185   Hs. 75574   mitochondrial ribosomal protein L19   5.669E−04   2.70   44.25       445715   AB012958   Hs. 13137   UV radiation resistance associated gene   1.087E−04   2.70   54.75       411213   AA676939   Hs. 69285   neuropilin 1   3.341E−03   2.70   53.75       412935   BE267045   Hs. 75064   tubulin-specific chaperone c   1.090E−04   2.70   47.75       408051   AI623351   Hs. 172148   ESTs   3.449E−02   2.70   41.75       457650   AA649162   Hs. 236456   ESTs   1.107E−05   2.69   80.25       422461   NM_003417   Hs. 117077   zinc finger protein 264   7.112E−04   2.69   33.75       421524   AA312082   Hs. 105445   GDNF family receptor alpha 1   1.572E−05   2.68   72       453779   N35187   Hs. 43388   28 kD interferon responsive protein   9.788E−08   2.68   183       425284   AF155568   Hs. 348043   NS1-associated protein 1   2.470E−04   2.68   44.5       451107   AA235108         Homo sapiens  ubiquitin protein ligase (U   1.976E−05   2.68   45.75       443849   BE566066   Hs. 9893   ASB-3 protein   6.219E−04   2.68   48.25       438182   AW342140   Hs. 182545   ESTs, Weakly similar to ALU1_HUMAN ALU S   7.507E−04   2.67   47       433312   AI241331   Hs. 131765   ESTs, Moderately similar to I38937 DNA/R   1.822E−04   2.67   44.5       437838   AI307229   Hs. 184304   ESTs   2.389E−03   2.67   43.75       426797   AW936258   Hs. 342849   ADP-ribosylation factor-like 5   3.447E−02   2.67   39.25       430594   AK000790   Hs. 246885   hypothetical protein FLJ20783   1.713E−02   2.67   31       429245   AW969785   Hs. 285885     Homo sapiens  cDNA FLJ11321 fis, clone PL   2.180E−02   2.67   30.75       407796   AA195509   Hs. 39733   postsynaptic protein CRIPT   9.005E−04   2.67   39.75       421939   BE169531   Hs. 109727   TAK1-binding protein 2; KIAA0733 protein   9.459E−04   2.67   83.25       429623   NM_005308   Hs. 211569   G protein-coupled receptor kinase 5   4.267E−03   2.67   62.75       432485   N90866   Hs. 276770   CDW52 antigen (CAMPATH-1 antigen)   2.966E−07   2.67   203       451690   AW451469   Hs. 209990   ESTs   2.664E−02   2.67   36.75       411777   BE067552       gb: MR4-BT0358-020200-002-g10 BT0358 Homo   1.338E−02   2.67   43.75       420623   BE245485   Hs. 99437     Homo sapiens  mRNA; cDNA DKFZp586G1924 (f   2.015E−03   2.66   48.25       450607   AL050373   Hs. 25213   hypothetical protein   3.968E−06   2.66   128.5       428466   AF151063   Hs. 184456   hypothetical protein   1.928E−03   2.66   42       424321   W74048   Hs. 1765   lymphocyte-specific protein tyrosine kin   3.892E−05   2.66   71.5       411943   BE502436   Hs. 7962   ESTs, Weakly similar to S44608 C02F5.6 p   8.939E−03   2.66   34.5       409161   W07662   Hs. 50861   sirtuin (silent mating type information   1.395E−05   2.66   45.25       407908   BE379758   Hs. 110853   uncharacterized hematopoietic stem/proge   4.698E−02   2.66   37.75       444057   AA316896   Hs. 257267   FYVE and coiled-coil domain containing 1   1.487E−04   2.66   56       419216   AU076718   Hs. 164021   small inducible cytokine subfamily B (Cy   2.333E−02   2.66   36.5       427297   AW292593   Hs. 334907     Homo sapiens , clone MGC: 17333, mRNA, com   7.913E−05   2.66   90.25       446783   AW138343   Hs. 141867   ESTs   3.076E−03   2.66   36       427528   AU077143   Hs. 179565   minichromosome maintenance deficient (S.   7.282E−06   2.65   64.75       446830   BE179030   Hs. 239307   Human DNA sequence from clone RP5-1174N9   2.019E−04   2.65   47.5       440529   AW207640   Hs. 16478     Homo sapiens  cDNA: FLJ21718 fis, clone C   5.403E−04   2.65   40.5       434821   AA159111   Hs. 284281   Human putative ribosomal protein S1 mRNA   2.483E−05   2.65   50.25       437830   AB020658   Hs. 5867   KIAA0851 protein; suppressor of actin 1   1.617E−03   2.65   58       418832   X04011   Hs. 88974   cytochrome b-245, beta polypeptide (chro   6.389E−05   2.64   56.25       445652   AL117473   Hs. 13036   DKFZP727A071 protein   7.158E−04   2.64   39       447387   AI268331   Hs. 102237   tubby super-family protein   7.552E−07   2.64   67.25       453315   BE544203   Hs. 24831   ESTs   3.624E−03   2.64   41.75       425266   J00077   Hs. 155421   alpha-fetoprotein   3.338E−03   2.64   43.75       414602   AW630088   Hs. 76550     Homo sapiens  mRNA; cDNA DKFZp564B1264 (f   1.652E−04   2.63   86.5       436235   AI084982   Hs. 120790   ESTs   2.470E−04   2.63   36.25       430027   AB023197   Hs. 227743   KIAA0980 protein   9.843E−07   2.63   78.5       440528   BE313555   Hs. 7252   KIAA1224 protein   2.713E−03   2.63   50       403976           Target Exon   4.265E−03   2.63   49.75       447657   AI953011   Hs. 345287   ESTs   5.146E−04   2.63   34.75       412230   AI810374   Hs. 124177   ESTs, Weakly similar to 2109260A B cell   1.925E−03   2.62   31.25       407804   AF228603   Hs. 39957   pleckstrin 2 (mouse) homolog   5.947E−04   2.62   61.25       410853   H04588   Hs. 30469   ESTs   6.105E−03   2.62   76.5       416611   AA568308       ESTs, Weakly similar to ALU6_HUMAN ALU S   5.669E−04   2.62   49.75       452207   NM_014517   Hs. 28423   upstream binding protein 1 (LBP-1a)   1.037E−05   2.62   76.75       435445   AA737345   Hs. 294041   ESTs   2.706E−03   2.61   35.5       434608   AA805443   Hs. 179909   hypothetical protein FLJ22995   1.133E−03   2.61   50       420058   AK001423   Hs. 94694     Homo sapiens  cDNA FLJ10561 fis, clone NT   6.456E−06   2.61   79.75       447769   AW873704   Hs. 320831     Homo sapiens  cDNA FLJ14597 fis, clone NT   4.253E−04   2.61   47.5       438441   AW664960   Hs. 205319   ESTs   2.024E−04   2.61   66       448770   AA326683   Hs. 21992   likely ortholog of mouse variant polyade   2.860E−04   2.61   69.5       431899   AA521381   Hs. 187726   ESTs   4.627E−03   2.61   37.75       449082   BE387561   Hs. 22981   DKFZP586M1523 protein   2.340E−04   2.60   52.5       449881   Z28444   Hs. 24119     Homo sapiens  mRNA; cDNA DKFZp586G2222 (f   9.477E−04   2.60   66.5       433913   AI694106   Hs. 72325   ESTs, Weakly similar to I38022 hypotheti   6.131E−02   2.60   43.25       442432   BE093589   Hs. 38178   hypothetical protein FLJ23468   1.031E−04   2.60   76.25       425118   AU076611   Hs. 154672   methylene tetrahydrofolate dehydrogenase   3.205E−03   2.60   59.25       422283   AW411307   Hs. 114311   CDC45 (cell division cycle 45, S.cerevis   1.561E−04   2.60   45.25       412520   AA442324   Hs. 795   H2A histone family, member O   1.669E−05   2.60   95.5       411580   AL080088   Hs. 70877   DKFZP564K2062 protein   7.455E−05   2.60   42.75       431562   AI884334   Hs. 11637   ESTs   9.075E−02   2.59   48.5       419426   AI214690   Hs. 346257   aldo-keto reductase family 1, member B1   2.462E−04   2.59   48       422241   Y00062   Hs. 170121   protein tyrosine phosphatase, receptor t   3.968E−06   2.58   129       401928           Target Exon   4.841E−02   2.57   32       427130   AB029020   Hs. 173694   KIAA1097 protein   9.832E−06   2.57   66.5       409614   BE297412   Hs. 55189   hypothetical protein   9.799E−08   2.57   161.5       448873   NM_003677   Hs. 22393   density-regulated protein   3.845E−04   2.56   40.25       413305   NM_000426   Hs. 323511     Homo sapiens  cDNA: FLJ23176 fis, clone L   1.835E−02   2.56   43.75       446771   AA128965   Hs. 60679   TATA box binding protein (TBP)-associate   1.873E−05   2.56   78.5       422392   NM_005908   Hs. 115945   mannosidase, beta A, lysosomal   1.898E−02   2.56   30       423968   AF098277   Hs. 136529   solute carrier family 23 (nucleobase tra   1.648E−06   2.55   74.25       418941   AA452970   Hs. 239527   E1B-55 kDa-associated protein 5   3.034E−02   2.55   56.75       434669   AF151534   Hs. 92023   core histone macroH2A2.2   2.738E−06   2.55   119.25       432476   T94344   Hs. 326263   ESTs   1.691E−03   2.55   93.5       452748   AB011128   Hs. 30512     Homo sapiens  mRNA for KIAA0556 protein,   7.507E−04   2.55   46.5       445757   AW449065   Hs. 13264   KIAA0856 protein   8.934E−03   2.55   44.25       434948   AI498469   Hs. 12622   ESTs, Highly similar to AF161436 1 HSPC3   2.011E−03   2.55   40       439372   AF088033   Hs. 159225   ESTs   1.200E−02   2.55   35.5       448888   AW196663   Hs. 200242   caspase recruitment domain protein 6   1.915E−04   2.55   40.25       417821   BE245149   Hs. 82643   protein tyrosine kinase 9   7.985E−03   2.54   66       415000   AW025529   Hs. 239812     Homo sapiens  serologically defined breas   4.108E−05   2.54   74.75       417558   AF045229   Hs. 82280   regulator of G-protein signalling 10   1.338E−02   2.54   37.75       418796   AA228351   Hs. 34060   ESTs   1.815E−04   2.54   38.5       450196   AW956868   Hs. 24608   DKFZP564D177 protein   1.175E−05   2.54   138.5       422043   AL133649   Hs. 110953   retinoic acid induced 1   3.856E−04   2.54   51.5       428985   AL134193   Hs. 194709   paraneoplastic antigen MA1   1.298E−03   2.53   42.5       411196   W31212   Hs. 69192   vacuolar protein sorting 29 (yeast homol   1.439E−02   2.53   41.25       427094   AB025254   Hs. 283761   tudor repeat associator with PCTAIRE 2   2.092E−07   2.53   90.5       452737   AK001680   Hs. 30488   DKFZP434F091 protein   2.090E−03   2.52   30.5       407355   AA846203   Hs. 193974   ESTs, Weakly similar to ALU1_HUMAN ALU S   9.360E−04   2.52   30.5       431374   BE258532   Hs. 251871   CTP synthase   6.831E−04   2.52   72.75       427647   W19744   Hs. 180059     Homo sapiens  cDNA FLJ20653 fis, clone KA   3.898E−05   2.52   73.5       407436   AF211977       gb:  Homo sapiens  LENG10 mRNA, partial seq   1.437E−02   2.52   30       437145   AF007216   Hs. 5462   solute carrier family 4, sodium bicarbon   1.134E−03   2.52   73.25       421446   AA682425   Hs. 118959   ESTs   1.774E−02   2.52   32.25       458079   AI796870   Hs. 54277   DNA segment on chromosome X (unique) 992   3.091E−06   2.52   130.5       424375   AF070547   Hs. 146312     Homo sapiens  clone 24820 mRNA sequence   4.423E−02   2.51   31       428727   AF078847   Hs. 191356   general transcription factor IIH, polype   9.891E−04   2.51   63.25       421405   AA251944   Hs. 104058   CGI-29 protein   1.567E−04   2.51   74.5       418733   AA227714   Hs. 179703   KIAA0129 gene product   1.650E−04   2.50   56       447225   R62676   Hs. 17820   Rho-associated, coiled-coil containing p   4.611E−05   2.50   95.75       433162   AI025842   Hs. 152530   ESTs   5.424E−05   2.50   102.75       423645   AI215632   Hs. 147487   ESTs   1.736E−04   2.50   56.75       446045   AV656268   Hs. 209153   angiopoietin-like 3   2.239E−04   2.50   56.25       430273   AI311127   Hs. 125522   ESTs   9.035E−04   2.50   46       401898           NM_024722*:  Homo sapiens  hypothetical pro   1.927E−03   2.50   45       427210   BE396283   Hs. 173987   eukaryotic translation initiation factor   6.852E−03   2.50   44.25       445664   AW968638   Hs. 237691   ESTs, Weakly similar to KIAA0601 protein   7.093E−05   2.50   39.25       422195   AB007903   Hs. 113082   KIAA0443 gene product   6.581E−03   2.50   33       423069   W15613   Hs. 1613   adenosine A2a receptor   5.618E−02   2.50   30.25       417928   AA209344   Hs. 30177   ESTs   2.878E−04   2.49   68.5       448717   R67419   Hs. 21851     Homo sapiens  cDNA FLJ12900 fis, clone NT   4.097E−03   2.49   50.25       433000   U26710   Hs. 3144   Cas-Br-M (murine) ectropic retroviral tr   2.036E−02   2.48   44.75       426011   AW996096   Hs. 58924   ESTs, Weakly similar to JC5594 jerky gen   5.152E−04   2.48   45.75       407112   AA070801   Hs. 51615   ESTs, Weakly similar to ALU7_HUMAN ALU S   3.450E−02   2.47   106.75       410196   AI936442   Hs. 59838   hypothetical protein FLJ10808   4.868E−05   2.47   65.5       430487   D87742   Hs. 241552   KIAA0268 protein   2.235E−04   2.47   43.5       427254   AL121523   Hs. 97774   ESTs   4.813E−03   2.47   36.5       452480   AI903526       gb: RC-BT031-090199-063 BT031 Homo sapien   4.994E−02   2.47   31.75       403027           C21000364*: gi|8394509|ref|NP_058778.1| u   2.380E−03   2.47   34.25       414760   BE298063   Hs. 77254   chromobox homolog 1 (Drosophila HP1 beta   5.090E−07   2.47   79.5       444931   AV652066   Hs. 75113   general transcription factor IIIA   7.180E−04   2.47   70.5       437708   AB033020   Hs. 5801   KIAA1194 protein   8.210E−06   2.47   64.25       440340   AW895503   Hs. 125276   ESTs   8.596E−03   2.47   33.75       448198   BE622100   Hs. 209406   ESTs, Weakly similar to I38600 zinc fing   2.871E−04   2.46   43.75       405689           NM_018850*:  Homo sapiens  ATP-binding cass   5.010E−03   2.46   133       418203   X54942   Hs. 83758   CDC28 protein kinase 2   1.692E−03   2.45   50.25       449239   T24653   Hs. 23360   likely ortholog of yeast ARV1   1.272E−06   2.45   46.5       434128   W93170   Hs. 284164   protein x 0004   2.354E−04   2.45   41       416354   NM_000633   Hs. 79241   B-cell CLL/lymphoma 2   5.720E−05   2.45   40       438141   AW946871       gb: RC2-ET0022-080500-012-d02 ET0022 Homo   1.547E−03   2.45   33.5       423983   AA333261       gb: EST37476 Embryo, 8 week I Homo sapien   2.578E−02   2.45   31.25       438922   R71288   Hs. 259664   ESTs   5.297E−02   2.45   31.5       426295   AW367283   Hs. 278270   zinc finger protein 6 (CMPX1)   3.307E−05   2.45   169.5       420936   AA456112   Hs. 99410   ESTs   6.341E−03   2.45   36.5       438475   W03856   Hs. 13188   ESTs, Highly similar to Gene product wit   1.714E−07   2.44   157.5       446487   AA195526   Hs. 44625   Rad50-interacting protein 1   2.288E−03   2.44   32.5       450253   AL133047   Hs. 24715     Homo sapiens  mRNA; cDNA DKFZp434D0215 (f   4.265E−03   2.44   62       421999   U50535   Hs. 110630   Human BRCA2 region, mRNA sequence CG006   3.673E−02   2.44   73.5       442643   U82756   Hs. 3991   PRP4/STK/WD splicing factor   4.032E−02   2.44   32.75       427156   BE621719   Hs. 173802   KIAA0603 gene product   2.841E−02   2.43   54.5       433201   AB040896   Hs. 21104   KIAA1463 protein   2.098E−03   2.43   45.75       442149   AB014550   Hs. 8118   KIAA0650 protein   2.829E−03   2.42   52.25       436021   R26877   Hs. 24128   ESTs   5.639E−03   2.42   38.5       451099   R52795   Hs. 25954   interleukin 13 receptor, alpha 2   4.993E−02   2.42   52       430526   AF181862   Hs. 242407   G protein-coupled receptor, family C, gr   4.126E−05   2.42   101.25       414404   W16712   Hs. 306117   KIAA0306 protein   9.266E−05   2.42   94       410664   NM_006033   Hs. 65370   lipase, endothelial   2.192E−03   2.42   57       436643   AA757626   Hs. 10941   ESTs, Weakly similar to IPP1_HUMAN PROTE   2.235E−04   2.41   65.75       418780   AA228078   Hs. 255096   ESTs   2.829E−03   2.41   41       427468   AB036829   Hs. 178347   SKIP for skeletal muscle and kidney enri   2.122E−04   2.41   41       437143   AW204056   Hs. 8917   ESTs   1.969E−07   2.41   124.75       439747   AK001148   Hs. 6671   COP9 complex subunit 4   2.349E−04   2.41   53       447881   BE620886   Hs. 75354   GCN1 (general control of amino-acid synt   4.442E−03   2.41   54       443562   AF118838   Hs. 9599   solute carrier family 25, member 13 (cit   5.142E−02   2.41   53.25       448280   AW014215   Hs. 357   zinc finger protein 134 (clone pHZ-15)   9.001E−04   2.41   37       439645   BE091801   Hs. 27167   ESTs, Weakly similar to I38022 hypotheti   5.430E−07   2.41   71.5       427657   AV652249   Hs. 180107   polymerase (DNA directed), beta   2.417E−07   2.41   116.5       412977   AA125910   Hs. 191461   ESTs   6.492E−04   2.41   55.25       450203   AF097994   Hs. 301528   L-kynurenine/alpha-aminoadipate aminotra   5.298E−02   2.40   47.75       417089   H52280   Hs. 18612     Homo sapiens  cDNA: FLJ21909 fis, clone H   1.131E−07   2.40   155.5       446044   H67567   Hs. 13572   calcium modulating ligand   6.632E−07   2.40   91       444088   AW297946   Hs. 138208   ESTs   3.911E−02   2.40   40.5       449118   R67477   Hs. 23103   Bet1 ( S. cerevisiae ) homolog   7.679E−03   2.40   39.25       441488   AW450935   Hs. 7862   hypothetical protein FLJ20312   1.044E−05   2.40   102.25       424088   AL049942   Hs. 139240   DKFZP564F1422 protein   3.007E−04   2.39   42.5       444755   AA431791   Hs. 113823   CIpX (caseinolytic protease X,  E. coli )   2.406E−02   2.39   33       439768   AI337300   Hs. 173138   hypothetical protein MGC4604   1.541E−06   2.39   98.5       427985   AI770170   Hs. 29643     Homo sapiens  cDNA FLJ13103 fis, clone NT   4.814E−03   2.39   42.25       448646   AU077149   Hs. 21704   transcription factor 12 (HTF4, helix-loo   3.170E−04   2.38   83.75       449845   AW971183   Hs. 9683   DnaJ (Hsp40) homolog, subfamily C, membe   1.829E−04   2.38   111       451578   NM_016323   Hs. 26663   cyclin-E binding protein 1   3.893E−07   2.38   146.25       446570   AV659177   Hs. 127160   ESTs   1.399E−05   2.38   79.5       430532   D61216   Hs. 18672   ESTs   1.599E−02   2.38   35.25       418822   Z43371   Hs. 7012   ESTs   5.219E−03   2.38   40.75       446507   AA352554   Hs. 15164   nuclear DNA-binding protein   3.630E−03   2.38   58       419203   AA488719   Hs. 190151   ESTs   2.387E−03   2.38   56.25       435427   AA682573   Hs. 188982   ESTs, Weakly similar to organic anion tr   2.012E−03   2.38   73.5       444372   AW377983   Hs. 298140     Homo sapiens  cDNA: FLJ22502 fis, clone H   1.269E−04   2.38   31       414496   W73853       ESTs   8.625E−04   2.38   73       430219   X99209   Hs. 235887   HMT1 (hnRNP methyltransferase, S. cerevi   2.494E−02   2.38   42       447211   AL161961   Hs. 17767   KIAA1554 protein   1.716E−07   2.38   143.5       427020   AA397546   Hs. 119151   ESTs   2.493E−03   2.38   35.25       425375   AA631977   Hs. 155995   KIAA0643 protein   1.240E−05   2.38   34.25       440341   AW664012   Hs. 132333   ESTs   6.525E−04   2.38   30.25       418300   AI433074   Hs. 86682     Homo sapiens  cDNA: FLJ21578 fis, clone C   3.787E−02   2.38   30.25       429978   AA249027       ribosomal protein S6   2.953E−03   2.37   85.25       422614   AI908006   Hs. 295362     Homo sapiens  cDNA FLJ14459 fis, clone HE   5.423E−03   2.37   35.25       447279   AA325308   Hs. 18016     Homo sapiens  mRNA; cDNA DKFZp586H0324 (f   1.694E−03   2.37   47.5       420613   AI873871   Hs. 122444   ESTs, Weakly similar to A47582 B-cell gr   4.453E−07   2.37   89.5       408521   AA055264   Hs. 260848   ESTs, Weakly similar to S23650 retroviru   1.971E−05   2.37   44.75       429617   X89984   Hs. 211563   B-cell CLL/lymphoma 7A   3.335E−03   2.36   30       414172   AW954324   Hs. 75790   phosphatidylinositol glycan, class C   8.270E−03   2.36   31       418416   U11700   Hs. 84999   ATPase, Cu transporting, beta polypeptid   1.764E−05   2.36   59.25       446071   N51527   Hs. 13659   hypothetical protein DKFZp586F2423   8.224E−06   2.36   102.75       451743   AW074266   Hs. 23071   ESTs   9.290E−05   2.36   56.25       437134   AA349944   Hs. 42915   ARP2 (actin-related protein 2, yeast) ho   1.199E−02   2.36   51.5       410612   AW502698   Hs. 118152   ESTs   3.734E−06   2.35   117.5       442439   U09759   Hs. 246857   mitogen-activated protein kinase 9   7.907E−05   2.35   70       439103   AF085959   Hs. 38705   ESTs   1.616E−03   2.35   41.5       427469   AA403084   Hs. 269347   ESTs, Weakly similar to 2109260A B cell   4.093E−03   2.35   40.75       428044   AA093322   Hs. 301404   RNA binding motif protein 3   6.130E−02   2.35   35.75       420137   AA306478   Hs. 95327   CD3D antigen, delta polypeptide (TiT3 co   2.255E−06   2.35   78.5       446594   AI311917   Hs. 16292   ESTs   5.144E−02   2.35   71.75       452685   AI634651   Hs. 30250   v-maf musculoaponeurotic fibrosarcoma (a   7.085E−07   2.34   145.75       439708   AI761369   Hs. 59584   hypothetical protein FLJ21144   1.735E−04   2.34   36.5       451589   AA424791   Hs. 5734   meningioma expressed antigen 5 (hyaluron   3.852E−04   2.33   57       414312   AA155694   Hs. 191060   ESTs   7.918E−05   2.32   54.75       439556   AI623752   Hs. 163603   ESTs   4.627E−03   2.32   45.5       421025   AW958975   Hs. 29397     Homo sapiens  cDNA FLJ13226 fis, clone OV   5.395E−04   2.32   37       435919   AI052189   Hs. 114104   ESTs   5.010E−03   2.32   30.75       408931   AA251995   Hs. 334648   poly(A) polymerase alpha   2.841E−02   2.32   37.25       438000   AI825880   Hs. 5985   non-kinase Cdc42 effector protein SPEC2   6.103E−03   2.32   72.5       402041           C15001201*: gi|6841178|gb|AAF28942.1|AF16   1.687E−03   2.32   40.5       437223   C15105   Hs. 330716     Homo sapiens  cDNA FLJ14368 fis, clone HE   8.248E−04   2.31   95.25       420717   AA284447   Hs. 271887   ESTs   7.277E−02   2.31   41       408340   AB037762   Hs. 44268   myelin gene expression factor 2   5.994E−05   2.31   39       452248   AA093668   Hs. 28578   muscleblind (Drosophila)-like   2.634E−05   2.31   62.25       436252   AI539519   Hs. 120969     Homo sapiens  cDNA FLJ11562 fis, clone HE   5.406E−04   2.31   70       420825   AI656727       gb: tt53f12.x1 NCI_CGAP_GC6  Homo sapiens     7.165E−04   2.31   42.5       442831   AI798959   Hs. 131686   ESTs   7.169E−04   2.31   76.75       407970   AW403814   Hs. 41714   BCL2-associated athanogene   1.038E−02   2.30   30       410726   AI623859   Hs. 15936   ESTs   2.595E−04   2.30   33.25       437109   AW006781   Hs. 5457   hypothetical protein FLJ10738   1.732E−04   2.30   45.25       415662   AW972481   Hs. 170610   ESTs, Highly similar to G01887 MEK kinas   6.380E−05   2.30   76.5       425913   AA365799   Hs. 50785   SEC22, vesicle trafficking protein (S. c   6.393E−05   2.30   79.75       410017   AW952426   Hs. 109438     Homo sapiens  clone 24775 mRNA sequence   1.089E−04   2.30   82.25       422900   M641201   Hs. 222051   ESTs   5.657E−04   2.30   54.75       420164   AW339037   Hs. 24908   ESTs   2.491E−02   2.30   33.75       413029   AL119399   Hs. 293850   ESTs   2.764E−05   2.30   44.5       457605   AV657778   Hs. 3314   selenoprotein P, plasma, 1   7.165E−04   2.30   82.25       407656   AW747986   Hs. 37443     Homo sapiens  mRNA; cDNA DKFZp434B2119 (f   3.664E−04   2.29   45       452852   AK001972   Hs. 30822   hypothetical protein FLJ11110   4.496E−06   2.29   121.5       456563   AA989220   Hs. 766   ESTs   1.715E−02   2.29   75       449103   T24968   Hs. 23038   HSPC071 protein   9.789E−05   2.29   53.75       425960   AW410646   Hs. 164649   hypothetical protein DKFZp434H247   2.493E−03   2.29   52.75       417386   AL037228   Hs. 82043   Dt23 gene product   2.841E−02   2.28   37.25       443189   AB023179   Hs. 9059   KIAA0962 protein   9.877E−04   2.28   38.5       439815   AA206079   Hs. 6693   hypothetical protein FLJ20420   8.804E−05   2.28   46.5       404298           C6001238*: gi|121715|sp|P26697|GTA3_CHICK   5.420E−03   2.28   42       441664   AW748420   Hs. 6236     Homo sapiens  cDNA: FLJ21487 fis, clone C   9.882E−04   2.28   58.5       448959   AI610343   Hs. 186355   ESTs   2.020E−04   2.27   46       417206   AA291183   Hs. 81648   hypothetical protein FLJ11021 similar to   1.184E−03   2.27   40.75       422460   AW445014   Hs. 197746   ESTs   2.659E−02   2.27   33.5       448410   AK000227   Hs. 21126   hypothetical protein FLJ20220   6.881E−02   2.27   32.75       424528   AW073971   Hs. 238954   ESTs, Weakly similar to KIAA1204 protein   6.225E−04   2.27   45.25       456721   AA533356       gb: nj67f10.s1 NCI_CGAP_Pr10  Homo sapiens     1.038E−02   2.27   30.25       416269   AA177138   Hs. 161671   ESTs   6.350E−03   2.27   47.75       430308   BE540865   Hs. 238990   cyclin-dependent kinase inhibitor 1B (p2   1.398E−05   2.27   105       446161   AA628206   Hs. 14125   p53 regulated PA26 nuclear protein   4.251E−04   2.27   74.75       414256   AW410035   Hs. 75862   MAD (mothers against decapentaplegic, Dr   1.968E−02   2.27   37.5       457819   AA057484   Hs. 35406   ESTs, Highly similar to unnamed protein   2.574E−02   2.27   30.5       420463   D51872   Hs. 23492   ESTs   4.267E−03   2.27   33       408077   AL133574   Hs. 42458     Homo sapiens  mRNA; cDNA DKFZp586C1817 (f   5.869E−03   2.27   75       401403           Target Exon   3.235E−02   2.26   59.75       440675   AW005054   Hs. 47883   ESTs, Weakly similar to KCC1_HUMAN CALCI   5.063E−06   2.26   163       417867   AW952547   Hs. 194603   ESTs, Moderately similar to I38022 hypot   7.964E−03   2.26   39.25       448356   AL120837   Hs. 20993   high-glucose-regulated protein 8   3.340E−02   2.25   32       421931   NM_000814   Hs. 1440   gamma-aminobutyric acid (GABA) A recepto   2.471E−04   2.25   74.25       435524   AK000001   Hs. 4914     Homo sapiens  mRNA for FLJ00031 protein,   4.354E−05   2.25   49.5       439475   AA836331   Hs. 134981   ESTs   4.626E−03   2.25   41       414436   U50078   Hs. 76127   hect (homologous to the E6-AP (UBE3A) ca   9.997E−03   2.25   62.25       436856   AI469355   Hs. 127310   ESTs   8.090E−07   2.25   210.5       407151   H25836   Hs. 301527   ESTs, Moderately similar to unknown [H.s   2.111E−07   2.25   231.25       435756   AI418466   Hs. 33665   ESTs   3.491E−04   2.25   56.25       416754   H07145   Hs. 6799   ESTs, Weakly similar to T12483 hypotheti   1.690E−03   2.25   46.75       444647   H14718   Hs. 11506   Human clone 23589 mRNA sequence   2.255E−02   2.25   45       440638   AI376551       gb: te64e10.x1 Soares_NFL_T_GBC_S1 Homo s   3.480E−03   2.25   36.25       429025   AI399910   Hs. 266782   KIAA1826 protein   3.338E−03   2.25   35.25       418383   AA218986   Hs. 118854   ESTs   3.769E−03   2.25   32.25       438829   AA826926   Hs. 204214   ESTs, Weakly similar to I38022 hypotheti   2.600E−03   2.25   42.75       416240   NM_001981   Hs. 79095   epidermal growth factor receptor pathway   2.219E−05   2.25   69.75       438030   X98427   Hs. 122634   ESTs   1.243E−03   2.24   213.75       419200   AW966405   Hs. 288856   prefoldin 5   3.897E−07   2.24   136.25       433713   AW976511   Hs. 112592   ESTs   8.288E−03   2.24   91       447109   X69086   Hs. 286161     Homo sapiens  cDNA FLJ13613 fis. clone PL   3.777E−03   2.24   52       452870   AW502761   Hs. 30909   KIAA0430 gene product   1.246E−02   2.24   31.25       427268   X78520   Hs. 174139   chloride channel 3   1.922E−04   2.24   87.25       439046   AA947354       gb: od86e11.s1 NCI_CGAP_Ov2  Homo sapiens     1.488E−04   2.24   39.25       453929   AW190054       gb: xl11d05.x1 NCI_CGAP_Ut4  Homo sapiens     1.657E−02   2.23   30.25       417944   AU077196   Hs. 82985   collagen, type V, alpha 2   3.331E−04   2.23   129.75       417303   NM_001698   Hs. 81886   AU RNA-binding protein/enoyl-Coenzyme A   3.330E−04   2.23   67       411495   AP000693   Hs. 70359   KIAA0136 protein   2.411E−02   2.23   36.25       452144   AA032197   Hs. 102558     Homo sapiens , clone MGC: 5352, mRNA, comp   2.789E−05   2.22   58.25       405270           NM_018850*:  Homo sapiens  ATP-binding cass   1.389E−02   2.22   58       452436   BE077546   Hs. 31447   ESTs, Moderately similar to A46010 X-lin   2.491E−03   2.22   40.25       450314   AA574309   Hs. 283402   TCR eta   2.286E−03   2.22   38       442806   AW294522   Hs. 149991   ESTs   3.790E−02   2.22   34.75       406274           Target Exon   1.084E−03   2.22   69.5       449437   AI702038   Hs. 100057     Homo sapiens  cDNA: FLJ22902 fis, clone K   1.922E−04   2.22   73.75       434260   AF121856   Hs. 284291   sorting nexin 6   1.321E−05   2.22   100.5       445893   AI610702   Hs. 28212   ESTs, Weakly similar to TRHY_HUMAN TRICH   2.942E−05   2.22   63.75       429520   AA160142   Hs. 205058   hypothetical protein FLJ20075   1.839E−02   2.22   39       437801   AA613866   Hs. 5848     Homo sapiens  mRNA; cDNA DKFZp564L222 (fr   4.426E−02   2.22   39       425508   AA991551   Hs. 97013     Homo sapiens , Similar to RIKEN cDNA 2310   3.290E−05   2.21   59.25       425303   AA354785       gb: EST63098 Jurkat T-cells V Homo sapien   5.450E−02   2.21   30.75       450157   AW961576   Hs. 60178   ESTs   3.074E−03   2.20   69       453927   AA082465   Hs. 125031   choline/ethanolaminephosphotransferase   9.265E−06   2.20   58       437580   AA761075   Hs. 293567   ESTs   4.094E−03   2.20   54.75       408990   AL022395   Hs. 49526   f-box and leucine-rich repeat protein 4   2.289E−03   2.20   44       438619   AB032773   Hs. 6341   TU12B1-TY protein   1.076E−02   2.20   39       404149           C6002509*: gi|5031885|ref|NP_005568.1|li   5.296E−02   2.20   36.25       448102   AI750793   Hs. 20295   CHK1 (checkpoint,  S. pombe ) homolog   1.901E−02   2.20   30       433618   AA602539   Hs. 345494   ESTs   4.698E−02   2.20   30.25       446591   H44186   Hs. 15456   PDZ domain containing 1   5.821E−07   2.20   113.5       416041   AA345547   Hs. 53263   hypothetical protein FLJ13287   5.649E−03   2.20   57.75       414588   AA302905       gb: EST10607 Adipose tissue, white I Homo   4.681E−04   2.20   38.25       459680   H96982   Hs. 42321   ESTs   3.860E−04   2.20   84.25       452574   AF127481   Hs. 301946   lymphoid blast crisis oncogene   1.483E−03   2.19   49       412240   H72176   Hs. 4273   hypothetical protein FLJ13159   2.713E−03   2.19   33.25       423996   AF205071   Hs. 137425   solute carrier family 21 (organic anion   8.139E−02   2.19   50.75       440113   AI916532   Hs. 188272   ESTs   1.078E−03   2.19   49.5       456073   AA587775   Hs. 66295   multi-PDZ-domain-containing protein   1.316E−05   2.19   56       419675   AL079310   Hs. 92260   high-mobility group protein 2-like 1   1.182E−03   2.18   50.25       427631   AB029023   Hs. 179946   KIAA1100 protein   5.139E−05   2.18   73       442332   AI693251   Hs. 8248   Target CAT   1.650E−04   2.18   91.5       450969   BE244603   Hs. 25726   transposon-derived Buster 1 transposase-l   2.101E−03   2.18   45       421077   AK000061   Hs. 101590   hypothetical protein   6.854E−03   2.17   46.5       444291   AI598022   Hs. 193989   TAR DNA binding protein   2.232E−04   2.17   40       407904   W44735   Hs. 9286     Homo sapiens  cDNA: FLJ21278 fis, clone C   1.647E−04   2.17   35.5       442129   N36918   Hs. 20142   PNAS-127 protein   2.948E−03   2.17   34       412025   AI827451   Hs. 24143   Wiskott-Aldrich syndrome protein interac   3.489E−05   2.17   82.75       412059   AA317962   Hs. 249721   ESTs, Moderately similar to PC4259 ferri   3.674E−02   2.17   42       432235   AA531129   Hs. 190297   ESTs   5.460E−02   2.17   36.75       424247   X14008   Hs. 234734   lysozyme (renal amyloidosis)   8.638E−04   2.17   158.25       413326   H88621   Hs. 19762   ESTs, Weakly similar to KIAA1140 protein   7.992E−03   2.17   45.75       416065   BE267931   Hs. 78996   proliferating cell nuclear antigen   2.240E−04   2.17   123.25       413012   D83777   Hs. 75137   KIAA0193 gene product   2.948E−03   2.16   53.75       442092   AW578669       hypothetical protein FLJ12439   1.619E−03   2.16   31.25       423630   AB011132   Hs. 129952   KIAA0560 gene product   3.203E−03   2.16   40.75       421921   H83363   Hs. 6820   translocase of inner mitochondrial membr   4.039E−04   2.15   52.25       429586   T73510   Hs. 209153   angiopoietin-like 3   4.604E−05   2.15   132       449217   AA278536   Hs. 23262   ribonuclease, RNase A family, k6   7.916E−02   2.15   45.5       409518   BE384836   Hs. 3454   KIAA1821 protein   8.314E−05   2.15   34.25       414525   C14904   Hs. 45184     Homo sapiens  cDNA FLJ12284 fis, clone MA   4.233E−04   2.15   44       411979   X85134   Hs. 72984   retinoblastoma-binding protein 5   9.468E−04   2.15   42.75       448705   H05072   Hs. 124984   ESTs, Moderately similar to ALU7_HUMAN A   2.180E−02   2.15   37.25       419165   AW860767   Hs. 118879   ESTs   1.038E−02   2.15   36       419479   AI288348   Hs. 23450   mitochondrial ribosomal protein S25   8.590E−02   2.15   35.5       432709   H17238       gb: ym42f03.r1 Soares infant brain 1NIB H   1.353E−03   2.15   33.5       440266   AA088809   Hs. 19525   hypothetical protein FLJ22794   9.808E−05   2.15   82.5       440010   AA534930   Hs. 127236   hypothetical protein FLJ12879   1.619E−03   2.15   46.25       408866   AW292096   Hs. 255036   ESTs   4.439E−03   2.14   43.5       438023   AF204883   Hs. 6048   FEM-1 ( C. elegans ) homolog b   3.849E−04   2.14   50       439318   AW837046   Hs. 6527   G protein-coupled receptor 56   3.331E−04   2.14   68.75       403576           C3000124: gi|12737057|ref|XP_012129.1|si   5.416E−03   2.14   35       429567   R35606   Hs. 326800   Human EST clone 53125 mariner transposon   3.623E−03   2.13   32       452679   Z42387   Hs. 83883   transmembrane, prostate androgen induced   3.069E−03   2.13   32       424904   AI221739   Hs. 96899   ESTs   1.035E−02   2.13   38.75       441991   AW844404   Hs. 126901     Homo sapiens  mRNA full length insert cDN   3.860E−04   2.13   45.25       433160   AW207002   Hs. 134342   TASP for testis-specific adriamycin sens   1.543E−02   2.13   58.25       409969   AW514668   Hs. 194258   ESTs, Moderately similar to ALU5_HUMAN A   2.333E−02   2.13   34.75       437796   AW407459   Hs. 5836   mitochondrial ribosomal protein S23   2.218E−05   2.13   57       404240           NM_018950:  Homo sapiens  major histocompat   6.450E−06   2.13   177.25       413587   AA156164   Hs. 286241   protein kinase, cAMP-dependent, regulato   1.842E−03   2.13   53.5       453022   AA031499   Hs. 118489   ESTs   1.483E−03   2.13   76       407183   AA358015       gb: EST66864 Fetal lung III  Homo sapiens     5.708E−05   2.13   49.25       408047   AW205461   Hs. 243612   ESTs   6.105E−03   2.13   40.5       445800   AA126419   Hs. 32944   inositol polyphosphate-4-phosphatase, ty   9.289E−03   2.13   40       401952           Target Exon   3.784E−02   2.13   31.5       407874   AI766311   Hs. 289047     Homo sapiens  cDNA FLJ14059 fis, clone HE   1.361E−06   2.12   156.25       430399   AI916284   Hs. 199671   ESTs   4.676E−04   2.12   62.25       444913   AI362726   Hs. 193656     Homo sapiens  mRNA for KIAA1658 protein,   2.218E−05   2.12   42.5       412760   AW379030   Hs. 41324   ESTs   4.117E−05   2.11   55.75       443804   AL135352   Hs. 255883   ESTs, Weakly similar to I38022 hypotheti   9.035E−04   2.11   44       454146   BE086548   Hs. 42346   calcineurin-binding protein calsarcin-1   1.848E−03   2.11   115       425745   U44060   Hs. 14427     Homo sapiens  cDNA: FLJ21800 fis, clone H   6.541E−04   2.11   81       426676   R19549   Hs. 13996     Homo sapiens  cDNA: FLJ23260 fis, clone C   1.640E−06   2.11   147.75       430587   AK000341   Hs. 246107   elongation of very long chain fatty acid   1.344E−04   2.11   91.5       448442   AB033281   Hs. 21229   f-box and WD-40 domain protein 1B   6.107E−03   2.11   52       429286   AA449239   Hs. 154855   ESTs   4.644E−04   2.11   35       439656   AW138241   Hs. 210846   ESTs   8.798E−05   2.11   45.25       438135   AI253025   Hs. 190426   ESTs   1.085E−03   2.11   99       407795   AA044754   Hs. 48821   ESTs   3.678E−04   2.11   58.5       447749   T53260   Hs. 191091   ESTs   7.069E−05   2.11   51.25       426685   R20212   Hs. 28454   ESTs   3.077E−03   2.10   40.25       440495   AA887212   Hs. 14161   hypothetical protein DKFZp434I1930   5.008E−03   2.10   32.5       456373   BE247706   Hs. 89751   membrane-spanning 4-domains, subfamily A   2.022E−04   2.10   61.75       445817   NM_003642   Hs. 13340   histone acetyltransferase 1   9.044E−04   2.10   52.75       449901   AI674072       gb: wd15h01.x1 Soares_NFL_T_GBC_S1 Homo s   5.149E−04   2.10   41.5       439161   Y15164   Hs. 6483   oral-facial-digital syndrome 1   6.522E−04   2.10   38.75       442229   AI885776   Hs. 8164   Mulibrey nanism   7.120E−03   2.10   37.5       441024   AW081530   Hs. 268231   ESTs   2.934E−03   2.10   31.5       417691   AU076610   Hs. 82399   low density lipoprotein receptor defect   6.847E−03   2.10   30       445447   H14522   Hs. 8358   ribosomal protein S4, X-linked   2.286E−03   2.10   50       423703   NM_014913   Hs. 131915   KIAA0863 protein   1.086E−04   2.10   54       448749   AW859679   Hs. 21902     Homo sapiens  clone 25237 mRNA sequence   2.491E−02   2.09   38       426272   AW450671   Hs. 189284   ESTs   2.953E−05   2.09   94       450124   N95443   Hs. 19180     Homo sapiens  mRNA; cDNA DKFZp564E122 (fr   2.013E−03   2.09   47       413856   D13639   Hs. 75586   cyclin D2   2.602E−03   2.09   45.75       446103   U90918   Hs. 13804   hypothetical protein dJ462O23.2   1.900E−02   2.09   31       453173   AB007902   Hs. 32168   KIAA0442 protein   3.965E−06   2.09   169.25       450903   AA011670   Hs. 114749   ESTs   3.668E−04   2.09   40.75       421766   AA481157   Hs. 108110   DKFZP547E2110 protein   1.620E−03   2.08   43.25       409259   AW608930   Hs. 52184   hypothetical protein FLJ20618   7.498E−07   2.08   83.5       438154   AI671957   Hs. 19523     Homo sapiens  clone 022f05 My030 protein   1.646E−06   2.08   84.5       437469   AW753112   Hs. 15514   hypothetical protein MGC3260   2.387E−03   2.08   55       451334   AI122691   Hs. 13268   ESTs   2.732E−04   2.08   49.25       418459   R85436   Hs. 268814   ESTs   2.866E−04   2.07   61.25       424737   BE301883   Hs. 152707   glioblastoma amplified sequence   1.146E−04   2.07   50.75       454038   X06374   Hs. 37040   platelet-derived growth factor alpha pol   2.713E−03   2.07   41.75       408951   AW407227   Hs. 49282   hypothetical protein FLJ11088   3.336E−02   2.07   32.75       431923   AI741770   Hs. 292690   ESTs, Weakly similar to I38022 hypotheti   2.599E−03   2.07   43.5       447560   AF065214   Hs. 18858   phospholipase A2, group IVC (cytosolic,   4.846E−02   2.07   40.25       413836   W92003   Hs. 70614   ESTs   2.751E−02   2.07   30       450331   AA009536   Hs. 38323   ESTs   8.945E−03   2.07   34.75       446229   AI744964   Hs. 14449   KIAA1609 protein   9.450E−04   2.07   38.75       440706   AA927562   Hs. 148234   ESTs   2.101E−03   2.07   38.75       441872   BE567100   Hs. 154938   hypothetical protein MDS025   6.092E−06   2.07   121.75       415710   J04543   Hs. 78637   annexin A7   1.245E−02   2.07   31.75       428220   BE183533   Hs. 347128   Human DNA sequence from clone 34B21 on c   2.733E−06   2.07   76.5       438363   AI886351   Hs. 22353   hypothetical protein FLJ21952   2.129E−04   2.07   65.25       414781   D50917   Hs. 77293   KIAA0127 gene product   2.237E−04   2.06   41       421297   AB037360       KIAA1255 protein   2.940E−05   2.06   74.5       452068   W76412   Hs. 57877   ESTs   9.454E−04   2.06   59       429788   U87791   Hs. 221040   HBS1 ( S. cerevisiae )-like   6.130E−02   2.05   38.5       414718   H95348   Hs. 107987   ESTs   3.234E−02   2.05   53       421727   Y13153   Hs. 107318   kynurenine 3-monooxygenase (kynurenine 3   1.389E−02   2.05   102.25       432401   NM_013330   Hs. 274479   NME7   2.193E−03   2.05   104.5       448920   AW408009   Hs. 22580   alkylglycerone phosphate synthase   2.599E−03   2.05   53.25       433735   AA608955   Hs. 109653   ESTs   3.337E−03   2.05   41.25       415083   AI632683   Hs. 27179     Homo sapiens  cDNA FLJ12933 fis, clone NT   2.842E−02   2.05   38.25       453078   AF053551   Hs. 31584   metaxin 2   3.467E−03   2.05   37.5       453574   AI767947   Hs. 50841   ESTs   1.246E−02   2.05   34.25       426124   AI268389   Hs. 250697   phosphatidylinositol glycan, class F   4.291E−02   2.05   31.5       451408   AI795947   Hs. 209596   ESTs   1.438E−02   2.05   30       414553   AI813865   Hs. 164478   hypothetical protein FLJ21939 similar to   2.038E−02   2.05   39.25       431192   AI670056   Hs. 137274   ESTs, Weakly similar to SP62_HUMAN SPLIC   7.401E−03   2.04   53.25       457830   BE147896   Hs. 14662   ESTs   7.394E−03   2.04   31.5       449480   AI741617   Hs. 108447   spinocerebellar ataxia 7 (olivopontocere   4.046E−04   2.04   44.25       448384   R12314   Hs. 21056     Homo sapiens  cDNA: FLJ21366 fis, clone C   1.085E−03   2.04   57.75       451798   BE297567   Hs. 27047   hypothetical protein FLJ20392   1.480E−03   2.04   32.25       409245   AA361037   Hs. 288036   tRNA isopentenylpyrophosphate transferas   4.991E−02   2.04   39.25       446946   AI878932   Hs. 317   topoisomerase (DNA) I   2.490E−02   2.04   32.75       421166   AA305407   Hs. 102308   potassium inwardly-rectifying channel, s   1.298E−03   2.04   69.25       434275   H92087   Hs. 114288   ESTs, Weakly similar to A47582 B-cell gr   5.672E−04   2.04   127.5       428706   AA432030   Hs. 265827   interferon, alpha-inducible protein (clo   8.647E−07   2.04   242       435841   R28522   Hs. 186937   ESTs   3.666E−04   2.03   44.5       422684   BE561617   Hs. 119192   H2A histone family, member Z   2.714E−03   2.03   53.25       410333   AL049538   Hs. 62349   ras association (RalGDS/AF-6) domain con   1.157E−02   2.03   33.25       446126   AW085909   Hs. 10177   pleckstrin homology domain interacting p   3.205E−03   2.03   62       421628   AL121317   Hs. 106210   hypothetical protein FLJ10813   3.780E−03   2.03   56.75       448939   BE267795   Hs. 22595   hypothetical protein FLJ10637   1.246E−02   2.03   49.25       420747   BE294407   Hs. 99910   phosphofructokinase, platelet   6.596E−03   2.03   50.25       420977   AW794019   Hs. 100651   golgi SNAP receptor complex member 2   4.088E−03   2.03   30.5       432886   BE159028   Hs. 279704   chromatin accessibility complex 1   4.034E−02   2.02   52       432960   AW150945   Hs. 144758   ESTs   8.629E−04   2.02   45.25       429857   AF089897   Hs. 294030   topoisomerase-related function protein 4   4.393E−06   2.02   43.75       407879   AA045464   Hs. 6557   zinc finger protein 161   3.776E−03   2.02   39.75       428708   NM_014897   Hs. 190386   KIAA0924 protein   1.543E−02   2.02   36.75       424670   W61215   Hs. 116651   epithelial V-like antigen 1   1.091E−04   2.02   93       421315   D78791   Hs. 103419   fasciculation and elongation protein zet   6.077E−06   2.02   90.25       437370   AL359567   Hs. 161962     Homo sapiens  mRNA; cDNA DKFZp547D023 (fr   3.501E−04   2.02   48.75       445330   R52656   Hs. 21691   ESTs   8.939E−03   2.02   63.75       433882   U90441   Hs. 3622   procollagen-proline, 2-oxoglutarate 4-di   7.522E−04   2.02   57.5       425409   H18021   Hs. 25005   hypothetical protein MGC3329   1.620E−03   2.02   30.75       407807   AL031427   Hs. 40094   Human DNA sequence from clone 167A19 on   6.339E−03   2.01   34       414900   AW452420   Hs. 248678   ESTs   3.481E−03   2.01   57.25       408194   AA601038   Hs. 191797   ESTs, Weakly similar to S65657 alpha-1C-   2.035E−02   2.01   38.75       410582   AW867197   Hs. 337561   hypothetical protein FLJ21616   5.072E−06   2.01   103.5       422576   BE548555   Hs. 118554   CGI-83 protein   6.601E−03   2.01   79.5       418504   BE159718   Hs. 85335     Homo sapiens  mRNA; cDNA DKFZp564D1462 (f   3.692E−05   2.01   80       422431   AI769410   Hs. 221461   ESTs   3.471E−03   2.01   34.5       426369   AF134157   Hs. 169487   Kreisler (mouse) maf-related leucine zip   1.765E−05   2.01   123.75       413949   AA316077   Hs. 75639   Human TB1 gene mRNA, 3′ end   2.410E−02   2.01   42.5       451625   R56793   Hs. 106576   alanine-glyoxylate aminotransferase 2-li   2.789E−05   2.00   184.5       405688           NM_018850*:  Homo sapiens  ATP-binding cass   1.551E−03   2.00   83.25       418838   AW385224   Hs. 35198   ectonucleotide pyrophosphatase/phosphodi   7.726E−06   2.00   64.5       437672   AW748265   Hs. 5741   flavohemoprotein b5?   6.821E−04   2.00   45.75       458389   H70284   Hs. 160152   ESTs, Weakly similar to FPHU alpha-fetop   8.798E−05   2.00   45.25       417727   AL133623   Hs. 82501   similar to mouse Xrn1/Dhm2 protein   6.585E−03   2.00   41       444743   AA045648   Hs. 301957   nudix (nucleoside diphosphate linked moi   1.715E−02   2.00   40.75       429167   BE465867   Hs. 197751   KIAA0666 protein   7.118E−03   2.00   40.25       451141   AW772713   Hs. 247186   ESTs   2.599E−03   2.00   40       430178   AW449612   Hs. 152475   ESTs   1.337E−02   2.00   34.75       421620   AA446183   Hs. 91885   ESTs, Weakly similar to I55214 salivary   4.811E−03   2.00   33.25       439898   AW505514   Hs. 209561   KIAA1715 protein   2.596E−03   2.00   32.5       452874   AK001061   Hs. 30925   hypothetical protein FLJ10199   3.337E−02   2.00   30                                                                          
 
     [0343]                       TABLE 3B                       Pkey   CAT Number   Accession                                            407992   103172_2   AW418811 AI743200 AI458141       408731   10774_1   R85652 AA114024 AA296219 AA375304 AW963796 AW885952 AW020969 AA114025 AI804930 BE350971 AI765355               AW317067 AW974763               H85930 AW172600 AI310231 AW612019 D62908 D62864 AA652738 AI674617 AI494064 AW138666 AI147620               AI147629 AW611793 AI668922               AI971005 AI864742 AA174171       410099   117647_1   AA081630 T08671 AI174254 D83874 AW959843 AA364503 AA693467 AW993370 BE327037 AA167714               N79906 AW901977 AW901980 W52882               T07735 AA484549 W60090 D52685 T23811 BE327043 AW901768 BE551237 AA917004 AA716027 AI439658               AA283724 AI805992 AI457096               AA084618 BE467736 AI092635 AI887863 AI697593 AA436618 AI167419 AI418634 T31586 AA436630 AA706191               AI041169 AI422304 T03534               AA211402 AI204899 AI366472 AW827081 AA788593 T32736 AI767935 AA167791 AA747914 AA663870 AI865504       411590   125064_1   T96183 T64070 AA094134       411656   1252973_1   AW855576 AW855650 AW855578 AW855577 AW855642 AW855619 AW855624 AW855621       411777   1257741_1   BE067552 BE067800 BE067593 BE067714 BE067819 H49900       413007   1343540_1   BE046662 BE046697 BE046655       413509   1374313_1   BE145419 BE145433       413645   138145_1   AA130992 AA503835 AW969537       414279   143227_1   AW021691 AI537404 R45431 AI333439 AI741845 AI674468 R44190 R52535 R52617 AI220925 AI979148 AI744688               AW242437 AA618148               AI983837 AA399623 AI676204 AI420077 N24944 D51042 AA282786 AA137264 AW236107 AW769997 N53529               AI624731 AI968243 AI863637               Z41183 N38931 H99461 AI129279 AI767302 AI474904 H72893 AI434776 AI498342 AI089287 AA398984 H79114               N33821 AA625451 AA282874               AA137263 H72493 AF236691 AA482849 R23405 R25093 R53271 BE073129 R52586 BE073137 Z33587 AW080738               Z45484 AW889665       414496   145392_1   W73853 AA928112 W77887 AW889237 AA148524 AI749182 AI754442 AI338392 AI253102 AI079403 AI370541               AI697341 H97538 AW188021               AI927669 W72716 AI051402 AI188071 AI335900 N21488 AW770478 W92522 AI691028 AI913512 AI144448 W73819               AA604358 N28900 W95221               AI868132 H98465 AA148793       414588   146467_1   AA302905 AA495793 AA149783       416475   1596398_1   T70298 H58072 R02750       416611   160379_1   AA568308 AI453629 AI984473 AI341559 AI983169 AA181902 AI708321 AI695791 AI695792 AI478300       418259   173388_1   AA215404 AI990909 BE464132 AW271459 N74332 AI262061       418304   173658_2   AA215702 AA368006 AA215703 BE066555 BE006876       418876   179960_1   AA740616 AA654854 AA229923       420825   196769_1   AI656727 AI697887 AI802122 AA910877 Z28718 T16711 AA651731 AL047264 BE000621 R68736 AW992695               AI768764 AW271284 AW974653               AI308951 AW055146 R93609 AW467031 AI096866 AI371871 AI126182 AI564756 AI361460 AI358914 AI419231               AW439733 R87059 AA628064               AW088970 AW008695 R68682 AI719136 R97752 AW196262       420985   19829_1   X94703 NM_004249 R52316 T87420 N46403 Z36855 BE076834       421057   198849_1   T58283 AA765038 AA283052 H99396 AA814751 AI032674 N81016 N81017 BE222349 AA830545       421272   200810_1   AA704157 AA286825 C15898 C15173 D81736 AI810506 BE466071 H84948 R88291 H85515 AW014470       421297   200_1   AB037360 NM_016376 AB033081 T25038 R94364 AA399607 AW814619 BE172335 AW609548 T83895 N40773               T86064 N40777 N40757               BE550945 AW450283 H62663 AI298087 AI288098 N55959 T83725 H65293 N30050 AW858563 AW858561               AW858575 AW861931 AW858569               AW363633 N30072 AW858524 AW754343 AW754342 AW604731 AW754345 AI363734 N30068 BE155949 T16974               R60281 BE071291 AI423079               BE071350 AI917153 AA256914 AA436381 AW383355 AI630341 AW383736 AW388181 BE002858               AW815513 AA351367       421718   20595_1   AL117574 AI681945 BE503055 AW015330 C16652 AA441855 AA329853               AW962502 AA441830 AF114049       423886   232905_1   AA332098 AW950499 AW950497       423983   233891_1   AA333261 AA333365 AA552870       425303   249780_1   AA354785 AA354792 AW958427       425757   255956_1   AA363171 AW963347 AA371863       427213   276052_1   AW007211 AA399252 AA960991 BE467259       427384   278072_1   T82854 AA401778 R92652       428342   290035_2   AI739168 AA426249 AI199636 AW505198 AW977291 AA824583 AA883419 AA724079 AI015524 AI377728 AW293682               AI928140 AA731438               AI092404 AI085630 AA731340       429978   31150_1   AA249027 AL038984 AK001993 AL080066 AV652725 BE566226 AA345557 AA315222 AA090585 AA375688               AA301092 AA298454 W05762               AW607939 H51658 D83880 N84323 BE296821 AW947007 D61461 AW079261 AA329482 AW901780 AI354442               AA772275 R31663 AI354441               AI767525 H92431 AI916735 H93575 AI394255 AW014741 AI573090 C06195 AW612857 AW265195 AI339558               AI377532 AI308821 AI919424               AI589705 AW055215 AI336532 AI338051 AA806547 C75509 C00618 AW071172 AW769904 AA630381 AI678018               AI863985 D79662 BE221049               AW265018 AI589700 AW196655 N76573 AI370908 BE042393 N75017 AI698870 AW960115       430068   312849_1   AA464964 M85405 AA947566       432474   348197_1   AA584042 AW973273 AA548798       432600   350959_1   AI821085 AW973464 AA554802 AI821831 AA657438 AA640756 AA650339       432676   352582_2   AI187366 AA558869 AA618478       432689   35275_1   AB018320 H56457 AA247916 N83488 N87920 AA095653 T19858 AL134279 AA094167 AI673378 AI000340               R47500 W16595 AW152297 AI625937               AA002027 AI814851 AA902666 AI039729 AW975053 BE302243 AI240793 AA193203 N55818 AI886651               AA877735 AA565288 AI284399               AA707069 AA775885 AI014967 AA524249 R56212 AA878627 H80252 AA085731 AA657859 AI753853 AA564328               H83107 H56458 AA193204               AI075230 AA001823 AI269462 F09349 N87900 AA653028 T71600 T71751 T71812 R58128 AI890218 AL134289               T71659 AA323827 N92477               T54867 AA985252 F11689 R56295 BE086764 N88917 AA013161 BE407758 AW993041 BE018672 AL120628               H54590 AW364176       432709   353139_1   H17238 AA563739 F05559 F06116       433464   367082_1   N92481 AI475594 AW674508 AA593748 AW974058       433847   374914_1   AA610266 AA610273 AA632625 AA812563 AI688018 AI094802 H79160 R99139       433891   376239_1   AA613792 AW182329 T05304 AW858385       434280   382816_1   BE005398 AA628622 AA994155       437151   433855_1   AA745618 AA745616 AW805449 BE159081       438141   450685_1   AW946871 AW946782 AW946955 AA778849       438980   467544_1   AW502384 AI982587 AA828822       439046   468133_1   AA947354 AA829660 AI687296       439195   46967_1   H89360 AF086037 H89546       440638   499025_1   AI376551 T87714 AA897445       442048   531432_1   AA974603 AI984319 AW340495       442092   532588_1   AW578669 AI862106 AW025563 AW193658 AA976004       444314   600667_1   AI140497 AW749625 AW749626 AW749644       448219   75529_4   AA228092 AW577775 AI033234 BE076308 AI377195 AW577769       449001   792914_1   AI619957 AI654836 R99473 H51659 R99472       449901   818599_1   AI674072 BE268487       451107   85931_1   AA235108 W00590 H30674 T12414 AA384068 AA482520 AA325367 AW955325 AW517234 AI749193               AW500012 AW503974 AI720354 AI769223               AW058126 AI371974 AW021415 AA017421 AI027749 R55450 W80453 AA601599 N63625 AA235217               AA015723 AI492264 AI075880 AW444749               AI056860 AI684298 AI826258 AA055649 AA558483 AAI59479 AA533567 AA496743 AA417823 AA069759               AA057021 BE247112 N68913               AA486633 AA486538 N93443 T12413       452480   919099_1   AI903526 AI903572 AI903574 AI903571       453929   98823_1   AW190054 AI263834 AA040074       456034   142696_1   AW450979 AA136653 AA136656 AW419381 AA984358 AA492073 BE168945 AA809054 AW238038               BE011212 BE011359 BE011367 BE011368               BE011362 BE011215 BE011365 BE011363       456721   222858_1   AA533356 AW468427 R67736 AA779031 AA614088 AI823404 AA318991 AA720986       457247   308656_1   AA458605 AW977252 AI261627 AW274550 AI418272 AW665579 AA731376 AW293861 D80453 AI217860                                            
     [0344]                           TABLE 3C                       Pkey   Ref   Strand   Nt_position                                                400517   9796686   Minus   49996-50346       401016   8117441   Plus   126234-126359, 128050-128236       401091   9958240   Plus   94760-94898       401197   9719705   Plus   176341-176452       401403   7710966   Plus   146180-146294       401898   8570008   Minus   72013-72132, 72400-72487       401928   3873182   Plus   54932-55070       401952   3319121   Minus   53770-53979       402041   7770639   Plus   69353-69454       402439   9796503   Minus   108604-108764       402507   9797889   Plus   118979-119086       402727   9211324   Plus   54596-54777       402737   9212184   Minus   13358-13552       402847   9408716   Minus   104107-104314       402964   9581599   Minus   46624-46784       403027   7670575   Plus   60696-60932, 61362-61521       403330   8516153   Plus   116558-116698       403575   8101156   Minus   81961-82068       403576   6862645   Minus   73475-73940, 74079-74207       403707   7108128   Minus   132794-133294       403738   7212067   Plus   38434-38562, 56876-57007,                   59789-59876, 60714-60933,                   62986-63265       403743   7652003   Minus   136463-136646       403790   8084957   Minus   87826-87947, 89835-90002       403809   8568861   Plus   33910-34129, 34583-34862       403976   7657840   Plus   24755-24969       404149   7534008   Plus   121831-121951, 124044-124150       404240   5002624   Minus   116132-116407, 116653-116922       404298   9944263   Minus   73591-73723       404676   9797204   Minus   56167-56342, 58066-58189,                   58891-59048, 60452-60628       405102   8076881   Minus   120922-121296       405141   8980911   Plus   99861-100054       405268   4156151   Minus   24404-24521       405270   4156145   Minus   3952-4123, 6886-7010, 8541-8728       405688   4508117   Minus   88702-88899       405689   4508117   Minus   92558-92698, 94282-94382,                   97977-98180, 99202-99285       406038   8389537   Plus   37764-37877       406274   7543787   Plus   932-1123       406423   9256411   Plus   165600-165824                                                    
     [0345] Table 4A lists about 200 genes down-regulated in Hepatitis C positive liver tissues compared to Hepatitis C negative liver tissues. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the Wilcoxon rank-sum test p-value between the 2 groups was less than 0.10, the ratio of the “weighted average” of Hepatitis C negative liver tissues to the “weighted average” of Hepatitis C positive liver tissues was equal to or above 2.0, and that the differences between the same 2 groups was equal to or above 30.0. The “weighted average” of the Hepatitis C negative liver tissues was set to the trimean of various different Hepatitis C negative liver tissues. The “weighted average” of the Hepatitis C positive liver tissues was set to the either 10 or the trimean of various different Hepatitis C positive liver tissues, whichever value was greater to eliminate ratios with a denominator of zero or less. Tables 4B and 4C relate to Table 4A as 3B and 3C relate to 3A.  
               TABLE 4A                          ABOUT 200 GENES DOWN-REGULATED IN HEPATITIS C POSITIVE LIVER TISSUES COMPARED TO       HEPATITIS C NEGATIVE LIVER TISSUES                                         Pkey   ExAccn   UnigeneID   Unigene Title   R1   R2   R3                                                 450912   AW939251   Hs. 25647   v-fos FBJ murine osteosarcoma viral onco   2.125E−06   21.50   645.75       451831   NM_001674   Hs. 460   activating transcription factor 3   1.410E−04   19.50   189.75       414559   AV656184   Hs. 76452   C-reactive protein, pentraxin-related   1.209E−04   19.31   425.75       447078   AW885727   Hs. 9914   ESTs   2.578E−02   14.00   138       405278           NM_002864: Homo sapiens pregnancy-zone pr   1.132E−03   11.92   115.5       451029   AA852097   Hs. 25829   ras-related protein   7.883E−04   11.12   346.75       416188   BE157260   Hs. 79070   v-myc avian myelocytomatosis viral oncog   7.173E−04   9.65   103.5       442941   AU076728   Hs. 8867   cysteine-rich, angiogenic inducer, 61   1.830E−04   8.74   309.5       434078   AW880709   Hs. 283683   chromosome 8 open reading frame 4   1.545E−02   8.47   76.75       414220   BE298094   Hs. 323806   gb: 601118231F1 NIH_MGC_17 Homo sapiens c   3.560E−02   6.63   57.25       448607   AL042506   Hs. 21599   Kruppel-like factor 7 (ubiquitous)   2.189E−03   6.50   57.5       446066   AI343931   Hs. 149383   ESTs   3.476E−03   6.42   54.75       404501   AW247252       nucleoside phosphorylase   2.939E−02   5.93   53       420101   AW500529   Hs. 95180   KIAA0767 protein   1.621E−03   5.84   61.75       407173   T64349       gb: yc10d08.s1 Stratagene lung (937210) H   1.543E−02   5.80   55       420548   AA278246   Hs. 920   ESTs   5.637E−03   5.46   45.75       414327   BE408145   Hs. 185254   ESTs, Weakly similar to T24435 hypotheti   5.401E−04   5.45   63.5       416434   AW163045   Hs. 79334   nuclear factor, interleukin 3 regulated   1.900E−02   5.45   101.75       427509   M62505   Hs. 2161   complement component 5 receptor 1 (C5a I   1.439E−02   5.43   89.75       419299   AI311085   Hs. 62406   hypothetical protein FLJ22573   3.630E−03   5.05   45.25       400425   AY004252   Hs. 287385   PR domain containing 12   1.922E−04   4.88   39.75       417752   C15737   Hs. 269386   ESTs   4.093E−03   4.80   43       430070   AF197927   Hs. 231967   ALL1 fused gene from 5q31   4.351E−05   4.80   51.25       401149           Target Exon   1.567E−04   4.75   45.75       409233   AK002001   Hs. 51305   v-maf musculoaponeurotic fibrosarcoma (a   2.734E−04   4.74   80.5       423053   BE312679       gb: 601148138F1 NIH_MGC_19 Homo sapiens c   1.242E−03   4.72   64.25       453196   AW003567   Hs. 345309   ESTs   2.602E−03   4.65   41.75       408278   AW876813   Hs. 3343   phosphoglycerate dehydrogenase   2.866E−04   4.52   35.5       401677   H18444       BAI1-associated protein 3   2.177E−02   4.40   34.5       428106   BE620016   Hs. 182470   PTD010 protein   8.236E−04   4.38   57.25       427557   NM_002659   Hs. 179657   plasminogen activator, urokinase recepto   8.798E−05   4.34   71       418303   AA215701   Hs. 186541   ESTs, Weakly similar to I38022 hypotheti   2.749E−02   4.32   44.75       431319   AA873350   Hs. 302232   ESTs   5.146E−02   4.20   81.75       449986   AW864502       gb: PM4-SN0016-120400-004-b12 SN0016 Homo   7.698E−02   4.17   33.75       458867   AW995393       gb: QV0-BN0042-170300-163-g12 BN0042 Homo   5.074E−07   4.16   126.25       423720   AL044191   Hs. 23388   hypothetical protein DKFZp434F0318   5.213E−03   4.15   82.25       433071   BE150229   Hs. 281564   retinal outer segment membrane protein 1   1.922E−03   4.15   32.25       450335   BE218355   Hs. 201781   ESTs, Weakly similar to B34087 hypotheti   1.000E−02   4.13   33.75       448871   BE616709   Hs. 159265   kruppel-related zinc finger protein hcKr   5.425E−03   4.10   47.25       409795   AI934808   Hs. 219132   ESTs, Weakly similar to T46338 hypotheti   3.624E−03   4.02   38.5       401913           ENSP00000249158*: CDNA   3.560E−02   4.00   33       403796           Target Exon   1.239E−03   3.97   44.25       436068   AK000038   Hs. 300979   ESTs, Weakly similar to I38022 hypotheti   1.038E−02   3.95   31.25       449236   AJ403126   Hs. 26373   Homo sapiens cDNA: FLJ23449 fis, clone H   2.255E−02   3.90   35.5       431394   AK000692   Hs. 252351   HERV-H LTR-associating 2   3.334E−03   3.88   35.25       454985   AW849292       gb: IL3-CT0215-020300-090-E06 CT0215 Homo   2.711E−03   3.88   42       444531   BE158822   Hs. 282469   ESTs, Weakly similar to I38022 hypotheti   4.629E−03   3.85   30.5       441063   AA913819   Hs. 188025   ESTs   9.074E−02   3.77   33.5       431861   AA521072   Hs. 292128   ESTs   3.666E−04   3.76   31.75       402517           Target Exon   1.902E−02   3.76   33.75       454598   AW809716       gb: MR4-ST0124-241199-026-h09 ST0124 Homo   7.123E−03   3.75   36       415477   NM_002228   Hs. 78465   v-jun avian sarcoma virus 17 oncogene ho   3.862E−04   3.75   135.25       411349   AW838313       gb: QV2-LT0051-030500-188-f06 LT0051 Homo   7.860E−04   3.70   35       410267   AW978005   Hs. 12600   N-ethylmaleimide-sensitive factor attach   2.814E−03   3.65   32.25       454292   N57559   Hs. 82273   hypothetical protein   7.123E−03   3.65   53       404958           Target Exon   2.491E−03   3.63   37.25       403794           Target Exon   1.763E−03   3.61   45       412176   AW898334       gb: RC3-NN0070-270400-011-f02 NN0070 Homo   7.511E−04   3.60   30       445402   AI222415   Hs. 147852   ESTs   6.522E−04   3.60   34.5       439760   AL355741   Hs. 21641   Homo sapiens mRNA full length insert cDN   7.856E−04   3.55   37.5       450875   AK000724   Hs. 301553   karyopherin alpha 6 (importin alpha 7)   2.938E−05   3.52   83.25       417551   AI816291   Hs. 82273   hypothetical protein   8.224E−04   3.52   103.25       429258   AA448765       gb: zx10e09.r1 Soares_total_fetus_Nb2HF8 —     5.001E−03   3.51   33.25       403324           C2000428*: gi|7705383|ref|NP_057536.1|GC   2.038E−02   3.50   30       411929   AA098880   Hs. 69297   ESTs   9.630E−03   3.50   50       418525   AW450369   Hs. 86937   ESTs   1.199E−02   3.47   32.5       403579           Target Exon   1.158E−02   3.47   38.25       449335   AW150717   Hs. 345728   STAT induced STAT inhibitor 3   4.096E−03   3.47   221.25       414428   BE296906   Hs. 182625   VAMP (vesicle-associated membrane protei   5.786E−02   3.45   43.5       449785   AI225235   Hs. 288300   hypothetical protein FLJ23231   2.255E−02   3.45   35.25       430389   AL117429   Hs. 240845   DKFZP434D146 protein   1.489E−02   3.42   31.5       454636   AW811502       gb: QV2-ST0145-061299-015-b04 ST0145 Homo   2.830E−03   3.42   38.75       402889           ENSP00000217123*: FLJ00118 protein (Fragm   2.011E−03   3.42   36.25       405600           C12001673: gi|9631264|ref|NP_048045.1|or   4.808E−03   3.39   36.5       408120   AW299900   Hs. 267632   TATA element modulatory factor 1   5.865E−03   3.38   37.75       446052   AA358760       gb: EST67699 Fetal lung II Homo sapiens c   3.886E−05   3.36   72       409840   AW502122       gb: UI-HF-BR0p-ajr-c-08-0-Ul.r1 NIH_MGC_5   9.284E−05   3.36   39.5       415897   H08323   Hs. 268712   ESTs   7.148E−04   3.35   30       456782   AK000462   Hs. 132071   ovarian carcinoma immunoreactive antigen   1.409E−04   3.35   38.75       417732   R36065       gb: yg69h06.r1 Soares infant brain 1NIB H   7.852E−04   3.31   31.25       402273           Target Exon   2.933E−02   3.30   34       440535   AI590563   Hs. 125910   ESTs   1.339E−02   3.30   32.75       450799   AW407504       gb: UI-HF-BM0-adk-g-12-0-Ul.r1 NIH_MGC_38   1.768E−03   3.27   42.5       403508           Target Exon   2.106E−02   3.25   36       443725   AW245680   Hs. 9701   growth arrest and DNA-damage-inducible,   5.085E−06   3.24   412.5       427536   BE277141   Hs. 115803   gb: 601178666F1 NIH_MGC_20 Homo sapiens c   9.859E−04   3.20   38       447306   AI373163   Hs. 170333   ESTs   2.254E−02   3.17   39.5       430071   AA355986   Hs. 232068   transcription factor 8 (represses interl   1.243E−03   3.15   142.75       410052   AA525225   Hs. 334630   Homo sapiens cDNA FLJ14462 fis, clone MA   1.903E−02   3.11   107.75       408952   S79854   Hs. 49322   deiodinase, iodothyronine, type III   2.471E−04   3.09   35.5       447819   U90544   Hs. 19710   solute carrier family 17 (sodium phospha   4.558E−02   3.07   30.5       433010   AW970018       gb: EST382097 MAGE resequences, MAGK Homo   2.492E−03   3.05   36.5       442364   AA993149   Hs. 129895   ESTs, Moderately similar to TBX3_HUMAN T   2.193E−03   3.05   32.5       403582           Target Exon   5.956E−02   3.02   33.75       449180   AI633836   Hs. 195649   ESTs   5.785E−02   3.02   30.25       415994   NM_002923   Hs. 78944   regulator of G-protein signalling 2, 24k   5.146E−02   3.02   117       447135   T58148       gb: yb98g06.s1 Stratagene lung (937210) H   2.012E−03   3.00   62.5       419555   AA244416       gb: nc07d11.s1 NCI_CGAP_Pr1  Homo sapiens     2.196E−03   2.99   95.5       412568   AI878826   Hs. 74034   caveolin 1, caveolae protein, 22 kD   3.035E−02   2.98   61       444047   AI097452   Hs. 135095   ESTs   1.900E−02   2.97   35.5       403180           Target Exon   3.858E−04   2.96   38.75       402777           C1002652*: gi|544327|sp|Q04799|FMO5_RABIT   1.117E−02   2.94   41.25       433095   AK001092   Hs. 302480   Homo sapiens cDNA FLJ10230 fis, clone HE   1.902E−02   2.93   33.75       402070           Target Exon   7.109E−03   2.89   35.5       402124           NM_031891: Homo sapiens cadherin 20, type   8.621E−04   2.88   36.25       402663           C1002133: gi|12697931|dbj|BAB21784.1| (AB   8.917E−03   2.88   30.5       447721   BE619620       lysyl oxidase   1.845E−03   2.85   32.25       422017   NM_003877   Hs. 110776   STAT induced STAT inhibitor-2   3.480E−03   2.84   108       432877   AW974111   Hs. 292477   ESTs   4.422E−02   2.84   67       444863   AW384082   Hs. 104879   serine (or cysteine) proteinase inhibito   2.331E−02   2.80   37.5       444207   AI565004   Hs. 343475   cathepsin D (lysosomal aspartyl protease   4.591E−05   2.80   194       428568   AC004755   Hs. 302038   Homo sapiens chromosome 19, fosmid 37502   7.492E−04   2.80   46.25       424042   Y10601   Hs. 137674   ankyrin-like with transmembrane domains   7.392E−03   2.78   35.25       440509   BE410132   Hs. 134202   ESTs, Weakly similar to T17279 hypotheti   4.906E−04   2.78   94.75       459721   AI299050   Hs. 143835   gb: qn14d12.x1 NCI_CGAP_Lu5  Homo sapiens     4.287E−02   2.78   37.75       402651           NM_000721*: Homo sapiens calcium channel,   2.705E−03   2.77   51       403545           Target Exon   2.012E−03   2.77   43       416666   H73028   Hs. 268992   ESTs   1.549E−03   2.74   32.25       447981   R53772   Hs. 8929   hypothetical protein FLJ11362   4.160E−02   2.74   37       453560   AA348626   Hs. 5890   hypothetical protein FLJ23306   4.700E−02   2.74   41.75       441269   AW015206   Hs. 178784   ESTs   4.422E−02   2.72   64       441427   BE550625   Hs. 126956   ESTs   4.030E−04   2.72   34       411283   AW852754       gb: PM1-CT0247-180100-009-c05 CT0247 Homo   1.337E−02   267   33.5       423433   AK000497   Hs. 128646   hypothetical protein FLJ20639   7.487E−02   2.66   34       421993   R22497   Hs. 110571   growth arrest and DNA-damage-inducible,   4.117E−05   2.65   371       442702   AW235697   Hs. 130980   ESTs   2.107E−02   2.65   38.25       414890   BE281095   Hs. 77573   uridine phosphorylase   1.084E−03   2.61   52.25       401346   BE041451       hypothetical protein   9.633E−03   2.60   46.5       408112   AW451982   Hs. 248613   ESTs   3.674E−02   2.60   40.75       432745   AI821926       gb: nt78f05.x5 NCI_CGAP_Pr3  Homo sapiens     4.904E−04   2.56   32.75       404717           NM_007313*: Homo sapiens v-abl Abelson mu   8.134E−02   2.56   30.75       437180   BE180234   Hs. 281462   Homo sapiens cDNA FLJ14793 fis. clone NT   5.867E−03   2.53   63       417213   BE257508   Hs. 24719   modulator of apoptosis 1   2.923E−05   2.52   38.75       422743   BE304678   Hs. 119598   ribosomal protein L3   1.837E−02   2.50   42.75       457148   AF091035   Hs. 184627   KIAA0118 protein   7.111E−03   2.50   60.25       417079   U65590   Hs. 81134   interleukin 1 receptor antagonist   1.839E−02   2.49   216.5       427899   AA829286   Hs. 332053   serum amyloid A1   9.814E−05   2.48   799       427413   BE547647   Hs. 177781   hypothetical protein MGC5618   1.159E−02   2.48   92.25       422924   AI480125   Hs. 185777   ESTs   9.609E−03   2.48   30.25       412429   AV650262   Hs. 75765   GRO2 oncogene   1.649E−06   2.47   246.25       407654   AW064121   Hs. 279175   ESTs   1.297E−03   2.46   40.5       447650   AW581199   Hs. 161137   ESTs, Moderately similar to I54374 gene   1.292E−02   2.45   40.5       434180   AA921757   Hs. 116180   ESTs   9.459E−04   2.45   50.25       414141   BE255083   Hs. 145729   hypothetical protein DKFZp564A1164   6.099E−03   2.42   30.5       410204   AJ243425   Hs. 326035   early growth response 1   1.419E−03   2.41   232       446912   AI347650   Hs. 128521   ESTs, Moderately similar to ALU4_HUMAN A   2.408E−02   2.40   37.25       448429   D17408   Hs. 21223   calponin 1, basic, smooth muscle   5.621E−02   2.40   31.5       423499   AW608884   Hs. 28068   ESTs   3.008E−04   2.40   31.75       424236   AW058114   Hs. 7837   phosphoprotein regulated by mitogenic pa   2.290E−03   2.37   47.5       426521   AF161445   Hs. 170219   hypothetical protein   2.841E−02   2.37   39.25       446378   AI905699   Hs. 239760   citrate synthase   8.200E−04   2.36   50.5       400818           Target Exon   3.204E−03   2.36   46.75       454339   AW381980       gb: QV4-HT0316-091199-028-d05 HT0316 Homo   1.969E−02   2.35   39       401942           C17001396*: gi|3212355|pdb|1A4P|A Chain A   1.759E−03   2.33   36       456147   H41324   Hs. 31581   ESTs, Moderately similar to ST1B_HUMAN S   6.882E−02   2.32   35.5       419305   AI609195   Hs. 304930   ESTs   5.144E−04   2.31   32.75       428403   AI393048   Hs. 326159   leucine rich repeat (in FLII) interactin   7.081E−02   2.30   52       456013   T92048       gb: yd54g12.s1 Soares fetal liver spleen   7.837E−04   2.29   30.25       435992   AI033259   Hs. 118317   Homo sapiens cDNA FLJ12088 fis, clone HE   2.663E−02   2.28   50.75       424272   AA360929   Hs. 144439   putative RNA binding protein   3.780E−03   2.28   34       411231   AW833501       gb: QV4-TT0008-091199-025-e09 TT0008 Homo   2.189E−03   2.27   30.5       434651   BE616902   Hs. 285313   core promoter element binding protein   9.321E−02   2.27   45.75       401376           Target Exon   1.773E−02   2.27   37.75       407338   AA773213   Hs. 200558   gb: ab66f10.s1 Stratagene lung carcinoma   1.038E−02   2.26   39.5       402012   AF106069       ubiquitin specific protease 15   9.915E−04   2.25   36       415759   AA169182   Hs. 182740   gb: zp20e02.s1 Stratagene fetal retina 93   9.630E−03   2.25   34.25       431387   AI878854   Hs. 252229   v-maf musculoaponeurotic fibrosarcoma (a   8.945E−03   2.23   35.5       452236   AI130858   Hs. 143218   ESTs   5.457E−02   2.22   31.25       405443           Target Exon   1.202E−02   2.21   132.75       402878           ENSP00000217420*: BA122O1.1 (A novel prot   1.132E−03   2.20   35.5       422831   R02504   Hs. 332943   ESTs   7.682E−03   2.20   39.75       410895   AW809679       gb: MR4-ST0124-261099-015-f05 ST0124 Homo   2.489E−02   2.20   34.75       405022           Target Exon   5.299E−02   2.19   33.75       403750           C5001092: gi|6671939|gb|AAF23199.1|AC0167   4.249E−03   2.19   30.75       404187           NM_019602: Homo sapiens butyrophilin-like   9.022E−04   2.19   53.25       420701   N42919   Hs. 88630   ESTs, Weakly similar to T14748 hypotheti   9.286E−03   2.19   31.75       434495   AW352170   Hs. 129086   Homo sapiens cDNA FLJ12007 fis, clone HE   9.997E−03   2.16   38.5       427700   AA262294   Hs. 180383   dual specificity phosphatase 6   3.340E−02   2.15   84       416348   H65887   Hs. 272163   ESTs   3.497E−04   2.15   30.5       426653   AA530892   Hs. 171695   dual specificity phosphatase 1   3.337E−04   2.14   399.5       440249   AI246590   Hs. 249175   ESTs   9.290E−05   2.14   53.75       458568   AI769067   Hs. 127824   ESTs, Weakly similar to T28770 hypotheti   1.340E−02   2.11   395.75       459711   BE386801   Hs. 21858   trinucleotide repeat containing 3   4.562E−02   2.10   37.5       409540   AW409569       gb: fh01e09.x1 NIH_MGC_17 Homo sapiens cD   2.287E−03   2.09   41.75       437389   AL359587   Hs. 271586   hypothetical protein DKFZp762M115   3.208E−03   2.09   87.75       455968   BE168828       gb: QV1-HT0517-020400-145-f04 HT0517 Homo   1.237E−03   2.08   50.5       419909   AL136653   Hs. 93675   decidual protein induced by progesterone   2.488E−03   2.07   80.25       407869   AI827976   Hs. 24391   hypothetical protein FLJ13612   1.358E−03   2.07   199       456465   M94065   Hs. 94925   dihydroorotate dehydrogenase   5.155E−04   2.07   121.75       412541   BE009398   Hs. 74002   nuclear receptor coactivator 1   9.647E−03   2.04   41.25       423935   BE382429   Hs. 268561   hypothetical protein FLJ10726   1.246E−02   2.03   38.75       408022   AW137208   Hs. 176000   ESTs   2.571E−02   2.03   42.25       406140           Target Exon   1.081E−03   2.03   48       417076   AW973454   Hs. 238442   ESTs, Moderately similar to ALU7_HUMAN A   9.630E−03   2.02   31.5       442321   AF207664   Hs. 8230   a disintegrin-like and metalloprotease (   1.926E−04   2.02   187       431111   AB033072   Hs. 250015   KIAA1246 protein   1.272E−04   2.01   37.25       445132   Z44811   Hs. 14928   hypothetical protein FLJ12903   5.935E−04   2.01   49       438808   M73980   Hs. 129053   Homo sapiens NOTCH 1 (N1) mRNA, complete   2.703E−03   2.01   34.25       406210           Target Exon   2.179E−02   2.01   34.5       422424   AI186431   Hs. 296638   prostate differentiation factor   2.333E-02   2.00   153.5                                                                          
 
     [0346]                       TABLE 4B                       Pkey   CAT Number   Accession                                            409540   1138613_1   AW409569 BE297044 BE295828       409840   1156071_1   AW502122 AW502125 AW501663 AW501720       410895   1226051_1   AW809679 AW809678 AW810113 AW810182 AW809900 AW809851 AW810110 AW810228 AW810342 AW810181               AW809632 AW809745               AW810372 AW809681 AW809792 AW809806 AW810452 AW809675 AW809964 AW810033 AW810111               AW809846 AW809847 AW809717       411231   1236356_1   AW833501 AW833506 AW833722 AW833332 AW833509 AW833511 AW833767 AW833339       411283   1237666_1   AW852754 AW852897 AW852757 AW852617 BE172755 AW835444       411349   1239900_1   AW838313 AW838353 AW838382 AW838207       412176   1281370_1   AW898334 H66426 AW899792       417732   1695922_1   R36065 R12062 R12616 Z43412       419555   185884_1   AA244416 AA244401       423053   224319_1   BE312679 BE314223 AA320990       429258   301917_1   AA448765 C04967 C03045 AA658293       432745   353673_1   AI821926 AA658826 AA564492 AA635129 AI791191       433010   357372_1   AW970018 AA573669 AA573622 R08736       446052   65988_1   AA358760 AA158850 AW062737 AW062738 AV656291       447135   70963_1   T58148 AW516579 AW059603       447721   73383_1   BE619620 AA448721 AI971709 AW175624 W24193 W24199 BE463718 AW193322 AI341487 AW072844               BE048584 AW593800 AI623222               AI983635 AW275114 AI952164 AI800442 AA385255 AW959076 AA977038 AI801910 AW513859 AW273202 AW337946               AA250733 AW273147               AI453134 AW235230 AI818468 AW166266 AI086791 AW300481 AI631778 AI561259 AW470887 AI207341               AW103087 AW193240 AI052433               AI128968 AW264492 AA327876 AI682412 AW771868 AI669677 AA448630 AA456607 AI128695 AI825128               AW195959 N79049 AI470892               AA902669 AI672486 AA769789 AI214684       449986   821463_1   AW864502 AW864369 AI678780       450799   847242_1   AW407504 W31274 AI738877       454339   1122972_1   AW381980 BE152244 BE152235 BE152238 BE152232       454598   1226062_1   AW809716 AW810152 AW809646 AW809747 AW809738 AW809826 AW809996 AW809798 AW809802 AW809840               AW809695       454636   1227589_1   AW811502 AW811521 AW811548 AW811471 AW811511 AW811508       454985   1248105_1   AW849292 AW849431 AW849422 AW849428 AW849420 AW849424 AW849427       455968   1391117_1   BE168828 BE168830 BE168823 BE168928 BE168820 BE168826       456013   1411982_1   T92048 BE242744       458867   80304_1   AW995393 AJ403118                                            
     [0347]                           TABLE 4C                       Pkey   Ref   Strand   Nt_position                                                400818   8569994   Plus   172644-172765, 173085-173200       401149   7229925   Plus   73117-74019       401346   9926605   Minus   12031-13032       401376   7417809   Plus   40584-40963       401677   9965537   Minus   62856-63086, 63603-63884       401913   9369520   Minus   33753-33904       401942   4982556   Minus   130749-131044       402012   7407997   Minus   111771-111909, 112107-112226,                   112519-112694       402070   8117335   Minus   68256-68484       402124   4033680   Plus   164206-164459       402273   2979528   Plus   28990-29203, 32299-32402,                   32474-32668       402517   9798106   Plus   17569-17721       402651   7960391   Plus   174215-174380       402663   8077020   Minus   14155-14364       402777   9588235   Plus   126786-126948       402878   9908870   Minus   56133-56522       402889   9931133   Plus   89392-89498, 90358-90571       403180   7523976   Minus   63603-63759       403324   8440025   Minus   107104-107309       403508   7630896   Plus   5570-5719       403545   8078400   Plus   25293-25640       403579   8101179   Minus   36167-36365       403582   8101186   Plus   18308-18458       403750   7229814   Minus   133638-134110       403794   8096910   Plus   163292-163884       403796   8099896   Minus   75073-77664       404187   4481839   Plus   7644-7991       404501   7229859   Minus   37270-37526       404717   9838068   Minus   165900-166052, 169415-169599,                   171430-171607, 172254-172338       404958   7407941   Minus   2731-4531       405022   7330304   Plus   217163-217439       405278   6139075   Minus   3863-3965, 4823-4891, 5439-5529,                   6043-6170, 6344-6562, 7835-7990       405443   7408143   Plus   90716-90887, 101420-101577       405600   5923640   Plus   26662-27225       406140   9168231   Minus   49887-50219       406210   7341959   Plus   58546-58687                                                    
     [0348] Table 5A lists about 164 genes up-regulated in Hepatitis C positive liver tissues at a time before pegylated-interferon-alpha plus ribavirin treatment that was found to be non-responsive (non-responders) to the treatment compared to Hepatitis C positive liver tissues at a time before pegylated-interferon-alpha plus ribavirin treatment that was found to be responsive to the treatment (responders). These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the Wilcoxon rank-sum test p-value between the 2 groups was less than 0.10, the ratio of the “weighted average” of non-responders to the “weighted average” of responders was equal to or above 2.0, and that the differences between the same 2 groups was equal to or above 30.0. The “weighted average” of the non-responders was set to the trimean of the non-responders. The “weighted average” of the responders was set to the either 10 or the trimean of the different responders, whichever value was greater to eliminate ratios with a denominator of zero or less. Tables 5B and 5C relate to Table 5A as 3B and 3C relate to 3A.  
                                       TABLE 5A                       Pkey   ExAccn   UnigeneID   Unigene Title   R1   R2   R3                                                            454075   R43826   Hs. 16313   Kruppel-like zinc finger protein GLIS2   6.136E−02   7.15   64.75       430273   AI311127   Hs. 125522   ESTs   7.404E−02   6.35   60       444342   NM_014398   Hs. 10887   similar to lysosome−associated membrane   5.766E−03   6.25   77.5       424381   AA285249   Hs. 146329   protein kinase Chk2   3.476E−02   6.17   52.75       444104   AW296150   Hs. 177151   ESTs   7.353E−02   5.97   57       447261   NM_006691   Hs. 17917   extracellular link domain-containing 1   5.091E−02   5.33   53       426990   AL044315   Hs. 173094   Homo sapiens mRNA for KIAA1750 protein,   7.404E−02   5.31   52.75       404493   NA       Target Exon   1.485E−02   5.13   42       412747   AW994222       gb: RC3-BN0036-250200-012-e02 BN0036 Homo   5.091E−02   5.07   51.75       404075   NA       Target Exon   5.132E−02   4.97   41       454525   BE280421   Hs. 94499   ESTs   5.681E−03   4.95   50.5       445098   AL050272   Hs. 12305   DKFZP566B183 protein   1.812E−02   4.92   39.25       402012   AF106069       ubiquitin specific protease 15   7.404E−02   4.91   44       452826   BE245286   Hs. 301636   peroxisomal biogenesis factor 6   2.299E−02   4.91   62.5       407828   AW959500   Hs. 49597   retinoic acid induced 2   4.200E−02   4.75   49.5       417123   BE326521   Hs. 159450   ESTs   3.381E−02   4.70   43.25       418483   W26076   Hs. 221847   ESTs   5.132E−02   4.70   41.25       414308   AI740705   Hs. 126485   hypothetical protein FLJ12604; KIAA1692   5.051E−02   4.55   42.25       426106   AI678765   Hs. 21812   ESTs   3.476E−02   4.49   53.25       437233   D81448   Hs. 339352   Homo sapiens brother of CDO (BOC) mRNA,   6.136E−02   4.47   59.25       403807   NA       NM_031889: Homo sapiens enamelin (ENAM),   5.681E−03   4.34   36.75       432250   AA452088   Hs. 274170   Opa-interacting protein 2   1.833E−02   4.32   39.75       452455   N25153   Hs. 61661   ESTs, Weakly similar to AF174605 1 F-box   2.251E−02   4.25   40       459171   AW967801   Hs. 64783   ESTs, Weakly similar to T42705 hypotheti   5.132E−02   4.17   35.5       435791   AA243086   Hs. 25204   chondroitin 4-O-sulfotransferase 2   1.485E−02   4.17   41.25       426798   AA385062   Hs. 130260   ESTs   5.132E−02   4.13   32.5       424017   AA333789       gb: EST37925 Embryo, 9 week  Homo sapiens     6.136E−02   4.10   35.25       446627   AI973016   Hs. 15725   hypothetical protein SBBI48   3.476E−02   4.06   72       442269   AI797066   Hs. 201995   ESTs   1.450E−02   4.05   31       447698   AI420156   Hs. 326733   ESTs   1.168E−02   4.05   47.25       432336   NM_002759   Hs. 274382   protein kinase, interferon-inducible dou   7.404E−02   4.02   35       408711   AW376061   Hs. 63335   ESTs, Moderately similar to A46010 X-lin   7.404E−02   4.02   31       427867   NM_005073   Hs. 2217   solute carrier family 15 (oligopeptide t   8.877E−03   3.97   49.5       437990   AI686579   Hs. 121784   ESTs   5.132E−02   3.97   34       444640   AL133933   Hs. 64310   interleukin 11 receptor, alpha   7.353E−02   3.97   30.75       437063   AA351109   Hs. 5437   Tax1 (human T-cell leukemia virus type I   7.404E−02   3.95   33.25       428108   AA421452       ESTs, Weakly similar to KIAA0926 protein   2.807E−02   3.95   31.5       412055   AA099907   Hs. 271806   ESTs, Weakly similar to ALU1_HUMAN ALU S   5.091E−02   3.93   33       417936   X01059   Hs. 82963   gonadotropin-releasing hormone 1 (leutin   4.200E−02   3.92   37.5       410099   AA081630       KIAA0036 gene product   1.485E−02   3.91   80.75       410541   AA065003   Hs. 64179   syntenin-2 protein   5.766E−03   3.85   123.25       424259   AK001776   Hs. 143954   hypothetical protein FLJ10914   2.299E−02   3.82   39.75       458381   AI041873   Hs. 132148   ESTs   5.132E−02   3.82   36.25       441897   AI264686   Hs. 23921   hypothetical protein DKFZp547A023   5.091E−02   3.77   42.75       405411           ENSP00000252213: SODIUM BICARBONATE COTRA   5.132E−02   3.75   64.25       427509   M62505   Hs. 2161   complement component 5 receptor 1 (C5a I   3.476E−02   3.75   30.25       428151   AA422028   Hs. 171136   ESTs   3.476E−02   3.72   32       422553   AI697720   Hs. 171455   ESTs, Weakly similar to T31613 hypotheti   5.091E−02   3.69   78       401842   NA       Target Exon   7.404E−02   3.67   38       433365   AF026944   Hs. 293797   ESTs   5.091E−02   3.65   68       402200   AL080200       DKFZP434F122 protein   2.275E−02   3.65   41       437191   NM_006846   Hs. 331555   serine protease inhibitor, Kazal type, 5   6.136E−02   3.63   31.75       444196   AW139633   Hs. 279582   GTP-binding protein Sara   5.132E−02   3.60   35       403436           NM_006548*: Homo sapiens IGF-II mRNA-bind   2.299E−02   3.59   39.5       435128   AF176832   Hs. 47005   low density lipoprotein-related protein   5.681E−03   3.57   39.25       422240   R60594   Hs. 29002   KIAA1706 protein   5.132E−02   3.57   32.75       431726   NM_015361   Hs. 268053   KIAA0029 protein   3.444E−02   3.52   30.25       407366   AF026942   Hs. 271530   gb: Homo sapiens cig33 mRNA, partial sequ   1.485E−02   3.51   91       404109           C6000844*: gi|7497891|pir||T20194 hypothe   1.468E−02   3.50   33       426788   U66615   Hs. 172280   SWI/SNF related, matrix associated, acti   7.404E−02   3.46   32       415822   D59243       gb: HUM526E07B Clontech human placenta po   2.299E−02   3.45   52.25       449922   AA004731       gb: zh93g05.s1 Soares_fetal_liver_spleen —     5.132E−02   3.43   32.75       458159   AA883831   Hs. 252924   ESTs   9.243E−03   3.42   44.5       446650   AB016625   Hs. 15813   solute carrier family 22 (organic cation   5.132E−02   3.42   38.25       450011   AW071789   Hs. 99233   ESTs   5.681E−03   3.42   38       432706   NM_013230   Hs. 286124   CD24 antigen (small cell lung carcinoma   8.760E−02   3.42   34.5       447898   AW969638   Hs. 112318   6.2 kd protein   3.476E−02   3.40   46.75       439478   AF049460   Hs. 6574   deformed epidermal autoregulatory factor   3.476E−02   3.36   50.25       414709   AA704703   Hs. 77031   Sp2 transcription factor   2.299E−02   3.35   63.5       450404   AA742544   Hs. 159231   hypothetical protein FLJ21551   5.132E−02   3.35   34       429505   AW820035   Hs. 278679   a disintegrin and metalloproteinase doma   3.476E−02   3.25   32.25       440258   AI741633   Hs. 125350   ESTs   9.243E−03   3.24   32.5       449713   AW027025   Hs. 345528   ESTs   3.476E−02   3.24   38       432791   NM_014554   Hs. 66450   sentrin/SUMO-specific protease   7.404E−02   3.22   38.5       408570   AL046406   Hs. 103483   KIAA1798 protein   7.302E−02   3.22   38       403512   NA       C3000579*: gi|12643308|sp|Q9Y4K1|AIM1_HUM   1.485E−02   3.13   46.75       406303           C16000922: gi|7499103|pir||T20903 hypothe   3.444E−02   3.07   30.5       449137   AW134478   Hs. 196033   ESTs   7.268E−03   3.05   52       401807           C7001350: gi|6578126|gb|AAF17706.1|AF0496   5.132E−02   3.05   31.5       423748   AI149048   Hs. 30211   hypothetical protein FLJ22313   5.132E−02   3.02   38       448497   BE613269   Hs. 21893   hypothetical protein DKFZp761N0624   1.168E−02   3.02   34.25       447164   AF026941   Hs. 17518   Homo sapiens cig5 mRNA, partial sequence   5.132E−02   2.98   128       450446   AI696334   Hs. 14450   ESTs   1.468E−02   2.97   43.75       435938   AI248774   Hs. 126707   hypothetical protein FLJ11457   4.970E−02   2.97   35.5       422744   AW268803   Hs. 119640   hBKLF for basic kruppel like factor   4.128E−02   2.97   34.5       453397   AA035378   Hs. 31222   ESTs, Weakly similar to DRPL_HUMAN ATROP   5.132E−02   2.96   34.25       454204   AW816498       gb: QV0-ST0236-171299-075-b02 ST0236 Homo   3.444E−02   2.95   30.25       443041   AA558677   Hs. 8928   hypothetical protein FLJ20291   2.299E−02   2.93   40.5       422366   T83882   Hs. 97927   ESTs   4.164E−02   2.92   31.75       429982   AW449534   Hs. 99607   hypothetical protein FLJ13841   9.366E−03   2.77   51.25       447278   AI934935   Hs. 158669   ESTs   8.760E−02   2.77   33.75       431250   BE264649   Hs. 251377   taxol resistance associated gene 3   7.404E−02   2.76   85.5       419270   NM_005232   Hs. 89839   EphA1   7.404E−02   2.76   45.75       425109   R37456   Hs. 184793   Homo sapiens cDNA: FLJ21880 fis, clone H   3.349E−02   2.75   35       417214   AW192804   Hs. 24719   modulator of apoptosis 1   5.766E−03   2.74   52.25       430259   BE550182   Hs. 127826   RalGEF-like protein 3, mouse homolog   5.766E−03   2.74   37.75       427765   AA412247   Hs. 111970   ESTs   5.132E−02   2.72   33.5       409947   AA078629   Hs. 27301   ESTs   3.444E−02   2.72   37       443493   AI074053   Hs. 127146   ESTs   3.349E−02   2.71   35       449394   AA004368   Hs. 18160   Homo sapiens cDNA FLJ11550 fis. clone HE   3.476E−02   2.70   45.75       405348   NA       C7001664: gi|12698061|dbj|BAB21849.1| (AB   3.476E−02   2.70   42.75       448030   N30714   Hs. 325960   membrane-spanning 4-domains, subfamily A   1.468E−02   2.68   39       418203   X54942   Hs. 83758   CDC28 protein kinase 2   5.132E−02   2.66   42.75       422833   BE141312       gb: MR0-HT0078-051099-002-h06 HT0078 Homo   1.468E−02   2.65   38.75       448124   AI470454   Hs. 199150   ESTs   3.444E−02   2.60   37       401536           NM_002530*: Homo sapiens neurotrophic tyr   8.760E−02   2.53   41.75       456370   AA234938   Hs. 87384   ESTs   3.476E−02   2.50   52.25       404607   NA       Target Exon   5.132E−02   2.50   48.5       436729   BE621807       transmembrane 4 superfamily member 1   7.353E−02   2.49   35       404801           NM_004286*: Homo sapiens GTP binding prot   2.299E−02   2.46   50.25       414173   N27495   Hs. 5565   hypothetical protein FLJ22626   2.275E−02   2.45   39.75       413719   BE439580   Hs. 75498   small inducible cytokine subfamily A (Cy   3.476E−02   2.45   64       413550   W03011   Hs. 306881   MSTP043 protein   8.705E−02   2.44   32.75       405416           C19001058*: gi|5080758|gb|AAD39268.1|AC00   3.476E−02   2.42   31.25       458388   W28887   Hs. 133142   Homo sapiens cDNA: FLJ22153 fis, clone H   7.404E−02   2.42   30.5       432886   BE159028   Hs. 279704   chromatin accessibility complex 1   1.485E−02   2.41   34.25       419497   NM_006410   Hs. 90753   Tat-interacting protein (30 kD)   8.760E−02   2.40   33.5       443743   AI084210   Hs. 303925   ESTs, Weakly similar to A46010 X-linked   8.760E−02   2.39   34.5       444811   AW137791   Hs. 148419   ESTs   1.485E−02   2.39   41       430291   AV660345   Hs. 238126   CGI-49 protein   7.404E−02   2.39   41       459119   AW844498   Hs. 306121   CDC20 (cell division cycle 20, S. cerevi   5.132E−02   2.38   38.75       432195   AJ243669   Hs. 8127   KIAA0144 gene product   3.476E−02   2.37   44.75       416046   H16054   Hs. 297644   ESTs   8.705E−02   2.36   46.5       421650   AA781795   Hs. 122587   ESTs   3.444E−02   2.35   59.5       455886   BE153549   Hs. 293818   ribosomal protein L7   5.132E−02   2.34   40       409775   AW499605       gb: UI-HF-BP0p-ain-c-05-O-Ul.r1 NIH_MGC_5   5.132E−02   2.32   49       402601           Target Exon   5.132E−02   2.31   55.5       439602   W79114   Hs. 58558   ESTs   7.353E−02   2.30   41       458946   AA009716   Hs. 42311   ESTs   6.136E−02   2.30   32.75       419445   AA884471   Hs. 90449   Human clone 23908 mRNA sequence   3.476E−02   2.30   31.5       439242   BE167324   Hs. 53996   ESTs, Weakly similar to ZN42_HUMAN ZINC   9.243E−03   2.29   50.5       444301   AK000136   Hs. 10760   asporin (LRR class 1)   5.132E−02   2.28   50.75       435706   W31254   Hs. 7045   GL004 protein   7.404E−02   2.27   46.5       405418   NA       Target Exon   5.766E−03   2.27   53.25       452032   BE244005   Hs. 27610   retinoic acid- and interferon-inducible   7.268E−03   2.25   53.5       444830   AI198854   Hs. 145437   ESTs   6.136E−02   2.24   32       428075   AW205525   Hs. 212511   ESTs   5.132E−02   2.23   48.75       446169   AA398857   Hs. 14142   nudix (nucleoside diphosphate linked moi   9.366E−03   2.23   31.25       453405   AI567972       ESTs, Highly similar to AF161437 1 HSPC3   7.302E−02   2.22   48       441942   AF182645   Hs. 8024   IK cytokine, down-regulator of HLA II   7.404E−02   2.19   38.5       417640   D30857   Hs. 82353   protein C receptor, endothelial (EPCR)   7.353E−02   2.19   37.5       425225   NM_003450   Hs. 155204   zinc finger protein 174   2.251E−02   2.18   40.25       430227   AI924441   Hs. 236218   TAT-INTERACTIVE PROTEIN, 72-KD   7.404E−02   2.17   49.5       458704   AI343613   Hs. 156600   ESTs   4.200E−02   2.17   33.25       404973   NA       Target Exon   5.091E−02   2.16   47.25       448362   AA641767   Hs. 21015   hypothetical protein DKFZp564L0864 simil   1.485E−02   2.14   37       428315   AA688152   Hs. 98505   ESTs   6.091E−02   2.13   44.75       415749   BE262529   Hs. 78771   phosphoglycerate kinase 1   7.166E−03   2.12   39       419104   AA709154   Hs. 191514   ESTs   5.132E−02   2.11   33       437849   AA769680   Hs. 18768   ESTs   3.476E−02   2.11   36.25       428726   AA432195   Hs. 98694   ESTs   5.132E−02   2.09   43.25       440495   AA887212   Hs. 14161   hypothetical protein DKFZp43411930   1.485E−02   2.08   41.75       446337   AW272746   Hs. 239818   phosphoinositide-3-kinase, catalytic, be   5.132E−02   2.07   39.5       404975   AL042279       uncharacterized hypothalamus protein HT0   7.302E−02   2.06   38.25       415599   Z44487   Hs. 8763   gb: HSC21F081 normalized infant brain cDN   7.353E−02   2.05   34.75       416404   AA180138   Hs. 107924   ESTs   7.404E−02   2.05   41.5       439277   R80061   Hs. 164478   hypothetical protein FLJ21939 similar to   8.649E−02   2.05   33.75       430108   AA465294   Hs. 291750   ESTs   1.485E−02   2.05   31.5       422746   NM_004484   Hs. 119651   glypican 3   7.404E−02   2.02   144.5       458410   H20380   Hs. 200250   ESTs, Moderately similar to ALU7_HUMAN A   8.760E−02   2.01   39.25       410204   AJ243425   Hs. 326035   early growth response 1   1.485E−02   2.01   148.75       441616   BE569122       RNA-binding protein (autoantigenic)   5.091E−02   2.01   31.25       414395   BE304888   Hs. 279834   EST   7.353E−02   2.00   40.25       456999   AA319798   Hs. 298581   eukaryotic translation elongation factor   3.476E−02   2.00   31.25                                                                          
 
     [0349]                       TABLE 5B                       Pkey   CAT Number   Accession                  409775   1154112_1   AW499605 AW501372 AW503065 AW500923 AW501639       410099   117647_1   AA081630 T08671 AI174254 D83874 AW959843 AA364503               AA693467 AW993370 BE327037 AA167714 N79906 AW901977 AW901980               W52882 T07735 AA484549 W60090 D52685 T23811 BE327043 AW901768 BE551237               AA917004 AA716027 AI439658 AA283724 AI805992               AI457096 AA084618 BE467736 AI092635 AI887863 AI697593 AA436618 AI167419               AI418634 T31586 AA436630 AA706191 AI041169               AI422304 T03534 AA211402 AI204899 AI366472 AW827081 AA788593 T32736               AI767935 AA167791 AA747914 AA663870 AI865504       412747   1324696_1   AW994222 AW994377       415822   155791_1   D59243 D63202 AA169716       422833   221904_1   BE141312 BE141417 BE141389 AA317747       424017   234338_1   AA333789 AA334317 AW966107       428108   287154_1   AA421452 BE302040 AI204456 AA833751 AA421483 AI825059       436729   42585_1   BE621807 AI445461 AI346835 AI453743 AI564644 AI928364 AW984527 BE156214               AI694111 AI591358 C17504 C17476 C17963 C18304               AW071625 AI678712 C17732 D57559 H61762 AI720939 AI262930 H27252 AA479712               AI927769 AA291465 AA155661 AI963432 AI567995               AA421678 AI925607 AA292956 AA192448 AW192593 AI865838 AI696905 AI871950               AI911921 BE619741 BE439796 AI161312 AI597801               AI424384 AI093510 AI240988 AW820230 AI492554 BE044033 AW262737 AW008570               AA043216 AW629505 AA136645 AA037722 AA706057               AA088439 AW806193 AW806183 AA479834 BE501957 AA129574 R38114 AA649494               AA524526 BE327120 AW572531 BE219784 BE349186               AW015724 AA043217 AW772000 AI799814 AI671727 AW779725 AA502832 AI470033               AA129575 W38161 AI972739 AA404570 AA627686               AA723200 AA147228 AA903050 AI990245 AI075878 T32487 C06123 AA157944 AI800106               W60075 AI859160 AA478328 AW673152 AA182640               AI990827 AW275048 AW103470 AI298935 AW471421 R79190 AW085158 W45410               AW300456 AA662517 T55840 AI823466               AI692846 AA962397 AW191997 AA136658 AI251817 BE044134 AW339104 AW517762 AA724739               R79933 AA411100 AA191349 AA037696               AA190966 AA757735 AW772283 AA010631 H80983 AI769516 H64985 AI061065 AI950693               AA085492 AI245632 H28594 AW088968 BE156360               AI349390 AI621320 AI738844 AW194272 AA148284 AA953883 C06365 AA487893               AI927217 AI918523 AI453453 AI798502 AI189366               AI261359 AI032569 AW338678 AI972899 AI500576 AI872628 AI693030 Z28771               AI985583 AI363829 AW339301 AA581093 AI650338 W60032               AA603586 AI686240 AW242958 AA719173 AI745717 AW675302 AI582462 AI244845               AI565439 F09579 AI918453 AA035576 AI472527               AW351556 AA191414 AW674145 D57558 AI446740 D57845 AI589264 C05782 AA722206               AI432033 R21752 BE157510 AI829640 AI468237               AW384233 AA989662 AI865912 AW197954 AI344941 X75684 AI344943 AW583310 AA988297               AI334860 AI348877 AI798415 D11921               AI377596 AI983655 AI744233 C06111 AI248307 AA948565 AI224807       441616   52161_2   BE569122 BE43964 BE621682 BE548066 N73920 AA164369 W80481               AI301065 N36665 AW071970 AW263496 AI499701 AA001425               AA781414 AI479737 AA922117 AW104450 AA026632 N30835 AW274584 AW173171 AW817587               R94765 AA019198 AA054252 H03499               AA954721 AI926512 AI685317 AI393574 AW166832 AA742324 AI749979 AA972701 AA434451               AI305153 AA678370 F12140 H16890 AI356800               AW613806 R73589 AI280399 AW627592 AI334386 AI200095 W47269 AI491703 AA837589 AI073728               AI367984 AI422897 AI282124 AA053948               AI218584 H84116 AI273274 AA731678 AW338258 AI347082 AA256494 AW022998               AA743354 AI698561 R69295 AI280442 AA480586               AA026691 AI948431 AI381988 AA417566 BE564055 AA365458 AA054003       449922   81925_1   AA004731 AA004787 AI240768       453405   96607_1   AI567972 AW196160 AA035448 AA934760 N70743 AA862404 AA485737               AA885091 AI926381 AA885115 AA284561 AA284560 C00839               W01732       454204   1050597_1   AW816498 AW808791 AW808515 AW808379 AW808532 AW808605 AW808977               AW808816 AW178676 AW178486 AW808514 AW178483               AW178485 AW809007 AW808524                                            
     [0350]                           TABLE 5C                       Pkey   Ref   Strand   Nt_position                  401536   7960358   Plus   100193-100336, 103486-103671       401807   7331536   Plus   152325-152912       401842   7684597   Plus   111602-111746       402012   7407997   Minus   111771-111909, 112107-112226,                   112519-112694       402200   7689783   Plus   28877-29398       402601   7705237   Minus   170567-170936, 171175-171610,                   173128-173238, 173317-173425,                   173505-173766       403436   9719642   Minus   96248-96361, 98626-98757       403512   7656757   Minus   114487-114610       403807   8439933   Minus   162963-165773       404075   7652011   Plus   53692-53938       404109   9211742   Minus   144675-144928, 151899-152064       404493   8140670   Plus   38930-39208       404607   7328770   Plus   28477-28591       404801   4582132   Plus   89110-89482, 94224-94347       404973   3213020   Plus   101602-102591       404975   3419864   Minus   86096-86605       405348   2914717   Minus   43310-43462       405411   3451356   Minus   17503-17778, 18021-18290       405416   6984492   Minus   28380-30235       405418   6997292   Plus   51839-51953       406303   8575868   Plus   173622-173786                                                    
     [0351] Table 6A lists about 284 genes up-regulated in Hepatitis C positive liver tissues at a time before pegylated-interferon-alpha plus ribavirin treatment that was found to be responsive (responders) to the treatment compared to Hepatitis C positive liver tissues at a time before pegylated-interferon-alpha plus ribavirin treatment that was found to be non-responsive to the treatment (non-responders). These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the Wilcoxon rank-sum test p-value between the 2 groups was less than 0.10, the ratio of the “weighted average” of responders to the “weighted average” of non-responders was equal to or above 2.0, and that the differences between the same 2 groups was equal to or above 30.0. The “weighted average” of the responders was set to the trimean of different non-responders. The “weighted average” of the non-responders was set to the either 10 or the trimean of different non-responders, whichever value was greater to eliminate ratios with a denominator of zero or less. Tables 6B and 6C relate to Table 6A as 3B and 3C relate to 3A.  
                                       TABLE 6A                       Pkey   ExAccn   UnigeneID   Unigene Title   R1   R2   R3                                                            433156   R59206   Hs. 17519   Homo sapiens cDNA: FLJ22539 fis, clone H   9.366E−03   9.97   91.25       425701   AA361850   Hs. 322149   Human clone 137308 mRNA, partial cds   2.299E−02   8.90   86.75       453822   NM_014116   Hs. 35416   PRO0132 protein   7.404E−02   8.15   71.75       421160   AL080215   Hs. 102301   Homo sapiens mRNA; cDNA DKFZp586J0323 (f   8.705E−02   7.32   74.5       424375   AF070547   Hs. 146312   Homo sapiens clone 24820 mRNA sequence   7.404E−02   7.27   75       435147   AL133731   Hs. 4774   Homo sapiens mRNA; cDNA DKFZp761C1712 (f   5.766E−03   6.52   104.5       416686   H75435   Hs. 169404   ESTs   3.476E−02   6.47   75.75       451078   AI927694   Hs. 340945   ESTs   5.132E−02   6.47   58.25       432474   AA584042       gb: nn65e09.s1 NCI_CGAP_Lar1  Homo sapiens     3.476E−02   6.40   54       415374   F06904   Hs. 8346   ESTs   2.299E−02   6.30   62.5       427958   AA418000   Hs. 98280   potassium intermediate/small conductance   5.681E−03   5.97   91       408806   AW847814   Hs. 289005   Homo sapiens cDNA: FLJ21532 fis, clone C   1.485E−02   5.82   54.75       401757           Target Exon   2.299E−02   5.77   59.75       400864           Target Exon   5.132E−02   5.63   55.5       432425   AF070619   Hs. 274539   Homo sapiens clone 24481 mRNA sequence   7.404E−02   5.60   65.5       401529           Target Exon   5.132E−02   5.57   47.75       451408   AI795947   Hs. 209596   ESTs   3.476E−02   5.55   60.5       444813   AW054834   Hs. 210356   ESTs   5.132E−02   5.40   57.5       418432   M14156   Hs. 85112   insulin-like growth factor 1 (somatomedi   7.404E−02   5.36   49       419831   AW448930   Hs. 5415   ESTs   7.353E−02   5.17   51.5       436593   AW085002   Hs. 156187   ESTs   2.698E−02   5.13   49       420315   NM_006299   Hs. 96448   zinc finger protein 193   7.353E−02   5.05   54       438098   AI076370   Hs. 134037   ESTs   7.404E−02   5.05   43.5       411755   BE327036   Hs. 117494   ESTs   2.807E−02   5.02   44       442719   H12048   Hs. 91564   ESTs   8.705E−02   5.02   41       449625   NM_014253       odz (odd Oz/ten-m, Drosophila) homolog 1   7.353E−02   4.92   63       407269   AJ245210       gb: Homo sapiens mRNA for immunoglobulin   4.164E−02   4.92   44.25       403609           C3001199: gi|7494834|pir||T15308 hypothet   9.366E−03   4.82   51.25       421417   AA291004   Hs. 326088   ESTs   1.468E−02   4.82   40       400279           NM_004581*: Homo sapiens Rab geranylgeran   3.476E−02   4.81   44.75       435545   AA687415   Hs. 28107   ESTs   5.681E−03   4.72   50.75       445757   AW449065   Hs. 13264   KIAA0856 protein   2.299E−02   4.70   40.75       401593           Target Exon   2.299E−02   4.70   48.5       442552   R20624       son of sevenless (Drosophila) homolog 1   3.476E−02   4.70   45.25       418660   AW161979   Hs. 100914   hypothetical protein FLJ10352   5.132E−02   4.70   39.5       435368   AI056230   Hs. 117122   ESTs   5.766E−03   4.57   83.25       434253   AI393345   Hs. 116215   ESTs   5.091E−02   4.57   49.75       407578   BE464417   Hs. 131035   ESTs, Weakly similar to CA24_HUMAN COLLA   7.404E−02   4.57   48.25       424014   AA333653   Hs. 24790   KIAA1573 protein   9.366E−03   4.55   41       440798   AB020648   Hs. 7426   KIAA0841 protein   5.766E−03   4.52   44.25       426075   AW513691   Hs. 270149   ESTs, Weakly similar to 2109260A B cell   6.136E−02   4.52   43.25       455358   AW902641       gb: QV3-NN1024-100500-181-d08 NN1024 Homo   7.404E−02   4.50   41.75       449621   AI656060   Hs. 195726   ESTs   5.132E−02   4.47   44       459674   AA180511       gb: zp53f03.r1 Stratagene NT2 neuronal pr   7.404E−02   4.42   79       433085   AA781270   Hs. 220943   ESTs   3.444E−02   4.40   50.25       434995   AW974995       gb: EST387100 MAGE resequences, MAGN Homo   7.404E−02   4.40   40       456250   U09196   Hs. 82520   polymerase (DNA-directed), delta 4   7.404E−02   4.38   44.75       425594   AA649842   Hs. 269334   ESTs   2.299E−02   4.38   34.75       402439           C1002445*: gi|4506787|ref|NP 003861.1|IQ   7.404E−02   4.37   43       429355   AW973253   Hs. 292689   ESTs   7.404E−02   4.35   46.75       453751   R36762   Hs. 101282   Homo sapiens cDNA: FLJ21238 fis, clone C   9.366E−03   4.32   63.75       444636   T96667   Hs. 17877   ESTs   5.132E−02   4.30   46.25       401197           ENSP00000229263*: HSPC213.   8.760E−02   4.27   39.25       432014   H66741   Hs. 38540   ESTs, Weakly similar to ALU4_HUMAN ALU S   7.404E−02   4.27   61.25       420556   AA278300   Hs. 124292   Homo sapiens cDNA: FLJ23123 fis, clone L   1.485E−02   4.25   59.75       413329   AI056885   Hs. 133539   ESTs   9.366E−03   4.25   40.25       427450   AB014526   Hs. 178121   KIAA0626 gene product   3.476E−02   4.24   41.25       431858   AA732530   Hs. 184019   Homo sapiens clone 23551 mRNA sequence   1.792E−02   4.22   45.75       408852   AW291435   Hs. 254961   ESTs   1.450E−02   4.22   39.5       433171   AA579425       gb: nf37c08.s1 NCI_CGAP_Pr2  Homo sapiens     3.476E−02   4.20   43.75       430920   U96402   Hs. 248132   goosecoid-like   7.404E−02   4.17   42.75       405206           Target Exon   8.705E−02   4.13   38.75       453815   AL135365   Hs. 126857   Homo sapiens cDNA FLJ12936 fis. clone NT   3.476E−02   4.07   44       440573   BE550891   Hs. 270624   ESTs   5.132E−02   4.05   32.25       411047   AW938479       gb: CM0-DT0057-290200-253-h06 DT0057 Homo   1.468E−02   4.04   39.5       400738           Target Exon   1.833E−02   4.00   36.5       423983   AA333261       gb: EST37476 Embryo, 8 week 1 Homo sapien   2.299E−02   4.00   32.5       403686           C4001366*: gi|9837427|gb|AAG00570.1|AF287   1.485E−02   3.95   39.75       418677   S83308   Hs. 87224   SRY (sex determining region Y)-box 5   1.468E−02   3.94   52.25       453861   AI026838   Hs. 30120   ESTs, Weakly similar to NUCL_HUMAN NUCLE   5.132E−02   3.93   33.75       401778   AA463798       MCT-1 protein   5.766E−03   3.90   40.75       448854   AW245617   Hs. 77703   hypothetical protein FLJ11506   7.404E−02   3.89   32.5       456327   H68741   Hs. 38774   ESTs   3.476E−02   3.85   49.5       431300   AA502346       gb: ne26b03.s1 NCI_CGAP_Co3  Homo sapiens     5.091E−02   3.82   56.75       438146   Z36842   Hs. 57548   ESTs   2.299E−02   3.82   35       443222   AW390067   Hs. 132762   ESTs   2.275E−02   3.82   31.75       457247   AA458605       KIAA1681 protein   9.366E−03   3.82   91.5       406299           Target Exon   5.132E−02   3.80   30       430383   AI861854   Hs. 210778   hypothetical protein FLJ10989   2.275E−02   3.77   49.75       453478   AF083898   Hs. 33021   neuro-oncological ventral antigen 2   6.091E−02   3.77   32       439601   AB029032   Hs. 6606   KIAA1109 protein   7.404E−02   3.76   49.75       421828   AW891965   Hs. 279789   histone deacetylase 3   3.476E−02   3.76   42.75       406528           Target Exon   3.476E−02   3.75   45.5       451614   AA298812   Hs. 98539   ESTs   7.353E−02   3.75   38.25       430320   BE245290   Hs. 239218   uncharacterized hypothalamus protein HCD   5.132E−02   3.75   36.5       441516   F06700   Hs. 7879   interferon-related developmental regulat   7.404E−02   3.73   30.75       430730   T71087   Hs. 44197   hypothetical protein DKFZp564D0462   2.299E−02   3.72   44.25       430446   AF131782   Hs. 241438   Homo sapiens clone 24941 mRNA sequence   5.766E−03   3.72   46.25       414899   AW975433   Hs. 36288   ESTs   5.132E−02   3.69   33       447695   AI420116   Hs. 161269   ESTs   2.299E−02   3.69   30.25       402842           ENSP00000241325*: DJ947L8.1.3 (novel CUB   5.681E−03   3.65   30.5       446001   AI827473   Hs. 346435   ESTs   9.366E−03   3.63   46.25       402836           ENSP00000251163*: Membrane-associated gua   4.164E−02   3.60   57.25       410469   AW749723   Hs. 43586   gb: QV3-BT0511-081299-035-d01 BT0511 Homo   8.705E−02   3.60   37       421471   U90545   Hs. 327179   solute carrier family 17 (sodium phospha   3.476E−02   3.58   110.75       456962   BE272095   Hs. 167791   reticulocalbin 1, EF-hand calcium bindin   6.136E−02   3.57   35.75       400301   X03635   Hs. 1657   estrogen receptor 1   1.485E−02   3.57   66.25       438099   AA777767   Hs. 187562   ESTs   4.200E−02   3.56   37.75       441243   AI767056   Hs. 193002   ESTs   2.299E−02   3.55   53       416401   N80139   Hs. 268916   ESTs   2.299E−02   3.55   49.75       402942           Target Exon   5.681E−03   3.55   35.5       451351   AW058261   Hs. 321435   ESTs, Weakly similar to ALU1_HUMAN ALU S   5.132E−02   3.53   38       457565   BE294029   Hs. 279903   Ras homolog enriched in brain 2   2.299E−02   3.52   35       419287   X91906   Hs. 89872   chloride channel 5 (nephrolithiasis 2, X   9.366E−03   3.52   31.75       430807   S74019   Hs. 247979   pre-B lymphocyte gene 1   2.807E−02   3.50   35.5       400302   N48056       folate hydrolase (prostate-specific memb   3.476E−02   3.48   63.75       404657           C9000088*: gi|6754878|ref|NP_035061.1|nu   1.468E−02   3.44   53.75       445664   AW968638   Hs. 237691   ESTs, Weakly similar to KIAA0601-protein   2.807E−02   3.42   39.5       436336   AJ011378   Hs. 186927   ESTs   4.056E−02   3.42   33.25       409959   BE349470       mucin 6, gastric   9.120E−03   3.40   47.5       458443   AV647010   Hs. 27   glycine dehydrogenase (decarboxylating;   4.200E−02   3.40   47.25       411214   BE046571       gb: hn40g11.x1 NCI_CGAP_RDF2  Homo sapiens     2.299E−02   3.38   39.25       437556   AI223078   Hs. 136776   ESTs   9.243E−03   3.35   36.25       425295   AA431366   Hs. 37251   ESTs   7.404E−02   3.32   50       409440   AI239685   Hs. 12315   hypothetical protein FLJ11608   5.091E−02   3.32   30.75       405543           C2002468*: gi|3334856|emb|CAA11279.1| (AJ   4.970E−02   3.30   35.75       449986   AW864502       gb: PM4-SN0016-120400-004-b12 SN0016 Homo   2.299E−02   3.25   60.75       451790   AA927403   Hs. 3803   reticulon 2   5.132E−02   3.24   41.5       456350   BE246762   Hs. 89499   arachidonate 5-lipoxygenase   5.132E−02   3.22   40.5       436169   AA888311   Hs. 17602   Homo sapiens cDNA FLJ12381 fis, clone MA   2.251E−02   3.22   33.25       421497   BE145334   Hs. 194637   BANP homolog, SMAR1 homolog   5.766E−03   3.22   30       449959   AI076834   Hs. 21160   ESTs   4.200E−02   3.20   35.25       441189   AW450266   Hs. 257276   ESTs   7.353E−02   3.19   31.75       411399   AI144416   Hs. 22248   ESTs   7.404E−02   3.15   31.75       447896   AI436124   Hs. 294069   Homo sapiens cDNA FLJ13384 fis, clone PL   2.299E−02   3.15   62       420728   AA767718   Hs. 93581   hypothetical protein FLJ10512   5.132E−02   3.15   41.25       444959   AV652120   Hs. 213232   ESTs, Weakly similar to 2004399A chromos   1.485E−02   3.15   117       424049   AB014524   Hs. 138380   KIAA0624 protein   5.597E−03   3.13   61.25       444363   AI142827   Hs. 143656   ESTs   8.760E−02   3.12   35.5       437056   AI147061       gb: ok33a11.s1 Soares_NSF_F8_9W_OT_PA_P_S   5.091E−02   3.11   32.75       408931   AA251995   Hs. 334648   poly(A) polymerase alpha   2.299E−02   3.11   60       447135   T58148       gb: yb98g06.s1 Stratagene lung (937210) H   1.468E−02   3.10   34.75       451513   AI800283   Hs. 155787   ESTs   2.780E−02   3.08   31.75       430448   AI633553   Hs. 13303   Homo sapiens cDNA: FLJ21784 fis, clone H   5.010E−02   3.07   31.75       413922   AI535895   Hs. 221024   ESTs   3.476E−02   3.07   56       440700   AW952281   Hs. 296184   guanine nucleotide binding protein (G pr   1.485E−02   3.06   96.25       442049   AA310393   Hs. 190044   ESTs   7.404E−02   3.05   36.25       445159   AI631036   Hs. 196843   ESTs   5.132E−02   3.03   30.5       402781           C1001326*: gi|7292419|gb|AAF47823.1|(AE0   3.444E−02   3.03   32.5       450127   AI698001   Hs. 200664   ESTs   1.833E−02   3.03   35.5       416336   R97949   Hs. 24128   ESTs   7.404E−02   3.02   42.5       428337   AA644508       gb: af75C01.r1 Soares_NhHMPu_S1 Homo sapi   2.275E−02   3.02   32.25       441959   BE536998   Hs. 200360   Homo sapiens cDNA FLJ13027 fis. clone NT   3.476E−02   3.01   34.25       450770   AA019924   Hs. 28803   ESTs   3.476E−02   3.01   52.75       414149   BE313317   Hs. 902   neurofibromin 2 (bilateral acoustic neur   7.404E−02   2.99   47.25       444622   H77824       ESTs   5.681E−03   2.98   51       444909   AI933051   Hs. 192280   ESTs   5.132E−02   2.97   42.75       419662   W87674       gb: zh66a01.r1 Soares_fetal_liver_spleen —     7.166E−03   2.97   36       439435   AI627654   Hs. 174497   ESTs, Weakly similar to S43529 165 K prot   6.091E−02   2.97   36.5       435902   AA701867   Hs. 297726   ESTs   7.404E−02   2.95   70       406526           C19001782*: gi|8922411|ref|NP_060558.1|h   5.766E−03   2.95   51.5       405846           Target Exon   5.132E−02   2.95   39.75       448920   AW408009   Hs. 22580   alkylglycerone phosphate synthase   4.164E−02   2.92   43       422561   AA991499   Hs. 118354   CAT56 protein   5.132E−02   2.92   42.75       440915   AI809240   Hs. 210383   olfactory receptor, family 4, subfamily   1.485E−02   2.92   31.25       449495   AI652833       gb: wb22c11.x1 NCI_CGAP_GC6  Homo sapiens     5.132E−02   2.90   34.75       411426   BE141714       gb: QV0-HT0101-061099-032-c04 HT0101 Homo   4.200E−02   2.90   33       435236   T03890   Hs. 157208   ESTs, Highly similar to ARX MOUSE HOMEOB   7.268E−03   2.88   44.75       405152           Target Exon   7.353E−02   2.88   37.5       457230   T73510   Hs. 209153   angiopoietin-like 3   1.468E−02   2.82   50       455485   AA102287   Hs. 26756   hypothetical protein FLJ20896   5.132E−02   2.82   46.5       452266   AI767250   Hs. 165240   ESTs   3.476E−02   2.81   49       418154   BE165866       nuclear receptor subfamily 1, group I, m   7.404E−02   2.80   65.75       405481           Target Exon   5.132E−02   2.80   46.5       404162           NM_022113*: Homo sapiens kinesin family m   3.476E−02   2.80   40.5       415647   F13458   Hs. 6985   ESTs   7.353E−02   2.80   40       456505   AA504595   Hs. 111418   ESTs   1.168E−02   2.78   52.5       447567   AW474513   Hs. 224397   ESTs, Weakly similar to I38931 Wiskott-A   5.766E−03   2.77   43       422473   U94780   Hs. 117242   meningioma expressed antigen 6 (coiled-c   7.353E−02   2.77   40.25       452830   AW976032   Hs. 288912   hypothetical protein FLJ22604   3.476E−02   2.76   30       428375   T65153   Hs. 260282   ESTs   6.091E−02   2.76   32.5       444618   AV653785   Hs. 173334   ELL-RELATED RNA POLYMERASE II, ELONGATIO   7.268E−03   2.73   30.25       432629   AW860548   Hs. 280658   ESTs   2.807E−02   2.73   55.25       457747   AW975000       gb: EST387105 MAGE resequences, MAGN Homo   9.366E−03   2.71   48       449210   AI635363   Hs. 345517   ESTs   7.404E−02   2.71   30       419711   C02621   Hs. 159282   ESTs   2.251E−02   2.71   32       407609   R43159   Hs. 238432   ESTs   5.132E−02   2.70   47.25       438850   R33727   Hs. 24688   EST   1.468E−02   2.70   37.75       449000   U69560   Hs. 3826   kelch-like protein C3IP1   3.444E−02   2.70   33.5       413359   AA524285   Hs. 154172   ESTs, Moderately similar to BCGF_HUMAN B   7.404E−02   2.67   34.75       402168           NM_022046*: Homo sapiens kallikrein 14 (K   5.132E−02   2.66   65       423665   BE167153   Hs. 24380   ESTs   5.132E−02   2.65   47.75       409872   AW502313       gb: UI-HF-BR0p-ajs-d-08-0-Ul.r1 NIH_MGC_5   7.404E−02   2.65   45.5       419853   AA252006   Hs. 190150   ESTs   7.404E−02   2.65   32.25       409277   T05558   Hs. 156880   ESTs   7.404E−02   2.65   59.75       401114           Target Exon   2.299E−02   2.64   33.25       433847   AA610266       ESTs   2.299E−02   2.64   42.25       412204   AI125507   Hs. 130829   ESTs   5.132E−02   2.63   37       454302   AA306105   Hs. 50785   SEC22, vesicle trafficking protein (S. c   6.136E−02   2.63   33.5       425744   AA362985       gb: EST72769 Ovary II Homo sapiens cDNA 5   3.476E−02   2.61   43       404265           ENSP00000243218*: DJ329L24.3 (member of M   1.485E−02   2.60   48.25       447113   AA741545   Hs. 282832   ESTs, Weakly similar to T24961 hypotheti   3.476E−02   2.60   36.75       418383   AA218986   Hs. 118854   ESTs   5.132E−02   2.60   31.5       448339   AL035920   Hs. 20938   RNA binding motif, single stranded inter   3.476E−02   2.60   33.5       435321   R16814   Hs. 112062   ESTs   1.485E−02   2.59   147.5       451898   T92572   Hs. 142019   ESTs, Weakly similar to 1207289A reverse   3.476E−02   2.59   32.25       436869   NM_014867   Hs. 5333   KIAA0711 gene product   1.168E−02   2.59   48.5       450016   AA249590   Hs. 100748   ESTs, Weakly similar to A28996 proline-r   2.299E−02   2.57   54.25       434421   AI915927   Hs. 34771   ESTs   7.353E−02   2.57   73.25       446783   AW138343   Hs. 141867   ESTs   1.485E−02   2.56   58       418812   AB018256   Hs. 283881   KIAA0713 protein   5.132E−02   2.55   34.5       417157   N49713       gb: yv23f06.s1 Soares fetal liver spleen   8.760E−02   2.54   32.75       400308   AF041410       Target   2.275E−02   2.53   34.5       431082   AA491600       gb: ne80a11.s1 NCI_CGAP_Ew1  Homo sapiens     5.132E−02   2.52   66.75       451850   R14553   Hs. 301663   ESTs   6.136E−02   2.51   31.75       406029           Target Exon   7.404E−02   2.50   46.25       413471   BE142098       gb: CM4-HT0137-220999-017-d11 HT0137 Homo   3.444E−02   2.50   44.5       405014   AF042838       mitogen-activated protein kinase kinase   7.353E−02   2.50   35.25       432634   AI650267   Hs. 196169   ESTs   5.132E−02   2.50   32.75       433187   R53995   Hs. 293381   ESTs, Moderately similar to ALU7_HUMAN A   5.132E−02   2.47   33.5       443832   AI829610   Hs. 23531   ESTs   3.476E−02   2.47   37.5       447371   AA334274   Hs. 18368   DKFZP564B0769 protein   7.404E−02   2.46   44.75       458455   AV648310   Hs. 213488   ESTs   3.444E−02   2.45   58.5       447980   AI703397   Hs. 202355   ESTs   8.705E−02   2.45   33       419511   AA429750   Hs. 75113   general transcription factor IIIA   1.485E−02   2.45   41.25       412510   AI056689   Hs. 133538   ESTs, Weakly similar to ALU1_HUMAN ALU S   5.681E−03   2.45   46.25       416153   R13894       gb: yf62a06.r1 Soares infant brain 1NIB H   1.468E−02   2.44   42.75       458492   AI143655   Hs. 231200   ESTs   1.168E−02   2.43   47.5       425224   AA352856   Hs. 147211   ESTs   7.404E−02   2.40   44.75       413489   BE144228       gb: MR0-HT0165-140200-009-d04 HT0165 Homo   1.168E−02   2.40   36.75       437114   AA836641   Hs. 163085   ESTs   1.485E−02   2.38   53.5       457558   AF083955   Hs. 279852   G protein-coupled receptor   5.132E−02   2.37   45       429886   AL050145   Hs. 225986   Homo sapiens mRNA; cDNA DKFZp586C2020 (f   1.168E−02   2.35   52.25       403171           C2001472*: gi|5809678|gb|AAB41848.2|(U64   3.476E−02   2.35   50.5       406126           ENSP00000246871: PMS6 PROTEIN (HPMS6 PROT   3.476E−02   2.35   47.25       428673   AW601325   Hs. 337757   Homo sapiens mRNA; cDNA DKFZp566M063 (fr   5.132E−02   2.35   37.75       421466   U88063   Hs. 104633   agouti (mouse) related protein   7.404E−02   2.33   37.5       453285   X99894   Hs. 32938   insulin promoter factor 1, homeodomain t   7.404E−02   2.32   36.5       441927   AW850555   Hs. 39925   ESTs, Weakly similar to A46010 X-linked   7.404E−02   2.32   30.75       443368   BE568891   Hs. 199210   ESTs, Moderately similar to bK116F5.2 [H   5.681E−03   2.32   42.25       430517   S80071   Hs. 241597   solute carrier family 6 (neurotransmitte   2.299E−02   2.31   45.5       450734   AI732317   Hs. 299119   ESTs, Moderately similar to 2211404A B21   7.353E−02   2.30   34.5       406466           Target Exon   9.243E−03   2.30   48.75       431025   AA490842   Hs. 105269   ESTs   2.807E−02   2.30   38.5       421573   AI302850   Hs. 262455   ESTs   4.200E−02   2.29   44.75       429031   BE002237   Hs. 239666   Homo sapiens cDNA FLJ13495 fis, clone PL   3.476E−02   2.28   42.25       403545           Target Exon   1.812E−02   2.27   40.5       418063   R38973   Hs. 329841   EST   2.299E−02   2.27   39       412243   W37901   Hs. 278349   ESTs   3.444E−02   2.27   31       447793   AI424924   Hs. 211203   ESTs   3.476E−02   2.26   42.25       402370           Target Exon   1.485E−02   2.25   58.25       404150           Target Exon   7.404E−02   2.25   53.75       431668   AW969610   Hs. 151179   ESTs   5.132E−02   2.25   37.75       442174   AI690080   Hs. 128907   ESTs, Weakly similar to ARIX homeodomain   7.404E−02   2.24   44.75       444758   AL044878   Hs. 11899   3-hydroxy-3-methylglutaryl-Coenzyme A re   5.132E−02   2.24   45       431395   AW752337   Hs. 193666   haspin   1.468E−02   2.24   36       447115   AI815852   Hs. 205865   ESTs, Weakly similar to S02392 alpha-2-m   3.444E−02   2.24   34.75       408847   AW290997   Hs. 30348   ESTs   2.275E−02   2.22   46       420843   H96982   Hs. 42321   ESTs   7.353E−02   2.22   39.25       423732   AF058056   Hs. 132183   solute carrier family 16 (monocarboxylic   7.404E−02   2.21   51.75       447083   AI472124   Hs. 157757   ESTs   5.766E−03   2.21   46.5       425757   AA363171       gb: EST72986 Ovary II Homo sapiens cDNA 5   3.476E−02   2.20   33.25       401941           Target Exon   3.476E−02   2.19   39       421193   D60983   Hs. 5096   ESTs, Weakly similar to I38022 hypotheti   1.450E−02   2.19   42.25       441357   AI240184   Hs. 126819   ESTs   7.404E−02   2.19   33.5       451068   AW294432   Hs. 144252   ESTs   7.404E−02   2.18   32.25       427332   R09418   Hs. 261101   ESTs, Weakly similar to I38022 hypotheti   8.760E−02   2.18   45.5       401929           C17001690: gi|6005701|ref|NP_009099.1|AT   5.091E−02   2.18   96.5       433444   AW975324   Hs. 129816   ESTs   3.476E−02   2.18   94.25       444331   AW193342   Hs. 24144   ESTs   7.353E−02   2.18   43.25       445828   F05802   Hs. 81907   ESTs   1.485E−02   2.17   64.25       452137   AI861840   Hs. 211687   ESTs   5.132E−02   2.17   34.75       409061   AI204994   Hs. 7874   Homo sapiens cDNA: FLJ21435 fis, clone C   2.299E−02   2.16   31       457281   BE253012   Hs. 153400   ESTs, Weakly similar to ALU1_HUMAN ALU S   7.404E−02   2.16   31.25       426129   NM_000348   Hs. 1989   steroid-5-alpha-reductase, alpha polypep   3.444E−02   2.15   40.75       453894   AW937825   Hs. 56847   Homo sapiens cDNA FLJ12874 fis, clone NT   6.136E−02   2.14   54.25       403923           Target Exon   3.444E−02   2.13   49.25       428655   H05769   Hs. 188757   Homo sapiens, clone MGC: 5564, mRNA, comp   2.299E−02   2.13   32.5       454333   AW373209       gb: RC5-BT0506-271199-031-C12 BT0506 Homo   3.444E−02   2.12   44.5       445805   C16975   Hs. 301444   KIAA1673   4.200E−02   2.11   32       446709   R10490   Hs. 156341   ESTs   5.431E−03   2.10   32.25       436505   AJ277841   Hs. 120963   ELG protein   7.404E−02   2.10   41.75       427761   AA412205   Hs. 140996   ESTs   4.929E−02   2.10   31.75       417720   AA205625   Hs. 208067   ESTs   5.766E−03   2.10   63.5       417688   R09170   Hs. 284350   ESTs   1.485E−02   2.10   36.25       434521   NM_002267   Hs. 3886   karyopherin alpha 3 (importin alpha 4)   7.353E−02   2.09   35       444900   AI360120   Hs. 148581   ESTs   5.132E−02   2.06   34.5       444595   AL121094   Hs. 83572   hypothetical protein MGC14433   3.444E−02   2.05   34       406180   AB018249       small inducible cytokine subfamily A (Cy   7.404E−02   2.05   45.25       423378   BE313601   Hs. 164866   hypothetical protein FLJ22558   3.476E−02   2.04   41       427227   AF103803   Hs. 283690   hypothetical protein   6.136E−02   2.03   36.25       438163   AI056258   Hs. 122523   ESTs   6.091E−02   2.02   55.75       429219   AI221480   Hs. 99161   ESTs   5.132E−02   2.02   39.25       438011   BE466173   Hs. 145696   splicing factor (CC1.3)   1.485E−02   2.02   38.25                                                                          
 
     [0352]                       TABLE 6B                       Pkey   CAT Number   Accession                  409872   1156673_1   AW502313 AW502681 AW502682       409959   1162663_1   BE349470 BE179199 BE179195 BE179198 BE179204 BE162686 AW513804       411047   1230266_1   AW938479 AW850678 AW814826       411214   1235915_1   BE046571 BE046734 BE046555 BE046651 AW827568       411426   1245515_1   BE141714 AW845993 AW845989       413471   1371778_1   BE142098 BE142092       413489   1373392_1   BE144228 BE144291       416153   1573947_1   R13894 H23037 R56371       417157   1653833_1   N49713 N49819 W03810       418154   17249_1   BE165866 BE165832 AA319621 AA401166 AI811901 H78857 X56199 R93797               AW896675 AA401072 AW374411 H52942 AW896685 AA348138               AI399764 AA010244 W90159 N90874 AA339496 AW967136 W38705 AA029093               AW444647 BE175700 AV651656 AV651847 AA332039               AV649227 AV649164 AV649491 N87956 AA332262 BE001561 H75493               BE218742 AA333298 AA095633 AA091968 M78602 T05342 W17094               AA126501 AW374665 AI452905 AW316900 AI185080 AI202928 AI651843 AA693541               AI681019 AV658257 AV658133 BE045335 BE089546               AA300830 AA361376 BE218739 AW207622 AA765340 AW612733 BE348741 AI806054               AI871563 AA808652 AI500693 AW342032 AA147066       419662   1870052_1   W87674 W87872 W87774       423983   233891_1   AA333261 AA333365 AA552870       425744   255834_1   AA362985 AW963337 T27244       425757   255956_1   AA363171 AW963347 AA371863       428337   289967_1   AA644508 AA479489 AA426174       431082   327710_1   AA491600 AA491645 AI920986       431300   331217_1   AA502346 BE159863       432474   348197_1   AA584042 AW973273 AA548798       433171   360292_1   AA579425 AW969965 AA579102       433847   374914_1   AA610266 AA610273 AA632625 AA812563 AI688018 AI094802 H79160 R99139       434995   397210_1   AW974995 AI821880 AI821932 AI791196 AA659617 AI821137 AA658925       437056   432262_1   AI147061 AA743380 AA765223 AW976398 AI803927       442552   54472_3   R20624 AA809852 AW025682 AW292949 H02596 AA633530 AA846566 AA806021               AA713679 AI364631 BE350976 AW076131 AW518885               AW263078 AI417702 AW086132 AI628605 AI769772 H02691 AW591478 H50040 AA227699               AI885558 AA400937 AI261878 R82844 AW075473               AI453800 N56889 AI922512 N51071 N51720 N51823 A1654491 W95290 AI272033 AI695006               AI918702 AI638383 BE552047 AI783684 AI126790               H01465 BE243273       444622   61286_1   H77824 AA370099 AW956039 H73387 R93651 AV650472       447135   70963_1   T58148 AW516579 AW059603       449495   808345_1   AI652833 AI695904 AW888916       449625   8113_1   NM_014253 AF100772 BE088769 AL022718 BE161779 AW863569 BE161640 AL039060               BE168542 AW296554 AA323193 AA235370 AW779760               N48674 AI375997 R45432 D59344 AI203107 F07491 R35360 R25094 AI913631 AI498402 T61382               AI016320 N45526 T61415 AA331486       449986   821463_1   AW864502 AW864369 AI678780       454333   1115507_1   AW373209 AW373205       455358   1284494_1   AW902641 AW902569 AW902654 AW902557 AW902650 AW902644 AW902741       457247   308656_1   AA458605 AW977252 AI261627 AW274550 AI418272 AW665579               AA731376 AW293861 D80453 AI217860       457747   397222_1   AW975000 AA658945 AA661558                                            
     [0353]                           TABLE 6C                       Pkey   Ref   Strand   Nt_position                  400738   7321559   Plus   150214-150446       400864   9798617   Minus   2555-2673, 27827-28000       401114   9966554   Plus   52327-53385       401197   9719705   Plus   176341-176452       401529   7770649   Minus   14577-15668       401593   7230957   Plus   10368-10572, 11293-12356       401757   7239630   Plus   88641-88751       401778   7249133   Minus   136881-137147, 137499-137628,                   137858-138143, 141015-142602       401929   3810670   Minus   3167-3286, 4216-4310       401941   4982556   Plus   112022-112204       402168   7458725   Minus   43245-43397       402370   9558580   Minus   14525-15733       402439   9796503   Minus   108604-108764       402781   7387389   Plus   100409-100666       402836   8745058   Minus   96756-96941       402842   9369121   Minus   76355-76479       402942   9368398   Plus   102152-102386       403171   9838164   Minus   74502-74703       403545   8078400   Plus   25293-25640       403609   8308266   Minus   125974-126320       403686   7387348   Minus   66625-68364       403923   7454203   Minus   1793-2128       404150   7534008   Plus   165811-165943       404162   9926427   Minus   107973-108135       404265   9437317   Minus   50752-50877       404657   9797066   Minus   12444-12548, 17348-17455       405014   6478993   Minus   100709-100845       405152   9965561   Minus   137662-137969       405206   6692345   Plus   17807-18338, 20430-20538       405481   3688109   Plus   5718-5837, 8719-8818       405543   9857582   Minus   104338-104449       405846   7637314   Plus   6623-7188       406029   8312328   Plus   63187-63801       406126   7108191   Minus   46035-46534       406180   7283201   Minus   38923-39107       406299   5686278   Minus   35655-36119       406466   9795550   Plus   115511-115658, 118766-118915,                   121699-121771       406526   7711448   Minus   102742-102944       406528   7711464   Minus   11201-11407, 12589-12733,                   13287-13499                                                    
     [0354] Table 7A lists about 1298 genes up-regulated in Hepatitis C positive liver tissues compared to Hepatitis C negative liver tissues. These genes have potential to be diagnostics and/or prognostic markers for Hepatitis C infected liver tissues. They may also provide clinical information on Hepatitis C infection and pathology. They may also be potential targets for therapeutic drugs and/or treatments. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the Wilcoxon rank-sum test p-value between the 2 groups was less than 0.10, the ratio of the “weighted average” of Hepatitis C positive liver tissues to the “weighted average” of Hepatitis C negative liver tissues was equal to or above 2.0, and that the differences between the same 2 groups was equal to or above 30.0. The “weighted average” of the Hepatitis C positive liver tissues was set to the trimean of several different Hepatitis C positive liver tissues. The “weighted average” of the Hepatitis C negative liver tissues was set to the either 10 or the trimean of several different Hepatitis C negative liver tissues, whichever value was greater to eliminate ratios with a denominator of zero or less.  
                                   TABLE 7A                       Pkey   ExAccn   UniGene   Unigene Title   R1   R2                                                        428227   AA321649   Hs. 2248   small inducible cytokine subfamily B (Cy   1.74E−07   25.27       414004   M737033   Hs. 7155   ESTs, Moderately similar to 2115357A TYK   3.18E−07   24.52       448111   AA053486   Hs. 20315   interferon-induced protein with tetratri   4.93E−07   24.00       417621   AV654694   Hs. 82316   interferon-induced, hepatitis C-associat   2.36E−07   23.13       422746   NM_004484   Hs. 119651   glypican 3   4.03E−06   22.55       426711   AA383471   Hs. 343800   conserved gene amplified in osteosarcoma   1.75E−07   20.97       424090   X99699   Hs. 139262   XIAP associated factor-1   2.78E−05   17.80       433854   AA610649   Hs. 333239   ESTs   2.26E−04   15.90       451652   AA018968   Hs. 133536   ESTs   1.62E−04   15.05       427283   AL119796   Hs. 174185   ectonucleotide pyrophosphatase/phosphodi   4.02E−06   14.90       413670   AB000115   Hs. 75470   hypothetical protein, expressed in osteo   6.13E−07   14.59       418216   AA662240   Hs. 283099   AF15q14 protein   4.93E−07   14.17       425787   AA363867   Hs. 155029   ESTs   7.26E−05   13.57       446094   AK001760   Hs. 13801   KIAA1685 protein   2.95E−05   12.90       450937   R49131   Hs. 26267   ATP-dependant interferon response protei   4.61E−06   12.07       442048   M974603       gb: op34f05.s1 Soares_NFL_T_GBC_S1 Homo s   3.34E−05   11.92       408393   AW015318   Hs. 23165   ESTs   1.31E−05   11.82       415443   T07353   Hs. 7948   ESTs   1.67E−03   11.80       417308   H60720   Hs. 81892   KIAA0101 gene product   2.17E−05   11.70       416206   AW206248   Hs. 111092   hypothetical protein FLJ22332   2.50E−06   11.35       432378   AI493046   Hs. 146133   ESTs   3.52E−06   11.13       430200   BE613337   Hs. 234896   geminin   7.59E−07   11.04       445823   AI478563   Hs. 145519   FKSG87 protein   1.15E−05   11.00       447973   AB011169   Hs. 20141   similar to  S. cerevisiae  SSM4   4.52E−05   10.97       409153   W03754   Hs. 50813   hypothetical protein FLJ20022   5.70E−07   10.72       451752   AB032997       KIAA1171 protein   1.74E−07   10.54       414052   AW578849   Hs. 283552   ESTs, Weakly similar to unnamed protein   1.77E−06   10.45       409231   AA446644   Hs. 692   GA733-2 antigen; epithelial glycoprotein   1.03E−04   10.30       432094   AI658580   Hs. 61426     Homo sapiens  mesenchymal stem cell prote   5.74E−05   10.17       403790           NM_001334*:  Homo sapiens  cathepsin O (CTS   1.08E−03   9.65       421057   T58283         Homo sapiens  cDNA: FLJ22063 fis, clone H   4.57E−03   9.27       428065   AI634046   Hs. 157313   ESTs   5.43E−03   9.22       444665   BE613126   Hs. 47783   B aggressive lymphoma gene   4.58E−06   9.17       435812   AA700439   Hs. 188490   ESTs   5.03E−04   9.13       418143   M283057   Hs. 266957   hypothetical protein FLJ14281   5.30E−04   9.00       435665   AI248952   Hs. 12320   ESTs   1.77E−06   8.85       407644   D16815       nuclear receptor subfamily 1, group D, m   4.31E−04   8.85       421282   AA286914   Hs. 40782   ESTs   4.54E−04   8.67       422546   AB007969   Hs. 301478   KIAA0500 protein   4.00E−05   8.52       409512   AW979187   Hs. 293591   melanoma differentiation associated prot   2.36E−07   8.50       429490   AI971131   Hs. 23889   ESTs, Weakly similar to ALU7 HUMAN ALU S   1.15E−04   8.50       442994   AI026718   Hs. 16954   ESTs   2.43E−03   8.47       416224   NM_002902   Hs. 79088   reticulocalbin 2, EF-hand calcium bindin   3.74E−06   8.45       417933   X02308   Hs. 82962   thymidylate synthetase   2.02E−03   8.35       405102           C15001220*: gi|4469558|gb|AAD21311.1| (AF   1.93E−03   8.20       444314   AI140497       gb: ow76b09.s1 Soares_fetal liver_spleen —     1.38E−03   8.10       426818   AA554827   Hs. 292996   DKFZp434A0131 protein   9.75E−03   8.02       432954   AI076345       ESTs   2.02E−03   7.88       449541   AA730673   Hs. 188634   ESTs   7.22E−04   7.85       410315   AI638871   Hs. 152519     Homo sapiens  cDNA: FLJ22524 fis. clone H   1.30E−05   7.80       433586   T85301       gb: yd78d06.s1 Soares fetal liver spleen   3.20E−03   7.80       436995   AI160015   Hs. 125489   ESTs   5.89E−04   7.80       446619   AU076643   Hs. 313   secreted phosphoprotein 1 (osteopontin,   4.00E−03   7.80       407949   W21874   Hs. 247057   ESTs, Weakly similar to 2109260A B cell   1.03E−04   7.72       421904   BE143533   Hs. 109309   hypothetical protein FLJ20035   7.61E−07   7.67       424848   AI263231   Hs. 327090   EST   2.11E−03   7.63       433401   AF039698   Hs. 284217   serologically defined colon cancer antig   1.57E−05   7.55       435571   AF212225   Hs. 283693   mitochondrial ribosomal protein L1   8.63E−05   7.55       419175   AW270037       KIAA0779 protein   1.01E−05   7.50       407930   AA045847   Hs. 188361     Homo sapiens  cDNA FLJ12807 fis, clone NT   6.86E−04   7.47       400247           Eos Control   8.61E−03   7.38       449935   AA004798   Hs. 108311   ESTs, Weakly similar to T00351 hypotheti   1.80E−05   7.38       435102   AW899053   Hs. 76917   F-box only protein 8   3.50E−03   7.32       418452   BE379749   Hs. 85201   C-type (calcium dependent, carbohydrate-   4.25E−07   7.32       425053   AF046024   Hs. 154320   ubiquitin-activating enzyme E1C (homolog   2.81E−04   7.30       431183   NM_006855   Hs. 250696   KDEL (Lys-Asp-Glu-Leu) endoplasmic retic   1.10E−02   7.30       446488   AB037782   Hs. 15119   KIAA1361 protein   2.12E−03   7.25       458725   AW970192   Hs. 171942   ras responsive element binding protein 1   1.71E−04   7.25       449718   AA459480   Hs. 23956   hypothetical protein FLJ20502   1.80E−05   7.17       418840   AI821614   Hs. 185831   ESTs   1.63E−02   7.10       408063   BE086548   Hs. 42346   calcineurin-binding protein calsarcin-1   1.71E−04   7.05       436024   AI800041       ESTs   2.81E−04   7.02       402727           NM_025065:  Homo sapiens  hypothetical prot   1.02E−02   7.00       447574   AF162666   Hs. 18895   tousled-like kinase 1   1.92E−04   6.97       447809   AW207605   Hs. 164230   ESTs, Highly similar to JC7266 3′,5′-cyc   7.31E−06   6.97       421379   Y15221   Hs. 103982   small inducible cytokine subfamily B (Cy   4.93E−07   6.97       424878   H57111   Hs. 221132   ESTs   2.67E−03   6.95       450016   AA249590   Hs. 4747   ESTs, Weakly similar to A28996 proline-r   8.16E−05   6.90       433230   AW136134   Hs. 220277   ESTs   1.45E−04   6.80       437967   BE277414   Hs. 5947   mel transforming oncogene (derived from   6.72E−03   6.80       419586   AI088485   Hs. 144759   ESTs, Weakly similar to I38022 hypotheti   1.54E−06   6.77       422506   R20909   Hs. 300741   sorcin   3.86E−02   6.77       433730   AK002135   Hs. 3542   hypothetical protein FLJ11273   1.08E−03   6.72       445929   AI089660   Hs. 323401   dpy-30-like protein   4.78E−04   6.72       405268           ENSP00000223174*: KIAA0783 PROTEIN.   2.96E−04   6.70       452973   H88409   Hs. 40527   ESTs   5.20E−03   6.70       452744   AI267652   Hs. 246107     Homo sapiens  mRNA; cDNA DKFZp434E082 (fr   5.70E−07   6.61       419407   AW410377   Hs. 41502   hypothetical protein FLJ21276   4.25E−05   6.60       443547   AW271273       hypothetical protein FLJ12666   5.23E−06   6.57       416475   T70298       gb: yd26g02.s1 Soares fetal liver spleen   2.32E−03   6.55       441976   AA428403   Hs. 106131   ESTs   2.50E−04   6.55       446493   AK001389   Hs. 15144   hypothetical protein DKFZp564O043   4.54E−04   6.55       408096   BE250162       dihydrofolate reductase   1.39E−02   6.52       434375   BE277910   Hs. 3833   3′-phosphoadenosine 5′-phosphosulfate sy   2.61E−05   6.52       453887   BE564037   Hs. 36237   hypothetical protein   1.61E−04   6.52       419550   D50918   Hs. 90998   KIAA0128 protein; septin 2   1.44E−06   6.50       424941   AA128376   Hs. 153884   ATP binding protein associated with cell   2.25E−04   6.47       416133   NM_001683   Hs. 89512   ATPase, Ca transporting, plasma membrane   5.20E−03   6.45       442993   BE018682   Hs. 166196   ATPase, Class I, type 8B, member 1   4.00E−05   6.40       445525   BE149866   Hs. 14831     Homo sapiens , Similar to zinc finger pro   1.91E−05   6.35       450293   N36754   Hs. 171118   hypothetical protein FLJ00026   2.52E−04   6.34       409052   AW898179   Hs. 50123   zinc finger protein 189   6.72E−03   6.33       442679   R53718       hypothetical protein FLJ10659   8.87E−06   6.27       418476   AA648431   Hs. 37883   hypothetical protein PNAS-131   3.67E−04   6.25       426925   NM_001196   Hs. 315689     Homo sapiens  cDNA: FLJ22373 fis, clone H   9.71E−05   6.25       451788   BE242857   Hs. 27021   hypothetical protein FLJ11159   7.26E−05   6.22       414183   AW957446   Hs. 301711   ESTs   1.45E−03   6.17       425073   W39609   Hs. 22003   solute carrier family 6 (neurotransmitte   1.05E−02   6.17       426110   NM_002913   Hs. 166563   replication factor C (activator 1) 1 (14   3.33E−05   6.13       452548   AL050321   Hs. 301532   CRP2 binding protein   3.29E−04   6.08       433745   AF075320   Hs. 28980   hypothetical protein FLJ14540   3.83E−03   6.07       422173   BE385828   Hs. 250619   phorbolin-like protein MDS019   7.58E−07   6.05       451406   AI694320   Hs. 6295   ESTs, Weakly similar to T17248 hypotheti   1.25E−03   6.04       443852   AI679966   Hs. 150603   ESTs   7.94E−03   6.02       445813   Z42023   Hs. 106576   alanine-glyoxylate aminotransferase 2-li   6.52E−04   6.02       413922   AI535895   Hs. 221024   ESTs   4.57E−03   6.00       426458   D83032   Hs. 169984   nuclear protein   8.28E−03   6.00       443035   Z45822   Hs. 8906     Homo sapiens  clone 24889 mRNA sequence   1.44E−04   5.97       447164   AF026941   Hs. 17518   vipirin; similar to inflammatory respon   8.74E−07   5.97       431604   AF175265   Hs. 264190   vacuolar protein sorting 35 (yeast homol   8.84E−04   5.95       445943   AW898533   Hs. 181574   ESTs   6.87E−04   5.95       451122   AA015767   Hs. 84522   ESTs   7.62E−03   5.95       411252   AB018549   Hs. 69328   MD-2 protein   2.60E−05   5.92       423598   BE247600   Hs. 155538   ESTs   9.75E−04   5.92       410361   BE391804   Hs. 62661   guanylate binding protein 1, interferon-   1.74E−03   5.88       417228   AL134324   Hs. 7312   ESTs   4.31E−04   5.88       434421   AI915927   Hs. 34771   ESTs   9.75E−04   5.87       424308   AW975531   Hs. 154443   minichromosome maintenance deficient (S.   2.17E−05   5.82       427484   N32859   Hs. 37288   nuclear receptor subfamily 1, group D, m   2.45E−05   5.82       430261   AA305127   Hs. 4147   hypothetical protein HT023   2.42E−03   5.82       443291   AA325633   Hs. 136102   KIAA0853 protein   3.06E−03   5.82       447735   AA775268   Hs. 6127     Homo sapiens  cDNA: FLJ23020 fis, clone L   5.86E−04   5.82       419644   AU076951   Hs. 179573   retinoblastoma-binding protein 1   6.08E−05   5.80       456619   AV647917   Hs. 107153   inhibitor of growth family, member 1-lik   7.31E−06   5.80       414812   X72755   Hs. 77367   monokine induced by gamma interferon   1.34E−06   5.78       430556   AW967807   Hs. 13797   ESTs   1.83E−03   5.77       408360   AI806090   Hs. 44344   hypothetical protein FLJ20534   4.24E−05   5.75       418224   AL036057   Hs. 83795   interferon regulatory factor 2   2.38E−04   5.75       418876   AA740616       gb: ny97f11.s1 NCI_CGAP_GCB1  Homo sapiens     5.09E−05   5.75       456236   AF045229   Hs. 82280   regulator of G-protein signalling 10   1.52E−03   5.72       437374   AL359571   Hs. 44054   ninein (GSK3B interacting protein)   6.85E−05   5.71       445529   H14421   Hs. 180513   ATP-binding cassette, sub-family A (ABC1   9.77E−04   5.70       400517           lengsin   2.45E−05   5.67       410577   X91911   Hs. 64639   glioma pathogenesis-related protein   1.76E−06   5.67       434210   AA665612       ESTs   3.27E−06   5.67       438011   BE466173   Hs. 145696   splicing factor (CC1.3)   7.94E−03   5.67       421594   R45689   Hs. 21889     Homo sapiens  cDNA FLJ12978 fis, clone NT   3.50E−03   5.65       400133           Eos Control   1.29E−02   5.63       452827   AI571835   Hs. 55468   ESTs   2.61E−05   5.63       448694   AA478756   Hs. 194477   E3 ubiquitin ligase SMURF2   2.26E−04   5.62       408214   AL120445   Hs. 77823   hypothetical protein FLJ21343   2.66E−04   5.60       449609   BE246434   Hs. 289026   guanine nucleotide binding protein (G pr   6.17E−04   5.59       409277   T05558   Hs. 156880   ESTs   6.17E−03   5.57       421650   AA781795   Hs. 122587   ESTs   1.22E−05   5.57       428172   U09367   Hs. 182828   zinc finger protein 136 (clone pHZ-20)   2.32E−03   5.57       433037   NM_014158   Hs. 279938   HSPC067 protein   3.77E−05   5.57       413509   BE145419       gb: IL5-HT0198-291099-009-E01 HT0198 Homo   1.75E−03   5.52       457130   NM_005651   Hs. 183671   tryptophan 2,3-dioxygenase   5.91E−03   5.52       433208   AW002834   Hs. 24095   ESTs   5.39E−02   5.51       410867   X63556   Hs. 750   fibrillin 1 (Marfan syndrome)   1.96E−02   5.50       412802   U41518   Hs. 74602   aquaporin 1 (channel-forming integral pr   5.89E−04   5.50       416309   R84694   Hs. 79194   cAMP responsive element binding protein   6.82E−05   5.50       437730   AW071087   Hs. 239176   insulin-like growth factor 1 receptor   2.54E−03   5.50       420520   AK001978   Hs. 98510   similar to rab11-binding protein   6.16E−03   5.47       422423   AF283777   Hs. 116481   CD72 antigen   5.67E−03   5.47       431586   AW971100   Hs. 293189   ESTs   2.79E−03   5.47       415660   AI909007   Hs. 78563   ubiquitin-conjugating enzyme E2G 1 (homo   1.96E−02   5.45       424243   AI949359   Hs. 143600   ESTs, Highly similar to cis Golgi-locali   9.29E−04   5.45       439008   AF075072   Hs. 167535   ESTs, Weakly similar to ALU1_HUMAN ALU S   2.66E−03   5.45       443441   AW291196   Hs. 92195   ESTs   4.42E−02   5.45       413010   AA393273   Hs. 75133   transcription factor 6-like 1 (mitochond   4.77E−03   5.42       439375   AA689526   Hs. 344249   steroid dehydrogenase homolog   9.70E−05   5.42       405141           zinc finger protein 200   1.69E−02   5.40       429747   M87507   Hs. 2490   caspase 1, apoptosis-related cysteine pr   1.39E−05   5.40       448901   AK001021   Hs. 22505   hypothetical protein FLJ10159   6.40E−06   5.40       450206   AI796450   Hs. 201600   ESTs   2.52E−04   5.38       437175   AW968078   Hs. 87773   protein kinase, cAMP-dependent, catalyti   2.96E−04   5.37       429588   AI080271       ESTs   2.55E−03   5.36       408048   NM_007203   Hs. 42322   A kinase (PRKA) anchor protein 2   1.01E−02   5.35       422553   AI697720   Hs. 171455   ESTs, Weakly similar to T31613 hypotheti   2.31E−05   5.35       448554   NM_016169   Hs. 21431   suppressor of fused   2.80E−04   5.33       420338   AA825595   Hs. 88269     Homo sapiens , clone MGC: 17339, mRNA, com   4.92E−06   5.32       425167   AA351629   Hs. 225567   ESTs   2.22E−03   5.31       449429   AA054224   Hs. 59847   ESTs   1.10E−02   5.30       436562   H71937   Hs. 322904   ESTs, Weakly similar to I38022 hypotheti   4.77E−03   5.29       407347   AA829847       gb: od40d07.s1 NCI_CGAP_GCB1  Homo sapiens     5.08E−05   5.29       433505   AW504027   Hs. 15301     Homo sapiens  cDNA FLJ12596 fis, clone NT   1.13E−03   5.27       439301   AA833784   Hs. 252888   ESTs   1.57E−02   5.27       439195   H89360       gb: yw28d08.s1 Morton Fetal Cochlea Homo   3.20E−03   5.27       414737   AI160386   Hs. 125087   ESTs   6.37E−06   5.25       419490   NM_006144   Hs. 90708   granzyme A (granzyme 1, cytotoxic T-lymp   1.29E−02   5.25       439971   W32474   Hs. 301746   RAP2A, member of RAS oncogene family   1.39E−05   5.25       450697   AW152166   Hs. 182113   ESTs   5.43E−03   5.25       432441   AW292425   Hs. 163484   ESTs   2.52E−04   5.22       410511   AA743475   Hs. 285655   ESTs   4.00E−03   5.20       421535   AB002359   Hs. 105478   phosphoribosylformylglycinamidine syntha   1.59E−03   5.20       427699   AW965076   Hs. 180378   hypothetical protein 669   1.14E−02   5.20       437650   AA814338   Hs. 292297   ESTs   7.30E−03   5.20       408405   AK001332   Hs. 44672   hypothetical protein FLJ10470   1.77E−06   5.18       413007   BE046662       gb: hn42f02.x1 NCI_CGAP_RDF2  Homo sapiens     8.00E−04   5.17       449365   AW968261   Hs. 118913   ESTs, Moderately similar to T46371 hypot   1.10E−02   5.17       452327   AK000196   Hs. 29052   hypothetical protein FLJ20189   5.73E−05   5.17       416701   R94977   Hs. 35416   PRO0132 protein   5.20E−03   5.15       447774   BE018118   Hs. 19554   chromosome 1 open reading frame 2   1.10E−02   5.14       437834   AA769294       gb: nz36g03.s1 NCI CGAP_GCB1  Homo sapiens     2.64E−04   5.13       458965   AA010319   Hs. 60389   ESTs   1.38E−03   5.13       421097   AI280112   Hs. 125232     Homo sapiens  cDNA FLJ13266 fis, clone OV   3.26E−02   5.10       410337   M83822   Hs. 62354   cell division cycle 4-like   4.31E−04   5.10       422267   AB033044   Hs. 114012   KIAA1218 protein   4.28E−04   5.10       442878   AI868648   Hs. 22315   ESTs   1.92E−03   5.10       451338   AW612322   Hs. 19131   transcription factor Dp-2 (E2F dimerizat   2.66E−04   5.10       407204   R41933   Hs. 140237   ESTs, Weakly similar to ALU1_HUMAN ALU S   2.52E−04   5.07       431049   AA846576   Hs. 103267   hypothetical protein FLJ22548 similar to   8.59E−05   5.07       419522   AI682428   Hs. 157728   ESTs   2.13E−04   5.05       431736   AI912234   Hs. 3297   ribosomal protein S27a   9.76E−04   5.02       433697   AA600357   Hs. 239489   TIA1 cytotoxic granute-associated RNA-bi   1.34E−02   5.02       403738           C4000675*: gi|3426332|gb|AAC32272.1| (AF0   7.30E−06   5.02       453742   AB037744   Hs. 34892   KIAA1323 protein   3.35E−03   5.02       426052   N49068   Hs. 93966   ESTs   2.96E−04   5.00       430268   AK000737   Hs. 237480   hypothetical protein FLJ20730   4.56E−03   5.00       430512   AF182294   Hs. 241578   U6 snRNA-associated Sm-like protein LSm8   1.39E−02   5.00       434658   AI624436   Hs. 310286   ESTs   1.22E−04   5.00       450086   AW016343   Hs. 233301   ESTs   4.98E−03   5.00       432606   NM_002104   Hs. 3066   granzyme K (serine protease, granzyme 3;   8.15E−05   4.99       450916   AA011597   Hs. 177398   ESTs   4.98E−03   4.98       444372   AW377983   Hs. 298140     Homo sapiens  cDNA: FLJ22502 fis, clone H   8.13E−05   4.98       439334   AI148976   Hs. 112062   ESTs   9.71E−04   4.98       440043   BE277457   Hs. 30661   hypothetical protein MGC4606   1.52E−03   4.97       424852   AI222779   Hs. 144848   ESTs   1.06E−02   4.95       443884   N20617   Hs. 194397   leptin receptor   2.54E−02   4.95       444670   H58373   Hs332938   hypothetical protein MGC5370   2.96E−04   4.95       409703   NM_006187   Hs. 56009   2′-5′-oligoadenylate synthetase 3 (100 k   1.74E−07   4.94       426793   X89887   Hs. 172350   HIR (histone cell cycle regulation defec   4.18E−03   4.93       407366   AF026942   Hs. 17518   gb:  Homo sapiens  cig33 mRNA, partial sequ   3.76E−06   4.92       428255   AI627478   Hs. 187670   ESTs   3.51E−03   4.91       415938   BE383507   Hs. 78921   A kinase (PRKA) anchor protein 1   6.44E−05   4.91       403904           ENSP00000251503*: WUGSC   7.31E−03   4.90       408831   AF090114   Hs. 48433   endocrine regulator   1.81E−04   4.90       414646   AA353776   Hs. 901   CD48 antigen (B-cell membrane protein)   7.82E−06   4.90       420151   AA255931   Hs. 186704   ESTs   8.60E−05   4.90       434158   T86534   Hs. 14372   ESTs   2.43E−03   4.90       450447   AF212223   Hs. 25010   hypothetical protein P15-2   3.99E−03   4.90       447769   AW873704   Hs. 320831     Homo sapiens  cDNA FLJ14597 fis, clone NT   4.79E−04   4.89       416050   U51903   Hs. 78993   IQ motif containing GTPase activating pr   3.14E−02   4.88       421215   AI868634   Hs. 246358   ESTs, Weakly similar to T32250 hypotheti   3.99E−05   4.87       408761   AA057264   Hs. 238936   ESTs, Weakly similar to (defline not ava   3.48E−04   4.86       449523   NM_000579   Hs. 54443   chemokine (C-C motif) receptor 5   2.78E−05   4.85       423857   N48902   Hs. 133481     Homo sapiens  mRNA; cDNA DKFZp564O0862 (f   1.66E−03   4.82       427384   T82854       gb: yd42a09.r1 Soares fetal liver spleen   1.14E−02   4.82       451273   NM_014811   Hs. 26163   KIAA0649 gene product   4.35E−03   4.82       431620   AA126109   Hs. 264981   2′-5′-oligoadenylate synthetase 2 (69-71   1.75E−07   4.82       439223   AW238299   Hs. 250618   UL16 binding protein 2   5.03E−04   4.82       451081   AI078645   Hs. 431   murine leukemia viral (bmi-1) oncogene h   7.30E−03   4.79       407609   R43159   Hs. 238432   ESTs   1.92E−03   4.77       424683   N87519   Hs. 27196   ESTs   2.52E−04   4.77       429966   BE081342   Hs. 283037   HSPC039 protein   6.93E−02   4.77       443998   AI620661   Hs. 296276   ESTs   8.63E−03   4.77       452820   N46161   Hs. 35274   ESTs   5.43E−03   4.77       454075   R43826   Hs. 16313   Kruppel-like zinc finger protein GLIS2   7.30E−03   4.77       429922   Z97630   Hs. 226117   H1 histone family, member 0   3.25E−02   4.77       422541   NM_005131   Hs. 1540   nuclear matrix protein p84   2.66E−03   4.76       449613   N63808   Hs. 34299   ESTs   5.99E−06   4.75       407309   AA526438   Hs. 281680   peroxisomal trans 2-enoyl CoA reductase;   7.68E−05   4.74       431966   AB037903   Hs. 272257     Homo sapiens  truncated AKR mRNA for trun   7.62E−03   4.73       410382   AW664971   Hs. 259546   ESTs   7.68E−05   4.72       434926   BE543269   Hs. 50252   mitochondrial ribosomal protein L32   3.29E−04   4.72       414219   W20010   Hs. 75823   ALL1-fused gene from chromosome 1q   8.62E−03   4.71       413048   M93221   Hs. 75182   mannose receptor, C type 1   1.91E−04   4.67       419110   AA234171   Hs. 187626   ESTs   1.71E−04   4.67       429952   AF080158   Hs. 226573   inhibitor of kappa light polypeptide gen   2.52E−04   4.67       450401   AW959281   Hs. 8184   ESTs   1.19E−03   4.67       432600   AI821085       gb: ns95a12.y5 NCI_CGAP_Pr3  Homo sapiens     2.55E−03   4.65       441892   AB028981   Hs. 8021   KIAA1058 protein   1.29E−04   4.65       446207   AW968535   Hs. 14328   hypothetical protein FLJ20071   9.27E−04   4.65       450516   AA902656   Hs. 21943   NIF3 (Ngg1 interacting factor 3.  S. pombe     7.19E−04   4.65       419590   AF005043   Hs. 91390   poly (ADP-ribose) glycohydrolase   6.44E−05   4.65       449909   AA004681   Hs. 59432   ESTs   4.77E−03   4.63       409401   AI201895   Hs. 181309   proteasome (prosome, macropain) subunit.   2.12E−03   4.63       441652   BE467811   Hs. 7471   BBP-like protein 1   1.75E−03   4.61       417688   R09170   Hs. 284350   ESTs   4.78E−04   4.61       411605   AW006831       ESTs   8.26E−03   4.60       408108   AI580492   Hs. 42743   hypothetical protein   1.38E−03   4.60       451079   AI827988   Hs. 240728   ESTs, Moderately similar to PC4259 ferri   8.00E−04   4.60       451326   AW296946   Hs. 256078   ESTs   5.57E−04   4.60       453555   N23574   Hs. 123649   ESTs, Moderately similar to ALU7_HUMAN A   6.81E−05   4.60       447541   AK000288   Hs. 18800   hypothetical protein FLJ20281   2.19E−02   4.60       402737           Target Exon   3.66E−04   4.60       454067   AA041455       ESTs   8.00E−04   4.59       408705   AA312135   Hs. 46967   HSPCO34 protein   3.06E−06   4.57       413786   AW613780   Hs. 13500   ESTs   5.69E−07   4.57       424626   AA344308   Hs. 128427     Homo sapiens  BAC clone RP11-335J18 from   2.45E−05   4.57       447023   AA356764   Hs. 17109   integral membrane protein 2A   1.92E−04   4.57       449500   AW956345   Hs. 12926   ESTs   5.56E−02   4.56       432572   AI660840   Hs. 191202   ESTs, Weakly similar to ALUE_HUMAN !!!!   1.06E−02   4.55       446927   AW503484   Hs. 16533   myosin phosphatase, target subunit 1   2.78E−03   4.55       452695   AW780199   Hs. 30327   mitogen-activated protein kinase-activat   2.32E−03   4.55       456034   AW450979       gb: UI-H-BI3-ala-a-12-0-UI.s1 NCI_CGAP_Su   3.26E−02   4.55       401091           decay accelerating factor for complement   7.98E−04   4.52       423250   BE061916   Hs 125849   chromosome 8 open reading frame 2   1.89E−02   4.52       451690   AW451469   Hs. 209990   ESTs   1.06E−02   4.52       443119   AA312264   Hs. 7980   hypothetical protein MGC12966   1.91E−04   4.50       410245   C17908   Hs. 194125   ESTs   1.69E−02   4.49       448760   AA313825   Hs. 323583   AD036 protein   8.13E−05   4.48       417954   AI633943   Hs. 26613   ESTs, Weakly similar to no similarities   5.56E−02   4.47       417973   NM_004490   Hs. 83070   growth factor receptor-bound protein 14   2.73E−02   4.47       419743   AW408762   Hs. 5957     Homo sapiens  clone 24416 mRNA sequence   4.88E−02   4.47       429276   AF056085   Hs. 198612   G protein-coupled receptor 51   2.80E−04   4.47       432967   AA572949   Hs. 207566   ESTs   7.59E−03   4.47       433226   AW503733   Hs. 9414   KIAA1488 protein   2.67E−03   4.47       445776   NM_001310   Hs. 13313   cAMP responsive element binding protein-   2.83E−02   4.47       426860   U04953   Hs. 172801   isoleucine-tRNA synthetase   1.34E−02   4.47       419943   AA252111   Hs. 15200   ESTs   4.54E−04   4.47       442202   BE272862   Hs. 106534   hypothetical protein FLJ22625   4.30E−04   4.47       432676   AI187366       gb: qf29c01.x1 Soares_testis_NHT Homo sap   1.45E−04   4.46       421181   NM_005574   Hs. 184585   LIM domain only 2 (rhombotin-like 1)   5.91E−03   4.45       428342   AI739168         Homo sapiens  cDNA FLJ13458 fis, clone PL   8.15E−05   4.45       434941   AW073202   Hs. 334825     Homo sapiens  cDNA FLJ14752 fis, clone NT   7.95E−03   4.45       446839   BE091926   Hs. 16244   mitotic spindle coiled-coil related prot   4.56E−03   4.45       421508   NM_004833   Hs. 105115   absent in melanoma 2   1.53E−04   4.43       438098   AI076370   Hs. 134037   ESTs   1.19E−02   4.42       449001   AI619957       ESTs   6.17E−03   4.42       409461   AA382169   Hs. 54483   N-myc (and STAT) interactor   4.91E−07   4.42       408461   AB037756   Hs. 45207   hypothetical protein KIAA1335   8.26E−03   4.40       413243   AA769266   Hs. 193657   ESTs   1.06E−02   4.40       450747   AI064821   Hs. 318535   ESTs, Highly similar to 1818357A EWS gen   5.92E−02   4.40       451658   AW195351   Hs. 250520   ESTs, Moderately similar to I38022 hypot   1.22E−04   4.38       419951   AI653415   Hs. 195789   ESTs   8.63E−05   4.38       421685   AF189723   Hs. 106778   ATPase, Ca transporting, type 2C, member   8.00E−04   4.38       424960   BE245380   Hs. 153952   5′ nucleotidase (CD73)   1.06E−02   4.38       432435   BE218886   Hs. 282070   ESTs   1.19E−03   4.38       431863   AA188185   Hs. 289043   spindlin   3.55E−05   4.37       408162   AA993833   Hs. 118527   ESTs   6.41E−03   4.35       417363   AW129357   Hs. 329700   ESTs   9.37E−03   4.35       422879   AI241409   Hs. 188092   ESTs   1.59E−03   4.35       438769   AA830684   Hs. 163426   ESTs   2.79E−03   4.35       443084   AI827639   Hs. 125539   ESTs   2.66E−03   4.35       425068   AL048716   Hs. 154387   KIAA0103 gene product   8.08E−02   4.35       445652   AL117473   Hs. 13036   DKFZP727A071 protein   8.40E−04   4.33       431328   AA502999   Hs. 291591   ESTs   2.03E−04   4.30       434666   AF151103   Hs. 112259   T cell receptor gamma locus   7.99E−04   4.30       452939   R35348   Hs. 24970   ESTs, Weakly similar to B34323 GTP-bindi   6.17E−03   4.30       407690   R47799   Hs. 266957   hypothetical protein FLJ14281   3.28E−06   4.27       432610   BE246615   Hs. 278507   histidyl-tRNA synthetase-like   3.35E−03   4.27       434198   AF119849   Hs. 283028   hypothetical protein PRO1598   2.38E−04   4.27       446751   AA766998   Hs. 79126   Human DNA sequence from clone RP11-16L21   4.58E−02   4.27       447887   AA114050   Hs. 19949   caspase 8, apoptosis-related cysteine pr   7.96E−04   4.27       411656   AW855576       gb: CM4-CT0278-221099-027-d01 CT0278 Homo   3.20E−03   4.25       428720   T90468   Hs. 178154   ESTs   1.25E−03   4.25       432195   AJ243669   Hs. 8127   KIAA0144 gene product   6.52E−04   4.25       433847   AA610266   Hs. 3631   ESTs   4.54E−04   4.25       434987   AW975114       ESTs   7.62E−03   4.25       443020   AI350058   Hs. 106129   ESTs   1.39E−02   4.24       440193   AW902312   Hs. 7037     Homo sapiens  clone 24923 mRNA sequence   8.57E−02   4.22       440201   AL359588   Hs. 7041   hypothetical protein DKFZp762B226   1.05E−02   4.22       447513   AW955776   Hs. 313500   ESTs, Moderately similar to ALU7_HUMAN A   2.03E−06   4.22       453793   AK002178   Hs. 35225   hypothetical protein FLJ11316   6.72E−03   4.22       434280   BE005398       gb: CM1-BN0116-150400-189-h02 BN0116 Homo   1.59E−03   4.22       414405   AI362533       KIAA0306 protein   6.39E−06   4.21       433437   U20536   Hs. 3280   caspase 6, apoptosis-related cysteine pr   7.81E−06   4.20       402507           Target Exon   5.30E−04   4.20       430569   AF241254   Hs. 178098   angiotensin | converting enzyme (peptidy   2.45E−02   4.20       442061   AA774284   Hs. 285728   abl-interactor 12 (SH3-containing protei   7.58E−04   4.20       414915   NM_002462   Hs. 76391   myxovirus (influenza) resistance 1, homo   2.36E−07   4.19       442045   C05768   Hs. 8078     Homo sapiens  clone FBD3 Cri-du-chat crit   1.31E−03   4.18       402964           NM_022095*:  Homo sapiens  hypothetical C2H   5.59E−04   4.17       452032   BE244005   Hs. 27610   retinoic acid-and interferon-inducible   4.54E−04   4.17       407218   AA095473       ubiquitin-conjugating enzyme E2H (homolo   7.93E−03   4.17       425387   AB037864   Hs. 156051   KIAA1443 protein   3.65E−04   4.17       431122   AI267593   Hs. 250535     Homo sapiens  mRNA; cDNA DKFZp434N2412 (f   6.51E−04   4.17       407756   AA116021   Hs. 38260   ubiquitin specific protease 18   3.41E−07   4.17       407992   AW418811       gb: ha21a06.x1 NCI-HD —   3.64E−03   4.16                   CGAP_Kid12 Homo sapien       416647   BE297139   Hs. 79411   replication protein A2 (32 kD)   7.98E−04   4.16       433017   Y15067   Hs. 279914   zinc finger protein 232   3.31E−05   4.15       435513   AW404075   Hs. 42785   DC11 protein   2.63E−02   4.15       447094   X65232   Hs. 17364   zinc finger protein 79 (pT7)   1.19E−03   4.15       450746   D82673   Hs. 278589   general transcription factor II, i   5.23E−06   4.15       432388   X15218   Hs. 2969   v-ski avian sarcoma viral oncogene homol   8.84E−04   4.15       431976   AA719001   Hs. 291065   ESTs   6.86E−05   4.14       453394   AW960474   Hs. 40289   ESTs   103E−04   4.13       418793   AW382987   Hs. 88474   prostaglandin-endoperoxide synthase 1 (p   1.39E−02   4.13       456439   AA251242   Hs. 103238   ESTs   7.94E−03   4.13       406423           C19000229*: gi|6753826|ref|NP_034311.1| f   2.04E−02   4.13       408392   U28831   Hs. 44566   KIAA1641 protein   5.67E−03   4.13       417601   NM_014735   Hs. 82292   KIAA0215 gene product   3.13E−04   4.13       425462   AI491852   Hs. 46783     Homo sapiens  cDNA: FLJ22382 fis, clone H   3.74E−02   4.12       440624   AF017987   Hs. 7306   secreted frizzled-related protein 1   1.10E−02   4.11       422040   AA172106   Hs. 110950   Rag C protein   6.53E−04   4.10       416987   D86957   Hs. 80712   KIAA0202 protein   4.37E−03   4.10       418720   AI381687   Hs. 39526   ESTs   5.39E−02   4.10       433556   W56321   Hs. 111460   calcium/calmodulin-dependent protein kin   1.15E−04   4.10       435260   H64245   Hs. 34458   ESTs   3.35E−03   4.09       443601   AI078554   Hs. 42658   ESTs   1.45E−04   4.09       435029   AF167706   Hs. 19280   cysteine-rich motor neuron 1   1.45E−02   4.08       446667   BE161878   Hs224805   ESTs   2.04E−02   4.06       406038           zinc finger protein 200   2.92E−03   4.05       430468   NM_004673   Hs. 241519   angiopoietin-like 1   1.69E−02   4.05       430522   N75750   Hs. 242271   KIAA0471 gene product   4.00E−03   4.05       423732   AF058056   Hs. 132183   solute carrier family 16 (monocarboxylic   2.02E−03   4.05       408548   AA055449   Hs. 63187   ESTs, Weakly similar to ALUC_HUMAN !!!!   3.66E−03   4.02       451593   AF151879   Hs. 26706   CGI-121 protein   1.71E−04   4.02       459297   BE300741   Hs. 125034   hypothetical protein FLJ13340   2.92E−03   4.02       433001   AF217513   Hs. 279905   clone HQ0310 PRO0310p1   3.13E−04   4.02       433233   AB040927   Hs. 301804   KIAA1494 protein   8.27E−03   4.00       445733   BE295568   Hs. 13225   UDP-Gal: betaGlcNAc beta 1,4-galactosylt   3.06E−03   4.00       444985   AI677737   Hs. 28329   hypothetical protein FLJ14005   8.82E−04   3.98       408380   AF123050   Hs. 44532   diubiquitin   1.54E−06   3.98       416999   AW195747   Hs. 21122   hypothetical protein FLJ11830 similar to   5.89E−04   3.97       424238   AA337401   Hs. 137635   ESTs   2.93E−02   3.97       425395   NM_014102   Hs. 156243   PRO1848 protein   9.70E−05   3.97       442485   BE092285   Hs. 29724   hypothetical protein FLJ13187   1.02E−02   3.97       401649           Target Exon   9.28E−04   3.95       426108   AA622037   Hs. 166468   programmed cell death 5   9.92E−02   3.95       441889   AI090455   Hs. 268371   hypothetical protein FLJ20274   3.74E−02   3.95       428467   AK002121   Hs. 184465   hypothetical protein FLJ11259   1.13E−03   3.95       452194   AI694413       Ubiquitin-like protein FAT10??? - diubiq   2.18E−06   3.93       421443   BE550141   Hs. 156148   hypothetical protein FLJ13231   7.59E−04   3.92       427213   AW007211       hypothetical protein FLJ12876   5.21E−03   3.92       449964   AW001741   Hs. 24243   hypothetical protein FLJ10706   2.01E−03   3.92       435970   H75410   Hs. 54452   zinc finger protein, subfamily 1 A, 1 (lk   1.44E−03   3.92       448965   AF092134   Hs. 22679   CGI-24 protein   5.74E−05   3.90       419737   H24185   Hs. 92918   hypothetical protein   1.75E−03   3.90       425210   AA054679   Hs. 155150   ribonuclease P (14 kD)   7.30E−03   3.90       437862   AW978107   Hs. 5884     Homo sapiens  mRNA; cDNA DKFZp586C0224 (f   5.67E−03   3.90       400475           NM_031436*:  Homo sapiens  hypothetical pro   2.91E−03   3.88       433075   NM_002959       sortilin 1   5.75E−02   3.88       428420   AL096858   Hs. 184245   KIAA0929 protein Msx2 interacting nuclea   5.26E−06   3.86       436139   AA765786   Hs. 120936   ESTs   8.16E−05   3.86       449509   AA001615   Hs. 84561   ESTs   4.13E−02   3.85       452642   AW474296   Hs. 29667   ESTs   1.24E−02   3.85       456107   AA160000   Hs. 137396   ESTs, Weakly similar to JC5238 galactosy   6.15E−03   3.85       457584   AA147979   Hs. 285005   mitochondrial import receptor Tom22   3.13E−04   3.84       414658   X58528   Hs. 76781   ATP-binding cassette, sub-family D (ALD)   4.18E−03   3.84       452866   R26969   Hs. 268016     Homo sapiens  cDNA: FLJ21243 fis, clone C   1.38E−03   3.84       412651   AA115333   Hs. 107968   ESTs   4.02E−06   3.84       403575           Target Exon   1.44E−03   3.82       418304   AA215702       gb: zr97g10.r1 NCI_CGAP_GCB1  Homo sapiens     1.59E−03   3.82       435354   AA678267   Hs. 117115   ESTs   4.42E−02   3.82       411400   AA311919   Hs. 69851   nucleolar protein family A, member 1 (H/   3.12E−04   3.82       408618   AK000637   Hs. 46624   HSPC043 protein   1.63E−02   3.81       419135   R61448   Hs. 106728   ESTs, Weakly similar to KIAA1353 protein   2.16E−05   3.80       421965   AA301100   Hs. 346482   gb: EST14128 Testis tumor  Homo sapiens  cD   3.33E−05   3.79       419908   AW971327   Hs. 293315   ESTs   1.13E−03   3.79       438021   AV653790       WW domain-containing protein 1   9.79E−04   3.78       423450   AJ290445   Hs. 128759   KIAA0524 protein   2.81E−04   3.77       432689   AB018320       Arg/Abl-interacting protein ArgBP2   1.51E−02   3.77       434526   AW085147   Hs. 152779   ESTs   8.24E−03   3.77       436385   BE551618   Hs. 144097   ESTs   5.39E−02   3.77       424003   BE274717   Hs. 137506     Homo sapiens , clone IMAGE: 3605104, mRNA,   1.69E−02   3.75       432409   AA806538   Hs. 130732   KIAA1575 protein   5.93E−02   3.75       432873   AW837268   Hs. 279639     Homo sapiens  mRNA; cDNA DKFZp586M2022 (f   1.14E−02   3.74       401016           ENSP00000227126: NAALADASE II PROTEIN.   2.92E−03   3.72       425397   J04088   Hs. 156346   topoisomerase (DNA) II alpha (170 kD)   3.37E−02   3.72       426310   NM_000909   Hs. 169266   neuropeptide Y receptor Y1   6.17E−03   3.72       430016   NM_004736   Hs. 227656   xenotropic and polytropic retrovirus rec   2.93E−02   3.72       434733   AI334367   Hs. 159337   ESTs   4.78E−04   3.72       447892   AI435848   Hs. 172978   ESTs   2.63E−02   3.72       453753   BE252983   Hs. 35086   ubiquitin specific protease 1   4.56E−02   3.72       410099   AA081630       KIAA0036 gene product   7.84E−02   3.72       421205   AL137540   Hs. 102541   netrin 4   6.12E−02   3.71       437629   AW574774   Hs. 121692   ESTs   7.98E−04   3.71       446506   AI123118   Hs. 15159   chemokine-like factor, alternatively spl   1.16E−06   3.71       405689           NM_018850*:  Homo sapiens  ATP-binding cass   8.40E−04   3.71       427399   NM_014883   Hs. 177664   KIAA0914 gene product   4.54E−04   3.70       417848   AA206581   Hs. 116586   ESTs, Weakly similar to JC5314 CDC28/cdc   1.75E−03   3.70       419511   AA429750   Hs. 75113   general transcription factor IIIA   5.20E−03   3.70       425423   NM_005897   Hs. 157180   intracisternal A particle-promoted polyp   1.44E−03   3.70       433891   AA613792       gb: no97h03.s1 NCI_CGAP_Pr2  Homo sapiens     2.19E−02   3.70       434924   AA443164   Hs. 23259   hypothetical protein FLJ13433   4.01E−05   3.70       442085   AA975688   Hs. 159955   ESTs   4.00E−03   3.70       444363   AI142827   Hs. 143656   ESTs   4.29E−04   3.70       423954   AW753164   Hs. 288604   KIAA1632 protein   2.11E−03   3.69       423494   AW504365   Hs. 24143   Wiskott-Aldrich syndrome protein interac   2.54E−03   3.67       429680   AL035754   Hs. 2474   toll-like receptor 1   1.62E−04   3.67       429686   AI871613   Hs. 28538     Homo sapiens  cDNA: FLJ21086 fis, clone C   1.75E−02   3.67       440865   AI281525   Hs. 130180   ESTs   2.43E−03   3.67       444508   AI554691   Hs. 334583   ring finger protein 23   1.02E−03   3.67       427581   NM_014788   Hs. 179703   KIAA0129 gene product   4.92E−07   3.67       438459   T49300   Hs. 35304     Homo sapiens  cDNA FLJ13655 fis, clone PL   2.38E−04   3.67       442160   AI337127   Hs. 156325   ESTs   4.00E−06   3.67       448071   BE621584   Hs. 6983     Homo sapiens  cDNA: FLJ22646 fis, clone H   1.62E−04   3.65       425757   AA363171       gb: EST72986 Ovary II  Homo sapiens  cDNA 5   1.13E−03   3.65       431560   BE244135   Hs. 260238   hypothetical protein FLJ10842   5.19E−03   3.65       444969   AI203334   Hs. 160628   ESTs   7.93E−03   3.65       443562   AF118838   Hs. 9599   solute carrier family 25, member 13 (cit   2.04E−02   3.64       435511   AA683336   Hs. 189046   ESTs   1.89E−02   3.64       436503   AJ277750   Hs. 183924   ubiquitin associated and SH3 domain cont   5.67E−03   3.63       417148   AA359896   Hs. 293885   hypothetical protein FLJ14902   6.31E−02   3.63       421114   AW975051   Hs. 293156   ESTs, Weakly similar to 178885 serine/th   2.73E−02   3.63       443373   AI792868   Hs. 135365   ESTs   1.06E−02   3.63       449720   AA311152   Hs. 288708   hypothetical protein FLJ21562   3.99E−05   3.63       451938   AI354355   Hs. 16697   down-regulator of transcription 1, TBP-b   1.38E−03   3.63       457231   AI472022   Hs. 301959   proline synthetase co-transcribed (bacte   1.02E−02   3.63       425332   AA633306   Hs. 127279   ESTs   9.28E−04   3.61       436860   H12751   Hs. 5327   PRO1914 protein   4.08E−04   3.60       400281           Eos Control   2.96E−05   3.60       407946   AA226495   Hs. 154292   ESTs   5.83E−04   3.60       418699   BE539639   Hs. 173030   ESTs, Weakly similar to ALU8_HUMAN ALU S   1.10E−02   3.60       422303   AW410382   Hs. 27556   hypothetical protein FLJ22405   6.32E−02   3.60       425345   AU077297   Hs. 155894   protein tyrosine phosphatase, non-recept   6.44E−03   3.60       425692   D90041   Hs. 155956   N-acetyltransferase 1 (arylamine N-acety   7.67E−05   3.60       428250   AW809208   Hs. 183297   DKFZP566F2124 protein   1.13E−03   3.60       443968   AA287702   Hs. 10031   KIAA0955 protein   1.51E−02   3.60       447433   AA651869   Hs. 5320   hypothetical protein   1.44E−02   3.60       456760   AW961251   Hs. 127828   guanine nucleotide binding protein (G pr   1.31E−03   3.60       430293   AI416988   Hs. 238272   inositol 1,4,5-triphosphate receptor, ty   2.14E−04   3.59       427051   BE178110   Hs. 173374     Homo sapiens  cDNA FLJ10500 fis, clone NT   3.49E−02   3.58       408438   AB011180   Hs. 100960   KIAA0608 protein   6.17E−03   3.57       413645   AA130992       gb: zo15e02.s1 Stratagene colon (937204)   1.63E−02   3.57       424881   AL119690   Hs. 153618   HCGVIII-1 protein   6.17E−03   3.57       427471   AA403131   Hs. 266782   KIAA1826 protein   4.37E−03   3.57       430024   AI808780   Hs. 227730   integrin, alpha 6   2.02E−04   3.57       447941   AW181928   Hs. 249946   ESTs   9.64E−02   3.57       418822   Z43371   Hs. 7012   ESTs   1.19E−03   3.56       409342   AU077058   Hs. 54089   BRCA1 associated RING domain 1   6.72E−03   3.55       410054   AL120050   Hs. 58220     Homo sapiens  cDNA: FLJ23005 fis, clone L   8.27E−03   3.55       419440   AB020689   Hs. 90419   KIAA0882 protein   7.61E−04   3.55       423886   AA332098       gb: EST36256 Embryo, 8 week I Homo sapien   2.21E−03   3.55       437133   AB018319   Hs. 5460   KIAA0776 protein   4.14E−02   3.55       445718   H79791   Hs. 15227   ESTs   2.78E−05   3.55       408731   R85652         Homo sapiens  mRNA; cDNA DKFZp434F1928 (f   1.29E−04   3.55       409038   T97490   Hs. 50002   small inducible cytokine subfamily A (Cy   7.24E−04   3.53       403809           NM_024743*:  Homo sapiens  hypothetical pro   3.37E−02   3.52       417301   AI478158   Hs. 164478   hypothetical protein FLJ21939 similar to   2.55E−03   3.52       421684   BE281591   Hs. 106768   hypothetical protein FLJ10511   4.14E−02   3.52       432834   F06459   Hs. 289113   cytochrome b5 reductase 1 (B5R.1)   1.69E−02   3.52       439763   AA845366   Hs. 184075   ESTs, Weakly similar to ALU1_HUMAN ALU S   4.36E−03   3.52       445240   AI217385   Hs. 147574   ESTs   2.45E−02   3.52       444545   AW995346   Hs. 146910   ESTs   2.63E−02   3.52       420789   AI670057   Hs. 199882   ESTs   4.73E−02   3.52       421662   NM_014141   Hs. 106552   cell recognition molecule Caspr2   6.19E−04   3.51       426181   AA371422   Hs. 334371   hypothetical protein MGC13096   1.59E−03   3.51       421951   BE327432   Hs. 109804   H1 histone family, member X   1.83E−03   3.50       426780   BE242284   Hs. 172199   adenylate cyclase 7   1.67E−03   3.50       429301   AA449416   Hs. 31395   ESTs   4.76E−03   3.50       430750   AI650360   Hs. 100256   ESTs   5.89E−03   3.50       443126   AI033503       gb: ox06d11.s1 Soares_fetal_liver_spleen —     1.39E−02   3.50       450253   AL133047   Hs. 24715     Homo sapiens  mRNA; cDNA DKFZp434D0215 (f   2.79E−03   3.50       442739   NM_007274   Hs. 8679   cytosolic acyl coenzyme A thioester hydr   1.31E−03   3.49       430478   NM_014349   Hs. 241535   apolipoprotein L, 3   1.74E−07   3.49       408784   AW971350   Hs. 63386   ESTs   1.90E−05   3.47       417562   AW888754   Hs. 134126   crystallin, gamma S   2.92E−03   3.47       437664   AW977714   Hs. 211610   ESTs, Moderately similar to ALU1_HUMAN A   3.35E−03   3.47       448219   AA228092       KIAA1681 protein   1.29E−02   3.47       403671           C4001270*: gi|7509005|pir||T26190 hypothe   8.28E−03   3.47       427008   Z45258   Hs. 286013   short coiled-coil protein   1.37E−04   3.46       409005   AW299806   Hs. 297256   ESTs   2.67E−03   3.46       446162   AI631319   Hs. 63841   hypothetical protein DKFZp434E2318   1.19E−02   3.45       453686   AL110326   Hs. 304679   ESTs, Moderately similar to Z195_HUMAN Z   3.66E−04   3.45       441297   AW403084   Hs. 7766   ubiquitin-conjugating enzyme E2E 1 (homo   8.85E−04   3.44       430457   AI436216   Hs. 191715   ESTs, Weakly similar to ZN91_HUMAN ZINC   3.66E−03   3.43       413392   AW021404   Hs. 13021   ESTs   1.29E−02   3.42       416980   AA381133   Hs. 80684   high-mobility group (nonhistone chromoso   1.45E−02   3.42       417244   T57053   Hs. 10136   ESTs   4.18E−03   3.42       422343   AI628633   Hs. 346823   gb: ty77d05.x1 NCI_CGAP_Kid11 Homo sapien   1.06E−02   3.42       426494   AL119528   Hs. 170098   KIAA0372 gene product   1.44E−02   3.42       427722   AK000123   Hs. 180479   hypothetical protein FLJ20116   4.28E−02   3.42       441466   AW673081   Hs. 54828   ESTs   1.14E−02   3.42       450850   AA648886   Hs. 151999   ESTs   9.18E−05   3.42       418259   AA215404       ESTs   3.54E−05   3.40       423032   AI684746   Hs. 119274   RAS p21 protein activator (GTPase activa   1.25E−03   3.40       452167   N75238   Hs. 13075     Homo sapiens  cDNA: FLJ23013 fis, clone L   4.18E−03   3.40       415023   AA932146         Homo sapiens  clone TCCCIA00164 mRNA sequ   6.18E−04   3.40       424088   AL049942   Hs. 139240   DKFZP564F1422 protein   8.79E−04   3.40       419438   AA406400   Hs. 12482   glyceronephosphate O-acyltransferase   7.62E−03   3.39       441077   AI241273   Hs. 15312   ESTs   3.07E−06   3.38       420664   AI681270   Hs. 99824   BCE-1 protein   4.09E−04   3.38       426979   AF161472   Hs. 173074   DKFZP564O1863 protein   7.37E−02   3.38       437410   AW023340   Hs. 14880   ESTs   4.36E−03   3.38       444430   AI611153   Hs. 6093     Homo sapiens  cDNA: FLJ22783 fis, clone K   4.89E−02   3.38       417678   X06560   Hs. 82396   2′,5′-oligoadenylate synthetase 1 (40-46   4.94E−07   3.37       410243   D83402   Hs. 302085   prostaglandin I2 (prostacyclin) synthase   4.88E−02   3.35       412634   U55984       heat shock 90 kD protein 1, alpha   2.51E−04   3.35       419970   AW612022       ESTs   8.62E−03   3.35       439717   W94472   Hs. 59529   ESTs, Moderately similar to ALU1_HUMAN A   1.29E−02   3.35       444013   T08531   Hs. 44404     Homo sapiens  PRO1488 mRNA, complete cds   5.91E−03   3.35       444454   BE018316   Hs. 11183   sorting nexin 2   1.37E−04   3.35       439776   AL360140   Hs. 176005     Homo sapiens  mRNA full length insert cDN   4.36E−03   3.34       408989   AW361666   Hs. 49500   KIAA0746 protein   3.99E−05   3.34       452187   AA400200   Hs. 19131   transcription factor Dp-2 (E2F dimerizat   7.94E−03   3.33       457701   AW855466   Hs. 271866   ESTs, Weakly similar to ALU1_HUMAN ALU S   7.23E−04   3.33       418318   U47732   Hs. 84072   transmembrane 4 superfamily member 3   4.54E−04   3.33       438922   R71288   Hs. 259664   ESTs   6.44E−03   3.33       430008   AW085625   Hs. 186838   ESTs, Weakly similar to Z295_HUMAN ZINC   1.06E−02   3.33       438543   AA810141   Hs. 192182   ESTs   2.16E−05   3.32       447188   H65423   Hs. 17631   hypothetical protein DKFZp434E2135   1.29E−02   3.32       454064   AI130731   Hs. 57967   ESTs   1.10E−02   3.32       433198   AA992841   Hs. 27263   KIAA1458 protein   3.04E−02   3.32       402041           C15001201*: gi|6841178|gb|AAF28942.1|AF16   3.19E−03   3.31       441028   AI333660   Hs. 17558     Homo sapiens  cDNA FLJ14446 fis, clone HE   9.30E−04   3.31       433483   AI926520   Hs. 31016   putative DNA binding protein   1.45E−02   3.31       419126   AI810144   Hs. 135276   ESTs   6.17E−03   3.30       417052   NM_000712   Hs. 81029   biliverdin reductase A   1.91E−05   3.30       433907   AW296107   Hs. 152686   ESTs   4.37E−03   3.29       433364   AI075407   Hs. 296083   ESTs, Moderately similar to I54374 gene   1.75E−07   3.29       449188   AW072939   Hs. 347187   myotubularin related protein 1   8.61E−05   3.29       442831   AI798959   Hs. 131686   ESTs   2.81E−04   3.28       420985   X94703       RAB28, member RAS oncogene family   1.02E−03   3.28       446111   W56338   Hs. 13880   CGI-143 protein   1.24E−02   3.28       456984   AB002349       Ral guanine nucleotide exchange factor R   6.43E−03   3.28       418945   BE246762   Hs. 89499   arachidonate 5-lipoxygenase   3.66E−04   3.27       427675   AW138190   Hs. 180248   zinc finger protein 124 (HZF-16)   6.43E−05   3.27       444030   AW021254   Hs. 135055   ESTs   1.75E−02   3.27       423828   AA331536       gb: EST35377 Embryo, 8 week I Homo sapien   4.17E−03   3.26       426030   BE243933   Hs. 108642   zinc finger protein 22 (KOX 15)   5.21E−02   3.26       411777   BE067552       gb: MR4-BT0358-020200-002-g10 BT0358 Homo   1.59E−03   3.26       413568   AA130381   Hs. 180257   ESTs   2.16E−05   3.25       421828   AW891965       histone deacetylase 3   1.01E−02   3.25       439389   AA318940   Hs. 56004   ESTs   4.72E−02   3.25       442297   NM_006202   Hs. 89901   phosphodiesterase 4A, cAMP-specific (dun   3.50E−03   3.25       451099   R52795   Hs. 25954   interleukin 13 receptor, alpha 2   1.76E−02   3.25       424915   R42755   Hs. 23096   ESTs   2.92E−03   3.24       452279   AA286844       hypothetical protein FLJ13164   9.93E−02   3.24       418791   AA935633   Hs. 194628   ESTs   5.92E−03   3.24       453822   NM_014116   Hs. 35416   PRO0132 protein   7.15E−02   3.24       456119   AA161411   Hs. 58668   chromosome 21 open reading frame 57   1.44E−03   3.23       439708   AI761369   Hs. 59584   hypothetical protein FLJ21144   1.03E−04   3.23       400189           Eos Control   1.34E−02   3.22       430929   AA489166   Hs. 156933   ESTs   4.54E−04   3.22       453128   AW026516   Hs. 31791   acylphosphatase 2, muscle type   350E−03   3.22       413129   AF292100   Hs. 104613   RP42 homolog   3.67E−04   3.22       435126   AI393666   Hs. 42315   p10-binding protein   5.04E−02   3.22       417831   H16423   Hs. 82685   CD47 antigen (Rh-related antigen, integr   9.76E−04   3.21       449209   BE616830   Hs. 294145   ESTs   3.05E−03   3.20       414821   M63835   Hs. 77424   Fc fragment of IgG, high affinity la, re   3.03E−02   3.20       442961   BE614474       F-box only protein 22   5.10E−05   3.20       436854   AA749167   Hs. 173911   ESTs   2.04E−02   3.20       450222   U75308   Hs. 24644   TATA box binding protein (TBP)-associate   2.32E−03   3.20       426312   AF026939   Hs. 181874   interferon-induced protein with tetratri   3.66E−07   3.18       418757   AI864193   Hs. 169728   hypothetical protein FLJ13150   4.99E−03   3.18       422150   AI867118       calpastatin   2.83E−02   3.18       403478           NM_022342:  Homo sapiens  kinesin protein 9   6.11E−02   3.17       414650   AA150435   Hs. 8248   ESTs   5.04E−02   3.17       431188   W05656   Hs. 169755   ESTs   1.19E−02   3.17       436262   AA707425       gb: ag83f05.r1 Stratagene hNT neuron (937   6.44E−03   3.17       439680   AW245741   Hs. 58461   ESTs, Weakly similar to A35659 krueppel-   3.50E−03   3.17       447371   AA334274   Hs. 18368   DKFZP564B0769 protein   1.51E−02   3.17       448914   AI927656   Hs. 196459   ESTs   9.91E−02   3.17       448481   W15284   Hs. 74832   ESTs   3.35E−03   3.17       414449   AA557660   Hs. 76152   decorin   3.49E−02   3.15       418721   NM_002731   Hs. 87773   protein kinase, cAMP-dependent, catalyti   1.71E−04   3.15       407821   AA346172   Hs. 195614   ESTs   2.65E−04   3.15       410390   AA876905   Hs. 125286   ESTs   6.72E−03   3.15       412977   AA125910   Hs. 191461   ESTs   6.51E−04   3.15       426506   AW935187   Hs. 170162   KIAA1357 protein   2.81E−04   3.15       436169   AA888311   Hs. 17602     Homo sapiens  cDNA FLJ 12381 fis, clone MA   7.20E−04   3.15       441879   AI521936   Hs. 107149   novel protein similar to archaeal, yeast   1.29E−04   3.15       444342   NM_014398   Hs. 10887   similar to lysosome-associated membrane   3.41E−07   3.15       448919   AI590605   Hs. 191036   ESTs   3.04E−03   3.15       408683   R58665   Hs. 46847   TRAF and TNF receptor-associated protein   2.03E−06   3.15       436535   AW295687   Hs. 254420   ESTs   1.29E−04   3.14       411060   NM_006074   Hs. 318501     Homo sapiens  mRNA full length insert cDN   2.74E−07   3.14       419195   AW291165   Hs. 25447   ESTs   4.57E−03   3.14       434821   AA159111   Hs. 284281   Human putative ribosomal protein S1 mRNA   1.36E−04   3.14       450056   BE047394   Hs. 8208   ESTs, Weakly similar to S71512 hypotheti   2.66E−04   3.13       429286   AA449239   Hs. 154855   ESTs   1.13E−03   3.13       418027   AB037807   Hs. 83293   hypothetical protein   6.08E−05   3.13       450374   AA397540   Hs. 60293     Homo sapiens  clone 122482 unknown mRNA   5.05E−02   3.13       426381   T61692   Hs. 269340   ESTs   7.37E−02   3.12       413838   AV661185   Hs. 75574   mitochondrial ribosomal protein L19   2.43E−03   3.12       408931   AA251995   Hs. 334648   poly(A) polymerase alpha   4.97E−03   3.12       430532   D61216   Hs. 18672   ESTs   4.77E−03   3.12       446177   AK001902   Hs. 14202   hypothetical protein FLJ11040   1.80E−04   3.11       407436   AF211977       gb:  Homo sapiens  LENG10 mRNA, partial seq   1.63E−02   3.11       418733   AA227714       KIAA0129 gene product   2.03E−06   3.11       403027           C21000364*: gi|8394509|ref|NP_058778.1|u   8.80E−04   3.11       419257   X53461   Hs. 89781   upstream binding transcription factor, R   1.15E−04   3.11       410425   BE278367   Hs. 63510   KIAA0141 gene product   1.63E−02   3.10       426647   AA243464   Hs. 294101   pre-B-cell leukemia transcription factor   1.92E−03   3.10       434629   AA789081   Hs. 4029   glioma-amplified sequence-41   2.12E−03   3.10       418182   AW016405   Hs. 16648   ESTs   1.67E−03   3.09       449832   AA694264   Hs. 60049   ESTs   2.73E−02   3.09       407813   AL120247   Hs. 40109   KIAA0872 protein   2.26E−04   3.08       452664   AA398859   Hs. 18397   hypothetical protein FLJ23221   3.07E−06   3.08       410851   AW612147   Hs. 32058     Homo sapiens  C1orf19 mRNA, partial cds   2.79E−03   3.07       448362   AA641767   Hs. 21015   hypothetical protein DKFZp564L0864 simil   4.14E−02   3.07       449656   AA002008   Hs. 188633   ESTs   2.02E−03   3.07       416039   AA376989   Hs. 78989   alcohol dehydrogenase 5 (class III), chi   1.03E−03   3.07       418729   AB028449   Hs. 87889   helicase-moi   2.52E−04   3.07       431629   AU077025   Hs. 265827   interferon, alpha-inducible protein (clo   2.74E−07   3.06       437151   AA745618       BANP homolog, SMAR1 homolog   5.93E−02   3.06       414948   C15240   Hs. 182155   ESTs   8.63E−05   3.05       419465   AW500239   Hs. 21187     Homo sapiens  cDNA: FLJ23068 fis, clone L   2.63E−02   3.05       432680   T47364   Hs. 278613   interferon, alpha-inducible protein 27   1.75E−07   3.05       418627   AL079835   Hs. 86858   ribosomal protein S6 kinase, 70 kD, polyp   1.02E−03   3.04       408753   AI337192   Hs. 47438   SH3 domain binding glutamic acid-rich pr   1.75E−02   3.04       421654   AW163267   Hs. 106469   suppressor of var1 ( S. cerevisiae ) 3-like   6.12E−02   3.03       421272   AA704157       ESTs   7.22E−04   3.03       420174   AI824144   Hs. 199749   ESTs   4.79E−05   3.03       439024   R96696   Hs. 35598   ESTs   3.61E−02   3.03       407705   AB023139   Hs. 37892   KIAA0922 protein   4.29E−04   3.02       409977   AW805510   Hs. 97056   hypothetical protein FLJ21634   5.58E−04   3.02       411960   R77776   Hs. 18103   ESTs   1.05E−02   3.02       437086   AW291411   Hs. 192531   ESTs, Weakly similar to S00754 zinc fing   5.20E−03   3.02       442071   BE048433   Hs. 276043   ESTs   2.02E−03   3.02       448030   N30714   Hs. 325960   membrane-spanning 4-domains, subfamily A   4.87E−02   3.02       430068   AA464964       gb: zx80f10.s1 Soares ovary tumor NbHOT H   9.30E−04   3.02       436090   AI640635   Hs. 332879   EST   2.04E−02   3.01       408047   AW205461   Hs. 243612   ESTs   1.81E−04   3.00       412288   NM_003005   Hs. 73800   selectin P (granule membrane protein 140   5.91E−03   3.00       432474   AA584042       gb: nn65e09.s1 NCI_CGAP_Lar1  Homo sapiens     6.72E−02   3.00       446851   AW007332         Homo sapiens  cDNA: FLJ22063 fis, clone H   2.43E−03   3.00       451171   AA248829   Hs. 112921   gb: jj6059.seq.F Human fetal heart, Lambd   7.98E−04   3.00       452429   AK000149   Hs. 29493   hypothetical protein FLJ20142   8.96E−03   3.00       413278   BE563085   Hs. 833   interferon-stimulated protein, 15 kDa   1.75E−07   2.98       426221   AB007881       KIAA0421 protein   2.55E−03   2.98       411190   AA306342   Hs. 69171   protein kinase C-like 2   3.87E−02   2.97       444437   AI377961   Hs. 44041   ESTs   8.62E−03   2.97       451572   AA018556   Hs. 268691   ESTs, Moderately similar to ALU2_HUMAN A   1.09E−04   2.97       452420   BE564871   Hs. 29463   centrin, EF-hand protein, 3 (CDC31 yeast   6.84E−05   2.97       412675   AA460716   Hs. 9788   hypothetical protein MGC10924 similar to   2.04E−02   2.97       446215   AW821329   Hs. 14368   SH3 domain binding glutamic acid-rich pr   6.45E−03   2.96       442287   AW952703   Hs. 8182   synaptic nuclei expressed gene 1b   1.67E−03   2.96       439658   AA332057   Hs. 6639   hypothetical protein MGC15440   5.03E−04   2.96       400471           Target Exon   6.12E−02   2.95       431266   AW149321   Hs. 105411   ESTs   2.12E−03   2.95       404433           C8000067*: gi|10432400|emb|CAC10290.1|(A   1.75E−02   2.95       435852   H72303   Hs. 36011   ESTs   4.18E−03   2.95       437275   AW976035   Hs. 292396   ESTs, Weakly similar to A47582 B-cell gr   4.18E−03   2.95       439601   AB029032   Hs. 6606   KIAA1109 protein   1.50E−02   2.95       458455   AV648310   Hs. 213488   ESTs   8.62E−03   2.95       411943   BE502436   Hs. 7962   ESTs, Weakly similar to S44608 C02F5.6 p   7.94E−03   2.95       421718   AL117574   Hs. 193602     Homo sapiens  mRNA; cDNA DKFZp434L2221 (f   1.71E−04   2.94       450256   AA286887   Hs. 24724   MFH-amplified sequences with leucine-ric   7.26E−05   2.94       401898           NM_024722*:  Homo sapiens  hypothetical pro   4.00E−03   2.94       458368   BE504731   Hs. 138827   ESTs   2.92E−03   2.94       456563   AA989220   Hs. 766   ESTs   1.51E−02   2.93       402836           ENSP00000251163*: Membrane-associated gua   3.86E−02   2.92       409444   H47933   Hs. 33983   ESTs, Weakly similar to ALU6_HUMAN ALU S   1.08E−04   2.92       418522   AA605038   Hs. 7149     Homo sapiens  cDNA: FLJ21950 fis, clone H   4.30E−04   2.92       423129   L44396   Hs. 124106     Homo sapiens  cDNA FLJ11941 fis, clone HE   4.77E−03   2.92       426279   AI648520   Hs. 169084   tubby like protein 3   1.75E−02   2.92       441969   AI733386       ESTs, Weakly similar to ALU1_HUMAN ALU S   7.20E−04   2.92       446552   AW470827   Hs. 156241   ESTs   2.02E−04   2.92       451644   N23235   Hs. 30567   ESTs, Weakly similar to B34087 hypotheti   2.25E−04   2.92       403330           Target Exon   7.23E−04   2.92       414617   AI339520   Hs. 288817   ESTs, Moderately similar to N Chain N, M   3.77E−05   2.92       459436   AA323121       gb: EST25881 Cerebellum II  Homo sapiens  c   6.52E−04   2.91       420181   AI380089   Hs. 158951   ESTs   7.30E−03   2.91       447002   BE242866   Hs. 16933   HepA-related protein   2.49E−06   2.91       408212   AA297567   Hs. 43728   hypothetical protein   1.19E−03   2.91       417008   AA191708   Hs. 325825     Homo sapiens  cDNA FLJ20848 fis, clone AD   1.52E−03   2.90       434263   N34895   Hs. 79187   ESTs   7.62E−03   2.90       403743           C1002604: gi|8393668|ref|NP 058989.1|kin   7.94E−03   2.90       414429   R51494   Hs. 71818   ESTs   9.10E−02   2.90       420265   AA766209   Hs. 88087   ESTs   2.93E−02   2.90       420683   AA830168   Hs. 271305   ESTs   1.06E−02   2.90       426590   AA617830   Hs. 28310   ESTs   2.02E−03   2.90       428738   NM_000380   Hs. 192803   xeroderma pigmentosum, complementation g   1.25E−03   2.90       437108   AA434054   Hs. 80624   hypothetical protein MGC2560   1.75E−02   2.90       451078   AI927694   Hs. 340945   ESTs   8.83E−02   2.90       442439   U09759   Hs. 246857   mitogen-activated protein kinase 9   7.24E−05   2.90       409939   AA463437   Hs. 11556     Homo sapiens  cDNA FLJ12566 fis, clone NT   2.52E−04   2.90       414493   AL133921   Hs. 76272   retinoblastoma-binding protein 2   1.58E−05   2.90       434045   AI065133   Hs. 152316   hypothetical protein PRO0971   9.77E−04   2.90       440668   AI989538   Hs. 191074   ESTs   2.22E−03   2.89       446217   AI651594   Hs. 99709   ESTs   4.26E−07   2.89       438914   N93892   Hs. 10727   ESTs   2.11E−02   2.89       443303   U67319   Hs. 9216   caspase 7, apoptosis-related cysteine pr   1.81E−04   2.89       418584   NM_004606   Hs. 1179   TATA box binding protein (TBP)-associate   3.66E−03   2.88       428695   AI355647   Hs. 189999   purinergic receptor (family A group 5)   4.24E−05   2.88       436372   AW972301   Hs. 310286   ESTs   1.03E−04   2.87       411360   AK001601   Hs. 69594   high-mobility group 20A   3.61E−02   2.87       437456   AL047045   Hs. 60293     Homo sapiens  clone 122482 unknown mRNA   2.55E−03   2.86       448198   BE622100   Hs. 209406   ESTs, Weakly similar to I38600 zinc fing   5.39E−05   2.86       428974   AA442693   Hs. 272006   ESTs, Weakly similar to I38022 hypotheti   3.33E−05   2.86       423568   NM_005256   Hs. 129818   growth arrest-specific 2   5.04E−04   2.85       418796   AA228351   Hs. 34060   ESTs   2.79E−04   2.85       406274           Target Exon   4.78E−04   2.85       427209   H06509   Hs. 92423   KIAA1566 protein   2.61E−05   2.85       430280   AA361258   Hs. 237868   interleukin 7 receptor   2.11E−03   2.85       440760   AK001145   Hs. 284216   hypothetical protein FLJ10283   3.19E−03   2.85       415914   AA306033   Hs. 78915   GA-binding protein transcription factor,   7.37E−02   2.85       448569   BE382657   Hs. 21486   signal transducer and activator of trans   1.75E−07   2.84       425284   AF155568       NS1-associated protein 1   1.59E−03   2.84       422614   AI908006   Hs. 295362     Homo sapiens  cDNA FLJ14459 fis, clone HE   6.44E−03   2.84       424755   AB033094   Hs. 152925   KIAA1268 protein   1.08E−06   2.83       411617   AA247994       neurocalcin delta   2.63E−02   2.83       452699   AW295390   Hs. 213062   ESTs   8.27E−03   2.83       401197           ENSP00000229263*: HSPC213.   4.72E−02   2.82       409205   AI952884   Hs. 14832   ESTs, Moderately similar to unnamed prot   1.06E−02   2.82       429503   AA394183   Hs. 204166   ESTs   3.50E−03   2.82       436114   AA778232   Hs. 19515   ESTs, Highly similar to NRG3_HUMAN PRO-N   8.26E−03   2.82       445564   AB028957   Hs. 12896   KIAA1034 protein   1.50E−02   2.82       443280   AA299688   Hs. 24183   ESTs   2.55E−03   2.82       410541   AA065003   Hs. 64179   syntenin-2 protein   2.55E−03   2.82       439653   AW021103   Hs. 6631   hypothetical protein FLJ20373   6.73E−03   2.82       446238   T95143   Hs. 14511   SCO (cytochrome oxidase deficient, yeast   3.13E−04   2.82       428418   AI368826   Hs. 8768   ESTs   6.46E−05   2.81       431392   AI371223   Hs. 288671     Homo sapiens  cDNA FLJ11997 fis, clone HE   6.18E−03   2.81       434519   AA635727   Hs. 136581   ESTs, Weakly similar to ARNO_HUMAN ARF N   2.32E−03   2.80       430027   AB023197   Hs. 227743   KIAA0980 protein   1.90E−06   2.80       425836   AW955696   Hs. 90960   ESTs   4.78E−05   2.80       428821   H91282   Hs. 286232     Homo sapiens  cDNA: FLJ23190 fis, clone L   8.62E−03   2.80       439773   AI051313   Hs. 143315   ESTs   5.41E−03   2.80       432485   N90866   Hs. 276770   CDW52 antigen (CAMPATH-1 antigen)   1.01E−06   2.80       456508   AA502764   Hs. 123469   ESTs, Weakly similar to AF208855 1 BM-01   4.98E−03   2.79       436235   AI084982   Hs. 120790   ESTs   8.15E−05   2.79       421446   AA682425   Hs. 118959   ESTs   1.34E−02   2.78       421524   AA312082   Hs. 105445   GDNF family receptor alpha 1   1.69E−05   2.77       421743   T35958   Hs. 107614   DKFZP564I1171 protein   3.48E−04   2.76       404676           Target Exon   7.31E−03   2.75       411352   NM_002890   Hs. 758   RAS p21 protein activator (GTPase activa   1.59E−03   2.75       424381   AA285249   Hs. 146329   protein kinase Chk2 (CHEK2)   2.54E−02   2.75       426416   AW612744   Hs. 169824   killer cell lectin-like receptor subfami   2.18E−02   2.75       432134   AI816782   Hs. 122583   hypothetical protein FLJ21934   1.84E−03   2.75       434521   NM_002267   Hs. 3886   karyopherin alpha 3 (importin alpha 4)   221E−03   2.75       434963   AW974957   Hs. 288719     Homo sapiens  cDNA FLJ12142 fis, clone MA   2.63E−02   2.75       436184   BE154067   Hs. 136660   ESTs, Weakly similar to ZN91_HUMAN ZINC   3.20E−03   2.75       439605   AF086431   Hs. 22380   ESTs   8.61E−05   2.75       449259   AW452058   Hs. 257519   ESTs   3.66E−04   2.75       452057   AW952005   Hs. 14928   hypothetical protein FLJ12903   3.83E−03   2.75       422231   AA443512   Hs. 101383   ESTs   1.84E−03   2.75       418941   AA452970   Hs. 239527   E1B-55 kDa-associated protein 5   5.56E−02   2.74       424637   NM_015057   Hs. 151411   KIAA0916 protein   8.30E−06   2.74       436741   AA860163   Hs. 291319   ESTs   2.79E−03   2.72       439462   AL133026   Hs. 6567     Homo sapiens  mRNA; cDNA DKF2p434C136 (fr   1.31E−03   2.72       414522   AW518944   Hs. 76325   Immunoglobulin J chain   2.12E−03   2.72       426125   X87241   Hs. 166994   FAT tumor suppressor (Drosophila) homolo   6.94E−02   2.72       427297   AW292593   Hs. 334907     Homo sapiens , clone MGC: 17333, mRNA, com   2.02E−04   2.72       423067   AA321355   Hs. 285401   colony stimulating factor 2 receptor, be   6.17E−03   2.72       444745   AF117754   Hs. 11861   thyroid hormone receptor-associated prot   9.77E−04   2.72       420962   NM_005904   Hs. 100602   MAD (mothers against decapentaplegic, Dr   1.68E−05   2.72       435427   AA682573   Hs. 188982   ESTs, Weakly similar to organic anion tr   1.67E−03   2.71       453779   N35187   Hs. 43388   28 kD interferon responsive protein   3.17E−07   2.71       439559   AW364675   Hs. 173921   ESTs, Weakly similar to 2109260A B cell   1.25E−03   2.71       451119   AA805417   Hs. 64753   ESTs   7.60E−03   2.70       420825   AI656727   Hs. 194657   gb: tt53f12.x1 NCI_CGAP_GC6  Homo sapiens     5.58E−04   2.70       440538   W76332   Hs. 79107   mitogen-activated protein kinase 14   1.45E−02   2.70       407796   AA195509   Hs. 39733   postsynaptic protein CRIPT   3.49E−03   2.70       401635           C11000702: gi|10048448|ref|NP_065258.1|g   1.24E−02   2.70       408051   AI623351   Hs. 172148   ESTs   3.04E−02   2.70       411213   AA676939   Hs. 69285   neuropilin 1   1.45E−02   2.70       412935   BE267045   Hs. 75064   tubulin-specific chaperone c   1.49E−05   2.70       416048   H16268       gb: ym22a06.r1 Soares infant brain 1NIB H   4.07E−04   2.70       445715   AB012958   Hs. 13137   UV radiation resistance associated gene   3.48E−04   2.70       437145   AF007216   Hs. 5462   solute carrier family 4, sodium bicarbon   1.29E−02   2.69       414404   W16712       KIAA0306 protein   3.99E−05   2.68       420058   AK001423   Hs. 94694     Homo sapiens  cDNA FLJ10561 fis, clone NT   1.91E−05   2.68       417558   AF045229   Hs. 82280   regulator of G-protein signalling 10   2.54E−02   2.68       420339   AW968259   Hs. 186647   ESTs   1.62E−04   2.68       419497   NM_006410   Hs. 90753   Tat-interacting protein (30 kD)   1.51E−03   2.67       426797   AW936258   Hs. 342849   ADP-ribosylation factor-like 5   8.07E−02   2.67       430594   AK000790   Hs. 246885   hypothetical protein FLJ20783   4.88E−02   2.67       433312   AI241331   Hs. 131765   ESTs, Moderately similar to I38937 DNA/R   7.59E−04   2.67       437838   AI307229       ESTs   1.19E−03   2.67       438182   AW342140   Hs. 182545   ESTs, Weakly similar to ALU1_HUMAN ALU S   7.69E−05   2.67       450468   AW379075   Hs. 141742     Homo sapiens  cDNA FLJ12211 fis, clone MA   5.67E−03   2.67       431315   AW972227   Hs. 163986     Homo sapiens  cDNA: FLJ22765 fis, clone K   2.81E−04   2.67       425548   AA890023   Hs. 1906   prolactin receptor   7.58E−04   2.67       434669   AF151534   Hs92023   core histone macroH2A2.2   6.01E−06   2.67       409600   AJ011679   Hs. 55099   rab6 GTPase activating protein (GAP and   1.08E−04   2.66       417928   AA209344   Hs. 30177   ESTs   1.81E−04   2.66       418832   X04011   Hs. 88974   cytochrome b-245, beta polypeptide (chro   2.52E−04   2.66       452696   AI826645   Hs. 211534   ESTs   2.45E−05   2.66       426126   AL118747   Hs. 26691   ESTs   6.18E−04   2.66       427528   AU077143   Hs. 179565   minichromosome maintenance deficient (S.   2.45E−05   2.65       434384   AA631910       ESTs   2.79E−03   2.65       440529   AW207640   Hs. 16478     Homo sapiens  cDNA: FLJ21718 fis, clone C   8.62E−03   2.65       446830   BE179030       Human DNA sequence from clone RP5-1174N9   6.85E−04   2.65       443405   AF031463   Hs. 9302   phosducin-like   2.65E−04   2.65       407807   AL031427   Hs. 40094   Human DNA sequence from clone 167A19 on   2.43E−03   2.65       421919   AJ224901   Hs. 109526   zinc finger protein 198   1.38E−03   2.64       429617   X89984   Hs. 211563   B-cell CLL/lymphoma 7A   3.65E−03   2.63       403976           Target Exon   2.43E−03   2.63       435631   BE254086   Hs. 29647   uncharacterized hematopoietic stem/proge   7.30E−03   2.63       447657   AI953011       ESTs   1.52E−03   2.63       412520   AA442324   Hs. 795   H2A histone family, member O   5.74E−05   2.62       417317   AW296584   Hs. 293782   ESTs   5.71E−05   2.62       450331   AA009536   Hs. 38323   ESTs   1.10E−02   2.61       438441   AW664960   Hs. 205319   ESTs   2.26E−04   2.61       413836   W92003   Hs. 70614   ESTs   1.24E−02   2.61       446006   NM_004403   Hs. 13530   deafness, autosomal dominant 5   1.45E−02   2.60       431214   AA294921   Hs. 348024   v-ral simian leukemia viral oncogene horn   1.39E−02   2.60       422283   AW411307   Hs. 114311   CDC45 (cell division cycle 45, S.cerevis   1.08E−04   2.60       425118   AU076611   Hs. 154672   methylene tetrahydrofolate dehydrogenase   9.36E−03   2.60       442432   BE093589   Hs. 38178   hypothetical protein FLJ23468   6.43E−05   2.60       452014   AI828174   Hs. 227049   ESTs   1.39E−02   2.60       408138   AA535740       tumor protein p53-binding protein, 1   1.75E−02   2.60       457819   AA057484   Hs. 35406   ESTs, Highly similar to unnamed protein   2.27E−02   2.60       451578   NM_016323   Hs. 26663   cyclin-E binding protein 1   1.16E−06   2.59       428330   L22524   Hs. 2256   matrix metalloproteinase 7 (matrilysin,   1.51E−02   2.59       444057   AA316896   Hs. 257267   FYVE and coiled-coil domain containing 1   2.26E−04   2.58       401928           Target Exon   7.00E−03   2.57       424375   AF070547   Hs. 146312     Homo sapiens  clone 24820 mRNA sequence   3.87E−02   2.57       445106   T10219   Hs. 12329   KIAA0697 protein   7.60E−04   2.57       447211   AL161961   Hs. 17767   KIAA1554 protein   3.68E−07   2.57       427704   AW971063   Hs. 292882   ESTs   7.84E−02   2.56       430399   AI916284   Hs. 199671   ESTs   5.58E−04   2.56       422461   NM_003417   Hs. 117077   zinc finger protein 264   1.30E−03   2.56       401952           Target Exon   1.05E−02   2.56       422392   NM_005908   Hs. 115945   mannosidase, beta A, lysosomal   7.14E−02   2.56       422722   H74219   Hs. 269772   ESTs   1.44E−03   2.56       414279   AW021691       GCN5 (general control of amino-acid synt   9.09E−02   2.55       446934   AK001943   Hs. 16577   F-box only protein 3   5.20E−03   2.55       434948   AI498469   Hs. 12622   ESTs, Highly similar to AF161436 1 HSPC3   2.73E−02   2.55       438865   H64256   Hs. 167619   ESTs, Moderately similar to ALUC_HUMAN!   8.08E−02   2.55       439372   AF088033   Hs. 159225   ESTs   3.25E−02   2.55       445757   AW449065   Hs. 13264   KIAA0856 protein   3.35E−03   2.55       409614   BE297412   Hs. 55189   hypothetical protein   2.74E−07   2.55       423932   T95633   Hs. 189703   ESTs   4.73E−02   2.55       451743   AW074266   Hs. 23071   ESTs   8.16E−05   2.54       416272   AA178882       gb: zp38b09.r1 Stratagene muscle 937209 H   1.29E−02   2.53       446161   AA628206   Hs. 14125   p53 regulated PA26 nuclear protein   1.45E−03   2.53       425303   AA354785       gb: EST63098 Jurkat T-cells V Homo sapien   2.04E−02   2.53       451253   H48299   Hs. 26126   claudin 10   1.38E−03   2.52       408340   AB037762   Hs. 44268   myelin gene expression factor 2   6.42E−05   2.52       410678   BE540516   Hs. 293732   hypothetical protein MGC3195   1.31E−03   2.52       414792   BE314949   Hs. 87128   hypothetical protein FLJ23309   4.23E−06   2.52       447387   AI268331   Hs. 102237   tubby super-family protein   3.51E−06   2.52       407765   AW076027   Hs. 257711   ESTs, Moderately similar to ALU8_HUMAN A   3.49E−02   2.51       421471   U90545   Hs. 327179   solute carrier family 17 (sodium phospha   2.19E−02   2.51       438980   AW502384       gb: UI-HF-BR0p-aka-f-12-0-UI.r1 NIH_MGC_5   1.39E−02   2.51       453906   AW444952   Hs. 257054   ESTs   3.83E−03   2.51       414760   BE298063   Hs. 77254   chromobox homolog 1 (Drosophila HP1 beta   8.78E−07   2.51       434822   AW076088   Hs. 4187   hypothetical protein 24636   2.38E−04   2.51       458079   AI796870   Hs. 54277   DNA segment on chromosome X (unique) 992   1.15E−05   2.50       408521   AA055264   Hs. 260848   ESTs, Weakly similar to S23650 retroviru   1.39E−05   2.50       409161   W07662   Hs. 50861   sirtuin (silent mating type information   5.39E−05   2.50       411931   AW675180   Hs. 36828   ESTs   2.28E−02   2.50       414172   AW954324   Hs. 75790   phosphatidylinositol glycan, class C   4.17E−03   2.50       414502   AL133721   Hs. 224680   ESTs   6.44E−03   2.50       420613   AI873871   Hs. 7041   ESTs, Weakly similar to A47582 B-cell gr   4.60E−06   2.50       422195   AB007903   Hs. 113082   KIAA0443 gene product   1.89E−02   2.50       423645   AI215632   Hs. 147487   ESTs   1.62E−04   2.50       427210   BE396283   Hs. 173987   eukaryotic translation initiation factor   1.96E−02   2.50       430273   AI311127   Hs. 125522   ESTs   1.25E−03   2.50       445664   AW968638   Hs. 237691   ESTs, Weakly similar to KIAA0601 protein   4.30E−04   2.50       437708   AB033020   Hs. 5801   KIAA1194 protein   8.63E−05   2.50       439748   AL389934   Hs. 23248   hypothetical protein from EUROIMAGE 2005   6.71E−03   2.50       435727   T78475   Hs. 269542   ESTs, Weakly similar to S65657 alpha-1C-   1.19E−02   2.49       414602   AW630088   Hs. 76550     Homo sapiens  mRNA; cDNA DKFZp564B1264 (f   7.23E−04   2.49       451693   BE220445   Hs. 279635   ESTs   1.29E−02   2.49       443849   BE566066   Hs. 9893   ASB-3 protein   2.79E−03   2.48       421405   AA251944   Hs. 104058   CGI-29 protein   7.60E−04   2.48       446591   H44186   Hs. 15456   PDZ domain containing 1   2.68E−06   2.48       432348   AA534353   Hs. 194081   ESTs, Weakly similar to I38022 hypotheti   4.76E−03   2.48       415323   BE269352   Hs. 949   neutrophil cytosolic factor 2 (65 kD, chr   2.73E−02   2.48       416436   H55746   Hs. 28704   ESTs, Weakly similar to A45910 ultra-hig   2.20E−02   2.48       446044   H67567   Hs. 13572   calcium modulating ligand   2.03E−06   2.48       446771   AA128965   Hs. 60679   TATA box binding protein (TBP)-associate   7.27E−05   2.48       407112   AA070801   Hs. 51615   ESTs, Weakly similar to ALU7_HUMAN ALU S   7.60E−02   2.47       410196   AI936442   Hs. 59838   hypothetical protein FLJ10808   3.30E−04   2.47       427254   AL121523   Hs. 97774   ESTs   9.75E−03   2.47       430487   D87742   Hs. 241552   KIAA0268 protein   7.98E−04   2.47       452480   AI903526       gb: RC-BT031-090199-063 BT031 Homo sapien   1.51E−02   2.47       422473   U94780   Hs. 117242   meningioma expressed antigen 6 (coiled-c   7.00E−03   2.47       405117           C11000181*: gi|7305349|ref|NP_038647.1|o   1.37E−03   2.47       449082   BE387561   Hs. 22981   DKFZP586M1523 protein   6.16E−04   2.47       439815   AA206079   Hs. 6693   hypothetical protein FLJ20420   2.02E−04   2.47       408145   AF182316   Hs. 234680   fer-1 ( C. elegans )-like 3 (myofertin)   5.38E−02   2.47       448122   AW665656   Hs. 173187   ESTs   5.92E−02   2.47       414895   AW894856   Hs. 116278     Homo sapiens  cDNA FLJ13571 fis, clone PL   3.82E−03   2.46       439747   AK001148   Hs. 6671   COP9 complex subunit 4   6.85E−04   2.46       440706   AA927562   Hs. 148234   ESTs   2.79E−03   2.46       400557           Target Exon   3.14E−02   2.46       456721   AA533356       gb: nj67f10.s1 NCI_CGAP_Pr10  Homo sapiens     4.00E−03   2.45       416354   NM_000633   Hs. 79241   B-cell CLL/lymphoma 2 (BCL2)   5.04E−04   2.45       418203   X54942   Hs. 83758   CDC28 protein kinase 2   4.57E−03   2.45       423983   AA333261       gb: EST37476 Embryo, 8 week 1 Homo sapien   1.10E−02   2.45       434128   W93170   Hs. 284164   protein x 0004   1.62E−04   2.45       438141   AW946871       gb: RC2-ET0022-080500-012-d02 ET0022 Homo   3.34E−03   2.45       449239   T24653   Hs. 23360   likely ortholog of yeast ARV1   3.06E−06   2.45       422241   Y00062   Hs. 170121   protein tyrosine phosphatase, receptor t   1.49E−05   2.45       414462   BE622743   Hs. 301064   arfaptin 1   5.44E−03   2.44       423706   U95218   Hs. 131924   G protein-coupled receptor 65   2.55E−03   2.44       431661   AB037830   Hs. 267150   KIAA1409 protein   1.71E−04   2.44       413856   D13639   Hs. 75586   cyclin D2   4.57E−03   2.44       422684   BE561617   Hs. 119192   H2A histone family, member Z   6.72E−03   2.44       420623   BE245485   Hs. 99437     Homo sapiens  mRNA; cDNA DKFZp586G1924 (f   6.45E−03   2.43       417377   NM_016603   Hs. 82035   potential nuclear protein C5ORF5; GAP-li   1.79E−05   2.43       409884   AI904455   Hs. 142684   hypothetical protein DKFZp667O116   1.59E−03   2.43       452748   AB011128   Hs. 30512     Homo sapiens  mRNA for KIAA0556 protein,   1.31E−03   2.43       434500   AF143877   Hs. 215047     Homo sapiens  clone IMAGE: 113431 mRNA seq   3.49E−02   2.43       436021   R26877   Hs. 24128   ESTs   3.25E−02   2.42       442149   AB014550   Hs. 8118   KIAA0650 protein   3.50E−03   2.42       408411   C15118   Hs. 322482   hypothetical protein DKFZp566J2046   9.48E−06   2.42       407656   AW747986   Hs. 37443     Homo sapiens  mRNA; cDNA DKFZp434B2119 (f   4.08E−04   2.42       430587   AK000341   Hs. 246107   elongation of very long chain fatty acid   4.52E−05   2.41       412019   AA485890   Hs. 69330     Homo sapiens  cDNA FLJ13835 fis, clone TH   1.81E−04   2.41       457650   AA649162   Hs. 236456   ESTs   4.25E−05   2.41       458971   AL119206   Hs. 101874   ESTs, Weakly similar to ALU1_HUMAN ALU S   2.28E−02   2.41       433902   AW292820   Hs. 144906   ESTs   5.91E−03   2.41       439645   BE091801   Hs. 27167   ESTs, Weakly similar to I38022 hypotheti   1.77E−06   2.41       430007   NM_014892   Hs. 227602   KIAA1116 protein   2.32E−03   2.41       427547   BE047653   Hs. 119183   ESTs, Weakly similar to ZN91_HUMAN ZINC   3.49E−03   2.41       448749   AW859679   Hs. 21902     Homo sapiens  clone 25237 mRNA sequence   1.84E−03   2.40       444913   AI362726   Hs. 193656     Homo sapiens  mRNA for KIAA1658 protein,   5.39E−05   2.40       428466   AF151063   Hs. 184456   hypothetical protein   4.00E−03   2.40       408636   BE294925   Hs. 46680   CGI-12 protein   3.06E−03   2.40       416517   AA775987   Hs. 79357   proteasome (prosome, macropain) 26S subu   1.06E−02   2.40       438041   AI394551       ESTs   4.56E−02   2.40       444088   AW297946   Hs. 138208   ESTs   2.54E−02   2.40       449118   R67477   Hs. 23103   Bet1 ( S. cerevisiae ) homolog   2.93E−02   2.40       452253   AA928891   Hs. 28608     Homo sapiens  cDNA: FLJ22115 fis. clone H   1.18E−03   2.40       435872   AA701357   Hs. 192759   ESTs   1.59E−03   2.40       409132   AJ224538   Hs. 50732   protein kinase, AMP-activated, beta 2 no   1.25E−06   2.40       414256   AW410035   Hs. 75862   MAD (mothers against decapentaplegic, Dr   2.93E−02   2.39       459680   H96982   Hs. 42321   ESTs   2.14E−04   2.39       427657   AV652249   Hs. 180107   polymerase (DNA directed), beta   7.07E−07   2.39       446570   AV659177   Hs. 127160   ESTs   2.31E−05   2.38       415668   AW957684   Hs. 306814   hypothetical protein FLJ21889   4.57E−02   2.38       428985   AL134193   Hs. 194709   paraneoplastic antigen MA1   4.00E−03   2.38       438030   X98427   Hs. 122634   ESTs   2.33E−03   2.38       457605   AV657778   Hs. 3314   selenoprotein P, plasma, 1   2.32E−03   2.38       422043   AL133649   Hs. 110953   retinoic acid induced 1   1.31E−03   2.38       425375   AA631977   Hs. 155995   KIAA0643 protein   2.44E−05   2.38       427020   AA397546   Hs. 119151   ESTs   1.01E−02   2.38       440341   AW664012   Hs. 132333   ESTs   1.93E−03   2.38       424321   W74048   Hs. 1765   lymphocyte-specific protein tyrosine kin   2.38E−04   2.37       416611   AA568308       ESTs, Weakly similar to ALU6_HUMAN ALU S   2.67E−03   2.37       416065   BE267931   Hs. 78996   proliferating cell nuclear antigen   6.21E−04   2.37       419424   BE041820   Hs. 38516     Homo sapiens , clone MGC: 15887, mRNA, com   4.30E−04   2.36       452207   NM_014517   Hs. 28423   upstream binding protein 1 (LBP-1a)   5.71E−05   2.36       414496   W73853       ESTs   1.92E−03   2.36       451107   AA235108   Hs. 17639     Homo sapiens  ubiquitin protein ligase (U   7.59E−04   2.35       452685   AI634651   Hs. 30250   v-maf musculoaponeurotic fibrosarcoma (a   6.41E−06   2.35       411196   W31212   Hs. 69192   vacuolar protein sorting 29 (yeast homol   2.45E−02   2.35       427647   W19744   Hs. 180059     Homo sapiens  cDNA FLJ20653 fis, clone KA   1.62E−04   2.35       422607   Z45471   Hs. 118684   stromal cell-derived factor 2   4.30E−04   2.35       427469   AA403084   Hs. 269347   ESTs, Weakly similar to 2109260A B cell   9.74E−03   2.35       429065   AI753247   Hs. 29643     Homo sapiens  cDNA FLJ13103 fis, clone NT   1.06E−02   2.35       439103   AF085959   Hs. 38705   ESTs   2.43E−03   2.35       427094   AB025254   Hs. 283761   tudor repeat associated with PCTAIRE 2   7.02E−07   2.35       451789   AW291532   Hs. 211297   ESTs   3.20E−03   2.35       414436   U50078   Hs. 76127   hect (homologous to the E6-AP (UBE3A) ca   5.43E−03   2.35       446487   AA195526   Hs. 44625   Rad50-interacting protein 1   2.79E−03   2.34       411580   AL080088   Hs. 70877   DKFZP564K2062 protein   1.80E−04   2.34       413880   AI660842   Hs. 110915   interleukin 22 receptor   5.87E−04   2.33       431899   AA521381   Hs. 187726   ESTs   1.06E−02   2.33       450607   AL050373   Hs. 25213   hypothetical protein   2.30E−05   2.33       440726   AL050333   Hs. 306425   DKFZP564B116 protein   4.14E−02   2.33       417089   H52280   Hs. 18612     Homo sapiens  cDNA: FLJ21909 fis, clone H   1.17E−06   2.33       450919   AA011616   Hs. 269877   ESTs   6.72E−03   2.33       414312   AA155694   Hs. 191060   ESTs   5.88E−04   2.32       421025   AW958975   Hs. 29397     Homo sapiens  cDNA FLJ13226 fis, clone OV   2.26E−04   2.32       439556   AI623752   Hs. 163603   ESTs   2.36E−02   2.32       424528   AW073971   Hs. 238954   ESTs, Weakly similar to KIAA1204 protein   1.25E−03   2.32       423365   AA324992   Hs. 257168   ESTs   3.20E−03   2.32       403920           suppressor of potassium transport defect   4.14E−02   2.32       448280   AW014215   Hs. 357   zinc finger protein 134 (clone pHZ-15)   2.54E−03   2.32       407687   AK002011   Hs. 37558   hypothetical protein FLJ11149   3.99E−03   2.31       409259   AW608930   Hs. 52184   hypothetical protein FLJ20618   2.16E−06   2.30       407804   AF228603   Hs. 39957   pleckstrin 2 (mouse) homolog   5.21E−03   2.30       423968   AF098277   Hs. 136529   solute carrier family 23 (nucleobase tra   1.31E−05   2.30       414525   C14904   Hs. 45184     Homo sapiens  cDNA FLJ12284 fis, clone MA   1.44E−03   2.30       420164   AW339037   Hs. 24908   ESTs   2.63E−02   2.30       422900   AA641201   Hs. 222051   ESTs   1.08E−03   2.30       423799   AW026300   Hs. 132906   19A24 protein   3.35E−03   2.30       440390   AW207385   Hs. 36475   KIAA0493 protein   1.92E−03   2.30       456351   AW971067   Hs. 293056   ESTs, Weakly similar to 138022 hypotheti   3.50E−03   2.30       431341   AA307211   Hs. 251531   proteasome (prosome, macropain) subunit.   1.22E−04   2.30       413029   AL119399   Hs. 293850   ESTs   5.05E−05   2.30       453315   BE544203   Hs. 24831   ESTs   8.62E−03   2.30       433160   AW207002   Hs. 134342   TASP for testis-specific adriamycin sens   1.96E−02   2.30       420137   AA306478   Hs. 95327   CD3D antigen, delta polypeptide (TiT3 co   6.39E−06   2.30       436252   AI539519   Hs. 120969     Homo sapiens  cDNA FLJ11562 fis, clone HE   1.03E-−03   2.30       437143   AW204056   Hs. 8917   ESTs   6.58E−07   2.30       440495   AA887212   Hs. 14161   hypothetical protein DKFZp43411930   1.75E−03   2.30       419203   AA488719   Hs. 190151   ESTs   8.98E−03   2.30       410017   AW952426   Hs. 109438     Homo sapiens  clone 24775 mRNA sequence   2.02E−04   2.29       415173   AW501735   Hs. 180059   ESTs   4.28E−02   2.29       419200   AW966405       prefoldin 5   7.61E−07   2.29       437109   AW006781   Hs. 5457   hypothetical protein FLJ10738   3.12E−04   2.29       438475   W03856   Hs. 13188   ESTs, Highly similar to Gene product wit   5.26E−06   2.28       417206   AA291183   Hs. 81648   hypothetical protein FLJ11021 similar to   2.66E−03   2.27       448410   AK000227   Hs. 21126   hypothetical protein FLJ20220   7.37E−02   2.27       448959   AI610343   Hs. 293267   ESTs   1.59E−03   2.27       440528   BE313555   Hs. 7252   KIAA1224 protein   1.01E−02   2.27       421620   AA446183   Hs. 91885   ESTs, Weakly similar to 155214 salivary   6.17E−03   2.27       451589   M424791   Hs. 5734   meningioma expressed antigen 5 (hyaluron   4.56E−03   2.27       421931   NM_000814   Hs. 1440   gamma-aminobutyric acid (GABA) A recepto   1.62E−04   2.27       431831   AW023204   Hs. 302743   ESTs   8.40E−04   2.27       428583   AA430589   Hs. 75410   heat shock 70 kD protein 5 (glucose-regul   5.91E−03   2.26       452248   AA093668   Hs. 28578   muscleblind (Drosophila)-like   9.71E−05   2.26       446045   AV656268   Hs. 209153   angiopoietin-like 3   1.13E−03   2.26       421297   AB037360       KIAA1255 protein   3.13E−05   2.26       440945   AW505345   Hs. 7540   f-box and leucine-rich repeat protein 3A   9.10E−02   2.26       452852   AK001972   Hs. 30822   hypothetical protein FLJ11110   1.31E−05   2.26       403496           C3000956*: gi|7710129|ref|NP_006141.2|LI   1.19E−03   2.26       439046   M947354       gb: od86e11.s1 NCI_CGAP_Ov2  Homo sapiens     4.78E−04   2.25       427268   X78520   Hs. 174139   chloride channel 3   6.19E−04   2.25       405122           NM_006798*:  Homo sapiens  UDP glycosyltran   1.59E−03   2.25       403320           fms-related tyrosine kinase 3   1.89E−02   2.25       416754   H07145   Hs. 6799   ESTs, Weakly similar to T12483 hypotheti   1.52E−03   2.25       418046   W49670   Hs. 56044   ESTs   2.04E−02   2.25       418383   AA218986   Hs. 118854   ESTs   1.96E−02   2.25       429025   AI399910   Hs. 266782   KIAA1826 protein   1.06E−02   2.25       435756   AI418466   Hs. 33665   ESTs   2.01E−03   2.25       440638   AI376551       gb: te64e10.x1 Soares_NFL_T_GBC.S1 Homo s   1.39E−02   2.25       447225   R62676   Hs. 17820   Rho-associated, coiled-coil containing p   2.81E−04   2.25       434747   AA837085       ESTs   1.25E−03   2.24       453041   AI680737   Hs. 289068     Homo sapiens  cDNA FLJ11918 fis, clone HE   2.45E−02   2.24       445044   AL137728   Hs. 12258     Homo sapiens  mRNA; cDNA DKFZp434B0920 (f   5.56E−02   2.24       448939   BE267795   Hs. 22595   hypothetical protein FLJ10637   1.01E−02   2.24       450196   AW956868   Hs. 24608   DKFZP564D177 protein   4.52E−05   2.23       453929   AW190054       gb: xl11d05.x1 NCI_CGAP_Ut4  Homo sapiens     2.04E−02   2.23       455959   AA131782   Hs. 182314   ESTs   1.10E−02   2.23       446594   AI311917   Hs. 16292   ESTs   9.93E−02   2.23       445893   AI610702   Hs. 202613   ESTs, Weakly similar to TRHY_HUMAN TRICH   1.09E−04   2.23       432476   T94344   Hs. 326263   ESTs   1.56E−02   2.23       448888   AW196663   Hs. 200242   caspase recruitment domain protein 6   7.58E−04   2.23       405270           NM_018850*:  Homo sapiens  ATP-binding cass   1.02E−02   2.22       442806   AW294522   Hs. 149991   ESTs   2.45E−02   2.22       450314   AA574309   Hs. 283402   TCR eta   4.77E−03   2.22       452144   AA032197   Hs. 102558     Homo sapiens , clone MGC: 5352, mRNA, comp   2.39E−04   2.22       452436   BE077546   Hs. 31447   ESTs, Moderately similar to A46010 X-lin   3.66E−03   2.22       455834   BE145364       gb: IL0-HT0198-151099-125-e05 HT0198 Homo   1.14E−02   2.22       436643   AA757626   Hs. 10941   ESTs, Weakly similar to IPP1_HUMAN PROTE   5.03E−04   2.22       448558   AW340579   Hs. 171165   ESTs   6.51E−04   2.22       414091   T83742   Hs. 334616   gb: yd67g02.s1 Soares fetal liver spleen   2.80E−04   2.21       421958   AA357185   Hs. 109918   ras homolog gene family, member H   5.58E−04   2.21       433648   AA603388   Hs. 44131   KIAA0974 protein   1.75E−03   2.21       428004   AA449563   Hs. 151393   glutamate-cysteine ligase, catalytic sub   4.72E−02   2.21       446229   AI744964   Hs. 14449   KIAA1609 protein   5.58E−04   2.21       421921   H83363       translocase of inner mitochondrial membr   8.81E−04   2.20       408866   AW292096   Hs. 255036   ESTs   1.14E−02   2.20       400120           Eos Control   1.82E−02   2.20       415000   AW025529   Hs. 239812     Homo sapiens  serologically defined breas   1.61E−04   2.20       408990   AL022395   Hs. 49526   f-box and leucine-rich repeat protein 4   3.19E−03   2.20       422371   NM_001882   Hs. 115617   corticotropin releasing hormone-binding   1.15E−04   2.20       437580   AA761075       ESTs   2.04E−02   2.20       453927   AA082465   Hs. 125031   choline/ethanolaminephosphotransferase   4.60E−06   2.20       405688           NM_018850*:  Homo sapiens  ATP-binding cass   2.52E−04   2.20       427130   AB029020   Hs. 173694   KIAA1097 protein   6.45E−05   2.20       414718   H95348   Hs. 107987   ESTs   1.96E−02   2.20       409549   AB029015   Hs. 54886   phospholipase C, epsilon 2   1.51E−03   2.20       424904   AI221739   Hs. 96899   ESTs   8.95E−03   2.20       449103   T24968   Hs. 23038   HSPC071 protein   3.87E−04   2.20       413326   H88621   Hs. 19762   ESTs, Weakly similar to KIAA1140 protein   2.63E−02   2.19       426011   AW996096   Hs. 58924   ESTs, Weakly similar to JC5594 jerky gen   1.67E−03   2.19       443352   H70284   Hs. 160152   ESTs, Weakly similar to FPHU alpha-fetop   9.75E−03   2.19       427156   BE621719   Hs. 173802   KIAA0603 gene product   4.14E−02   2.19       418980   T77130   Hs. 268606   ESTs   3.60E−02   2.19       425745   U44060   Hs. 159437     Homo sapiens  cDNA: FLJ21800 fis, clone H   2.55E−03   2.19       433162   AI025842       ESTs   2.96E−04   2.19       412240   H72176       hypothetical protein FLJ13159   3.35E−03   2.19       440113   AI916532   Hs. 188272   ESTs   4.35E−03   2.19       430526   AF181862   Hs. 242407   G protein-coupled receptor, family C, gr   2.81E−04   2.18       447881   BE620886       GCN1 (general control of amino-acid synt   1.51E−02   2.18       407151   H25836   Hs. 301527   ESTs, Moderately similar to unknown [H.s   4.59E−07   2.18       411590   T96183       gb: ye09f07.s1 Stratagene lung (937210) H   3.04E−02   2.18       413823   AI341417   Hs. 29406   ESTs   6.00E−06   2.18       401627           Target Exon   8.62E−03   2.18       414588   AA302905       gb: EST10607 Adipose tissue, white I Homo   9.77E−04   2.18       425508   AA991551   Hs. 97013     Homo sapiens , Similar to RIKEN cDNA 2310   8.14E−05   2.18       434260   AF121856   Hs. 284291   sorting nexin 6   4.52E−05   2.18       407904   W44735   Hs. 9286     Homo sapiens  cDNA: FLJ21278 fis, clone C   8.83E−04   2.17       421077   AK000061   Hs. 101590   hypothetical protein   2.54E−02   2.17       427120   R42099   Hs. 21965   ESTs   1.37E−03   2.17       442129   N36918   Hs. 20142   PNAS-127 protein   4.37E−03   2.17       444291   AI598022   Hs. 193989   TAR DNA binding protein   3.99E−03   2.17       418416   U11700   Hs. 84999   ATPase, Cu transporting, beta polypeptid   1.79E−05   2.17       403576           C3000124: gi|12737057|ref|XP_012129.1|si   5.20E−03   2.17       446126   AW085909       pleckstrin homology domain interacting p   6.72E−03   2.17       424699   AW206227   Hs. 287727   hypothetical protein FLJ23132   8.99E−03   2.17       437223   C15105   Hs. 330716     Homo sapiens  cDNA FLJ14368 fis, clone HE   2.02E−03   2.17       432540   AI821517   Hs. 105866   ESTs   2.35E−02   2.17       425266   J00077   Hs. 155421   alpha-fetoprotein   1.14E−02   2.17       438619   AB032773       TU12B1-TY protein   3.86E−02   2.17       442053   R35343   Hs. 24968   Human DNA sequence from clone RP1-233G16   9.74E−03   2.16       430308   BE540865   Hs. 238990   cyclin-dependent kinase inhibitor 1B (p2   4.25E−05   2.16       434608   AA805443   Hs. 179909   hypothetical protein FLJ22995   4.37E−03   2.16       408527   AL135018   Hs. 33074     Homo sapiens , clone IMAGE: 3606519, mRNA,   4.28E−02   2.16       410612   AW502698   Hs. 42400   ESTs   9.16E−05   2.16       410800   BE280421   Hs. 94499   ESTs   1.25E−03   2.15       456073   AA587775   Hs. 66295   multi-PDZ-domain-containing protein   3.76E−05   2.15       411468   AW857470       gb: CM3-CT0310-180200-098-g03 CT0310 Homo   1.19E−03   2.15       411979   X85134   Hs. 72984   retinoblastoma-binding protein 5   5.21E−03   2.15       419165   AW860767   Hs. 118879   ESTs   1.14E−02   2.15       419479   AI288348   Hs. 23450   mitochondrial ribosomal protein S25   7.60E−02   2.15       432709   H17238       gb: ym42f03.r1 Soares infant brain 1NIB H   3.65E−03   2.15       448705   H05072   Hs. 124984   ESTs, Moderately similar to ALU7_HUMAN A   6.51E−02   2.15       440266   AA088809   Hs. 19525   hypothetical protein FLJ22794   1.29E−04   2.15       449881   Z28444   Hs. 24119     Homo sapiens  mRNA; cDNA DKFZp586G2222 (f   5.68E−03   2.15       457500   NM_002759   Hs. 274382   protein kinase, interferon-inducible dou   1.10E−02   2.15       417713   D42047   Hs. 82432   KIAA0089 protein   3.66E−03   2.14       416269   AA177138   Hs. 161671   ESTs   8.29E−03   2.14       437370   AL359567   Hs. 161962     Homo sapiens  mRNA; cDNA DKFZp547D023 (fr   2.55E−03   2.14       413305   NM_000426   Hs. 323511     Homo sapiens  cDNA: FLJ23176 fis, clone L   6.93E−02   2.14       413012   D83777   Hs. 75137   KIAA0193 gene product   3.50E−03   2.14       431874   AW610031   Hs. 323914   translocase of inner mitochondrial membr   9.73E−03   2.14       421166   AA305407   Hs. 102308   potassium inwardly-rectifying channel, s   3.06E−03   2.13       414883   AA926960       CDC28 protein kinase 1   6.41E−06   2.13       426685   R20212   Hs. 28454   ESTs   7.31E−03   2.13       407874   AI766311   Hs. 289047     Homo sapiens  cDNA FLJ14059 fis, clone HE   4.92E−06   2.13       423703   NM_014913   Hs. 131915   KIAA0863 protein   8.83E−04   2.13       443804   AL135352   Hs. 255883   ESTs, Weakly similar to I38022 hypotheti   1.52E−03   2.13       436100   AA704806   Hs. 143842   ESTs, Weakly similar to 2004399A chromos   8.32E−02   2.13       444931   AV652066   Hs. 75113   general transcription factor IIIA   4.01E−03   2.13       403742           Target Exon   8.00E−04   2.13       407183   AA358015       gb: EST66864 Fetal lung III  Homo sapiens     3.47E−04   2.13       430048   T65054   Hs. 73605   ESTs   1.29E−02   2.13       445800   AA126419   Hs. 32944   inositol polyphosphate-4-phosphatase, ty   2.54E−02   2.13       438829   AA826926   Hs. 204214   ESTs, Weakly similar to 138022 hypotheti   1.14E−02   2.12       443189   AB023179   Hs. 9059   KIAA0962 protein   3.49E−03   2.12       421633   AF121860   Hs. 106260   sorting nexin 10   6.51E−02   2.12       408475   AA315514   Hs. 47986   hypothetical protein MGC10940   5.93E−02   2.12       436237   R11528   Hs. 271968   ESTs   2.39E−04   2.12       409509   AL036923   Hs. 322710   ESTs   3.74E−02   2.11       408358   D20044   Hs. 12929   hypothetical protein FLJ20721   2.91E−03   2.11       417867   AW952547   Hs. 194603   ESTs, Moderately similar to I38022 hypot   1.68E−02   2.10       417691   AU076610   Hs. 82399   low density lipoprotein receptor defect   1.19E−03   2.10       439161   Y15164   Hs. 6483   oral-facial-digital syndrome 1   1.84E−03   2.10       441024   AW081530   Hs. 268231   ESTs   7.28E−03   2.10       445817   NM_003642   Hs. 13340   histone acetyltransferase 1   2.12E−03   2.10       446783   AW138343   Hs. 141867   ESTs   9.75E−03   2.10       449901   AI674072       gb: wd15h01.x1 Soares_NFL_T —     2.95E−05   2.10                   GBC_S1 Homo s       456373   BE247706   Hs. 89751   membrane-spanning 4-domains, subfamily A   9.78E−04   2.10       451582   AI963026   Hs. 289958   ESTs, Weakly similar to putative p150 [H   1.24E−02   2.10       432106   N58323   Hs. 269098   ESTs, Weakly similar to RETROVIRUS-RELAT   2.43E−03   2.10       426295   AW367283       zinc finger protein 6 (CMPX1)   1.30E−04   2.09       426272   AW450671   Hs. 189284   ESTs   4.52E−05   2.09       444647   H14718   Hs. 11506   Human clone 23589 mRNA sequence   6.93E−02   2.09       458476   AA336878   Hs. 9842   Human DNA sequence from clone RP4-788L20   2.92E−03   2.09       428220   BE183533   Hs. 347128   Human DNA sequence from clone 34B21 on c   6.84E−06   2.09       446103   U90918   Hs. 13804   hypothetical protein dJ462O23.2   4.76E−03   2.09       431742   NM_016652   Hs. 268281   crooked neck protein (cm)   1.10E−02   2.09       412760   AW379030   Hs. 41324   ESTs   3.99E−05   2.08       450203   AF097994   Hs. 301528   L-kynurenine/alpha-aminoadipate aminotra   8.57E−02   2.08       405086           NM_006662*:  Homo sapiens  Snf2-related CBP   1.82E−02   2.08       429567   R35606   Hs. 326800   Human EST clone 53125 mariner transposon   2.36E−02   2.08       418459   R85436   Hs. 268814   ESTs   2.21E−03   2.07       424737   BE301883   Hs. 152707   glioblastoma amplified sequence   4.77E−04   2.07       454038   X06374   Hs. 37040   platelet-derived growth factor alpha pol   1.75E−02   2.07       427468   AB036829   Hs. 178347   SKIP for skeletal muscle and kidney enri   1.25E−03   2.07       412748   BE083158   Hs. 10862     Homo sapiens  cDNA: FLJ23313 fis, clone H   4.56E−03   2.07       455705   AW161061       ESTs, Weakly similar to zinc finger prot   2.36E−07   2.07       421483   NM_003388   Hs. 104717   hypothetical protein MGC11333   1.19E−02   2.06       433713   AW976511   Hs. 112592   ESTs   2.83E−02   2.06       457171   AA433896   Hs. 201634   ESTs   1.29E−02   2.06       433201   AB040896   Hs. 21104   KIAA1463 protein   7.30E−03   2.06       432841   M93425   Hs. 62   protein tyrosine phosphatase, non-recept   2.83E−02   2.06       437469   AW753112   Hs. 15514   hypothetical protein MGC3260   2.92E−03   2.06       402929           ENSP00000243914*: DJ579F20.2 (similar to   4.00E−03   2.06       408246   N55669   Hs. 333823   mitochondrial ribosomal protein L13   4.50E−05   2.06       410582   AW867197   Hs. 337561   hypothetical protein FLJ21616   1.15E−05   2.05       411495   AP000693   Hs. 70359   KIAA0136 protein   5.38E−02   2.05       412059   AA317962   Hs. 249721   ESTs, Moderately similar to PC4259 ferri   6.72E−02   2.05       414548   AW937036   Hs. 183506   hypothetical protein FLJ14213   3.29E−04   2.05       433735   AA608955   Hs. 109653   ESTs   3.14E−02   2.05       441872   BE567100   Hs. 154938   hypothetical protein MDS025   2.04E−05   2.05       448920   AW408009   Hs. 22580   alkylglycerone phosphate synthase   5.92E−03   2.05       448980   AL137527   Hs. 289038   hypothetical protein MGC4126   5.43E−03   2.05       453078   AF053551   Hs. 31584   metaxin 2   7.28E−03   2.05       453574   AI767947   Hs. 50841   ESTs   2.63E−02   2.05       410664   NM_006033   Hs. 65370   lipase, endothelial   7.31E−03   2.05       436856   AI469355   Hs. 127310   ESTs   2.87E−06   2.05       408483   AA464836   Hs. 291079   ESTs, Weakly similar to T27173 hypotheti   4.24E−05   2.05       444775   AI040384   Hs. 19102   ESTs, Weakly similar to organic anion tr   6.08E−05   2.04       423996   AF205071   Hs. 137425   solute carrier family 21 (organic anion   7.84E−02   2.04       451334   AI122691   Hs. 13268   ESTs   9.76E−04   2.04       418504   BE159718   Hs. 85335     Homo sapiens  mRNA; cDNA DKFZp564D1462 (f   8.16E−05   2.04       457830   BE147896   Hs. 14662   ESTs   7.61E−03   2.04       408194   AA601038   Hs. 191797   ESTs, Weakly similar to S65657 alpha-1C-   4.72E−02   2.04       428706   AA432030   Hs. 265827   interferon, alpha-inducible protein (clo   2.68E−06   2.04       435841   R28522   Hs. 186937   ESTs   8.82E−04   2.03       429586   T73510   Hs. 209153   angiopoietin-like 3   1.29E−04   2.03       453173   AB007902   Hs. 32168   KIAA0442 protein   5.73E−05   2.03       415662   AW972481   Hs. 170610   ESTs, Highly similar to G01887 MEK kinas   2.02E−04   2.03       407879   AA045464   Hs. 6557   zinc finger protein 161   1.89E−02   2.02       417303   NM_001698   Hs. 81886   AU RNA-binding protein/enoyl-Coenzyme A   2.02E−03   2.02       429857   AF089897   Hs. 294030   topoisomerase-related function protein 4   8.03E−05   2.02       432886   BE159028   Hs. 279704   chromatin accessibility complex 1   7.38E−02   2.02       432960   AW150945   Hs. 8739   ESTs   1.51E−02   2.02       436797   AA731491   Hs. 334477   hypothetical protein MGC14879   3.73E−05   2.02       439564   W77911   Hs. 110006   ESTs   5.56E−02   2.02       449845   AW971183   Hs. 6019   DnaJ (Hsp40) homolog, subfamily C, membe   6.20E−04   2.02       419426   AI214690   Hs. 346257   aldo-keto reductase family 1, member B1   3.19E−03   2.02       424571   BE379766       polymerase (RNA) II (DNA directed) polyp   1.24E−06   2.02       441965   AA972712   Hs. 269737   ESTs   4.77E−03   2.02       421456   AW579842   Hs. 104557   hypothetical protein FLJ10697   1.96E−02   2.02       408395   BE072425   Hs. 44579   hypothetical protein FLJ20199   5.59E−04   2.02       427561   AI123333   Hs. 134191   ESTs   2.67E−06   2.02       411678   AI907114   Hs. 71465   squalene epoxidase   3.03E−02   2.02       448873   NM_003677   Hs. 22393   density-regulated protein   1.24E−02   2.02       420747   BE294407   Hs. 99910   phosphofructokinase, platelet   9.75E−03   2.02       430213   AW993446   Hs. 235445   hypothetical protein FLJ21313   4.42E−02   2.02       417971   Y08991   Hs. 83050   phosphoinositide-3-kinase, regulatory su   1.19E−02   2.01       424247   X14008   Hs. 234734   lysozyme (renal amyloidosis)   3.06E−03   2.01       404240           NM_018950*:  Homo sapiens  major histocompat   2.45E−05   2.01       400906           C18000324: gi|12229928|sp|Q9PTW9|PSA7_CAR   6.69E−03   2.01       422431   AI769410   Hs. 221461   ESTs   4.37E−03   2.01       444654   AV650572   Hs. 23440   KIAA1105 protein   1.59E−03   2.01       418248   NM_005000   Hs. 83916   NM_005000*:  Homo sapiens  NADH dehydrogena   8.07E−02   2.01       437830   AB020658   Hs. 5867   KIAA0851 protein; suppressor of actin 1   6.71E−03   2.01       438023   AF204883   Hs. 6048   FEM-1 ( C. elegans ) homolog b   2.43E−03   2.01       448770   AA326683   Hs. 21992   likely ortholog of mouse variant polyade   8.37E−04   2.00       416430   H60487   Hs. 159440   bile acid Coenzyme A: amino acid N-acylt   1.52E−03   2.00       421360   AA297012   Hs. 103839   erythrocyte membrane protein band 4.1-li   2.02E−03   2.00       418838   AW385224   Hs. 35198   ectonucleotide pyrophosphatase/phosphodi   5.60E−06   2.00       425145   BE242802   Hs. 154797   KIAA0090 protein   3.19E−03   2.00       437672   AW748265   Hs. 5741   flavohemoprotein b5?   1.19E−03   2.00       439898   AW505514   Hs. 209561   KIAA1715 protein   3.19E−03   2.00       444743   AA045648   Hs. 301957   nudix (nucleoside diphosphate linked moi   8.32E−02   2.00       445790   AV655170   Hs. 49015   chromosome 21 open reading frame 35   2.55E−03   2.00       451141   AW772713   Hs. 247186   ESTs   2.04E−02   2.00       454105   NM_001259   Hs. 38481   cyclin-dependent kinase 6   3.82E−03   2.00       458389   H70284   Hs. 160152   ESTs, Weakly similar to FPHU alpha-fetop   4.50E−05   2.00                                                                  
 
     [0355]                       TABLE 7B                           CAT           Pkey   Number   Accession                  442048   750422_1   AW340495 AI984319 AA974603       451752   10408_5   AB032997 AI141678 AW978722 BE467119 AI761408 BF727385 AW237035               AI934521 BF436248 AI479668 Z40632 AA832081 AW295901               BF057835 BE465977 AI621269 BE465983 BF756369 N74056 AI817896 AA716567 AA934774               H62600 H09497 BF943762 BE395335               BE883333       421057   265006_1   BE222349 AA830545 BF224127 H99396 N81017 N81016 AI525205 T58283       407644   27910_1   D16815 AL563603 BG399756 AI935028 N41813 L31785 AL529953 AA428473               AA401262 BF802576 AA373868 BE886120 BM479352 T28309               N57167 BI551531 BG037160       444314   1027984_1   AW749625 AW749626 AW749644 AI140497       432954   2159612_1   AI076345 AI887648 AA572691       433586   32908_1   BC011194 AW517087 AA601054 T85512       419175   35068_1   AB018322 BC012480 BI524873 AW665554 AI934469 AI479916 BF096179 BF096162               BF096132 AA744972 AI951988 AI858339 BE076331               AA886998 AI570585 AI916688 AI678811 AI693109 AI308135 AA669046 AA961064               AI018062 H80618 BE221942 R52609 AI915164 AA365626               Z44671 BI052776 BF882486 BG286184 AI589558 AA931663 AA534979 AI275392               AI273455 R52553 AA829920 H80652 AA360728 F10618               AW953666 AW176773 H85527 AA765570 AA081927 BF093262 BG743753               AL037576 AA534314 BE814964 BE973713 N49493 BE006634               BE006630 AW270037 AA234765 AI334004 BF057179 AI857450 AI341191               AI434143 AI917449 AW517207 AA255424 AW008334 AA847572               AA994211 AA861901 AA581873 AI580157 AI364363 AW242357 AW235291               N55645 AA319869 R36911 AA256551 AW044188 AI203159               N49403 F02090 AI187299 AI609644 Z40516 AW952314       400247   2764_1   BC022339 BC009610 BC010537 X79805 NM_006713 U12979 BM467814 BM450743               AU132951 AU137129 BG493425 AV758819 BG708412               BG705885 BG702217 AV716638 BG777009 BI545689 BI552153 BM476712               BG770858 BG527656 BG528277 BG391388 AV716861 BI602926               BG290073 BI667399 BM451469 BI667173 BI602139 BG532171 BI669216               BI544727 BG721852 AV716503 AV701327 BM090738 BI492000               AI308856 BI544904 AL599813 AV715829 AV716505 AV714587 AV717902               BF668072 AV716385 BI461927 BM090954 AV717826 BG503676               AV647719 BG501392 BG428433 BE895629 BM313117 AW021050 BG435032               BM152910 AA313503 AA872377 BG574714 AV712054               AV732696 AA252476 AV712759 AL599643 BE790872 BG654930 W73337               AW675377 AV760376 AV725139 AV716379 AA887165 BE830003               AW023796 AL599291 AI902948 BG944042 F00781 AA352483 BG217897               N33888 AW581924 BG654730 D31410 AA353088 D31288               AA295029 H95170 BE935104 AU139980 BG772963 BG776470 BG532512               BG105449 BI545421 AV715456 AW386083 BG699714 AL535832               AL514940 BG190861 BG210593 AW999254 H95138 AA353863 BE764809               N50375 BE091363 BG701255 BI860846 BI832485 BG168150               BG028647 BE546301 BG900321 BI909737 BG702363 BG614141 BG611137               BG700121 BF031492 N85802 AV715940 N51590 BG993478               BE172016 AW893622       436024   138548_1   AI800041 AA703553 AA984529       443547   137089_2   AV645808 AA701657 AW271273 AI796734 AI472316 AI017531 AI061178 BF109096               AA548964 N83805 AA131648 AA156589 BE708349               AW952494 D30877 AV684717 Z24837 F00167 BF576150 T63841 R78995 N87474       416475   1972665_1   R02750 H58072 T70298 BF367306 R02749 T80873       408096   9330_1   U61981 NM_002439 J04810 BC004177 BC011817 BC017273 BG876463               BG876469 BG876468 NM_000791 BC009634 BE741138 AI830697               AW572941 AA489055 AA463881 AI186480 AI803332 AA129465 AA749344 AW572255               AA447680 AI184392 H94631 BC000192 BC003584               J00140 V00507 AL525560 BG532440 AU130196 AU130635 BG699143 BE295309               BG771877 BG497327 AV714645 BE397236 BI458721               AU127142 BE252613 AW575796 BG328723 BE250809 BI759776 BM051687 AL040147               AA314334 BE780925 AU099092 T29009 BE250162               AU139133 AA421716 H99382 BG188773 BE514324 BG199292 BG217128 BG188772               BG202122 N44579 BE250719 AW473270 AA382889               AU157895 BF907195 J00146 BM475776 AA974401 BF514204 BE743689 AW993728               AW364498 BE514508 BG195205 AW069265 BF881506               BF928376 BE874450 AI909030 AW051136 AL514516 AW970133 AL514515 AA701106               AA516401 AA578546 BF792184 BE566555       442679   31783_3   BG621493 BI056706 BG496376 R53718 W65356 R79357 BG434247               AA357769 AW978686 BG573200 BF132113 BF086709 AA366938               D79234 BG494628 AA156754 BG434311 AW978683 AW273417 BM054662 AI799886               AI433351 AI160798 AI433742 BF056186 AI281606               AW015046 AI439585 AI245530 AI078267 AA807170 AA837395 W61252 AA831085               AA287371 AW768354 AA890606 AI302539 AI708575               AI673031 AI242260 AW514069 AA283958 AA825452 AI371234 AA425696 AA453422               AA827697 R23653 D20240 AA772517 H13802 R66972               R79360 R27351 F03379 AA031952 N69504 R33143 R79358 R39136 R38800               R15089 R52937 R37502 H01021 R33634 R46551 Z40404               BG291052 BG570357 AW391046 BG496872 H23558       418876   121279_1   AA740616 AA654854 AA229923       434210   54921_1   AK057015 AI026834 BE857936 AA149091 AI742972 AW439172 AI253168               AA255613 BF513175 AI005006 T03406 AW338149 AA836442               AA420530 R88566 AI611672 AA433916 AA442855 BF063008 AA812568 AI889706               AA715313 AA768539 AA767620 AA665471 AA404380               AA665612 BF056442 AA706388 AI650676 AA627448 AI141769 H78227 AW901852               H78221 BE701982 BF689273 AA397464 N33072 R60218               AW968247 H14833 AA768305 AA043348 R56470 BF739832 R51827 AI474963               BG494574 AA149090 BF238154 AI802210 BE000129               BF734513 R41964 H21055 R85253 R17705 R40844 BF790218 BG388356               BF003037 AA703138 AA377348 W24822       400133   2368_1   NM_005648 BC013809 L34587 BF103775 BG702618 BG716553               BI667090 BG505863 BF983483 BG718195 BI857891 BG501016 BM043599               AL521812 BG705730 BI495545 BI495546 BF112248 BM023182 BM023123 AI075173 AW051799               BF058224 BI324885 BF436008 AA398446               BG822375 BM019558 BM023382 BG164174 N56909 BI467064 BM023464 AI207475               BM311415 BG758430 BG758807 AI934826 N90351               BG422026 BE910312 AI027778 AI081950 AI360890 BM009115 AI191829 BG759697               AI138728 AA399403 AI355589 AI336427 AA868702               AA393660 AA025127 BG027630 AA962774 AA631224 BG940967 BE791087 AA573315               W81685 AA393525 BG944103 AI339125 AI149864               AA977655 N90314 BE612839 BG491847 AI129091 AA461234 AA781198 AA759256               AA888954 AA975844 AI184099 AI018025 AA398363               AI003331 AI193380 AA626020 AI244476 AI601114 AW135664 AI206607 AW263599               AA813219 AI684453 AA878626 AA772222 AI085496               AI630226 BG940966 AI022010 AA770649 AA887624 AA491739 AA974295 BG530040               AA037091 AA019912 BI160457 H64512 BG503896       413509   1518543_1   BE145433 BE145419       429588   1396089_1   AI092511 AI080271 AA455177 AI381859 AI381721       407347   810943_1   T23514 AI655785       439195   21979_1   AF086037 H89360 H89546       413007   1343540_1   BE046662 BE046697 BE046655       437834   294580_1   BG110129 AW749287 BE535498 AW749299 AW749293 AW749302 AW749298               AW749291 AW749294 AW749289 AW749288 AW749296               AA769294 AW749297 AW749295 AW749292 BE002573       427384   1367813_1   AA401778 R92652 T82854       432600   114582_1   AW973464 AI821831 AI821085 AA640756 AA657438 AA554802 AA650339       411605   10026_3   BG256892 H10532 N46614 R52610 AW977696 BM460488 W56819 BI042183 BG977498               BE767451 BF870009 BG477472 R61137 R14274               R20259 R09686 BI838226 BF034269 AA429173 BE741829 AW867495 AI123683               AW006831 BE831162 AW452753 AV742717 W86152               BF115102 AI633815 BF921562 AA094230 BE092587 W86151 AA526153 AI672156               BF914496 R12579 BF852352 AA699780 T57386               BF903022 R09933 AA678298       454067   98108_1   AI809849 AW241782 AA041455       456034   685586_1   AA136653 AA136656 AW450979 AA984358 AA809054 AW238038 AA492073 BE168945       432676   3503_22   AI187366 AA618478 AA558869       428342   6712_1   AK056315 AI015524 AA724079 BI713619 AI377728 AW293682 AI928140 AI092404               AI085630 AA731340 BM469629 AW968804 AA425658               AA769094 BF446026 AW118719 AI332765 AW500888 AW576556 AI859571               AW499664 AW614573 AW629495 AW505314 W74704 AI356361               AI923640 AW070509 AI521500 AL042095 AA609309 AA761319 AI381489 H45700               AA761333 AW265424 AA909524 AA635311 AA649040               AI392620 Z40708 AI985564 AW263513 AA913892 AI693486 AW263502 AI806164               AW291137 BI061872 BI059498 AA134476 AW084888               AA036967 AW370823 T55263 BI002756 AA489664 BF827261 W74741 BF963166       449001   1968002_1   AI654836 AI619957 H51659 R99472 R99473       411656   1095889_1   AW855650 AW855576 AW855577 AW855642 AW855578 AW855621 BG950916               BG950923 AW855619 AW855624       434987   121985_1   AW975114 AI096634 AI767001 AA658364 AW517542       434280   1474904_1   BE005398 AA628622 AA994155       414405   112689_1   AL047596 AA393792 AI670731 AI037957 AW874364 AI038137 N62286 AI241379 BE501096               AW090696 AI927369 AI669226 AI369437               AI371075 AW612409 AI686711 AI183289 AA477717 AI076122 AA635190 AA700984               AA781508 D81020 BF575223 AI356183 D79312               AI375558 H61111 BG283489 BE090666 BE090664 BE090662 H26545       407218   34845_3   AK026094 AK024519 BG697329 BI768179 BG680257               BE275725 BF945273 AW674728 H62658 BG951138 AA326011 AW993688 W67819               BI036861 AA524981 N28558 AW799454 BG286696 BG434856 AA317171 BE548299               BF987870 H12577 H87965 BE867572 BG107813               BE747295 AL118999 T95439 AA363896 H16012 H27146 H41959 R63045 N49563               AA032167 BI917617 H02466 AA207162 AA081975               BG749301 T11901 AA091553 BG945206 AA095473 BM172375       407992   101407_1   AI458141 AI743200 AW418811       452194   90339_1   AI694413 AW994700 AI912946 N73548 AI082035 AW271652 W24189 W24182 AI719718               AA024658 AW810120 AW015394 T79755 AA988043               AI709339       427213   507972_1   AW007211 BE467259 AA960991 AA399252       433075   78_6   X98248 NM_002959 AU127082 AU143346 BE327147 AI168442 AA426361 BF056336               AA418378 AI470560 AI365213 BI032745 BI032986               AA969895 AA233278 AW291971 AA418326 AI198417 AI337018 BI032747 AA888000               AU099083 AU129681 AL036861 AA418275 BF887436               BF767448 AA232975 BI094065 BI859449 AL079651 BF877391 AW902319 BF878798               BG281450 AA418268 BG770672 BE890328 BI520437               BE387505 AW375004 BI020046 BI033747 BF800905 BF869732 N99710 BF905459               BE715637 BE746496 BF918537 BF751392 BF751390               BF369123 BG949840 AA984366 H85743 AW593418 AI990196 T92267 AA018359               H38111 BM050097 BF692315 AW805907 AI547305               AA631091 BF845219 BG949806 T92310 BE277220       418304   1093209_1   BE883520 BI057842 AA215702 AA215703 AA368006 BE006876 BE066555       438021   45849_1   AY043361 NM_007013 AL136739 U96113 AL049041 AI750898 AA054855 BF887778               BF333173 BI061338 BC015380 BG569062 BM090890               AI769300 BE466554 AI091728 AI800660 AA832035 AI342285 AI750899 H66486               AA455942 H20821 AI187877 AI417440 AW198099 AI245158               T91227 AI373068 AW194829 AA680229 BG291204 AW885601 BF380168 D82380               D82098 BF885552 AL050082 BE552267 AI458088               AW137654 BM014715 AA418921 AI159868 AA845398 AI743920 AI159888               AI653531 AA843952 AI799752 AI360957 R67562 BF445478               AA854844 AA552895 C21152 BE614563 BI260650 AU155187 AW169673 AI915801 N29619               AA435618 AI361252 AI424627 AI219018 R67514               AA548141 AI246669 AA156867 R67561 R67513 AW263860 AA089478 AV653790               AA354846 BI560015 AW794547 R52020 H18923 R67555               AI302490 AL582101 AI871884 AW029104 AI582326 AV688960 AL040820               AI804339 T57931 R67554 AA418232 AA393281 BE076206               AW189435 AW979344 AW953494 BF056797 AA310720 N64062 W92065 AI761704               AA418824 H89156 H88930 W92048 AV733096 AW007773               AI745541 BE504125 AW243111 AI201009 AI187909 R44411 AI795988               BF222383 R29593 AA156952 BF029856       432689   11004_5   AL563022 BC011883 AI625937 BE302243 AI240793 AI886651               AL134289 AA877735 AI284399 H80252 AI753853 AA564328 AI075230               AA657859 AI269462 F09349 AA653028 T71751 T71812 R58128 AI890218 T71659       410099   16732_1   AK055674 AW965247 AV751598 AA290926 R53043 AA331387 AK056148 BI917678 BG819395               BG911971 BG820167 AI174254 AA348720               AA364503 BG714279 AW893230 AA081774 H24222 AV727176 BF875715 AA081630               BE000834 AA334880 AL563737 BG029709 W52882               AI439658 BE551237 AA283724 BF109530 AI457096 AI805992 BE467736 AA693467               AI697593 AI887863 AI167419 AW901980 AW901768               BE702179 AA484549 T23811 BE327043 AA716027 AA917004 AA167714 BF339675               AA084618 AI418634 T31586 AA436630 AI366472               AA706191 AI422304 AI204899 AI041169 AA211402 AW827081 AA788593 T32736               AI767935 AA747914 T03534 AW959843 AL119527               BE327037 AW901982 AW993370 AW901977 AW902071 W60090 N79906 D52685 T07735               BE702069 BE702172 T08671 BE767121 BE767117               BE767113       433891   647290_1   AW182329 AA613792 T05304 AW858385       425757   1228540_1   AW963347 AA371863 AA363171       400281   9758_4   BE564506 Z47727 BF028489 BI597545 AA152273 AA730753               W07504 M406507 AA316220 AA424683 N35844 N72473 AA442109 W01788               AA747605 AA235894 N41438 AA382786 AI906934 AI906935 BF091197 N85572 N75678               AV758098 BE719745 BE719744 BE719735       413645   1234345_1   AA130992 AW969537 AA503835       423886   887218_1   AW950497 AA332098 AW950499       408731   11725_2   AF305826 BE350971 AI765355 AW172600 AI310231 BM271766 AI547292 AW612019               AI674617 AW138666 AI147629 AI147620 BF857810               BF886300 BF885952 BF886303 BF885956 BG565497 BE670834 AA114025 BF886396 BF886928 AV750861 D62864       443126   1057340_1   AI033503 AW801770 AW801782       448219   22785_8   AW577769 BE076308 T98501 AW577775       418259   133853_1   BM310925 AA426110 BM310629 BF434286 AW015091 BF475996 AW118867               BE675186 AI688568 AI453594 AW590589 AI652425 AI827969               BF056946 AI802866 AI393380 AI476224 AW590639 AW136271 AI458252               AI524726 AA843768 AA782158 AI336058 AI097532 AW451563               AA459408 AA459633 AA418444 W23607 BG940150 AI493445 AW054729 AI221929 AI868744               AA215405 AA766713 AA621546 BF928317               BE464132 AI990909 AW271459 AI262061 AA215404 N74332 BG940151 BG952261 AA972115               W96315 AA689586 R69057 BF766886               BE769254 W05240       415023   37164_1   BG763540 BI115604 BG325282 AY007096 BE048206 BE048060 AA356949               BG469451 BE267760 AI683752 AI702004 BE247172 T47611               T47612 BE780300 AA932146 AA652369 AI784281 BM055020 BM023299 AI382709               AA159351 BI262171 AI863355 AI674922 AI754389               AW295190 BE673083 AW469497 AI949042 AW131720 AI990060 AI623178 BE673420               AI863364 AA620354 BF431793 AI056058 AI056059               BI258269 BI823911 BG482172 BI261556 BI519838       412634   131633_1   U55984 AA195883 AA447957 AA393452 AA384799 AW958952 W68044               AA197345 AI241933 R59505 W67965 AA826474 AI336006 AA931733               AW025414 AI769180 AI355738 AI860952 AA907417 AW408679 AA453139 AA938346 AI279697               AA121899 AA400768 AI559827 AA448889               N62400 AW236656 AA904207 W79380 R59504       419970   13569_1   AK055270 BE348291 AI190289 AW612022 AI269506 AI266578               AI269675 AW271406 BE879851 BF574163 BI497126 AW903775 BI917368               AW150900 BF244813 H79201       420985   455_7   X94703 NM_004249 AL521205 BF886672 N46403 T87420 Z36855 BF934259               BI549507 BG899191 BI517479 BI818431 H39666       456984   29289_2   W28684 AW959164 AI909150 AW750651 BF055016 AW750639 AI909163 AA358374               AV753402 AW968411 BF196253 AI697716 AI656043               AW138212 AU146192 AI582306 AI814242 BF036992 AA723154 AW301605 AI378151               AI680949 AL589221 AW304035 AA984657 AI290310               AI668884 BG149396 AI537796 AA995333 AA402863 AA416859 AI300148 AA889348               BE674396 AA740711 AI041113 AA723177 AW976742               BF951876 AI909164 AI909181 H08832 R80981 W28685               W28701 H18426 R80781 AW842470       423828   886732_1   AW962569 AA331536 AA331754 AW962568       411777   1104614_1   BE067593 H49900 BF331057 BF331045 BF331063 BE067552 BF331011               BE067819 BF331039 BE067694 AW861997 BF331052 BF331005 BE067800 BE067714       421828   207_22   AW891965 AW604749 BE080872 R15559 BE177623 AW883520 AW945343               AI246167 T07082 AW805679 W96278 AA135796 W32615               AW995418 AW801688 BE003837 AW801621 AW385721 AW385742 AW385714 AW604757 W87409               AW604738 AW385757 AW580796               AW801247 BE003239 BE003183 AA847112 AW580975 AW604760 AW385727 BE164590               BE003090 AW362791 AW604759 AW866589               AW604758 N44337 AI378548 AW890438 AA077172 AI288683 AA229639 AA091945               AW945454 AA063629 AA702504 AW861938 AW894816               AW580841 AA094372 T06399 AW885686 BE244086 BE005035 AW861913 AA551773               AW858460 AW370926 AW754352 AW889695               AW384408 AI907428 BE067491 AW861939 AA248197 AW381373 AW177325               AW806879 AA935217 BE067498 BE083742 BE067470               AW894935 BE082529 AI248811 BE179917 BE002200 AW607506 AW392889 AW894560               AW381360 AI904206 AW863533 C00609 AW381372               BE082530 AW898120 BE075323 AW392799 AW601420 AI695314 BE083790 AW858568               AW945550 BE177153 AW970506 BE350419               AI906919 AW360794 AI906917 AW885979 AW794240 AW945566 AI688683 AI688694               AW009660 AW601421 AW360793 BE066524 BE083901               AW369847 AW381871 AW935435 AW664582 AW877775 AW838449 BE180466 AW858501               BE180464 AI371163 AA778231 AI174991               BE011720 AW877776 AW877800 AW877795 T19900 AW866365 AW898099 BE011715               BE167842 BE011718 BE011724 AW363639               AW878658 AW878662 AW894887 BE082356 AW389211 AW804286 AW610312 AI904717               AW610318 AW996909 AW610296 AW901923               AW880003 AI762171 AW062582 AW368713 AW062593 AW176663 AW842064 AW842089               AW842095 AI243049 AW902074 AW062592               AW176664 AW751692 BE087703 AI907439 BE009686 BE172115 BE077030 AW608556               AW835577 AI909628 BE077029 AW176241               BE077552 BE160370 BE160288 AW835656 AW606765 AW606770 AW835678 AW606758               AW606778 AI907484 BE172821 AW606768               AW999517 AW844165 BE171738 AW751683 AW610493 BE177484 BE177487 AA090510               AW844117 BE173367 AW999878 AI124870               BE163472 AW841823 AW379762 AW893297 AI290296 BE089132 AA610287 AW176676               AW607622 BE172639 AW893232 AA329629               BE089008 BE178350 BE178214 BE063291 AW820236 AW999653 BE089486 BE173126               BE171775 BE185787 AA558280 AI174840 AW999112               BE218391 BE172734 BE178021 BE172738 BE173324 AW603494 AL036722 R38192               R60905 H53721 H41052 AL037917 R37795 AW998972               AA767189 AW044272 H50689 AA768399 AA767764 AI087888 H44202 BE222792               N90597 W81396 N90615 AI935353 BE501168 F10945               AW118215 AI970480 AI627641 AW236081 AA574090 AI627652 AI681913 AI759983               N69591 N69276 BE467722 AW392780 BE172467 H92861               AI524921 F02989 Z39328 F02705 F01414 T88678 AI215165 H87220 AW374781       452279   11990_1   AF392454 AK023074 AI884890 AI814455 AW966220 BF736545 AA026021 AA286843               AA251918 BG197710 AA026294 AA337356 BC010422               AK023226 NM_022776 BM459496 AA769310 AI826460 AU153650 AU160375 AW166211 AW292992               BF433538 AI823888 AI684798 AI655985               AW770982 AI400454 AI276257 AA639510 AI689818 AW772604 AA807639 AU130298               AU132028 BF900889 BF904822 AY007102 AU143256               BG621460 AA829630 AI864665 AI084922 AA025234 AI360060 AA766554 AA026295               AA825817 AA251762 BE180751 BM464530 AV715833               AA779447 AI452519 AW418525 AA435643 D25894 AA435651 AA286844 N64369               AI702262 BG288063 BE170545 BM466232 BE299160               AA169573 AL567428 BF217285 BE967276       400189   2140_1   Y08200 NM_004581 BC003093 BE733834 BI753321 BG773890               BF091906 BI917541 AI023762 AA587230 BF435086 AI264262 AI687392               AI810536 AW589886 AI244419 AA749261 AA535435 AW205689 AI765770 AI765431               C02465 AW305347 AI818456 AA322111 AW381845               AW381829 AV749407 AA811636 AU159893 AA603065 AA652542 AI468678 R49616               AW381863 BE389867 BE182387 BF087771 AA527551               AA134051 AA831504 AA134052 AI871759 AW089048 BI913532 AA367709 BG828155 BF093014       442961   60316_2   BE966247 BE220885 BE467384 BE350135 BE672094 AI811582 AW665254               AA772731 AI283601 AA417067 AW197746 AI868357 AI792143               AA931120 AI758506 AA843761 BE737582 AW379586 N38812 BG567321 H13257       422150   782_1   BI086421 BF059136 AW003898 BF446659 AI632891 AI628067 AI703179               AI961149 BF111022 AW614154 BE674215 AA687350 AA779426               BF591963 AW243344 AI356530 AI492508 AI694049 AI090422 AA465307 AI273387 BE674625               AW271971 AA969153 AW468593 AA984014               AI817491 AA970258 AI914450 AI018697 AW577591 AW577616 AA382101 AW954455               AI867266 AI707995 AI337384 BF208406 BF037100               BF223433 BF195517 BE673984 BF224124 BE813387 BG036579 BI553906 AA304995               AW361269 AW754160 AW361276 AW361271 AI867118               AW805555 AW361284 AW954458 AW958551 BG681507 H79011 AW205696 AW134957               AA747667 AW753296 BF939060 AW958549               BF910827 BG573750 BG168639       436262   2276_7   BG028838 AL597498 AW938817 AA707425 BE089516 BE175202       418733   18099_4   BM473699 N33854 N35083 BE090367 AI306129 AA911920 AA633160 AI302415 AA609954               AI365203 AA911919 AW995271 AA234587               BF996091 AW956344 AW389533 R60133       437151   282041_1   AA745618 AW606658 AA745616 AW805449 BF897789       421272   64950_1   BG819964 R87567 BF062036 BF062044 AW014470 BG057316 AI810506 BE466071 R88291               AA704157 C15898 C15173 AA286825 BF594141               R84605 H85515       430068   1177709_2   AA947566       432474   1237469_1   AW973273 AA584042 AA548798       446851   9025_1   AL530311 AI929658 BE504156 AW160973 AW007332 BE327718 AI268061 BE219811               AW162577 AW139586 AI142112 AI929817 BE348817               AI281962 AI694916 AI694425 AA476502 AA911355 AI867757 AL522996 AK025716 BI966713               AI823741 BF435119 AI740654 AI377656               AI380387 AW612765 AI190300 AI080728 AI425090 AA927634 AI911024 AA826114 AA693577               AI003964 AA680381 AI203302 AI004628               N75950 AI497985 AI918293 AW168793 AA909369 AA884574 AI191792 AI868413 AI458050               AA233857 BM462189 W72450 BG775793               AF064843 AI458158 AA568445 AI802171 AA604222 AI393739 BE044639 AI351150 R43836               AL523063 AW960720 AA621125 AA587562               AA810864 T86692 AA007682 AA055564 AL523983 AA007681 N39693 W04974 AA449174               T86786 W76299 R54146       426221   MH1660_70   AF186377 U32581 AA776981 AW473826 AU127861 N24261 W31964 BE702576 BM455665               BF371317 BF371314 BF371305 BF371302       441969   2681178_1   AI733449 AI733386 AA972780 AA988876 AI791798 AI791748       459436   880261_1   AI908449 AA323121       425284   3834_5   BM476120 BE672181 AI697653 AA938187 AI280879 AW340123 AI912727 AI081775               AI089556 AI191349 AI871604 AI631607 AI890800               AI701917 AW771624 AA663041 AI991576 AI160622 AA771763 BE089784 BE089788 AI222942 AW418516               AA329211 AI095736 BE550294               AA738345 BE218683 BE670548 BG149505 BF061776 D19821 BE005786 BE178892               BE005728 BF841237 BE005648 R27634       411617   11546_6   BF037031 AV752097 AL602446 AI004475 AA312353 N94870 N28394 AA179069               BF746111 AA351029 AA096257 AA247994 BM313163               AW364986 R25275 AA837053 AA191277 AA809755 AA094345 BM152038               BF514649 BM151933 BE769272       416048   1904153_1   H16413 H16268 H19416 Z43074       414404   19538_5   BG036308 AW813969 AW579686 BE147476 AW813871 BE147474 BE147589               BE147582 AA767716 AW813960 AW813958 BE147583               AW813608 AW813612 AW813965 AW813954 BE706154 BF843546 AW813870 BE147801               AW813962 R80512 BG681408 AA344564               AW370224 BG614838 AW582118 AW582114 AW370227 W16712 BF209670 BG117739               BE762802 BE087964 BE888647 R89145 BF342601               BI752591 BG435038 AA166732 N79515 BF541709 N79567 BG503029       437838   2512601_1   AI308202 AI307229 AA769348       434384   132928_1   M631910 AI928421 AA687629       446830   41421_1   BC020595 BI488430 BG168023 BE179030 AW294203 BF849776 AA459064 AI917452               AW403072 W27419 BF914568 BF798468 AW370558               T35055 AW370623 AA399232 AA214221 AW802987 BF902228 AW370622 BF819597               AW370567 BF914313 AW954040 BF060706 AA194237               T25074 C01285 BI489433       447657   2957064_1   AI953011 AI953026 AI936839 AI418034       408138   14592_2   AW374043 BG568336 AW374058 AW961372 AA328028 BF438186 AI268678 AV724415               BG029720 AA725816 AI926580 BM310209 AA968470               BF430989 AI185775 AW002091 AI969941 AI718705 AI360440 AW008856 AA862294 AA625752               AI610753 AA471020 AA723203 AL044614               D80637 H77377 AA745928 AA743114 W25004 AI127139 AA953939 AA908426 AI800072 AI417080               AW874111 AI439293 AI370639 AI277179               AA883338 AA469058 AI200997 W94913 AA047544 W91966 W69102 W84439               W52870 W67288 W69103 H98077 AA111874 AI913850               AA535740 N92824 AA973639 W68358 BE170126 T81345 N50135 AI567418 W67220 BF437728       414279   5766_2   BG430995 R53271 Z33587 BE073129 BE073137 R52586 AA137263               BG031848 AI983837 AI434776 AI767302 AW236107 AI676204 AI420077               AA282786 AI498342 BM310542 BM310847 AI089287 AA398984 AI129279 H79114               BF431053 N53529 AI741845 AI333439 AI674468               AA137264 AI624731 AA399623 AI968243 AI863637 AW769997 AA618148 AI220925               BI492628 R52535 AI474904 H72893 D51042 AI744688               AW021691 N38931 N24944 AI537404 AW242437 H99461 Z41183 R52617 BF448803 AI979148               R44190 R45431 BG436113 AF236691 H72493               AA482849 BF219145 AA625451 BM312732 AA282874 N33821 AW970080 BE780127 R23405 R25093       416272   3292291_1   AA178882 AA178897 AA179898       425303   1223924_1   AW958427 AA354785 AA354792       438980   917280_1   AW502384 AA828822 AI982587       452480   3144986_1   AI903574 AI903572 AI903526 AI903571       456721   17316_2   AK027110 AI823404 AI311783 AA552514 AI936370 BF435170 AW468427               AA533356 AA779031 AA318991 AA614088 BF868935 R67736               BG007848 AA720986       423983   888204_1   AA333365 AA552870 AA333261       438141   1173217_1   AA778849 AW946871 AW946782 AW946955       438041   2523562_1   AI394551 AA812658 AA776285       416611   10454_1   BC010161 BG576118 AI708321 AI478300 BF111611 AA568308 AI984473               AI453629 BI495582 BI495581 AI983169 AI695792 AI695791               AA181902 AI376993 AI472805 W26851 AI341559 BF735125       414496   1526_1   AK058006 BF724822 W65303 AW887764 AW023806 Z25353 AW022095 AA730973               W00417 W73819 BF982096 AI927669 AW188021               AW770478 AI913512 AA604358 AI697341 AI691028 AI338392 AI079403 H97538 AI144448               AI253102 AI051402 AI335900 AI868132 N28900               H98465 AF268386 AI799915 AI819228 BE048413 AW304723 AI819923 BF223106 AA155907               AW298079 BF055272 BF446804 BF197697               W58588 BF197538 AA032180 AA992597 AW590254 AA027824 AI129369 AI131331 AI655843               AA932907 AW104493 AI150615 BF110226               AW172271 AI312659 AA057312 BE673669 AA722984 AW104985 AI129232 AI078648               AI653086 AI703481 AW515897 AI352206 N67076               AW297281 AI686162 AA029184 AI610743 AW772016 AI091778 W65401 AI687374               AI218085 AI765158 AI018002 AI653068 AI335704               AI520850 AW275228 AW275204 AI420247 AA975336 AI697042 AW182235 AA736386               AI281682 AW169698 AW263325 BE645834 AI377438               AI146706 AA613808 AA716538 BI496247 AA032248 AI698930 AI193399 N70026               H86792 AA404489 W61267 BF447230 AA910805 AA150774               AA621907 AA902526 AI827634 AW022037 BF059000 BI496246 BG577007               BG571077 AA460779 AW816890 AW816893 AW816891               AA029183 AA010295 H86850 T83320 BE160823 H12925 N40087 AA096372               BE160847 AW816892 AW816889 AW816882 AW816868               AW816941 AW816578 AW816940 AW816577 AI431628 AI828113 AA033677               AA033654 AA452704 AA317582 AA346971 BF836584 H48669               BI861605 BG925200 AA463277 H89048 AA155952 W03252 W01510 W00915 W58589               AA164519 N24017 N24622 N27149 N70109 R43771               AA010296 W84611 H98889 H88965 AW594424 AA034139 AA065223 N99696               BG981481 N94371 AA767970 W47146 N70977 H05510 W61268               T90796 AA164518 W47244 AA150883 AA034138 BF338483 F13671 H51317               W72716 N21488 AI188071 AI370541 AI754442 AA148524               AI749182 W95221 W92522 R20385       419200   9531_1   BF036043 AW190446 BG194731 AW662036 AI445021               BE937550 AW818972 AW393132 AA834685 BF112058 AV721682 H16423 AI270167               AI857345 AA937302 AW818444 BE929780 BG498678 BF155010 BI598271               BI599811 BE161728 AW578737 AW753711 AW379707 AW381918               BG506608 AW028637 AW994240 BF887392 BF790073 AW381624 AV727105               BF439618 AA443174 AI018009 N42850 AW573242 AI417258               AA463483 AI676131 AI167170 AA836627 AA443828 AW592922 AA235129               AA730278 AW439062 AW474332 BI043239 AW474342 BG708553               AW362423 BF090028 BE827256 R16550 R39478 R39479 R94368 BG540916               BM314745 AA251087 D54231 D55274 BF085805 D31589               AW966405 AW994425 D81879 BE093545 AW901107 AA383529 BI021552               R56420 N39976 AA573281 H82595 AA234955 BE093539               AW367006 BF358697 BF366318 AA663856 BE702099 BF035969 AI267384               AI267232 BE348320 AA621574 AA861212 BF083343 BF083341               AV745131 D53074 AW954476 AW954472 AA376836 AV724531 D53063 C14928               AA093287 AA062638 BG483558 BE940050 AA765954               T70171 BE938775 BE940057 D53502 AW373300 AL118798 BM128728 AA193411               AW444709 AW952455 AI887612 BF431948 BI496876               AI264159 BM128481 AI624657 AI689301 AI969467 AA861685 AA251595               AA625761 AA872090 AI826790 AA328366 BE827416 R75951               D56918 R68122 BE827384 AL118797 AI184164 AA164411 BI495332 BE858113               AI863860 H00660 T69849 AW780389 C14667 BE934995               BI018652 R92801 AA164410 H00752 AW373305 AW373299 AW373302       421297   16064_1   AB033081 AK074324 AW450283 BM128413 BE550945 BE670081 BE674137 AI298087               N30050 BF110807 N30072 AI288098 N30068               AW861931 AW858575 AI363734 AK025483 BF882045 BM128581 AW771330 BE669540 NM_016376               AB037360 AA399607 R94364 BE514643               BG684040 BG759578 T83725 AW858561 AW858524 H65293 AW754345 AK025960               BM477612 BE071291 BF087041 BG995615 BE071350               AI917153 AA436381 BE815318 AK025717 BE857148 AI741138 AW027718 BI789162               AI492263 AI690072 AI420179 BI789249 AI637804               AW957459 BF222458 AI094328 AW510893 AW295994 AI760430 BE464934 BE220458               AI042022 AI653315 BM128472 AW337972 AW515837               AI669489 AW664176 AI768730 AW271660 T16381 AI823834 AJ346113 AI242353               BF437578 AI273673 AW513498 AI797424 AI674242               AI277236 AW731756 AA373089 AW207589 AW467879 AL550999 N30075 BE883669               BF155456 AI423079 R60281 T16974 BG676892               BF927070 BI962758 BE811485 BE811591 BE811702 BE811600 BE811483 BE811533               BF927061 BG008257 BF873368 AL574815 BF946447               H70934 BF939868 BF378761 BE082381 BG984527 AA244447 BG983567 AW885571               AW293182 AW885607 AA811057 AA610310 AI434406               AA514352 H71020 BF740351 BE814815 N66648 AA737686 AI025403 AA255490               N26754 AI094233 AA629548 AA716234 BF343632               AW363633 H62663 N40757 N55959 AW858569 AW604731 N40773 N40777 T83895               AI905899 BG007487 BF820299 R60231 R60787               AA456130 AW383736 BF087045 BG995619       439046   2580645_1   AA829660 AI687296 AA947354       440638   371165_1   BG009500 AI376551 AA897445 T87714       434747   117643 _1   AW976537 AI033582 AA837085 AA745261 AA648395       453929   97058_1   AA045461 AA284145 AI494193 AI469576 AV700262 BF222563 AW190054 AI263834 AA040074 AA045137       455834   1518503_1   BE145364 BE145429 BE145418       421921   100_2   BC011987 AA976353 AA858127 AI370017 AW150562 N22469 AI823318 T39763 AW594422               T39771 T39737 T39788 AA857399 T39764               T39745 NM_012456 AF150089 BI835353 BG683054 BM021899 AI693046               AI350334 AA609007 AA405045 AA412628 AW175775 AA035114               BE729995 AV755393 AW027107 AI500393 H83363 F27315 BI966096 BG338889 BF342663               AI097243 BE047615 AA628513 AI004714               AA147779 AA993774 AA670296 AA845320 AA908522 AI002166 W61055 BE349980               AW205379 R80128 AA383242 AI016394 AA035115               AI309333 AI568254 AI094665 W04770 W24624 F27773 AA378373 AA353029 R50427               BF341287 R99348 BF374303 N75319 AA563593               BF933630       400120   133_1   BC014030 NM_004068 BC004996 AK057883 D63475 BM468205               BG386792 BG750447 BG575842 BG479084 BG741027 AU118129               BE901043 AU141281 BG825395 BG338276 BE396231 AU121493 AU131489 BF341132               BG335659 BI769251 AU142779 AU124483 BG480828               AU121353 BG702326 AU137866 BG759046 BI460601 BE887290 BG750415 BF127710               BG757819 BI160266 AU122086 BG824046 BG744180               BE884943 BM006610 BG702599 BI870749 BF307033 BI334771 BG480606 AU142599               AU141336 BM018563 BI335565 AU138308 BE391241               BG774488 BE278025 BG717959 BG706920 BE312567 AU138300 BE303034 BE303016               AU139252 BE336797 BG470940 BE336735               BF305197 AU134288 AU139907 BE261245 BE208718 BG761912 BF212890 AW732692               BM011258 AW247629 AU136696 BF530078               BF204146 AL048752 BG328927 BE388385 BE260122 AU138789 BE253465 BF733914               AW249415 AW239535 BE311791 BE256236 BF529742               BG770465 AW245777 AW245813 BE296677 BE266852 BE168115 BE396596 BE280057               BE168229 AI750820 AU134137 BF792191 AI272215               AI907348 AW238875 BF805152 BF568397 BE712727 BE081443 BE001805 BF724536               BF744705 AW247385 BE796369 AU133759 AV705142               BE794402 BM465821 BG281284 AW384831 BM450689 AU134125 BE311650 BF356318               BM462831 BG420555 BE749127 AU134590               BM019438 BC013796 BG761223 BG122058 BE872076 BG748496 BG821374 BE619159               BG423244 AU137110 AU127210 BE270081               AA496860 AA351380 AA356303 AU099781 AA355912 AA371411 AA325535 U36188               AL569574 AL577204 AL525543 AL567342 AL567334               AL567122 AL536527 AL567098 BG681585 BG824951 BI870652 BI225855 AW393878               BG750632 BI223803 BE877552 BE270473 BE389392               BE779021 BM017845 BI117816 BE396513 BM049006 AW393945 BE786941 BE267724               BE562981 BE314236 BF744102 BM019781 BF806063               AA909846 BF924341 AW361460 AA425174 BE940557 BF761585 BF931276 BF934886               W68597 BF933977 BI035906 BE836064 BF837576               BI018368 AA205908 H54612 R88902 BE812330 BE932300 BF924562 AW805376 BE769859               R87381 M371901 BE838855 AA326381 W56191               AA341231 AA464093 AL575977 AL518650 AL547393 BG338327 AL517563 AL536921 BG207096               BG207589 BG199290 BG220159 BG744842               BG104730 AA555035 AA618009 AA861062 AA610582 AW245418 AI040983 AA521380               AW245455 AU147292 AU155236 BE620286               AW250767 BF888236 BE620819 AU154343 AU150827 AU148334 AW069495 AA701091               AU155225 AW250019 AA666235 AU147764               AA449739 BF907598 AW043731 AU144390 AI924565 BE300631 AW874021 BE208088               BF732773 BF594057 AI159873 AU143930 N24100               AI052499 AI989370 AI366151 AI139248 AU144776 AA838250 AI095433 Al269227               BF811358 AU151352 AA477554 AI131290 AI049797               AU157349 AA620559 AA581533 AI338299 AA402755 AI050079 AU157614 AI280691               AA706590 BE206615 AA861056 AU153214 AU155712               AW069554 AI081124 AU155846 AI081123 AA719876 AI754976 AI027763 AA723095               BI518782 AW050706 F37521 R79062 AA565530 H39826               AA404670 AU158884 AI139682 AA513633 AI283202 AA651856 AI623515 AA427413               AW248474 BF841432 BM453246 AI302390 AA808269               AI249357 AA132775 AA716732 AA479932 AI198296 AI208674 AI088433 F36977               AA496899 AW615762 AA602541 AA341161 D58785 T15399               AI286077 W69152 F28418 AI272156 AA338034 AA568455 BE206121 AI080033               AI699680 AA861255 AI953465 AI613240 AL581773 AL531577               BF526361 AA657809 AW152670 BE621523 AW078705 AW673719 AA102613               AA195604 R72209 AA402208 AA404305 N24999 AI963535               D54741 BI461415 BM475959 BI260926 BI116213 BE280120 BE940258 BE280044               AI905744 BG001474 BE937718 BF799283 BI091621               BG421006 BG289235 BF736825 BI253429 BG170064 R72512 T92815 BF931257               BM455183 BG033362 BG574220 N31395 BF739185               AA371995 BE879011 BI198754 BF378989 T12266 BM019421 BI194570 BF378992               AW996595 BI858649 W94605 W61345 AA122384               AA171923 T92736 AA761504 AI819039 AI439358 AL517777 AL565919 AA622001               AA642695 AA704144 AA081465 AA070621 AA375562               AA700011 AA926863 W37310 AL566236 BF677809 BG760021 AW361433 BE828605               BE268449 BF805977 BG292452 BF981071 BF217108               BF928698 R33993 AW882841 AI857453 AW078733 AI433035 AI018103 R90927               AA804720 AA551734 R33835 H19741 R78754 BF930494               BG109583 AA631926 BE834008 BG996533       437580   1240047_1   AW976343 AA761075 AA983906       433162   2167905_1   AI742311 AI025842 AA578843       412240   8235_1   BF963346 BI460763 BI599382 AI188089 AY055003 AW959185 AA187681 AI692282 AU153608               BI493898 BI493899 AI797349 BE550679               AI701137 AA744561 AA082682 BE218816 AW511501 BF447881 AI859101               BF059295 AI914038 AI346564 AI685003 AI676076 AI125336               AW469637 T10225 AI831296 R53451 AI453440 AA983739 AW470873 AI348290               BE857670 D55901 Z43908 T34429 F07305 AK074340               AL538118 BG201484 AI334192 T35535 AW176751 BI496132 BI496133 AA469961               H72176 BF326265 AI770016 AI693177 BF223634               BF963661 BF962265 BI034894 AI475851 N69071 AI910707 BE219038 AI918036               BE670589 BM193515 AI338497 AA805525 AA487625               AA830336 AA749368 AW104323 AI628055 AI932332 AI272788 AI536849 AW162414               AW161923 T23854 AA610763 AA912188 AW339028               Z39946 T10224 F03171 AI205478 AI638791 F02580 F01551 AW207551 AA421030               BE246012 BI034937 BI035373 BF939581 H19984               BE867247 H92677 N55988 BF957332 H18615 R16442 BF956229 BF961886 R12698               AA101186 AA365932 R53452 BF062714 BF959364               H41634 AW086187 H19985 BF054881 F02581 H18616 H41527 AW003446 BE243443               H92276 AW954002 BI670132       447881   44623_1   AK074291 AW293424 BE676135 AI832125 BE019146               BE465019 AI761124 AA617778 AI279232 AW575897 AI672039 F28618 BF924261               AA722184 BF934174 BE004328 AV749301 BE880282 BI019798 BI019389 BF928776               AW813409 AV726604 AA077560 BE272975 BF949119               AW814195 BE879126 AI697926 BF594155 BE205787 BF063513 N35828 AI948557               AI433839 AI379679 BG056182 AI589094 N23123               AA588805 AW316581 AI080272 AI421980 AI493318 BF194830 N87590 AA495993               N32996 AA699844 H96845 H96592 N28741 BI035539               BF747723 BF171066 W01350 H05495 AI243785 Z39622 AA887432 AI350659 R46102       411590   2329293_1   T96183 T64070 AA094134       414588   296561_1   AA495793 AA302905 AA149783 BI059949 BF916498 BF924146 AW838065 BF990024 AW837915 AW837899 AW837927               AW837919               AW837903 AW838051       446126   610_2   BF946219 BF946218 BF851494 AL536879 AA457150 AI590194 AI582629               AA464515 AA916242 M337109 AA336509 N46906 AA336322               AA336407 AA337222 AA319240 BI026817 BI027058 AL536880 AI693827 AA651730               AI701013 BM068789 AW339506 AA293021 BF891108               AI458885 AW361203 AW974652 AI761251 AI655763 AA628063 BE047125               AW085916 AI129587 N52070 AW172361 AA052951 AW085909               AI000008 AA962570 AI371342 AI364207 AA464514 AI962506 AI824603               AW376300 AA058439 AW361192 AV656660 N50282 BF820514               BF891008 H40784 BF891112 BE708029 AW043567 AA056762       438619   35124_1   NM_016575 AB032773 AI765521 BF593742 AI497757 AI761233 AW467938 BF000670               AI818496 N24761 AL043306 BF476138 BF593836               AA132787 AI147248 AI086795 AA151317 T95298 AW083548 AA058371 N27951               AI769860 AI784548 AW205506 AI800679 AI041733 AI459902               BE327641 AI865829 AI254736 AI302433 AI744176 AI241825 AA027842 AL524933               AL524932 BF947764 BF340737 BF948700 BG996395               N53455 N21027 AI127616 N35901 M682443 AA678249 AA719371 M132582 T15981               H99958 N40717 AW959402 AI267251 BF909329               AI142035 T95379 H29420 R59632 H17318 H17331 H29327 R40829 R43395 R59573               AI749561 R56599 H16755 AI694500 AA027907       411468   1085621_1   AW857472 AW847920 AW857357 AW857470 AW857354       432709   1870037_1   H17238 AA563739 F05559 F06116       414883   8371_2   AF274943 BG494894 AI719075 AA908783 AI935150 AI422691 AA910644 AA583187 BM272167 AI828996               AA527373 AW972459 AI831360               AA772418 AI033892 AA100926 AU154749 AI459432 AI423513 AI094597               AA740817 AI991988 AI090262 AI312104 BI256707 AA459522               AA416871 AI075239 AI339996 AA701623 AI139549 AI336880 AA633648               AI989380 AI362835 AA399239 AI146955 BF514270 N92892               AI348243 AI278887 AA459292 AI494230 BF507531 AI492600 M962596 AW613002               AA293140 AA235549 BF108854 AA954344 N49682               AI457100 AW589407 AW300758 BE220715 BE220698 BE569091 BM009647               BF900351 AI537692 AI203723 AI857576 AA584410 AW371667               BM172363       449901   1269988_2   BI227033 AI674072       426295   510_1   BE880923 BG390191 AW470082 AW014585 AI423255 BI714731 BG054894 AW780248 N31683 AW664132               AW467353 AI983152 AA617918               BF447795 AI088357 AA807328 AA576970 AI741153 AI755003 AI474016               AI422030 AI348114 AW997085 BM271753 AI363147 BM311311               AM146640 AI246771 AW512619 AI359020 BG054897 AI292234 AI215830               AI283836 C06205 AW503423 AW272680 N33205 AW873021               AA070724 AI753886 AW192487 AI087151 AA658909 AI346368 AI335677               AA825442 AW440066 AW131357 AW513210 AI082314 AI085455               BE551404 AA780704 AW008596 AI796964 AA917471 AI400531 AA668626               N72207 AI306482 AW440562 AI084687 AA347280 AA063536               BF477389 AI241662 AA931543 AA484310 AA812486 AI032216 AA665779               AI916336 AI350590 BF198106 AI433377 AI300638 AI672626               AI282741 AI351487 AW105544 AA973627 AW517914 AA715424 AA508454               BF334080 AI274618 AW367201 AW572619 AW469088 AA382095               AI368364 AI146934 AI357180 AI361181 BI911347 BI871044 AA136325               BF084010 BF084007 AA335788 AI920878 AA809614 BE932941               AI678261 C75308 AI148479 BE178174 W88513 BM013627       455705   77478_2   BF971018 BE513812 AA133359 AW581719 BF434402 AL600619 BG699731 BI551395 AW027136               AW055130 BF939512 AI076048 H18584               AW161061 AA864334 AI816101 BE049456 AW044012 AA954079 AI274682               AI370526 AW131990 AA853195 AA853191 BG118295 AA761620               BG705371 BF355591 BF336596 AA360497 H28072 BG198352 AW364709               H40926 H44214 AA836538 BI059563       424571   9758_1   BE379766 AW152643 AI803450 AI564343 AI092711 AI140525 AW152156 AI620740 AI554689               AI161209 AI290242 AI339745 AI374611               AI347388 AI858296 Al140529 AI366124 AA493912 AA406235 AA493889               AI057160 AW022264 AI097277 AM144126 AI080051 AA983529               AA860507 N53469 AA843767 N81163 N70628 AA424577 AA983537 BF003004               AA626688 AA235977 AI057152 AI095366 AI095356 AA458646               AW194479 AA150439 AI375272 AW571777 AI359198 AA993793 BE614394 BE738239               AA127883 AI034344 T59504 D81608 AA908704               AW051665 AA382785 AA307208 N24639 AI370715 BE244980 AA548596 AW449675               AM91008 BF223749 N70752 N22266 AI191012               AA028001 AI419106 BF215661 BF591548 BG942356 AI474968 BE858217 BF793358               AV756758 BG483603 AI093724 BF693395 BG545345               AI744294 T59549 AA811773 BG499757                                            
     [0356]                           TABLE 70                       Pkey   Ref   Strand   Nt_position                  403790   8084957   Minus   87826-87947,89835-90002       405102   8076881   Minus   120922-121296       402727   9211324   Plus   54596-54777       405268   4156151   Minus   24404-24521       400517   9796686   Minus   49996-50346       405141   8980911   Plus   99861-100054       403738   7212067   Plus   38434-38562,56876-57007,                   59789-59876,6071       403904   7710675   Minus   8129-8261,41911-42053       402737   9212184   Minus   13358-13552       401091   9958240   Plus   94760-94898       402507   9797889   Plus   118979-119086       402964   9581599   Minus   46624-46784       406423   9256411   Plus   165600-165824       406038   8389537   Plus   37764-37877       401649   9090641   Plus   80229-80762       400475   9957990   Minus   64771-64887,67396-67563       403575   8101156   Minus   81961-82068       401016   8117441   Plus   126234-126359,128050-128236       405689   4508117   Minus   92558-92698,94282-94382,                   97977-98180.9920       403809   8568861   Plus   33910-34129,34583-34862       403671   7272159   Plus   104461-104701       402041   7770639   Plus   69353-69454       403478   9958258   Plus   116458-116564       403027   7670575   Plus   60696-60932, 61362-61521       400471   9931670   Minus   105629-105760       404433   7407979   Minus   124561-124764       401898   8570008   Minus   72013-72132, 72400-72487       402836   8745058   Minus   96756-96941       403330   8516153   Plus   116558-116698       403743   7652003   Minus   136463-136646       406274   7543787   Plus   932-1123       401197   9719705   Plus   176341-176452       404676   9797204   Minus   56167-56342, 58066-58189,                   58891-59048, 6045       401635   7145001   Minus   51895-52764       403976   7657840   Plus   24755-24969       401928   3873182   Plus   54932-55070       401952   3319121   Minus   53770-53979       405117   8096945   Minus   109169-109866       400557   9801261   Plus   208453-208528, 209633-209813       403920   7710868   Plus   40312-40490       403496   7523883   Minus   140940-141126, 144920-145123       405122   8137462   Minus   95449-95646       403320   8318526   Plus   127978-128124       405270   4156145   Minus   3952-4123, 6886-7010, 8541-8728       405688   4508117   Minus   88702-88899       401627   8575953   Minus   72828-73029       403576   6862645   Minus   73475-73940, 74079-74207       403742   7212067   Plus   84805-85525, 91096-91227,                   93970-94057, 9523       405086   8072509   Plus   73664-73841, 74081-74217,                   74610-74779, 7492       402929   8217647   Minus   51862-52032       404240   5002624   Minus   116132-116407, 116653-116922       400906   9966290   Plus   112863-112989, 120162-120286                                                    
     [0357] Table 8A lists about 254 genes down-regulated in Hepatitis C positive liver tissues compared to Hepatitis C negative liver tissues. These genes have the potential to be diagnostics and/or prognostic markers for Hepatitis C infected liver tissues. They may also provide clinical information on Hepatitis C infection and pathology. They may also be potential targets for therapeutic drugs and/or treatments. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the Wilcoxon rank-sum test p-value between the 2 groups was less than 0.10, the ratio of the “weighted average” of Hepatitis C negative liver tissues to the “weighted average” of Hepatitis C positive liver tissues was equal to or above 2.0, and that the differences between the same 2 groups was equal to or above 30.0. The “weighted average” of the Hepatitis C negative liver tissues was set to the trimean of several different Hepatitis C negative liver tissues. The “weighted average” of the Hepatitis C positive liver tissues was set to the either 10 or the trimean of several different Hepatitis C positive liver tissues, whichever value was greater to eliminate ratios with a denominator of zero or less.  
                                   TABLE 8A                       Pkey   ExAccn   UniGene   Unigenen Title   R1   R2                                                        451831   NM_001674   Hs. 460   activating transcription factor 3   2.25E−04   23.90       450912   AW939251   Hs. 25647   v-fos FBJ murine osteosarcoma viral onco   7.80E−06   23.32       414559   AV656184   Hs. 76452   C-reactive protein, pentraxin-related   9.77E−04   20.48       447078   AW885727   Hs. 9914   ESTs   2.93E−02   14.42       416188   BE157260   Hs. 79070   v-myc avian myelocytomatosis viral oncog   8.41E−04   12.75       451029   AA852097   Hs. 25829   ras-related protein   9.37E−03   10.77       434078   AW880709   Hs. 283683   chromosome 8 open reading frame 4   1.93E−03   10.32       442941   AU076728   Hs. 8867   cysteine-rich, angiogenic inducer, 61   9.18E−05   10.10       405278           NM_002864:  Homo sapiens  pregnancy-zone pr   5.19E−03   8.45       428106   BE620016   Hs. 182470   PTD010 protein   5.03E−04   7.47       446066   AI343931   Hs. 149383   ESTs   2.01E−03   7.30       407173   T64349       gb: yc10d08.s1 Stratagene lung (937210) H   4.77E−03   6.90       414220   BE298094   Hs. 101150   gb: 601118231F1 NIH_MGC_17  Homo sapiens  c   5.74E−02   6.65       431319   AA873350   Hs. 302232   ESTs   1.19E−02   6.52       416434   AW163045   Hs. 79334   nuclear factor, interleukin 3 regulated   2.63E−02   6.50       448607   AL042506   Hs. 21599   Kruppel-like factor 7 (ubiquitous)   4.36E−03   6.50       420101   AW500529   Hs. 95180   KIAA0767 protein   6.53E−04   6.49       414327   BE408145   Hs. 185254   ESTs, Weakly similar to T24435 hypotheti   3.13E−04   6.32       446584   U53445   Hs. 15432   downregulated in ovarian cancer 1   5.39E−02   5.82       404501           nucleoside phosphorylase   6.12E−02   5.70       420548   AA278246   Hs. 920   ESTs   7.62E−03   5.68       409233   AK002001   Hs. 51305   v-maf musculoaponeurotic fibrosarcoma (a   1.09E−04   5.55       427509   M62505   Hs. 2161   complement component 5 receptor 1 (C5a I   7.95E−03   5.48       400425   AY004252   Hs. 287385   PR domain containing 12   1.91E−04   5.40       401149           Target Exon   2.04E−05   5.35       427557   NM_002659   Hs. 179657   plasminogen activator, urokinase recepto   3.33E−05   5.26       449986   AW864502       gb: PM4-SN0016-120400-004-b12 SN0016 Homo   3.61E−02   5.25       419299   AI311085       hypothetical protein FLJ22573   3.50E−03   5.15       450335   BE218355   Hs. 201781   ESTs, Weakly similar to B34087 hypotheti   3.06E−03   5.15       417752   C15737   Hs. 269386   ESTs   5.87E−04   5.07       423053   BE312679       gb: 601148138F1 NIH_MGC_19  Homo sapiens  c   1.81E−04   5.02       448871   BE616709   Hs. 159265   kruppel-related zinc finger protein hcKr   2.22E−03   5.02       408278   AW876813       phosphoglycerate dehydrogenase   2.66E−04   5.00       431326   AW970580   Hs. 198689   KIAA0728 protein   6.12E−02   4.92       436068   AK000038   Hs. 300979   ESTs, Weakly similar to I38022 hypotheti   5.92E−03   4.85       409795   AI934808       ESTs, Weakly similar to T46338 hypotheti   2.32E−03   4.84       430070   AF197927   Hs. 231967   ALL1 fused gene from 5q31   2.94E−05   4.83       411929   AA098880   Hs. 69297   ESTs   1.14E−02   4.75       402273           Target Exon   2.11E−03   4.72       453196   AW003567       ESTs   3.50E−03   4.72       418303   AA215701   Hs. 186541   ESTs, Weakly similar to I38022 hypotheti   2.63E−02   4.70       455510   AA422029   Hs. 143640   ESTs, Weakly similar to hyperpolarizatio   6.12E−02   4.65       423720   AL044191   Hs. 23388   hypothetical protein DKFZp434F0318   1.13E−03   4.63       402517           Target Exon   1.13E−03   4.61       454598   AW809716       gb: MR4-ST0124-241199-026-h09 ST0124 Homo   3.06E−03   4.40       448429   D17408   Hs. 21223   calponin 1, basic, smooth muscle   1.89E−02   4.35       429258   AA448765   Hs. 184252   gb: zx10e09.r1 Soares_total_fetus_Nb2HF8 —     7.00E−03   4.34       412176   AW898334       gb: RC3-NN0070-270400-011-f02 NN0070 Homo   7.60E−04   4.27       441269   AW015206   Hs. 178784   ESTs   1.29E−02   4.22       458867   AW995393       gb: QV0-BN0042-170300-163-g12 BN0042 Homo   1.16E−06   4.22       417732   R36065       gb: yg69h06.r1 Soares infant brain 1NIB H   9.14E−05   4.13       444863   AW384082   Hs. 104879   serine (or cysteine) proteinase inhibito   6.12E−02   4.13       415477   NM_002228   Hs. 78465   v-jun avian sarcoma virus 17 oncogene ho   7.23E−04   4.12       415994   NM_002923   Hs. 78944   regulator of G-protein signalling 2, 24 k   9.78E−04   4.05       417551   AI816291   Hs. 82273   hypothetical protein   4.30E−04   3.98       426006   R49031   Hs. 22627   ESTs   3.61E−02   3.95       401553           Target Exon   8.32E−02   3.95       432877   AW974111   Hs. 292477   ESTs   9.36E−02   3.92       410052   AA525225   Hs. 334630     Homo sapiens  cDNA FLJ14462 fis, clone MA   1.14E−02   3.92       459476   BE185844       gb: IL5-HT0731-110500-087-c08 HT0731 Homo   7.31E−03   3.92       404958           Target Exon   9.30E−04   3.90       431394   AK000692   Hs. 252351   HERV-H LTR-associating 2   4.76E−03   3.88       403324           C2000428*: gi|7705383|ref|NP_057536.1|GC   1.34E−02   3.88       447744   AA313230   Hs. 19413   S100 calcium-binding protein A12 (calgra   1.69E−02   3.88       447802   AW593432   Hs. 161455   ESTs   1.83E−03   3.87       424946   M64572   Hs. 153932   protein tyrosine phosphatase, non-recept   5.38E−02   3.85       401913           ENSP00000249158*: CDNA   8.32E−02   3.84       430389   AL117429   Hs. 240845   DKFZP434D146 protein   1.10E−02   3.83       441188   AW292830   Hs. 255609   ESTs   3.14E−02   3.82       449236   AJ403126   Hs. 26373     Homo sapiens  cDNA: FLJ23449 fis, clone H   4.73E−02   3.82       446052   AA358760   Hs. 95893   gb: EST67699 Fetal lung II  Homo sapiens  c   2.16E−05   3.81       431861   AA521072   Hs. 292128   ESTs   5.29E−04   3.76       411993   AA099329   Hs. 151764   ESTs   2.54E−02   3.75       449335   AW150717   Hs. 345728   STAT induced STAT inhibitor 3   2.11E−03   3.73       403794           Target Exon   1.08E−03   3.71       409840   AW502122       gb: UI-HF-BR0p-ajr-c-08-0-Ul.r1 NIH_MGC_5   4.51E−05   3.67       410057   R66634   Hs. 268107   multimerin   1.39E−02   3.65       456525   AW468397   Hs. 100000   S100 calcium-binding protein A8 (calgran   4.57E−02   3.65       447572   AI631546   Hs. 287331   zinc finger protein ZNF286   1.45E−03   3.65       449785   AI225235   Hs. 288300   hypothetical protein FLJ23231   1.69E−02   3.65       412568   AI878826   Hs. 74034   caveolin 1, caveolae protein, 22 kD   2.93E−02   3.64       454985   AW849292       gb: IL3-CT0215-020300-090-E06 CT0215 Homo   2.04E−02   3.63       424554   AA747563   Hs. 131799   ESTs, Weakly similar to ALU8_HUMAN ALU S   2.93E−02   3.60       440535   AI590563   Hs. 125910   ESTs   5.43E−03   3.60       403180           Target Exon   1.15E−04   3.58       435715   T78013   Hs. 167279   FYVE-finger-containing Rab5 effector pro   7.62E−03   3.57       402651           NM_000721*:  Homo sapiens  calcium channel,   1.31E−03   3.57       419555   AA244416       gb: nc07d11.s1 NCI_CGAP_Pr1  Homo sapiens     1.53E−04   3.54       404359           Target Exon   5.67E−03   3.52       418525   AW450369   Hs. 86937   ESTs   2.32E−03   3.52       453899   AW134536   Hs. 243994   ESTs   5.20E−03   3.52       402889           ENSP00000217123*: FLJ00118 protein (Fragm   1.31E−03   3.52       403796           Target Exon   9.27E−04   3.50       404473           ENSP00000247423: D-siglec precursor.   1.18E−03   3.50       408120   AW299900   Hs. 267632   TATA element modulatory factor 1   2.55E−03   3.50       447819   U90544   Hs. 19710   solute carrier family 17 (sodium phospha   2.45E−02   3.50       402023           Target Exon   7.83E−02   3.47       415897   H08323   Hs. 268712   ESTs   2.13E−04   3.47       445402   AI222415   Hs. 147852   ESTs   1.08E−03   3.47       404518           CD83 antigen (activated B lymphocytes, i   7.15E−02   3.45       450875   AK000724       karyopherin alpha 6 (importin alpha 7)   2.65E−04   3.45       454636   AW811502       gb: QV2-ST0145-061299-015-b04 ST0145 Homo   5.43E−03   3.44       403579           Target Exon   1.96E−02   3.40       456782   AK000462   Hs. 132071   ovarian carcinoma immunoreactive antigen   1.15E−04   3.39       433010   AW970018       gb: EST382097 MAGE resequences, MAGK Homo   3.05E−03   3.35       443725   AW245680   Hs. 9701   growth arrest and DNA-damage-inducible,   1.92E−05   3.33       400407   AF210247   Hs. 283949   enamelin   7.19E−04   3.32       432304   AA932186   Hs. 69297   ESTs   1.25E−03   3.32       447721   BE619620       lysyl oxidase   5.40E−05   3.32       433095   AK001092   Hs. 302480     Homo sapiens  cDNA FLJ10230 fis, clone HE   2.92E−03   3.30       442364   AA993149   Hs. 129895   ESTs, Moderately similar to TBX3_HUMAN T   5.58E−04   3.30       444080   AW812664       gb: RC4-ST0185-191099-012-h10 ST0185 Homo   4.41E−02   3.30       403545           Target Exon   1.03E−03   3.26       454741   BE154396       gb: CM2-HT0342-091299-050-b05 HT0342 Homo   8.27E−03   3.24       428177   AA423967       ESTs   8.37E−04   3.24       454292   N57559   Hs. 82273   hypothetical protein   5.05E−02   3.22       427536   BE277141   Hs. 115803   gb: 601178666F1 NIH_MGC_20  Homo sapiens  c   8.81E−04   3.20       439760   AL355741   Hs. 21641     Homo sapiens  mRNA full length insert cDN   1.31E−03   3.20       450799   AW407504       gb: UI-HF-BM0-adk-g-12-0-UI.r1 NIH_MGC_38   1.08E−03   3.16       447135   T58148       gb: yb98g06.s1 Stratagene lung (937210) H   2.38E−04   3.13       417079   U65590   Hs. 81134   interleukin 1 receptor antagonist   5.21E−03   3.11       428568   AC004755         Homo sapiens  chromosome 19, fosmid 37502   1.19E−03   3.11       406060           Target Exon   2.02E−03   3.07       421224   AW402154   Hs. 125812   ESTs   1.92E−03   3.05       459399   BE407712   Hs. 153998   creatine kinase, mitochondrial 1 (ubiqui   3.06E−03   3.05       440509   BE410132   Hs. 134202   ESTs, Weakly similar to T17279 hypotheti   2.25E−04   3.05       408952   S79854   Hs. 49322   deiodinase, iodothyronine, type III   6.52E−04   3.04       410619   BE512730   Hs. 65114   keratin 18   8.62E−03   3.03       452236   AI130858   Hs. 143218   ESTs   1.29E−02   3.02       436651   BE045962   Hs. 275998   ESTs   5.55E−02   2.97       430071   AA355986   Hs. 232068   transcription factor 8 (represses interl   2.04E−02   2.97       405600           C12001673: gi|9631264|ref|NP_048045.1|or   2.19E−02   2.97       416666   H73028   Hs. 268992   ESTs   2.13E−04   2.96       414141   BE255083   Hs. 145729   hypothetical protein DKFZp564A1164   2.92E−03   2.95       427408   AA583206   Hs. 2156   RAR-related orphan receptor A   9.92E−02   2.92       422017   NM_003877   Hs. 110776   STAT induced STAT inhibitor-2   4.57E−03   2.92       444047   AI097452       ESTs   2.73E−02   2.90       440898   AL035690   Hs. 165   glucagon-like peptide 1 receptor   1.96E−02   2.90       408253   AW807476   Hs. 21051     Homo sapiens  mRNA for FLJ0012 protein,   2.11E−02   2.88       446912   AI347650   Hs. 128521   ESTs, Moderately similar to ALU4_HUMAN A   2.54E−03   2.88       457148   AF091035   Hs. 184627   KIAA0118 protein   2.32E−03   2.86       444207   AI565004       cathepsin D (lysosomal aspartyl protease   3.53E−05   2.84       438460   AB020702   Hs. 6224   KIAA0895 protein   1.51E−03   2.82       405502           C7000609*: gi|628012|pir||A53933 myosin I   4.72E−02   2.82       453560   AA348626   Hs. 5890   hypothetical protein FLJ23306   1.19E−02   2.82       417213   BE257508   Hs. 24719   modulator of apoptosis 1   5.05E−05   2.81       403582           Target Exon   8.57E−02   2.80       408112   AW451982   Hs. 248613   ESTs   2.83E−02   2.80       437180   BE180234   Hs. 281462     Homo sapiens  cDNA FLJ14793 fis clone NT   2.67E−03   2.79       412429   AV650262   Hs. 75765   GRO2 oncogene   1.01E−06   2.79       421993   R22497   Hs. 110571   growth arrest and DNA-damage-inducible,   1.62E−04   2.79       407338   AA773213   Hs. 200558   gb: ab66f10.s1 Stratagene lung carcinoma   2.32E−03   2.78       448778   AF074913       gb:  Homo sapiens  transcription factor Pax   1.14E−02   2.77       422743   BE304678   Hs. 119598   ribosomal protein L3   2.36E−02   2.75       427413   BE547647   Hs. 177781   hypothetical protein MGC5618   5.43E−03   2.70       447306   AI373163   Hs. 170333   ESTs   5.21E−02   2.70       447526   AL048753   Hs. 303649   small inducible cytokine A2 (monocyte ch   2.20E−02   2.69       400818           Target Exon   2.26E−04   2.69       432128   AA127221   Hs. 296502   ESTs   3.25E−02   2.67       414890   BE281095   Hs. 77573   uridine phosphorylase   1.59E−03   2.65       413731   BE243845   Hs. 75511   connective tissue growth factor   2.45E−02   2.65       434180   AA921757   Hs. 116180   ESTs   1.37E−04   2.64       435992   AI033259   Hs. 118317     Homo sapiens  cDNA FLJ12088 fis, clone HE   2.83E−02   2.63       419180   T95449   Hs. 220817   ESTs   1.56E−02   2.63       457054   NM_014137   Hs. 177258   PRO0650 protein   1.75E−02   2.63       432745   AI821926       gb: nt78f05.x5 NCI_CGAP_Pr3  Homo sapiens     7.21E−04   2.62       427899   AA829286   Hs. 332053   serum amyloid A1   1.75E−03   2.61       405443           Target Exon   6.44E−03   2.61       428403   AI393048   Hs. 326159   leucine rich repeat (in FLII) interactin   6.94E−02   2.61       409463   AI458165   Hs. 17296   hypothetical protein MGC2376   2.63E−02   2.60       402878           ENSP00000217420*: BA122O1.1 (A novel prot   3.12E−04   2.57       404046           NM_019120*:  Homo sapiens  protocadherin be   1.66E−03   2.56       458873   AW150717   Hs. 345728   STAT induced STAT inhibitor 3   3.05E−03   2.55       426653   AA530892   Hs. 171695   dual specificity phosphatase 1   2.52E−04   2.55       411920   AW876263       gb: PM4-PT0019-131299-006-E09 PT0019 Homo   1.75E−02   2.54       454339   AW381980       gb: QV4-HT0316-091199-028-05 HT0316 Homo   2.04E−02   2.52       432909   AA570111       ESTs, Weakly similar to ALUE_HUMAN !!!!   1.30E−03   2.51       411283   AW852754       gb: PM1-CT0247-180100-009-c05 CT0247 Homo   3.03E−02   2.50       415759   AA169182   Hs. 182740   gb: zp20e02.s1 Stratagene fetal retina 93   2.43E−03   2.50       447650   AW581199   Hs. 161137   ESTs, Moderately similar to 154374 gene   8.28E−03   2.50       402012           ubiquitin specific protease 15   3.88E−04   2.50       423499   AW608884   Hs. 28068   ESTs   2.96E−04   2.49       402124           NM_031891:  Homo sapiens  cadherin 20, type   3.05E−03   2.47       412755   BE144306   Hs. 179891   ESTs, Weakly similar to P4HA_HUMAN PROLY   1.38E−03   2.47       418443   NM_005239   Hs. 85146   v-ets avian erythroblastosis virus E26 o   1.37E−04   2.47       419239   AA468183   Hs. 184598     Homo sapiens  cDNA: FLJ23241 fis, clone C   6.72E−02   2.47       419909   AL136653   Hs. 93675   decidual protein induced by progesterone   1.08E−03   2.45       402608           CD83 antigen (activated B lymphocytes, i   4.57E−02   2.44       402022           Target Exon   4.00E−03   2.42       458568   AI769067   Hs. 127824   ESTs, Weakly similar to T28770 hypotheti   8.65E−05   2.42       442702   AW235697   Hs. 130980   ESTs   6.12E−02   2.42       424236   AW058114   Hs. 7837   phosphoprotein regulated by mitogenic pa   6.17E−03   2.42       427700   AA262294   Hs. 180383   dual specificity phosphatase 6   2.04E−02   2.41       410204   AJ243425   Hs. 326035   early growth response 1   4.00E−03   2.41       424221   NM_014478   Hs. 300684   calcitonin gene-related peptide-receptor   8.59E−05   2.41       401376           Target Exon   8.26E−03   2.40       456147   H41324   Hs. 31581   ESTs, Moderately similar to ST1B_HUMAN S   4.28E−02   2.40       407654   AW064121   Hs. 279175   ESTs   1.83E−03   2.38       402364           CCAAT/enhancer binding protein (C/EBP),   3.25E−02   2.37       438808   M73980   Hs. 129053     Homo sapiens  NOTCH 1 (N1) mRNA, complete   1.30E−05   2.36       401942           C17001396*: gi|3212355|pdb|1A4P|A Chain A   3.80E−03   2.33       426521   AF161445   Hs. 170219   hypothetical protein   3.03E−02   2.32       446378   AI905699       citrate synthase   3.18E−03   2.31       408935   BE539706   Hs. 285363   ESTs   4.77E−03   2.31       424028   AF055084   Hs. 153692     Homo sapiens  cDNA FLJ14354 fis, clone Y7   6.93E−02   2.29       433070   N75346       CDC20 (cell division cycle 20, S. cerevi   5.56E−02   2.29       456825   H67220   Hs. 169681   death effector domain-containing   1.24E−02   2.26       459711   BE386801   Hs. 21858   trinucleotide repeat containing 3   8.29E−03   2.26       406140           Target Exon   8.12E−05   2.26       400327   M18679       Human variant 5S rRNA-like gene and ORF,   8.07E−02   2.25       455968   BE168828       gb: QV1-HT0517-020400-145-f04 HT0517 Homo   2.65E−04   2.25       431387   AI878854   Hs. 252229   v-maf musculoaponeurotic fibrosarcoma (a   1.75E−02   2.24       421233   AA209534   Hs. 284243   tetraspan NET-6 protein   1.82E−02   2.23       401522           CGI-35 protein   5.42E−03   2.22       422831   R02504   Hs. 332943   ESTs   1.14E−02   2.22       401346           hypothetical protein   2.93E−02   2.21       410268   AA316181   Hs. 61635   six transmembrane epithelial antigen of   2.36E−02   2.20       434495   AW352170   Hs. 129086     Homo sapiens  cDNA FLJ12007 fis, clone HE   1.56E−02   2.20       442321   AF207664   Hs. 8230   a disintegrin-like and metalloprotease (   1.69E−05   2.19       458692   BE549905   Hs. 231754   ESTs   7.60E−02   2.19       403750           C5001092: gi|6671939|gb|AAF23199.1|AC0167   5.90E−03   2.18       441516   F06700   Hs. 7879   interferon-related developmental regulat   2.93E−02   2.18       423503   M92843   Hs. 343586   zinc finger protein homologous to Zfp-36   1.19E−03   2.18       456465   M94065   Hs. 94925   dihydroorotate dehydrogenase   6.84E−05   2.17       440249   AI246590   Hs. 249175   ESTs   1.53E−04   2.16       459235   BE246010         Homo sapiens  mRNA for FLJ00038 protein,   4.54E−04   2.15       409540   AW409569   Hs. 101550   gb: fh01e09.x1 NIH_MGC_17  Homo sapiens  cD   7.98E−04   2.14       412541   BE009398   Hs. 74002   nuclear receptor coactivalor 1   7.31E−03   2.13       449713   AW027025       ESTs   6.19E−04   2.13       442351   W52642   Hs. 8261   hypothetical protein FLJ22393   8.39E−04   2.13       407869   AI827976   Hs. 24391   hypothetical protein FLJ13612   3.06E−03   2.13       411372   AI147861   Hs. 213289   low density lipoprotein receptor (famili   7.71E−05   2.12       423168   R34385   Hs. 124940   GTP-binding protein   1.06E−02   2.11       414002   NM_006732   Hs. 75678   FBJ murine osteosarcoma viral oncogene h   4.02E−06   2.10       419048   T91158   Hs. 268605   ESTs   1.37E−03   2.09       433178   AB038269   Hs. 253706   cysteinyl leukotriene CysLT2 receptor; c   1.92E−03   2.08       432190   T80206   Hs. 14716   ESTs   1.25E−03   2.07       447261   NM_006691   Hs. 17917   extracellular link domain-containing 1   9.36E−02   2.07       436869   NM_014867   Hs. 5333   KIAA0711 gene product   2.67E−03   2.06       402441           Target Exon   4.77E−03   2.05       441475   AI929602   Hs. 177   phosphatidylinositol glycan, class H   2.02E−04   2.05       404126           ENSP00000211797*: Helicase SKI2W (Helicas   1.08E−03   2.05       443514   BE464288   Hs. 141937   ESTs   8.57E−02   2.05       404187           NM_019602:  Homo sapiens  butyrophilin-like   3.35E−03   2.03       424125   M31669   Hs. 1735   inhibin, beta B (activin AB beta polypep   1.82E−02   2.03       400409   AF153341         Homo sapiens  winged helix/forkhead trans   4.37E−03   2.02       404752           NM_024778:  Homo sapiens  hypothetical prot   2.82E−02   2.02       449338   H73444   Hs. 394   adrenomedullin   2.36E−02   2.02       437389   AL359587   Hs. 271586   hypothetical protein DKFZp762M115   2.63E−02   2.02       401405           Target Exon   3.49E−02   2.01       429446   AI547111       gb: PN2.1_A01_G12.r mynorm  Homo sapiens  c   2.36E−02   2.01       431111   AB033072   Hs. 250015   KIAA1246 protein   1.44E−04   2.01       406210           Target Exon   1.82E−02   2.01       417076   AW973454   Hs. 115175   ESTs, Moderately similar to ALU7_HUMAN A   2.04E−02   2.00                                                                  
 
     [0358]                       TABLE 8B                       Pkey   CAT Number   Accession                  449986   2292_10   AK055879 AW007836 AA873089 N74374 AV720071 AA702706 AW055276               BE672779 AW864502 AI678780 AW864369 AI052145 T40984               N74426       419299   36328_1   BM477587 BE675426 AA827059 AI597639 AI571409 AI719948 AI311085               AA953361 AI498787 AI364049 AI311084 BF871020 BE549868               AI356384 AA236660       423053   367623_1   BE314223 AA320990 BE312679 BI054000 BI324838 AW057717       408278   MH337_68   BG422281 BG422108 AW177973 BG750536 AW876813 AW876814       409795   MH905_27   AI498073 AI934808 AW374654 BI036066 BE709215 AA077985 BI831355               BF932450 BF770705 BF379220 AA077682 AA076814 AA076875               BI027970 AA077787 AA077311 BF811798 AW393752 BF327269 AA077305               AA078114 BF800885 BF942930 AW903223 BF916052 AW903170               AW903224 BF352664 BF379209       453196   505145_1   AW003567 AI963955 AI990231       454598   1063474_1   BF374577 AW809840 AW809996 AW809798 AW809695 AW809646 AW809738 BF374582               AW809716 AW809826 AW809802 AW809747               AW810152       412176   199671_1   BF818635 AW898334 H66426 AW899792       458867   1246993_1   AW995393 AJ403118       417732   299677_1   R12062 R12616 Z43412 R36065       459476   169217_1   AA584407 BE185844 BF764955       409840   915929_1   AW502122 AW501663 AW501720 AW502125       454985   1087722_1   AW849431 AW849428 AW849424 AW849422 AW849420 AW849292 AW849427       419555   252042_1   AA244401 AA244416       450875   10801_1   AL041364 BE393266 AA573189 BF589066 AI623423 AI889612 H54292               AA085863 AA669816 BE542832 BI094274 AI360690 T61853 AW081194               AI541147 AW750358       454636   1064998_2   AW811471 AW811548 AW811521       433010   1234715_1   AW970018 BE843649 BE843644 AA573622 R08736 AA573669       447721   1889_2   BC013767 AL572931 BE742185 BI520113 AW959076 AI341487 AI623222 BM091074               AW593800 AI983635 AW275114 AI952164 BM091378               AA977038 AW513859 AI801910 AW273202 AW166266 AW337946 AI086791               BE907359 AW273147 AI453134 AA250733 AW072844 AI818468               AI561259 AW470887 AW300481 AW103087 AW175624 BE048584 BF063936               AI207341 AW193240 AW193322 AW264492 AI682412 AI631778               AI669677 AI128695 AA448630 AA456607 BF313680 BG898294 BI195544               BG421755 BI760100 BE383304 BF329916 BF526599 AA385255               BI520887 AA410939 AA448721 BF525380 BG423666 BI761786 BF944570       444080   20054_4   AL545854 H05874 AW812663 BE146011 AW812664 AV647861               AW812655 AW812611 BG718126       454741   220369_1   BE154396 BF846839 AW842318 AW817959 BE154393 BI050168       428177   8737_7   AA779866 AA423967 AA423968       450799   819959_1   W31274 AW407504 AI738877       447135   579607_1   T58148 AW516579 AW059603       428568   738084_1   BE259137 BE251523       444047   56634_1   AK057279 AI939345 BF748883 AI161300 AI097452 AI097450 BF958187 BE936529               AW890840 AW890825 BE763814 AW408933 BI038453               BE735308       444207   9172_3   BE739425 AA514221 AA865491 AI828293 AA470456 AI276739 AA169357 BE932464               AA514889 AW819039 AW819083 BE843048 AI432496               AI470335 AI247243 BG533994 AA513783 AI887309 AA528036 AW972006 AW873028 AI924914 AI818810               AW152378 AW084946 AI521413               AI669583 BE932521 AI581370 BE180238 AW089750 AW771461 AW089714 AI590949 AI819148               AA731056 BF815234 BF911506 AA235803               AA485373 AI735658 AW393133 AW073080 AI707637 BF353320 BE843111 AW819036 AW393135               BG697291 AV648670 AV654332 AV687530               BG566964 AI807430 AI676072 AA837010 AI452482 AI625817 AW241750 BE048616 AI290928               AI680714 AA485530 BE175687 AV648513               AW130312 AI000556 AA632893 BE674169 BF001208 AA948166 BE175650 AA524664 AA490345               AI244948 AA602956 AA483492 AA918178               AW802049 BG675859 AV658871 BG678060 AI565004 AW819026 BE843092 AV686437 AV723049               BG616948 AI911647 AI743490 AI091096               BE857251 AI962074 AA040027 AW769317 AA343477 AA640112 BF876213 R82948 H26425 H82876               BE843095 BE843140 BG536641               BG617830 AA235802 BE774985 BE006682 BF342375 AA903144 BF338083 BF984258 AV657996               AI749532 BE768614 BE857252 BE932516               BE768573 AV657993 AV657777 AV752631 BE774974 T55847 BF095761 BF911511 BE710793               BE180119 BG617338 H45942 T55897 AV657718               BG563497       448778   7800_1   AW505435 U62539       432745   112643_1   AA658826 AI821926 AI791191 AA635129 AA564492       411920   1141803_1   AW876134 AW876141 AW876398 AW876328 AW876308 AW876331 AW876415 AW876326               AW876181 AW876138 AW876131 AW876240               AW876206 AW876289 AW876218 AW876261 AW876343 AW876347 AW876188               AW876371 AW876273 AW876231 AW876191 AW876209               AW876322 AW876314 AW876165 AW876363 AW876378 AW876376 AW876169 AW876412 AW876426               AW876407 AW876257 AW876263               AW876366 AW876334       454339   789006_1   BE152238 AW381980 BE152235 BE152244 BE152232       432909   137712_1   AA702596 AA570111 AI348435 AW192161       411283   215263_1   AW852754 AW852757 AW852617 BE172755 AW852897 AW835444 AW835440               AW801490 AW801489 BF839901 AW835520       446378   10288_1   BC010106 AL560552 AU133296 AU133086 BE268567 BE268523 BI544879               BE398161 BG473088 BI544445 BE258021 BE296339 BE255040               BE263020 BG706790 AL598627 AW952337 BG758113 AW512753 BE267666 BE253415 BI225718 BE268350               BE258245 BI224965 AW772605               BG723903 BE397282 BI196341 BG702880 AI878949 AL600437 AA416759 BE259917 AI031582 BF512142               AI088248 BE560328 AI802623               AI288613 AL597585 AW768553 AI816352 BF732831 BI225687 AA833686 AA722593 AA807750               AW068064 AA405187 AI923236 N51593               AL527710 BG282576 AL525927 AL525971 BI869547 AI064725 R91856 H46814 H20112               W01682 AW848870 AW848585 AW376662 AW848985               AW848937 AW848862 AW848581 AW848512 AW848176 AW752623 AW752618 AW376822               AW376821 AW376684 AW376623 AW376622               BE706047 AW752602 AW752691 AW752674 AW752652 AA379167 AW752610 AW752684               AW752613 AW752660 AW848709 AW848576               AW849155 AW848981 AW848980 AW848979 AW848978 AW848973 AW848916 AW848713               AW848708 AW848642 AW848641 AW848639               AW848573 AW848493 AW848492 AW848489 AW848488 AW848487 AW848353 AW848352               AW848220 AW752698 AW752697 AW752682               AW752681 AW752680 AW752679 AW752664 AW752651 AW752638 AW752637 AW752636               AW752628 AW752626 AW752624 AW752619               AW752596 AW752608 AL582019 BE875587 AL529175 AW965868 BG686208 AA259073               BE696973 AA459543 AA358314 W40564 BF926427               AW849000 AW848718 AW848515 AW848507 AW848444 AW848440 AW848232 AW848222               AW752657 AW376786 AW376781 AW376615               AW376614 BI752581 AA534520 AI748906 AA047799 AI014753 AL514460 AL581982               BG743146 W24171 H20102 H11227 AW752607 AW006596               AW130378 BE716519 AW752661 AW848289 BF349557 AW752612 AW752632 AW848910               NM_004077 AF047042 AL560606 BI765896               BI196831 BI855656 BE906674 BG749937 BE535486 BE019810 AA313713 AA992542               AA332541 AA682985 AA356125 BE140478 BG750945               BI457548 BG025661 BF326302 AA325019 BG980676 AA337465 AA321974 BG949285               BG427585 R23979 BG611485 BE560678 W16977               N50379 BG824101 BG471750 BI463171 W04691 AU099360 BG471590               BM011999 BE262945 BE559801 BF756438 BE881957 BE314546               BG911831 BG150811 BG112017 AA157518 T92368 AW752620       433070   22399_1   BE794397 BG121933 BI194378 AW410585 AW954321 BI045952 AW024741               AW444579 AI973044 AI075432 AI093319 AI635673 AA625246               D45465 BE173394 AV724875 AW954889 AI366776 AI498872 AA027096 AI351434 AA916072               AA302868 AA535890 AI420076 AI669179               AI240010 AI201405 AW451691 AA317478 AA424952 AW772292 BE857671               AI869583 AI470411 AI804946 AI744155 D80532       455968   1557068_1   BE168828 BE168823 BE168830 BE168820 BE168931 BE168826 BE168928       459235   26808_3   AW814516 AW815927 AW814504 BF375203 AW814522 AW814521               AW814524 BF375206 AW814518 AW814517 AI940652 BF837881               AW751232 BF374342 AW176453 AW814505 BF886651               AW814525 BG001382 BE933380       449713   519163_1   AW027025 AW028264 AI660390       429446   352_30   AI547111 BG945630 BG913104 AA558007 AW973749                                            
     [0359]                           TABLE 8C                       Pkey   Ref   Strand   Nt_position                  405278   6139075   Minus   3863-3965, 4823-4891,                   5439-5529, 6043-6170       404501   7229859   Minus   37270-37526       401149   7229925   Plus   73117-74019       402273   2979528   Plus   28990-29203, 32299-32402,                   32474-32668       402517   9798106   Plus   17569-17721       401553   8099284   Minus   83990-84161       404958   7407941   Minus   2731-4531       403324   8440025   Minus   107104-107309       401913   9369520   Minus   33753-33904       403794   8096910   Plus   163292-163884       403180   7523976   Minus   63603-63759       402651   7960391   Plus   174215-174380       404359   7630876   Minus   11789-12516       402889   9931133   Plus   89392-89498, 90358-90571       403796   8099896   Minus   75073-77664       404473   8079921   Plus   22639-22773       402023   7528158   Minus   132872-133040       404518   8151988   Plus   84494-84603       403579   8101179   Minus   36167-36365       403545   8078400   Plus   25293-25640       406060   6899623   Minus   20339-20746       405600   5923640   Plus   26662-27225       405502   9211311   Minus   50360-50584       403582   8101186   Plus   18308-18458       400818   8569994   Plus   172644-172765, 173085-173200       405443   7408143   Plus   90716-90887, 101420-101577       402878   9908870   Minus   56133-56522       404046   3688074   Minus   2-773       402012   7407997   Minus   111771-111909, 112107-112226,                   112519-11269       402124   4033680   Plus   164206-164459       402608   9910096   Plus   37495-37669       402022   7139714   Plus   165595-165748       401376   7417809   Plus   40584-40963       402364   9454515   Minus   54983-55240, 56507-56785,                   56982-57365       401942   4982556   Minus   130749-131044       406140   9168231   Minus   49887-50219       401522   7717114   Minus   154437-154847, 155420-155505,                   155568-15615       401346   9926605   Minus   12031-13032       403750   7229814   Minus   133638-134110       402441   9796503   Plus   140903-141106       404126   9796876   Plus   48919-49155       404187   4481839   Plus   7644-7991       404752   7109522   Minus   120168-120326       401405   7768126   Minus   69276-69452, 69548-69958       406210   7341959   Plus   58546-58687                                                    
     [0360] Table 9A lists about 100 genes up-regulated in Hepatitis C positive liver tissues from patients that are non-responsive to pegylated-interferon-alpha plus ribavirin treatment (non-responders) compared to Hepatitis C positive liver tissues from patients that are responsive to the treatment (responders). In both cases, the liver biopsies were obtained prior to treatment. The 100 genes have the potential to be diagnostics and/or prognostic markers for determining the responsiveness of Hepatitis C infected liver tissues to pegylated-interferon-alpha plus ribavirin treatment. They may also provide clinical information on Hepatitis C infection and pathology. They may also be potential targets for therapeutic drugs and/or treatments. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the Wilcoxon rank-sum test p-value between the 2 groups was less than 0.10, the ratio of the “weighted average” of non-responders to the “weighted average” of responders was equal to or above 2.0, and that the differences between the same 2 groups was equal to or above 30.0. The “weighted average” of the non-responders was set to the trimean of several different non-responders. The “weighted average” of the responders was set to the either 10 or the trimean of several different responders, whichever value was greater to eliminate ratios with a denominator of zero or less.  
                                   TABLE 9A                       Pkey   ExAccn   UniGene   UnigeneID   R1   R2                                                        444342   NM_014398   Hs. 10887   similar to lysosome-associated membrane   2.34E−02   5.21       431326   AW970580   Hs. 198689   KIAA0728 protein   2.34E−02   4.92       424017   AA333789       gb: EST37925 Embryo, 9 week  Homo sapiens     5.29E−02   4.82       410099   AA081630       KIAA0036 gene product   1.13E−02   4.77       407360   X13075       gb: Human 2a12 mRNA for kappa-immunoglobu   6.19E−02   4.52       447514   AI809314   Hs. 208501   ESTs, Weakly similar to B34087 hypotheti   8.30E−02   4.52       437233   D81448   Hs. 339352     Homo sapiens  brother of CDO (BOC) mRNA,   1.34E−02   4.47       454525   BE280421   Hs. 94499   ESTs   4.53E−02   4.47       452455   N25153       ESTs, Weakly similar to AF174605 1 F-box   2.31E−02   4.45       458393   AI792868   Hs. 135365   ESTs   8.24E−02   4.30       458026   H12028   Hs. 6396   jumping translocation breakpoint   1.63E−02   4.20       459171   AW967801   Hs. 151293   ESTs, Weakly similar to T42705 hypotheti   4.55E−02   4.17       426798   AA385062   Hs. 130260   ESTs   8.27E−02   4.13       447339   AI770001   Hs. 209445   ESTs   4.55E−02   4.10       447686   AI939440       ESTs   9.52E−02   4.10       433312   AI241331   Hs. 131765   ESTs, Moderately similar to I38937 DNA/R   3.29E−02   4.09       435391   AA704588   Hs. 58934   ESTs   5.29E−02   4.05       437994   U92012   Hs. 251659   ESTs, Weakly similar to mariner transpos   3.83E−02   4.00       437990   AI686579   Hs. 121784   ESTs   7.15E−02   3.97       406355           C5000598: gi|2136258|pir||I59377 template   8.30E−02   3.95       401745           Target Exon   2.34E−02   3.92       435903   AA701890   Hs. 118163   ESTs   4.43E−02   3.92       407366   AF026942   Hs. 17518   gb:  Homo sapiens  cig33 mRNA, partial sequ   1.64E−02   3.80       442269   AI797066   Hs. 201995   ESTs   1.10E−02   3.75       452941   AL110347   Hs. 31074   N-sulfoglucosamine sulfohydrolase (sulfa   5.11E−03   3.72       455604   BE011183       gb: PM3-BN0218-100500-003-d09 BN0218 Homo   4.55E−02   3.58       401376           Target Exon   8.27E−02   3.55       456445   AK000735   Hs. 93581   hypothetical protein FLJ10512   3.86E−02   3.52       416814   AW192307   Hs. 80042   dolichyl-P-Glc: Man9GlcNAc2-PP-dolichylgl   8.30E−02   3.50       444640   AL133933   Hs. 64310   interleukin 11 receptor, alpha   3.27E−02   3.48       445882   AI948717   Hs. 225155   ESTs, Weakly similar to A46302 PTB-assoc   6.17E−02   3.42       453471   AL037887   Hs. 208179   ESTs   8.30E−02   3.42       449756   W16700   Hs. 94542   ESTs   8.27E−02   3.42       437774   AW978199   Hs. 291648   ESTs, Weakly similar to I38022 hypotheti   6.17E−02   3.30       437929   T09353   Hs. 106642   ESTs, Weakly similar to T09052 hypotheti   6.19E−02   3.30       405513           ENSP00000241075: TRRAP PROTEIN.   7.15E−02   3.28       404098           Target Exon   8.27E−02   3.25       408570   AL046406   Hs. 103483   KIAA1798 protein   7.12E−02   3.22       426101   AL049987         Homo sapiens  mRNA; cDNA DKFZp564F 112 (fr   4.55E−02   3.22       447164   AF026941   Hs. 17518   vipirin; similar to inflammatory respon   8.30E−02   3.20       401242           mitogen-activated protein kinase 8 inter   4.55E−02   3.10       435154   AA668764       ESTs   8.30E−02   3.10       449137   AW134478   Hs. 196033   ESTs   3.32E−03   3.05       448497   BE613269   Hs. 21893   hypothetical protein DKFZp761N0624   2.31E−02   3.02       410541   AA065003   Hs. 64179   syntenin-2 protein   8.30E−02   3.02       405723           Target Exon   8.30E−02   3.00       449613   N63808   Hs. 34299   ESTs   2.76E−02   3.00       459697   AA406062   Hs. 98002   ESTs   7.59E−03   3.00       417958   AA767382   Hs. 193417   ESTs   8.27E−02   2.97       444736   AA533491   Hs. 23317   hypothetical protein FLJ14681   9.49E−02   2.96       417042   C75563   Hs. 113029   ribosomal protein S25   6.14E−02   2.92       403512           C3000579*: gi|12643308|sp|Q9Y4K1|AIM1_HUM   7.66E−03   2.92       404226           Target Exon   4.53E−02   2.90       443884   N20617   Hs. 194397   leptin receptor   8.30E−02   2.88       432222   AI204995       gb: an03c03.x1 Stratagene schizo brain S1   8.30E−02   2.88       407284   AI539227   Hs. 214039   hypothetical protein FLJ23556   6.19E−02   2.86       439737   AI751438   Hs. 41271     Homo sapiens  mRNA full length insert cDN   2.34E−02   2.83       408503   AW119059       ESTs, Weakly similar to T12552 hypotheti   8.30E−02   2.80       419743   AW408762   Hs. 5957     Homo sapiens  clone 24416 mRNA sequence   8.30E−02   2.77       456727   BE350986   Hs. 33254   hypothetical protein FLJ21817 similar to   1.11E−02   2.75       440409   AW294316   Hs. 125608   ESTs   3.27E−02   2.73       408891   NM_006577   Hs. 284284   ESTs, Highly similar to beta-1,3-N-acety   4.53E−02   2.70       430291   AV660345   Hs. 238126   CGI-49 protein   2.34E−02   2.66       410851   AW612147   Hs. 32058     Homo sapiens  C1orf19 mRNA, partial cds   7.15E−02   2.65       414737   AI160386   Hs. 125087   ESTs   3.86E−02   2.65       422744   AW268803   Hs. 119640   hBKLF for basic kruppel like factor   5.24E−02   2.60       429867   AW204372       tomosyn   5.19E−02   2.56       431926   AW972724       gb: EST384816 MAGE resequences, MAGL Homo   5.29E−02   2.55       430259   BE550182   Hs. 127826   RalGEF-like protein 3, mouse homolog   3.35E−03   2.54       428558   AI587502       ESTs   9.52E−02   2.53       435145   AI277259   Hs. 116631   ESTs   2.76E−02   2.52       403436           NM_006548*:  Homo sapiens  IGF-II mRNA-bind   8.30E−02   2.52       447698   AI420156   Hs. 326733   ESTs   7.15E−02   2.52       407339   AA777542   Hs. 132670   ESTs   2.76E−02   2.50       410401   AW673335   Hs. 259641   ESTs   2.34E−02   2.50       418481   M81945       CD34 antigen   3.29E−02   2.50       430654   AW970081   Hs. 325603   ESTs   8.27E−02   2.50       433102   AI343966   Hs. 158528   ESTs   1.13E−02   2.44       442191   W95186   Hs. 8136   endothelial PAS domain protein 1   3.86E−02   2.42       447384   AI377221   Hs. 40528   ESTs   7.15E−02   2.40       430552   AA176374   Hs. 243886   nuclear autoantigenic sperm protein (his   6.14E−02   2.38       444811   AW137791   Hs. 148419   ESTs   1.64E−02   2.37       435519   AI218950   Hs. 125461   hypothetical protein FLJ11539   5.29E−02   2.37       435675   AA694099   Hs. 266820   ESTs   8.30E−02   2.36       402305           C19000735*: gi|4508027|ref|NP_003414.1|z   1.12E−02   2.35       438084   AW516099   Hs. 121925   ESTs   8.30E−02   2.32       450747   AI064821   Hs. 318535   ESTs, Highly similar to 1818357A EWS gen   7.15E−02   2.32       452032   BE244005   Hs. 27610   retinoic acid-and interferon-inducible   8.27E−02   2.25       455751   BE075281       gb: PM1-BT0585-290200-005-d07 BT0585 Homo   8.10E−02   2.21       427471   AA403131   Hs. 266782   KIAA1826 protein   8.30E−02   2.20       437210   AA311443   Hs. 293563     Homo sapiens  mRNA; cDNA DKFZp586E2317 (f   6.19E−02   2.17       458025   AI275406   Hs. 32450   gb: ql63c10.x1 Soares_NhHMPu_S1 Homo sapi   2.76E−02   2.17       444830   AI198854   Hs. 145437   ESTs   6.17E−02   2.12       455086   AW855386       gb: CM3-CT0275-191099-024-d05 CT0275 Homo   8.30E−02   2.10       421904   BE143533   Hs. 109309   hypothetical protein FLJ20035   4.55E−02   2.07       414395   BE304888   Hs. 279834   EST   3.27E−02   2.02       404973           Target Exon   8.27E−02   2.01       428701   NM_013276   Hs. 190207   carbohydrate kinase-like   3.86E−02   2.01       436651   BE045962   Hs. 275998   ESTs   1.34E−02   2.00       448959   AI610343   Hs. 293267   ESTs   7.12E−02   2.00                                                                  
 
     [0361]                       TABLE 9B                       Pkey   CAT Number   Accession                  424017   888651_1   AW966107 AA334317 AA333789       410099   16732_1   AK055674 AW965247 AV751598 AA290926 R53043 AA331387 AK056148 BI917678               BG819395 BG911971 BG820167 AI174254 AA348720               AA364503 BG714279 AW893230 AA081774 H24222 AV727176 BF875715               AA081630 BE000834 AA334880 AL563737 BG029709 W52882               AI439658 BE551237 AA283724 BF109530 AI457096 AI805992 BE467736 AA693467               AI697593 AI887863 AI167419 AW901980 AW901768               BE702179 AA484549 T23811 BE327043 AA716027 AA917004 AA167714 BF339675               AA084618 AI418634 T31586 AA436630 AI366472               AA706191 AI422304 AI204899 AI041169 AA211402 AW827081 AA788593 T32736               AI767935 AA747914 T03534 AW959843 AL119527               BE327037 AW901982 AW993370 AW901977 AW902071 W60090 N79906 D52685               T07735 BE702069 BE702172 T08671 BE767121 BE767117               BE767113       452455   928588_1   BE877195 BG988071 AI902576 N25153 AW518714 N25154       447686   2958543_1   AI939440 AI424128 AI419682       455604   1478710_1   BE011183 BE011324 BE011170 BE011188 BE011181 BE011333 BE011169 BE011161       426101   3211_1   AL049987 BG620667 BG571984 AW362842 BE150456 BE326465               AW872412 AA868553 AI024689 AA442638 AA813604 AA442648 AA663108               AA442379 AA229448 N56349 AA460220 AW971193 AA453725 AI742087               AI860142 AW769479 AI917507 AI860141 BE045272 AW277065               AI921333 AI354470 BE466760 AI827987 AI005467 AA833517 AA563934               AA522837 AA812876 AW020895 AA600372 AA663178 AI187977               AA229164 AW270324 AA703066 T78981 AA632986 BE708493 R31132 AI253986               AI916737 T84796 T84294 AW961515 AI459289 BF109829               BI491853 AI084517 AW103830 BE835233 A1472712 AV741009 AA551512               N28268 AA436880 AA447794 BE835410 BE835385 BE818352               BE818350 R64648 BE646467 AA493776 AA437299 BE818343 R95914 R31089               BF576826 AU186065 BF802058 AI217018 AA247541 AI191725               BE766918       435154   126605_1   AW972063 AA668764 AA804491 AW665688 AA765069       432222   539529_1   BG207209 BE166299 AI204995 BG199355 AW969908 AA528756 AW440776 BI044354       408503   24663_2   NM_054110 BC014789 BI552129 BG896227 BG900557 AY035399 AW119059               BF432376 AW629242 AA971319 AI378176 AI275884 AA236602               BG898257 BG897636 BG900588 AF361251 BG926353 BG714178               AA368180 BG896473 BG715977 BG900230 BG901163 BF342939       429867   1003_2   BE467551 AI214965 AW204372       431926   1237041_1   AW972724 AA877998 AA522631 AU185388       428558   1382530_1   AA430150 AA888768 AI587502       418481   17381_1   S53911 NM_001773 AL572644 AL550179 AI688653 AW025002 AW614285               AU158779 AI017002 AA434387 AI252665 AI262206 AU147582               AI144193 AW952860 AI128776 AI017793 AI160509 AA906021 AI149563               AU154950 AI128488 W74409 AI970362 AI141453 AU158772 W58493               BM148338 R73091 AW020496 BI491517 AA022917 AI432610 AI879448               R69099 AI708954 AW014274 AA483672 AA528783 AA912271               AI926942 BE677587 AI874217 AA152376 AA640408 AI287334 BF830285               AA311473 C18678 AA922603 C00910 AI124073 R38730 AA043439               W94644 W58646 AA664247 BE061934 H01096 R69613 AI383162 AU133723               AA311526 R67942 H01097 H72113 R72430 R39494 AV744074               AA535925 BI759288 BI052385 BF854687 AW608286 AA043438 R72478               AL513811 R69214 AA188435 AA054965       455751   1497052_1   BE075281 BE075119 BE075123 BE075219 BE075046       455086   1095746_1   AW855553 AW855417 AW855386                                            
     [0362] Table 10A lists about 149 genes up-regulated in Hepatitis C positive liver tissues from patients that are responsive to pegylated-interferon-alpha plus ribavirin treatment (responders) compared to Hepatitis C positive liver tissues from patients that are not responsive to the treatment (non-responders). In both cases, the liver biopsies were obtained prior to treatment. The 149 genes have the potential to be diagnostics and/or prognostic markers for determining the responsiveness of Hepatitis C infected liver tissues to pegylated-interferon-alpha plus ribavirin treatment. They may also provide clinical information on Hepatitis C infection and pathology. They may also be potential targets for therapeutic drugs and/or treatments. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the Wilcoxon rank-sum test p-value between the 2 groups was less than 0.10, the ratio of the “weighted average” of responders to the “weighted average” of non-responders was equal to or above 2.0, and that the differences between the same 2 groups was equal to or above 30.0. The “weighted average” of the responders was set to the trimean of several different responders. The “weighted average” of the non-responders was set to the either 10 or the trimean of several different non-responders, whichever value was greater to eliminate ratios with a denominator of zero or less.  
                                   TABLE 10A                       Pkey   ExAccn   UniGene   Unigene Title   R1   R2                                                        400301   X03635   Hs. 1657   estrogen receptor 1   5.11E−03   8.42       440700   AW952281   Hs. 296184   guanine nucleotide binding protein (G pr   1.63E−02   6.41       421911   AL041520       gb: DKFZp434G2317_s1 434 (synonym: htes3)   3.27E−02   5.67       400302   N48056   Hs. 283946   folate hydrolase (prostate-specific memb   2.34E−02   5.61       414559   AV656184   Hs. 76452   C-reactive protein, pentraxin-related   3.86E−02   5.60       418363   AA218628   Hs. 202977   ESTs   8.30E−02   5.50       427450   AB014526   Hs. 178121   KIAA0626 gene product   1.63E−02   5.29       404354           Target Exon   1.64E−02   5.05       436674   AA725002   Hs. 272018   low molecular mass ubiquinone-binding pr   8.30E−02   5.00       455191   AW864547       gb: PM4-SN0016-120500-003-b12 SN0016 Homo   6.17E−02   4.90       415374   F06904   Hs. 8346   ESTs   6.19E−02   4.83       404483           C8000657*: gi|1504040|dbj|BAA13219.1|(D8   1.13E−02   4.77       444813   AW054834   Hs. 210356   ESTs   8.30E−02   4.77       401197           ENSP00000229263*: HSPC213.   8.27E−02   4.75       449959   AI076834   Hs. 21160   ESTs   2.76E−02   4.60       444402   AL138436   Hs. 49359   hypothetical protein DKFZp547E052   2.30E−02   4.57       451898   T92572   Hs. 142019   ESTs, Weakly similar to 1207289A reverse   1.64E−02   4.55       457231   AI472022   Hs. 301959   praline synthetase co-transcribed (bacte   4.55E−02   4.52       413303   AW836130   Hs. 75277   hypothetical protein FLJ3910   8.20E−02   4.40       435147   AL133731   Hs. 4774     Homo sapiens  mRNA; cDNA DKFZp761C1712 (f   6.19E−02   4.40       442552   R20624       son of sevenless (Drosophila) homolog 1   6.19E−02   4.40       401635           C11000702: gi|10048448|ref|NP_065258.1|g   9.52E−02   4.27       430048   T65054   Hs. 73605   ESTs   8.27E−02   4.27       406570           NM_024889*:  Homo sapiens  hypothetical pro   2.34E−02   4.17       433122   AB019391   Hs. 58049   ESTs   7.15E−02   4.13       431940   H06075   Hs. 270232   ESTs   3.35E−03   4.07       411047   AW938479       gb: CM0-DT0057-290200-253-h06 DT0057 Homo   8.27E−02   4.04       403609           C3001199: gi|7494834|pir||T15308 hypothet   3.29E−02   4.00       430165   AW849764   Hs. 314330   ESTs   3.25E−02   4.00       443935   NM_000236   Hs. 9994   lipase, hepatic   9.52E−02   3.98       458875   AA814517   Hs. 321775   hypothetical protein DKFZp434D1428   1.13E−02   3.96       403686           C4001366*: gi|9837427|gb|AAG00570.1|AF287   5.29E−02   3.95       403767           Target Exon   7.15E−02   3.95       401114           Target Exon   4.55E−02   3.89       412286   AW935866       gb: QV3-DT0019-120100-055-b04 DT0019 Homo   2.33E−02   3.88       417505   T73280   Hs. 193228   alanine-glyoxylate aminotransferase 2   6.19E−02   3.85       440798   AB020648   Hs. 7426   KIAA0841 protein   3.29E−02   3.85       403743           C1002604: gi|8393668|ref|NP_058989.1|kin   8.30E−02   3.81       429031   BE002237   Hs. 239666     Homo sapiens  cDNA FLJ13495 fis, clone PL   6.17E−02   3.79       453815   AL135365   Hs. 126857     Homo sapiens  cDNA FLJ12936 fis, clone NT   3.29E−02   3.77       423983   AA333261       gb: EST37476 Embryo, 8 week 1 Homo sapien   4.55E−02   3.75       405206           Target Exon   7.12E−02   3.72       425057   AA826434   Hs. 1619   achaete-scute complex (Drosophila) homol   4.55E−02   3.72       446847   T51454   Hs. 82845     Homo sapiens  cDNA: FLJ21930 fis, clone H   4.55E−02   3.71       414535   W27834   Hs. 333417   capping protein (actin filament) muscle   8.13E−02   3.70       456250   U09196   Hs. 82520   polymerase (DNA-directed), delta 4   9.52E−02   3.69       446885   T74107   Hs. 122613   ESTs   2.31E−02   3.67       409313   NM_001325   Hs. 693   cleavage stimulation factor, 3′pre-RNA,   2.33E−02   3.65       441159   AI198604   Hs. 126682   ESTs   4.53E−02   3.63       422519   AA347877   Hs. 122730   ESTs   5.29E−02   3.63       435545   AA687415   Hs. 28107   ESTs   1.12E−02   3.63       439910   H66765   Hs. 339397   ESTs   2.34E−02   3.55       458991   AI743502       gb: wf63h12.x2 Soares_NFL_T_GBC —     8.30E−02   3.54                   S1 Homo s       403789           NM_001334*:  Homo sapiens  cathepsin O (CTS   8.30E−02   3.52       433156   R59206   Hs. 17519     Homo sapiens  cDNA: FLJ22539 fis, clone H   3.29E−02   3.52       404902           NM_025213:  Homo sapiens  spectrin, beta, n   5.29E−02   3.50       436499   AJ276678   Hs. 283102   HEF like Protein   5.29E−02   3.50       424092   AI085286   Hs. 133476   ESTs   6.19E−02   3.38       458443   AV647010   Hs. 27   glycine dehydrogenase (decarboxylating;   1.63E−02   3.35       446681   AJ003624   Hs. 15896   kendrin   4.55E−02   3.32       401778           MCT-1 protein   8.30E−02   3.25       402244           C19000767*: gi|4508027|ref|NP_003414.1|z   6.19E−02   3.23       419287   X91906   Hs. 89872   chloride channel 5 (nephrolithiasis 2, X   1.64E−02   3.22       405543           C2002468*: gi|3334856|emb|CAA11279.1|(AJ   8.17E−02   3.20       429624   AA458648   Hs. 99476   ESTs, Weakly similar to 1313184B alpha 1   8.27E−02   3.18       453751   R36762   Hs. 101282     Homo sapiens  cDNA: FLJ21238 fis, clone C   4.55E−02   3.17       404511           NM_004349:  Homo sapiens  core-binding fact   1.35E−02   3.13       445159   AI631036   Hs. 196843   ESTs   3.27E−02   3.10       457565   BE294029   Hs. 279903   Ras homolog enriched in brain 2   3.29E−02   3.10       404717           NM_007313*:  Homo sapiens  v-abl Abelson mu   6.19E−02   3.07       403920           suppressor of potassium transport defect   3.29E−02   3.07       445664   AW968638   Hs. 237691   ESTs, Weakly similar to KIAA0601 protein   5.27E−02   3.05       403442           Target Exon   6.19E−02   3.02       436336   AJ011378       ESTs   4.41E−02   3.00       446783   AW138343   Hs. 141867   ESTs   1.64E−02   2.97       451790   AA927403   Hs. 3803   reticulon 2   8.30E−02   2.96       427958   AA418000   Hs. 98280   potassium intermediate/small conductance   1.62E−02   2.92       430989   AB009249   Hs. 248192   fibroblast growth factor 17   8.27E−02   2.91       425744   AA362985       gb: EST72769 Ovary II  Homo sapiens  cDNA 5   8.30E−02   2.91       419511   AA429750   Hs. 75113   general transcription factor IllA   4.55E−02   2.89       446001   AI827473       ESTs   6.19E−02   2.88       442602   R46488   Hs. 187497   ESTs   4.50E−02   2.85       443589   H52931   Hs. 165067   ESTs   8.27E−02   2.85       457142   AI924353   Hs. 290969   EST   7.59E−03   2.83       404956           C1003210*: gi|6912582|ref|NP_036524.1|pe   3.27E−02   2.83       426181   AA371422   Hs. 334371   hypothetical protein MGC13096   6.19E−02   2.83       454086   AW885909   Hs. 279789   PRO1073 protein   6.19E−02   2.82       450770   AA019924   Hs. 28803   ESTs   8.30E−02   2.81       452357   AI638176   Hs. 283865   ESTs   6.19E−02   2.80       456758   AA325170   Hs. 224627   ESTs, Weakly similar to FAHUAA alpha-act   6.17E−02   2.79       409959   BE349470       mucin 6, gastric   1.11E−02   2.77       417674   R07915   Hs. 20039   ESTs   6.19E−02   2.75       446548   AI769392   Hs. 200215   ESTs   8.30E−02   2.75       407988   N47760   Hs. 285107   hypothetical protein FLJ13397   9.24E−03   2.70       435236   T03890   Hs. 157208   ESTs, Highly similar to ARX MOUSE HOMEOB   9.52E−02   2.69       447090   AI361114   Hs. 270711   ESTs   7.59E−03   2.67       451068   AW294432   Hs. 144252   ESTs   3.29E−02   2.63       431668   AW969610   Hs. 151179   ESTs   3.29E−02   2.63       449000   U69560   Hs. 3826   kelch-like protein C3IP1   9.17E−03   2.63       443832   AI829610   Hs. 23531   ESTs   8.27E−02   2.62       405481           Target Exon   7.15E−02   2.60       438922   R71288   Hs. 259664   ESTs   4.53E−02   2.60       402168           NM_022046*:  Homo sapiens  kallikrein 14 (K   1.95E−02   2.59       444280   AI380835   Hs. 148505   ESTs   3.27E−02   2.58       435471   AA682544       ESTs   4.55E−02   2.58       452137   AI861840   Hs. 211687   ESTs   2.76E−02   2.58       424049   AB014524   Hs. 138380   KIAA0624 protein   1.62E−02   2.55       418154   BE165866       nuclear receptor subfamily 1, group I, m   6.19E−02   2.52       447113   AA741545   Hs. 282832   ESTs, Weakly similar to T24961 hypotheti   1.13E−02   2.50       439389   AA318940   Hs. 56004   ESTs   3.77E−02   2.48       442049   AA310393   Hs. 190044   ESTs   7.15E−02   2.47       445119   AF035121   Hs. 12337   kinase insert domain receptor (a type II   1.12E−02   2.47       454341   AI654712   Hs. 54424   hepatocyte nuclear factor 4, alpha   4.48E−02   2.45       420028   AB014680   Hs. 8786   carbohydrate (N-acetylglucosamine-6-O) s   4.55E−02   2.45       420556   AA278300   Hs. 124292     Homo sapiens  cDNA: FLJ23123 fis, clone L   6.19E−02   2.45       456558   BE410992   Hs. 258730   heme-regulated initiation factor 2-alpha   6.17E−02   2.45       423954   AW753164   Hs. 288604   KIAA1632 protein   8.30E−02   2.43       450565   T72234   Hs. 193228   alanine-glyoxylate aminotransferase 2   5.29E−02   2.40       446068   AL049801   Hs. 13649   Novel human gene mapping to chomosome 13   5.27E−02   2.39       419662   W87674       gb: zh66a01.r1 Soares_fetal_liver_spleen —     1.55E−02   2.38       432547   BE350533   Hs. 306418     Homo sapiens  cDNA FLJ10958 fis, clone PL   6.19E−02   2.38       403440           Target Exon   4.55E−02   2.37       407625   AA148766   Hs. 293885   hypothetical protein FLJ14902   2.33E−02   2.35       415770   M79237       gb: EST01385 Subtracted Hippocampus, Stra   7.59E−03   2.34       433224   AB040919   Hs. 210958   KIAA1486 protein   4.53E−02   2.32       421573   AI302850   Hs. 262455   ESTs   5.29E−02   2.30       459283   NM_016940   Hs. 34136   chromosome 21 open reading frame 6   4.55E−02   2.26       424602   AK002055   Hs. 151046   hypothetical protein FLJ11193   8.30E−02   2.25       406180           small inducible cytokine subfamily A (Cy   3.29E−02   2.24       404810           Target Exon   8.30E−02   2.24       457841   AI678031   Hs. 122813   ESTs, Weakly similar to ZN22_HUMAN ZINC   8.30E−02   2.24       458492   AI143655       ESTs   2.76E−02   2.22       443708   AI082689   Hs. 63970   ESTs   2.31E−02   2.21       444758   AL044878   Hs. 11899   3-hydroxy-3-methylglutaryl-Coenzyme A re   8.30E−02   2.21       454302   AA306105   Hs. 50785   SEC22, vesicle trafficking protein (S. c   5.29E−02   2.20       456400   W28090       gb: 41h3 Human retina cDNA randomly prime   6.19E−02   2.20       408568   AW448965   Hs. 270087   ESTs, Weakly similar to I39295 X-linked   8.30E−02   2.18       444073   H68409   Hs. 38715   ESTs   8.27E−02   2.15       404437           C1000815: gi|9653274|gb|AAF27628.2|AF2175   8.30E−02   2.14       453315   BE544203   Hs. 24831   ESTs   6.19E−02   2.13       408931   AA251995   Hs. 334648   poly(A) polymerase alpha   8.30E−02   2.10       433444   AW975324   Hs. 129816   ESTs   4.55E−02   2.09       446226   AW889132   Hs. 11916   ribokinase   4.55E−02   2.08       452266   AI767250   Hs. 201446   ESTs   8.30E−02   2.05       436869   NM_014867   Hs. 5333   KIAA0711 gene product   3.86E−02   2.04       433906   AI167816   Hs. 43355   ESTs   5.29E−02   2.02       402370           Target Exon   8.30E−02   2.02       434306   AW081757   Hs. 44241     Homo sapiens  cDNA: FLJ21447 fis, clone C   6.19E−02   2.01       422721   R41154   Hs. 275711   hypothetical protein MGC2452   6.19E−02   2.01                                                                  
 
     [0363]                       TABLE 10B                       Pkey   CAT Number   Accession                  421911   863300_1   AL041520 AA300086       455191   1107840_1   AW864356 AW864547 AW864277 AW864496       442552   3248_3   BE566571 BE143063 BF367361 AW954369 AA412572 W95547 BE005367               AA374200 AI769772 AA809852 AI918702 AW025682 AI272033               AA713679 AI638383 Al364631 AW518885 N51823 AA256588 N47774 BE707161               BF980035 AI628605 AW292949 BE350976 AW263078 AI885558               AI261878 BE671974 N51071 AI695006 BM264289 BG055084 AI922512 AA633530 BM263987               N56889 AW075473 BE700841 AW023886 BF527967               AW591478 BE669905 N51720 AA806021 AA846566 W95290 AI453800 AI783684 AI417702 AW086132               BE552047 AA227699 AW076131 AI126790               AI654491 H01465 BF437982 AA400937 R20624 BF825527 H02691 W56480 BF944773               R21195 R82844 H02596 BE243273 H50040       411047   1067666_1   AW850678 AW938479 AW814826       412286   210181_1   AW935866 BE069200 BF838900 BG989737 BG989811 BF833185 BF837808       423983   888204_1   AA333365 AA552870 AA333261       458991   3076691_1   AI743502 AI807438       436336   53728_1   AJ011378 AA416944 AA469902 AI015437       425744   320952_2   AW963337 AA362985 T27244       446001   647827_1   AI827473 AW510751 AW182908 AI269760       409959   2781_3   AW513804 BE179199 BE179195 BE179198 BE179204 BE162686       435471   131589_1   AA682544 AI248010 AA703577       418154   23972_1   X56199 AU119734 AW967136 W38705 W90159 AW444647 BF094079               BE694692 AA339496 AA029093 BG925977 AA401072 AA348138 N90874               BF055081 BF111983 BF091812 AI399764 BE931041 BF999882 BF352250               BI049436 AA010244 AW374411 H52942 BF364437 AL538880               AU137031 BE218742 BE175700 BE708041 AV651847 AV649491 AV649227               AV649164 AV698455 AV651656 M78602 BF910285 AA333298 H75493               AA332039 BM463335 AL603109 BF753137 BF083242 AI309717 AI349651               BE174377 AW361207 BE159533 AL603126 BI003025 AA319706               AW903950 AU118470 AU135122 AI811901 AA401166 BE165866 BE165832               AA319621 BF749419 AI903726 BE833899 BI061305 BI061311 H78857               BF912227 BF912224 AV747164 AA126644 W17094 T05342 AW374665 AA091968               AA095633 BI009746 AL038020 BE010083 BE008038 BF808424               BE010133 BF364245 BF328029 BE010189 AW903901 AW844209 AW879041 AL037999               AV690829 AV693074 AV693056 AV690862 BE159515               BE074613 AW905394       419662   2431548_1   W87872 W87674 W87774       415770   2051914_1   AA169260 AI267298 M79237       458492   2797412_1   AI869287 AI143655       456400   2391890_1   W27943 W28090                                            
     [0364]                           TABLE 10C                       Pkey   Ref   Strand   Nt_position                  404354   7630858   Minus   115516-115702       404483   8096904   Minus   162212-163710       401197   9719705   Plus   176341-176452       401635   7145001   Minus   51895-52764       406570   3983519   Minus   88469-88570       403609   8308266   Minus   125974-126320       403686   7387348   Minus   66625-68364       403767   7767782   Plus   142903-143081       401114   9966554   Plus   52327-53385       403743   7652003   Minus   136463-136646       405206   6692345   Plus   17807-18338, 20430-20538       403789   8084957   Minus   64056-64148, 65262-65425       404902   7331453   Plus   36243-36358       401778   7249133   Minus   136881-137147, 137499-137628,                   137858-13814       402244   7690152   Plus   36938-38272       405543   9857582   Minus   104338-104449       404511   8151864   Minus   148501-148659       404717   9838068   Minus   165900-166052, 169415-169599,                   171430-17160       403920   7710868   Plus   40312-40490       403442   7210003   Plus   174560-175270       404956   7387343   Plus   55883-56203       405481   3688109   Plus   5718-5837, 8719-8818       402168   7458725   Minus   43245-43397       403440   9743372   Minus   34592-34661, 41940-42100       406180   7283201   Minus   38923-39107       404810   3702433   Minus   65278-65642       404437   5354481   Minus   17773-17938, 20263-20429       402370   9558580   Minus   14525-15733                                                    
     [0365] Table 11A lists about 2410 genes up-regulated in Hepatitis C positive liver tissues compared to Hepatitis C negative liver tissues. These genes have the potential to be diagnostics and/or prognostic markers for Hepatitis C infected liver tissues. They may also provide clinical information on Hepatitis C infection and pathology. They may also be potential targets for therapeutic drugs and/or treatments. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the t-test p-value between the Hepatitis C positive liver tissues group and the Hepatitis C negative liver tissues was less than 0.01, and that the differences between the average “standardized values” of the different Hepatitis C positive liver tissues was equal to or above 1.0 more than the average standardized values of the different Hepatitis C negative liver tissues. The “standardized values” of the Hepatitis C liver tissues were derived by subtracting the median of the several different Hepatitis C negative liver tissue values from each probeset value, then divided by the interquantile range (IQR) of the same Hepatitis C negative liver tissue values.  
                                   TABLE 11 A                       Pkey   ExAccn   UnigeneID   Unigene Title   R1   R2                                                        413278   BE563085   Hs. 833   interferon-stimulated protein, 15 kDa   1.24E−10   13.42       447164   AF026941   Hs. 17518   vipirin; similar to inflammatory respon   1.68E−07   11.03       426312   AF026939   Hs. 181874   interferon-induced protein with tetratri   8.68E−10   9.84       431629   AU077025   Hs. 265827   interferon, alpha-inducible protein (clo   9.17E−13   9.06       422596   AF063611   Hs. 118633   2′-5′-oligoadenylate synthetase−like   4.59E−09   8.28       426711   AA383471   Hs. 343800   conserved gene amplified in osteosarcoma   3.15E−15   6.94       427579   AA366143   Hs. 179669   hypothetical protein FLJ20637   4.05E−09   6.76       409461   AA382169   Hs. 54483   N-myc (and STAT) interactor   5.26E−12   6.61       453779   N35187   Hs. 43388   28 kD interferon responsive protein   1.47E−11   6.48       418396   AI765805   Hs. 26691   ESTs   4.41E−08   6.33       433364   AI075407   Hs. 296083   ESTs, Moderately similar to I54374 gene   2.97E−15   6.27       414404   W16712       KIAA0306 protein   1.42E−06   6.25       455705   AW161061       ESTs, Weakly similar to zinc finger prot   5.43E−11   6.24       430478   NM_014349   Hs. 241535   apolipoprotein L, 3   3.88E−17   6.09       413880   AI660842   Hs. 110915   interleukin 22 receptor   5.13E−05   5.91       417621   AV654694   Hs. 82316   interferon-induced, hepatitis C-associat   2.55E−12   5.55       432680   T47364   Hs. 278613   interferon, alpha-inducible protein 27   2.59E−15   5.35       418622   AW971960   Hs. 236456   ESTs, Weakly similar to A46010 X-linked   9.09E−04   5.26       448569   BE382657   Hs. 21486   signal transducer and activator of trans   1.56E−15   5.00       421379   Y15221   Hs. 103982   small inducible cytokine subfamily B (Cy   9.16E−09   4.97       414004   AA737033   Hs. 7155   ESTs, Moderately similar to 2115357A TYK   3.33E−10   4.73       414760   BE298063   Hs. 77254   chromobox homolog 1 (Drosophila HP1 beta   3.99E−10   4.66       446217   AI651594   Hs. 99709   ESTs   2.36E−09   4.63       431620   AA126109   Hs. 264981   2′-5′-oligoadenylate synthetase 2 (69-71   4.54E−12   4.57       414737   AI160386   Hs. 125087   ESTs   4.78E−06   4.43       421904   BE143533   Hs. 109309   hypothetical protein FLJ20035   2.86E−10   4.36       402994           NM_002463*:  Homo sapiens  myxovirus (influ   7.92E−05   4.29       428467   AK002121   Hs. 184465   hypothetical protein FLJ11259   2.14E−04   4.28       409703   NM_006187   Hs. 56009   2′-5′-oligoadenylate synthetase 3 (100 k   4.28E−14   4.25       438154   AI671957   Hs. 19523     Homo sapiens  clone 022f05 My030 protein   6.70E−09   4.13       437938   AI950087       gb: wq05c02.x1 NCI_CGAP_Kid12 Homo sapien   1.51E−08   4.08       432204   AI916132   Hs. 121593     Homo sapiens  cDNA FLJ13123 fis, clone NT   6.22E−09   4.07       406659   AA663985   Hs. 277477   major histocompatibility complex, class   1.50E−06   4.06       406621   X57809   Hs. 8997   immunoglobulin lambda locus   1.85E−04   4.03       414915   NM_002462   Hs. 76391   myxovirus (influenza) resistance 1, homo   2.02E−12   4.03       435665   AI248952   Hs. 12320   ESTs   3.98E−07   4.01       442700   AA377618   Hs. 103834   hypothetical protein MGC5576   2.54E−07   3.96       410240   AL157424   Hs. 61289   synaptojanin 2   7.09E−06   3.95       447747   AW853144   Hs. 49203   ESTs   1.01E−03   3.88       452194   AI694413       Ubiquitin-like protein FAT10??? - diubiq   4.53E−08   3.85       409614   BE297412   Hs. 55189   hypothetical protein   1.22E−08   3.85       419071   AL137330   Hs. 301055   hypothetical protein DKFZp434F0272   7.16E−06   3.80       427283   AL119796   Hs. 174185   ectonucleotide pyrophosphatase/phosphodi   6.28E−07   3.78       437834   AA769294       gb: nz36g03.s1 NCI_CGAP_GCB1  Homo sapiens     9.13E−06   3.75       419200   AW966405       prefoldin 5   1.36E−09   3.75       419150   T29618   Hs. 89640   TEK tyrosine kinase, endothelial (venous   8.23E−04   3.74       434210   AA665612       ESTs   2.80E−10   3.73       427094   AB025254   Hs. 283761   tudor repeat associator with PCTAIRE 2   3.92E−10   3.71       407151   H25836   Hs. 301527   ESTs, Moderately similar to unknown [H. s   1.13E−09   3.69       427562   R56424   Hs. 134191   ESTs   1.84E−06   3.67       452690   AI536070   Hs. 15085   ESTs   5.53E−05   3.64       416126   R66415       gb: yh01a04.s2 Soares infant brain 1NIB H   7.65E−03   3.64       442439   U09759   Hs. 246857   mitogen-activated protein kinase 9   1.51E−07   3.62       443378   AW392550   Hs. 9280   proteasome (prosome, macropain) subunit,   4.69E−10   3.62       419550   D50918   Hs. 90998   KIAA0128 protein; septin 2   2.13E−10   3.57       451578   NM_016323   Hs. 26663   cyclin-E binding protein 1   1.88E−08   3.54       419438   AA406400   Hs. 12482   glyceronephosphate O-acyltransferase   2.63E−04   3.53       409899   U07418   Hs. 57301   mutL ( E. coli ) homolog 1 (colon cancer,   7.69E−05   3.51       441423   AI793299   Hs. 126877   ESTs   4.67E−06   3.50       409153   W03754   Hs. 50813   hypothetical protein FLJ20022   9.52E−06   3.50       448128   U71267   Hs. 20423   CCR4-NOT transcription complex, subunit   5.13E−09   3.48       409893   AW247090   Hs. 57101   minichromosome maintenance deficient (S.   1.21E−06   3.48       444342   NM_014398   Hs. 10887   similar to lysosome-associated membrane   7.46E−09   3.43       406906   Z25424       gb:  H. sapiens  protein-serine/threonine ki   5.22E−05   3.42       409512   AW979187   Hs. 293591   melanoma differentiation associated prot   7.83E−13   3.41       416844   AA299330   Hs. 1042   Sjogren syndrome antigen A1 (52 kD, ribon   3.64E−08   3.40       446452   AB018283   Hs. 15099   KIAA0740 gene product   3.88E−07   3.39       448111   AA053486   Hs. 20315   interferon-induced protein with tetratri   3.07E−11   3.39       400244           Eos Control   1.17E−09   3.36       433409   AI278802   Hs. 25661   ESTs   2.37E−03   3.33       408411   C15118   Hs. 322482   hypothetical protein DKFZp566J2046   2.97E−08   3.31       408393   AW015318   Hs. 23165   ESTs   6.98E−08   3.29       439971   W32474   Hs. 301746   RAP2A, member of RAS oncogene family   1.02E−08   3.28       453023   AW028733   Hs. 31439   serine protease inhibitor, Kunitz type,   7.29E−06   3.27       428706   AA432030   Hs. 265827   interferon, alpha-inducible protein (clo   1.46E−08   3.26       424865   AF011333   Hs. 153563   lymphocyte antigen 75   2.38E−06   3.22       422598   W93032   Hs. 325568   ESTs, Weakly similar to A46010 X-linked   9.27E−13   322       423436   R21176   Hs. 100926   ESTs   2.71E−03   3.21       418918   X07871   Hs. 89476   CD2 antigen (p50), sheep red blood cell   3.03E−09   3.20       438769   AA830684   Hs. 163426   ESTs   4.96E−05   3.19       458379   T78886   Hs. 284450   ESTs   2.70E−05   3.17       426572   AB037783   Hs. 170623   hypothetical protein FLJ11183   1.66E−03   3.15       419257   X53461   Hs. 89781   upstream binding transcription factor, R   7.32E−07   3.13       422746   NM_004484   Hs. 119651   glypican 3   7.65E−06   3.13       427657   AV652249   Hs. 180107   polymerase (DNA directed), beta   7.44E−12   3.10       433679   AA393968   Hs. 180145   HSPC030 protein   2.98E−04   3.09       418838   AW385224   Hs. 35198   ectonucleotide pyrophosphatase/phosphodi   3.18E−06   3.07       417678   X06560   Hs. 82396   2′,5′-oligoadenylate synthetase 1 (40-46   1.67E−09   3.06       428227   AA321649   Hs. 2248   small inducible cytokine subfamily B (Cy   3.03E−12   3.06       408989   AW361666   Hs. 49500   KIAA0746 protein   1.59E−06   3.03       410340   AW182833   Hs. 112188   hypothetical protein FLJ13149   3.80E−05   3.03       417389   BE260964   Hs. 82045   midkine (neurite growth-promoting factor   3.24E−07   3.01       423461   AB020527   Hs. 128827   solute carrier family 17 (sodium phospha   3.52E−06   3.00       411837   AW866282       gb: QV4-SN0024-080400-167-a03 SN0024 Homo   1.26E−03   3.00       427528   AU077143   Hs. 179565   minichromosome maintenance deficient (S.   1.35E−06   2.99       420058   AK001423   Hs. 94694     Homo sapiens  cDNA FLJ10561 fis. clone NT   1.16E−06   2.99       432967   AA572949   Hs. 207566   ESTs   2.85E−03   2.98       415653   AA165400   Hs. 5321   hypothetical protein R33729_1   1.33E−04   2.95       419329   AY007220   Hs. 288998   S100-type calcium binding protein A14   1.31E−04   2.94       450937   R49131   Hs. 26267   ATP-dependant interferon response protei   1.74E−08   2.93       414617   AI339520   Hs. 288817   ESTs, Moderately similar to N Chain N, M   5.82E−05   2.92       450236   AW162998   Hs. 24684   KIAA1376 protein   1.00E−03   2.91       413179   N99692   Hs. 75227   Target CAT   2.78E−03   2.90       436746   AA730045   Hs. 187866   ESTs   1.29E−05   2.89       448879   Z44154   Hs. 22394   hypothetical protein FLJ10893   3.34E−06   2.88       414052   AW578849   Hs. 283552   ESTs, Weakly similar to unnamed protein   7.88E−08   2.87       408080   AW149754   Hs. 248652   ESTs, Weakly similar to T00273 hypotheti   5.99E−07   2.87       406990   S82075       gb: PA4 = candidate oncogene {3′region} [h   1.14E−05   2.86       409444   H47933   Hs. 33983   ESTs, Weakly similar to ALU6_HUMAN ALU S   6.32E−05   2.85       453883   AI638516   Hs. 347524   cofactor required for Sp1 transcriptiona   3.20E−09   2.85       434130   AL036067   Hs. 18925   protein x 0001   4.32E−05   2.84       408510   AA731642   Hs. 285017   hypothetical protein FLJ21799   8.74E−06   2.84       409231   AA446644   Hs. 692   GA733-2 antigen; epithelial glycoprotein   1.04E−04   2.83       448465   AW500269   Hs. 21264   KIAA0782 protein   8.90E−03   2.83       422440   NM_004812   Hs. 116724   aldo-keto reductase family 1, member B10   1.65E−03   2.83       432378   AI493046   Hs. 146133   ESTs   5.01E−07   2.82       432279   N95104   Hs. 274260   ATP-binding cassette, sub-family C (CFTR   8.30E−08   2.81       443119   AA312264   Hs. 7980   hypothetical protein MGC12966   6.95E−06   2.80       402264           NM_020657*:  Homo sapiens  zinc finger prot   4.15E−04   2.75       422112   BE540240   Hs. 111783   Lsm1 protein   3.36E−06   2.74       422553   AI697720   Hs. 171455   ESTs, Weakly similar to T31613 hypotheti   2.97E−05   2.74       432401   NM_013330   Hs. 274479   NME7   5.36E−05   2.73       442607   AA507576   Hs. 288361     Homo sapiens  cDNA: FLJ22696 fis, clone H   4.35E−05   2.73       448550   AL161983   Hs. 21415     Homo sapiens  mRNA; cDNA DKFZp761K2024 (f   2.37E−06   2.73       439237   AW408158   Hs. 318893   ESTs, Weakly similar to A47582 B-cell gr   5.16E−08   2.73       417308   H60720   Hs. 81892   KIAA0101 gene product   3.87E−07   2.71       433489   AW629150       ESTs   2.41E−04   2.68       433437   U20536   Hs. 3280   caspase 6, apoptosis-related cysteine pr   1.32E−07   2.67       452327   AK000196   Hs. 29052   hypothetical protein FLJ20189   1.23E−06   2.67       447880   AA214240   Hs. 301226   KIAA1085 protein   6.35E−08   2.65       430308   BE540865   Hs. 238990   cyclin-dependent kinase inhibitor 1B (p2   5.39E−08   2.65       431967   AJ243653   Hs. 283404   organic cation transporter   6.95E−03   2.62       425342   AA534073   Hs. 155751   voltage-dependent anion channel 3   2.81E−05   2.61       441737   X79449   Hs. 7957   adenosine deaminase, RNA-specific   1.72E−10   2.61       431939   AW008061   Hs. 231994   ESTs   1.34E−04   2.60       456463   AA380180   Hs. 56896   ESTs   3.87E−03   2.60       407756   AA116021   Hs. 38260   ubiquitin specific protease 18   1.46E−11   2.59       411060   NM_006074   Hs. 318501     Homo sapiens  mRNA full length insert cDN   1.27E−12   2.58       435839   AF249744   Hs. 25951   Rho guanine nucleotide exchange factor   7.50E−03   2.57       413431   AW246428   Hs. 75355   (ubiquitin-conjugating enzyme E2N (homolo   4.19E−03   2.57       411605   AW006831       ESTs   1.58E−04   257       423545   AP000692   Hs. 129781   chromosome 21 open reading frame 5   7.99E−04   2.57       453917   BE297466   Hs. 36587   protein phosphatase 1, regulatory subuni   1.90E−06   2.57       429680   AL035754   Hs. 2474   toll-like receptor 1   9.61E−06   2.56       449718   AA459480   Hs. 23956   hypothetical protein FLJ20502   6.31E−07   2.56       433163   R40468   Hs. 163582   ESTs   1.53E−03   2.56       423753   Y11312   Hs. 132463   phosphoinositide−3-kinase, class 2, beta   1.90E−05   2.55       419082   AW953977   Hs. 78825   matrin3   3.07E−05   2.54       450698   W31489   Hs. 95044   ESTs, Weakly similar to I38022 hypotheti   8.19E−05   2.54       447400   AK000322   Hs. 18457   hypothetical protein FLJ20315   1.76E−10   2.54       426172   AA371307   Hs. 125056   ESTs   9.68E−06   2.54       431685   AW296135   Hs. 267659   vav 3 oncogene   1.05E−06   2.54       423617   AA741058   Hs. 20065   ESTs   3.05E−06   2.54       413670   AB000115   Hs. 75470   hypothetical protein, expressed in osteo   6.06E−08   2.53       449613   N63808   Hs. 34299   ESTs   4.88E−06   2.53       432388   X15218   Hs. 2969   v-ski avian sarcoma viral oncogene homol   2.62E−04   2.51       416795   AI497778   Hs. 20509   HBV pX associated protein-8   7.52E−05   2.51       409259   AW608930   Hs. 52184   hypothetical protein FLJ20618   1.37E−09   2.51       435017   AA336522   Hs. 12854   angiotensin II, type I receptor-associat   1.94E−08   2.51       420292   AW991781       gb: QV2-BN0007-280300-104-d06 BN0007 Homo   3.31E−03   2.51       410582   AW867197   Hs. 337561   hypothetical protein FLJ21616   5.40E−07   2.50       449478   AA829848   Hs. 193059   ESTs   3.55E−03   2.50       409346   AL162066   Hs. 54320   hypothetical protein DKFZp762D096   6.84E−08   2.50       418416   U11700   Hs. 84999   ATPase, Cu transporting, beta polypeptid   3.76E−08   2.49       448570   AI923944   Hs. 30913   ESTs   8.37E−06   2.47       418476   AA648431   Hs. 37883   hypothetical protein PNAS-131   6.13E−05   2.46       432710   AA609685   Hs. 278672   membrane component, chromosome 11, surfa   8.84E−08   2.45       442679   R53718       hypothetical protein FLJ10659   2.05E−07   2.45       416309   R84694   Hs. 79194   cAMP responsive element binding protein   6.20E−06   2.45       424090   X99699   Hs. 139262   XIAP associated factor-1   1.47E−06   2.44       448901   AK001021   Hs. 22505   hypothetical protein FLJ10159   1.09E−08   2.44       429635   AW968360   Hs. 14355     Homo sapiens  cDNA FLJ13207 fis, clone NT   2.80E−03   2.44       422173   BE385828   Hs. 250619   phorbolin-like protein MDS019   2.07E−08   2.44       439708   AI761369   Hs. 59584   hypothetical protein FLJ21144   4.54E−05   2.43       449239   T24653   Hs. 23360   likely ortholog of yeast ARV1   1.44E−06   2.43       441327   AK001706   Hs. 7778   hypothetical protein FLJ10751   1.41E−07   2.43       407366   AF026942   Hs. 17518   gb:  Homo sapiens  cig33 mRNA, partial sequ   7.03E−06   2.43       412898   AI129903   Hs. 74669   vesicle-associated membrane protein 5 (m   1.35E−04   2.42       452355   N54926   Hs. 29202   G protein-coupled receptor 34   1.31E−05   2.42       446526   H89616         Homo sapiens  cDNA FLJ13357 fis, clone PL   9.78E−04   2.42       421915   AW207000   Hs. 126857     Homo sapiens  cDNA FLJ12936 fis, clone NT   7.84E−06   2.41       443486   NM_003428   Hs. 9450   zinc finger protein 84 (HPF2)   4.22E−03   2.40       457465   AW301344   Hs. 122908   DNA replication factor   1.19E−04   2.40       439718   AA307634   Hs. 6650   vacuolar protein sorting 45B (yeast homo   6.66E−08   2.40       440874   NM_003188   Hs. 7510   mitogen-activated protein kinase kinase   5.30E−05   2.40       420137   AA306478   Hs. 95327   CD3D antigen, delta polypeptide (TiT3 co   1.30E−05   2.40       429164   AI688663   Hs. 116586   ESTs   4.14E−04   2.40       427484   N32859   Hs. 37288   nuclear receptor subfamily 1, group D, m   1.58E−07   2.39       413815   AL046341   Hs. 75562   discoidin domain receptor family, member   5.22E−04   2.39       452835   AK001269   Hs. 30738   hypothetical protein FLJ10407   2.27E−09   2.39       414669   Z83850   Hs. 76838   serine (or cysteine) proteinase inhibito   2.67E−13   2.39       409154   U72882   Hs. 50842   interferon-induced protein 35   2.65E−09   2.39       420952   AA282067   Hs. 88972   ESTs, Moderately similar to A46010 X-lin   8.44E−04   2.39       416068   R45985   Hs. 115175   sterile-alpha motif and leucine zipper c   2.72E−03   2.38       450607   AL050373   Hs. 25213   hypothetical protein   2.15E−06   2.38       421040   AA715026   Hs. 135280   ESTs   1.18E−06   2.38       450206   AI796450   Hs. 201600   ESTs   4.49E−06   2.38       426805   AB032945   Hs. 172506   myosin VB   8.69E−05   2.37       436436   AI417516   Hs. 202091   ESTs   6.37E−04   2.37       428928   BE409838   Hs. 194657   cadherin 1, type 1, E-cadherin (epitheli   3.30E−07   2.37       414489   AI620677   Hs. 73105   ESTs   3.01E−08   2.37       443854   AI089079   Hs. 135214   hypothetical protein FLJ12800   3.53E−05   2.36       402424           NM_024901:  Homo sapiens  hypothetical prot   1.01E−05   2.36       451752   AB032997       KIAA1171 protein   1.18E−14   2.36       435458   F11872   Hs. 4892     Homo sapiens  clone 24841 mRNA sequence   2.25E−03   2.36       428180   AI129767   Hs. 182874   guanine nucleotide binding protein (G pr   2.38E−05   2.35       448760   AA313825   Hs. 323583   AD036 protein   1.47E−07   2.35       425235   AA353113   Hs. 112497     Homo sapiens  cDNA: FLJ22743 fis, clone H   2.65E−06   2.34       404649           Target Exon   1.06E−08   2.34       420174   AI824144   Hs. 199749   ESTs   5.79E−07   2.34       423258   L13460   Hs. 1644   cytochrome P450, subfamily VIIA (cholest   1.20E−05   2.34       444324   AI301330   Hs. 143838   ESTs   3.55E−05   2.33       414283   AW960011   Hs. 154993   ESTs   1.70E−07   2.33       412802   U41518   Hs. 74602   aquaporin 1 (channel-forming integral pr   5.06E−04   2.33       425375   AA631977   Hs. 155995   KIAA0643 protein   4.34E−05   2.33       428514   AW236861   Hs. 193139   ESTs   6.38E−09   2.32       423645   AI215632   Hs. 147487   ESTs   5.17E−06   2.32       448222   AI648587   Hs. 20725   Mov10 (Moloney teukemia virus 10, mouse)   7.56E−06   2.31       422633   X56832   Hs. 118804   enolase 3, (beta, muscle)   2.83E−09   2.31       429756   AB022663   Hs. 215857   ring finger protein 14   2.40E−07   2.31       428342   AI739168         Homo sapiens  cDNA FLJ13458 fis, clone PL   5.59E−06   2.31       421246   AW582962   Hs. 102897   CGI-47 protein   1.36E−06   2.30       442821   BE391929   Hs. 8752   transmembrane protein 4   7.86E−06   2.30       410541   AA065003   Hs. 64179   syntenin-2 protein   2.03E−03   2.29       441872   BE567100   Hs. 154938   hypothetical protein MDS025   2.15E−09   2.29       423804   AW403448   Hs. 16725   interferon-stimulated transcription fact   3.25E−07   2.28       411049   AW814885   Hs. 19553   ESTs   6.16E−05   2.28       426272   AW450671   Hs. 189284   ESTs   6.41E−06   2.28       440975   AW499914   Hs. 7579   hypothetical protein FLJ10402   6.22E−07   2.28       447651   T60407   Hs. 217882   ESTs, Moderately similar to ALU1_HUMAN A   5.50E−08   2.28       410577   X91911   Hs. 64639   glioma pathogenesis-related protein   8.61E−07   2.27       433309   AA807060   Hs. 126558   ESTs   2.10E−03   2.26       447973   AB011169   Hs. 20141   similar to  S. cerevisiae  SSM4   1.75E−06   2.26       426437   BE076537   Hs. 169895   ubiquitin-conjugating enzyme E2L 6   1.56E−09   2.26       452744   AI267652   Hs. 246107     Homo sapiens  mRNA; cDNA DKFZp434E082 (fr   4.59E−11   2.25       418452   BE379749   Hs. 85201   C-type (calcium dependent, carbohydrate-   4.78E−11   2.25       420245   AA256902   Hs. 252433     Homo sapiens  cDNA FLJ13794 fis, clone TH   4.55E−05   2.24       431677   AK000496   Hs. 306989   hypothetical protein FLJ20489   2.67E−05   2.24       421902   BE392717       gb: 601307571F1 NIH_MGC_44  Homo sapiens  c   1.28E−04   2.24       413869   NM_000878   Hs. 75596   interleukin 2 receptor, beta   2.47E−07   2.24       443787   AV646505   Hs. 122155   ESTs   5.12E−04   2.24       427581   NM_014788   Hs. 179703   KIAA0129 gene product   1.27E−10   2.23       416224   NM_002902   Hs. 79088   reticulocalbin 2, EF-hand calcium bindin   1.37E−07   2.23       405533           Target Exon   1.20E−04   2.23       402230           Fgenesh predicted: CYTOCHROME P450 4F5 (   2.46E−06   2.23       429857   AF089897   Hs. 294030   topoisomerase-related function protein 4   5.01E−06   2.21       437536   X91221   Hs. 144465   ESTs   1.55E−05   2.21       446094   AK001760   Hs. 13801   KIAA1685 protein   1.54E−07   2.20       444097   AW517412   Hs. 150757   ESTs   3.40E−03   2.20       425268   AI807883   Hs. 180059     Homo sapiens  cDNA FLJ20653 fis, clone KA   3.58E−04   2.20       400751           NM_003105*:  Homo sapiens  sortilin-related   4.17E−04   2.20       424145   AW802763   Hs. 193124   pyruvate dehydrogenase kinase, isoenzyme   2.84E−06   2.19       430339   W28608   Hs. 239625   integral membrane protein 2B   2.63E−06   2.19       419287   X91906   Hs. 89872   chloride channel 5 (nephrolithiasis 2, X   1.23E−06   2.19       427374   AI150033   Hs. 143686   ESTs   8.34E−03   2.19       427043   AA397679       ESTs   2.93E−04   2.19       400694           Target Exon   5.84E−07   2.18       421014   NM_012227       Pseudoautosomal GTP-binding protein-like   6.96E−03   2.17       408078   N50928   Hs. 45203   ESTs   8.51E−04   2.17       447009   AB002340   Hs. 16950   KIAA0342 gene product   8.64E−07   2.17       422239   AI878922   Hs. 180139   SMT3 (suppressor of mif two 3. yeast) ho   6.16E−07   2.16       413786   AW613780   Hs. 13500   ESTs   6.01E−10   2.16       438307   AB011093   Hs. 6150   hypothetical protein MGC15913   1.91E−08   2.16       455187   AW864050       gb: PM2-SN0013-120400-003-c12 SN0013 Homo   1.69E−03   2.15       459487   AA699665       gb: zi78b05.s1 Soares_fetal_liver_spleen —     7.20E−04   2.15       449935   AA004798   Hs. 108311   ESTs, Weakly similar to T00351 hypotheti   9.75E−09   2.15       428695   AI355647   Hs. 189999   purinergic receptor (family A group 5)   1.45E−06   2.15       449964   AW001741   Hs. 24243   hypothetical protein FLJ10706   1.23E−04   2.14       427398   AW390020   Hs. 20415   chromosome 21 open reading frame 11   3.46E−04   2.14       440548   AL117408   Hs. 7274   DKFZP434P1750 protein   3.31E−03   2.14       440464   AI917706   Hs. 129997   ESTs   1.49E−05   2.14       422515   AW500470   Hs. 117950   multifunctional polypeptide similar to S   1.55E−05   2.14       451190   H38361   Hs. 26045   protein tyrosine phosphatase, receptor t   2.99E−05   2.13       422649   BE258692   Hs. 118910   tumor susceptibility gene 101   1.82E−06   2.13       435374   AI049889       ESTs   4.37E−04   2.13       423062   NM_003655   Hs. 5637   ESTs   8.76E−07   2.13       425164   R18189       gb: yf98f10.r1 Soares infant brain 1NIB H   4.67E−04   2.12       421685   AF189723   Hs. 106778   ATPase, Ca transporting, type 2C, member   6.05E−05   2.12       440266   AA088809   Hs. 19525   hypothetical protein FLJ22794   5.23E−06   2.12       443574   U83993   Hs. 321709   purinergic receptor P2X, ligand-gated io   7.69E−05   2.12       447735   AA775268   Hs. 6127     Homo sapiens  cDNA: FLJ23020 fis, clone L   3.38E−04   2.11       433426   H69125   Hs. 133525   ESTs   1.40E−07   2.11       450056   BE047394   Hs. 8208   ESTs, Weakly similar to S71512 hypotheti   3.36E−04   2.11       418027   AB037807   Hs. 83293   hypothetical protein   1.30E−06   2.11       421650   AA781795   Hs. 122587   ESTs   2.45E−07   2.11       453909   AW004045   Hs. 203365   ESTs   2.51E−04   2.11       444847   AI199345   Hs. 153393   ESTs   1.43E−04   2.11       416448   L13210   Hs. 79339   lectin, galactoside-binding, soluble, 3   3.05E−11   2.10       449140   AW013840   Hs. 202092   ESTs   6.30E−05   2.10       430593   AA985190   Hs. 246875   hypothetical protein FLJ20059   5.90E−04   2.10       408791   AW272251   Hs. 254651   ESTs   1.02E−04   2.10       416435   AI431301       KIAA0129 gene product   4.53E−07   2.10       431637   AI879330   Hs. 265960   hypothetical protein FLJ10563   9.82E−04   2.10       442547   AA306997   Hs. 217484   ESTs, Weakly similar to ALU1_HUMAN ALU S   3.06E−04   2.10       419560   AA456130       KIAA1255 protein   7.10E−05   2.10       441673   AI018657       ESTs   1.80E−04   2.09       452827   AI571835   Hs. 55468   ESTs   9.60E−07   2.09       430341   NM_006348   Hs. 239631   golgi transport complex 1 (90 kDa subuni   2.32E−04   2.09       442160   AI337127   Hs. 156325   ESTs   6.80E−09   2.09       416754   H07145   Hs. 6799   ESTs, Weakly similar to T12483 hypotheti   1.55E−05   2.09       446731   BE378875   Hs. 16059   HSPC009 protein   1.50E−03   2.09       434128   W93170   Hs. 284164   protein x 0004   2.58E−06   2.08       426801   AA486846   Hs. 271795   ESTs, Weakly similar to I38022 hypotheti   4.92E−05   2.08       412556   AW961963       gb: EST374036 MAGE resequences, MAGG Homo   4.04E−03   2.08       401467           NM_022137*:  Homo sapiens  secreted modular   8.05E−03   2.08       416714   AF283770   Hs. 79630   CD79A antigen (immunoglobulin-associated   2.38E−03   2.08       441297   AW403084   Hs. 7766   ubiquitin-conjugating enzyme E2E 1 (homo   4.09E−05   2.08       449689   AF228421   Hs. 23889   DKFZP564A032 protein   1.72E−04   2.07       432360   BE045243   Hs. 274416   Target CAT   4.08E−07   2.07       424308   AW975531   Hs. 154443   minichromosome maintenance deficient (S.   2.18E−07   2.07       424618   L29472   Hs. 1802   major histocompatibility complex, class   3.53E−06   2.07       421261   AA600853   Hs. 98133   ESTs   1.01E−03   2.06       430200   BE613337   Hs. 234896   geminin   1.10E−11   2.06       423968   AF098277   Hs. 136529   solute carrier family 23 (nucleobase tra   1.34E−07   2.06       453313   BE005771   Hs. 153746   hypothetical protein FLJ22490   3.19E−03   2.06       403789           NM_001334*: Homo-sapiens cathepsin O (CTS   4.24E−05   2.06       427561   AI123333   Hs. 134191   ESTs   1.07E−08   2.06       454877   AW836463       gb: PM3-LT0032-231299-001-d01 LT0032 Homo   6.46E−07   2.06       408716   AI567839   Hs. 151714     Homo sapiens  mRNA for KIAA1769 protein,   7.10E−07   2.06       438182   AW342140   Hs. 182545   ESTs, Weakly similar to ALU1_HUMAN ALU S   3.05E−05   2.05       441993   BE395143   Hs. 71523   ESTs, Weakly similar to S44243 endosomal   7.66E−04   2.05       427648   AI376722   Hs. 180062   proteasome (prosome, macropain) subunit,   6.20E−10   2.05       414646   AA353776   Hs. 901   CD48 antigen (B-cell membrane protein)   4.38E−07   2.05       458079   AI796870   Hs. 54277   DNA segment on chromosome X (unique) 992   1.32E−05   2.05       446783   AW138343   Hs. 141867   ESTs   3.84E−03   2.05       406117           C19001795: gi|10434258|dbj|BAB14191.1|(A   3.18E−06   2.05       453255   AA278167   Hs. 19215     Homo sapiens , clone IMAGE: 3605822, mRNA   3.20E−04   2.04       446619   AU076643   Hs. 313   secreted phosphoprotein 1 (osteopontin,   9.85E−03   2.04       437967   BE277414   Hs. 5947   mel transforming oncogene (derived from   1.65E−04   2.04       400137           Eos Control   1.05E−07   2.04       417787   R14948   Hs. 23883   ESTs   9.00E−07   2.04       417600   R01279   Hs. 16179   hypothetical protein FLJ23467   8.47E−03   2.04       411562   AL050201   Hs. 70769   hypothetical protein DKFZp586E1923   1.33E−06   2.04       418733   AA227714       KIAA0129 gene product   1.31E−09   2.03       412651   AA115333   Hs. 107968   ESTs   6.35E−09   2.03       406420           C19000229*: gi|6753826|ref|NP_034311.1|f   1.99E−03   2.03       423397   NM_001838   Hs. 1652   chemokine (C-C motif) receptor 7   4.05E−05   2.03       447002   BE242866   Hs. 16933   HepA-related protein   1.96E−06   2.03       409038   T97490   Hs. 50002   small inducible cytokine subfamily A (Cy   4.88E−04   2.03       419737   H24185   Hs. 92918   hypothetical protein   2.46E−04   2.03       436235   AI084982   Hs. 120790   ESTs   4.48E−05   2.03       447043   BE410773   Hs. 115412   hypothetical protein FLJ13881   3.32E−06   2.02       411987   AA375975   Hs. 24831   ESTs, Moderately similar to ALU8_HUMAN A   5.80E−04   2.02       400245           Eos Control   1.28E−06   2.02       447906   AL050062   Hs. 19999   DKFZP566K023 protein   5.25E−05   2.02       451820   AW058357   Hs. 199248   ESTs   2.88E−05   2.02       418216   AA662240   Hs. 283099   AF15q14 protein   5.20E−10   2.02       408949   AF189011   Hs. 49163   putative ribonuclease III   2.94E−05   2.01       423962   R73257   Hs. 42586   KIAA1560 protein   2.03E−04   2.01       432053   AI024572       ESTs   8.07E−08   2.01       412754   AW160375   Hs. 74565   amyloid beta (A4) precursor-like protein   1.10E−03   2.01       453927   AA082465   Hs. 125031   choline/ethanolaminephosphotransferase   6.17E−08   2.01       430556   AW967807   Hs. 13797   ESTs   3.75E−04   2.01       451494   AI799444   Hs. 247095   ESTs, Moderately similar to ALU7_HUMAN A   9.08E−04   2.00       422546   AB007969   Hs. 301478   KIAA0500 protein   1.62E−06   2.00       424755   AB033094   Hs. 152925   KIAA1268 protein   5.02E−08   2.00       406782   AA430373       gb: zw20f11.s1 Soares ovary tumor NbHOT H   2.29E−03   1.99       427128   AW301984   Hs. 49349   hypothetical protein FLJ12619   1.86E−07   1.99       414159   AW511414   Hs. 257352   apolipoprotein L, 6   5.86E−12   1.99       418348   AI537167   Hs. 96322   hypothetical protein FLJ23560   6.15E−04   1.99       410369   AW975159   Hs. 293097   ESTs, Weakly similar to A55380 faciogeni   5.39E−05   1.99       410315   AI638871   Hs. 152519     Homo sapiens  cDNA: FLJ22524 fis, clone H   4.48E−07   1.99       407644   D16815       nuclear receptor subfamily 1, group D, m   1.10E−05   1.98       459107   AA811881   Hs. 28505   ubiquitin-conjugating enzyme E2H (homolo   1.49E−03   1.98       433150   AB035274   Hs. 21320   postreplication repair protein hRAD18p   8.38E−04   1.98       413823   AI341417   Hs. 29406   ESTs   9.53E−08   1.97       409518   BE384836   Hs. 3454   KIAA1821 protein   2.52E−04   1.97       439225   AA192669   Hs. 45032   ESTs   1.00E−06   1.97       430619   AF129756   Hs. 247452   HLA-B associated transcript-5   1.86E−06   1.97       432606   NM_002104   Hs. 3066   granzyme K (serine protease, granzyme 3;   1.05E−06   1.97       441298   AW136267   Hs. 166629   ESTs   6.99E−03   1.96       450931   N25156   Hs. 25648   tumor necrosis factor receptor superfami   4.52E−08   1.96       457234   AW968360   Hs. 14355     Homo sapiens  cDNA FLJ13207 fis, clone NT   1.08E−04   1.96       442328   AI952430   Hs. 150614   ESTs, Weakly similar to ALU4_HUMAN ALU S   1.07E−04   1.96       414493   AL133921   Hs. 76272   retinoblastoma-binding protein 2   1.41E−07   1.96       427209   H06509   Hs. 92423   KIAA1566 protein   1.67E−06   1.96       416430   H60487   Hs. 159440   bile acid Coenzyme A: amino acid N-acylt   1.43E−05   1.96       448692   AW013907   Hs. 167531   methylcrotonoyl-Coenzyme A carboxylase 2   2.14E−03   1.95       418707   U97502   Hs. 87497   butyrophilin, subfamily 3, member A2   2.72E−11   1.95       440256   U23841   Hs. 18851   hypothetical protein FLJ10875   5.24E−06   1.95       436578   AI091435   Hs. 134859   ESTs   1.08E−06   1.94       423597   AL043117   Hs. 129872   sperm associated antigen 9   2.72E−04   1.94       446669   AW972832   Hs. 29468   ESTs   1.10E−04   1.93       436061   AI248584   Hs. 190745     Homo sapiens  cDNA: FLJ21326 fis, clone C   3.75E−03   1.93       408291   AB023191   Hs. 44131   KIAA0974 protein   4.99E−05   1.93       432485   N90866   Hs. 276770   CDW52 antigen (CAMPATH-1 antigen)   5.39E−07   1.93       420653   AI224532   Hs. 88550   ESTs   6.18E−03   1.93       418504   BE159718   Hs. 85335     Homo sapiens  mRNA; cDNA DKFZp564D1462 (f   1.63E−06   1.93       444398   AI146775   Hs. 143550   ESTs   7.61E−03   1.93       408731   R85652         Homo sapiens  mRNA; cDNA DKFZp434F1928 (f   3.52E−04   1.93       436395   AJ227900       gb:  Homo sapiens  partial mRNA; ID EE2-16B   4.64E−08   1.92       429276   AF056085   Hs. 198612   G protein-coupled receptor 51   8.50E−05   1.92       426476   NM_003296   Hs. 2042   testis specific protein 1 (probe H4-1 p3   1.20E−03   1.92       454075   R43826   Hs. 16313   Kruppel-like zinc finger protein GLIS2   7.10E−03   1.92       445245   AB032973   Hs. 12461   LCHN protein   2.74E−10   1.91       457665   BE551196   Hs. 114275   ESTs   5.71E−03   1.91       418090   U57059   Hs. 83429   tumor necrosis factor (ligand) superfami   1.34E−09   1.91       427675   AW138190   Hs. 180248   zinc finger protein 124 (HZF-16)   3.00E−06   1.91       435745   AW967059         Homo sapiens  clone 24711 mRNA sequence   5.05E−04   1.91       429798   AL117578   Hs. 222909   DKFZP434C128 protein   5.79E−09   1.91       424637   NM_015057   Hs. 151411   KIAA0916 protein   7.41E−07   1.91       445447   H14522       ribosomal protein S4, X-linked   4.52E−05   1.91       428372   AK000684   Hs. 183887   hypothetical protein FLJ22104   4.09E−08   1.90       444454   BE018316   Hs. 11183   sorting nexin 2   1.42E−06   1.90       431122   AI267593   Hs. 250535     Homo sapiens  mRNA; cDNA DKFZp434N2412 (f   2.54E−04   1.90       436318   T77359   Hs. 14040     Homo sapiens  cDNA: FLJ21772 fis, clone C   4.82E−04   1.90       446553   AB021179   Hs. 15299   HMBA-inducible   6.90E−08   1.90       433401   AF039698   Hs. 284217   serologically defined colon cancer antig   6.31E−08   1.89       421677   H64092   Hs. 38282   ESTs   2.70E−08   1.89       424194   BE245833   Hs. 169854   gb: TCBAP1E1908 Pedialric pre-B cell acut   2.67E−03   1.89       426990   AL044315   Hs. 173094     Homo sapiens  mRNA for KIAA1750 protein.   2.18E−04   1.89       439810   AL109710   Hs. 85568   EST   1.53E−03   1.89       414757   U46922   Hs. 77252   fragile histidine triad gene   6.95E−06   1.89       430587   AK000341   Hs. 246107   elongation of very long chain fatty acid   1.22E−05   1.88       440527   AV657117   Hs. 184164   ESTs, Moderately similar to S65657 alpha   2.16E−06   1.88       414405   AI362533       KIAA0306 protein   1.88E−06   1.88       414171   AA360328   Hs. 865   RAP1 A, member of RAS oncogene family   1.72E−04   1.88       448198   BE622100   Hs. 209406   ESTs, Weakly similar to I38600 zinc fing   7.63E−07   1.88       433017   Y15067   Hs. 279914   zinc finger protein 232   1.66E−06   1.88       449609   BE246434   Hs. 289026   guanine nucleotide binding protein (G pr   4.83E−05   1.88       427600   AW630918   Hs. 179774   proteasome (prosome, macropain) activato   1.19E−06   1.88       409362   AC008044   Hs. 54418   alkylation repair; alkB homolog   6.66E−03   1.88       450379   T77813   Hs. 268590   ESTs   4.05E−04   1.87       404426           C8000068*: gi|5453579|ref|NP_006120.1| bo   1.01E−08   1.87       407949   W21874   Hs. 247057   ESTs, Weakly similar to 2109260A B cell   9.97E−06   1.87       446570   AV659177   Hs. 127160   ESTs   4.44E−07   1.87       409896   AW205479   Hs. 279780   NY-REN-18 antigen   2.36E−08   1.87       419867   NM_014246   Hs. 252387   cadherin, EGF LAG seven-pass G-type rece   3.90E−04   1.87       447178   AW594641   Hs. 192417   ESTs   5.76E−07   1.87       438475   W03856   Hs. 13188   ESTs, Highly similar to Gene product wit   6.54E−09   1.87       443492   AI073989   Hs. 144913   hypothetical protein FLJ23514   3.68E−04   1.87       400303   AA242758   Hs. 79136   LIV-1 protein, estrogen regulated   1.02E−09   1.87       417052   NM_000712   Hs. 81029   biliverdin reductase A   1.44E−08   1.87       452406   AI002968   Hs. 235402   ESTs, Weakly similar to T26525 hypotheti   5.04E−08   1.86       432857   NM_016103   Hs. 279582   GTP-binding protein Sara   4.59E−07   1.86       428933   AA743433   Hs. 119292   ESTs   1.97E−04   1.86       429360   AK000658   Hs. 200332   hypothetical protein FLJ20651   2.52E−06   1.86       422352   AA766296   Hs. 99200   ESTs   6.40E−05   1.86       438449   AK001333   Hs. 6216     Homo sapiens  hepatocellular carcinoma-as   5.96E−04   1.86       421524   AA312082   Hs. 105445   GDNF family receptor alpha 1   5.48E−08   1.86       419598   AW410557   Hs. 91471   ATPase, Class II, type 9B   1.54E−03   1.86       445317   AI219856       ESTs   2.25E−04   1.86       401274           Target Exon   9.48E−05   1.86       433028   AI199144   Hs. 283737   AD-017 protein   2.06E−05   1.86       419439   BE252908       thyroglobulin   2.28E−06   1.86       453037   AA045175   Hs. 17914   ESTs   8.76E−07   1.86       432468   AW402155   Hs. 3003   CD3E antigen, epsilon polypeptide (TiT3   2.04E−03   1.86       450997   AW580830   Hs. 35254   hypothetical protein FLB6421   8.02E−10   1.86       441787   AA813278   Hs. 9788   hypothetical protein MGC10924 similar to   1.19E−06   1.86       450381   AW291767   Hs. 189829   hypothetical protein FLJ12765   1.37E−03   1.86       410199   AW377424   Hs. 205126     Homo sapiens  cDNA: FLJ22667 fis, clone H   2.36E−08   1.86       423215   C16770       gb: C16770 Clontech human aorta polyA mRN   8.56E−03   1.85       422085   AB018257   Hs. 288773   zinc finger protein 294   1.80E−04   1.85       429358   AB037825   Hs. 200317   KIAA1404 protein   1.28E−08   1.85       447631   AW140016   Hs. 161415   ESTs   4.33E−06   1.85       453954   AW118336   Hs. 75251   DEAD/H (Asp-Glu-Ala-Asp/His) box binding   6.32E−04   1.85       438050   BE262816   Hs. 6061   protein kinase, AMP-activated, beta 1 no   6.39E−04   1.85       425939   AK001527   Hs. 163953   hypothetical protein FLJ10665   2.37E−03   1.85       426911   AA812691   Hs. 278985   ESTs   1.44E−04   1.85       426126   AL118747   Hs. 26691   ESTs   7.85E−05   1.85       400929           ENSP00000252232*: Sterol regulatory eleme   1.42E−03   1.85       413048   M93221   Hs. 75182   mannose receptor, C type 1   6.72E−07   1.85       420613   AI873871   Hs. 7041   ESTs, Weakly similar to A47582 B-cell gr   5.30E−09   1.85       409533   AW969543   Hs. 21291   mitogen-activated protein kinase kinase   2.39E−04   1.85       430024   AI808780   Hs. 227730   integrin, alpha 6   5.50E−07   1.85       407110   AA018042   Hs. 252085   Prader-Willi/Angelman syndrome-5   1.23E−05   1.85       403790           NM_001334*:  Homo sapiens  cathepsin O (CTS   1.67E−05   1.84       408214   AL120445   Hs. 77823   hypothetical protein FLJ21343   9.69E−06   1.84       443285   AI301918   Hs. 334264   ESTs   7.83E−04   1.84       445615   AW449905   Hs. 40919     Homo sapiens  cDNA FLJ14511 fis. clone NT   321E−04   1.84       449720   AA311152   Hs. 288708   hypothetical protein FLJ21562   4.25E−06   1.84       445806   AL137516   Hs. 13323   hypothetical protein FLJ22059   1.57E−04   1.84       457400   AF032906   Hs. 252549   cathepsin Z   1.05E−07   1.84       424571   BE379766       polymerase (RNA) II (DNA directed) polyp   1.04E−10   1.84       408328   R93852   Hs. 28411   ESTs   5.70E−04   1.84       436363   AA843926   Hs. 124434   ESTs   6.44E−05   1.84       418850   AJ242977   Hs. 89278   hypothetical protein FLJ11186   4.88E−09   1.83       422711   D60641         Homo sapiens  mRNA; cDNA DKFZp586l1518 (f   3.71E−05   1.83       444889   AI917770       ESTs   6.36E−05   1.83       446506   AI123118   Hs. 15159   chemokine-like factor, alternatively spl   3.56E−11   1.83       424437   BE244700   Hs. 147049   cut (Drosophila)-like 1 (CCAAT displacem   1.49E−04   1.83       422371   NM_001882   Hs. 115617   corticotropin releasing hormone-binding   2.26E−07   1.83       419461   AI452601   Hs. 288869   nuclear receptor subfamily 2, group F, m   5.42E−09   1.83       434629   AA789081   Hs. 4029   glioma-amplified sequence-41   1.80E−05   1.83       425367   BE271188   Hs. 155975   protein tyrosine phosphatase, receptor t   1.53E−05   1.82       453275   AW247236   Hs. 32826   CGI-130 protein   1.86E−07   1.82       418751   BE389014       phosphoinositide-3-kinase, regulatory su   1.59E−07   1.82       445525   BE149866   Hs. 14831     Homo sapiens , Similar to zinc linger pro   5.85E−07   1.82       432107   AA779945   Hs. 303294   ESTs, Weakly similar to ALUB_HUMAN !!!!   3.18E−03   1.82       407355   AA846203   Hs. 193974   ESTs, Weakly similar to ALU1_HUMAN ALU S   5.23E−04   1.82       422646   H87863   Hs. 151380   ESTs, Weakly similar to T16584 hypotheti   1.30E−04   1.82       414485   W27026   Hs. 182625   VAMP (vesicle-associated membrane protei   4.19E−03   1.82       421931   NM_000814   Hs. 1440   gamma-aminobutyric acid (GABA) A recepto   9.00E−05   1.82       454056   AI368836   Hs. 24808   ESTs, Weakly similar to I38022 hypotheti   2.84E−04   1.82       459067   AW207623   Hs. 262716   ESTs, Moderately similar to S65657 alpha   1.04E−03   1.81       422530   AW972300   Hs. 118110   bone marrow stromal cell antigen 2   5.31E−11   1.81       432051   AF112461   Hs. 272383   G protein-coupled receptor 57   2.98E−03   1.81       405268           ENSP00000223174*: KIAA0783 PROTEIN.   7.25E−05   1.81       419951   AI653415   Hs. 195789   ESTs   3.51E−06   1.81       457259   AA459713   Hs. 36475   KIAA0493 protein   1.47E−04   1.81       441683   BE564214   Hs. 102946   ESTs   4.30E−07   1.81       421263   AB020638   Hs. 103000   KIAA0831 protein   4.10E−08   1.80       431696   AA259068   Hs. 267819   protein phosphatase 1, regulatory (inhib   2.00E−03   1.80       437143   AW204056   Hs. 8917   ESTs   2.07E−09   1.80       450728   AW162923   Hs. 25363   presenilin 2 (Alzheimer disease 4)   5.41E−05   1.80       417312   AW888411   Hs. 250811   leukemia-associated phosphoprotein p18 (   3.81E−06   1.80       432647   AI807481   Hs. 278581   fibroblast growth factor receptor 2 (bac   8.16E−07   1.80       424232   AB015982   Hs. 143460   protein kinase C, nu   1.49E−04   1.80       412715   NM_000947   Hs. 74519   primase, polypeptide 2A (58 kD)   8.01E−05   1.80       450260   AW090384   Hs. 7739   hypothetical protein MGC12904   1.06E−04   1.80       424862   AB011472   Hs. 153546   CDC23 (cell division cycle 23, yeast, ho   9.20E−08   1.80       430060   NM_002941   Hs. 301198   roundabout (axon guidance receptor, Dros   4.39E−03   1.80       420338   AA825595   Hs. 88269     Homo sapiens , clone MGC: 17339, mRNA, com   8.17E−07   1.80       402855           NM_001839*:  Homo sapiens  calponin 3, acid   8.44E−04   1.80       430043   AI040009   Hs. 306327     Homo sapiens  mRNA; cDNA DKFZp434A012 (fr   4.12E−07   1.79       438122   AI620270   Hs. 129837   ESTs, Weakly similar to Z263_HUMAN ZINC   1.45E−03   1.79       432460   H12912   Hs. 274691   adenylate kinase 3   4.12E−10   1.79       445523   Z30118   Hs. 293788   ESTs, Moderately similar to unnamed prot   7.17E−05   1.79       406765   AA609132   Hs. 76662   hypothetical protein MGC2993   9.48E−08   1.79       400517           lengsin   4.89E−07   1.79       421804   AF032105   Hs. 108447   spinocerebellar ataxia 7 (olivopontocere   2.48E−05   1.79       424653   AW977534   Hs. 151469   calcium/calmodulin-dependent serine prot   8.73E−04   1.79       418240   BE019261   Hs. 83869   hypothetical protein   1.76E−05   1.79       458196   AI802408       ubiquitin A-52 residue ribosomal protein   1.02E−03   1.79       433528   AK001605   Hs. 3376   hypothetical protein FLJ10743   2.88E−05   1.79       402976           Target Exon   3.60E−04   1.78       433730   AK002135   Hs. 3542   hypothetical protein FLJ11273   6.69E−06   1.78       446874   AW968304   Hs. 56156   ESTs   1.09E−05   1.78       436856   AI469355   Hs. 127310   ESTs   5.43E−09   1.78       459724   AI732889   Hs. 47341   ESTs, Weakly similar to alternatively sp   2.77E−03   1.78       433707   AI791584   Hs. 130741   ESTs   3.51E−03   1.78       449523   NM_000579   Hs. 54443   chemokine (C-C motif) receptor 5   3.38E−06   1.78       453250   AI346520   Hs. 121619   chromosome 11 open reading frame 15   2.30E−08   1.77       430718   AI792814         Homo sapiens  BAC clone RP11-335J18 from   8.53E−04   1.77       452065   AK000360   Hs. 27721   Wolf-Hirschhorn syndrome candidate 1-lik   8.41E−04   1.77       426899   AL043221   Hs. 172825   KIAA1037 protein   9.25E−07   1.77       441791   AW372449   Hs. 61271   hypothetical protein FLJ21159   1.05E−04   1.77       413029   AL119399   Hs. 293850   ESTs   7.99E−05   1.76       453319   AI985369   Hs. 301134   ESTs   1.19E−03   1.76       457425   AW139202   Hs. 301209   myeloid/lymphoid or mixed-lineage leukem   5.83E−05   1.76       445786   AW629819   Hs. 144502   hypothetical protein FLJ22055   3.11E−06   1.76       419175   AW270037       KIAA0779 protein   7.55E−08   1.76       428291   AA534009   Hs. 183487   interferon stimulated gene (20 kD)   9.79E−06   1.76       408405   AK001332   Hs. 44672   hypothetical protein FLJ10470   2.98E−11   1.76       426310   NM_000909   Hs. 169266   neuropeptide Y receptor Y1   1.50E−03   1.75       414812   X72755   Hs. 77367   monokine induced by gamma interferon   5.22E−06   1.75       453020   AL162039   Hs. 31422     Homo sapiens  mRNA; cDNA DKFZp434M229 (fr   2.69E−04   1.75       403743           C1002604: gi|8393668|ref|NP_058989.1| kin   1.47E−04   1.75       433675   AW977653   Hs. 75319   ribonucleotide reductase M2 polypeptide   7.35E−05   1.75       410691   AW239226   Hs. 65450   reticulon 4   3.22E−06   1.75       421443   BE550141   Hs. 156148   hypothetical protein FLJ13231   9.38E−05   1.74       414183   AW957446   Hs. 301711   ESTs   1.83E−04   1.74       427221   L15409   Hs. 174007   von Hippel-Lindau syndrome   3.24E−04   1.74       443589   H52931   Hs. 165067   ESTs   3.32E−05   1.74       449480   AI741617   Hs. 108447   spinocerebellar ataxia 7 (olivopontocere   1.75E−05   1.74       442272   AA988302   Hs. 129172   ESTs   2.85E−03   1.74       429747   M87507   Hs. 2490   caspase 1, apoptosis-related cysteine pr   2.73E−07   1.74       414261   BE267466   Hs. 13561   hypothetical protein MGC4692   9.05E−03   1.74       442138   AA445973   Hs. 13303     Homo sapiens  cDNA: FLJ21784 fis, clone H   3.64E−05   1.74       412584   X54870   Hs. 74085   DNA segment on chromosome 12 (unique) 24   1.90E−06   1.74       406825   AI982529   Hs. 84298   CD74 antigen (invariant polypeptide of m   9.75E−06   1.73       421893   NM_001078   Hs. 109225   vascular cell adhesion molecule 1   6.57E−07   1.73       432094   AI658580   Hs. 61426     Homo sapiens  mesenchymal stem cell prote   7.20E−07   1.73       420344   BE463721   Hs. 97101   putative G protein-coupled receptor   9.18E−04   1.73       431740   N75450   Hs. 183412   ESTs, Moderately similar to AF116721 67   4.00E−04   1.73       419652   AL157485   Hs. 91973   hypothetical protein   1.88E−04   1.73       453173   AB007902   Hs. 32168   KIAA0442 protein   6.67E−07   1.72       407690   R47799   Hs. 266957   hypothetical protein FLJ14281   4.68E−08   1.72       426817   AL122088   Hs172627     Homo sapiens  mRNA; cDNA DKFZp564C0671 (f   4.70E−08   1.72       418945   BE246762   Hs. 89499   arachidonate 5-lipoxygenase   2.44E−04   1.72       403828           C4000447*: gi|7705570|ref|NP_038851.1| KI   1.13E−04   1.72       427920   Z11502   Hs. 181107   annexin A13   7.84E−04   1.72       421394   S49953   Hs. 103989   DNA-binding transcriptional activator   1.79E−03   1.72       447513   AW955776   Hs. 313500   ESTs, Moderately similar to ALU7_HUMAN A   3.04E−08   1.71       405689           NM_018850*:  Homo sapiens  ATP-binding cass   2.61E−04   1.71       441879   AI521936   Hs. 107149   novel protein similar to archaeal, yeast   4.46E−06   1.71       414781   D50917   Hs. 77293   KIAA0127 gene product   3.90E−05   1.71       444619   BE538082   Hs. 8172   ESTs, Moderately similar to A46010 X-lin   4.33E−04   1.71       451334   AI122691   Hs. 13268   ESTs   2.68E−05   1.71       446436   BE392690       activating transcription factor 5   4.25E−08   1.71       423332   AI091466   Hs. 127241   sorting nexin 7   7.16E−08   1.71       431660   T30267   Hs. 267120   hypothetical protein DKFZp434O1427   1.48E−04   1.70       425274   BE281191   Hs. 155462   minichromosome maintenance deficient (mi   4.90E−09   1.70       442961   BE614474       F-box only protein 22   4.42E−08   1.70       425995   M92432   Hs. 1974   guanylate cyclase 2D, membrane (retina-s   1.35E−03   1.70       429937   AL080155   Hs. 226372   DKFZP434J154 protein   1.69E−06   1.70       410660   AI061118   Hs. 65328   Fanconi anemia, complementation group F   3.51E−04   1.70       444866   BE620779   Hs. 12094   mitochondrial ribosomal protein L30   8.52E−05   1.70       416602   NM_006159   Hs. 79389   Protein kinase C-binding protein NELL2   5.82E−05   1.70       431263   AW129203   Hs. 322915   ESTs   2.31E−03   1.69       423201   NM_000163   Hs. 125180   growth hormone receptor   1.38E−05   1.69       430844   T94960       gb: ye38d07.r1 Stratagene lung (937210) H   8.59E−05   1.69       403742           Target Exon   9.17E−06   1.69       433001   AF217513   Hs. 279905   clone HQ0310 PRO0310p1   1.05E−05   1.69       426214   H59846   Hs. 321127   ESTs, Moderately similar to ALU7_HUMAN A   7.93E−03   1.69       430007   NM_014892   Hs. 227602   KIAA1116 protein   9.67E−06   1.69       429689   R77698   Hs. 337778   ESTs   4.90E−04   1.69       424626   AA344308   Hs. 128427     Homo sapiens  BAC clone RP11-335J18 from   1.61E−04   1.69       410678   BE540516   Hs. 293732   hypothetical protein MGC3195   1.88E−05   1.69       439645   BE091801   Hs. 27167   ESTs, Weakly similar to I38022 hypotheti   7.02E−09   1.69       431530   X61615   Hs. 2798   leukemia inhibitory factor receptor   7.86E−05   1.69       434995   AW974995       gb: EST387100 MAGE resequences, MAGN Homo   2.70E−04   1.69       423420   AI571364   Hs. 128382     Homo sapiens  mRNA; cDNA DKFZp761l1224 (f   3.52E−05   1.69       453210   AL133161   Hs. 32360   hypothetical protein FLJ10867   1.57E−05   1.69       446096   AI276454       gb: ql71a12.x1 Soares_NhHMPu_S1 Homosapi   3.79E−04   1.69       433546   AI075877   Hs. 125461   hypothetical protein FLJ11539   1.21E−03   1.68       435496   AW840171   Hs. 265398   PAR-6 beta   6.80E−05   1.68       447211   AL161961   Hs. 17767   KIAA1554 protein   1.96E−11   1.68       438277   AL022326   Hs. 6139   synaptogyrin 1   4.42E−03   1.68       403319           fms-related tyrosine kinase 3   4.52E−05   1.68       436332   AL049679   Hs. 82302     Homo sapiens  cDNA FLJ14814 fis, clone NT   2.08E−05   1.68       434669   AF151534   Hs. 92023   core histone macroH2A2.2   3.36E−07   1.68       428123   AI702275   Hs. 104842   hypothetical protein FLJ23407   6.64E−05   1.68       436957   AA902488   Hs. 122952   ESTs   1.38E−05   1.68       421777   BE562088   Hs. 108196   HSPC037 protein   6.55E−04   1.68       437708   AB033020   Hs. 5801   KIAA1194 protein   8.24E−07   1.68       444821   AA053564   Hs. 12040   STE20-like kinase   1.25E−05   1.68       400170           Eos Control   3.70E−04   1.68       450221   AA328102   Hs. 24641   cytoskeleton associated protein 2   9.27E−06   1.68       448440   AA173467   Hs. 62402   p21/Cdc42/Rac1-activated kinase 1 (yeast   1.29E−06   1.68       424354   NM_014314   Hs. 145612   RNA helicase   2.12E−03   1.68       407369   AA989060   Hs. 193989   TAR DNA binding protein   4.61E−07   1.68       423054   AW449073   Hs. 278346   CDC2-related protein kinase 7   6.94E−08   1.67       443542   AI927065   Hs. 146040   ESTs   3.92E−05   1.67       452696   AI826645   Hs. 211534   ESTs   8.04E−06   1.67       438378   AW970529   Hs. 86434   hypothetical protein FLJ21816   2.17E−07   1.67       446552   AW470827   Hs. 156241   ESTs   2.20E−06   1.67       417707   AL035786   Hs. 82425   actin related protein 2/3 complex, subun   1.18E−07   1.67       442993   BE018682   Hs. 166196   ATPase, Class I, type 88, member 1   2.23E−07   1.67       430048   T65054   Hs. 73605   ESTs   3.31E−03   1.67       451050   AW937420       ESTs   5.05E−04   1.67       404602           C9001493*: gi|12735190|ref|XP_005622.2| t   1.97E−05   1.66       423882   BE387203   Hs. 134406   hypothetical protein FLJ20511   2.36E−03   1.66       421508   NM_004833   Hs. 105115   absent in melanoma 2   6.80E−05   1.66       419131   AA406293   Hs. 109526   ESTs   8.36E−06   1.66       452207   NM_014517   Hs. 28423   upstream binding protein 1 (LBP-1a)   1.14E−06   1.66       445411   AL137255   Hs. 12646   hypothetical protein FLJ22693   2.80E−08   1.66       403654           NM_003071:  Homo sapiens  SWI/SNF related,   1.90E−04   1.66       423450   AJ290445   Hs. 128759   KIAA0524 protein   1.00E−03   1.66       430315   NM_004293   Hs. 239147   guanine deaminase   2.69E−05   1.66       443547   AW271273       hypothetical protein FLJ12666   2.60E−10   1.66       417758   U27699   Hs. 82535   solute carrier family 6 (neurotransmitte   8.60E−07   1.66       417689   AA828347   Hs. 90998   KIAA0128 protein; septin 2   3.65E−09   1.66       449901   AI674072       gb: wd15h01.x1 Soares_NFL_T_GBC_S1 Homos   8.34E−07   1.66       425905   AB032959   Hs. 318584   novel C3HC4 type Zinc finger (ring finge   1.11E−03   1.66       407976   AI633875   Hs. 77823   hypothetical protein FLJ21343   2.07E−05   1.65       416276   U41060   Hs. 79136   LIV-1 protein, estrogen regulated   1.29E−05   1.65       418419   X55039   Hs. 85004   centromere protein B (80 kD)   1.89E−09   1.65       438384   W22358   Hs. 109778   KIAA1449 protein   9.10E−08   1.65       443065   H29584   Hs. 288198   hypothetical protein FLJ13949   3.07E−06   1.65       438527   AI969251   Hs. 115325   RAB7, member RAS oncogene family-like 1   2.96E−04   1.65       427507   AF240467   Hs. 179152   toll-like receptor 7   5.62E−03   1.65       439980   AL039706   Hs. 19414   ESTs, Weakly similar to S25150 gene p27   7.11E−05   1.64       419493   AF001212   Hs. 90744   proteasome (prosome, macropain) 26S subu   1.48E−04   1.64       437325   AF142481   Hs. 5548   f-box and leucine-rich repeat protein 5   9.02E−08   1.64       435525   AI831297   Hs. 123310   ESTs   2.20E−03   1.64       430515   AA746503   Hs. 283313   ESTs   6.68E−05   1.64       410165   BE560228   Hs. 71869   apoptosis-associated speck-like protein   1.09E−06   1.64       425996   W67330       hypothetical protein AL110115   6.40E−08   1.64       444665   BE613126   Hs. 47783   B aggressive lymphoma gene   7.26E−08   1.64       424960   BE245380   Hs. 153952   5′ nucleotidase (CD73)   2.14E−04   1.64       449722   BE280074   Hs. 23960   cyclin B1   2.23E−05   1.64       435427   AA682573   Hs. 188982   ESTs, Weakly similar to organic anion tr   4.66E−04   1.64       437186   AA338305   Hs. 5472   hypothetical protein FLJ20173   1.90E−04   1.64       448797   BE614460       ribosomal protein L17   6.90E−06   1.64       446684   AI910777   Hs. 125087   ESTs   2.60E−03   1.63       428413   AI984187   Hs. 245798   ESTs   4.04E−04   1.63       435787   AW162767   Hs. 100914   hypothetical protein FLJ10352   3.26E−05   1.63       448377   AI494514   Hs. 21264   ESTs   5.24E−04   1.63       451684   AF216751   Hs. 26813   CDA14   1.14E−03   1.63       402396           Target Exon   2.00E−04   1.63       441969   AI733386       ESTs, Weakly similar to ALU1_HUMAN ALU S   1.84E−04   1.63       421138   AA687420   Hs. 190145   ESTs   1.54E−05   1.63       417353   AA375752   Hs. 348140     Homo sapiens  mRNA; cDNA DKFZp586F1822 (f   5.38E−04   1.63       410261   AF145713   Hs. 61490   schwannomin-interacting protein 1   3.36E−04   1.63       458476   AA336878   Hs. 9842   Human DNA sequence from clone RP4-788L20   4.80E−05   1.63       405372           NM_006841:  Homo sapiens  transporter prote   2.82E−04   1.63       452059   AI222069   Hs. 13015   hypothetical protein similar to mouse Dn   1.82E−05   1.63       410568   AW162948   Hs. 64542   cleavage and polyadenylation specific fa   1.28E−04   1.63       407502   U52096       gb: Human zinc finger protein (kr-znf1) m   2.30E−04   1.63       420560   AW207748   Hs. 59115   ESTs   4.40E−05   1.63       412530   AA766268   Hs. 266273   hypothetical protein FLJ13346   2.49E−06   1.63       448888   AW196663   Hs. 200242   caspase recruitment domain protein 6   2.43E−05   1.62       428220   BE183533   Hs. 347128   Human DNA sequence from clone 34B21 on c   1.64E−07   1.62       450621   AW297288   Hs. 55918   hypothetical protein FLJ11354   2.40E−06   1.62       419437   U61262   Hs. 90408   neogenin (chicken) homolog 1   7.24E−05   1.62       403694           Target Exon   8.29E−06   1.62       441253   AI632744   Hs. 129501   ESTs   4.42E−03   1.62       457770   BE065030   Hs. 124179   ESTs   7.93E−04   1.62       416647   BE297139   Hs. 79411   replication protein A2 (32 kD)   1.54E−06   1.62       410408   NM_012260   Hs. 63290   2-hydroxyphytanoyl-CoA lyase   3.56E−05   1.62       430248   AW958965   Hs. 236774   high-mobility group (nonhistone chromoso   1.57E−09   1.62       447547   NM_007229   Hs. 18842   protein kinase C and casein kinase subst   3.40E−06   1.61       431863   AA188185   Hs. 289043   spindlin   1.87E−08   1.61       430422   AI078115   Hs. 54680   ESTs   1.05E−06   1.61       445657   AW612141   Hs. 279575     Homo sapiens  G-protein coupled receptor   1.89E−05   1.61       456740   AF068302   Hs. 125031   choline/ethanolaminephosphotransferase   2.48E−05   1.61       410382   AW664971   Hs. 259546   ESTs   5.40E−05   1.61       421410   AI472323   Hs. 134353   ESTs   7.65E−05   1.61       438176   AW138970   Hs. 144759   ESTs   7.85E−05   1.61       404584           Target Exon   3.42E−03   1.61       422423   AF283777   Hs. 116481   CD72 antigen   1.72E−03   1.61       441894   AA134329         Homo sapiens , clone IMAGE: 3685398, mRNA,   7.36E−04   1.61       421801   AI431597   Hs. 284294   Breakpoint cluster region protein, uteri   2.69E−05   1.61       428379   X06026   Hs. 2259   CD3G antigen, gamma polypeptide (TiT3 co   8.68E−05   1.61       451788   BE242857   Hs. 27021   hypothetical protein FLJ11159   2.35E−06   1.61       444708   AW971049   Hs. 11774   protein (peptidyl-prolyl cis/trans isome   9.22E−05   1.61       442358   BE567985   Hs. 18585   ESTs, Moderately similar to ALU4_HUMAN A   3.12E−06   1.60       422521   AW363324   Hs. 126906   hypothetical protein FLJ 12598   1.19E−07   1.60       428475   AF172940   Hs. 184542   CGI-127 protein   1.11E−06   1.60       449027   AJ271216   Hs. 22880   dipeptidylpeptidase III   7.55E−04   1.60       404240           NM_018950:  Homo sapiens  major histocompat   3.66E−09   1.60       414792   BE314949   Hs. 87128   hypothetical protein FLJ23309   1.12E−08   1.60       416747   AW876523   Hs. 15929   hypothetical protein FLJ12910   9.45E−06   1.60       418001   R80582   Hs. 24625   ESTs   1.62E−03   1.60       433009   AA761668       gb: nz24c08.s1 NCI_CGAP_GCB1  Homo sapiens     6.37E−03   1.60       421016   AA504583   Hs. 101047   transcription factor 3 (E2A immunoglobul   9.01E−06   1.60       436256   T87113   Hs. 193825   ESTs   1.46E−04   1.60       428418   AI368826   Hs. 8768   ESTs   1.04E−06   1.60       451253   H48299   Hs. 26126   claudin 10   1.22E−03   1.60       425913   AA365799       SEC22, vesicle trafficking protein (S. c   1.11E−06   1.60       418460   M26315   Hs. 85258   CD8 antigen, alpha polypeptide (p32)   4.30E−04   1.60       420680   AA648758   Hs. 187791   ESTs   2.56E−04   1.60       425691   NM_005328   Hs. 159226   hyaluronan synthase 2   3.04E−03   1.60       446307   T50083   Hs. 22247   ESTs   5.05E−03   1.60       422805   AA436989   Hs. 121017   H2A histone family, member A   2.11E−05   1.60       420092   AA814043   Hs. 88045   ESTs   2.86E−03   1.59       443959   AL120546       gb: DKFZp761A069_r1 761 (synonym: hamy2)   3.44E−04   1.59       404409           C8001172*: gi|10432395|emb|CAC10285.1| (A   5.86E−04   1.59       405601           Target Exon   5.21E−04   1.59       431543   AW969619   Hs. 259768   adenylate cyclase 1 (brain)   1.20E−03   1.59       428826   AL048842   Hs. 194019   atlractin   3.04E−07   1.59       439498   AA908731   Hs. 58297   CLLL8 protein   2.01E−04   1.59       438661   AA813539   Hs. 123414   ESTs, Weakly similar to I37570 zinc fing   7.79E−06   1.59       447105   AW377610   Hs. 11123   DKFZP564G092 protein   2.19E−05   1.59       412983   AI478828   Hs. 16570   ESTs, Weakly similar to I38022 hypotheti   6.13E−05   1.59       440764   AA905406   Hs. 9905   ESTs, Weakly similar to unnamed protein   1.78E−03   1.59       452806   AW014549   Hs. 58373   ESTs   4.21E−04   1.59       404919           ENSP00000237577*: Polycystin 2 (Autosomal   5.59E−03   1.59       424737   BE301883   Hs. 152707   glioblastoma amplified sequence   7.59E−05   1.59       435205   X54136   Hs. 181125   immunoglobulin lambda locus   5.77E−03   1.59       403738           C4000675*: gi|3426332|gb|AAC32272.1| (AF0   4.04E−09   1.59       408705   AA312135   Hs. 46967   HSPCO34 protein   7.26E−09   1.59       431377   AW178807   Hs. 246182   ESTs   2.46E−03   1.58       433359   H70007       gb: yr89e07.r1 Soares fetal liver spleen   2.39E−03   1.58       447809   AW207605   Hs. 164230   ESTs, Highly similar to JC7266 3′,5′-cyc   3.29E−08   1.58       415938   BE383507   Hs. 78921   A kinase (PRKA) anchor protein 1   1.35E−06   1.58       434375   BE277910   Hs. 3833   3′-phosphoadenosine 5′-phosphosulfate sy   7.89E−08   1.58       408412   AW193033   Hs. 124436   ESTs   9.63E−04   1.58       419672   AA465113   Hs. 23853   ESTs, Weakly similar to A34615 profilagg   4.60E−04   1.58       435931   AI077464       RNA binding motif protein 9   1.37E−04   1.58       432645   014041   Hs. 347340   H-2K binding factor-2   3.91E−03   1.58       412886   AF041163   Hs. 74647   Human T-cell receptor active alpha-chain   3.77E−06   1.58       424696   BE439547   Hs. 151903   GrpE-like protein cochaperone   2.03E−04   1.57       446725   AL050173   Hs. 16007   chromosome 21 open reading frame 25   1.32E−05   1.57       439788   N71241   Hs. 119275   ESTs   1.99E−03   1.57       431736   AI912234   Hs. 3297   ribosomal protein S27a   2.14E−05   1.57       449368   AW009668   Hs. 232284   ESTs   1.48E−03   1.57       452866   R26969   Hs. 268016     Homo sapiens  cDNA: FLJ21243 fis, clone C   4.10E−05   1.57       429586   T73510   Hs. 209153   angiopoietin-like 3   4.09E−07   1.57       453887   BE564037   Hs. 36237   hypothetical protein   4.59E−06   1.57       428759   AC007059   Hs. 193065   hypothetical protein DKFZp547M136 simila   8.66E−06   1.57       401847           C17000828: gi|1666071|emb|CAA69174.1| (Y0   6.56E−05   1.57       434747   M837085       ESTs   4.24E−03   1.57       449601   AA461509   Hs. 293565   ESTs, Weakly similar to putative p150 [H   4.36E−05   1.57       457758   AI475671   Hs. 88607   ESTs, Highly similar to F-box protein FB   3.83E−04   1.57       447574   AF162666   Hs. 18895   tousled-Iike kinase 1   7.59E−07   1.57       401928           Target Exon   2.68E−03   1.57       406274           Target Exon   6.32E−05   1.56       449291   BE176893   Hs. 23440   KIAA1105 protein   1.17E−06   1.56       429280   AI445960   Hs. 3685   hypothetical protein FLJ20209   5.66E−09   1.56       419946   AI298508   Hs. 18963   ESTs   1.24E−04   1.56       439008   AF075072   Hs. 167535   ESTs, Weakly similar to ALU1_HUMAN ALU S   3.38E−03   1.56       444756   AA278501   Hs. 200332   hypothetical protein FLJ20651   5.36E−03   1.56       425409   H18021   Hs. 25005   hypothetical protein MGC3329   1.55E−03   1.56       453387   AI990741   Hs. 252809   ESTs   5.19E−04   1.56       438156   Z20244   Hs. 192906   ESTs   3.43E−05   1.56       401558           ENSP00000220478*: SECRETOGRANIN III.   1.17E−04   1.56       420807   M280627   Hs. 57846   ESTs   6.07E−04   1.56       434942   M021562   Hs. 347950     Homo sapiens . Similar to nuclear localiz   3.13E−06   1.55       444479   AA194980   Hs. 30818     Homo sapiens  cDNA FLJ13681 fis. clone PL   2.39E−03   1.55       444078   BE246919   Hs. 10290   U5 snRNP-specific 40 KDa protein (hPrp8-   6.70E−04   1.55       421612   AF161254   Hs. 106196   8D6 antigen   7.97E−10   1.55       432740   AF061034   Hs. 278898   tumor necrosis factor alpha-inducible ce   1.66E−07   1.55       456563   AA989220   Hs. 766   ESTs   1.09E−04   1.55       420573   AA278407   Hs. 88528   ESTs   4.79E−03   1.55       437998   U92025   Hs. 200680   ESTs, Moderately similar to KIAA0573 pro   3.78E−03   1.55       423570   AW838306   Hs. 129819   hypothetical protein FLJ11160   2.25E−05   1.55       425356   BE244879   Hs. 155939   inositol polyphosphate-5-phosphatase, 14   6.94E−04   1.55       443661   AA336609   Hs. 10862     Homo sapiens  cDNA: FLJ23313 fis, clone H   1.04E−04   1.55       433878   AA613245   Hs. 259181   ESTs   4.25E−04   1.55       449337   AW772245   Hs. 223978   ESTs   2.97E−05   1.55       434608   AA805443   Hs. 179909   hypothetical protein FLJ22995   3.60E−04   1.55       418310   AA814100   Hs. 86693   ESTs   9.87E−04   1.54       436388   AI806172   Hs. 166486     Homo sapiens  cDNA FLJ11432 fis, clone HE   4.35E−06   1.54       417848   AA206581   Hs. 116586   ESTs, Weakly similar to JC5314 CDC28/cdc   1.02E−05   1.54       435438   H84421   Hs. 4890   ubiquitin-conjugating enzyme E2E 3 (homo   2.83E−04   1.54       427790   NM_002887   Hs. 180832   hypothetical protein MGC8641   2.02E−05   1.54       442968   AK000606   Hs. 8868   golgi SNAP receptor complex member 1   3.73E−09   1.54       416727   W05023       gb: za45a11.ri Soares fetal liver spleen   4.98E−03   1.54       440201   AL359588   Hs. 7041   hypothetical protein DKFZp762B226   4.87E−04   1.54       415670   AA166633   Hs. 117183   gb: zq39b01.r1 Stratagene hNT neuron (937   4.54E−04   1.54       408380   AF123050   Hs. 44532   diubiquitin   3.89E−09   1.54       403746           ENSP00000226812*: KIAA1494 protein (Fragm   9.67E−04   1.53       420172   AA601122   Hs. 95655   secreted and transmembrane 1   5.53E−03   1.53       415200   AL040328   Hs. 78202   SWI/SNF related, matrix associated, acti   6.23E−08   1.53       441488   AW450935   Hs. 7862   hypothetical protein FLJ20312   7.06E−07   1.53       413859   AW992356   Hs. 8364     Homo sapiens  pyruvate dehydrogenase kina   1.25E−04   1.53       425601   AW629485   Hs. 140720   GSK-3 binding protein FRAT2   1.63E−06   1.53       439704   AW020018   Hs. 293267   ESTs   2.65E−05   1.53       409344   R47279   Hs. 285673   hypothetical protein FLJ20950   2.38E−06   1.53       424602   AK002055   Hs. 151046   hypothetical protein FLJ11193   1.23E−04   1.53       429556   AW139399   Hs. 98988   ESTs   2.67E−03   1.53       446756   AW028485   Hs. 26136   hypothetical protein MGC14156   5.35E−07   1.53       418827   BE327311   Hs. 47166   HT021   1.00E−05   1.53       438204   AI589645   Hs. 128690   ESTs   2.96E−04   1.53       417377   NM_016603   Hs. 82035   potential nuclear protein C5ORF5; GAP-li   3.15E−08   1.52       422536   AA311915   Hs. 187726   gb: EST182621 Jurkat T-cells VI Homo sapi   6.56E−05   1.52       431945   AW000827   Hs. 11962   apoptosis regulator BCL-G   3.53E−03   1.52       421025   AW958975   Hs. 29397     Homo sapiens  cDNA FLJ13226 fis. clone OV   7.11E−06   1.52       444652   BE513613   Hs. 11538   actin related protein 2/3 complex, subun   7.17E−03   1.52       458345   AI864078   Hs. 144076   ESTs   3.45E−04   1.52       425692   D90041   Hs. 155956   N-acetyltransferase 1 (arylamine N-acety   2.04E−06   1.52       400120           Eos Control   8.78E−04   1.52       440591   AA431599   Hs. 132799   hypothetical protein FLJ23451   7.90E−05   1.52       412826   BE001722   Hs. 14877   ESTs, Weakly similar to (defline not ava   1.45E−03   1.52       408683   R58665   Hs. 46847   TRAF and TNF receptor-associated protein   2.29E−09   1.52       424852   AI222779   Hs. 144848   ESTs   9.90E−03   1.52       423694   NM_003747   Hs. 131814   tankyrase, TRF1-interacting ankyrin-rela   2.70E−08   1.52       432134   AI816782   Hs. 122583   hypothetical protein FLJ21934   7.31E−06   1.52       447131   NM_004585   Hs. 17466   retinoic acid receptor responder (tazaro   3.80E−06   1.52       427212   AW293849   Hs. 58279   ESTs, Weakly similar to ALU7_HUMAN ALU S   4.87E−06   1.52       423524   AF055989   Hs. 129738   potassium voltage gated channel, Shaw-re   4.04E−04   1.52       457933   AA759062   Hs. 121434   ESTs   1.63E−03   1.52       425769   U72513   Hs. 159486   Human RPL13-2 pseudogene mRNA, complete   3.40E−06   1.51       431262   NM_006672   Hs. 251395   solute carrier family 22 (organic anion   6.08E−05   1.51       457764   AW028284   Hs. 4815   nudix (nucleoside diphosphate linked moi   3.11E−04   1.51       438712   AW978161   Hs. 268555   5′-3′ exoribonuclease 2   1.00E−03   1.51       420514   N32301   Hs. 102496   ESTs   6.01E−04   1.51       410972   AW812259       gb: RC0-ST0174-191099-031-b05 ST0174 Homo   2.97E−03   1.51       446493   AK001389   Hs. 15144   hypothetical protein DKFZp564O043   2.66E−06   1.51       415000   AW025529   Hs. 239812     Homo sapiens  serologically defined breas   8.80E−08   1.51       427647   W19744   Hs. 180059     Homo sapiens  cDNA FLJ20653 fis, clone KA   7.28E−06   1.50       409022   BE222648   Hs. 241432   ESTs, Highly similar to C380A1.1b [H. sap   3.80E−06   1.50       441980   AK001441   Hs. 8055   hypothetical protein FLJ10579   1.53E−03   1.50       445424   AB028945   Hs. 12696   cortactin SH3 domain-binding protein   9.78E−07   1.50       414948   C15240   Hs. 182155   ESTs   2.68E−06   1.50       442878   AI868648   Hs. 22315   ESTs   7.00E−05   1.50       438021   AV653790       WW domain-containing protein 1   1.28E−06   1.50       426723   AW003069   Hs. 183860   ESTs   7.02E−06   1.50       420847   AI356920   Hs. 23510   ESTs   2.14E−03   1.50       406972   M32053       gb: Human H19 RNA gene, complete cds.   6.00E−03   1.50       445309   AL157474   Hs. 12504   likely ortholog of mouse Arkadia   3.14E−05   1.50       421712   AK000140   Hs. 107139   hypothetical protein   9.42E−09   1.50       414091   T83742   Hs. 334616   gb: yd67g02.s1 Soares fetal liver spleen   2.35E−05   1.50       402945           Target Exon   1.02E−03   1.50       400487           ENSP00000238977*: lnterferon-induced prot   1.77E−04   1.50       438308   AI343469   Hs. 127685   KIAA1627 protein   7.96E−06   1.50       411227   AW833258       gb: RC2-TT0007-131099-011-b10_1 TT0007 Ho   7.01E−04   1.50       451452   BE560065   Hs. 26433   dolichyl-phosphate(UDP-N-acetylglucosam   1.34E−04   1.49       451806   NM_003729   Hs. 27076   RNA 3′-terminal phosphate cyclase   1.25E−04   1.49       424924   AL039103   Hs. 153834   pumilio (Drosophila) homolog 1   3.26E−06   1.49       452136   AU076713   Hs. 479   RAB5C, member RAS oncogene family   4.25E−03   1.49       439375   AA689526   Hs. 344249   steroid dehydrogenase homolog   3.64E−06   1.49       410177   NM_015425   Hs. 59475   DKFZP586M0122 protein   1.00E−03   1.49       407813   AL120247   Hs. 40109   KIAA0872 protein   1.86E−05   1.49       420505   AW967984   Hs. 122552   G-2 and S-phase expressed 1   4.16E−03   1.49       456373   BE247706   Hs. 89751   membranE−spanning 4-domains, subfamily A   4.10E−03   1.49       412853   M34175   Hs. 74626   adaptor-related protein complex 2, beta   2.89E−04   1.49       434369   AI650363   Hs. 116462   ESTs   1.34E−03   1.49       442751   AI358404       gb: qw20f03.x1 NCI_CGAP_Ut3  Homo sapiens     2.61E−05   1.49       442432   BE093589   Hs. 38178   hypothetical protein FLJ23468   3.18E−06   1.49       408784   AW971350   Hs. 63386   ESTs   9.38E−05   1.49       449629   AA031547   Hs. 298442   adaptor-related protein complex 3, mu 1   4.62E−05   1.49       419110   AA234171   Hs. 187626   ESTs   2.44E−04   1.49       457238   U07358   Hs. 211601   mitogen-activated protein kinase kinase   2.21E−03   1.49       408483   AA464836   Hs. 291079   ESTs, Weakly similar to T27173 hypotheti   5.75E−07   1.49       456633   AW139036   Hs. 108957   40S ribosomal protein S27 isoform   6.06E−04   1.48       450746   D82673   Hs. 278589   general transcription factor II, i   1.58E−09   1.48       438637   BE500941   Hs. 126730   ESTs, Weakly similar to KIAA1214 protein   1.08E−03   1.48       444775   AI040384   Hs. 19102   ESTs, Weakly similar to organic anion tr   1.50E−07   1.48       426335   AI054347   Hs. 2017   ribosomal protein L38   6.98E−03   1.48       450253   AL133047   Hs. 24715     Homo sapiens  mRNA; cDNA DKFZp434D0215 (f   4.78E−05   1.48       434466   AB037829   Hs. 3862   regulator of nonsense transcripts 2; DKF   2.91E−06   1.48       446164   AW273539       hypothetical protein FLJ23577   3.00E−03   1.48       458533   AA314487   Hs. 11123   DKFZP564G092 protein   7.99E−05   1.48       450377   AB033091       KIAA1265 protein   7.22E−05   1.48       411798   AW864049   Hs. 133505   gb: PM2-SN0013-120400-003-c06 SN0013 Homo   1.10E−03   1.48       419715   AF070523   Hs. 92384   vitamin A responsive; cytoskeleton relat   4.88E−07   1.48       422611   AA158177   Hs. 118722   fucosyltransferase 8 (alpha (1, 6) fucosy   1.93E−06   1.48       453186   AK001708   Hs. 32271   hypothetical protein FLJ10846   3.21E−04   1.48       403330           Target Exon   4.62E−05   1.47       447095   AI361424   Hs. 265174   ESTs   1.74E−03   1.47       445175   AV652851   Hs. 20255   ESTs   3.04E−05   1.47       406868   AA505445   Hs. 300697   immunoglobulin heavy constant gamma 3 (G   1.24E−04   1.47       424683   N87519   Hs. 27196   ESTs   1.58E−05   1.47       453394   AW960474   Hs. 40289   ESTs   5.61E−06   1.47       416744   AL135579   Hs. 79709   phosphotidylinositol transfer protein   3.24E−07   1.47       416206   AW206248   Hs. 111092   hypothetical protein FLJ22332   1.53E−09   1.47       400975           Target Exon   1.06E−03   1.47       452068   W76412   Hs. 57877   ESTs   1.45E−04   1.47       444985   AI677737   Hs. 28329   hypothetical protein FLJ14005   3.04E−05   1.47       430945   U80669   Hs. 55999   NK homeobox (Drosophila), family 3. A   1.72E−05   1.47       424180   AB032987   Hs. 320861   KIAA1161 protein   1.08E−04   1.47       446189   H85224   Hs. 214013   ESTs   4.67E−05   1.47       433991   AA912749       ESTs   7.45E−03   1.47       412972   AA771898   Hs. 33412   ESTs   2.53E−03   1.47       433418   AA587831   Hs. 87134   ESTs   2.47E−03   1.47       429520   AA160142   Hs. 205058   hypothetical protein FLJ20075   2.48E−03   1.46       452852   AK001972   Hs. 30822   hypothetical protein FLJ11110   1.77E−08   1.46       419083   AI479560   Hs. 98613     Homo sapiens  cDNA FLJ12292 fis. clone MA   5.14E−06   1.46       422643   D42045   Hs. 1560   DNA-crosslink repair gene SNM1   2.05E−04   1.46       421965   AA301100   Hs. 346482   gb: EST14128 Testis tumor  Homo sapiens  cD   1.07E−06   1.46       448277   BE622827   Hs. 99486   hypothetical protein FLJ13044   1.67E−07   1.46       423979   AF229181   Hs. 136644   CS box-containing WD protein   1.77E−03   1.46       459169   AI905517       gb: RC-BT091-210199-105 BT091 Homo sapien   1.19E−03   1.46       442220   AL037800   Hs. 8148   selenoprotein T   1.41E−05   1.46       407807   AL031427   Hs. 40094   Human DNA sequence from clone 167A19 on   5.25E−04   1.46       426642   AW068223   Hs. 171581   ubiquitin C-terminal hydrolase UCH37   4.71E−06   1.46       442348   BE315496   Hs. 8258   DKFZP434D1335 protein   1.18E−03   1.46       443487   AI073491   Hs. 269887   ESTs, Highly similar to KPBB_HUMAN PHOSP   1.03E−03   1.46       419586   AI088485   Hs. 144759   ESTs, Weakly similar to I38022 hypotheti   6.52E−08   1.46       433514   AW183734   Hs. 189782   hypothetical protein FLJ10747   7.13E−04   1.46       417321   N68722   Hs. 191368   ESTs   6.13E−04   1.46       408521   AA055264   Hs. 260848   ESTs, Weakly similar to S23650 retroviru   7.91E−07   1.45       438510   AL080220   Hs. 6285   DKFZP586P0123 protein   1.59E−05   1.45       441458   AW815108       gb: QV4-ST0212-091199-023-h01 ST0212 Homo   4.05E−04   1.45       420568   F09247   Hs. 247735   protocadherin alpha 10   1.65E−05   1.45       431186   NM_012249   Hs. 250697   ras-like protein   4.34E−07   1.45       451987   AA815092   Hs. 77554     Homo sapiens  cDNA FLJ14967 fis, clone TH   6.89E−04   1.45       419998   AA252691   Hs. 346200   gb: zs26d09.r1 NCI_CGAP_GCB1  Homo sapiens     2.32E−03   1.45       421272   AA704157       ESTs   2.59E−04   1.45       400200           NM_002788*:  Homo sapiens  proteasome (pros   7.15E−05   1.45       400440   X83957   Hs. 83870   nebulin   3.35E−03   1.45       444654   AV650572   Hs. 23440   KIAA1105 protein   6.77E−06   1.45       446793   AW590131   Hs. 156468   ESTs   5.34E−03   1.45       445919   T53519   Hs. 334692   hypothetical protein MGC14141   5.08E−03   1.45       433422   AW976627   Hs. 284294   Breakpoint cluster region protein, uteri   2.98E−07   1.45       421721   AB037799   Hs. 107279   KIAA1378 protein   4.59E−03   1.45       444913   AI362726   Hs. 193656     Homo sapiens  mRNA for KIAA1658 protein,   1.15E−06   1.45       421957   AW068637   Hs. 109857   hypothetical protein DKFZp434H0820   8.29E−03   1.45       412935   BE267045   Hs. 75064   tubulin-specific chaperone c   4.27E−08   1.44       413884   AI668892   Hs. 239758   hypothetical protein FLJ12389 similar to   1.04E−04   1.44       417961   Z44190   Hs. 83023   peroxisomal biogenesis factor 11B   1.35E−07   1.44       442619   AA447492   Hs. 20183   ESTs, Weakly similar to AF164793 1 prote   3.67E−06   1.44       439894   AA853077   Hs. 300697   immunoglobulin heavy constant gamma 3 (G   7.44E−03   1.44       422241   Y00062   Hs. 170121   protein tyrosine phosphatase, receptor t   1.57E−08   1.44       407687   AK002011   Hs. 37558   hypothetical protein FLJ11149   8.19E−04   1.44       427929   BE613835   Hs. 181159     Homo sapiens  mRNA; cDNA DKFZp434F0217 (f   2.28E−05   1.44       410054   AL120050   Hs. 58220     Homo sapiens  cDNA: FLJ23005 fis, clone L   1.21E−03   1.44       443639   BE269042   Hs. 9661   proteasome (prosome, macropain) subunit,   4.08E−07   1.44       449437   AI702038   Hs. 100057     Homo sapiens  cDNA: FLJ22902 fis, clone K   2.51E−05   1.44       406918   M88357       gb:  Homo sapiens  DNA-binding protein (ZNF   6.10E−03   1.44       424286   AA338285   Hs. 90744   proteasome (prosome, macropain) 26S subu   2.50E−07   1.44       425261   BE385099       hypothetical protein MGC3017   1.12E−04   1.44       452822   X85689   Hs. 288617   hypothetical protein FLJ22621   6.51E−04   1.44       425289   AW139342   Hs. 155530   interferon, gamma-inducible protein 16   8.16E−06   1.44       428894   AA437066   Hs. 271736   ESTs   2.54E−03   1.44       418533   NM_004533   Hs. 85937   myosin-binding protein C, fast-type   8.68E−03   1.43       411030   BE387193   Hs. 67896   7-60 protein   8.65E−06   1.43       435882   AW194987       ESTs   2.85E−04   1.43       444773   BE156256   Hs. 11923   hypothetical protein   6.80E−03   1.43       435522   N64214   Hs. 9774   synovial sarcoma translocation gene on c   2.42E−07   1.43       400552           Target Exon   2.09E−04   1.43       449103   T24968   Hs. 23038   HSPC071 protein   6.24E−06   1.43       411492   T46848   Hs. 70337   immunoglobulin superfamily, member 4   2.14E−06   1.43       450456   AA600192       ESTs, Weakly similar to ALUB_HUMAN !!!!   6.66E−06   1.43       440515   AJ131245   Hs. 7239   SEC24 ( S. cerevisiae ) related gene famil   3.40E−03   1.43       434924   AA443164   Hs. 23259   hypothetical protein FLJ13433   7.81E−07   1.43       439981   AI348408   Hs. 124675   ESTs, Weakly similar to T14742 hypotheti   3.16E−07   1.43       452268   NM_003512   HS. 28777   H2A histone family, member L   6.16E−09   1.43       408358   D20044   Hs. 12929   hypothetical protein FLJ20721   2.62E−04   1.42       446755   AW451473   Hs. 16134   serine/threonine kinase 10   1.34E−03   1.42       435772   AA700019   Hs. 132992   ATP-binding cassette, sub-family G (WHIT   1.62E−05   1.42       457250   AA811987   Hs. 125779   ESTs   5.09E−03   1.42       415192   D17793   Hs. 78183   aldo-keto reductase family 1, member C3   1.35E−05   1.42       418506   AA084248   Hs. 85339   G protein-coupled receptor 39   1.28E−03   1.42       407972   AA827639   Hs. 18587   KIAA1588 protein   8.57E−03   1.42       452718   AI762301   Hs. 44017   sirtuin (silent mating type information   1.90E−04   1.42       443325   BE398006   Hs. 90462     Homo sapiens , clone IMAGE: 4132043, mRNA,   3.44E−03   1.42       422040   AA172106   Hs. 110950   Rag C protein   9.07E−05   1.42       442296   NM_007275   Hs. 8186   lung cancer candidate   1.13E−05   1.42       418475   AI858732   Hs. 30443   sentrin/SUMO-specific protease   1.94E−04   1.42       403147           Target Exon   4.29E−03   1.42       452647   N29495   Hs. 96870   staufen (Drosophila, RNA-binding protein   4.56E−03   1.42       415049   N67334   Hs. 50158   ESTs   1.54E−03   1.41       406605           Target Exon   9.18E−05   1.41       434152   AI792665   Hs. 291190   ESTs   1.11E−03   1.41       433307   AI393009   Hs. 153385   hypothetical protein MGC5509   6.73E−04   1.41       414245   BE148072   Hs. 75850   WAS protein family, member 1   1.25E−03   1.41       419407   AW410377   Hs. 41502   hypothetical protein FLJ21276   2.41E−07   1.41       414548   AW937036   Hs. 183506   hypothetical protein FLJ14213   5.51E−04   1.41       421958   AA357185   Hs. 109918   ras homolog gene family, member H   3.31E−04   1.41       450122   BE313765       ESTs, Weakly similar to I38022 hypotheti   6.86E−06   1.41       445308   AW975748   Hs. 5724   sclerostin   5.31E−05   1.41       434045   AI065133   Hs. 152316   hypothetical protein PRO0971   1.76E−04   1.41       423262   NM_005479   Hs. 126057   frequently rearranged in advanced T-cell   1.49E−07   1.41       451413   AA448974   Hs. 26367   PC3-96 protein   1.90E−06   1.41       434978   AA321238   Hs. 4310   eukaryotic translation initiation factor   2.64E−03   1.41       417100   AI828908   Hs. 4552   ubiquilin 2   1.80E−04   1.41       445692   AI248322   Hs. 182099   ESTs   2.29E−05   1.41       436486   AA742221   Hs. 120633   ESTs   3.93E−03   1.41       441976   AA428403   Hs. 106131   ESTs   1.08E−05   1.41       445530   BE294791       hypothetical protein FLJ12666   3.72E−04   1.41       402907           NM_024777*:  Homo sapiens  hypothetical pro   9.75E−03   1.41       419165   AW860767   Hs. 118879   ESTs   1.90E−03   1.41       406815   AA833930       tRNA isopentenylpyrophosphate transferas   1.03E−03   1.41       421726   AK001237   Hs. 319088   hypothetical protein FLJ10375   1.04E−07   1.41       437392   AL359943   Hs. 132272     Homo sapiens  mRNA; cDNA DKFZp762D186 (fr   3.68E−03   1.41       439128   AI949371   Hs. 13854   ESTs   9.06E−06   1.41       457393   AW970603       gb: EST382684 MAGE resequences, MAGK Homo   7.71E−03   1.40       449975   BE546004   Hs. 22350   hypothetical protein LOC56757   8.49E−04   1.40       451436   W86497       KIAA0729 protein   9.49E−05   1.40       429490   AI971131   Hs23889   ESTs, Weakly similar to ALU7_HUMAN ALU S   2.97E−06   1.40       454117   BE410100   Hs. 40368   adaptor-related protein complex 1, sigma   5.93E−04   1.40       401431           Target Exon   1.27E−03   1.40       442445   AA082665   Hs. 209561   KIAA1715 protein   1.22E−04   1.40       410297   AA148710       lumican   3.82E−08   1.40       444960   AI611317   Hs. 341531   ESTs   6.84E−07   1.40       418835   AL023694   Hs. 88977   hypothetical protein dJ511E16.2   1.04E−05   1.40       446178   AI278844   Hs. 149450   ESTs   2.18E−04   1.40       430299   W28673   Hs. 106747   serine carboxypeptidase 1 precursor prot   8.74E−05   1.40       420790   L04791   Hs. 99924   excision repair cross-complementing rode   5.78E−03   1.40       427701   AA411101   Hs. 243886   nuclear autoantigenic sperm protein (his   3.52E−04   1.40       433225   AW816515   Hs. 173540   ATPase, Class V, type 10D   9.45E−05   1.40       444670   H58373   Hs. 332938   hypothetical protein MGC5370   1.04E−05   1.40       435099   AC004770   Hs. 4756   flap structure-specific endonuclease 1   1.89E−03   1.40       446291   BE397753   Hs. 14623   interferon, gamma-inducible protein 30   1.32E−03   1.40       417628   T84214       gb: yd32f10.r1 Soares fetal liver spleen   2.53E−05   1.40       428820   AA436187   Hs. 172631   integrin, alpha M (complement component   2.63E−06   1.39       438356   AA805530   Hs. 48527   ESTs   7.22E−03   1.39       422310   AA316622   Hs. 98370   cytochrome P450, subfamily IIS, polypept   2.06E−05   1.39       441149   AI569766   Hs. 13205   ESTs   2.12E−03   1.39       443490   AB018313   Hs. 9452   KIAA0770 protein   1.66E−07   1.39       425272   AA354138   Hs. 47209   ESTs, Weakly similar to C35826 hypotheti   3.57E−03   1.39       443037   AW500305   Hs. 8906   syntaxin 7   1.61E−05   1.39       409330   AK001231   Hs. 53940   hypothetical protein FLJ10369   9.63E−04   1.39       408822   AW500715   Hs. 57079     Homo sapiens  cDNA FLJ13267 fis, clone OV   2.44E−06   1.39       426809   BE313114   Hs. 29706   ESTs   2.91E−05   1.39       416197   AA176253   Hs. 110309   major histocompatibility complex, class   2.96E−07   1.39       410334   AW979261   Hs. 291993   ESTs   5.81E−05   1.39       422645   L40027   Hs. 118890   glycogen synthase kinase 3 alpha   3.13E−05   1.39       414931   AK000342   Hs. 77646     Homo sapiens  mRNA; cDNA DKFZp761M0223 (f   2.07E−04   1.39       434809   AW974687       gb: EST386776 MAGE resequences, MAGM Homo   6.88E−03   1.39       421315   D78791   Hs. 103419   fasciculation and elongation protein zet   4.60E−07   1.39       420985   X94703       RAB28, member RAS oncogene family   8.20E−05   1.39       422653   AI092590   Hs. 118962   far upstream element (FUSE) binding prot   1.20E−03   1.39       401047           Target Exon   5.92E−03   1.39       408417   AI124541   Hs. 44720   hypothetical protein P1 p373c6   3.93E−04   1.39       415130   W85893   Hs. 249867   ESTs   1.44E−05   1.39       447511   BE274845   Hs. 17110     Homo sapiens  mRNA; cDNA DKFZp434C2016 (f   9.71E−03   1.39       421970   AF227156   Hs. 110103   RNA polymerase l transcription factor RR   9.45E−04   1.38       414733   BE514535   Hs. 77171   minichromosome maintenance deficient (S.   8.98E−06   1.38       451107   AA235108   Hs. 17639     Homo sapiens  ubiquitin protein ligase (U   1.06E−04   1.38       428104   AA421350       ESTs   1.62E−04   1.38       435124   AA725362   Hs. 120456   ESTs   2.46E−04   1.38       423558   AW865643   Hs. 275865   ribosomal protein S18   7.10E−05   1.38       430933   AW863635       gb: MR3-SN0010-270300-103-h02 SN0010 Homo   1.88E−03   1.38       419511   AA429750   Hs. 75113   general transcription factor IIIA   3.02E−05   1.38       423787   AJ295745   Hs. 236204   nuclear pore complex protein   2.58E−04   1.38       438441   AW664960   Hs. 205319   ESTs   5.62E−05   1.38       457186   AW371847   Hs. 313499   ESTs   2.77E−04   1.38       444388   AB033058   Hs. 11101   KIAA1232 protein   2.86E−03   1.38       419135   R61448   Hs. 106728   ESTs, Weakly similar to KIAA1353 protein   1.43E−08   1.38       417386   AL037228   Hs. 82043   D123 gene product   7.23E−04   1.38       444363   AI142827   Hs. 143656   ESTs   8.10E−05   1.38       447829   AI433029   Hs. 164104   ESTs   7.35E−03   1.38       434848   BE256304   Hs. 32148   AD-015 protein   1.74E−03   1.38       443186   AI885827   Hs. 7149   ESTs, Weakly similar to T13963 formin re   1.89E−03   1.38       436563   AJ239450   Hs. 157874   ESTs   1.04E−04   1.38       414176   BE140638   Hs. 75794   EDG-2 (endothelial differentiation, lys   6.98E−03   1.38       413771   AA810047   Hs. 4112   acetyl-Coenzyme A acetyltransferase 2 (a   3.74E−04   1.38       430027   AB023197   Hs. 227743   KIAA0980 protein   3.32E−09   1.38       432403   AA550815   Hs. 124840   ESTs   1.03E−05   1.37       454038   X06374   Hs. 37040   platelet-derived growth factor alpha pol   2.84E−03   1.37       409593   AB032985   Hs. 55069   neurexophilin 3   7.75E−04   1.37       408124   U89337   Hs. 42853   cAMP responsive element binding protein-   4.40E−07   1.37       457062   AA404520   Hs. 125845   ribulose-5-phosphate-3-epimerase   8.18E−04   1.37       434894   AW977850   Hs. 23856   hypothetical protein MGC5297   4.62E−03   1.37       456619   AV647917   Hs. 107153   inhibitor of growth family, member 1-lik   1.49E−08   1.37       447811   C15005   Hs. 17121   ESTs, Moderately similar to GRPM MOUSE G   2.97E−04   1.37       421662   NM_014141   Hs. 106552   cell recognition molecule Caspr2   1.32E−03   1.37       411678   AI907114   Hs. 71465   squalene epoxidase   7.96E−04   1.37       411352   NM_002890   Hs. 758   RAS p21 protein activator (GTPase activa   2.60E−05   1.37       420962   NM_005904   Hs. 100602   MAD (mothers against decapentaplegic, Dr   2.22E−07   1.37       408388   AF091086   Hs. 44563   hypothetical protein   1.02E−04   1.37       438517   AI439688   Hs. 6289   hypothetical protein FLJ20886   4.50E−05   1.37       404813           Target Exon   1.79E−03   1.37       448361   H82028   Hs. 238707   hypothetical protein FLJ22457   1.29E−04   1.37       441077   AI241273   Hs. 15312   ESTs   5.25E−08   1.36       459190   AW410601   Hs. 30026   HSPC182 protein   2.26E−04   1.36       421297   AB037360       KIAA1255 protein   1.33E−07   1.36       417929   R27219   Hs. 74647   Human T-cell receptor active alpha-chain   9.13E−05   1.36       421983   AI252640   Hs. 110364   peptidylprolyl isomerase C (cyclophilin   4.89E−06   1.36       444842   AF084479   Hs. 194688   bromodomain adjacent to zinc finger doma   1.24E−05   1.36       423485   AB037809   Hs. 129268   KIAA1388 protein   2.34E−03   1.36       446110   AI305223   Hs. 148056   ESTs   3.07E−04   1.36       435635   AF220050   Hs. 181385   uncharacterized hematopoietic stem/proge   1.29E−04   1.36       408360   AI806090   Hs. 44344   hypothetical protein FLJ20534   1.33E−08   1.36       412622   AW664708   Hs. 171959   ESTs   9.40E−03   1.36       414718   H95348   Hs. 107987   ESTs   1.35E−03   1.36       444886   AW340504   Hs. 148557   ESTs   1.75E−03   1.36       449188   AW072939   Hs. 347187   myotubularin related protein 1   6.45E−07   1.36       410804   U64820   Hs. 66521   Machado-Joseph disease (spinocerebellar   2.44E−04   1.36       400296   AA305627   Hs. 139336   ATP-binding cassette, sub-family C (CFTR   3.61E−03   1.36       427080   AW068287   Hs. 301175   ras-related C3 botulinum toxin substrate   6.15E−05   1.36       452934   AA581322   Hs. 4213   hypothetical protein MGC16207   4.31E−05   1.36       409353   NM_006858   Hs. 54411   putative T1/ST2 receptor binding protein   7.85E−05   1.36       410426   AA085039   Hs. 285013   putative human HLA class II associated p   8.45E−03   1.36       421944   AA344367   Hs. 109760   Target CAT   5.43E−05   1.36       412288   NM_003005   Hs. 73800   selectin P (granule membrane protein 140   9.21E−03   1.35       445165   AV652831   Hs. 234058   gb: AV652831 GLC  Homo sapiens  cDNA clone   2.67E−06   1.35       432372   AI659280   Hs. 155004   ESTs   3.61E−05   1.35       421887   AW161450   Hs. 109201   CGI-86 protein   9.93E−06   1.35       418962   AA714835   Hs. 271863   ESTs   1.92E−07   1.35       407885   AA373889   Hs. 41007   mitochondrial ribosomal protein L22   4.57E−07   1.35       443835   AF016371   Hs. 9880   peptidyl prolyl isomerase H (cyclophilin   1.23E−06   1.35       456113   H71616   Hs. 135233   ESTs   2.62E−03   1.35       423878   AI907090   Hs. 52891   hypothetical protein PRO1853   4.29E−05   1.35       434509   AA193565   Hs. 79276     Homo sapiens  clone IMAGE: 121558 mRNA seq   2.52E−03   1.35       413129   AF292100   Hs. 104613   RP42 homolog   7.65E−06   1.35       419985   H66373   Hs. 5856   ESTs, Highly similar to bA393J16.3 [H. sa   8.31E−04   1.35       432623   AA557351   Hs. 152448   ESTs, Moderately similar to S14147 multi   7.55E−04   1.35       421489   AI922821   Hs. 32433   ESTs   2.40E−03   1.35       424539   L02911   Hs. 150402   Activin A receptor, type I (ACVR1) (ALK   5.27E−05   1.35       410256   AB037732   Hs. 61441   KIAA1311 protein   1.95E−05   1.35       410365   AI287518         Homo sapiens  mRNA; cDNA DKFZp586D0923 (f   1.10E−03   1.35       458439   AV647220   Hs. 106576   alanine-glyoxylate aminotransferase 2-li   1.43E−05   1.35       406137           NM_000179*:  Homo sapiens  mutS ( E. coli ) h   1.43E−03   1.35       428466   AF151063   Hs. 184456   hypothetical protein   1.07E−04   1.35       432358   AI093491   Hs. 274413   hypothetical protein FLJ11218   5.55E−04   1.35       416676   AW392022   Hs. 79507   KIAA0582 protein   2.42E−03   1.35       447139   AL134744   Hs. 10852   ESTs   4.56E−08   1.35       436137   AI056769   Hs. 133512   ESTs   9.06E−05   1.35       438459   T49300   Hs. 35304     Homo sapiens  cDNA FLJ13655 fis, clone PL   3.65E−05   1.35       424649   BE242035   Hs. 151461   embryonic ectoderm development   9.97E−07   1.35       413806   L12535   Hs. 75551   Ras suppressor protein 1   3.39E−05   1.35       424972   BE247567   Hs. 154045   KIAA0082 protein   8.45E−07   1.35       447387   AI268331   Hs. 102237   tubby super-family protein   1.42E−07   1.34       413858   NM_001610   Hs. 75589   acid phosphatase 2, lysosomal   1.36E−03   1.34       427399   NM_014883   Hs. 177664   KIAA0914 gene product   2.29E−06   1.34       455631   BE063031       gb: MR0-BT0265-231199-002-e09 BT0265 Homo   3.66E−03   1.34       409542   AA503020   Hs. 36563   hypothetical protein FLJ22418   6.76E−03   1.34       429598   AA811257   Hs. 269710   ESTs   8.67E−05   1.34       421166   AA305407   Hs. 102308   potassium inwardly-rectifying channel, s   4.96E−07   1.34       432523   AA551756       ESTs   7.86E−06   1.34       445652   AL117473   Hs. 13036   DKFZP727A071 protein   2.35E−05   1.34       433923   AI823453   Hs. 146625   ESTs   2.49E−05   1.34       420843   H96982   Hs. 42321   ESTs   1.00E−03   1.34       440328   AW392243       endogenous retroviral protease   5.80E−04   1.34       442406   NM_014846   Hs. 8294   KIAA0196 gene product   5.90E−05   1.34       400763           Target Exon   2.50E−03   1.34       440973   AI656743   Hs. 127514   ESTs   9.83E−03   1.34       427674   NM_003528   Hs. 2178   H2B histone family, member Q   1.03E−04   1.34       429837   NM_003896   Hs. 225939   sialyltransferase 9 (CMP-NeuAc: lactosylc   1.21E−04   1.34       452887   AI702223   Hs. 107253   hypothetical protein DKFZp761F241   1.70E−03   1.34       424321   W74048   Hs. 1765   lymphocyte-specific protein tyrosine kin   1.54E−05   1.34       412347   AW970026   Hs. 73818   ubiquinol-cytochrome c reductase hinge p   1.38E−05   1.34       425843   BE313280   Hs. 159627   death associated protein 3   5.79E−05   1.34       412710   AA115819   Hs. 187593   ESTs   1.53E−03   1.34       422607   Z45471   Hs. 118684   stromal cell-derived factor 2   1.25E−06   1.34       441004   AL137488   Hs. 7615     Homo sapiens  mRNA; cDNA DKFZp434N2030 (f   1.10E−04   1.34       441229   AW083064       ESTs   8.72E−05   1.33       445718   H79791   Hs. 15227   ESTs   1.85E−06   1.33       426032   H63477   Hs. 81188   ESTs, Moderately similar to ALU1_HUMAN A   7.52E−04   1.33       414080   AA135257   Hs. 47783   B aggressive lymphoma gene   1.15E−04   1.33       407309   AA526438   Hs. 281680   peroxisomal trans 2-enoyl CoA reductase;   9.94E−06   1.33       409977   AW805510   Hs. 97056   hypothetical protein FLJ21634   2.34E−04   1.33       447347   AA570056   Hs. 122730   ESTs, Moderately similar to KIAA1215 pro   1.70E−07   1.33       429682   NM_006306   Hs. 211602   SMC1 (structural maintenance of chromoso   6.55E−03   1.33       428023   AL038843         Homo sapiens  cDNA; FLJ23602 fis, clone L   1.70E−03   1.33       412677   AW029608   Hs. 17384   ESTs   1.00E−03   1.33       424967   AI188435       RAB27A, member RAS oncogene family   5.80E−05   1.33       403608           C3001199: gi|7494834|pir||T15308hypothet   1.24E−03   1.33       445292   AV653264   Hs. 13982     Homo sapiens  cDNA FLJ14666 fis, clone NT   1.47E−04   1.33       425882   U83115   Hs. 161002   absent in melanoma 1   2.79E−09   1.33       421767   AW390255   Hs. 108112   histone fold protein CHRAC17; DNA polyme   4.64E−05   1.33       439908   AI168031   Hs. 155507   ESTs   1.11E−04   1.33       421282   AA286914   Hs. 40782   ESTs   6.68E−06   1.33       420838   AW118210   Hs. 42321   ESTs   2.32E−04   1.33       453403   BE466639   Hs. 61779     Homo sapiens  cDNA FLJ13591 fis, clone PL   4.15E−04   1.33       426343   NM_014642   Hs. 169387   KIAA0036 gene product   1.55E−04   1.33       445592   AV654382   Hs. 17947   ESTs, Weakly similar to T16534 hypotheti   1.22E−05   1.33       446048   AI272364   Hs. 182081   KIAA1811 protein   4.47E−03   1.33       415023   AA932146         Homo sapiens  clone TCCCIA00164 mRNA sequ   9.58E−07   1.33       427726   AI359144   Hs. 143688     Homo sapiens  cDNA: FLJ23031 fis, clone L   8.02E−07   1.33       417947   AA323563   Hs. 325309   hypothetical protein FLJ14596   2.89E−04   1.33       434260   AF121856   Hs. 284291   sorting nexin 6   2.30E−08   1.33       437306   AW270552       ESTs   1.55E−03   1.32       410125   AK000846   Hs. 58679   solute carrier family 7, (cationic amino   1.60E−04   1.32       451168   D31770   Hs. 26014   activin A receptor, type II   4.12E−03   1.32       416315   AA179483   Hs. 73605   ESTs   1.38E−05   1.32       411784   AK001715   Hs. 72085   hypothetical protein FLJ10853   5.04E−08   1.32       452144   AA032197   Hs. 102558     Homo sapiens , clone MGC: 5352, mRNA, comp   3.29E−05   1.32       426012   AA367507   Hs. 75874   pregnancy-associated plasma protein A   7.29E−03   1.32       425295   AA431366   Hs. 37251   ESTs   4.74E−04   1.32       437986   AA774575   Hs. 121776   testis expressed sequence 11   2.42E−03   1.32       442332   AI693251   Hs. 8248   Target CAT   1.30E−05   1.32       439208   AK000299   Hs. 180952   dynactin 4 (p62)   1.04E−05   1.32       456073   AA587775   Hs. 66295   multi-PDZ-domain-containing protein   3.40E−05   1.32       428738   NM_000380   Hs. 192803   xeroderma pigmentosum, complementation g   1.52E−05   1.32       452479   AI903573       gb: RC-BT031-280199-114 BT031 Homo sapien   5.19E−03   1.32       452548   AL050321   Hs. 301532   CRP2 binding protein   3.09E−06   1.32       450016   AA249590   Hs. 4747   ESTs, Weakly similar to A28996 proline-r   5.01E−06   1.32       431675   AA699965       ESTs   6.72E−04   1.32       430261   AA305127   Hs. 4147   hypothetical protein HT023   4.00E−06   1.32       411885   AA452636   Hs. 131057   ESTs, Moderately similar to CRGD_HUMAN G   2.36E−03   1.32       426857   AW581992   Hs. 301434   KIAA1387 protein   7.58E−04   1.32       407825   NM_006152   Hs. 40202   lymphoid-restricted membrane protein   3.74E−03   1.32       441647   AA534210   Hs. 285280     Homo sapiens  cDNA: FLJ22096 fis, clone H   5.30E−04   1.32       409401   AI201895   Hs. 181309   proteasome (prosome, macropain) subunit,   2.42E−05   1.32       437293   AA836401   Hs. 87860   ESTs   1.61E−04   1.32       418780   AA228078   Hs. 255096   ESTs   2.84E−03   1.31       431586   AW971100   Hs. 293189   ESTs   6.50E−04   1.31       438979   AW976218   Hs. 32565   ESTs   2.44E−06   1.31       458207   T28472   Hs. 7655   U2 small nuclear ribonucleoprotein auxil   1.40E−03   1.31       453320   AW450240   Hs. 257274   ESTs   5.85E−03   1.31       426796   S78234   Hs. 172405   cell division cycle 27   1.75E−04   1.31       432600   AI821085       gb: ns95a12.y5 NCl_CGAP_Pr3  Homo sapiens     1.05E−03   1.31       409572   AL048938   Hs. 54971   hypothetical protein   1.72E−08   1.31       408758   NM_003686   Hs. 47504   exonuclease 1   1.43E−04   1.31       445648   AW362302   Hs. 164090   ESTs   4.03E−04   1.31       432987   AI864771   Hs. 27954   CD86 antigen (CD28 antigen ligand 2, B7-   1.27E−06   1.31       419943   AA252111   Hs. 15200   ESTs   9.35E−05   131       413274   NM_004893   Hs. 75258   H2A histone family, member Y   5.15E−04   1.31       449365   AW968261   Hs. 118913   ESTs, Moderately similar to T46371 hypot   4.97E−03   1.31       414411   X54079   Hs. 76067   heat shock 27 kD protein 1   1.14E−06   1.31       400271           NM_004344:  Homo sapiens  centrin, EF-hand   2.70E−04   1.31       448071   BE621584   Hs. 6983     Homo sapiens  cDNA: FLJ22646 fis, clone H   1.50E−05   1.31       450289   AI690295   Hs. 243598   ESTs   6.16E−04   1.31       417089   H52280   Hs. 18612     Homo sapiens  cDNA: FLJ21909 fis, clone H   6.27E−10   1.31       418876   AA740616       gb: ny97f11.s1 NCI_CGAP_GCB1  Homo sapiens     2.19E−06   1.31       443199   AJ002030   Hs. 9071   progesterone membrane binding protein   1.42E−06   1.31       411529   AA430348   Hs. 317596     Homo sapiens  cDNA FLJ12927 fis, clone NT   7.08E−03   1.31       453407   AW409745   Hs. 32967   Cockayne syndrome 1 (classical)   2.06E−03   1.31       416365   U15131   Hs. 79265   suppression of tumorigenicity 5   4.90E−04   1.31       440188   AK001812   Hs. 7036   N-Acetylglucosamine kinase   9.80E−05   1.31       440779   AI651910   Hs. 128556   ESTs   9.12E−03   1.31       400840           Target Exon   2.57E−05   1.31       431663   NM_016569   Hs. 267182   TBX3-iso protein   9.11E−05   1.31       409052   AW898179   Hs. 50123   zinc finger protein 189   5.93E−05   1.31       446254   BE179829   Hs. 179852     Homo sapiens  cDNA FLJ12832 fis, clone NT   9.61E−03   1.31       407177   W88954   Hs. 203709   ESTs   3.43E−03   1.31       417933   X02308   Hs. 82962   thymidylate synthetase   9.19E−06   1.31       418207   C14685   Hs. 34772   ESTs   3.94E−03   1.31       452139   AA099969   Hs. 16331     Homo sapiens  cDNA: FLJ21482 fis, clone C   1.07E−07   1.31       446641   AL049229   Hs. 15787     Homo sapiens  mRNA; cDNA DKFZp564O1016 (f   2.24E−03   1.31       407890   AK001607   Hs. 41127   hypothetical protein FLJ13220   1.58E−06   1.30       417928   AA209344   Hs. 30177   ESTs   5.53E−06   1.30       446044   H67567   Hs. 13572   calcium modulating ligand   7.83E−09   1.30       431921   N46466   Hs. 58879   ESTs   2.21E−05   1.30       418020   R35510   Hs. 24990   ESTs   7.14E−04   1.30       409619   AK001015   Hs. 55220   BCL2-associated athanogene 2   3.09E−05   1.30       425836   AW955696   Hs. 90960   ESTs   2.22E−06   1.30       444735   BE019923   Hs. 243122   hypothetical protein FLJ13057 similar to   5.41E−04   1.30       436535   AW295687   Hs. 254420   ESTs   1.12E−05   1.30       415910   U20350   Hs. 78913   chemokine (C-X3-C) receptor 1   8.53E−05   1.30       445388   AI925280   Hs. 128777   EST   2.59E−06   1.30       448965   AF092134   Hs. 22679   CGI-24 protein   3.13E−08   1.30       445757   AW449065   Hs. 13264   KIAA0856 protein   7.74E−04   1.30       414783   AW069569       unactive progesterone receptor, 23 kD   8.35E−06   1.30       448244   BE613416   Hs. 336425     Homo sapiens , clone MGC: 17296. mRNA, com   3.74E−06   1.30       423032   AI684746   Hs. 119274   RAS p21 protein activator (GTPase activa   1.31E−04   1.30       437527   AI241019   Hs. 145644   ESTs   3.77E−04   1.30       408063   BE086548   Hs. 42346   calcineurin-binding protein calsarcin-1   3.50E−04   1.30       437065   AL036450   Hs. 103238   ESTs   1.43E−03   1.29       446841   AV660567       gb: AV660567 GLC  Homo sapiens  cDNA clone   4.29E−04   1.29       418673   NM_005582   Hs. 87205   lymphocyte antigen 64 (mouse) homolog (   4.79E−04   1.29       433671   AW138797   Hs. 132906   19A24 protein   1.26E−03   1.29       420919   M57892   Hs. 100322   carbonic anhydrase VI   6.69E−04   1.29       447094   X65232   Hs. 17364   zinc finger protein 79 (pT7)   2.23E−04   1.29       417437   U52682   Hs. 82132   interferon regulatory factor 4   9.46E−04   1.29       453929   AW190054       gb: xl11d05.x1 NCI_CGAP_Ut4  Homo sapiens     3.94E−03   1.29       417782   T10149   Hs. 4243   hypothetical protein FLJ12650   9.78E−07   1.29       414438   AI879277   Hs. 76136   thioredoxin   7.32E−05   1.29       459436   AA323121       gb: EST25881 Cerebellum II  Homo sapiens  c   1.90E−04   1.29       424650   AW576156   Hs. 250824     Homo sapiens  cDNA: FLJ23435 fis. clone H   1.85E−04   1.29       422843   AA317826   Hs. 188361   gb: EST19817 Retina II  Homo sapiens  cDNA   1.68E−04   1.29       458389   H70284   Hs. 160152   ESTs, Weakly similar to FPHU alpha-fetop   2.39E−06   1.29       443562   AF118838   Hs. 9599   solute carrier family 25, member 13 (cit   3.94E−04   1.29       452617   H22717   Hs. 7174   hypothetical protein FLJ22759   5.18E−04   1.29       430488   D19589   Hs. 13453   hypothetical protein FLJ14753   2.68E−04   1.29       413568   AA130381   Hs. 180257   ESTs   1.58E−07   1.29       458725   AW970192   Hs. 171942   ras responsive element binding protein 1   2.03E−05   1.29       403827           C4000447*: gi|7705570|ref|NP_038851.1|KI   9.50E−03   1.29       440740   H87832   Hs. 7388   ketch (Drosophila)-like 3   1.23E−05   1.29       410434   AF051152   Hs. 63668   toll-like receptor 2   5.21E−04   1.29       409161   W07662   Hs. 50861   sirtuin (silent mating type information   5.83E−04   1.29       440213   AW246253   Hs. 7043   succinate-CoA ligase, GDP-forming, alpha   1.79E−08   1.29       443316   AI478463   Hs. 18443   aldehyde dehydrogenase 8 family, member   5.31E−05   1.29       436139   AA765786   Hs. 120936   ESTs   5.79E−06   1.29       427224   AL135554       sine oculis homeobox (Drosophila) homolo   2.33E−06   1.29       412520   AA442324   Hs. 795   H2A histone family, member O   1.46E−06   1.29       452303   R27257   Hs. 57734   heat shock 70 kD protein 1B   1.14E−04   1.28       420151   AA255931   Hs. 186704   ESTs   7.07E−06   1.28       443601   AI078554   Hs. 42658   ESTs   1.61E−05   1.28       450305   AA009477   Hs. 17572   ESTs, Weakly similar to A46010 X-linked   2.83E−05   1.28       431255   AA497043   Hs. 115685   ESTs   9.13E−03   1.28       419935   AB020980   Hs. 93832   putative membrane protein   1.02E−06   1.28       429686   AI871613   Hs. 28538     Homo sapiens  cDNA: FLJ21086 fis, clone C   3.27E−03   1.28       442484   AF075360       gb: AF075360 Human fetal liver cDNA libra   1.79E−03   1.28       437916   BE566249   Hs. 20999   hypothetical protein FLJ23142   2.64E−03   1.28       451789   AW291532   Hs. 211297   ESTs   9.14E−03   1.28       429529   AA454190   Hs. 24283   ESTs, Moderately similar to reduced expr   1.14E−03   1.28       434658   AI624436   Hs. 310286   ESTs   8.22E−06   1.28       418831   AA488082       gb: ab13e05.s1 Stratagene lung (937210) H   8.61E−04   1.28       429673   AA884407   Hs. 211595   protein tyrosine phosphatase, non-recept   3.23E−03   1.28       414430   AI346201   Hs. 76118   ubiquitin carboxyl-terminal esterase L1   6.36E−03   1.28       448079   R76981       thyroid hormone receptor-associated prot   7.51E−04   1.28       408677   AI279892   Hs. 46801   sorting nexin 14   4.91E−05   1.28       456508   AA502764   Hs. 123469   ESTs, Weakly similar to AF208855 1 BM-01   8.25E−05   1.28       421290   NM_014368   Hs. 103137   LIM homeobox protein 6   3.64E−04   1.28       431829   BE467737   Hs. 146125   ESTs   1.95E−03   1.28       431892   AA521315   Hs. 194424   ESTs   5.86E−03   1.28       425587   AB018332   Hs. 158319   KIAA0789 gene product   1.52E−03   1.28       428248   AI126772   Hs. 40479   ESTs   4.53E−03   1.28       428580   AF118452   Hs. 184945   gastrulation brain homeo box 2   2.37E−03   1.28       447023   AA356764   Hs. 17109   integral membrane protein 2A   2.36E−05   1.28       442287   AW952703   Hs. 8182   synaptic nuclei expressed gene 1b   6.33E−05   1.28       421215   AI868634   Hs. 246358   ESTs, Weakly similar to T32250 hypotheti   2.84E−06   1.28       410383   AA084561   Hs. 151093   hypothetical protein DKFZp434G1415   9.07E−04   1.28       446832   NM_006314   Hs. 16232   connector enhancer of KSR-like (Drosophi   1.67E−03   1.28       453648   W21493   Hs. 28329   hypothetical protein FLJ14005   3.53E−05   1.27       450869   R05747       ESTs, Weakly similar to organic anion tr   4.55E−05   1.27       429722   U48629   Hs. 12731   ESTs   3.48E−03   1.27       427247   AW504221   Hs. 174103   integrin, alpha L (antigen CD11A (p180).   7.71E−03   1.27       415276   U88666   Hs. 78353   SFRS protein kinase 2   2.57E−05   1.27       437406   AL390182         Homo sapiens  mRNA full length insert cDN   8.76E−04   1.27       451743   AW074266   Hs. 23071   ESTs   3.36E−06   1.27       429379   NM_014840   Hs. 200598   KIAA0537 gene product   2.54E−03   1.27       409205   AI952884   Hs. 14832   ESTs, Moderately similar to unnamed prot   4.80E−04   1.27       433590   N98410   Hs. 48364     Homo sapiens  regulator of G-protein sign   2.79E−07   1.27       411096   U80034   Hs. 68583   mitochondrial intermediate peptidase   5.65E−03   1.27       433658   L03678   Hs. 156110   immunoglobulin kappa constant   1.89E−03   1.27       411202   AW163223   Hs. 315482   ESTs, Weakly similar to I38022 hypotheti   7.62E−06   1.27       437612   AA827715   Hs. 105153     Homo sapiens , clone IMAGE: 3461987, mRNA,   5.16E−03   1.27       450459   AI697193   Hs. 299254     Homo sapiens  cDNA: FLJ23597 fis, clone L   1.63E−03   1.27       458172   BE007237       gb: PM0-BN0139-050500-003-g09 BN0139 Homo   6.27E−04   1.27       437543   H16443   Hs. 7117   glutamate receptor, ionotropic, AMPA 1   6.23E−08   1.27       430958   M81829   Hs. 248160   somatostatin receptor 1   6.82E−06   1.27       408196   AL034548   Hs. 43627   SRY (sex determining region Y)-box 22   1.40E−05   1.27       422385   BE549407   Hs. 115823   ribonuclease P, 40 kD subunit   6.73E−05   1.27       449736   R50120   Hs. 25367   ESTs, Weakly similar to ALR  H. sapiens     1.37E−03   1.27       414992   D63302       gb: HUM521A10B Clontech human placenta po   4.14E−06   1.27       438847   AA827232   Hs. 245362   ESTs   1.91E−03   1.27       447445   AW169369   Hs. 158936   ESTs   1.04E−03   1.27       452386   R12499   Hs. 20468   ESTs   1.20E−04   1.27       410215   AI694353       ESTs, Weakly similar to AF205600 1 trans   9.81E−03   1.27       411115   AW818453       gb: RC1-ST0278-020300-015-d01 ST0278 Homo   4.06E−03   1.27       445589   AI565993   Hs. 222189   ESTs   5.35E−05   1.27       433689   AI802331   Hs. 98289   ESTs, Weakly similar to I38022 hypotheti   2.84E−03   1.27       449704   AK000733   Hs. 23900   GTPase activating protein   2.01E−05   1.27       407604   AW191962       collagen, type VIII, alpha 2   6.07E−03   1.27       453985   N44545   Hs. 251865   ESTs   3.21E−05   1.27       409652   BE208589   Hs. 55601   host cell factor 2   1.24E−04   1.26       403809           NM_024743*:  Homo sapiens  hypothetical pro   2.01E−03   1.26       417798   Y09858   Hs. 82577   spindlin-like   1.17E−03   1.26       445813   Z42023   Hs. 106576   alanine-glyoxylate aminotransferase 2-li   5.56E−06   1.26       447769   AW873704   Hs. 320831     Homo sapiens  cDNA FLJ14597 fis, clone NT   1.34E−05   1.26       451593   AF151879   Hs. 26706   CGI-121 protein   9.80E−06   1.26       452780   BE171598       ESTs, Weakly similar to I38022 hypotheti   5.91E−07   1.26       438032   BE045624   Hs. 152992   ESTs   2.14E−03   1.26       426925   NM_001196   Hs. 315689     Homo sapiens  cDNA: FLJ22373 fis, clone H   5.81E−07   1.26       445870   AW410053   Hs. 13406   syntaxin 18   7.80E−10   1.26       422043   AL133649   Hs. 110953   retinoic acid induced 1   4.15E−04   1.26       403142           NM_002706*:  Homo sapiens  protein phosphat   8.57E−05   1.26       437109   AW006781   Hs. 5457   hypothetical protein FLJ10738   2.23E−06   1.26       443551   AI654356   Hs. 272792   hypothetical protein FLJ20307   1.53E−06   1.26       439161   Y15164   Hs. 6483   oral-facial-digital syndrome 1   3.38E−04   1.26       411143   AI525989   Hs. 9088   hypothetical protein MGC3200   4.14E−04   1.26       449082   BE387561   Hs. 22981   DKFZP586M1523 protein   2.46E−06   1.26       441700   AA233556   Hs. 126908   hypothetical protein FLJ12994   7.57E−03   1.26       402813           ENSP00000236495*: DJ1024N4.1 (novel Sodiu   4.14E−03   1.26       440043   BE277457   Hs. 30661   hypothetical protein MGC4606   7.22E−05   1.26       427629   AA233210   Hs. 179943   ribosomal protein L11   6.93E−04   1.26       437231   BE303000   Hs. 288929   hypothetical protein FLJ13258 similar to   8.51E−05   1.25       433043   W57554   Hs. 125019   lymphoid nuclear protein (LAF-4) mRNA   1.39E−04   1.25       408088   AW157022   Hs. 343551   hypothetical protein FLJ22584   6.02E−05   1.25       423598   BE247600   Hs. 155538   ESTs   1.11E−03   1.25       452767   AW014195   Hs. 61472   ESTs, Weakly similar to YAE6_YEAST HYPOT   9.61E−06   1.25       459245   BE242623   Hs. 31939   manic fringe (Drosophila) homolog   1.38E−03   1.25       448984   AW751955   Hs. 22753   hypothetical protein FLJ22318   3.98E−04   1.25       409513   AW966728   Hs. 54642   methionine adenosyltransferase II, beta   1.85E−06   1.25       425508   AA991551   Hs. 97013     Homo sapiens , Similar to RIKEN cDNA 2310   4.63E−05   1.25       408348   AW269752   Hs. 249828   ESTs   2.09E−03   1.25       407783   AW996872   Hs. 172028   a disintegrin and metalloproteinase doma   4.38E−04   1.25       451188   AA054214   Hs. 60684   ESTs   7.70E−03   1.25       458311   AF069478       gb: AF069478  Homo sapiens  astrocytoma lib   3.91E−04   1.25       439747   AK001148   Hs. 6671   COP9 complex subunit 4   1.38E−05   1.25       422481   AL050163   Hs. 117339   DNAX-activation protein 10   1.87E−03   1.25       417954   AI633943   Hs. 26613   ESTs, Weakly similar to no similarities   1.54E−03   1.25       417831   H16423   Hs. 82685   CD47 antigen (Rh-related antigen, integr   7.34E−07   1.25       411252   AB018549   Hs. 69328   MD-2 protein   1.16E−08   1.25       403538           Target Exon   4.75E−03   1.25       424464   R68537   Hs. 17962   ESTs   9.59E−05   1.25       413533   BE146973       gb: QV4-HT0222-011199-019-e05 HT0222 Homo   6.62E−07   1.25       416959   D28459   Hs. 80612   ubiquitin-conjugating enzyme E2A (RAD6 h   2.81E−05   1.25       445715   AB012958   Hs. 13137   UV radiation resistance associated gene   1.01E−05   1.25       408738   NM_014785   Hs. 47313   KIAA0258 gene product   3.07E−05   1.25       424931   BE244070   Hs. 1845   MHC class 1 region ORF   2.06E−07   1.24       431118   BE264901   Hs. 250502   carbonic anhydrase VIII   4.32E−03   1.24       450196   AW956868   Hs. 24608   DKFZP564D177 protein   1.20E−08   1.24       452537   AW247390   Hs. 77735   hypothetical protein FLJ11618   9.35E−04   1.24       439653   AW021103   Hs. 6631   hypothetical protein FLJ20373   8.13E−04   1.24       407827   BE278431   Hs. 40323   BUB3 (budding uninhibited by benzimidazo   4.90E−05   1.24       457300   AW297436   Hs. 40328     Homo sapiens  cDNA: FLJ21663 fis, clone C   2.26E−04   1.24       425575   AB012851   Hs. 158311   Musashi (Drosophila) homolog 1   7.90E−03   1.24       442410   AW996503   Hs. 197680   ESTs   6.94E−03   1.24       402969           ENSP00000217067*: DJ781B1.3 (A novel prot   7.49E−05   1.24       438899   AF085833   Hs. 135624   ESTs   3.90E−03   1.24       416877   BE386266   Hs. 85658   hypothetical protein FLJ23436   1.12E−05   1.24       434664   R98754   Hs. 271119   ESTs   5.52E−03   1.24       423846   AW978332   Hs. 133260   hypothetical protein FLJ20354   5.39E−03   1.24       442952   AI743261   Hs. 131860   ESTs   4.40E−03   1.24       432201   AI538613   Hs. 298241   Transmembrane protease, serine 3   2.00E−04   1.24       439921   AL110209   Hs. 6770   LCAT-like lysophospholipase   4.54E−06   1.24       431183   NM_006855   Hs. 250696   KDEL (Lys-Asp-Glu-leu) endoplasmic retic   2.31E−03   1.24       407705   AB023139   Hs. 37892   KIAA0922 protein   8.97E−06   1.24       406182           Target Exon   3.52E−03   1.24       433394   AI907753   Hs. 93810   cerebral cavernous malformations 1   5.10E−06   1.24       451687   AL041260   Hs. 26837     Homo sapiens  mRNA; cDNA DKFZp586K1123 (f   1.55E−04   1.24       456497   AW967956   Hs. 123648   ESTs, Weakly similar to AF108460 1 ubinu   1.58E−04   1.24       408392   U28831   Hs. 44566   KIAA1641 protein   1.52E−03   1.24       446501   AI302616       ESTs   1.06E−04   1.24       456023   R00028   Hs. 274344   gb: ye70a06.s1 Soares fetal liver spleen   8.92E−04   1.24       433215   AB040912   Hs. 191098   hypothetical protein FLJ11598   1.73E−04   1.24       415261   T40928   Hs. 8346   ESTs   4.69E−04   1.24       414408   BE294783   Hs. 279497   hypothetical protein MGC4638   3.34E−04   1.24       407478   L77559       gb:  Homo sapiens  DGS-B partial mRNA.   6.01E−03   1.24       406364           Target Exon   2.36E−03   1.24       445006   W91903   Hs. 124814   ESTs   1.24E−03   1.24       411821   BE299339   Hs. 72249   three-PDZ containing protein similar to   1.81E−05   1.24       430275   Z11773   Hs. 237786   zinc finger protein 187   1.54E−03   1.24       445932   BE046441   Hs. 333555     Homo sapiens  clone 24859 mRNA sequence   1.72E−03   1.24       409324   W76202   Hs. 9280   lipoic acid synthetase   8.62E−04   1.24       450371   R34926       son of sevenless (Drosophila) homolog 1   2.33E−04   1.24       419309   AW574793   Hs. 321687     Homo sapiens . Similar to F-box only prot   8.89E−04   1.24       436343   H08024   Hs. 5148   FLN29 gene product   1.34E−05   1.24       413654   AA331881   Hs. 75454   peroxiredoxin 3   1.24E−04   1.23       420776   W38672   Hs. 184067   ESTs   8.11E−04   1.23       414496   W73853       ESTs   3.85E−04   1.23       434521   NM_002267   Hs. 3886   karyopherin alpha 3 (importin alpha 4)   5.40E−05   1.23       434158   T86534   Hs. 14372   ESTs   6.53E−04   1.23       430367   AW607425   Hs. 239938   hypothetical protein   1.32E−03   1.23       447783   AF054178   Hs. 19561   NM_005001:  Homo sapiens  NADH dehydrogenas   2.94E−04   1.23       459697   AA406062   Hs. 98002   ESTs   1.09E−03   1.23       434519   AA635727   Hs. 136581   ESTs, Weakly similar to ARNO_HUMAN ARF N   1.26E−04   1.23       449843   R85337   Hs. 24030   solute carrier family 31 (copper transpo   1.12E−05   1.23       457000   NM_006750   Hs. 172278   syntrophin, beta 2 (dystrophin-associate   3.72E−03   1.23       423743   AB023148   Hs. 173373   KIAA0931 protein   1.13E−03   1.23       457231   AI472022   Hs. 301959   proline synthetase co-transcribed (bacte   8.57E−05   1.23       433192   AB040880   Hs. 98968   ESTs   8.41E−05   1.23       444636   T96667   Hs. 17877   ESTs   8.18E−07   1.23       430289   AK001952   Hs. 238039   hypothetical protein FLJ11090   5.85E−03   1.23       459647   R34107   Hs. 321450   pregnancy specific beta-1-glycoprotein 1   1.04E−04   1.23       427729   AB033100   Hs. 300646   KIAA1274 protein (similar to mouse palad   1.97E−03   1.23       414884   R54418   Hs. 183745   hypothetical protein FLJ13456   7.32E−07   1.23       448554   NM_016169   Hs. 21431   suppressor of fused   2.82E−06   1.23       413116   AA127161   Hs. 4783   hypothetical protein FLJ22035   6.43E−05   1.23       453563   AW608906. comp   Hs. 181163   hypothetical protein MGC5629   9.15E−03   1.23       407955   BE536739   Hs. 109909   ESTs   3.61E−04   1.23       405232           NM_015832:  Homo sapiens  methyl-CpG bindin   2.82E−03   1.23       457634   AA609738   Hs. 16525   ESTs   5.66E−05   1.23       455100   BE160198       gb: QV1-HT0413-010200-059-h03 HT0413 Homo   2.91E−03   1.23       419424   BE041820   Hs. 38516     Homo sapiens , clone MGC: 15887, mRNA, com   4.91E−04   1.23       408770   AW270608   Hs. 170195   bone morphogenetic protein 7 (osteogenic   1.86E−03   1.23       433854   AA610649   Hs. 333239   ESTs   5.52E−05   1.23       440453   AA885523   Hs. 157003   ESTs   6.78E−03   1.23       439452   AA918317   Hs. 57987   B-cell CLL/lymphoma 11B (zinc finger pro   3.39E−03   1.22       403417           C18000266*: gi|7243027|dbj|BAA92561.1|(A   5.34E−03   1.22       452582   AL137407   Hs. 29911     Homo sapiens  mRNA; cDNA DKFZp434M232 (fr   4.03E−04   1.22       410043   D30612   Hs. 58167   zinc finger protein 282   1.77E−06   1.22       405257           Target Exon   1.89E−03   1.22       441869   NM_003947   Hs. 8004   huntingtin-associated protein interactin   7.73E−03   1.22       442103   AA333367   Hs. 8088   similar to  S. cerevisiae  Sec6p and R. no   3.85E−03   1.22       450256   AA286887   Hs. 24724   MFH-amplified sequences with leucine−ric   7.06E−07   1.22       444693   AB002327   Hs. 11711   KIAA0329 gene product   8.55E−05   1.22       429574   BE268321   Hs. 208912   hypothetical protein MGC861   5.48E−03   1.22       436906   H95990   Hs. 181244   major histocompatibility complex, class   7.11E−06   1.22       444476   AF020038   Hs. 11223   isocitrate dehydrogenase 1 (NADP), solub   2.03E−03   1.22       438393   AA351815   Hs. 50740     Homo sapiens  cDNA: FLJ22272 fis, clone H   3.30E−08   1.22       422267   AB033044   Hs. 114012   KIAA1218 protein   1.57E−05   1.22       436796   BE515260   Hs. 5320   hypothetical protein   9.92E−05   1.22       431328   AA502999   Hs. 291591   ESTs   1.24E−04   1.22       450273   AW296454   Hs. 24743   hypothetical protein FLJ20171   6.29E−03   1.22       457284   AF102850   Hs. 227933   Alg5,  S. cerevisiae , homolog of   3.22E−05   1.22       417767   BE242241   Hs. 82542   acyloxyacyl hydrolase (neutrophil)   1.33E−05   1.22       438010   BE243045   Hs. 5990   tetratricopeptide repeat domain 4   1.84E−06   1.22       408981   AW500797   Hs. 49427   Gem-interacting protein   1.50E−05   1.22       403585           Target Exon   6.89E−05   1.22       433556   W56321   Hs. 111460   calcium/calmodulin-dependent protein kin   2.49E−06   1.22       418077   AA112036   Hs. 83419   KIAA0252 protein   8.72E−05   1.22       411806   AW864547       gb: PM4-SN0016-120500-003-b12 SN0016 Homo   9.46E−04   1.22       452664   AA398859   Hs. 18397   hypothetical protein FLJ23221   1.42E−08   1.22       432458   AI968598   Hs. 78768   malignant cell expression-enhanced gene/   9.31E−07   1.22       453122   AI953717   Hs. 232214   ESTs   3.42E−04   1.22       424914   AA348410   Hs. 119065   ESTs   3.37E−04   1.22       412633   AF001691   Hs. 74304   periplakin   2.95E−04   1.21       451254   AI571016   Hs. 172967   ESTs   6.90E−04   1.21       439136   AA830610   Hs. 209011   ESTs   1.64E−03   1.21       420231   R06866   Hs. 19813   ESTs   4.37E−04   1.21       428720   T90468   Hs. 178154   ESTs   7.33E−04   1.21       452032   BE244005   Hs. 27610   retinoic acid-and interferon-inducible   3.55E−05   1.21       422032   AA476966   Hs. 110857   polymerase (RNA) III (DNA directed) poly   6.42E−03   1.21       430107   AA465293   Hs. 105069   ESTs   2.55E−04   1.21       442202   BE272862   Hs. 106534   hypothetical protein FLJ22625   1.28E−05   1.21       429012   AW629596   Hs. 194726   BCL2-associated athanogene 4   9.71E−05   1.21       432676   AI187366       gb: qf29c01.x1 Soares_testis_NHT Homo sap   2.09E−05   1.21       407946   AA226495   Hs. 154292   ESTs   2.27E−05   1.21       458216   AW024282   Hs. 104938   hypothetical protein MGC15906   5.72E−07   1.21       403832           C4000013*: gi|11427234|ref|XP_009399.1|z   2.50E−03   1.21       448334   AA767011   Hs. 119960   DKFZP727G051 protein   6.83E−03   1.21       437378   AI198823   Hs. 160473   ESTs   7.48E−04   1.21       425604   U94320   Hs. 158330   neuropeptide Y receptor Y5   5.70E−05   1.21       423024   AA593731   Hs. 325823   ESTs, Moderately similar to ALU5_HUMAN A   6.88E−04   1.21       423609   AA328348   Hs. 218289   ESTs   5.96E−04   1.21       439317   AF086127   Hs. 50600   ESTs, Weakly similar to T47156 hypotheti   1.32E−04   1.21       441765   AI474058   Hs. 170514   ESTs   5.09E−03   1.21       425251   Z22521   Hs. 155342   protein kinase C, delta   3.47E−07   1.21       452185   AA076467   Hs. 246218     Homo sapiens  cDNA: FLJ21781 fis, clone H   2.31E−03   1.21       433018   AI669760   Hs. 188881   ESTs   4.27E−05   1.21       450622   AI660285   Hs. 58210   ESTs, Highly similar to ITH4_HUMAN INTER   1.13E−04   1.21       453314   R05604   Hs. 19507   ESTs   9.85E−03   1.21       431375   AI767882   Hs. 264347   ESTs   1.96E−05   1.21       435521   W23814   Hs. 6361   mitogen-activated protein kinase kinase   6.96E−07   1.21       422642   AA314041       gb: EST185894 Colon carcinoma (HCC) cell   2.63E−03   1.21       429855   AW385597   Hs. 199630   ESTs, Weakly similar to B34087 hypotheti   8.01E−03   1.21       412141   AI183838   Hs. 48938   hypothetical protein FLJ21802   2.02E−03   1.21       423799   AW026300   Hs. 132906   19A24 protein   6.14E−03   1.21       432377   AA534670       ESTs, Weakly similar to 2004399A chromos   2.76E−03   1.21       450663   H43540   Hs. 25292   ribonuclease HI, large subunit   2.34E−03   1.21       435561   AA351978   Hs. 4943   hepatocellular carcinoma associated prot   9.96E−04   1.21       415660   AI909007   Hs. 78563   ubiquitin-conjugating enzyme E2G 1 (homo   4.03E−04   1.21       432387   BE094222   Hs. 274457     Homo sapiens  mRNA; cDNA DKFZp434H2226 (f   1.53E−03   1.21       458443   AV647010   Hs. 27   glycine dehydrogenase (decarboxylating;   9.56E−04   1.21       442281   N34742   Hs. 170065     Homo sapiens  cDNA FLJ13492 fis, clone PL   6.38E−06   1.21       428553   AA181641   Hs. 184907   G protein-coupled receptor 1   3.19E−04   1.21       431604   AF175265   Hs. 264190   vacuolar protein sorting 35 (yeast homol   1.69E−05   1.20       458468   AV648170   Hs. 58756   ESTs   8.67E−04   1.20       427546   AA405280   Hs. 36793   hypothetical protein FLJ23188   2.59E−04   1.20       402964           NM_022095*:  Homo sapiens  hypothetical C2H   1.55E−04   1.20       442818   AK001741   Hs. 8739   hypothetical protein FLJ10879   3.66E−03   1.20       417957   H53497   Hs. 83006   CGI-139 protein   2.93E−06   1.20       445298   AW295700       ESTs   1.03E−03   1.20       437594   AA761431   Hs. 74335   heat shock 90 kD protein 1, beta   1.32E−03   1.20       414704   NM_014757   Hs. 76986   mastermind (Drosophila), homolog of   3.10E−03   1.20       420339   AW968259   Hs. 186647   ESTs   6.90E−06   1.20       436754   AI061288   Hs. 133437   ESTs   3.43E−03   1.20       422798   R92347   Hs. 34574   ESTs, Weakly similar to ALU1_HUMAN ALU S   254E−03   1.20       444059   R69743   Hs. 116774   integrin, alpha 1   9.70E−06   1.20       433032   AI084066   Hs. 20072   myosin regulatory light chain interactin   9.91E−06   1.20       408761   AA057264   Hs. 238936   ESTs, Weakly similar to (defline not ava   3.30E−07   1.20       443791   N64458   Hs. 143345   ESTs   1.29E−05   1.20       434359   AF129536   Hs. 284226   F-box only protein 6   6.18E−06   1.20       413277   H24177   Hs. 75262   cathepsin O   1.91E−07   1.20       445464   AW172389   Hs. 249999   ESTs   1.75E−03   1.20       401060           Target Exon   3.25E−05   1.20       407588   AW969534   Hs. 267905   hypothetical protein FLJ10422   1.12E−06   1.20       415245   N59650   Hs. 27252   ESTs   1.05E−03   1.20       456577   BE246444   Hs. 283685   hypothetical protein FLJ20396   2.94E−03   1.20       456761   D59899   Hs. 127842   CGI-142   8.55E−03   1.20       446868   AV660737       ESTs   6.71E−03   1.20       421506   BE302796   Hs. 105097   thymidine kinase 1, soluble   2.57E−04   1.20       426181   AA371422   Hs. 334371   hypothetical protein MGC13096   6.57E−05   1.20       417177   NM_004458   Hs. 81452   fatty-acid-Coenzyme A ligase, long-chain   1.65E−04   1.20       425199   R97184       gb: yq58f12.r1 Soares fetal liver spleen   6.03E−03   1.20       414709   AA704703   Hs. 77031   Sp2 transcription factor   1.06E−04   1.20       406350           Target Exon   5.04E−03   1.20       418253   AA215539   Hs. 283643     Homo sapiens  cDNA FLJ11606 fis, clone HE   1.06E−04   1.20       419367   AW132011   Hs. 118236     Homo sapiens  cDNA: FLJ22132 fis, clone H   3.41E−04   1.19       420517   AB011115   Hs. 98507   KIAA0543 protein   1.61E−04   1.19       432441   AW292425   Hs. 163484   ESTs   6.62E−05   1.19       434163   AW974720   Hs. 25206   group XII secreted phospholipase A2   2.63E−03   1.19       408688   AI634522   Hs. 152925   KIAA1268 protein   4.18E−05   1.19       434560   R13052   Hs. 3964     Homo sapiens  clone 24877 mRNA sequence   6.15E−03   1.19       420468   NM_006980   Hs. 97996   transcription termination factor, mitoch   5.07E−04   1.19       409646   AW161391   Hs. 709   deoxycytidine kinase   8.94E−05   1.19       431234   AL389985   Hs. 301637   zinc finger protein 258   6.12E−04   1.19       449259   AW452058   Hs. 257519   ESTs   6.09E−05   1.19       420104   U09825   Hs. 1287   zinc finger protein 173   3.24E−08   1.19       436692   AW243158   Hs. 5297   DKFZP564A2416 protein   6.42E−10   1.19       452715   Z21093   Hs. 30352   ribosomal protein S6 kinase, 52 kD, polyp   8.38E−06   1.19       412372   R65998   Hs. 285243   hypothetical protein FLJ22029   8.03E−04   1.19       452007   AA426234   Hs. 34906   ESTs, Weakly similar to T17210 hypotheti   1.59E−07   1.19       437943   NM_016353   Hs. 5943   rec   6.25E−05   1.19       452983   L32140   Hs. 531   afamin   8.93E−06   1.19       422283   AW411307   Hs. 114311   CDC45 (cell division cycle 45, S.cerevis   2.07E−04   1.19       422061   BE178434   Hs. 267995   ESTs, Moderately similar to G02654 ribos   2.33E−03   1.19       439318   AW837046   Hs. 6527   G protein-coupled receptor 56   4.41E−03   1.19       428972   AK001470   Hs. 194692   cysteine desulfurase   5.56E−03   1.19       418384   AW149266   Hs. 25130     Homo sapiens  cDNA FLJ14923 fis, clone PL   1.66E−03   1.19       409442   AA310162   Hs. 169248   cytochrome c   8.53E−05   1.19       411299   BE409857   Hs. 69499   hypothetical protein   1.40E−06   1.19       441307   AW071696   Hs. 209065   hypothetical protein FLJ14225   1.90E−06   1.19       421413   AI826128   Hs. 55209   ESTs, Weakly similar to A49364 59 protei   1.64E−04   1.19       418560   AW291332   Hs. 194414   ESTs   9.68E−03   1.19       428873   AI701609   Hs. 98908   ESTs   8.52E−03   1.19       433330   AW207084   Hs. 132816   hypothetical protein MGC14801   1.55E−04   1.19       424212   NM_005814   Hs. 143131   glycoprotein A33 (transmembrane)   2.16E−03   1.19       444445   AA342329   Hs. 115920     Homo sapiens  cDNA: FLJ22816 fis, clone K   1.88E−07   1.19       412994   D32257   Hs. 75113   general transcription factor IIIA   1.32E−04   1.19       439077   AW297762   Hs. 255690   ESTs   2.12E−03   1.19       437714   AA766346       ESTs   4.83E−04   1.19       407142   AA412535       gb: zt99b10.s1 Soares_testis_NHT Homo sap   3.74E−04   1.18       407331   AI570416   Hs. 99910   phosphofructokinase, platelet   5.67E−03   1.18       447960   AW954377   Hs. 26412   ring finger protein 26   9.47E−04   1.18       428829   R14050   Hs. 194051     Homo sapiens  mRNA; cDNA DKFZp566B213 (fr   1.47E−05   1.18       426888   H41090   Hs. 97373   ESTs   6.98E−06   1.18       418539   AA224753   Hs. 159500   ESTs   1.06E−05   1.18       435037   AA355113   Hs. 35380   x 001 protein   1.26E−07   1.18       416987   D86957   Hs. 80712   KIAA0202 protein   8.14E−05   1.18       428828   AL117508   Hs. 194035   KIAA0737 gene product   2.66E−06   1.18       427433   D82070   Hs. 177972   chromosome 4 open reading frame 6   2.70E−05   1.18       434707   AI378570   Hs. 116397   ESTs   5.75E−04   1.18       445266   BE222118   Hs. 12479   associated molecule with the SH3 domain   3.36E−05   1.18       427792   M63928   Hs. 180841   tumor necrosis factor receptor superfami   4.60E−03   1.18       403056           eukaryotic translation elongation factor   5.76E−04   1.18       415080   X81789   Hs. 77897   splicing factor 3a, subunit 3, 60 kD   4.92E−04   1.18       418473   AA243335   Hs. 309943   nuclear body protein Sp140   2.69E−03   1.18       419270   NM_005232   Hs. 89839   EphA1   2.89E−03   1.18       419856   AK001401   Hs. 93391   hypothetical protein FLJ10539   5.31E−04   1.18       446207   AW968535   Hs. 14328   hypothetical protein FLJ20071   1.49E−05   1.18       416999   AW195747   Hs. 21122   hypothetical protein FLJ11830 similar to   9.52E−06   1.18       415013   R35274   Hs. 24951   ESTs   1.63E−04   1.18       426143   BE379836       proteasome (prosome, macropain) subunit,   3.16E−07   1.18       439815   AA206079   Hs. 6693   hypothetical protein FLJ20420   4.52E−07   1.18       412723   AA648459   Hs. 335951   hypothetical protein AF301222   2.94E−04   1.18       420882   AA830074   Hs. 291915   ESTs   5.89E−03   1.18       434198   AF119849   Hs. 283028   hypothetical protein PRO1598   2.28E−04   1.18       414602   AW630088   Hs. 76550     Homo sapiens  mRNA; cDNA DKFZp564B1264 (f   5.33E−06   1.18       425729   L22647   Hs. 159360   prostaglandin E receptor 1 (subtype EP1)   5.73E−03   1.18       420123   W24330   Hs. 5301   hypothetical protein FLJ14936   5.77E−05   1.18       456495   NM_003403   Hs. 97496   YY1 transcription factor   1.59E−05   1.18       440350   AA883475   Hs. 257103   ESTs   5.34E−03   1.18       437374   AL359571   Hs. 44054   ninein (GSK3B interacting protein)   1.17E−06   1.17       424006   AF054815   Hs. 137548   CD84 antigen (leukocyte antigen)   1.93E−04   1.17       444372   AW377983   Hs. 298140     Homo sapiens  cDNA: FLJ22502 fis, clone H   2.17E−07   1.17       426523   S68616   Hs. 170222   solute carrier family 9 (sodium/hydrogen   1.42E−05   1.17       410388   AA831460       KIAA0758 protein   2.88E−03   1.17       421660   R17959   Hs. 106529   CGI-65 protein   8.90E−03   1.17       434759   BE279230   Hs. 4113   S-adenosylhomocysteine hydrolase like 1   9.02E−04   1.17       459122   AI002968   Hs. 235402   ESTs, Weakly similar to T26525 hypotheti   1.59E−03   1.17       450850   AA648886   Hs. 151999   ESTs   5.32E−06   1.17       416326   AF186780   Hs. 79219   RalGDS-like gene; KIAA0959 protein   9.26E−03   1.17       450038   AA005159   Hs. 188489   ESTs   3.51E−03   1.17       447315   AI613123   Hs. 342148   ESTs   1.28E−05   1.17       426773   NM_015556   Hs. 172180   KIAA0440 protein   9.85E−03   1.17       443035   Z45822   Hs. 8906     Homo sapiens  clone 24889 mRNA sequence   3.24E−06   1.17       420705   A8032251   Hs. 99872   fetal Alzheimer antigen   9.87E−04   1.17       431661   AB037830   Hs. 267150   KIAA1409 protein   7.91E−06   1.17       435314   AA677891   Hs. 272138   ESTs, Weakly similar to ALU1_JHUMAN ALU S   9.44E−04   1.17       439798   AA203345   Hs. 102178   syntaxin 16   6.96E−04   1.17       430629   AA482392   Hs. 275184   ESTs, Weakly similar to ATS1_HUMAN ADAM-   1.78E−03   1.17       450612   AL359946   Hs. 14779   acetyl-CoA synthetase   2.31E−04   1.17       416771   AA868956   Hs. 13794   sorting nexin 5   2.18E−03   1.17       426244   AI064808   Hs. 168289   succinate dehydrogenase complex, subunit   1.87E−05   1.17       451338   AW612322   Hs. 19131   transcription factor Dp-2 (E2F dimerizat   3.41E−05   1.17       443209   AI040125   Hs. 150521   ESTs   1.48E−03   1.17       458455   AV648310   Hs. 213488   ESTs   2.67E−03   1.17       446975   BE246446   Hs. 16695   ubiquitin-activating enzyme E1-like   3.39E−07   1.17       418796   AA228351   Hs. 34060   ESTs   1.16E−04   1.17       453209   AW887701   Hs. 32356   hypothetical protein FLJ20628   1.00E−04   1.17       416240   NM_001981   Hs. 79095   epidermal growth factor receptor pathway   1.15E−06   1.17       449773   R76294   Hs. 302383   ESTs   7.90E−03   1.17       435918   AF263538   Hs. 86232   growth differentiation factor 3   2.72E−03   1.17       448694   AA478756   Hs. 194477   E3 ubiquitin ligase SMURF2   1.00E−05   1.17       445866   H20899   Hs. 13399     Homo sapiens  clone 25032 mRNA sequence   1.92E−05   1.17       411122   F00809   Hs. 172004   coactivator-associated arginine methyltr   4.93E−04   1.17       426307   F24978   Hs. 297962   ESTs   1.19E−05   1.17       442107   AI692286       ESTs   7.80E−03   1.17       416133   NM_001683   Hs. 89512   ATPase, Ca transporting, plasma membrane   7.02E−04   1.17       445784   AI253155   Hs. 146065   ESTs   1.22E−04   1.17       427750   AA693991   Hs. 224737   ESTs   1.79E−03   1.16       406341           C5000881*: gi|2661590|emb|CAA15709.1|(AL   5.21E−05   1.16       430006   BE144167   Hs. 321056   hypothetical protein similar to RNA-bind   2.21E−07   1.16       407821   AA346172   Hs. 195614   ESTs   2.93E−04   1.16       452299   AW206330       hypothetical protein FLJ10901   2.86E−03   1.16       457701   AW855466   Hs. 271866   ESTs, Weakly similar to ALU 1_HUMAN ALU S   4.53E−05   1.16       446106   AA377165   Hs. 44833   ESTs   2.32E−05   1.16       415382   AI743539   Hs. 72465   ESTs, Weakly similar to non-lens beta ga   1.22E−03   1.16       426261   AW242243   Hs. 168670   peroxisomal farnesylated protein   1.89E−05   1.16       440248   AA876138       ESTs   8.70E−04   1.16       452600   AI910842   Hs. 103381   ESTs   2.27E−04   1.16       433023   AW864793       thrombospondin 1   6.72E−06   1.16       404694           Target Exon   6.77E−03   1.16       402668           C1003810: gi|3766132|gb|AAC64377.1| (AC00   1.80E−03   1.16       409141   AW341059   Hs. 250664   EST   2.66E−03   1.16       418757   AI864193   Hs. 169728   hypothetical protein FLJ13150   1.50E−03   1.16       431828   AA572994   Hs. 325489   ESTs   3.69E−06   1.16       410086   AI268405   Hs. 13467   hypothetical protein MGC3251   6.24E−06   1.16       435515   N40080   Hs. 6879   DC13 protein   4.50E−04   1.16       458965   AA010319   Hs. 60389   ESTs   1.59E−04   1.16       442127   AW276851   Hs. 8107     Homo sapiens  mRNA; cDNA DKFZp586B0918 (f   7.48E−05   1.16       408127   AW957168   Hs. 289064   hypothetical protein FLJ22251   1.95E−07   1.16       446259   AA425204   Hs. 334721   hypothetical protein FLJ13391   1.62E−03   1.16       405296           C7000453: gi|7301410|gb|AAF56536.1| (AE00   4.75E−04   1.16       410184   AW503667   Hs. 59545   ring finger protein 15   3.38E−06   1.16       445893   AI610702   Hs. 202613   ESTs, Weakly similar to TRHY_HUMAN TRICH   6.11E−08   1.16       432599   R99849   Hs. 269434     Homo sapiens  cDNA FLJ12206 fis, clone MA   5.84E−05   1.16       417601   NM_014735   Hs. 82292   KIAA0215 gene product   1.84E−05   1.16       443804   AL135352   Hs. 255883   ESTs, Weakly similar to I38022 hypotheti   1.76E−04   1.16       422302   AF018253   Hs. 114676   tumor necrosis factor receptor superfami   3.44E−04   1.16       416215   BE397505   Hs. 79081   protein phospbatase 1, catalytic subunit   4.93E−08   1.16       433037   NM_014158   Hs. 279938   HSPC067 protein   1.44E−06   1.16       449971   AA807346   Hs. 288581     Homo sapiens  cDNA FLJ14296 fis, clone PL   4.28E−06   1.16       447313   U92981   Hs. 18081     Homo sapiens  clone DT1P1B6 mRNA, CAG rep   1.16E−03   1.16       430661   AC005551   Hs. 130714     Homo sapiens  HSPC323 mRNA, partial cds   6.11E−04   1.16       445817   NM_003642   Hs. 13340   histone acetyltransferase 1   3.99E−04   1.16       430665   BE350122   Hs. 157367   ESTs, Weakly similar to I78885 serine/th   8.58E−06   1.16       428019   W85913   Hs. 30827   insulin receptor substrate 3-like   8.44E−03   1.16       440351   AF030933   Hs. 7179   RAD1 (S. pombe) homolog   3.92E−05   1.15       426455   AK002196   Hs. 264076     Homo sapiens  cDNA FLJ11334 fis, clone PL   1.58E−03   1.15       448905   BE242730   Hs. 79093   EBNA-2 co-activator (100 kD)   3.95E−03   1.15       429966   BE081342   Hs. 283037   HSPC039 protein   2.93E−04   1.15       450353   AI244661   Hs. 103296   ESTs, Weakly similar to S65657 alpha-1C-   3.41E−04   1.15       432650   D00860   Hs. 56   phosphoribosyl pyrophosphale synthetase   4.23E−07   1.15       453085   AW954243       KIAA0251 protein   1.99E−03   1.15       407832   AW976516   Hs. 283707     Homo sapiens  cDNA: FLJ21354 fis, clone C   7.53E−04   1.15       442159   AW163390   Hs. 278554   heterochromatin-like protein 1   1.35E−05   1.15       444635   Al184268   Hs. 339665   ESTs   2.17E−03   1.15       432541   AW131368       ESTs   9.15E−04   1.15       414134   X60188   Hs. 861   mitogen-activated protein kinase 3   4.95E−04   1.15       437644   AA748575   Hs. 136748   lectin-like NK cell receptor   2.69E−06   1.15       409193   AA131483       gb: zo08e05.r1 Stratagene neuroepithelium   4.60E−03   1.15       422451   AA310753   Hs. 42491   ESTs, Weakly similar to S65657 alpha-1C-   2.28E−04   1.15       402729           Target Exon   7.41E−05   1.15       447505   AL049266   Hs. 18724     Homo sapiens  mRNA; cDNA DKFZp564F093 (fr   1.57E−04   1.15       458140   BE268806       gb: 601139917F1 NIH_MGC_8  Homo sapiens  cD   2.74E−05   1.15       424670   W61215   Hs. 116651   epithelial V-like antigen 1   2.25E−06   1.15       405122           NM_006798*:  Homo sapiens  UDP glycosyltran   6.77E−06   1.15       416022   R44729   Hs. 21286   ESTs   6.32E−04   1.15       421772   Z24958   Hs. 108139   zinc finger protein 212   2.77E−07   1.15       422965   H90576   Hs. 28113   ESTs   1.18E−03   1.15       430464   BE393070   Hs. 188541   ESTs   2.44E−03   1.15       416710   AI268325   Hs. 54890   hypothetical protein FLJ23590   2.20E−03   1.15       448366   AI970841   Hs. 271269   ESTs   2.44E−03   1.15       428464   BE615473   Hs. 184447   sirtuin (silent mating type information   9.06E−04   1.15       427879   AA435939   Hs. 98186   chromosome 21 open reading frame 22   2.46E−04   1.15       417226   AW505054   Hs. 4283   ESTs   3.24E−04   1.15       447757   AA071276   Hs. 19469   KIAA0859 protein   7.22E−04   1.15       407575   W27235   Hs. 64311   a disintegrin and metalloproteinase doma   4.80E−04   1.15       446064   AV656376   Hs. 282851   ESTs, Weakly similar to I38022 hypotheti   1.02E−03   115       425372   NM_14663   Hs. 155983   KIAA0677 gene product   4.28E−04   1.15       402737           Target Exon   4.79E−04   1.15       428107   AA421443   Hs. 104835   ESTs   2.00E−04   1.15       434667   D61329   Hs. 32196   mitochondrial ribosomal protein L36   3.49E−06   1.15       423067   AA321355   Hs. 285401   colony stimulating factor 2 receptor, be   2.94E−03   1.15       445208   AI216103       ESTs   1.56E−03   1.15       439581   AI539852   Hs. 118738   KIAA0800 gene product   6.14E−03   1.15       446012   AV656098   Hs. 172382   betainE-homocysteine methyltransferase 2   1.27E−04   1.15       437234   AI472213   Hs. 247711   hypothetical protein FLJ20557   6.90E−03   1.15       408203   AA053137   Hs. 42390   nasopharyngeal carcinoma susceptibility   6.04E−05   1.15       456352   AA233094   Hs. 191517   ESTs   3.71E−03   1.15       422497   D29642   Hs. 1528   KIAA0053 gene product   9.72E−05   1.15       414762   AW068349   Hs. 77257   KIAA0068 protein   9.50E−05   1.15       458799   AI688547       ESTs   3.89E−03   1.15       434271   AA897778   Hs. 201677   ESTs, Weakly similar to Z257_HUMAN ZINC   6.94E−03   1.15       410423   AW402432   Hs. 63489   protein tyrosine phosphatase, non-recept   4.56E−04   1.15       434421   AI915927   Hs. 34771   ESTs   2.00E−04   1.14       423623   AB011117   Hs. 129943   KIAA0545 protein   1.39E−09   1.14       404231           Target Exon   2.75E−03   1.14       423717   AA330036   Hs. 152003   ESTs   8.79E−03   1.14       453370   AI470523   Hs. 139336   ATP-binding cassette, sub-family C (CFTR   6.17E−05   1.14       420820   W26096         Homo sapiens , clone IMAGE: 4179482, mRNA   1.41E−09   1.14       448959   AI610343   Hs. 293267   ESTs   2.10E−04   1.14       423582   BE000831   Hs. 23837     Homo sapiens  cDNA FLJ11812 fis, clone HE   6.93E−03   1.14       428310   AF100749   Hs. 183655   sec22 homolog   5.55E−06   1.14       405287           Target Exon   7.91E−04   1.14       426532   AA486725       hypothetical protein FLJ20489   7.45E−04   1.14       423494   AW504365   Hs. 24143   Wiskott-Aldrich syndrome protein interac   1.50E−03   1.14       446161   AA628206   Hs. 14125   p53 regulated PA26 nuclear protein   1.05E−06   1.14       433481   AL040235   Hs. 3346   hypothetical protein FLJ11280   3.23E−03   1.14       434072   H70854         Homo sapiens  PRO1082 mRNA, complete cds   7.75E−04   1.14       427691   AW194426   Hs. 20726   ESTs   3.63E−04   1.14       437825   AA769123   Hs. 291947   ESTs   9.72E−04   1.14       430255   AK000703   Hs. 323822     Homo sapiens  mRNA for KIAA1551 protein,   3.00E−04   1.14       414872   U82010   Hs. 77513   COX10 (yeast) homolog. cytochrome c oxid   4.26E−03   1.14       439741   BE379646   Hs. 6904     Homo sapiens  mRNA full length insert cDN   7.07E−06   1.14       417025   AA262170   Hs. 80917   adaptor-related protein complex 3, sigma   4.41E−05   1.14       418917   X02994   Hs. 1217   adenosine deaminase   2.96E−03   1.14       426367   AW611704   Hs. 48578   ESTs   7.75E−03   1.14       423855   AA331761   Hs. 254859   ESTs   5.33E−05   1.14       450832   AW970602   Hs. 105421   ESTs   4.74E−04   1.14       449028   BE616023   Hs. 25298   KIAA1813 protein   5.52E−04   1.14       426384   AI472078   Hs. 303662   hypothetical protein FLJ13189 (FLJ13189)   1.75E−03   1.14       429652   AA766810   Hs. 259290   ESTs   6.17E−03   1.14       415205   H71616   Hs. 135233   ESTs   5.85E−06   1.14       436860   H12751   Hs. 5327   PRO1914 protein   1.93E−06   1.14       427973   AW851123   Hs. 98286   gb: IL3-CT0220-150200-070-H02 CT0220 Homo   1.93E−03   1.14 ,       426940   AA393537   Hs. 98347   ESTs, Weakly similar to JC5308 testis-sp   2.52E−03   1.14       455588   AI129903   Hs. 74669   vesicle-associated membrane protein 5 (m   4.99E−06   1.14       422532   AL008726   Hs. 118126   protective protein for beta-galactosidas   1.22E−03   1.14       431316   AA502663   Hs. 145037   ESTs   1.70E−04   1.14       408329   AF155510   Hs. 44227   heparanase   7.40E−03   1.14       457415   AK000010   Hs. 258798   hypothetical protein FLJ20003   9.74E−04   1.14       409509   AL036923   Hs. 322710   ESTs   8.97E−03   1.14       414713   BE465243   Hs. 12664   ESTs   8.42E−03   1.13       422567   AF111178   Hs. 118407   glypican 6   4.15E−08   1.13       457346   AI734178   Hs. 93379   ESTs, Highly similar to 1207289A reverse   7.22E−03   1.13       449559   AW614016   Hs. 282131   ESTs   8.76E−05   1.13       447932   AA837474   Hs. 20021   vesicle-associated membrane protein 1 (s   3.47E−06   1.13       434981   AW182577   Hs. 293077   ESTs   1.26E−03   1.13       452186   M120761   Hs. 28307   WW domain binding protein 4 (formin bind   6.11E−03   1.13       442161   AI733230   Hs. 128805   ESTs   6.46E−04   1.13       438580   AA811262   Hs. 299202   ESTs   6.12E−04   1.13       424941   AA128376   Hs. 153884   ATP binding protein associated with cell   7.86E−06   1.13       424867   AI024860   Hs. 153591   Not56 (D. melanogaster)-like protein   1.15E−04   1.13       455063   AW854160       gb: RC3-CT0254-060400-029-f09 CT0254 Homo   4.21E−04   1.13       431874   AW610031   Hs. 323914   translocase of inner milochondrial membr   6.87E−04   1.13       405695           Target Exon   5.77E−03   1.13       424065   NM_016388   Hs. 138701   T-cell receptor interacting molecule   9.24E−05   1.13       441192   AA526626   Hs. 7736   mitochondrial ribosomal protein L27   3.59E−05   1.13       450316   W84446   Hs. 226434   hypothetical protein M6C4643   5.68E−05   1.13       456859   X92521   Hs. 154057   matrix metalloproteinase 19   3.33E−03   1.13       421639   NM_012082   Hs. 106309   Friend of GATA2   5.03E−03   1.13       427844   AV658308   Hs. 2210   thyroid hormone receptor interactor 3   4.55E−05   1.13       412019   AA485890   Hs. 69330     Homo sapiens  cDNA FLJ13835 fis. clone TH   4.85E−06   1.13       441892   AB028981   Hs. 8021   KIAA1058 protein   7.83E−06   1.13       416033   NM_012201   Hs. 78979   Golgi apparatus protein 1   1.08E−04   1.13       450455   AL117424   Hs. 25035   chloride intracellular channel 4   3.45E−05   1.13       406658   AI920965   Hs. 77961   major histocompatibility complex, class   3.18E−05   1.13       406827   AA971409       gb: op92c04.s1 NCI_CGAP_Lu5  Homo sapiens     2.85E−05   1.13       457065   AI476318   Hs. 192480   ESTs   4.47E−03   1.13       425538   BE270918   Hs. 164026     Homo sapiens , clone IMAGE: 3534875, mRNA,   1.63E−03   1.13       416852   AF283776   Hs. 80285     Homo sapiens  mRNA; cDNA DKFZp586C1723 (f   4.61E−04   1.13       422929   AA356694   Hs. 94011   ESTs, Weakly similar to MGB4_HUMAN MELAN   1.74E−04   1.13       435274   AA887547   Hs. 150905   ESTs   7.03E−06   1.13       415825   Y18024   Hs. 78877   inositol 1,4,5-trisphosphate 3-kinase B   6.01E−04   1.13       416957   U86749   Hs. 80598   transcription elongation factor A (Sll),   4.33E−06   1.13       420721   AA927802   Hs. 159471   ZAP3 protein   3.70E−03   1.13       421313   NM_014923   Hs. 103329   KIAA0970 protein   1.14E−04   1.13       420885   NM_005652   Hs. 100030   telomeric repeat binding factor 2   1.65E−05   1.13       437156   AI916600   Hs. 121194     Homo sapiens  cDNA: FLJ21569 fis, clone C   1.03E−03   1.13       436614   AW104388   Hs. 149091   ESTs   6.83E−03   1.13       451591   AA886446   Hs. 23590   solute carrier family 16 (monocarboxylic   5.25E−04   1.13       445977   BE550048   Hs. 145735   ESTs   7.77E−05   1.13       401112           NM_024997*:  Homo sapiens  hypothetical pro   2.93E−03   1.13       418096   AA282660   Hs. 193520   ESTs   3.07E−03   1.13       410247   AF181721   Hs. 61345   RU2S   2.71E−03   1.13       407754   AA527348   Hs. 288967     Homo sapiens  cDNA FLJ14105 fis, clone MA   2.18E−03   1.13       403671           C4001270*: gi|7509005|pir||T26190 hypothe   2.04E−04   1.13       448294   AI479918   Hs. 192859   ESTs   5.40E−04   1.13       414726   BE466863   Hs. 280099   ESTs   1.35E−04   1.13       422489   AA311216   Hs. 183953   ESTs   3.48E−03   1.13       429595   AI910584   Hs. 127639   ESTs   9.52E−04   1.13       419854   AW664873   Hs. 87836     Homo sapiens  PAC clone RP5-1087M19 from   1.17E−05   1.12       418522   AA605038   Hs. 7149     Homo sapiens  cDNA: FLJ21950 (is, clone H   2.05E−05   1.12       452717   AW160399   Hs. 30376   hypothetical protein   9.03E−04   1.12       445495   BE622641   Hs. 38489   ESTs, Weakly similar to I38022 hypotheti   6.31E−05   1.12       438724   AW612553   Hs. 114670   Human DNA sequence from clone RP11-16L21   7.89E−08   1.12       426110   NM_002913   Hs. 166563   replication factor C (activator 1) 1 (14   5.22E−09   1.12       416411   AA180188   Hs. 10706   ADP-ribosylation factor-like 4   1.05E−04   1.12       422614   AI908006   Hs. 295362     Homo sapiens  cDNA FLJ14459 fis, clone HE   5.79E−04   1.12       438650   AA843728   Hs. 123533   ESTs   5.65E−03   1.12       437175   AW968078   Hs. 87773   protein kinase, cAMP-dependent, catalyti   2.02E−O6   1.12       445278   BE391904   Hs. 12482   glyceronephosphate O-acyltransferase   1.81E−03   1.12       424577   AI346124   Hs. 28813   ESTs, Weakly similar to A23772 UNE-1 hy   1.80E−03   1.12       410575   BE207480   Hs. 6994     Homo sapiens  cDNA: FLJ22044 fis, clone H   2.56E−06   1.12       424779   AL046851   Hs. 153053   CD37 antigen   7.40E−03   1.12       452057   AW952005   Hs. 14928   hypothetical protein FLJ12903   2.36E−04   1.12       427008   Z45258   Hs. 286013   short coiled-coil protein   2.52E−06   1.12       417944   AU077196   Hs. 82985   collagen, type V, alpha 2   6.04E−05   1.12       443260   AW896265   Hs. 127310   ESTs, Weakly similar to 1805352A splicin   3.66E−05   1.12       420152   AW968080   Hs. 171553     Homo sapiens  clone 24630 mRNA sequence   2.74E−05   1.12       430050   AA430993   Hs. 227913   APIS-like 1   6.41E−04   1.12       425302   U79115   Hs. 155566   CASP2 and RIPK1 domain containing adapto   9.39E−05   1.12       411988   AA455459   Hs. 164480   ESTs, Weakly similar to T50609 hypotheti   3.48E−05   1.12       406657   AI678644   Hs. 277477   major histocompatibility complex, class   2.78E−05   1.12       421940   AA311445   Hs. 9052     Homo sapiens  cDNA: FLJ22042 fis, clone H   1.17E−05   1.12       458812   W57902   Hs. 90744   proteasome (prosome, macropain) 26S subu   2.72E−06   1.12       409008   AA059392   Hs. 66791   ESTs   2.07E−04   1.12       410700   AA352335   Hs. 65641   hypothetical protein FLJ 20073   4.95E−04   1.12       458229   AI929602   Hs. 177   phosphatidylinositol glycan, class H   6.18E−03   1.12       400886           Target Exon   4.47E−04   1.12       422993   AF154415   Hs. 122843   CASP8 associated protein 2   1.49E−03   1.12       452501   AB037791   Hs. 29716   hypothetical protein FLJ 10980   1.47E−03   1.12       443202   AW843882   Hs. 19669   ESTs, Weakly similar to T17346 hypotheti   8.03E−04   1.12       402474           NM_004079:  Homo sapiens  cathepsin S (CTSS   7.68E−07   1.12       440993   A1274880   Hs146339   ESTs   6.87E−03   1.12       400157           Eos Control   5.48E−05   1.12       449209   BE616830   Hs. 294145   ESTs   5.38E−07   1.12       446771   AA128965   Hs. 60679   TATA box binding protein (TBP)-associate   6.52E−07   1.12       433533   D53304   Hs. 9028   fusion, derived from t(12;16) malignant   1.09E−04   1.12       430799   C19035   Hs. 164259   ESTs   6.28E−04   1.12       453870   AW385001   Hs. 8042     Homo sapiens  cDNA: FLJ23173 fis, clone L   1.66E−03   1.12       421748   NM_014718   Hs. 107809   KIAA0726 gene product   8.58E−05   1.11       414181   AK000476   Hs. 75798   hypothetical protein   5.55E−06   1.11       409327   L41162   Hs. 53563   collagen, type IX, alpha 3   2.49E−05   1.11       407804   AF228603   Hs. 39957   pleckstrin 2 (mouse) homolog   2.09E−03   1.11       434821   AA159111   Hs. 284281   Human putative ribosomal protein S1 mRNA   2.44E−07   1.11       411887   AW182924   Hs. 128790   ESTs   4.06E−03   1.11       414515   AA947457   Hs. 135560   ESTs, Weakly similar to T43458 hypotheti   8.13E−03   1.11       440706   AA927562   Hs. 148234   ESTs   2.22E−03   1.11       424928   AW753193   Hs. 188361     Homo sapiens  cDNA FLJ12807 fis, clone NT   1.01E−03   1.11       410342   R31350   Hs. 743   Fc fragment of IgE, high affinity I, rec   7.13E−03   1.11       449261   AI637592       ESTs   5.50E−03   1.11       448391   H71025   Hs. 21075   GTF2I repeat domain-containing 1   4.49E−06   1.11       419384   AA490866   Hs. 39429   ESTs   9.16E−04   1.11       414256   AW410035   Hs. 75862   MAD (mothers against decapentaplegic, Dr   3.56E−04   1.11       451652   AA018968   Hs. 133536   ESTs   2.21E−05   1.11       430235   BE268048   Hs. 236494   RAB10, member RAS oncogene family   2.93E−06   1.11       452694   AK001736   Hs. 30318   hypothetical protein FLJ10874   9.45E−03   1.11       444377   AA134369   Hs. 11042   hypothetical protein   5.02E−07   1.11       420309   AW043637   Hs. 21766   ESTs, Weakly similar to ALU5_HUMAN ALU S   1.91E−04   1.11       436845   AA732297   Hs. 113928   ESTs   2.01E−03   1.11       443530   BE563088   Hs. 9552   binder of Arl Two   1.45E−04   1.11       414618   AI204600   Hs. 96978   hypothetical protein MGC10764   8.68E−04   1.11       434636   AA083764       hypothetical protein MGC3178   4.36E−04   1.11       422001   AW891476   Hs. 122764   BRCA1 associated protein   2.23E−03   1.11       413186   AU077141       solute carrier family 16 (monocarboxylic   2.27E−04   1.11       423692   BE621056   Hs. 131731   hypothetical protein FLJ11099   1.29E−03   1.11       417890   R79048       gb: yi87gO2.r1 Soares placenta Nb2HP Homo   3.79E−03   1.11       453823   AL137967       gb: DKFZp761D2315_r1 761 (synonym: hamy2)   8.96E−03   1.11       431976   AA719001   Hs. 291065   ESTs   3.97E−06   1.11       421183   AL135740   Hs. 102447   TSC-22-like   1.31E−04   1.11       417382   AI818489   Hs. 139709   hypothetical protein FLJ12572   6.22E−03   1.11       436643   AA757626   Hs. 10941   ESTs, Weakly similar to IPP1_HUMAN PROTE   6.13E−06   1.11       436763   AI168278       ESTs   9.15E−03   1.11       422426   W79117   Hs. 58559   ESTs   7.92E−03   1.11       418018   AW973655   Hs. 286184   hypothetical protein dJ551D2.5   8.85E−03   1.11       425145   BE242802   Hs. 154797   KIAA0090 protein   4.53E−04   1.11       435313   AI769400   Hs. 189729   ESTs   3.81E−03   1.11       421305   BE397354   Hs. 324830   diptheria toxin resistance protein requi   5.71E−03   1.11       427939   T92459   Hs. 16886   ESTs   1.26E−03   1.11       433365   AF026944   Hs. 293797   ESTs   1.03E−04   1.11       458524   N63262   Hs. 135965   ESTs   1.76E−03   1.11       419590   AFO05043   Hs. 91390   poly (ADP-ribose) glycohydrolase   4.96E−06   1.11       418224   AL036057   Hs. 83795   interferon regulatory lactor 2   3.93E−05   1.10       429272   W25140   Hs. 110667   ESTs   3.57E−03   1.10       452586   AW958479   Hs. 289043   spindlin   9.58E−05   1.10       438363   AI886351   Hs. 22353   hypothetical protein FLJ21952   8.36E−06   1.10       437042   AK000702   Hs. 5420   hypothetical protein FLJ20695   3.05E−03   1.10       457130   NM_005651   Hs. 183671   tryptophan 2,3-dioxygenase   9.64E−06   1.10       456651   AA302420   Hs. 163622   ESTs   1.91E−03   1.10       446002   AI346468       ESTs   1.53E−04   1.10       441389   AF134838   Hs. 7835   endocytic receptor (macrophage mannose r   3.16E−03   1.10       442524   H45879   Hs. 37288   nuclear receptor subfamily 1, group D, m   1.56E−04   1.10       437888   AA373314   Hs. 5897     Homo sapiens  mRNA; cDNA DKFZp586P1622 (f   1.82E−08   1.10       448822   BE149845   Hs. 289038   hypothetical protein MGC4126   2.67E−04   1.10       409835   AW501362       gb: UI-HF-BP0p-aiv-a-08-0-Ul.r1 NIH_MGC_5   2.67E−04   1.10       420181   AI380089   Hs. 158951   ESTs   6.82E−04   1.10       457650   AA649162   Hs. 236456   ESTs   3.31E−09   1.10       409717   AW452871   Hs. 56043   CGI-115 protein   3.69E−03   1.10       408831   AF090114   Hs. 48433   endocrine regulator   5.13E−05   1.10       420131   F08286   Hs. 95262   nuclear factor related to kappa B bindin   2.43E−05   1.10       427468   AB036829   Hs. 178347   SKIP for skeletal muscle and kidney enri   3.88E−04   1.10       442990   AA197226   Hs. 19347   hypothetical protein MGC11321   1.85E−04   1.10       420867   NM_014183   Hs. 100002   HSPC162 protein   1.64E−08   1.10       450401   AW959281   Hs. 8184   ESTs   4.53E−04   1.10       453259   R93125   Hs. 124187   ESTs   4.73E−03   1.10       448384   R12314   Hs. 21056     Homo sapiens  cDNA: FLJ21366 fis, clone C   1.32E−04   1.10       446141   AW631255   Hs. 324470   L-3-hydroxyacyl-Coenzyme A dehydrogenase   4.46E−04   1.10       428746   AW503820   Hs. 192861   Spi-B transcription factor (Spi-1/PU.1 r   1.56E−03   1.10       435523   T62849   Hs. 11090   membrane-spanning 4-domains, subfamily A   3.95E−06   1.10       418816   T29621   Hs. 88778   carbonyl reductase 1   2.36E−08   1.10       450222   U75308   Hs. 24644   TATA box binding protein (TBP)-associate   3.72E−04   1.10       408633   AW963372   Hs. 46677   PRO2000 protein   8.12E−04   1.10       439898   AW505514   Hs. 209561   KIAA1715 protein   3.80E−04   1.10       411111   AW818127       gb: CM1-ST0277-061299-059-b07 ST0277 Homo   5.18E−04   1.10       435010   N89307   Hs. 124696   oxidoreductase UCPA   2.08E−07   1.10       434039   L32977   Hs. 3712   ubiquinol-cytochrome c reductase, Rieske   4.10E−04   1.10       417094   NM_006895   Hs. 81182   histamine N-methyltransferase   4.50E−07   1.10       408655   AJ243950   Hs. 46735   deafness locus associated putative guani   1.30E−04   1.10       421968   W22587   Hs. 110095     Homo sapiens  mRNA; cDNA DKFZp761E0711(f   3.52E−03   1.10       427172   AA398844   Hs. 64595   ESTs, Weakly similar to AF151831 1 CGI-7   2.07E−06   1.10       426059   BE292842   Hs. 166120   interferon regulatory factor 7   4.26E−06   1.10       408047   AW205461   Hs. 243612   ESTs   5.99E−05   1.10       446616   R65964   Hs. 334873   ESTs, Weakly similar to ALU8_HUMAN ALU S   1.80E−03   1.10       423252   AB005289   Hs. 125856   ATP-binding cassette, sub-family B (MDR/   5.53E−03   1.09       437869   W91976   Hs. 290834   ESTs   2.89E−05   1.09       412577   Z22968   Hs. 74076   CD163 antigen   8.49E−06   1.09       420664   AI681270   Hs. 99824   BCE-1 protein   1.33E−06   1.09       432891   AF161483   Hs. 279761   HSPC134 protein   9.54E−03   1.09       448346   AW515030   Hs. 258526   ESTs   1.07E−04   1.09       408594   BE144666       gb: CM2-HT0176-041099-017-c02 HT0176 Homo   4.37E−05   1.09       437730   AW071087   Hs. 239176   insulin-like growth factor 1 receptor   3.49E−03   1.09       414966   BE544579   Hs. 77690   RAB5B, member RAS oncogene family   8.08E−03   1.09       422722   H74219   Hs. 269772   ESTs   1.24E−03   1.09       446392   AF142419   Hs. 15020   homolog of mouse quaking QKI (KH domain   8.53E−05   1.09       405064           Target Exon   4.07E−03   1.09       453555   N23574   Hs. 123649   ESTs, Moderately similar to ALU7_HUMAN A   3.02E−06   1.09       448928   AI350260   Hs. 301539   mitochondrial ribosomal protein L34   2.32E−03   1.09       421643   BE281170   Hs. 106357   valosin-containing protein   8.84E−06   1.09       436749   AA584890   Hs. 5302   leclin, galactoside-binding, soluble, 4   9.82E−04   1.09       449223   AB002348   Hs. 23263   KIAA0350 protein   3.59E−05   1.09       446927   AW503484   Hs. 16533   myosin phosphatase, target subunit 1   1.36E−03   1.09       439616   BE018635   Hs. 58582     Homo sapiens  cDNA FLJ12789 fis, clone NT   4.53E−06   1.09       433361   AW469373       ribosomal protein L39   6.62E−03   1.09       410781   AI375672   Hs. 165028   ESTs   4.93E−05   1.09       421535   AB002359   Hs. 105478   phosphoribosylformylglycinamidine syntha   6.66E−04   1.09       442079   AW183787       ESTs   2.49E−03   1.09       443274   BE540891       protein kinase, cAMP-dependent, regulato   3.02E−04   1.09       437070   AA765471   Hs. 154494   ESTs, Weakly similar to 2109260A B cell   4.49E−03   1.09       424690   BE538356   Hs. 151777   eukaryotic translation initiation factor   1.30E−05   1.09       418510   R94322   Hs. 271642   ESTs, Weakly similar to I38022 hypotheti   2.87E−03   1.09       422773   AB028962   Hs. 301552   KIAA1039 protein   1.54E−03   1.09       436907   AA737171   Hs. 131809   ESTs   1.38E−05   1.09       420087   AI653368   Hs. 81889   ESTs   2.56E−03   1.09       426407   BE272112   Hs. 48563   ESTs, Moderately similar to ALU2_HUMAN A   3.11E−04   1.09       425917   W28517   Hs. 117167     Homo sapiens  cONA: FLJ23067 fis, clone L   5.77E−08   1.09       417973   NM_004490   Hs. 83070   growth factor receptor-bound protein 14   2.92E−03   1.09       444026   AA205759   Hs. 10119   hypothetical protein FLJ14957   1.40E−06   1.09       413840   AI301558       RNA binding motif protein, X chromosome   1.30E−04   1.09       451612   AI928962   Hs. 26761   DKFZP586L0724 protein   3.91E−05   1.09       414839   X63692   Hs. 77462   DNA (cytosine-5-)-methyltransferase 1   1.24E−03   1.09       438827   AI288188   Hs. 32124   ESTs, Moderately similar to ALU1 _HUMAN A   9.62E−06   1.09       438897   R52285   Hs. 289018     Homo sapiens  cDNA: FLJ22918 fis, clone K   2.03E−03   1.08       427547   BE047653   Hs. 119183   ESTs, Weakly similar to ZN91_HUMAN ZINC   4.93E−04   1.08       439205   AF087990   Hs. 42758     Homo sapiens , clone IMAGE: 3354845, mRNA,   4.77E−03   1.08       427095   AA316080   Hs. 173554   ubiquinol-cytochrome c reductase core pr   4.13E−06   1.08       425154   NM_001851   Hs. 154850   collagen, type IX, alpha 1   1.08E−03   1.08       426466   BE619053   Hs. 170001   eukaryotic translation initiation factor   2.34E−04   1.08       413580   T64632   Hs. 202974   ESTs, Weakly similar to B57785 zinc fing   1.99E−03   1.08       443084   AI827639   Hs. 125539   ESTs   1.18E−03   1.08       434724   AA644555   Hs. 136568   ESTs   3.11E−03   1.08       429292   AW161453   Hs. 198767   COP9 (constitutive photomorphogenic, Ara   2.29E−09   1.08       423120   AW160551   Hs. 124021   soggy-1 gene   1.53E−03   1.08       433350   BE563152   Hs. 10362     Homo sapiens  cDNA: FLJ20944 fis, clone A   1.35E−06   1.08       421759   AA027968   Hs. 107979   small membrane protein 1   4.31E−05   1.08       434645   AF255303   Hs. 112227   membrane-associated nucleic acid binding   1.47E−08   1.08       435632   AF220049   Hs. 43549   uncharacterized hematopoietic stem/proge   3.86E−04   1.08       410196   AI936442   Hs. 59838   hypothetical protein FLJ10808   3.40E−05   1.08       430010   AI434760   Hs. 279949   KIAA1007 protein   2.32E−03   1.08       402007           C18000503: gi|8922165|ref|NP_060080.1| h   3.30E−03   1.08       423303   AW593818   Hs. 186421   ESTs   6.72E−03   1.08       445529   H14421   Hs. 180513   ATP-binding cassette, sub-family A (ABC1   2.31E−04   1.08       414038   BE242722   Hs. 180040   hypothetical protein FLJ22439   3.84E−05   1.08       456640   AW207000   Hs. 126857     Homo sapiens  cDNA FLJ12936 fis, clone NT   2.91E−07   1.08       450649   NM_001429   Hs. 25272   E1A binding protein p300   3.10E−03   1.08       422461   NM_003417   Hs. 117077   zinc finger protein 264   4.28E−04   1.08       411850   AK002033   Hs. 72782   hypothetical protein FLJ11171   6.36E−04   1.08       433847   AA610266   Hs. 3631   ESTs   5.50E−04   1.08       431049   AA846576   Hs. 103267   hypothetical protein FLJ22548 similar to   1.17E−05   1.08       400967           Target Exon   2.95E−03   1.08       415987   R41275   Hs. 346886   gb: yf85c07.s1 Soares infant brain 1NIB H   2.19E−04   1.08       414427   L19711   Hs. 76111   dystroglycan 1 (dystrophin-associated gl   5.18E−07   1.08       416039   AA376989   Hs. 78989   alcohol dehydrogenase 5 (class III), chi   2.67E−05   1.08       438951   U51336   Hs. 6453   inositol 1,3,4-triphosphate 5/6 kinase   7.07E−04   1.08       427979   BE379776   Hs. 181309   proteasome (prosome, macropain) subunit.   1.02E−05   1.08       419852   AW503756   Hs. 286184   hypothetical protein dJ551D2.5   8.58E−06   1.08       456115   F01082   Hs. 172004   titin   3.41E−03   1.08       416396   R91986   Hs. 209508   ESTs, Moderately similar to ALU1_HUMAN A   7.17E−05   1.08       419080   AW150835   Hs. 18878   hypothetical protein FLJ21620   3.78E−05   1.08       421013   M62397   Hs. 1345   mutated in colorectal cancers   9.61E−04   1.08       425465   L18964   Hs. 1904   protein kinase C, iota   1.12E−04   1.08       433198   AA992841   HS27263   KIAA1458 protein   4.26E−03   1.08       456792   BE502835   Hs. 15463     Homo sapiens , clone IMAGE: 2959994, mRNA   2.30E−05   1.08       424904   AI221739   Hs. 96899   ESTs   2.08E−03   1.08       439655   AI925740   Hs. 91559   ESTs, Weakly similar to S72576 hypotheti   2.14E−03   1.08       409026   AL137554   Hs. 49927   protein kinase NYD-SP15   9.99E−05   1.08       430715   AC004908         Homo sapiens  PAC clone RP5-855D21   2.72E−06   1.08       456647   AI252640   Hs. 110364   peptidylprolyl isomerase C (cyclophilin   4.65E−06   1.08       429261   AW176254   Hs. 342389   ESTs   3.21E−03   1.08       451813   NM_16117   Hs. 27182   phospholipase A2-activating protein   7.17E−05   1.07       438117   AA328041   Hs. 194329   hypothetical protein FLJ21174   6.88E−07   1.07       451326   AW296946   Hs. 256078   ESTs   5.35E−05   1.07       425116   AU076686   Hs. 154668   KIAA0391 gene product   1.18E−03   1.07       451938   AI354355   Hs. 16697   down-regulator of transcription 1, TBP-b   1.61E−06   1.07       450234   AI688524       ESTs   2.54E−04   1.07       411739   AW859623   Hs. 8262   lysosomal-associated membrane protein 2   1.96E−03   1.07       445372   N36417   Hs. 144928   ESTs   1.34E−03   1.07       421522   R48881   Hs. 102991   hypothetical protein FLJ13956   9.67E−03   1.07       419426   AI214690   Hs. 346257   aldo-keto reductase family 1, member B1   2.34E−05   1.07       459126   AA478866   Hs. 288809   hypothetical protein FLJ20159   2.40E−04   1.07       417395   BE564245   Hs. 82084   integrin beta 3 binding protein (beta3-e   9.69E−03   1.07       445133   AW157646   Hs. 198689   ESTs   3.39E−03   1.07       417688   R09170   Hs. 284350   ESTs   1.12E−05   1.07       432858   BE618609   Hs. 279591     Homo sapiens  clone 25056 mRNA sequence   3.83E−05   1.07       439363   AW979183   Hs. 292414   ESTs, Weakly similar to I38022 hypotheti   8.83E−03   1.07       452260   AA453208   Hs. 330994   RAB9, member RAS oncogene family   4.08E−05   1.07       449838   AB020653   Hs. 24024   KIAA0846 protein   9.84E−04   1.07       451900   AB023199   Hs. 27207   KIAA0982 protein   8.47E−07   1.07       450014   N41322   Hs. 18441   ESTs   2.19E−06   1.07       414257   AI828600   Hs. 21124   ESTs, Weakly similar to ALU8_HUMAN ALU S   8.09E−05   1.07       424906   AI566086   Hs. 153716     Homo sapiens  mRNA for Hmob33 protein, 3′   5.69E−04   1.07       404497           Target Exon   5.11E−04   1.07       448598   NM_005701   Hs. 21577   RNA, U transporter 1   4.71E−07   1.07       423767   H18283   Hs. 132753   F-box only protein 2   3.06E−04   1.07       454514   AW802838       gb: IL2-UM0076-130500-084-B12 UM0076 Homo   5.61E−04   1.07       441356   BE384361   Hs. 182885   ESTs, Weakly similar to JC5024 UDP-galac   6.59E−06   1.07       426378   U80082   Hs. 169600   KIAA0826 protein   4.00E−04   1.07       428420   AL096858   Hs. 184245   KIAA0929 protein Msx2 interacting nuclea   8.62E−09   1.07       453827   AF201948   Hs. 35660   BUP protein   5.87E−07   1.07       454462   AW754153   Hs. 155976   cullin 4B   5.88E−03   1.07       427120   R42099   Hs. 21965   ESTs   3.67E−04   1.07       427297   AW292593   Hs. 334907     Homo sapiens , clone MGC: 17333, mRNA, com   3.42E−06   1.07       408876   AI961060   Hs. 129908   KIAA0591 protein   4.75E−04   1.07       445929   AI089660   Hs. 323401   dpy-30-like protein   1.14E−05   1.07       457913   AA748613   Hs. 311977   ESTs, Highly similar to SWI/SNF related,   4.55E−03   1.07       409278   AA346683   Hs. 52763   anaphase-promoting complex subunit 7   1.06E−03   1.07       430939   AI269471   Hs. 187018   ESTs   5.61E−03   1.07       450943   AA020964   Hs. 24734   oxysterol binding protein   6.29E−03   1.07       449893   T97999   Hs. 18214   ESTs, Weakly similar to B34087 hypotheti   1.03E−03   1.07       428821   H91282   Hs. 286232     Homo sapiens  cDNA: FLJ23190 fis, clone L   4.16E−03   1.07       449540   AA001713       gb: zh86e08.s1 Soares_fetal_liver_spleen —     1.69E−03   1.07       447060   H79103   Hs. 270997   ESTs, Weakly similar to S47072 finger pr   9.50E−05   1.07       404692           Target Exon   4.70E−04   1.07       421307   BE539976   Hs. 103305     Homo sapiens  mRNA; cDNA DKFZp434B0425 (f   1.04E−04   1.07       440523   AW501153   Hs. 7243   ubiquitin specific protease 24   8.40E−07   1.07       418627   AL079835   Hs. 86858   ribosomal protein S6 kinase, 70 kD, polyp   2.28E−05   1.07       439427   AA938150   Hs. 190534   ESTs   4.17E−04   1.07       451923   BE019040   Hs. 27258   calcyclin binding protein   3.75E−05   1.07       405166           Target Exon   1.21E−03   1.06       434825   N87549   Hs. 125287   zinc finger protein ZNF140-like protein   3.48E−06   1.06       425395   NM_014102   Hs. 156243   PRO1848 protein   1.37E−05   1.06       422008   AJ000534   Hs. 110708   sarcoglycan, epsilon   1.10E−05   1.06       407656   AW747986   Hs. 37443     Homo sapiens  mRNA; cDNA DKFZp434B2119 (f   1.28E−05   1.06       433935   AF112208   Hs. 44163   13 kDa differentiation-associated protein   8.27E−07   1.06       446045   AV656268   Hs. 209153   angiopoietin-like 3   7.72E−05   1.06       444156   AW500059       ESTs, Highly similar to AF219140 1 gastr   1.00E−04   1.06       407621   AA128805   Hs. 6815     Homo sapiens , clone IMAGE: 3626458, mRNA,   8.90E−07   1.06       409506   NM_006153   Hs. 54589   NCK adaptor protein 1   6.83E−03   1.06       458287   AA987556   Hs. 12867   ESTs   1.25E−03   1.06       454552   AW806924       gb: QV4-ST0023-160400-172-h10 ST0023 Homo   5.69E−03   1.06       408931   AA251995   Hs. 334648   poly(A) polymerase alpha   5.04E−03   1.06       417414   AA434589       dUTP pyrophosphatase   1.69E−04   1.06       405270           NM_018850*:  Homo sapiens  ATP-binding cass   5.68E−03   1.06       421544   AK001445   Hs. 105633   hypothetical protein FLJ10583   7.06E−04   1.06       449881   Z28444   Hs. 24119     Homo sapiens  mRNA; cDNA DKFZp586G2222 (f   1.68E−04   1.06       450295   AI766732   Hs. 210628   ESTs   2.38E−03   1.06       413530   AA130158   Hs. 19977   ESTs, Moderately similar to ALU8_HUMAN A   9.93E−04   1.06       422622   AW753452   Hs. 118757   enhancer of rudimentary (Drosophila) horn   6.78E−04   1.06       410602   AI370306   Hs. 158622   ESTs   4.91E−04   1.06       453959   Z18859       guanine nucleotide binding protein (G pr   4.95E−04   1.06       436503   AJ277750   Hs. 183924   ubiquitin associated and SH3 domain cont   9.83E−04   1.06       424459   R56570   Hs. 50547   ESTs   1.03E−03   1.06       433230   AW136134   Hs. 220277   ESTs   1.55E−05   1.06       453436   AW504292   Hs. 193261   ESTs   1.05E−04   1.06       459097   AW062839   Hs. 154230   nuclear domain 10 protein   5.24E−03   1.06       426934   AI301623   Hs. 172918   hypothetical protein   1.56E−05   1.06       449240   AF107455   Hs. 334540     Homo sapiens , clone IMAGE: 4138787, mRNA,   3.35E−03   1.06       439195   H89360       gb: yw28d08.s1 Morton Fetal Cochlea Homo   2.58E−03   1.06       440367   BE091101   Hs. 188606   ESTs   1.63E−05   1.06       431689   AA305688   Hs. 267695   UDP-Gal: betaGlcNAc beta 1,3-galactosyltr   8.24E−03   1.06       409598   NM_014018   Hs. 55097   mitochondrial ribosomal protein S28   1.16E−06   1.06       402109           Target Exon   547E−03   1.06       437207   T27503   Hs. 15929   hypothetical protein FLJ12910   8.55E−05   1.06       430607   AW973521   Hs. 247324   mitochondrial ribosomal protein S14   5.97E−04   1.06       420893   AK001326   Hs. 100090   tetraspan 3   1.73E−06   1.06       422868   AA425589   Hs. 121076   peptidylprolyl isomerase (cyclophilin)-l   1.42E−05   1.06       418977   AA233094   Hs. 191517   ESTs   2.97E−03   1.06       411388   X72925   Hs. 69752   desmocollin 1   1.80E−03   1.06       440417   AW298070   Hs. 278675   ESTs   1.24E−04   1.06       448780   W92071   Hs. 22033   Human DNA sequence from clone 366N23 on   6.62E−06   1.06       452405   AW451241   Hs. 225641   hypothetical protein FLJ13171   4.88E−07   1.06       439259   BE464643   Hs. 242322   ESTs   1.85E−03   1.05       423652   AF052122   Hs. 130712     Homo sapiens  clone 23929 mRNA sequence   1.77E−03   1.05       409939   AA463437   Hs. 11556     Homo sapiens  cDNA FLJ12566 fis, clone NT   9.73E−06   1.05       403363           Target Exon   6.72E−03   1.05       406023           Target Exon   5.18E−04   1.05       416363   T78325   Hs. 81001   F-box only protein 25   6.64E−03   1.05       441736   AW292779   Hs. 8182   ESTs   2.58E−03   1.05       403185           Target Exon   5.61E−04   1.05       432538   BE258332   Hs. 278362   male-enhanced antigen   9.50E−04   1.05       447042   AB035863   Hs. 182217   succinate-CoA ligase, ADP-forming, beta   1.08E−06   1.05       450631   AW139773   Hs. 246827   ESTs   8.76E−03   1.05       453195   BE241876   Hs. 32352   hypothetical protein DKFZp434K1210   1.16E−04   1.05       407596   R86913   Hs. 107622   gb: yq30f05.r1 Soares fetal liver spleen   2.86E−03   1.05       431752   AW337166   Hs. 43018   ESTs   4.94E−04   1.05       445637   W58459   Hs. 8949   hypothetical protein MGC4172   4.47E−05   1.05       424285   BE207168   Hs. 144630   nuclear receptor subfamily 2, group F, m   2.95E−04   1.05       408395   BE072425   Hs. 44579   hypothetical protein FLJ20199   8.66E−05   1.05       420825   AI656727   Hs. 194657   gb: tt53f12.x1 NCI_CGAP_GC6  Homo sapiens     1.85E−05   1.05       414291   AI289619   Hs. 13040   G protein-coupled receptor 86   2.40E−06   1.05       406922   S70284   Hs. 119597   gb: stearoyl-CoA desaturase [human, adipo   2.97E−04   1.05       438805   AA826048   Hs. 117887   ESTs   8.57E−04   1.05       400223           Eos Control   1.09E−04   1.05       432332   AA305351   Hs. 274369   uncharacterized hypothalamus protein HAR   2.30E−03   1.05       413628   L42542   Hs. 75447   ralA binding protein 1   1.23E−07   1.05       454067   AA041455       ESTs   2.09E−04   1.05       442965   AL134235   Hs. 222442   ESTs   8.21E−03   1.05       422174   AL049325   Hs. 112493     Homo sapiens  mRNA; cDNA DKFZp564D036 (fr   1.08E−03   1.05       431799   AK000283   Hs. 270502   hypothetical protein FLJ20276   1.53E−03   1.05       413004   T35901   Hs. 75117   interleukin enhancer binding factor 2, 4   1.60E−03   1.05       442092   AW578669       hypothetical protein FLJ12439   6.77E−04   1.05       424201   L33075   Hs. 1742   IQ motif containing GTPase activating pr   2.54E−04   1.05       415673   BE242249   Hs. 78592   eukaryotic translation initiation factor   4.67E−05   1.05       424909   S78187   Hs. 153752   cell division cycle 25B   3.66E−05   1.05       432467   T03667   Hs. 239388   Human DNA sequence from clone RP1-304B14   3.85E−03   1.05       429623   NM_005308   Hs. 211569   G protein-coupled receptor kinase 5   6.02E−03   1.05       403611           NM_017886*:  Homo sapiens  hypothetical pro   4.13E−04   1.05       449517   AW500106   Hs. 23643   serine/threonine protein kinase MASK   8.52E−05   1.05       422480   AB029016   Hs. 117333     Homo sapiens  mRNA for KIAA1093 protein,   8.52E−03   1.05       440719   AA150869   Hs. 26267   ATP-dependant interferon response protei   6.72E−03   1.05       420520   AK001978   Hs. 98510   similar to rab11-binding protein   1.06E−04   1.05       409439   AW390511   Hs. 288862     Homo sapiens  cDNA: FLJ21260 fis, clone C   2.58E−03   1.05       430504   H52761         Homo sapiens , clone MGC: 12617, mRNA, com   9.26E−05   1.05       429750   AB007916   Hs. 214646   KIAA0447 gene product   3.20E−05   1.05       438887   R68857   Hs. 265499   ESTs   5.09E−04   1.05       447726   AL137638   Hs. 19368   matrilin 2   2.15E−03   1.05       448859   BE272446   Hs. 265317   hypothetical protein MGC2562   8.34E−04   1.05       409132   AJ224538   Hs. 50732   protein kinase, AMP-activated, beta 2 no   9.27E−09   1.04       446838   AW978336   Hs. 20999   nucleolar protein p40; homolog of yeast   6.42E−05   1.04       426441   AA297257   Hs. 169907   glutathione S-transferase A4   4.55E−05   1.04       458096   AF052138   Hs. 6580     Homo sapiens  cDNA: FLJ23227 fis, clone C   6.20E−04   1.04       406731   AI559131       gb: tq31g07.x1 NCI_CGAP_Ut1  Homo sapiens     3.80E−04   1.04       403707           Target Exon   9.16E−03   1.04       451572   AA018556   Hs. 268691   ESTs, Moderately similar to ALU2_HUMAN A   2.08E−04   1.04       434959   AW974949   Hs. 186564   ESTs, Weakly similar to I38022 hypotheti   8.06E−03   1.04       439802   R06364   Hs. 18001   ESTs   1.02E−07   1.04       457447   X78261         H. sapiens  mRNA for TRE17 5′ extremity an   1.60E−03   1.04       425866   BE270097   Hs. 159971   SWI/SNF related, matrix associated, acti   2.57E−03   1.04       416065   BE267931   Hs. 78996   proliferating cell nuclear antigen   1.96E−07   1.04       426506   AW935187   Hs. 170162   KIAA1357 protein   7.93E−06   1.04       424088   AL049942   Hs. 139240   DKFZP564F1422 protein   2.35E−04   1.04       438374   AA321866   Hs. 6193   hypothetical protein FLJ14590   4.88E−03   1.04       455833   BE145360   Hs. 190064   ESTs, Weakly similar to I38022 hypotheti   1.77E−03   1.04       407874   AI766311   Hs. 289047     Homo sapiens  cDNA FLJ14059 fis, clone HE   1.27E−08   1.04       432656   NM_000246   Hs. 3076   MHC class II transactivator   1.71E−03   1.04       413781   J05272   Hs. 850   IMP (inosine monophosphate) dehydrogenas   6.46E−03   1.04       449865   AW204272   Hs. 199371   ESTs   1.78E−08   1.04       452420   BE564871   Hs. 29463   centrin, EF-hand protein, 3 (CDC31 yeast   1.33E−06   1.04       423314   AI400661   Hs. 127811   disintegrin metalloproteinase with throm   1.34E−03   1.04       443303   U67319   Hs. 9216   caspase 7, apoptosis-related cysteine pr   1.41E−06   1.04       456175   BE241702   Hs. 79402   polymerase (RNA) II (DNA directed) polyp   8.45E−03   1.04       420179   N74530   Hs. 21168   ESTs   7.87E−04   1.04       410209   AI583661   Hs. 60548   hypothetical protein PRO1635   5.97E−04   1.04       434148   AW291716   Hs. 116113     Homo sapiens  cDNA FLJ14182 fis, clone NT   1.60E−03   1.04       459274   AA382590   Hs. 46366   KIAA0948 protein   1.05E−06   1.04       450848   AI677994   Hs. 428   fms-related tyrosine kinase 3 ligand   5.70E−04   1.04       411580   AL080088   Hs. 70877   DKFZP564K2062 protein   3.19E−06   1.04       436523   BE612990   Hs. 5212   single-strand selective monofunctional u   3.67E−03   1.04       428137   AA421792   Hs. 170999   ESTs   8.38E−04   1.04       426494   AL119528   Hs. 170098   KIAA0372 gene product   1.22E−03   1.04       434805   AW974666   Hs. 293024   ESTs   3.83E−03   1.04       455679   BE066529       gb: RC3-BT0333-300300-017-a12 BT0333 Homo   5.56E−04   1.04       437739   AW579216   Hs. 264610   ESTs, Moderately similar to Ibd1 [H. sapi   3.46E−05   1.04       412672   AA158910   Hs. 74441   chromodomain helicase DNA binding protei   2.77E−03   1.04       447749   T53260   Hs. 191091   ESTs   4.48E−05   1.04       452461   N78223   Hs. 108106   transcription factor   7.56E−04   1.04       447915   AW450650   Hs. 20013   GCIP-interacting protein p29   1.82E−05   1.04       447030   AW444659   Hs. 232184   ESTs   9.89E−03   1.04       430919   AA489041   Hs. 295448   ESTs   1.01E−03   1.04       406684   X16354   Hs. 50964   carcinoembryonic antigen-related cell ad   4.34E−04   1.03       433882   U90441   Hs. 3622   procollagen-proline, 2-oxoglutarate 4-di   2.44E−04   1.03       430534   AA480908       gb: aa28f09.s1 NCI_CGAP_GCB1  Homo sapiens     3.51E−03   1.03       413010   AA393273   Hs. 75133   transcription factor 6-like 1 (mitochond   1.08E−05   1.03       409490   AA075064       gb: zm85e12.s1 Stratagene ovarian cancer   2.11E−03   1.03       422231   AA443512   Hs. 101383   ESTs   3.11E−04   1.03       425376   H10612       gb: ym08f03.r1 Soares infant brain 1NIB H   2.49E−03   1.03       434733   AI334367   Hs. 159337   ESTs   1.56E−04   1.03       425973   BE379570   Hs. 165439   arsA (bacterial) arsenite transporter, A   1.41E−03   1.03       458477   NM_000314   Hs. 10712   phosphatase and tensin homolog (mutated   2.73E−04   1.03       440708   AF038962   Hs. 7381   voltage−dependent anion channel 3   1.07E−04   1.03       412338   AA151527   Hs. 69485   hypothetical protein FLJ12436   1.38E−05   1.03       424277   AA338057   Hs. 29131   nuclear receptor coactivator 2   1.94E−03   1.03       427625   AF008216   Hs. 285013   putative human HLA class II associated p   2.54E−03   1.03       410017   AW952426   Hs. 109438     Homo sapiens  clone 24775 mRNA sequence   6.00E−06   1.03       404124           Target Exon   6.53E−04   1.03       446895   AA166655   Hs. 26860   ESTs   8.18E−05   1.03       448848   AF131851   Hs. 22241   hypothetical protein   1.70E−03   1.03       403292           Target Exon   4.58E−03   1.03       425728   T84535   Hs. 303001     Homo sapiens  cDNA: FLJ21335 fis, clone C   3.27E−03   1.03       437440   AA846804       ESTs   1.45E−03   1.03       433486   AW976937   Hs. 54452   ESTs, Weakly similar to T00329 hypotheti   7.37E−06   1.03       445790   AV655170   Hs. 49015   chromosome 21 open reading frame 35   4.70E−03   1.03       424139   D86979   Hs. 141296   KIAA0226 gene product   1.13E−05   1.03       451658   AW195351   Hs. 250520   ESTs, Moderately similar to I38022 hypot   7.97E−06   1.03       458409   AV645567   Hs. 120391   ESTs   7.85E−04   1.03       425210   AA054679   Hs. 155150   ribonuclease P (14 kD)   1.78E−03   1.03       429762   AI346255   Hs. 216354   ring finger protein 5   5.43E−06   1.03       449578   AL050331   Hs. 284141   KIAA0721 protein   5.02E−06   1.03       440244   AI743977   Hs. 205144   ESTs   5.07E−04   1.03       453784   AA456246   Hs. 271541     Homo sapiens  cDNA FLJ11653 fis, clone HE   3.05E−04   1.03       453327   AW500180       tryptophanyl-tRNA synthetase   1.81E−05   1.03       422298   NM_005683   Hs. 114545   G protein-coupled receptor 55   1.63E−04   1.03       428384   M54968       v-Ki-ras2 Kirsten rat sarcoma 2 viral on   7.06E−04   1.03       447982   H22953   Hs. 137551   ESTs   1.77E−05   1.03       436911   AA142984   Hs. 5344   adaptor-related protein complex 1, gamma   1.96E−03   1.03       421873   AI132988   Hs. 109052   chromosome 14 open reading frame 2   2.16E−05   1.03       432221   M21191   Hs. 273415   aldolase A, fructose-bisphosphate   4.65E−03   1.03       403027           C21000364*: gi|8394509|ref|NP_058778.1|u   2.37E−04   1.03       449845   AW971183   Hs. 6019   DnaJ (Hsp40) homolog, subfamily C, membe   1.48E−05   1.03       447221   AB007861   Hs. 17803   KIAA0401 protein   1.88E−05   1.03       419725   U66048   Hs. 92683     Homo sapiens  clone 161455 breast express   1.11E−05   1.03       456863   T16837   Hs. 4241   ESTs   1.83E−05   1.03       430599   NM_004855   Hs. 247118   phosphatidylinositol glycan, class B   1.54E−04   1.03       426295   AW367283       zinc finger protein 6 (CMPX1)   1.72E−06   1.03       414312   AA155694   Hs. 191060   ESTs   1.81E−04   1.03       428484   AF104032   Hs. 184601   solute carrier family 7 (cationic amino   9.02E−08   1.03       452019   AL157503   Hs. 27552     Homo sapiens  mRNA; cDNA DKFZp586N2424 (f   6.94E−04   1.02       445896   W37944   Hs. 4007   Sarcolemmal-associated protein   8.01E−04   1.02       452606   N45202   Hs. 90012   hypothetical protein FLJ23441   9.66E−04   1.02       438940   AF075045   Hs. 271609   ESTs   5.84E−04   1.02       436685   W28661   Hs. 5288     Homo sapiens  mRNA; cDNA DKFZp434M245 (fr   1.76E−05   1.02       407233   X16354   Hs. 50964   carcinoembryonic antigen-related cell ad   6.24E−04   1.02       432021   AA524470   Hs. 58753   ESTs   1.30E−04   1.02       444239   R57988   Hs. 10706   epithelial protein lost in neoplasm beta   2.69E−03   1.02       444461   R53734   Hs. 25978   ESTs, Weakly similar to 2109260A B cell   4.54E−03   1.02       439467   AW292275   Hs. 158365   ESTs   4.93E−03   1.02       417713   D42047   Hs. 82432   KIAA0089 protein   7.09E−04   1.02       443968   AA287702   Hs. 10031   KIAA0955 protein   2.40E−03   1.02       411400   AA311919   Hs. 69851   nucleolar protein family A, member 1 (H/   1.09E−05   1.02       406535           Target Exon   2.33E−05   1.02       426007   AA724983   Hs. 144743   ESTs, Weakly similar to AD08_HUMAN ADAM   4.26E−04   1.02       408103   AA992592   Hs. 42712   MAX protein   1.83E−08   1.02       436024   AI800041       ESTs   1.16E−05   1.02       448393   AW117691   Hs. 224517   ESTs, Moderately similar to hypothetical   5.08E−04   1.02       410277   R88621   Hs. 26249   ESTs, Weakly similar to T2D3_HUMAN TRANS   2.62E−03   1.02       443985   BE613332   Hs. 132055   ESTs, Weakly similar to GNMSLL retroviru   5.17E−03   1.02       420168   AF217508   Hs. 95594   serine carboxypeptidase vitellogenic-lik   7.46E−06   1.02       458649   AI291047   Hs. 49053   ESTs   1.64E−03   1.02       439462   AL133026   Hs. 6567     Homo sapiens  mRNA; cDNA DKFZp434C136 (fr   1.26E−04   1.02       439871   R88518   Hs. 46736   hypothetical protein FLJ23476   5.31E−03   1.02       443724   AA446783   Hs. 288932   hypothetical protein FLJ13194   1.35E−03   1.02       408627   BE313882   Hs. 46659   DKFZP58612223 protein   3.10E−03   1.02       443291   AA325633   Hs. 136102   KIAA0853 protein   4.07E−04   1.02       441243   AI767056   Hs. 193002   ESTs   1.55E−03   1.02       419881   AA329340       mannosyl (alpha-1,3-)-glycoprotein beta-   3.38E−05   1.02       438081   H49546   Hs. 251391   claudin 16   3.84E−03   1.02       423456   AL110151   Hs. 128797   DKFZP586D0824 protein   3.80E−06   1.02       422090   W05345   Hs. 293884   ESTs   1.52E−05   1.02       433920   NM_000430   Hs77318   platelet-activating factor acetylhydrola   2.37E−04   1.02       411142   NM_014256   Hs. 69009   transmembrane protein 3   7.98E−04   1.02       437119   AI379921   Hs. 177043   ESTs   5.38E−04   1.02       414022   W44916       myosin regulatory light chain 2, smooth   2.93E−03   1.02       415524   F11541       gb: HSC2YD011 normalized infant brain cDN   5.94E−03   1.02       442119   AW970826   Hs. 6185   KIAA1557 protein   2.43E−03   1.02       440865   AI281525   Hs. 130180   ESTs   2.56E−03   1.02       449227   AJ403106   Hs. 121824   ESTs   3.98E−03   1.02       426224   BE085860   Hs. 168075   karyopherin (importin) beta 2   9.60E−07   1.02       435272   AA906415   Hs. 110041   ESTs   2.06E−03   1.02       449269   AI564682   Hs. 175870   ESTs   3.26E−05   1.02       438685   AA814034   Hs. 123581   ESTs   1.79E−03   1.02       422558   NM_006420   Hs. 118249   brefeldin A-inhibited guanine nucleotide   5.07E−05   1.02       441244   BE612935   Hs. 184052   PP1201 protein   1.09E−04   1.02       420473   AL118782   Hs. 300208   Sec23-interacting protein p125   2.28E−03   1.02       445504   NM_006590   Hs. 12820   SnRNP assembly defective 1 homolog   4.35E−03   1.02       437952   D63209   Hs. 5944   solute carrier family 11 (proton-coupled   7.25E−09   1.02       431109   AA492271   Hs. 143672   ESTs   3.55E−05   1.02       418535   R98238   Hs. 268874   ESTs, Weakly similar to ZN91_HUMAN ZINC   2.05E−03   1.02       425245   AI751768   Hs. 155314   KIAA0095 gene product   1.68E−05   1.02       445903   AI347487   Hs. 132781   class I cytokine receptor   4.56E−04   1.02       445558   R99105   Hs. 173522   ESTs   3.62E−03   1.01       410625   AI753267   Hs. 15220   zinc finger protein 106   5.62E−03   1.01       409162   H25530   Hs. 50868   solute carrier family 22 (organic cation   1.30E−04   1.01       411990   AW963624   Hs. 31707   ESTs, Weakly similar to YEW4_YEAST HYPOT   2.38E−04   1.01       419497   NM_006410   Hs. 90753   Tat-interacting protein (30 kD)   9.78E−05   1.01       428974   AA442693   Hs. 272006   ESTs, Weakly similar to I38022 hypotheti   3.99E−07   1.01       435014   BE560898   Hs. 10026   mitochondrial ribosomal protein L17   3.50E−03   1.01       430268   AK000737   Hs. 237480   hypothetical protein FLJ20730   1.21E−05   1.01       408340   AB037762   Hs. 44268   myelin gene expression factor 2   2.84E−06   1.01       410576   AI421612   Hs. 30864   ESTs   3.10E−03   1.01       444187   AW138466   Hs. 151274   ESTs   1.63E−03   1.01       430487   D87742   Hs. 241552   KIAA0268 protein   1.29E−05   1.01       431214   AA294921   Hs. 348024   v-ral simian leukemia viral oncogene hom   4.89E−04   1.01       428592   AA479487   Hs. 105642     Homo sapiens  cDNA: FLJ23271 fis, clone H   1.27E−04   1.01       412938   AU077050   Hs. 75066   translin   3.21E−06   1.01       414355   BE272157   Hs. 75925   proteasome (prosome, macropain) inhibito   4.98E−05   1.01       424026   AI798295   Hs. 137576   ribosomal protein L34 pseudogene 1   2.24E−04   1.01       432975   AA331517   Hs. 286055   chimerin (chimaerin) 2   5.03E−03   1.01       419170   BE002798   Hs. 287850   integral membrane protein 1   3.08E−04   1.01       459428   AA258989       ESTs   5.76E−03   1.01       451579   AW607731   Hs. 26670   Human PAC clone RP3-515N1 from 22q11.2-q   4.45E−06   1.01       408128   N72794   Hs. 37716   ESTs, Weakly similar to ataxin-2-like pr   1.94E−03   1.01       412634   U55984       heat shock 90 kD protein 1, alpha   9.53E−05   1.01       425620   AA447450   Hs. 124219   hypothetical protein FLJ12934   3.30E−03   1.01       421829   AB018330   Hs. 108708   calcium/calmodulin-dependent protein kin   4.76E−05   1.01       434552   AA639618   Hs. 325116     Homo sapiens , clone MGC: 2962, mRNA, comp   3.66E−03   1.01       426348   BE466586   Hs. 17433   hypothetical protein FLJ20967   1.18E−04   1.01       458984   AA011185   Hs. 221189   hypothetical protein FLJ14431   3.93E−04   1.01       420112   NM_005109   Hs. 95220   oxidative-stress responsive 1   4.32E−03   1.01       437142   AI791617   Hs. 145068   ESTs, Moderately similar to A46010 X-lin   2.45E−04   1.01       410913   AL050367   Hs. 66762     Homo sapiens  mRNA; cDNA DKFZp564A026 (fr   6.41E−05   1.01       422749   W01076   Hs. 278573   CD59 antigen p18-20 (antigen identified   7.76E−03   1.01       456926   AB018284   Hs. 158688   KIAA0741 gene product   5.40E−06   1.01       444745   AF117754   Hs. 11861   thyroid hormone receptor-associated prot   8.02E−05   1.01       416721   H80001       gb: ys65d09.r1 Soares retina N2b4HR Homo   4.32E−05   1.01       425218   NM_014909   Hs. 155182   KIAA1036 protein   4.15E−03   1.01       415724   NM_003580   Hs. 78687   neutral sphingomyelinase (N-SMase) activ   3.02E−06   1.01       419013   T90378   Hs. 14463   ESTs   2.26E−03   1.01       440461   R52728   Hs. 7193   KIAA1183 protein   4.24E−04   1.01       445760   AW370515   Hs. 13273   KIAA0592 protein   9.19E−07   1.01       422732   AA577455   Hs. 24937   transformer-2 alpha (htra-2 alpha)   3.04E−04   1.01       453528   AL137459   Hs. 33104   Huntingtin interacting protein C   5.40E−05   1.01       454900   AW838129       gb: QV2-LT0051-240300-097-g12 LT0051 Homo   7.63E−03   1.01       421395   D90084   Hs. 1023   pyruvate dehydrogenase (lipoamide) alpha   3.22E−04   1.01       414662   AL036058   Hs. 76807   major histocompatibility complex, class   6.04E−04   1.01       433505   AW504027   Hs. 15301     Homo sapiens  cDNA FLJ12596 fis, clone NT   2.97E−05   1.01       431712   R26584   Hs. 267993   hypothetical protein FLJ10143   2.30E−05   1.01       432145   AB040890   Hs. 272759   KIAA1457 protein   1.58E−03   1.01       432878   BE386490   Hs. 279663   Pirin   3.32E−06   1.01       412025   AI827451   Hs. 24143   Wiskott-Aldrich syndrome protein interac   8.61E−06   1.00       408988   AL119844   Hs. 49476     Homo sapiens  clone TUA8 Cri-du-chat regi   5.19E−04   1.00       430408   AA478540   Hs. 108336   ESTs, Weakly similar to ALUE_HUMAN !!!!   1.07E−05   1.00       419021   AI908330   Hs. 10554   hypothetical protein FLJ12761   2.11E−07   1.00       447188   H65423   Hs. 17631   hypothetical protein DKFZp434E2135   6.76E−04   1.00       409065   AB033113   Hs. 50187   KIAA1287 protein   1.25E−04   1.00       410868   T06529   Hs. 98518     Homo sapiens  cDNA FLJ11490 fis, clone HE   5.88E−04   1.00       442462   AF031405       gb: AF031405 Soares fetal liver spleen 1N   1.37E−03   1.00       434665   AA642125       gb: nr60c01.s1 NCI_CGAP_Lym3  Homo sapiens     8.06E−03   1.00       435869   AF255910   Hs. 54650   junctional adhesion molecule 2   8.84E−04   1.00       405922           Target Exon   2.64E−03   1.00       400239           NM_001610:  Homo sapiens  acid phosphatase   2.26E−04   1.00       419632   AK000155   Hs. 91684     Homo sapiens  mRNA; cDNA DKFZp667I103 (fr   5.91E−03   1.00       431857   W19144   Hs. 271742   ADP-ribosyltransferase (NAD; poly (ADP-r   8.59E−06   1.00       438543   AA810141   Hs. 192182   ESTs   2.40E−06   1.00       458430   AV646505   Hs. 122155   ESTs   6.08E−03   1.00       445106   T10219   Hs. 12329   KIAA0697 protein   2.01E−04   1.00       422926   NM_016102   Hs. 121748   ring finger protein 16   3.85E−03   1.00       443956   Z45647   Hs. 107968   ESTs   3.22E−03   1.00       453128   AW026516   Hs. 31791   acylphosphatase 2, muscle type   2.24E−04   1.00       431195   AA503083   Hs. 79742   ESTs, Weakly similar to T29959 DNA-direc   1.99E−03   1.00       447348   AI270615   Hs. 18192   Ser/Arg-related nuclear matrix protein (   2.85E−04   1.00       455148   AW858403       gb: CM0-CT0341-181299-130-f04 CT0341 Homo   4.78E−03   1.00       434775   AA648983       ESTs   2.20E−05   1.00       433456   AA593447   Hs. 124296   ESTs   1.75E−03   1.00       410800   BE280421   Hs. 94499   ESTs   5.76E−05   1.00       447370   AW248150   Hs. 18349   mitochondrial ribosomal protein L15   1.29E−05   1.00       406238           Target Exon   1.03E−03   1.00                                                                  
 
     [0366]                       TABLE 11B                           CAT           Pkey   Number   Accession                  414404   19538_5   BG036308 AW813969 AW579686 BE147476 AW813871 BE147474 BE147589 BE147582 AA767716 AW813960 AW813958               BE147583               AW813608 AW813612 AW813965 AW813954 BE706154 BF843546 AW813870 BE147801 AW813962 R80512 BG681408               AA344564 AW370224               BG614838 AW582118 AW582114 AW370227 W16712 BF209670 BG117739 BE762802 BE087964 BE888647 R89145               BF342601 BI752591               BG435038 AA166732 N79515 BF541709 N79567 BG503029       455705   77478_2   BF971018 BE513812 AA133359 AW581719 BF434402 AL600619 BG699731 BI551395 AW027136 AW055130 BF939512               AI076048 H18584               AW161061 AA864334 AI816101 BE049456 AW044012 AA954079 AI274682 AI370526 AW131990 AA853195 AA853191               BG118295 AA761620               BG705371 BF355591 BF336596 AA360497 H28072 BG198352 AW364709 H40926 H44214 AA836538 BI059563       437938   66997_1   U71456 AA482911 W78802 AW856538 BF737212 N36809 N35320 AA282915 AW505512 AI653832 W87891 AI961530               T85904 H59397 R97278               W01059 AI820532 T82391 AI820501 T63226 R66056 R67840 AW961101 AA337499 W37181 AA180009 AW205862               AA988777 AA856975               BF172457 BG751124 AI741346 AI950344 AI689062 AI872193 AW102898 AW173586 AI763273 AI890387 AW150329               AI762688 AA488892               AI356394 AI539642 AA642789 AI950087 BF589902 N70208 AA283144 AA488964 H60052 R97040 BF886630 AW967677               AW971573 AW967671               AI308119 AA251875 AA908598 AI819225 AI564269 AA908741 AA293273 AA969759 AW276905 AA044209 H83488               T92487       452194   90339_1   AI694413 AW994700 AI912946 N73548 AI082035 AW271652 W24189 W24182 AI719718 AA024658               AW810120 AW015394               T79755 AA988043               AI709339       437834   294580_1   BG110129 AW749287 BE535498 AW749299 AW749293 AW749302 AW749298 AW749291 AW749294               AW749289 AW749288               AW749296               AA769294 AW749297 AW749295 AW749292 BE002573       419200   9531_1   BF036043 AW190446 BG194731 AW662036 AI445021 BE937550 AW818972 AW393132 AA834685 BF112058 AV721682               H16423 AI270167               AI857345 AA937302 AW818444 BE929780 BG498678 BF155010 BI598271 BI599811 BE161728 AW578737 AW753711               AW379707 AW381918               BG506608 AW028637 AW994240 BF887392 BF790073 AW381624 AV727105 BF439618 AA443174 AI018009 N42850               AW573242 AI417258               AA463483 AI676131 AI167170 AA836627 AA443828 AW592922 AA235129 AA730278 AW439062 AW474332 BI043239               AW474342 BG708553               AW362423 BF090028 BE827256 R16550 R39478 R39479 R94368 BG540916 BM314745 AA251087 D54231 D55274               BF085805 D31589               AW966405 AW994425 D81879 BE093545 AW901107 AA383529 BI021552 R56420 N39976 AA573281 H82595 AA234955               BE093539 AW367006               BF358697 BF366318 AA663856 BE702099 BF035969 AI267384 AI267232 BE348320 AA621574 AA861212 BF083343               BF083341 AV745131               D53074 AW954476 AW954472 AA376836 AV724531 D53063 C14928 AA093287 AA062638 BG483558 BE940050               AA765954               T70171 BE938775               BE940057 053502 AW373300 AL118798 BM128728 AA193411 AW444709 AW952455 AI887612 BF431948 BI496876               AI264159 BM128481               AI624657 AI689301 AI969467 AA861685 AA251595 AA625761 AA872090 AI826790 AA328366 BE827416 R75951               D56918 R68122 BE827384               AL118797 AI184164 AA164411 BI495332 BE858113 AI863860 H00660 T69849 AW780389 C14667 BE934995               BI018652 R92801 AA164410               H00752 AW373305 AW373299 AW373302       434210   54921_1   AK057015 AI026834 BE857936 AA149091 AI742972 AW439172 AI253168 AA255613               BF513175 AI005006 T03406               AW338149 AA836442               AA420530 R88566 AI611672 AA433916 AA442855 BF063008 AA812568 AI889706 AA715313 AA768539 AA767620               AA665471 AA404380               AA665612 BF056442 AA706388 AI650676 AA627448 AI141769 H78227 AW901852 H78221 BE701982 BF689273               AA397464               N33072 R60218               AW968247 H14833 AA768305 AA043348 R56470 BF739832 R51827 AI474963 BG494574 AA149090 BF238154 AI802210               BE000129 BF734513               R41964 H21055 R85253 R17705 R40844 BF790218 BG388356 BF003037 AA703138 AA377348 W24822       416126   12435_2   AK057910 H24547 R46556 BI043624 H20063 R66415       406906       400244   12188_1   X79449 BC017853 AL121035 BF196384 AW119044 AI028023 AW451110 AI971911               AW015069 AI079170 AI376367               AI264113 AA829646               AA737579 AA449679 AA740864 NM_001111 U18121 AL567297 BG773801 BF973874 AV687104 AA527579               AA843525 BE706355 AI074589               AI523475 BE890249 AW406263 BE074258 AV729485 BF809610 BG058619 AA677244 BE179838 AA622264 AI460106               AA740411 AI499168               AI078223 AI682923 BE696559 AW375385 AA788739 BG984978 240874 T17054 F09669 AW844043 U10439 BI711870               AW245957 AU158567               AA679305 AA679316 W72510 AI346029 BG059762 AW251062 AA132373 AI925621 AI860230 AI340172 AW192891               AI707980 AI094937               AI042115 AI200901 BE328452 AA644678 AA551209 BE351065 AA970761 N68609 AW002028 AA160826 AI422774               AW873114 AW073597               AW664483 AI218710 AW020550 AW190607 AI984545 AI871921 AI333970 AI452887 AI818335 AA398655 AI554424               AI274187 BE465703               AW512940 AW241366 AI923954 AA576649 AW168294 AA813181 AA912168 AI049738 AW514073 AA548255 AI569630               BE710031 AA244182               AI341697 AA563904 AI537990 AW517908 AW172943 Z39498 AI750294 AW150414 AI253293 BE825720 T31860               AW150775               D20310 AA150892               AU133933 BE781148 AL038957 BF910979 AA352297 BG988142 AW372175 BF229106 AW866705 BE093482 BG990396               AI499917 AA054452               H05484 AI828502 BM467331 AU140570 AL135417 BF947202 AW391926 BE813418 BF998473 T92021 BI021048               BM048783 AW501366               AW501342 W501549 E939021 BE707147 BE160974 BE305207 N49011 AA947119 AA678801 BE536876 AW897428               BG329648 BG818540               BE542344 BI919250 BI253018 AW130996 BE074249 BE895428 BI034862 BE083277 BF952166       411837   1110600_1   AW866303 AW866402 AW866310 AW866282       406990   48529_1   S82075 AA327293       433489   1000815_1   AA594718 AI698673 AA907314 AW629150       411605   10026_3   BG256892 H10532 N46614 R52610 AW977696 BM460488 W56819 BI042183 BG977498 BE767451 BF870009 BG477472               R61137 R14274               R20259 R09686 BI838226 BF034269 AA429173 BE741829 AW867495 AI123683 AW006831 BE831162 AW452753               AV742717 W86152               BF115102 AI633815 BF921562 AA094230 BE092587 W86151 AA526153 AI672156 BF914496 R12579 BF852352 AA699780               T57386 BF903022 R09933 AA678298       420292   2556_2   AW991897 AW991891 AW991894 AW991841 AW991840 AW991777 AW991797 AW991779 AW991766               AW991774 AW991793 AW991786               AW991782 AW991773 AW991783 AW991828 BF326561 AW991887 AW991888 AW991896 AW991901 AW991893               AW991898 AW991895               AW991902 AW991899 BF326532 AW991727 AW991742 AW991731 AW991738 AW991736 AW991739 AW991740               AW991729 AW991741               AW991730 AW991733 AW991804 AW991803 AW991808 AW991805 AW991801 AW991806 AW991802 AW991798               AW991728 AW991807               AW991776 AW991714 BF326565 BF326506 AW991726 AW991734 AW991732 BF326535 AW991800 AW991809               BF326568 AW991900               BF326518 BF326524 AW991716 AW991795 AW991718       442679   31783_3   BG621493 BI056706 BG496376 R53718 W65356 R79357 BG434247 AA357769 AW978686 BG573200 BF132113               BF086709 AA366938 D79234               BG494628 AA156754 BG434311 AW978683 AW273417 BM054662 AI799886 AI433351 AI160798 AW33742               BF056186 AI281606 AW015046               AI439585 AI245530 AI078267 AA807170 AA837395 W61252 AA831085 AA287371 AW768354 AA890606 AI302539               AI708575 AI673031               AI242260 AW514069 AA283958 AA825452 AI371234 AA425696 AA453422 AA827697 R23653 D20240 AA772517 H13802               R66972 R79360               R27351 F03379 AA031952 N69504 R33143 R79358 R39136 R38800 R15089 R52937 R37502 H01021 R33634 R46551               Z40404 BG291052               BG570357 AW391046 BG496872 H23558       446526   11131_17   AK023419 BE464935 BE221668 AI148885 BI859909 AI374780 AA766892 AI347967 AI582917 AA477117               AA229236 AA652637 AA636109               AU134580 F21298 BF802607 BE769124 AV658891 H89616 AV659853       451752   10408_5   AB032997 AI141678 AW978722 BE467119 AI761408 BF727385 AW237035 AI934521 BF436248 AI479668               Z40632 AA832081               AW295901               BF057835 BE465977 AI621269 BE465983 BF756369 N74056 AI817896 AA716567 AA934774 H62600 H09497 BF943762               BE395335 BE883333       428342   6712_1   AK056315 AI015524 AA724079 BI713619 AI377728 AW293682 AI928140 AI092404 AI085630 AA731340 BM469629               AW968804               AA425658               AA769094 BF446026 AW118719 AI332765 AW500888 AW576556 AI859571 AW499664 AW614573 AW629495 AW505314               W74704 AI356361               AI923640 AW070509 AI521500 AL042095 AA609309 AA761319 AI381489 H45700 AA761333 AW265424 AA909524               AA635311 AA649040               AI392620 Z40708 AI985564 AW263513 AA913892 AI693486 AW263502 AI806164 AW291137 BI061872 BI059498               AA134476 AW084888               AA036967 AW370823 T55263 BI002756 AA489664 BF827261 W74741 BF963166       421902   276321_1   BG171436 BE079601 BE079534 AA299964 BE392717 BE883402 BE079532 BE018148 BF889427 W00396       427043   2736_6   BF511666 BF447624 BF817650 AW974087 BF437901 BE504352 AA568952 AA460669 BE220596 AA397679 AI217920               AA399531       421014   24169_1   NM_012227 Y14391 AK024630 BC014636 BG281479 AL556021 AW778818 BF196455 AW592274 AI376720               BI438310 AW511106 AW304443               AI568597 BE326797 BG056985 AI569473 AI475975 BF448109 AA853022 AI886592 BG755959 BI084711 BF683496               BE177141 AI742415               AW001158 BG747230 BI116434 AI984821 AW0816S9 AL543852 T08792 BF526529 AL582296 AA830141 AA789136               H26527 AA425013 F32744               N62859 AA535316 BE872483       455187   1107511_1   AW864071 AW864059 AW864056 AW864070 AW864050 AW864067 AW864072 AW864057 AW864065       459487   135353_1   AA699665 R84889       435374   129988_1   AI049889 AI733663 AA678730       425164   1276257_1   BM462532 R18189 R22638 R22639 AA351604 R17880       416435   18099_1   BF107196 BF804739 AA249165 AA227714 BI002580 BI254772 BE856761 AA843533 AI692783 AI769103 AI479234               BF055564 AI332623               AI560964 AI431301 BE675257 AA406642 AA707195 AI961161 AI218736 AI149261 AW474460 BE466679 AI989624               AA765123 AA180333               BF507849 AI281064 AI500253 AW468519 AI473781 AI263097 BF433898 AI912120 AI692780 AI262308 AI266734               AA923774 AA227960               BE644676 AI034302 AI352401 AI869528 AA862001 AI221573 AI565227 R60069 AW593430 N67562 AI346969               AI925794 C21540 BG291961               BG255029 BF852350 BF805364 BF852050 BE504626 BF432250 AW947402 AW071704 AW008413 BE717229 H94353       419560   16064_1   AB033081 AK074324 AW450283 BM128413 BE550945 BE670081 BE674137 AI298087 N30050 BF110807 N30072               AI288098 N30068               AW861931 AW858575 AI363734 AK025483 BF882045 BM128581 AW771330 BE669540 NM_016376 AB037360               AA399607 R94364 BE514643               BG684040 BG759578 T83725 AW858561 AW858524 H65293 AW754345 AK025960 BM477612 BE071291 BF087041               BG995615 BE071350               AI917153 AA436381 BE815318 AK025717 BE857148 AI741138 AW027718 BI789162 AI492263 AI690072 AI420179               BI789249 AI637804               AW957459 BF222458 AI094328 AW510893 AW295994 AI760430 BE464934 BE220458 AI042022 AI653315 BM128472               AW337972 AW515837               AI669489 AW664176 AI768730 AW271660 T16381 AI823834 AJ346113 AI242353 BF437578 AI273673 AW513498               AI797424 AI674242 AI277236               AW731756 AA373089 AW207589 AW467879 AL550999 N30075 BE883669 BF155456 AI423079 R60281 T16974               BG676892 BF927070               BI962758 BE811485 BE811591 BE811702 BE811600 BE811483 BE811533 BF927061 BG008257 BF873368               AL574815 BF946447 H70934               BF939868 BF378761 BE082381 BG984527 AA244447 BG983567 AW885571 AW293182 AW885607 AA811057               AA610310 AI434406 AA514352               H71020 BF740351 BE814815 N66648 AA737686 AI025403 AA255490 N26754 AI094233 AA629548 AA716234               BF343632 AW363633 H62663               N40757 N55959 AW858569 AW604731 N40773 N40777 T83895 AI905899 BG007487 BF820299 R60231 R60787 AA456130               AW383736 BF087045 BG995619       441673   2674292_1   AI018657 AA952933       412556   1227313_1   AW961963 T08284 R14658       454877   195659_1   AW836463 AW836621 AW836541 AW836569 BF948429 AW836577 AW836640 BE072108 BF813547 BE072090               BE072048       400137   22730_1   L42572 NM_006839 D21094 BC002412 D21092 AL581583 BG744690 BE890015 BM145018               AW780309               AW117715 AW273302 AI935295               AI017768 AW117697 AA528074 BM091568 AW026362 AI807072 AI217643 AI754482 BE220790 AU150440 AA488365               AU150883 AU149798               AW136866 AI037898 AA948432 AL044717 BM091271 AA165119 AI572998 AI159802 AI420707 AA988336 AA465659               AA773194 AU146496               AA910663 AA584371 AI310749 AI305278 AI951728 AI266446 AI446326 AI283854 AI270681 AI016194 W26444 AI984515               AA261848 AI498094               AW514651 AA627739 BE887828 AI123491 AA868942 AA677859 AI809730 AI810303 AA496031 AI952462 AA996053               AI184087 AA693666               AA136578 AA773609 AW900608 AA928404 AW405313 AI907129 AI907123 AI986051 AU150633 AU153325 AU153368               AU153017 AI285394               AW592096 AI250862 AI869677 AI084968 AA857716 AA862132 AA931138 T96072 H71166 AU151501 AU153688               AU150884 AU160131               AU152428 AU151809 AU153189 AU152726 AU153115 AU153153 AA191478 AU152952 AA085945 AI092312 AA489369               AU144684 R89265               AU153572 AW969804 N62534 H04597 BE893641 BE613265 AA136661 AI912911 AA834897 AI886988 AI364744               AA813233 H27147 AW874123               AI263151 AW732074 AI439378 AI283359 AI203130 BF477675 T10242 AA528336 Z41162 AA502970 AI611989               AI802818 AI907127 F03630               AA427945 AA928575 AI926261 BE165012 AA188614 AA864217 F25274 AI264826 AI003178 AA115133 AA579080               N64601 AA807718               AA079255 W37786 H02330 T49457 R49175 H64168 AF148646 BC005983 AU142948 AU131105 BG388364 BM006108               BM011315 BG459126               AA631333 BI552181 BF220333 AU128630 AU128629 AU129731 AU120428 BI560973 AA075620 AW862160 AW411337               AI906984 BE966671       418733   18099_4   BM473699 N33854 N35083 BE090367 AI306129 AA911920 AA633160 AI302415 AA609954               AI365203 AA911919               AW995271 AA234587               BF996091 AW956344 AW389533 R60133       400245   12188_1   X79449 BC017853 AL121035 BF196384 AW119044 AI028023 AW451110 AI971911 AW015069 AI079170 AI376367               AI264113 AA829646               AA737579 AA449679 AA740864 NM_001111 U18121 AL567297 BG773801 BF973874 AV687104 AA527579 AA843525               BE706355 AI074589               AI523475 BE890249 AW406263 BE074258 AV729485 BF809610 BG058619 AA677244 BE179838 AA622264 AI460106               AA740411 AI499168               AI078223 AI682923 BE696559 AW375385 AA788739 BG984978 Z40874 T17054 F09669 AW844043 U10439 BI711870               AW245957 AU158567               AA679305 AA679316 W72510 AI346029 BG059762 AW251062 AA132373 AI925621 AI860230 AI340172 AW192891               AI707980 AI094937               AI042115 AI200901 BE328452 AA644678 AA551209 BE351065 AA970761 N68609 AW002028 AA160826 AI422774               AW873114 AW073597               AW664483 AI218710 AW020550 AW190607 AI984545 AI871921 AI333970 AI452887 AI818335 AA398655 AI554424               AI274187 BE465703               AW512940 AW241366 AI923954 AA576649 AW168294 AA813181 AA912168 AI049738 AW514073 AA548255 AI569630               BE710031 AA244182               AI341697 AA563904 AI537990 AW517908 AW172943 Z39498 AI750294 AW150414 AI253293 BE825720 T31860               AW150775 D20310 AA150892               AU133933 BE781148 AL038957 BF910979 AA352297 BG988U2 AW372175 BF229106 AW866705 BE093482 BG990396               AI499917               AA054452               H05484 AI828502 BM467331 AU140570 AL135417 BF947202 AW391926 BE813418 BF998473 T92021 BI021048               BM048783 AW501366               AW501342 AW501549 BE939021 BE707147 BE160974 BE305207 N49011 AA947119 AA678801 BE536876 AW897428               BG329648 BG818540               BE542344 BI919250 81253018 AW130996 BE074249 BE895428 BI034862 BE083277 BF952166       432053   11371_6   AL519914 AL562407 AA778932 BF111318 AW467038 AV729266 AI269598               BE939277 AI026690 AW269662 AI024572               BF909447 N58843               R06838 R07017 T83038 R07054 T90358 N75259       406782   0_0   AA430373 AA968771       407644   27910_1   D16815 AL563603 BG399756 AI935028 N41813 L31785 AL529953 AA428473 AA401262 BF802576               AA373868 BE886120 BM479352 T28309               N57167 BI551531 BG037160       408731   11725_2   AF305826 BE350971 AI765355 AW172600 AI310231 BM271766 AI547292 AW612019 AI674617               AW138666 AI147629 AI147620 BF857810               BF886300 BF885952 BF886303 BF885956 BG565497 BE670834 AA114025 BF886396 BF886928 AV750861 D62864       436395   47269_1   AJ227900 BF512806 F00947 BG614207 BF103731 AA310707 AI094933 BM023235 AW051119               BE882892 BG567751 BG567665 BG504662               BG562750       435745   37547_1   AK056461 BG686518 BE387225 AW967059 BE297996 AL135538 BE294837 AW449002 AW451121               T16848 AF055029 AL134724 W60898               BE856266 AU148963 AW575704 AW152356 AI084072 AW054888 AI935155 AA284068 AW007543 AI986179 AI857721               AW190129 AA150977               BE208028 BF439037 AA833823 AI377038 BF941216 AI829982 AA468807 AA847169 AI218694 AI129353 AI934898               AI184525 AI379211               AW769491 AI307200 AI128809 N27928 AA431873 AA136861 AI750062 T03747 AA554767 AA450096 AI278743               AA706407 AI039607 AI654580               AI031667 AI061299 AA733104 AI359421 AI869544 AI200267 BI335847 BF589867 AW008863 AI471924 AI222650               AW662717 AI803848               AA887775 AI282703 AI246010 AA721306 AA470395 AI245744 F10546 F09656 N67194 C04809 Z38698 AW580747               AA769725 AW374451               AW953981 AW578740 BF887002 BE617814 BG685745 AW855788 AW578790 AW578794 BE767704 BF874200 BE767729               AA365623               AW057997 BE938847 BG572984 BE536806 BI598918 W76362 AA371887 BE703956 AA143026 AW578800 AW578799               AW578802 AW578791               AW578764 AA193300 AA284124 BF369529 BM458893 AW403361 F12947 AA336566 AA331865 T75183 H00830               BM469137 BI256518               AA344657 T08539 BG980264 AA873643 BI871195 N40688 H14973 AA337355 AW977829 AL134723 AW452446               BE785578 BG977972               AA317124 BE962224 BE962220 AW379371 BE935858       445447   6500_2   BF966635 BF672146 BE180458 AI686634 AA523860 AW271362 AI861821 BF431163 AI022823               BF444980 AI765435 AA573781 BI712102               AW612498 AI262492 AA398744 AA505593 AW196232 BF941119 AI685545 AW130178 AW044369 BF430926               AI275587 AI025611 AI309750               AA815111 AI149346 AI174556 AW003736 AI469520 AW992548 AI204623 AI270522 AI084323 AW576339               AA922706 AI306116 AI554469               AA825775 T03628 BE243372 AA436568 AW263457 AA587932 AA587928 AW262892 R79805 AI681690 AI681693               AA393332 BE221894 N50660               AA915886 BE702216 H24038 AA074283 R70676 AW576178 H01876 R81147 R81148 R76841 N27519 AW593637       414405   112689_1   AL047596 AA393792 AI670731 AI037957 AW874364 AI038137 N62286 AI241379               BE501096 AW090696 AI927369 AI669226 AI369437 AI371075               AW612409 AI686711 AI183289 AA477717 AI076122 AA635190 AA700984 AA781508 D81020 BF575223 AI356183               D79312 AI375558 H61111               BG283489 BE090666 BE090664 BE090662 H26545       445317   844744_1   AW468777 AI219856 AI873492       419439   62687_1   BC007205 BI757428 BG768253 BE793505 BI756175 BG700401 AW247795 BE378793               AA485818 BG110861 BM006282               AI003793 AI351302               D80663 AI457745 AW248460 AA242934 AA456472 AL532788 AA536088 AW119049 AI472227 BF056172 AA827644               AI688691 AI590089               AI885138 AI885668 AW514618 AI368119 AI312763 AA587359 AI800927 AW629702 AI083644 AI306565 AI569261               AI311737 AW514616               AI309534 AI167269 AI220241 AI290334 AI352197 AA470701 AW613233 AA252032 AW248068 AA668416 AA252804               AI038616 AA909996               AA872009 AI272751 AI334419 AA454578 AI688702 AA485686 AA665245 AA878526 AI245998 AI871261 AW058650               N31716 AI869672 H20492               AA639593 R85327 AI951564 AI954026 BM007182 BI836891 BI758274 BI256473 BG331377 BG679123 AL532835               BE393403 AI400134               BG742026 BE389332 BI601732 BG698900 AA314318 BM006355 BI002658 BE252908 BG029560 BI196755 AA991163       423215   880395_1   AW963653 AA323281 AA372970 C16770       424571   9758_1   BE379766 AW152643 AI803450 AI564343 AI092711 AI140525 AW152156 AI620740 AI554689 AI161209               AI290242 AI339745 AI374611 AI347388               AI858296 AI140529 AI366124 AA493912 AA406235 AA493889 AI057160 AW022264 AI097277 AI144126 AI080051               AA983529 AA860507               N53469 AA843767 N81163 N70628 AA424577 AA983537 BF003004 AA626688 AA235977 AI057152 AI095366 AI095356               AA458646 AW194479               AA150439 AI375272 AW571777 AI359198 AA993793 BE614394 BE738239 AA127883 AI034344 T59504 D81608               AA908704 AW051665               AA382785 AA307208 N24639 AI370715 BE244980 AA548596 AW449675 AI191008 BF223749 N70752 N22266 AI191012               AA028001 AI419106               BF215661 BF591548 BG942356 AI474968 BE858217 BF793358 AV756758 BG483603 AI093724 BF693395 BG545345               AI744294 T59549 AA811773 BG499757       422711   16701_1   AK055669 AL049378 AW377544 AI033709 AI472253 BI963224 AI743449 AA621561 AI749846 AW804052               AW020579 AI097382 AA016179               AI290937 AI016441 AA988531 AI339453 AW470330 AA931074 AA026185 BI491566 AA953819 D80556 AI479362               BE856176 BE856995               AI418530 AA453318 AA315363 AA974727 AU185136 BE817293 AI825808 AW117512 AA993526 AW517982 AI937289               AW005886 BG034928               AV716846 BG655435 BI964900 AW371588 AA811110 W31610 C15669 AW161626 AI683982 AA120857 BF222558               N39089 AW261816               AW167241 AW003602 AA873113 AI633319 AI953905 AA451704 AA287917 AA588470 AA134756 AA872118 AA554169               N59186 BG655495               AA026186 BF435907 BE049379 AA984507 AA987200 AI803323 BF445688 AW440533 AW439141 AW661740 R76524               D60440 BF942226               BI850115 AI432094 BF942170 AW262510 AA370302 AA885665 R62142 AI567199 C00263 BI495346 W15536 R37823               AW673791 BF989408               AA134662 BE300698 R15856 AI625064 AW591350 BM148617 D80991 BE004938 R76240 AV735001 D60083       444889   722791_1   AI201251 AI917770 AW293546       418751   21393_1   BF690141 BE159368 AI937311 AU151256 AW341542 AW274231 AW341609 AW450447               AA843698 AW188066 AW007171 AW007027 AI075008               AL520351 AA608992 AW151842 AA622181 AI273454 AI005661 AA205946 AA677899 AW473512 AW296620 AA872899               AI094216 AI025188               AA256998 AI539154 AI500192 AI289493 AI040740 BE167841 AW151374 BE167754 BF036108 AA299181 N23237 T62967               W96060 AA574412               AW606697 W96059 R51303 R09158 R59113 T48473 T59023 AA122066 AW606643 R38386 R06567       458196   60860_1   AK057790 AU159145 AI802408 BE856709 AI302762 AA907424 BE045678 AI302328 025594 N33153               BE326823 AI863332 AV739134 AU149843               AI279233 Z20793 AW173558       430718   583102_−3   AI792814       419175   35068_1   AB018322 BC012480 BI524873 AW665554 AI934469 AI479916 BF096179 BF096162 BF096132               AA744972 AI951988 AI858339 BE076331               AA886998 AI570585 AI916688 AI678811 AI693109 AI308135 AA669046 AA961064 AI018062 H80618 BE221942 R52609               AI915164 AA365626               Z44671 BI052776 BF882486 BG286184 AI589558 AA931663 AA534979 AI275392 AI273455 R52553 AA829920 H80652               AA360728 F10618               AW953666 AW176773 H85527 AA765570 AA081927 BF093262 BG743753 AL037576 AA534314 BE814964 BE973713               N49493 BE006634               BE006630 AW270037 AA234765 AI334004 BF057179 AI857450 AI341191 AI434143 AI917449 AW517207 AA255424               AW008334 AA847572               AA994211 AA861901 AA581873 AI580157 AI364363 AW242357 AW235291 N55645 AA319869 R36911 AA256551               AW044188 AI203159 N49403               F02090 AI187299 AI609644 Z40516 AW952314       446436   12330_1   BG474471 AW963784 AL541138 BI091480 AI023457 AV658395 BG991788 BG168902 AL568755 BF515750               BG413457 AI073545 AI457986               AA553973 AA826823 AI025831 AA722816 AI078414 AI252218 AA570134 AA313183 AI689327 AI609660 BI089971               AW614345 BM145877               AW182468 AI138446 AW054973 AI433252 BE392690 AA644254 AA621649 AI027916 H74280 H74279 R05903 BG504738               BE243125 BG398720       442961   60316_2   BE966247 BE220885 BE467384 BE350135 BE672094 AI811582 AW665254 AA772731 AI283601 AA417067 AW197746               AI868357 AI792143               AA931120 AI758506 AA843761 BE737582 AW379586 N38812 BG567321 H13257       430844   450932_1   BM470823 AA487679 AV736625 T94960 T95013       434995   122184_1   AW974995 AI791196 AI821880 AI821932 AA659617 AI821137 AA658925       446096   2855992_1   AI633717 AI276454 AI275116       451050   11847_4   BM453041 AA760783 BE218582 AI340046 AW166131 BF515854 AI630296 AA461307 AI090881 AW023059 AA155797               AA115486 AL597396               AW889004 AW937420 AA137082 AA013374 BG619478 BG401839       443547   137089_2   AV645808 AA701657 AW271273 AI796734 AI472316 AI017531 AI061178 BF109096 AA548964 N83805 AA131648               AA156589 BE708349               AW952494 D30877 AV684717 Z24837 F00167 BF576150 T63841 R78995 N87474       449901   1269988_2   BI227033 AI674072       425996   138046_1   BM006551 AA367152 AW953705 AI631833 AW237429 AW027804 AA729038 BE503409 AI521935 BF739953               AA702982 AA557633 AA780065               AI218139 AW194264 D20120 AI082715 AI969980 BE857686 BE326711 AW953706 AI393749 AI383821 W67199 AI431759               AI796526               AI521794 AI796380 AW117545 AI749657 AI537634 N50122       448797   14543_1   BE614460 BF115119 AI670868 AW590674 AW003998 AI925103 AI521807 AI861967 AI765452 AI758865 AW028509               AA708099 AA836286               AI468465 AI208587 AW952300 AI824281 AA447219 AA468043 AI373421 AA708115 H13541 BF093497 AA461538               BF377943 C01108 BF377920               AV714521 AW206741 AW968126 AA774415 AI350171 AI275658       441969   2681178_1   AI733449 AI733386 AA972780 AA988876 AI791798 AI791748       441894   2338_5   BE869838 AI148042 AI827471 BG426916 AI684451 AI949551 AW006378 AA535914 BF222911 AI925829 AL044604               AW769002 N62372 N52347               AW002732 AI537926 AI886148 AA953912 BI862037 D61326 AA055633 BE544632 AW954810 N75119       433009   2142268_1   AA761668 AA573621 R09670 R92814       425913   4123_2   AV703649 AW959818 AI582119 AI523459 AI674473 AW663543 AA825476 AI935231 BF742805 AA426156 AI253626               AA846477 AI024230               BF221780 AI493027 AW006841 AA814699 H99650 AI088977 AA442691 AI783526 BF207915 AI752847               AA782635 AI978980               AA788634               BG119454 BF678528 AI627829 BG993975 AV701283       443959   2780939_1   AL120546 AI093444       433359   1155535_1   H70007 AW896257 AW896334 AA584680 AW896386       435931   55043_1   AK057055 BI868744 AL537388 AL601343 BI917121 AW965676 BE163455 AA401842 BI836992 BE169604               AW603254 BF224353 BI000120               T09411 T33851 AL566789 AW383995 E504296 BE670066 BE221088 AW612265 A421866 AW044202 BG107771 BE621522               AA400384               AI668813 AI680704 BE855622 AL047416 AI085944 BE328123 AI951915 AI693159 AI633745 AI472220 AI127849               AI601128 BF224203               AA403117 AI624409 AW510999 AI199722 AI375679 AI369300 AW008158 BF437759 AI142992 AI299713 AA987655               AA954216 AA081613               D53173 N90948 N40544 AW172528 N94307 AW274872 AA833541 T03787 AI144167 AI678975 N58937 AI864431               AI064741 AW664341               BF222277 BE327850 AI625361 AI032746 N73790 W58072 AW204818 W02128 BF445630 AI073621 AA022615 AA084503               AI215722 BE856978               T56046 AI581993 AI139961 AI569338 AI207177 AI873359 AI682604 AI215528 AI700342 N90316 AA610054 F08873               AI459512 AA676678               BF589573 AI383046 AA947775 T90475 T90482 T33850 AA009789 W73132 H22902 F10123 H67882 T56062               R11653 T89037 N27199 BE169725               AA022614 D81394 AA502780 AI093041 T03878 W32393 N99415 AW418560 BE834542 AW197315 AI025774 BF793398               AA994729 H50611 BE965743 BI766426 BE536391       434747   117643_1   AW976537 AI033582 AA837085 AA745261 AA648395       416727   1988165_1   W05023 N59520 H80405       400120   133_1   BC014030 NM_004068 BC004996 AK057883 D63475 BM468205 BG386792 BG750447 BG575842 BG479084               BG741027 AU118129 BE901043               AU141281 BG825395 BG338276 BE396231 AU121493 AU131489 BF341132 BG335659 BI769251 AU142779 AU124483               BG480828 AU121353               BG702326 AU137866 BG759046 BI460601 BE887290 BG750415 BF127710 BG757819 BI160266 AU122086 BG824046               BG744180 BE884943               BM006610 BG702599 BI870749 BF307033 BI334771 BG480606 AU142599 AU141336 BM018563 BI335565 AU138308               BE391241 BG774488               BE278025 BG717959 BG706920 BE312567 AU138300 BE303034 BE303016 AU139252 BE336797 BG470940 BE336735               BF305197 AU134288               AU139907 BE261245 BE208718 BG761912 BF212890 AW732692 BM011258 AW247629 AU136696 BF530078 BF204146               AL048752 BG328927               BE388385 BE260122 AU138789 BE253465 BF733914 AW249415 AW239535 BE311791 BE256236 BF529742 BG770465               AW245777 AW245813               BE296677 BE266852 BE168115 BE396596 BE280057 BE168229 AI750820 AU134137 BF792191 AI272215 AI907348               AW238875 BF805152               BF568397 BE712727 BE081443 BE001805 BF724536 BF744705 AW247385 BE796369 AU133759 AV705142 BE794402               BM465821 BG281284               AW384831 BM450689 AU134125 BE311650 BF356318 BM462831 BG420555 BE749127 AU134590 BM019438 BC013796               BG761223 BG122058               BE872076 BG748496 BG821374 BE619159 BG423244 AU137110 AU127210 BE270081 AA496860 AA351380 AA356303               AU099781 AA355912               AA371411 AA325535 U36188 AL569574 AL577204 AL525543 AL567342 AL567334 AL567122 AL536527 AL567098               BG681585 BG824951               BI870652 BI225855 AW393878 BG750632 BI223803 BE877552 BE270473 BE389392 BE779021 BM017845 81117816               BE396513 BM049006               AW393945 BE786941 BE267724 BE562981 BE314236 BF744102 BM019781 BF806063 BF828673 BF829181 BI008788               BF829180 BF829175               BF433802 BE909928 BF839784 AW578564 BF943095 AW328030 AA448596 AW882688 AA909846 BF924341 AW361460               AA425174 BE940557               BF761585 BF931276 BF934886 W68597 BF933977 BI035906 BE836064 BF837576 BI018368 AA205908 H54612 R88902               BE812330 BE932300               BF924562 AW805376 BE769859 R87381 AA371901 BE838855 AA326381 W56191 AA341231 AA464093 AL575977               AL518650 AL547393               BG338327 AL517563 AL536921 BG207096 BG207589 BG199290 BG220159 BG744842 BG104730 AA555035 AA618009               AA861062 AA610582               AW245418 AI040983 AA521380 AW245455 AU147292 AU155236 BE620286 AW250767 BF888236 BE620819 AU154343               AU150827 AU148334               AW069495 AA701091 AU155225 AW250019 AA666235 AU147764 AA449739 BF907598 AW043731 AU144390 AI924565               BE300631 AW874021               BE208088 BF732773 BF594057 AI159873 AU143930 N24100 AI052499 AI989370 AI366151 AI139248 AU144776               AA838250 AI095433 AI269227               BF811358 AU151352 AA477554 AI131290 AI049797 AU157349 AA620559 AA581533 AI338299 AA402755 AI050079               AU157614 AI280691               AA706590 BE206615 AA861056 AU153214 AU155712 AW069554 AI081124 AU155846 AI081123 AA719876 AI754976               AI027763 AA723095               BI518782 AW050706 F37521 R79062 AA565530 H39826 AA404670 AU158884 AI139682 AA513633 AI283202 AA651856               AI623515 AA427413               AW248474 BF841432 BM453246 AI302390 AA808269 AI249357 AA132775 AA716732 AA479932 AI198296 AI208674               AI088433 F36977               AA496899 AW615762 AA602541 AA341161 D58785 T15399 AI286077 W69152 F28418 AI272156 AA338034 AA568455               BE206121 AI080033               AI699680 AA861255 AI953465 AI613240 AL581773 AL531577 BF526361 AA657809 AW152670 BE621523 AW078705               AW673719 AA102613               AA195604 R72209 AA402208 AA404305 N24999 AI963535 D54741 BI461415 BM475959 BI260926 BI116213 BE280120               BE940258 BE280044               AI905744 BG001474 BE937718 BF799283 BI091621 BG421006 BG289235 BF736825 BI253429 BG170064 R72512 T92815               BF931257               BM455183 BG033362 BG574220 N31395 BF739185 AA371995 BE879011 BI198754 BF378989 T12266 BM019421               BI194570 BF378992               AW996595 BI858649 W94605 W61345 AA122384 AA171923 T92736 AA761504 AI819039 AI439358 AL517777 AL565919               AA622001 AA642695               AA704144 AA081465 AA070621 AA375562 AA700011 AA926863 W37310 AL566236 BF677809 BG760021 AW361433               BE828605 BE268449               BF805977 BG292452 BF981071 BF217108 BF928698 R33993 AW882841 AI857453 AW078733 AI433035 AI018103               R90927 AA804720               AA551734 R33835 H19741 R78754 BF930494 BG109583 AA631926 BE834008 BG996533       410972   480035_1   BG113822 AW812262 AW812259 AW812255       438021   45849_1   AY043361 NM_007013 AL136739 U96113 AL049041 AI750898 AA054855 BF887778 BF333173               BI061338 BC015380 BG569062 BM090890               AI769300 BE466554 AI091728 AI800660 AA832035 AI342285 AI750899 H66486 AA455942 H20821 AI187877 AI417440               AW198099 AI245158               T91227 AI373068 AW194829 AA680229 BG291204 AW885601 BF380168 D82380 D82098 BF885552 AL050082 BE552267               AI458088               AW137654 BM014715 AA418921 AI159868 AA845398 AI743920 AI159888 AI653531 AA843952 AI799752 AI360957               R67562 BF445478               AA854844 AA552895 C21152 BE614563 BI260650 AU155187 AW169673 AI915801 N29619 AA435618 AI361252 AI424627               AI219018 R67514               AA548141 AI246669 AA156867 R67561 R67513 AW263860 AA089478 AV653790 AA354846 BI560015 AW794547 R52020               H18923 R67555               AI302490 AL582101 AI871884 AW029104 AI582326 AV688960 AL040820 AI804339 T57931 R67554 AA418232               AA393281 BE076206               AW189435 AW979344 AW953494 BF056797 AA310720 N64062 W92065 AI761704 AA418824 H89156 H88930 W92048               AW33096 AW007773               AI745541 BE504125 AW243111 AI201009 AI187909 R44411 AI795988 BF222383 R29593 AA156952               BF029856       411227   1073598_1   AW833298 AW833294 AW833272 AW833271 AW833274 AW833308 AW833275 AW833296               AW833295 AW833258 AW833306       442751   1767112_1   BE567123 AI358404       446164   41648_2   AK026817 AI559708 AW273539 AW892986       450377   12109_1   AB033091 AL520743 BE811813 N53332 N99716 AL561910 AA280655 BE710392 AV705100 AW293978 AW444556               AA281459 AI679751               AI873695 BG700891 BI553517 R80518 BG779771 BG534451 AA479402 AW961580 BF061430 AI857643 AI768486               AW512118 AA479302               AW770384 AW072470 AI041596 AI049699 AW592865 AA976261 BE879747 BG114119 AW183811 AA909938 BF571621               BF350794 BF351375               BE925699 AL050294 BC010371 BF982270 AL042656 BF095732 AW812618 BF095731 BG212397 BF678765 BI038602               BG388664 AW675337               BG289398 BE939598 AW805570 AA527097 AW150540 AI693720 AA743364 AI915793 N48185 AI573107 AA043474               AI351615 AI969490               AI910763 R50866 AI699181 N73808 H08164       433991   2208777_1   AA824302 AI806816 AA621207 AA621208 AA912749       459169   3146528_1   AI905455 AI905452 AI905517       441458   306062_1   AW815108 BF928501 AW815254 AW815139 BE064292 AA935099 AA934531 BF955469 BI009962       421272   64950_1   BG819964 R87567 BF062036 BF062044 AW014470 BG057316 AI810506 BE466071 R88291 AA704157 C15898               C15173 AA286825 BF594141               R84605 H85515       400200   3806_1   BC005265 BG176720 AW006027 BM352064 AW026316 AI635822 AI880584 AI693769 AI092211 BI492387               AI400449 AW166297 BF939910               AA232282 AW021432 AI333893 AA494308 AA854899 AI436795 AW069256 AA682373 AI092748 AA993184 AI126077               AI081758 AI240686               AI261863 AI378423 AA465237 AI376096 AA035579 AI087306 AA448162 AA129977 AI090903 AI080686 AI288939               N33004 AI801240               AW021546               AI370773 AI086064 AA669528 AI250053 AI870113 AA853181 AA858014 BG055562 BG939559 AW080765 AA032283               AW467587 H40506               D00762 NM_002788 AA641134 AI582295 AI417525 AI563975 AI093566 AI707743 AI290741 AW073417               BE875418 BM264076 BG876884               AI680535 AW854219 BE774635 AW854212 BG952443 AW854221 AW854208 BE156348 BE843056 AW858991               BE937569 BG878291               BG876450 AW819099 AI908570 AA449871 AU135228 BM478404 BF126296 AA375499 AA248473       425261   MH337_5   AK054563 AF339812 AA528225 AI819825 BF434272 AW009758 BM023283 AI367158 AI954564 AA564676 BM353611               AI151187 AW518909               AI688072 BE207868 AA680236 AW001919 BE206150 AI814780 AW513625 AI204573 AW517297 AI276223 N49193               AI868635 AA877533               AW514291 T03476 M410444 AA973195 AI826725 AA662719 AW071134 AI620613 AI285995 AI241782 AI243244               AI344384 AI017846 AI423377               AI346069 AI399834 AI366843 AA814351 F25816 AA927979 AI141159 AA720769 AA953724 AI383799               AI572402 AW002178 N29888 AW472873               AW193742 AA614853 AI476008 AW771672 AW083617 AW591173 BM450662 AI922272 BM463462 BE879542 AA149308               BG205668 R94706               T98497 BF917910 BE964015 AI311930 BF303765 F22493 D20169 AA147668       435882   136881_1   AA701431 AW194987 AA704261 AA705688       450456   10568_3   BI869374 AW608173 AA481283 AA779091 AI091407 AI380767 AI161247 AA775262 AI804165 AA742296 AI620960               BF057560 BE644921               AI360753 AW271412 AA243424 AI082407 AA779083 AA670202 AA233657 AI032843 AW768251 AW016884 AW838625               AA233693 AA766578               AI246454 AI097182 AA774648 AA630743 H25879 AA233157 BF475907 AU153405 AI342173 T50088 N23013 AI817953               W15432 AA404548               AA009914 AW014445 AA243486 AA291931 N33512 BG987649 BF981538 BG619175 BG977894       450122   1398_1   BI830320 H45858 BI821969 AA834581 AA999871 BI831412 BI827162 BI826049 AA531076 AA327326 BF344394               BI860338 BE382517 BI600376               BI598227 BG754268 BI962938 BE907670 AI339466 BE222828 BE906305 AA662096 AI570621 AI088762 AI817835               AI310480 BF725056               AI669307 AI076748 BI966768 AI310414 BE158972 AW444735 AI333025 AI310004 BE393365 BF940054 BE858296               AI498530 AI376399               AI138476 AI289161 AI378371 BE857636 N40684 AI301684 AI370578 AI928410 AI568228 AI214670 BE782530 F19317               AA468593 AI359175               AI300708 BE070822 AA369484 AW959944 AA371588 BI604202 AI308854 AA636048 AA729907 BE743989 W42852               AA644403 AA047301               AA737174 BG054990 BF338479 AA948684 AA807788 AA844504 AI885673 AI927015 M662133 N98291 AA401721               AA045902 T58832 W42908 BG996868 BI521617       445530   8558_4   BE294791 AA115300 BE677858 AW592684 BF061022 AI969919 H10240 AW183605 AI620788 F13488 AW468877               BE172330 AA115340               AV654146 D79658 T75088 T75087 R14638 D63008 BG623753 BG926180 R91348 AW885760 AA249136               BG926100 BE175717 BE175718 C16690 Z42755       406815   0_0   AA833930 AI684135       457393   5773_1   AW970603 AA503455 M85475 AA503437       451436   5742_10   AA017575 R56724 BE836659 BE836660 BE817256 BE817335 AA258389 AA258459 BE817739 BE817702 BE817325               BE836614               BE139090               AW861931 AW858575 AI363734 AK025483 BF882045 BM128581 AW771330 BE669540 NM_016376               AB037360 AA399607 R94364 BE514643               BG684040 BG759578 T83725 AW858561 AW858524 H65293 AW754345 AK025960 BM477612 BE071291 BF087041               BG995615 BE071350               AI917153 AA436381 BE815318 AK025717 BE857148 AI741138 AW027718 BI789162 AI492263 AI690072               AI420179 BI789249 AI637804               AW957459 BF222458 AI094328 AW510893 AW295994 AI760430 BE464934 BE220458 AI042022 AI653315               BM128472 AW337972 AW515837               AI669489 AW664176 AI768730 AW271660 T16381 AI823834 AJ346113 AI242353 BF437578 AI273673 AW513498               AI797424 AI674242 AI277236               AW731756 AA373089 AW207589 AW467879 AL550999 N30075 BE883669 BF155456 AI423079 R60281 T16974               BG676892 BF927070               BI962758 BE811485 BE811591 BE811702 BE811600 BE811483 BE811533 BF927061 BG008257 BF873368 AL574815               BF946447 H70934               BF939868 BF378761 BE082381 BG984527 AA244447 BG983567 AW885571 AW293182 AW885607 AA811057 AA610310               AI434406 AA514352               H71020 BF740351 BE814815 N66648 AA737686 AI025403 AA255490 N26754 AI094233 AA629548 AA716234 BF343632               AW363633 H62663               N40757 N55959 AW858569 AW604731 N40773 N40777 T83895 AI905899 BG007487 BF820299 R60231 R60787 AA456130               AW383736               H05232 R59374 H12223 AI935759 AI362553 D60006 N29572 AI916833 N75273 AA148710 BI597117 BG740471               AA332671 AA333874       410365   60627_2   AL050199 AI872323 BE883872 AA424083 BG109354 AI243745 AA834941 AW102813 AW196535 AW973796               AA559860 AI475291 AA559908               R34681 H96211 Z39807 BF954386       417628   2137209_1   T84214 Z43709 R05654       434809   118540_1   AW974687 AA652145 AA649656       420985   455_7   X94703 NM_004249 AL521205 BF886672 N46403 T87420 Z36855 BF934259 BI549507 BG899191 BI517479               BI818431 H39666       428104   1376802_1   AI205993 AA421350 AA421440       430933   605836_1   BG284105 BE080356 BF372738 BF372697 AA489179 AW863789 BE179901 BE179402 AW863635 BG995706 BE010747       421297   16064_1   AB033081 AK074324 AW450283 BM128413 BE550945 BE670081 BE674137 AI298087 N30050 BF110807 N30072               AI288098 N30068               AW861931 AW858575 AI363734 AK025483 BF882045 BM128581 AW771330 BE669540 NM_016376 AB037360               AA399607 R94364 BE514643               BG684040 BG759578 T83725 AW858561 AW858524 H65293 AW754345 AK025960 BM477612 BE071291 BF087041               BG995615 BE071350               AI917153 AA436381 BE815318 AK025717 BE857148 AI741138 AW027718 BI789162 AI492263 AI690072 AI420179               BI789249 AI637804               AW957459 BF222458 AI094328 AW510893 AW295994 AI760430 BE464934 BE220458 AI042022 AI653315 BM128472               AW337972 AW515837               AI669489 AW664176 AI768730 AW271660 T16381 AI823834 AJ346113 AI242353 BF437578 AI273673 AW513498               AI797424 AI674242 AI277236               AW731756 AA373089 AW207589 AW467879 AL550999 N30075 BE883669 BF155456 AI423079 R60281 T16974               BG676892 BF927070               BI962758 BE811485 BE811591 BE811702 BE811600 BE811483 BE811533 BF927061 BG008257 BF873368 AL574815               BF946447 H70934               BF939868 BF378761 BE082381 BG984527 AA244447 BG983567 AW885571 AW293182 AW885607 AA811057 AA610310               AI434406 AA514352               H71020 BF740351 BE814815 N66648 AA737686 AI025403 AA255490 N26754 AI094233 AA629548 AA716234               BF343632 AW363633 H62663               N40757 N55959 AW858569 AW604731 N40773 N40777 T83895 AI905899 BG007487 BF820299 R60231 R60787               AA456130 AW383736               BF087045 BG995619       410365   60627_2   AL050199 AI872323 BE883872 AA424083 BG109354 AI243745 AA834941 AW102813 AW196535 AW973796               AA559860 AI475291 AA559908               BE670565 AI919258 BI002664 AA557197 AI581597 AW604533 W69379 N66899 H84695 N53879 AA644631 H24627       455631   1488654_1   BE063040 BE063006 BE063031 BE063002 BE063072 BE063024 BE063008       432523   1031284_1   AW972205 AA551756 AW815357 AI023998 AW895029 AW856039 AW753791       440328   15103_5   BG203047 BG208248 BG211369 AW392243 AW392234 AW392226 AW392246       441229   591349_1   AW083064 AA923345 AI744267 AW517768       428023   MH1660_24   AK027255 BE856281 AW182584 AW027872 AI819831 AI936994 AI278611 AW338658 N29885 AA687514               AI824306 AI038904 AI034339               AI292064 AA973469 AI291616 AI079733 AI038683 AA491599 AA776023 BE813865 AA993675 AA837380 BF806738               BF803246 AI087090               BE930098 AA911116 AW137988 AI989393 AI283557 AW175908       424967   2139_1   BI116740 BM312146 H84589 BI831716 AW468329 W35384 W37216 BG818478 AI188435 BM311546 AI885302 BF448603               AI870012 AI797830               AI185731 AI336328 AI292299 AI240858 AW057899 AI970695 AI350388 AI292131 AA846185 AW665469 AW002306               AI144304 AI306407               AA465170 AI283059 AI026124 AA771949 AI038429 AA725179 AA846193 BE773021 AI201261 AI797645 BF593616               AI245212 AI301420               BE466901 AI203386 AW592346 AW748053 AA854554 BE719868 BG475523 W33173 BI019056 BI831085 BG005729               AW075722 AI201542       415023   37164_1   BG763540 BI115604 BG325282 AY007096 BE048206 BE048060 AA356949 BG469451 BE267760 AI683752               AI702004 BE247172 T47611               T47612 BE780300 AA932146 AA652369 AI784281 BM055020 BM023299 AI382709 AA159351 BI262171               AI863355 AI674922 AI754389               AW295190 BE673083 AW469497 AI949042 AW131720 AI990060 AI623178 BE673420 AI863364 AA620354 BF431793               AI056058 AI056059               BI258269 BI823911 BG482172 BI261556 BI519838       437306   708160_1   AW977693 AW270552 AA748487 AA767827 AA827207 AA934962       452479   3144985_1   AI903527 AI903576 AI903573 AI903529 AI903528 AI903525       431675   135623_1   AA699965 AA513572 AI696381       432600   114582_1   AW973464 AI821831 AI821085 AA640756 AA657438 AA554802 AA650339       400271   893_1   BM467047 BI668430 AV723510 AA383564 BM466286 BI756033 BI752301 BE741302 AA312107 BF219348               BF224233 AA372905 BE972765               BG530510 BG430596 BG430439 D56385 BE566653 AI761953 AI361096 AW771495 T65962 BI494838 AW271309 AI423700               AI762323 N72193               AW007571 BC013873 X72964 NM_004344 BC008415 BC005334 AL554338 AL559625 AL559603 BG696707 AV733516               BI670087 BI600577               BI043582 BE866235 BE293715 AI681691 AA283060 AW612235 T29090 BE694176 Z30203 AA379970 W21362 BG179242               AI681294 AI694310               AI670881 AI074606 BF940039 AI858065 AI681393 AI991986 AI400174 AI910439 AI089029 BE048642 AW614075               AW262850 AI431584               BI495202 AA582224 BI495201 BF197587 AA459997 AA282970 AI769114 AA632011 AI091029 AI375169 AI400216               AA782032 AW044700               AI633913 AI129124 AI624690 AI799764 AA916363 BE503032 M492546 AA987867 AI373064 AW772272 AW015455               AI368642 AW243721               D45517 AI868673 C20558 AI130836 AI928680 AI191010 AA834469 AI963630 N93012 N67416 AL577079 BG532126               AI640172 AI670873               AI457787 AA460091 BE090147 AA614862 BE182933 AV733272 AI909822 BI494839 BG121897 BE293433 BI044033               BF910106       418876   121279_1   AA740616 AA654854 AA229923       414783   262554_1   BE972667 AW069569 AI392889 H85161 AI074962 AA423935 BE671254 AA912627 H39845 H69083 AA280259               N67746 AA155722       446841   127420_1   AW958927 AW002054 R00045 AA384616 AA669984 AI571663 BF439133 AA302636 AV660567 R02526 T90529               AI678912 AI185622 AI963670       453929   97058_1   AA045461 AA284145 AI494193 AI469576 AV700262 BF222563 AW190054 AI263834 AA040074 AA045137       459436   880261_1   AI908449 AA323121       427224   25669_1   BC014914 AW025233 BG433378 AI348364 AA917746 AL135554 AA708134 AI095765 AI291861               AI264632 AI032834               BM464145 AW575013               AI383072 AA815134 AA765181 D59880 H29890 AA825534 AI696290 M399405 BE669700 BF224225 AI914181 AI674625               AI125811 AI022371               N63064 R93084 AW977125 BE568027 BG434014 AA403200 AF062366 AW891180 AA401207 AA477849               BE764638 BE764629 AW891194 AW439069 AW891199       442484   3699_10   AI110863 AF075362 AI110861 AF075360       418831   245538_1   AA488082 AA228970 AA230043       448079   74377_1   AK054894 AW978550 AI984051 AW205843 AW205839 AI379941 AI383948 AW129532 BF197455 AI954133               AI668869 AI360826 AW614392               AI619505 AA927599 R64287 AI803003 AI675123 AW023079 AI638324 AW134959 AA831069 BE772132 F29901               BF210719 AI376624               AW960171 AI275045 BE856533 AW243724 AI051487 R68631 C17731 Z44230 AA309094 BI837972 AA122297 BE929614               BE006483 AA098802               BG252168 BG928816 BI091300 AW963375 AA213871 BE925757 T90131 BG426009 BG611801 BE090425 BF672863               BF132610 BF184312       450869   2827_1   AK074246 AB062418 AI040384 AA694057 BG566618 R83450 AA011459 H57230 H93947 AA033972 N91333               AI040705 AA705512 H57154               R05747 H66758 T97233 H61474 AA033971       437406   5564_1   AL355708 AL390182 AW961056 AW026094 AI201896 AI339096 AW753013 AW377575 AL359597 AA458509               AA101706 AA430395 BE218599               AI580153 AI337252 AW672987 AW117483 BF477914 AI159869 AI469834 BE328727 AI800118 AI049995 AI739268               W40584 AI695716               AW008980 AI689764 AI393298 AW139228 AI097595 AI762231 AA454591 BE219638 AI291020 BG149193 AI769982               AW189752 AI418017               AI363808 AI926110 AW590852 AI524293 AI424269 D30993 AI669931 AW873757 AA355695 AI392826 AU147571               AU154893 AI685419               BE326844 AW024382 AI271608 BE856703 AI739564 AI588871 BF437288 D55501 AW883430 AI991167               AI681404 AA534707 W78925 AI547249               W85910 AA702573 AA677590 AA971286 AA452238 AA582421 AA262979 AI023007 AI038705 AA977918 AA454590               AA973696 AI091861               N66679 R39883 AA868049 AA846818 AA150827 AA151064 AA101707 N50264 N49212 H05824 BF856686 T26533               AI983044 AA730190               BE856310 AA009812 N20978 AA009813 T26532 T07386 AI084242 Z38902 AA904453 T78860 H84638       458172   363900_1   BE007237 BE546311 AA984819 BI256810 W19919 BE007263 BG000322 BF327011 AA890198 BE007496       414992   1785181_1   D63302 D78793 C17962       410215   15479_2   BI914830 BG209254 AI694353 AI312853 BF593037 AI088624 AW340577 AW015288 BF589940 BF222096               BF431760 AA781252 AA449828               BF436265 AI572104 AI695710 AI627770 AI524498 AW662141 AI572181 AA988863 AA782797 BI766911       411115   1070123_1   AW818312 AW818453 AW818380 AW818207 AW818214 BF375509 AW862010       407604   43771_1   AK074129 AL138071 AI806793 AI453544 AI084616 BF062435 BE672932 AI828296 BF062464 AI803443               AI264326 AI280956 AI743547               AW295227 AW139967 AI972561 AI863570 AW062752 AW062756 AW062753 AW176904 AW062755 AW062750               AW062749 AW176886               AI751694 BG251391 AA043621 W30872 BI524827 N94581 AI084614 AA776976 AI377572 AI751695 AI016576               AW439994 AW194255               AW627763 AA668249 AI079870 AW022524 AI968540 AI248360 AA702490 AA043262 AA631511 AW176883 AW751767               AW176887 AW062748               AW062745 AW176862 AW176815 AW176814 AW176846 AW176841 AW176871 AW176874 AW176819               AI927437 AW191962 R36548 AA853713               AW196059 AA618567 AW176881 AW062754 AW062751 AW062746 AW176888 AW751772 AW176859               AW751765 AW751762 AW176833               AW176873 AW751745 AA694513 AA780815 AW176857 AW176834 AW176839 AW751771 AW176878               AW176843 AW176842 AW751755               AW176847 AW176812 AW176830 AW176849 AW176844 AW176877 AW751757 AW176850 AW176851               AW751758 AW751746 AW176858               AW176853 AW751766 AW176845 AW176872 AW176840 AW176876 AW176852 AW751754 AW176836               AW176856 AW751773 AW751760               AW751751 AL138070 AA639738 AL602588 AA853712 AA317570 R38469 AW291569       452780   73430_3   BF576403 N79410 AA028160 BE171598 BF090519       458311   2694866_1   AF069480 AF069479 AF069478       413533   12274_1   AK055111 BI560412 BI600640 BI549250 BI463611 BG898612 BE468008               BG675527 BE146768 BF853416 BE146973 BE146972 BE146767               BE146985 BE147021 BE147018 BE146793 BE146783 BE147020 BE146760 BE146954 BE146771 BE147044               BE146766 BE146952 BE146776               BE147048 AI686856 BE147042 BE147019 BE147025 BE146797 BE146781 BE147030 BG420528 AW294469               AW248308 D29070 BG152458 AA908606       446501   2873469_1   AI308174 AI307311 AI302616       450371   1627928_1   AI694038 BE464839 AI803494 BE241794 H86709 R34926 BE241681       414496   1526_1   AK058006 BF724822 W65303 AW887764 AW023806 Z25353 AW022095 AA730973 W00417 W73819 BF982096               AI927669 AW188021               AW770478 AI913512 AA604358 AI697341 AI691028 AI338392 AI079403 H97538 AI144448 AI253102 AI051402 AI335900               AI868132 N28900               H98465 AF268386 AI799915 AI819228 BE048413 AW304723 AI819923 BF223106 AA155907 AW298079               BF055272 BF446804 BF197697               W58588 BF197538 AA032180 AA992597 AW590254 AA027824 AI129369 AI131331 AI655843 AA932907 AW104493               AI150615 BF110226               AW172271 AI312659 M057312 BE673669 AA722984 AW104985 AI129232 AI078648 AI653086 AI703481 AW515897               AI352206 N67076               AW297281 AI686162 AA029184 AI610743 AW772016 AI091778 W65401 AI687374 AI218085 AI765158 AI018002               AI653068 AI335704 AI520850               AW275228 AW275204 AI420247 AA975336 AI697042 AW182235 AA736386 AI281682 AW169698 AW263325 BE645834               AI377438 AI146706               AA613808 AA716538 BI496247 AA032248 AI698930 AI193399 N70026 H86792 AA404489 W61267 BF447230 AA910805               AA150774 AA621907               AA902526 AI827634 AW022037 BF059000 BI496246 BG577007 BG571077 AA460779 AW816890 AW816893 AW816891               AA029183 AA010295               H86850 T83320 BE160823 H12925 N40087 AA096372 BE160847 AW816892 AW816889 AW816882 AW816868 AW816941               AW816578               AW816940 AW816577 AI431628 AI828113 AA033677 AA033654 AA452704 AA317582 AA346971 BF836584 H48669               BI861605 BG925200               AA463277 H89048 AA155952 W03252 W01510 W00915 W58589 AA164519 N24017 N24622 N27149 N70109 R43771               AA010296 W84611               H98889 H88965 AW594424 AA034139 AA065223 N99696 BG981481 N94371 AA767970 W47146 N70977 H05510 W61268               T90796 AA164518               W47244 AA150883 AA034138 BF338483 F13671 H51317 W72716 N21488 AI188071 AI370541 AI754442 AA148524               AI749182 W95221 W92522               R20385       455100   1096250_1   BE160198 AW935930 AW856073 AW861034 AW935898 T11520       411806   1107840_1   AW864356 AW864547 AW864277 AW864496       432676   3503_22   AI187366 AA618478 AA558869       422642   873508_1   AW961201 AA314041 D63247 C18669       432377   1620366_1   AA535140 AA534670 AA535021       445298   724820_1   AW295700 AI219199       446868   15525_1   AK074473 BC017997 BI831060 BF971101 AI886394 AI082824 AV708785 W86073 W07772 AV660737 AI816793               R52250 BG183529 AA633473               AI191256 R44763 R19947 BF571346 W86257       425199   1276656_1   R97184 H47493 AA352099       437714   845454_1   AW977404 AA836116 AA766346 AA809877 AW469598       426143   3806_1   BC005265 BG176720 AW006027 BM352064 AW026316 AI635822 AI880584 AI693769 AI092211 BI492387               AI400449 AW166297 BF939910               AA232282 AW021432 AI333893 AA494308 AA854899 AI436795 AW069256 AA682373 AI092748 AA993184 AI126077               AI081758 AI240686               AI261863 AI378423 AA465237 AI376096 AA035579 AI087306 AA448162 AA129977 AI090903 AI080686 AI288939               N33004 AI801240 AW021546               AI370773 AI086064 AA669528 AI250053 AI870113 AA853181 AA858014 BG055562 BG939559 AW080765 AA032283               AW467587 H40506               D00762 NM_002788 AA641134 AI582295 AI417525 AI563975 AI093566 AI707743 AI290741 AW073417               BE875418 BM264076 BG876884               AI680535 AW854219 BE774635 AW854212 BG952443 AW854221 AW854208 BE156348 BE843056 AW858991 BE937569               BG878291               BG876450 AW819099 AI908570 AA449871 AU135228 BM478404 BF126296 AA375499 AA248473       410388   36281_5   AW386165 AA831460 AA772198 AA687734 AI469486 Z39019 AI829314 AI809944 AI969600 BE348981 AW439586               AI207192 AI307374 AA084590 AA738148 AA309799 H89072       442107   2684347_1   AI912225 AI692286 AA976601       452299   89203_1   BE221822 AA025352 H43596 AI452797 AW206330 BF824812 BF748930 AA025363 BF856465       440248   2616908_1   AA876138 AI239602 AI698953       433023   3970_8   BE999967 BF438599 AW864793 AI802899 BE815132 AW468888 AI672189 AI052004 BF112024 AA772335 AW275054               AA573845 AI144148               AI968683 AA846676 AA927355 H80424 AW973295 R88209 F29868 BE928871       453085   10017_1   BC017336 BG716430 BG501286 BI458528 AI582223 N98532 AI338138 AI273442 AW102617 AA831177               AA745642 AA412583 AA355375               BG547492 AW954243 BI766546 BG057641 AI192435 AI338935 AI312651 AI708679 AI191125 AI206832 AA676899               AI078010 AI888718               AA452830 BF445542 N69930 AA715017 BF446713 BE046852 AW771909 AA907729 AI143749 AI761290 AA890233               BF925759 AI783713               AI767267 AA814538 W56778 AA918481 BG743526 BE645242 AI025328 AI298436 AI290445 H27710 AI475034 BG740023               AI090348 AI340003               BI602481 W38495 AI183314 AI927418 BG397181 AA878310 W19369 W56507 C05751 AW380760 AW380770 AW380790               BF930729 H28425 AA037326 AA375805       432541   625908_1   AW973316 AA552525 AW131368 AA614350       409193   22239_1   BC014317 BC015099 AF229179 NM_020665 BI760941 BG427247 BG429705 BG432624 BG399046               BG430790 BF940314 AW242855 AI793025               BE048959 BF589928 AA999850 AI767568 AW612416 AI911520 AI793193 AI373739 AI985237 AI433883 AW779364               AI253234 AI478325               AI524824 AI613056 AI650909 AW299600 BE465778 BF431418 AI470468 AA345162 AI671437 AI473091 BE501448               AI431850 BG400513               BG429618 BG400845 BG429174 BG429011 BG400319 BG399402 BG427839 BG433974 BG428217 BG426067 BG428990               BI762437 BG209271               AV653898 BG188580 BG400436 AI765078 BG184374 BG193796 BG431368 AA131483 AA065156 AA076448 BF031348       458140   1648556_1   BE559806 R12767 BE268806       445208   2826769_1   AI681579 AI216103 AI692734       458799   643053_1   AW173151 AI688547 AI768659 AI476487 AI797300       420820   26124_3   W73822 AI686053 T10508 AA722451 BF750857 BI858823 BF964200 AL577848 W26760               W73854 AA476662 AA280705 W26998 W27144       426532   1297511_1   AA486726 AA380886 AA486725       434072   73667_1   AF116655 AI114499 BF760333 H70853 BF326768 H70854       455063   1094851_1   AW854160 AW854156 AW854149 AW854147 AW854158       406827   0_0   AA971409       400157   2764_1   BC022339 BC009610 BC010537 X79805 NM_006713 U12979 BM467814 BM450743 AU132951               AU137129 BG493425 AV758819 BG708412               BG705885 BG702217 AV716638 BG777009 BI545689 BI552153 BM476712 BG770858 BG527656 BG528277 BG391388               AV716861 BI602926               BG290073 BI667399 BM451469 BI667173 BI602139 BG532171 BI669216 BI544727 BG721852 AV716503 AV701327               BM090738 BI492000               AI308856 BI544904 AL599813 AV715829 AV716505 AV714587 AV717902 BF668072 AV716385 BI461927 BM090954               AV717826 BG503676               AV647719 BG501392 BG428433 BE895629 BM313117 AW021050 BG435032 BM152910 AA313503 AA872377 BG574714               AV712054 AV732696               AA252476 AV712759 AL599643 BE790872 BG654930 W73337 AW675377 AV760376 AV725139 AV716379 AA887165               BE830003 AW023796               AL599291 AI902948 BG944042 F00781 AA352483 BG217897 N33888 AW581924 BG654730 D31410 AA353088 D31288               AA295029 H95170               BE935104 AU139980 BG772963 BG776470 BG532512 BG105449 BI545421 AV715456 AW386083 BG699714 AL535832               AL514940 BG190861               BG210593 AW999254 H95138 AA353863 BE764809 N50375 BE091363 BG701255 BI860846 BI832485 BG168150               BG028647 BE546301               BG900321 BI909737 BG702363 BG614141 BG611137 BG700121 BF031492 N85802 AV715940 N51590 BG993478               BE172016 AW893622       449261   3029652_1   AI923721 AI860294 AI637592       434636   15423_1   AJ420454 AF147430 AA910497 BF432963 AI701451 AI743089 AA429326 AI887812 AA315932 AI005464 AL043321               AI300993 AA425105               BE467230 BE669770 AA885637 BE503044 AW014324 AI809584 AW167510 AA921331 AA903224 W01644 AI762128               AA031404 BE550653               AI694045 BE043088 BE670430 AI630969 AI457315 BE644737 BE327316 AW295247 N92784 AI630807 BE328180               AI269949 AW245292               AA083765 AA256898 AI375535 AA430673 AI168735 AI589717 AA015942 AI693885 AW341205 AA931651 BF856764               BE468094 BF433393               BF445511 AA928976 AI817684 BF111008 AA428316 AA455858 N25716 AA568727 AI581817 AA427482 H40678               AA041483 N71630 H51826               BF969052 AA094470 AI560352 T98937 W52816 AA083764       413186   10095_1   AI800480 AI675873 AI492036 AA285369 AA043133 AI565092 AI094934 AI127591 AA774663 AW262141               AW184007 AI423287 AI282115               AI309111 AA206116 AI984711 AI218432 AA565473 AW439256 AI915825 AI690350 AI867581 AA888739 AW135142               BG202056 Z39676 T16640               AA765047 AW020940 AI961664 AI636487 AA492375 BF511091 BF511214 AI129459 AW117212 AI968323 AI656300               BE503348 BE503313               AI361209 AI925328 AA968416 AW611654 AW614387 BG108803 AA029159 BF176324 R16207 AL567126 AA224460               BM145135 BE855388               BI491899 BI493821 AL581038 R49543 AA422156 H92081 AA325525 R66331 BF748472 AI990318 AA279568 R67472               R32365 AI361184 R66332               AA029056 BE738339 BM145028 D29452 BE619671 R80926 AA130505 AW271168       417890   6087_3   NM_003777 AJ320497 BF980177 AA489276 AI042319 BF881839 BG999412 BI003305               W31815 AJ132087 BF369731 BG186912 AI740921               AI453059 AI027448 AI027859 AI041705 AI087934 BF056332 BF109708 AA937198 W20023 R23111 R79048 N90533       453823   1489490_1   AL137967 BE064160 BE064186       436763   1050498_1   BG928040 AI095270 AI990086 AI991608 AA730741 AA868238 BE815056 BE550792 AI168278 AI522194 AA973538               AI628424 BE814976 AI819707       446002   2852062_1   AI346468 AI347958 AI269775 AI269780       409835   915194_1   AW501362 AW501275       411111   1070063_1   AW818161 R09719 AW818127       408594   685806_1   BE184942 BE184946 AW238414 BE144666       433361   25962_1   AF026526 BG210339 AW611839 AI333926 AI719252 AI478251 AW469373 AI678201 BF056830 BE552206 AA706678               AW594061 AI744564               AI025408 AI744629 AI033875 AI051333 BF438997 AI991433       442079   648638_1   AL046653 AW183787 AA977613 AA975487 AI051504       443274   33097_1   AK023535 BI850449 BI494019 BG113829 BI494020 BF378857 AW262721 AI339175 AW029243 AI417477 AI679401               AI083840 BF475695               F26528 AI679908 AA659612 AI453737 AI523378 AW630773 AA251578 AA658039 R72090 AI832404 AV693821               AV698231 AV685465               BM423386 R80276 W39196 BI258049 AA508602 T85159 AA156499 AA664240 BF212163 AU156501       413840   38807_1   BC020284 AW953495 AW402677 BF890739 Z44378 AI660081 AI769242 T84954 C05886 AI224851 AI568340 AI024026               AW015010 AI032051               AA505095 AA830304 H98001 H63431 BG249610 AI284792 AA205732 AI598130 AW516813 AI123905               AA132557 AI140199               H53399 AA928496               AI200299 AI400044 BE940512 BE940609 H28028 BF913868 AI301558 D79095 AI762695 AA311547 AI673408               AI673002 N67358 AA885913               AI288094 N67347 Z40311 T94918 AV722693 AW170339 AW975566 AA452774 AA504759 AA370643 T79706 AA721603               BF858887 BG982917               AI343373 AW236167 BE568091 BF747959 BF241262 BE940663 AI435278 R05794 AW027091 AI860259 AI268890               T94871 AW182884 N67183               AW149083 H42473 AI678254 R26706 AI419684 R24905 AW388568 AW363261 N31299 H63489 AW195475 AA452592               BE844216 T91205               H64955 BF858811 AW962779 AW388295 BF857615 BF856552 BF856548 BF857611 AW866752       430715   32242_1   AI148194       450234   707416_1   AI797978 AI688524 AW270069       454514   1058176_1   AW802838 BE170861       449540   79180_1   AA001803 H63836 AA001713 H63784       444156   7612_13   BM456075 AA287437 AW503282 AW500236 AW505532 BM476391 BM151675 AW500059 AW503519               AW505387 AV760244 BM463484               AW499930 AW499907 AW504121 AW504494 AA286674 AI276686 AA286673 AW407901 AW503798 BG177295               BG389213 BM145086       454552   1061234_1   AW806924 AW866478 AW866473 AW866390 AW866309 BF373982 AW866298 AW866539 AW866521 AW866547               AW866454 AW866537               AW866517 BF373957 BF373949 AW866403 AW866369       417414   10043_1   AB049113 U31930 NM_001948 U90223 AK000629 BI091680 BG697899 BG700386 BE644721 BE673841 BE670064               BE218639 AW160384               BI489866 AW341118 AW629827 AI697600 BE222283 BF938984 BE550008 BF058963 BE549576 BE504213 AI951891               BG654389 AW162006               BE551158 BG655751 BI438412 AI634515 AW967946 AI373097 AI937879 BF477872 AI693247 AA284034               AW968574 AW968748 AL519489               AA491130 M89913 BG403290 M504296 AA263067 AA366402 BF899218 AW007239 AU119115 D55898 BI333317               AI879028 AV651114               BE502892 AW341323 BF478012 BG705392 BG505144 AV747151 AA416647 W65362 BF170355 AI361859 AI061446               AA744361 AI800124               AI888707 AI810305 AW950219 AI266370 AI202472 AA731309 AI352257 BE327789 D19871 AW059539 BM263848               AI828180 AA994216               AA721362 R76541 AA806886 AA861025 AA687747 AI304562 BI091131 BF206146 BI255334 BE254729 BG610639               AA278989 BF698002               AA446533 BF970255 BE928140 AI348028 AI521455 AW474561 AW591403 AI654314 AV701730 AI433388 AW166689               AW976899 BE568767               AA887905 AA766415 BG168154 BF317403 BI855761 BI758597 BF216176       453959   9900_1   NA       439195   21979_1   AF086037 H89360 H89546       400223   2368_1   NM_005648 BC013809 L34587 BF103775 BG702618 BG716553 BI667090 BG505863               BF983483 BG718195 BI857891 BG501016 BM043599               AL521812 BG705730 BI495545 BI495546 BF112248 BM023182 BM023123 AI075173 AW051799 BF058224               BI324885 BF436008 AA398446               BG822375 BM019558 BM023382 BG164174 N56909 BI467064 BM023464 AI207475 BM311415 BG758430 BG758807               AI934826 N90351               BG422026 BE910312 AI027778 AI081950 AI360890 BM009115 AI191829 BG759697 AI138728 AA399403 AI355589               AI336427 AA868702               AA393660 AA025127 BG027630 AA962774 AA631224 BG940967 BE791087 AA573315 W81685 AA393525 BG944103               AI339125 AI149864               AA977655 N90314 BE612839 BG491847 AI129091 AA461234 AA781198 AA759256 AA888954 AA975844 AI184099               AI018025 AA398363               AI003331 AI193380 AA626020 AI244476 AI601114 AW135664 AI206607 AW263599 AA813219 AI684453 AA878626               AA772222 AI085496               AI630226 BG940966 AI022010 AA770649 AA887624 AA491739 AA974295 BG530040 AA037091 AA019912 BI160457               H64512 BG503896       454067   98108_1   AI809849 AW241782 AA041455       442092   22756_2   BM449821 BM069895 BM023170 AW025563 BG152606 BM023452 AI862106 BG959957       430504   5477_6   BE219720 BF475241 AI571723 BE219848 BI789268 AI224899 AA724864 AW771467 AA480255 AW845616               AI440295 H52800 BE218790               AI681575 AW300064 AW262133 H21568 AI363015 AI884914 H86948       406731   0_0   AI559131       457447   44331_1   X78261 AI214094 AA483530 AW972127       455679   151610_1   BG007296 BF330853 BF747375 BE066356 BE066292 BF330900 BF747142 BE066419 BF742510 BE066529               BE066298 BF742516 BF746603               BE066274 BF334312       430534   1233361_1   AW968508 AA480908 AA480971       409490   2925095_1   AA084745 AA084736 AA075064       425376   34867_1   AB075838 AK056181 AW958603 BE390381 AA356365 BF196303 H10404 Z39522 AV725320 AV727868 BM454236               AA365277 R38602 H10612               BF212958 AA481673 R13757 BG026236 AI498819 AA894612 AA610077 AW352149 AA481433 AW079577 AI885666               AA532463 AI624958               AI624974 H93131 BE566327 AI955749 AI478116 BE546266       437440   2497201_1   AA846804 AA757581 AI050950 AI092024 AA838807       453327   23886_2   AL562496 BF696621 AV704702 BG898086 AW968374 AA481612 AA431838 AA476509 BM271915 BI438471 AW021944               AA465428 BI492903               AW500180 AI337886 AW628927 AI337904 AI865657 AI095827 AI277333 AI192671 M910864 AI056123 AI359717               AI801670 AA554891               BF002895 AI146699 AI277967 AI421245 AI554684 AI076969 AA127232 AI090547 AW295617 AI339523 AI144431               AA857201 AA476409               AA465393 BF445672 AI247616 AA905002 AA723681 AA465357 AA465372 AI027015 BF939274 BE769036 AA983718               AI796838 BF373700               AW864097 AA506221 BE326573 AW368726 AA035002 AA149487 BE887617 AI692779 AI183608 AA858044 BI467397               AA046036 W67790               W32699 AA431436 AA035510 AA836772 AA481546 BM264551 AA465448 AA339752 BF698980 AA621703 BE825936               W67848 BE766805               N66434 N59817 N26170 AA668310 BE768929       428384   775_1   M54968 AA861543 AA356548 AI469981 NM_004985 BC013572 AW242010 AI740449 BF588730 AA425263               W21091 AI554920 T28976               AW966530 BC010502 BM146110 AW504574 BG142117 AA232870 AI539465 AU123937 BI260541 BG261289 N24354               N32462 H08297 F05452               AA281203 N80109 AA330460 D51551 BE178107 BE177839 BE178094 BE178141 BE931948 BE178093 BE178215               AL138354 AI091259               AW020801 AA287991 BE178352 AA281183 BE178186 R70669 BI833742 BE178449 BE178043 W47526 BE178018               BE834453 W93668               BE177936 AL576273 AU151852 AI004579 AW453052 AA287927 BM144801 AU155143 AA281094 AA737010 AA872481               AA676681 AA843916               AI697660 AA564243 BF109372 AI015987 BF432094 AA937541 AI334416 AI281159 AA582189 AA553559 AW160515               AA255527 AA670007               AA808271 AA281015 AA649252 BE464958 AW167917 BF436494 AA525301 AI889481 AI364302 AW173466 AI676214               AA243624 AA648116               AA854442 AA721296 F01713 BE178360 BE178299 BE178460 BE178385 BE178424 AI301629 BE049265 AU151277               AU155121 AU155337               AA889246 AU153181 AA342730 AW601642 H08199 R41588 R99351 H84241 W47527 R26447 R49696 H02312 R79833               AV716970 AA262387               BE178441 BE178356 BE178100 BI491761 BE178467 BE931952 BF758698 BE177893 BE178336 AA256711 W80934               BE178447 AV689618               BE178438 BE177844 AV659669 BG619554 AU134516 R35396 BE178029 R28455 AW368425 BE178017 BE177999               R34165 R79640 BE178422               BF761849 BE178196 BE178443       426295   510_1   BE880923 BG390191 AW470082 AW014585 AI423255 BI714731 BG054894 AW780248 N31683 AW664132               AW467353 AI983152 AA617918               BF447795 AI088357 AA807328 AA576970 AI741153 AI755003 AI474016 AI422030 AI348114 AW997085 BM271753               AI363147 BM311311               AI146640 AI246771 AW512619 AI359020 BG054897 AI292234 AI215830 AI283836 C06205 AW503423 AW272680               N33205 AW873021               AA070724 AI753886 AW192487 AI087151 AA658909 AI346368 AI335677 AA825442 AW440066 AW131357 AW513210               AI082314 AI085455               BE551404 AA780704 AW008596 AI796964 AA917471 AI400531 AA668626 N72207 AI306482 AW440562 AI084687               AA347280 AA063536               BF477389 AI241662 AA931543 AA484310 AA812486 AI032216 AA665779 AI916336 AI350590 BF198106 AI433377               AI300638 AI672626               AI282741 AI351487 AW105544 AA973627 AW517914 AA715424 AA508454 BF334080 AI274618 AW367201 AW572619               AW469088 AA382095               AI368364 AI146934 AI357180 AI361181 BI911347 BI871044 AA136325 BF084010 BF084007 AA335788 AI920878               AA809614 BE932941               AI678261 C75308 AI148479 BE178174 W88513 BM013627       436024   138548_1   AI800041 AA703553 AA984529       419881   3973_1   AL573520 BF058611 AA329340 AL578426 AA748587 AA251524 BG056795 AA989242 AA716558 BI860141               AW967619 AI949529 AI889732               AI871690 AA830473 AA769808 AA570708 AA844702 AA838659 AI653883 AW768563 AA442846 AW273448 AA437017               AI493986 AW628781               AL562775 AI870399 AI432295 AW439601       414022   32320_46   W44916 F07627       415524   1875412_1   R13958 Z45262 F11541       459428   259201_1   AW502680 AA258989       412634   131633_1   U55984 AA195883 AA447957 AA393452 AA384799 AW958952 W68044 AA197345 AI241933               R59505 W67965 AA826474 AI336006 AA931733               AW025414 AI769180 AI355738 AI860952 AA907417 AW408679 AA453139 AA938346 AI279697 AA121899 AA400768               AI559827 AA448889               N62400 AW236656 AA904207 W79380 R59504       416721   1987834_1   H80001 H87290       454900   1077113_1   AW838132 AW838129 AW838458 AW838513 AW838430 AW838373       442462   1984399_1   AF031405 H73415       434665   115504_1   AA642125 BG311079 BG311075 AA654516 BG311138 BG311173       400239   16458_1   BC003160 NM_001610 X12548 BG386685 BI760866 BI559619 BG323829 AU135543 BI834101 AU142120               AU124511 AU124889 AL558171               AU117286 BI824000 BG386610 BI753285 BI223475 AU134828 BM126369 BE206493 BF751498 AL544274 AY007137               BI828921 BE870130               BF771242 BI835451 BI765655 BI820955 BI223344 BG015924 BI759894 AL527413 BF310588 N31870 N23974 BE514914               T48863 AW860257               BF334625 AA883860 AU144168 AA442562 AU159491 AU148353 AA564123 AU148667 AI377256 AW664004 AI871712               AI141486 AI332351               AI339094 BE206109 AW519033 AI817729 AI332490 AI149455 AI857411 AI763154 AI751608 AI377222 AI081956               AW664229 AI275872               AW168546 AA975270 AI367408 AI687729 AI269164 AW105344 BM193081 BE550930 AI082116 AA854691 AI056249               AI221062 AI290113               D51818 AA732409 BG055125 N85878 AU156121 BF093671 AA053070 T28548 AL570460 BI006862 BI007207 AA373620               W95069 AA629136               AA708164 AI014886 AW168697 D51623 AA577168 AI094208 AA028946 AA975078 R16815 BG151132 AI276297 D51676       455148   1099439_1   AW858423 AW858403 AW858594 AW858406 AW858587 AW858549       434775   118125_1   AA648983 AA741088 AW029205 AI925642 AA715292                                            
     [0367]                           TABLE 11C                       Pkey   Ref   Strand   Nt_position                  402994   2996643   Minus   4727-4969       402264   3289984   Plus   184006-185825       402424   9796344   Minus   64925-65073       404649   9796926   Minus   100027-100399       405533   9755498   Minus   75690-75853       402230   9966312   Minus   29782-29932       400751   7331445   Minus   35395-35533       400694   8118802   Plus   94288-94442       401467   6682292   Minus   66845-67037       403789   8084957   Minus   64056-64148, 65262-65425       406117   9142932   Plus   54304-54584       406420   9256411   Plus   157797-158054       404426   7407959   Plus   77842-77954       401274   8954206   Minus   111258-111378       400929   7651921   Minus   122033-122241, 123483-124028       403790   8084957   Minus   87826-87947, 89835-90002       405268   4156151   Minus   24404-24521       402855   9662953   Minus   59763-59909       400517   9796686   Minus   49996-50346       402976   9795206   Minus   25819-25969       403743   7652003   Minus   136463-136646       403828   9838214   Plus   31755-32148       405689   4508117   Minus   92558-92698, 94282-94382,                   97977-98180, 9920       403742   7212067   Plus   84805-85525, 91096-91227,                   93970-94057, 9523       403319   8318526   Plus   124240-124459, 125182-125409       404602   8705107   Minus   138628-138893       403654   8736093   Minus   28634-28758       402396   1905896   Plus   4426-4648       405372   2078459   Minus   10148-10272, 11205-11349,                   11436-11560, 1178       403694   7107765   Plus   142925-143080,                   165505-166186, 167486-16763       404584   9857511   Plus   138651-139153       404240   5002624   Minus   116132-116407, 116653-116922       404409   7342122   Plus   22113-22290       405601   5815493   Minus   147835-147935, 149220-149299       404919   7341872   Plus   1482-1609       403738   7212067   Plus   38434-38562, 56876-57007,                   59789-59876, 6071       401847   7139731   Plus   85447-85593       401928   3873182   Plus   54932-55070       406274   7543787   Plus   932-1123       401558   7139678   Plus   103510-104090       403746   7652036   Plus   93612-93887       402945   9368458   Minus   100591-100710       400487   8919452   Plus   19369-20782       403330   8516153   Plus   116558-116698       400975   7139779   Minus   108473-108847       400552   9801071   Plus   93101-93276       403147   9799812   Plus   171145-171419       406605   8272666   Minus   23275-23493, 23723-23903       402907   6706902   Minus   8561-8692       401431   8217913   Plus   81467-81661       401047   6705887   Minus   4804-5035, 5133-5314       404813   3355600   Plus   2672-2989       406137   9166422   Minus   30487-31058       400763   8131616   Minus   35537-35784       403608   8308266   Minus   121321-121476       400840   9188586   Plus   113882-114121       403827   9838214   Minus   14941-15869       403809   8568861   Plus   33910-34129, 34583-34862       403142   9444521   Plus   89286-90131       402813   6714723   Minus   45613-45781, 47581-47731,                   49698-49805, 5095       403538   8077008   Minus   119579-119926, 120614-120784       402969   9581784   Minus   19036-19175       406182   5923650   Minus   28256-28935       406364   9256114   Minus   50715-50833       405232   7249042   Plus   125904-126063       403417   6862691   Plus   199375-199572       405257   7329310   Plus   73121-73273       403585   8101208   Minus   131266-131769       403832   2121307   Plus   76091-77344       402964   9581599   Minus   46624-46784       401060   8117674   Minus   110262-110791       406350   9256015   Minus   186117-186362, 190904-191095       403056   8954178   Plus   95479-95570, 96434-96703       406341   9255965   Minus   117712-117896       404694   9799957   Minus   128092-128227       402668   7283250   Plus   67493-68044       405296   3779036   Plus   8072-8273       402729   9211639   Plus   78980-79093, 79333-79467,                   80173-80290       405122   8137462   Minus   95449-95646       402737   9212184   Minus   13358-13552       404231   8218035   Minus   61077-61322       405287   3928029   Plus   89802-89999       405695   4309958   Plus   51860-52162       401112   9966198   Minus   60628-61041       403671   7272159   Plus   104461-104701       400886   9958187   Plus   70649-71114       402474   7547175   Minus   53526-53628, 55755-55920,                   57530-57757       405064   7658416   Plus   81207-81416       402007   7381786   Plus   143964-144081       400967   7770682   Minus   32697-32999       404497   8151650   Minus   593-1416       404692   9799952   Plus   49258-49403, 54226-54341,                   63837-63988       405166   9966302   Plus   40526-40891       405270   4156145   Minus   3952-4123, 6886-7010, 8541-8728       402109   8131678   Minus   171722-171859, 173197-173303       403363   8571785   Plus   67156-67285, 67620-68007       406023   8272661   Plus   205623-205936       403185   9838287   Minus   108676-108803       403611   8347965   Minus   130635-130774       403707   7108128   Minus   132794-133294       404124   9796734   Plus   13539-14192       403292   7230870   Plus   99123-99367       403027   7670575   Plus   60696-60932, 61362-61521       406535   7711477   Plus   83135-83362       405922   6758795   Plus   126307-126677       406238   7417725   Plus   31155-31657                                                    
     [0368] Table 12A lists about 254 genes down-regulated in Hepatitis C positive liver tissues compared to Hepatitis C negative liver tissues. These genes have the potential to be diagnostics and/or prognostic markers for Hepatitis C infected liver tissues. They may also provide clinical information on Hepatitis C infection and pathology. They may also be potential targets for therapeutic drugs and/or treatments. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the t-test p-value between the Hepatitis C positive liver tissues group and the Hepatitis C negative liver tissues was less than 0.01, and that the differences between the average “standardized values” of the several different Hepatitis C negative liver tissues was equal to or above 1.0 more than the average “standardized values” of the several different Hepatitis C positive liver tissues. The “standardized values” of the Hepatitis C liver tissues were derived by subtracting the median of the Hepatitis C negative liver tissue values from each probeset value, then divided by the interquantile range (IQR) of the same Hepatitis C negative liver tissue values.  
                                   TABLE 12A                       Pkey   ExAccn   UniGene   Unigene Title   R1   R2                                                        441475   AI929602   Hs. 177   phosphatidylinositol glycan, class H   6.80E−05   9.91       453863   X02544   Hs. 572   orosomucoid 1   1.46E−03   5.21       449761   AB009698   Hs. 23965   solute carrier family 22 (organic anion   2.10E−03   4.68       445610   AI831648   Hs. 143993   ESTs   1.53E−03   4.63       404473           ENSP00000247423: D-siglec precursor.   3.16E−03   4.40       440721   AW183540   Hs. 85273   ESTs   9.60E−05   4.14       442820   AW293459   Hs. 6314   ESTs   1.50E−05   4.04       446221   AI744445   Hs. 167073     Homo sapiens  cDNA FLJ13047 fis, clone NT   7.92E−05   3.41       449184   AW296295   Hs. 196491   ESTs   5.21E−10   3.23       454947   AW846590       gb: QV0-CT0180-011099-025-d07 CT0180 Homo   1.84E−06   3.21       434180   AA921757   Hs. 116180   ESTs   7.08E−07   3.01       423744   D26158   Hs. 1701   ELAV (embryonic lethal, abnormal vision,   2.94E−03   3.00       410482   AW772187   Hs. 191859   ESTs   7.60E−06   2.93       422472   R59096   Hs. 279939   mitochondrial carrier homolog 1   9.77E−05   2.89       454136   AA046477   Hs. 62813   insulinoma-associated protein IA-6   4.63E−04   2.89       458818   AI523857   Hs. 232257   ESTs   4.91E−05   2.87       457960   AA771881   Hs. 298149   ESTs   3.65E−03   2.84       446433   AW293404   Hs. 211986   ESTs   1.75E−04   2.73       409212   AI082423   Hs. 141892   ESTs   1.60E−06   2.72       435590   AF216389   Hs. 148932   sema domain, transmembrane domain (TM),   8.04E−05   2.72       402845           ENSP00000246267: KIAA0444 PROTEIN (FRAGME   9.30E−06   2.67       400692           Target Exon   4.42E−10   2.67       411449   AW847318   Hs. 290131   KIAA1819 protein   1.36E−04   2.66       455765   BE082222       gb: QV2-BT0636-070500-196-b08 BT0636 Homo   2.68E−03   2.64       458674   AI304386   Hs. 150836   ESTs   5.42E−07   2.59       455919   BE157345       gb: RC3-HT0371-110300-017-b01 HT0371 Homo   6.41E−04   2.58       412998   BE046254       gb: hn38g09.x2 NC_CGAP_RDF2  Homo sapiens     6.95E−05   2.56       417574   R00348       gb: ye69e06.r1 Soares fetal liver spleen   1.30E−03   2.53       437957   T97069   Hs. 282787   gb: ye50f03.r1 Soares fetal liver spleen   7.21E−08   2.51       452777   AW449161   Hs. 217300   ESTs   2.81E−07   2.50       428547   AF120491   Hs. 184889   potassium voltage-gated channel, Shal-re   3.13E−04   2.49       435715   T78013   Hs. 167279   FYVE-finger-containing Rab5 effector pro   2.14E−04   2.48       456636   AW205448       complement component 3   1.09E−05   2.46       432342   AL036128   Hs. 274404   plasminogen activator, tissue   3.57E−05   2.46       427269   AA400147   Hs. 125234   chromosome 21 open reading frame 54   2.37E−07   2.42       409840   AW502122       gb: UI-HF-BR0p-ajr-c-08-0-UI.r1NIH_MGC_5   2.53E−06   2.42       414562   AW955734   Hs. 112195   ESTs, Weakly similar to 2108402A carniti   1.68E−05   2.41       420796   L34355   Hs. 99931   sarcoglycan, alpha (50 kD dystrophin-asso   3.13E−03   2.38       432745   AI821926       gb: nt78f05.x5 NCI_CGAP_Pr3  Homo sapiens     1.10E−04   2.37       428006   AA418743   Hs. 98306   KIAA1862 protein   8.66E−04   2.35       407563   R06177   Hs. 19613   ESTs   1.89E−08   2.34       400435   AF282973       protocadherin beta 8   1.15E−05   2.32       430878   BE500985   Hs. 248107   EDG-3 (endothelial differentiation, sph   2.20E−05   2.30       413946   BE185066   Hs. 2055   gb: MR1-HT0709-100500-002-c09 HT0709 Homo   1.67E−03   2.30       437015   AI970163   Hs. 237198   ESTs   3.21E−03   2.27       458988   AW410431   Hs. 283670   CGI-119 protein   9.83E−06   2.26       454810   AW832917       gb: QV2-TT0003-161199-013-h06 TT0003 Homo   3.07E−03   2.24       458299   AI024834   Hs. 131729   ESTs   2.45E−06   2.22       438397   AA806478   Hs. 123206   ESTs   1.20E−04   2.22       404224           Target Exon   2.72E−10   2.22       405800           Target Exon   1.33E−06   2.22       411772   BE170301       gb: QV4-HT0536-040500-193-f05 HT0536 Homo   5.16E−04   2.21       401149           Target Exon   9.04E−07   2.20       405334           Target Exon   3.80E−04   2.20       441611   AW590829   Hs. 133463   ESTs   1.73E−08   2.19       407457   AJ242724       gb:  Homo sapiens  mRNA for partial putativ   4.71E−05   2.18       414024   AA134712   Hs. 22410   gb: zm79g08.r1 Stratagene neuroepithelium   3.72E−07   2.18       450703   AA011202       nuclear factor I/C (CCAAT-binding transc   1.02E−06   2.17       436871   X15667       gb: Human mRNA for glutathione peroxidase   3.18E−07   2.16       417752   C15737   Hs. 269386   ESTs   2.59E−05   2.16       404958           Target Exon   8.05E−05   2.16       459235   BE246010         Homo sapiens  mRNA for FLJ00038 protein.   3.75E−05   2.14       416626   H69171   Hs. 205978   ESTs, Moderately similar to ZN91_HUMAN Z   3.33E−03   2.14       419695   N99713   Hs. 109514   ESTs   6.58E−04   2.13       412496   R87592   Hs. 12509   gb: ym91b06.r1 Soares adult brain N2b4HB5   9.12E−05   2.12       426505   BE185582       gb: IL5-HT0731-010500-078-g07 HT0731 Homo   7.94E−04   2.12       453840   AW846927   Hs. 46808   gb: RC3-CT0197-150999-011-A01 CT0197 Homo   1.36E−04   2.12       423053   BE312679       gb: 601148138F1 NIH_MGC_19  Homo sapiens  c   1.00E−05   2.12       436690   AA373970   Hs. 183096   ESTs, Highly similar to S15536 homeotic   9.53E−05   2.11       405058           Target Exon   5.01E−07   2.11       426402   BE387327   Hs. 80475   polymerase (RNA) II (DNA directed) polyp   3.46E−06   2.10       449243   AW295031   Hs. 198671   ESTs   1.86E−05   2.10       444163   AI126098       FGENESH predicted RNaseH domain-containi   6.37E−04   2.10       440730   BE561722       gb: 601345466F1 NIH_MGC_8  Homo sapiens  cD   5.62E−05   2.09       437161   AA054477   Hs. 25391   ESTs   9.90E−05   2.08       447721   BE619620       lysyl oxidase   1.33E−06   2.08       455973   BE175424       gb: RC4-HT0578-170300-012-d01 HT0578 Homo   1.01E−03   2.06       407598   AW083834   Hs. 246397   ESTs   3.87E−03   2.06       457736   AK000390   Hs. 150549   hypothetical protein FLJ20124   2.25E−03   2.05       433303   AW444881   Hs. 77829   ESTs   1.28E−05   2.04       456040   AW390834   Hs. 75874   pregnancy-associated plasma protein A   2.69E−04   2.04       454707   AW814989       gb: MR1-ST0206-170400-024-g05 ST0206 Homo   2.84E−04   2.04       410739   AL157438   Hs. 324473     Homo sapiens  mRNA; cDNA DKFZp434A115 (fr   4.80E−03   2.04       430070   AF197927   Hs. 231967   ALL1 fused gene from 5q31   1.38E−06   2.03       452621   N44030       gb: yy50c11.r1 Soares_multiple_sclerosis —     3.48E−06   2.02       422375   AA768234   Hs. 292430   ESTs   5.15E−04   2.02       419555   AA244416       gb: nc07d11.s1 NCI_CGAP_Pr1  Homo sapiens     1.34E−06   2.01       427840   AI216654   Hs. 98251   ESTs   5.62E−06   2.00       431249   NM_004283   Hs. 8036   RAB3D, member RAS oncogene family   2.90E−03   2.00       438573   AW135084   Hs. 127264   ESTs, Weakly similar to JC5314 CDC28/cdc   1.64E−05   1.98       451402   AI793167       ESTs, Highly similar to AC004836 1 simil   1.74E−04   1.98       447715   AW291714   Hs. 221703   ESTs   1.95E−07   1.98       428744   BE267033   Hs. 192853   ubiquitin-conjugating enzyme E2G 2 (homo   2.70E−04   1.98       414063   H26904   Hs. 75736   apolipoprotein D   1.83E−05   1.98       434646   AF147445       gb:  Homo sapiens  full length insert cDNA   3.61E−03   1.97       425036   BE467912   Hs. 154294   discs, large (Drosophila) homolog 1   1.65E−03   1.97       452742   AW589945   Hs. 97876   hypothetical protein DKFZp564K0322   1.71E−05   1.96       400663           Target Exon   9.40E−04   1.95       454328   AW372097   Hs. 278429   hepatocellular carcinoma-associated anti   5.19E−03   1.95       403686           C4001366*: gi|9837427|gb|AAG00570.1|AF287   2.69E−04   1.94       402399           C19001025*: gi|11275298|dbj|BAB18302.1|(   5.65E−04   1.94       414584   BE409585   Hs. 117715   hypothetical protein MGC10850   2.52E−05   1.94       409795   AI934808       ESTs, Weakly similar to T46338 hypotheti   6.48E−04   1.93       445123   AI762911   Hs. 145369   ESTs   3.97E−07   1.93       457561   AA331517   Hs. 286055   chimerin (chimaerin) 2   7.32E−04   1.93       421511   AA488940   Hs. 105216   hypothetical protein FLJ11125   4.63E−06   1.93       415167   AA160784   Hs. 26410   ESTs   9.17E−03   1.92       445403   AI222423   Hs. 308322   ESTs   8.85E−04   1.92       442793   AI017798       ESTs, Weakly similar to TI47_HUMAN CARGO   7.50E−08   1.91       401624           Target Exon   6.28E−07   1.91       413537   BE146866       gb: QV4-HT0222-211099-014-f06 HT0222 Homo   2.43E−05   1.90       444832   AI807563   Hs. 148452   ESTs   3.77E−03   1.88       455968   BE168828       gb: QV1-HT0517-020400-145-f04 HT0517 Homo   1.48E−05   1.88       401706           Target Exon   2.57E−04   1.87       416648   R97488       gb: yq53b09.r1 Soares fetal liver spleen   7.47E−05   1.87       458867   AW995393       gb: QV0-BN0042-170300-163-g12 BN0042 Homo   2.20E−07   1.86       405263           ATPase, Na? transporting, alpha 2 () pol   1.42E−04   1.86       457148   AF091035   Hs. 184627   KIAA0118 protein   8.35E−05   1.84       403796           Target Exon   2.31E−03   1.84       450657   AK001579   Hs. 25277   hypothetical protein FLJ21065   3.73E−05   1.84       405639           Target Exon   4.60E−03   1.84       425526   AA359933       gb: EST69040 Fetal lung II  Homo sapiens  c   1.86E−03   1.84       407290   AA633861   Hs. 12106   ESTs, Weakly similar to ALU7_HUMAN ALU S   5.47E−04   1.83       448647   AI702965   Hs. 45005   hypothetical protein FLJ12960   1.49E−04   1.83       448871   BE616709   Hs. 159265   kruppel-related zinc finger protein hcKr   7.64E−05   1.83       432018   AA524447   Hs. 152377   ESTs   2.23E−04   1.81       433545   AA868510   Hs. 112496   ESTs   5.50E−05   1.81       427789   AA412428   Hs. 48642   hypothetical protein FLJ23093   2.54E−03   1.81       429013   AJ012590   Hs. 194728   hexose-6-phosphate dehydrogenase (glucos   2.54E−05   1.80       446887   AI346656   Hs. 156652   hypothetical protein FLJ22800   7.83E−07   1.79       441718   AW573183   Hs. 127380   ESTs   3.62E−06   1.79       454287   AF075292   Hs. 49585   fibroblast growth factor 18   2.82E−05   1.79       435125   AA381895   Hs. 284204   F-box only protein 29   6.24E−07   1.79       408099   AW151637       ESTs, Moderately similar to Z195_HUMAN Z   1.70E−05   1.78       434884   AF161340         Homo sapiens  HSPC077 mRNA, partial cds   3.95E−04   1.77       428303   AW974476   Hs. 183601   regulator of G-protein signalling 16   2.82E−04   1.76       435028   AW193035   Hs. 187370   ESTs   2.89E−03   1.75       421472   NM_003323   Hs. 104636   tubby like protein 2   1.28E−04   1.75       438687   AA814084       ESTs   5.89E−04   1.74       412004   NM_005042   Hs. 73952   praline-rich protein Haelll subfamily 2   6.32E−05   1.74       403794           Target Exon   9.24E−05   1.74       441184   AA922009       ESTs   6.67E−07   1.73       430358   AW604424   Hs. 239891   G protein-coupled receptor 35   1.21E−05   1.73       410312   AW850953       gb: IL3-CT0220-150200-068-A11 CT0220 Homo   4.73E−06   1.73       403772           NM_003061:  Homo sapiens  slit (Drosophila)   1.08E−04   1.73       405126           Target Exon   2.23E−04   1.72       438338   NM_014861   Hs. 6168   KIAA0703 gene product   4.80E−05   1.72       456782   AK000462   Hs. 132071   ovarian carcinoma immunoreactive antigen   8.79E−05   1.72       422097   X61755   Hs. 111473   homeo box C5   6.28E−03   1.71       415593   F13043   Hs. 6918   ESTs   4.22E−03   1.71       409545   BE296182   Hs. 19002   hypothetical protein MGC4675   8.81E−03   1.71       453855   AA039576   Hs. 37858   ESTs, Weakly similar to ALUB_HUMAN !!!!   5.82E−03   1.71       400729           Target Exon   3.52E−05   1.70       457505   AL044659   Hs. 43791   ESTs   6.22E−04   1.70       420548   AA278246   Hs. 920   ESTs   1.27E−03   1.69       433899   AW628168   Hs. 152684   ESTs   1.22E−03   1.69       423103   AA322029       gb: EST24685 Cerebellum II  Homo sapiens  c   7.95E−04   1.68       435367   AI917684   Hs. 85524   for muscle specific ring finger 2   2.37E−03   1.68       447135   T58148       gb: yb98g06.s1 Stratagene lung (937210) H   2.13E−06   1.68       429642   X68264   Hs. 211579   melanoma cell adhesion molecule (MCAM) (   1.65E−06   1.68       422189   AF252292   Hs. 112933   Tax interaction protein 40   7.46E−03   1.68       422028   AW090340   Hs. 14337     Homo sapiens  cDNA FLJ14407 fis, clone HE   3.17E−03   1.67       441777   AI733440   Hs. 127735   ESTs   8.00E−04   1.67       415897   H08323   Hs. 268712   ESTs   3.51E−04   1.67       403243           Target Exon   3.28E−05   1.66       402690           Target Exon   1.11E−05   1.66       445132   Z44811   Hs. 14928   hypothetical protein FLJ12903   1.10E−05   1.66       405677           Target Exon   9.97E−03   1.66       441477   BE379434   Hs. 192127     Homo sapiens , clone IMAGE: 3609326, mRNA,   1.03E−03   1.66       400522           Target Exon   1.90E−06   1.66       407283   T51008       gb: yb55e08.s1 Stratagene ovary (937217)   7.26E−05   1.65       440509   BE410132   Hs. 134202   ESTs, Weakly similar to T17279 hypotheti   6.14E−06   1.65       453449   W16752   Hs. 32981   sema domain, immunoglobulin domain (Ig),   4.49E−06   1.65       431107   AW451602   Hs. 153590   ESTs   2.58E−06   1.65       410736   AA205850   Hs. 122823   thousand and one amino acid protein kina   2.55E−04   1.65       410255   AA234006   Hs. 321264   LBP protein 32   1.07E−03   1.64       457394   M86528   Hs. 266902   neurotrophin 5 (neurotrophin 4/5)   1.37E−05   1.63       406140           Target Exon   7.83E−06   1.63       408932   AW594172   Hs. 278513   TP53TG3 protein   8.73E−03   1.63       453992   AW014995   Hs. 281080   ESTs   7.00E−06   1.62       418141   AW845738   Hs. 171118   hypothetical protein FLJ00026   1.34E−04   1.62       454430   AI082777   Hs. 61384   sema domain, seven thrombospondin repeat   2.32E−04   1.61       439335   AA742697   Hs. 62492   NM_052863:  Homo sapiens  secretoglobin, fa   1.22E−05   1.61       433095   AK001092   Hs. 302480     Homo sapiens  cDNA FLJ10230 fis, clone HE   4.03E−05   1.61       454527   AW804626   Hs. 151237   hypothetical protein FLJ12526   7.10E−03   1.61       444462   AA127530   Hs. 286035     Homo sapiens  mRNA for KIAA1783 protein,   6.17E−04   1.60       435724   N39308   Hs. 117898   ESTs   5.43E−08   1.60       411181   AW820794   Hs. 252406   hypothetical protein FLJ12296 similar to   1.80E−04   1.60       446705   AW206634   Hs. 224879   ESTs   3.59E−06   1.59       416249   R85267   Hs. 107692   ESTs   6.97E−04   1.59       421539   AA292747   Hs. 97296   ESTs   1.44E−04   1.59       423658   AB003062   Hs. 130760   myosin phosphatase, target subunit 2   3.00E−04   1.59       426254   BE018103       PP3111 protein   1.45E−06   1.58       442674   AI124736   Hs. 142921   ESTs   1.19E−03   1.58       407845   AL036518   Hs. 118598     Homo sapiens  mRNA for KIAA1878 protein,   2.96E−04   1.58       410626   BE407727   Hs. 199316   gb: 601299771F1 NIH_MGC_21  Homo sapiens  c   1.10E−03   1.58       415160   T82802       gb: yd38a04.r1 Soares fetal liver spleen   3.67E−06   1.58       416397   H53035         Homo sapiens  AFG3L1 isoform 1 mRNA, part   3.78E−03   1.58       401371           ENSP00000198192*: BA438F9.1 (novel protei   1.37E−04   1.58       457008   AA410446   Hs. 112011   ESTs, Weakly similar to unknown [H.sapie   7.30E−05   1.57       456093   AL135220   Hs. 77579   apoptotic protease activating factor   3.53E−04   1.57       408518   BE162203   Hs. 314758   ESTs   2.86E−03   1.57       406357           Target Exon   1.40E−03   1.56       401554           Target Exon   4.40E−03   1.56       423143   M64676   Hs. 124212   potassium voltage-gated channel, Shaw-re   6.15E−06   1.56       409911   N43177   Hs. 284217   serologically defined colon cancer antig   5.78E−03   1.56       445889   BE465186   Hs. 266958   ESTs   2.38E−05   1.55       405137           Target Exon   1.73E−03   1.55       418525   AW450369   Hs. 86937   ESTs   2.90E−04   1.55       425169   AW292500   Hs. 128514   ESTs   3.54E−03   1.55       404843           C22000088*: gi|6678165|ref|NP_033461.1|s   8.09E−04   1.55       456764   AA325560   Hs. 346401   ESTs   4.17E−04   1.55       412371   AW946621       gb: RC2-ET0021-280400-011-e12 ET0021 Homo   6.83E−03   1.55       458211   AA922156   Hs. 144751   ESTs   1.58E−03   1.55       403613           C3000680*: gi|5852484|gb|AAD54072.1|AF131   2.05E−03   1.54       402534           Target Exon   2.23E−04   1.54       428189   AA424030   Hs. 46627   ESTs   2.07E−06   1.54       401629           ENSP00000251306*: HYPOTHETICAL 42.6 kDa P   1.46E−05   1.54       426449   AL134009   Hs. 169936     Homo sapiens  mRNA; cDNA DKFZp586N1918 (f   4.75E−03   1.53       404731           NM_006180*:  Homo sapiens  neurotrophic tyr   3.51E−03   1.53       422111   W04245   Hs. 107761   ESTs, Weakly similar to unnamed protein   4.17E−04   1.53       451461   AI968438   Hs. 265349   ESTs   4.55E−03   1.53       450235   AA007512   Hs. 17538   ESTs   3.39E−03   1.52       416323   N72630         Homo sapiens  genomic DNA, chromosome 21q   1.17E−05   1.52       438808   M73980   Hs. 129053     Homo sapiens  NOTCH 1 (N1) mRNA, complete   3.12E−07   1.52       452655   R85491   Hs. 33466   ESTs, Weakly similar to DPOZ_HUMAN DNA P   9.50E−04   1.52       431777   AA570296   Hs. 105470   found in inflammatory zone 1   4.41E−05   1.52       423086   AB028984   Hs. 123420   KIAA1061 protein   2.50E−06   1.51       407173   T64349       gb: yc10d08.s1 Stratagene lung (937210) H   2.11E−04   1.51       449482   AI784266   Hs. 28774   ESTs, Weakly similar to I38022 hypotheti   1.71E−03   1.51       404219           NM_004557*:  Homo sapiens  Notch (Drosophil   1.02E−05   1.51       441493   AW070446   Hs. 127037   ESTs   6.77E−04   1.51       405913           NM_004349:  Homo sapiens  core-binding fact   2.61E−03   1.50       458223   AW297673   Hs. 190526   ESTs   6.98E−04   1.50       452854   AA437061   Hs. 14060   prokineticin 1 precursor   1.67E−06   1.50       445735   AW503939   Hs. 107149   novel protein similar to archaeal, yeast   1.23E−03   1.50       446052   AA358760   Hs. 95893   gb: EST67699 Fetal lung II  Homo sapiens  c   1.00E−06   1.50       407124   R08160       gb: yf18a07.s1 Soares fetal liver spleen   8.86E−03   1.49       458968   AI933128   Hs. 25220   like-glycosyltransferase   1.73E−03   1.49       408937   AA210734   Hs. 291386   ESTs   8.62E−03   1.49       403180           Target Exon   8.69E−05   1.49       432202   BE301302   Hs. 7200   ESTs, Highly similar to AC007055 5 unkno   4.82E−03   1.49       407654   AW064121   Hs. 279175   ESTs   1.06E−03   1.48       437408   AL359598   Hs. 36606     Homo sapiens  mRNA; cDNA DKFZp547B086 (fr   7.68E−05   1.48       443495   N95833   Hs. 80395   ESTs   4.96E−05   1.48       436666   AI191588   Hs. 1179   TATA box binding protein (TBP)-associate   6.61E−03   1.48       426330   M77235   Hs. 169331   sodium channel, voltage-gated, type V, a   3.38E−04   1.48       446066   AI343931   Hs. 149383   ESTs   7.17E−05   1.48       422754   AA316476   Hs. 171811   adenylate kinase 2   1.62E−03   1.48       401595           Rag C protein   3.73E−05   1.48       406089           Target Exon   4.83E−03   1.48       401899           Target Exon   8.77E−05   1.47       412433   AA102400       ESTs   7.09E−05   1.47       402137           Target Exon   2.63E−03   1.46       404701           NM_022779:  Homo sapiens  hypothetical prot   2.50E−03   1.46       455663   BE065679       gb: RC3-BT0316-270400-016-e10 BT0316 Homo   7.55E−04   1.46       407032   U73799       gb: Human dynactin mRNA, partial cds.   1.67E−08   1.46       449904   AW304472   Hs. 200088   ESTs   1.91E−03   1.46       403474           NM_030968:  Homo sapiens  G protein coupled   2.90E−05   1.45       438991   W78940   Hs. 20526   ESTs   6.38E−03   1.45       443503   AV645438   Hs. 282927   ESTs   7.43E−03   1.45       453224   AI989700   Hs. 232320   ESTs   4.46E−05   1.45       452263   AA025116   Hs. 33333   ESTs   1.96E−05   1.45       405762           CX000374*: gi|11433304|ref|XP_006583.1|h   2.15E−04   1.45       427626   AI364292   Hs. 283696   ESTs, Weakly similar to A43932 mucin 2 p   5.41E−03   1.45       417741   R12418   Hs. 274728   ESTs   1.12E−03   1.45       438526   AI090671   Hs. 134807   hypothetical protein FLJ12057   7.48E−03   1.45       438173   AK001271   Hs. 6092   f-box and leucine-rich repeat protein 2   2.09E−03   1.44       458826   AI918672   Hs. 213783   ESTs   1.92E−05   1.44       415255   R39947   Hs. 7237   ESTs   8.01E−03   1.44       422091   AI906339   Hs. 97927   ESTs   9.01E−03   1.44       433010   AW970018       gb: EST382097 MAGE resequences, MAGK Homo   2.64E−03   1.44       422800   AW953176         Homo sapiens  cDNA: FLJ23260 fis, clone C   1.03E−03   1.44       439070   AI733278   Hs. 7621   ESTs   1.64E−03   1.44       405590           CX001497*: qi|4557543|ref|NP_001384.1| ex   1.91E−06   1.43       414648   H54381       gb: yq89a03.s1 Soares fetal liver spleen   1.07E−05   1.43       409319   AW752736   Hs. 33565   ESTs   6.79E−03   1.43       426065   N32049   Hs. 29423   gb: yw96g08.s1 Soares_placenta_8to9weeks —     2.67E−04   1.43       445771   AI804325   Hs. 201060   ESTs   5.21E−04   1.43       418642   AA226049   Hs. 297915   ESTs   2.51E−05   1.42       429521   BE048708   Hs. 50949   ESTs   3.99E−05   1.42       414262   AW975616   Hs. 291469   ESTs   1.22E−04   1.42       437093   AA744334       gb: ny59b06.s1 NCI_CGAP_Pr18  Homo sapiens     1.78E−04   1.42       421093   AA906434   Hs. 3776   zinc finger protein 216   4.09E−05   1.42       404825           C22000161*: gi|2443331|dbj|BAA22375.1|(D   5.52E−03   1.42       408768   AW663111   Hs. 94958   tubulin tyrosine ligase-like 1   8.41E−04   1.41       402638           guanine nucleotide binding protein (G pr   1.03E−03   1.41       406458           C14000133*: gi|1082739|pir|C44324 protea   2.14E−06   1.41       414327   BE408145   Hs. 185254   ESTs, Weakly similar to T24435 hypotheti   2.01E−05   1.41       435026   AA744812   Hs. 177135   ESTs   1.80E−03   1.41       445481   AW661846       ESTs   3.72E−05   1.40       410922   AW810845       gb: MR2-ST0129-221099-013-a03 ST0129 Homo   3.02E−03   1.40       412044   BE086167       gb: PM3-BT0673-260200-001-d01 BT0673 Homo   2.88E−08   1.40       457994   AW136239   Hs. 132922   ESTs, Weakly similar to TI47_HUMAN CARGO   4.12E−07   1.40       448464   AI522053       ESTs   1.16E−03   1.40       442340   AW882532   Hs. 8257   cytokine inducible SH2-containing protei   3.53E−04   1.39       428887   AA437009   Hs. 98984   ESTs   6.17E−09   1.39       436558   AI360238   Hs. 157730   ESTs   3.23E−04   1.39       428406   BE279930   Hs. 98564   hypothetical protein DKFZp434G0920   1.31E−03   1.39       427267   AI201185   Hs. 119164   ESTs   9.05E−04   1.39       436549   AJ297365   Hs. 334478   hypothetical protein MPMGp800M05499Q3   1.76E−04   1.38       404923           NM_020131*:  Homo sapiens  ataxin-1 ubiquit   3.88E−05   1.38       403209           Target Exon   3.66E−03   1.38       432909   AA570111       ESTs, Weakly similar to ALUE_HUMAN!!!!   8.59E−04   1.38       459304   AW005809   Hs. 158291   ESTs, Weakly similar to CHD4_HUMAN CHROM   5.40E−03   1.38       415597   Z44384       gb: HSC1ZC041 normalized infant brain cDN   5.65E−05   1.38       458544   AI631036   Hs. 196843   ESTs   4.62E−04   1.37       440075   BE268806       gb: 601139917F1 NIH_MGC_8  Homo sapiens  cD   2.27E−04   1.37       441194   BE274581       ESTs, Moderately similar to S65657 alpha   6.64E−03   1.37       457451   H06075   Hs. 270232   ESTs   6.68E−06   1.37       400635           C10000818*: gi|7661882|ref|NP_055697.1|K   2.66E−06   1.37       432092   AF135026       kallikrein 9   1.01E−03   1.36       419042   T81429   Hs. 221065   ESTs   1.20E−03   1.36       454537   BE391493       Human DNA sequence from clone RP5-852M4   9.75E−03   1.36       446403   AW452904       gb: UI-H-BI3-aly-h-11-0-UI.s1 NCI_CGAP_Su   8.47E−04   1.36       402349           Target Exon   4.33E−05   1.36       442907   AI023763   Hs. 79707   ESTs   1.21E−03   1.36       436394   AA531187   Hs. 126705   ESTs   5.26E−09   1.36       440745   AW303627   Hs. 143301   ESTs   1.69E−04   1.36       441662   AI807406       ESTs   3.93E−03   1.36       427951   AI826125   Hs. 43546   ESTs   3.49E−03   1.36       458354   AI024181   Hs. 131657   ESTs   3.18E−03   1.36       414871   BE549179   Hs. 29008   gb: 601078714F1 NIH_MGC_12  Homo sapiens  c   7.53E−04   1.36       454930   AW845987   Hs. 68864   ESTs, Weakly similar to phosphatidylseri   1.57E−03   1.36       456922   AA477435   Hs. 193669   hypothetical protein DKFZp586J1119   1.19E−03   1.35       453356   BE539237   Hs. 182698   mitochondrial ribosomal protein L20   8.58E−03   1.35       411154   AW819848       gb: QV0-ST0294-070300-151-b04 ST0294 Homo   8.20E−04   1.35       442558   AI000792   Hs. 108209   ESTs   2.62E−04   1.35       459002   AI915933   Hs. 102647   ESTs, Weakly similar to WASP interacting   7.83E−05   1.35       452236   AI130858   Hs. 143218   ESTs   2.66E−03   1.35       456110   AW872878   Hs. 289072   hypothetical protein FLJ22175   9.25E−03   1.35       421324   BE257515   Hs. 103503   deoxyribonuclease I-like 2   9.35E−05   1.34       414614   BE390050   Hs. 48642   hypothetical protein FLJ23093   5.55E−03   1.34       448544   AI535819       gb: jun1.P1.G1 conorm  Homo sapiens  cDNA 3   9.28E−04   1.34       458575   AW362488   Hs. 12797   DEAD/H (Asp-Glu-Ala-Asp/His) box polypep   9.57E−05   1.34       417597   BE297053   Hs. 347310   hypothetical protein FLJ14627   1.63E−04   1.34       430725   AA485056       ESTs   3.62E−03   1.34       432190   T80206   Hs. 14716   ESTs   6.52E−04   1.34       445690   AW675572   Hs. 193620   ESTs   2.53E−03   1.34       420813   X51501   Hs. 99949   prolactin-induced protein   2.38E−03   1.34       422579   BE407266       gb: 601301004F1 NIH_MGC_21  Homo sapiens  c   3.32E−03   1.34       402951           ENSP00000243967*: DJ1100H13.4 (putative R   4.06E−04   1.34       436516   AW134701   Hs. 245358   ESTs   1.00E−03   1.34       424334   AA393460   Hs. 13386   gb: zt71e05.r1 Soares_testis_NHT Homo sap   1.50E−05   1.33       432081   AW972788       gb: EST384883 MAGE resequences, MAGL Homo   9.35E−04   1.33       458306   AF039185   Hs. 41974     Homo sapiens , clone IMAGE: 4100953, mRNA   1.53E−03   1.33       421228   AA811598   Hs. 275809   ESTs   1.31E−04   1.33       402447           C1000201: gi|204416|gb|AAA02627.1|(L0519   6.43E−05   1.33       403545           Target Exon   5.81E−06   1.33       408376   AW971303   Hs. 241869   ESTs   7.57E−03   1.33       420693   NM_001972   Hs. 99863   elastase 2. neutrophil   6.28E−04   1.33       426157   AA370977   Hs. 345728   STAT induced STAT inhibitor 3   1.99E−10   1.33       453196   AW003567       ESTs   1.98E−04   1.32       421798   N74880       N-acylsphingosine amidohydrolase (acid c   4.05E−03   1.32       458077   AA100768   Hs. 48485   ESTs, Weakly similar to I38022 hypotheti   1.60E−03   1.32       400343   AB045830   Hs. 160953   Target   3.15E−04   1.32       402561           Target Exon   2.63E−04   1.32       454803   AW860148       gb: RC0-CT0379-290100-032-b10 CT0379 Homo   4.50E−05   1.32       413619   BE153524       gb: PM0-HT0339-241199-002-C03 HT0339 Homo   2.33E−06   1.31       446749   NM_016069   Hs. 16089   CGI-136 protein   2.11E−05   1.31       447680   AW768676   Hs. 302022   PR domain containing 16   1.19E−03   1.31       425012   T77666   Hs. 92414     Homo sapiens  cDNA: FLJ22030 fis, clone H   6.29E−03   1.31       416675   H73802   Hs. 35381   ESTs   1.60E−03   1.31       437568   AI954795   Hs. 156135   ESTs   4.02E−03   1.30       401516           C3001641*: gi|11359861|pir||JC7326 bood P   1.62E−03   1.30       428177   AA423967       ESTs   1.80E−03   1.30       452320   AA042873   Hs. 160412   ESTs   1.14E−03   1.30       442496   R55073   Hs. 76780   ESTs   6.05E−07   1.30       405691           NM_013439*:  Homo sapiens  paired immunoglo   1.56E−06   1.30       409540   AW409569   Hs. 101550   gb: fh01e09.x1 NIH_MGC_17  Homo sapiens  cD   7.89E−05   1.30       411288   AW835511       gb: QV0-LT0015-180200-127-d02 LT0015 Homo   1.34E−03   1.30       418551   T75517       gb: yd63c01.r1 Soares fetal liver spleen   8.37E−03   1.30       415449   H15034       gb: ym20a03.s1 Soares infant brain 1NIB H   1.60E−03   1.29       457677   AA628890       ESTs   1.76E−03   1.29       423310   AA325225   Hs. 124023     Homo sapiens  cDNA FLJ14218 fis, clone NT   1.17E−03   1.29       420800   AI041991   Hs. 132227     Homo sapiens , clone MGC: 13138, mRNA, com   2.29E−03   1.29       438292   AI139006   Hs. 122352   ESTs   1.97E−03   1.29       412429   AV650262   Hs. 75765   GRO2 oncogene   5.81E−08   1.29       446528   AU076640   Hs. 15243   nucleolar protein 1 (120 kD)   1.99E−04   1.28       454908   AW840458       gb: CM3-LT0079-180200-096&lt;01 LT0079 Homo   1.91E−03   1.28       423505   AF064090   Hs. 129708   tumor necrosis factor (ligand) superfami   9.02E−04   1.28       404126           ENSP00000211797*: Helicase SKI2W (Helicas   2.12E−03   1.28       432749   NM_014438   Hs. 278909   interleukin 1, eta   1.09E−03   1.28       450675   AA010662   Hs. 188639   ESTs   4.57E−04   1.28       404046           NM_019120*:  Homo sapiens  protocadherin be   9.68E−05   1.28       402991           Target Exon   3.40E−04   1.28       452165   R17489   Hs. 28264     Homo sapiens  mRNA; cDNA DKFZp564L0822 (f   2.07E−04   1.28       445268   AI218358   Hs. 175048   ESTs   4.78E−03   1.28       433664   AW292176   Hs. 245834   ESTs   8.30E−03   1.27       416348   H65887   Hs. 272163   ESTs   1.09E−03   1.27       442705   AI264634   Hs. 131127   ESTs   5.94E−04   1.27       440625   BE539853   Hs. 22452     Homo sapiens  mRNA for KIAA1737 protein,   3.66E−04   1.27       420459   AF016045   Hs. 97905   ovo (Drosophila) homolog-like 1   6.83E−03   1.27       413737   BE160704       gb: PM1-HT0422-170100-005-b07 HT0422 Homo   5.31E−06   1.27       408183   AW968065   Hs. 44143   polybromo 1   1.93E−03   1.27       420380   AA640891   Hs. 102406   ESTs   4.61E−05   1.27       454186   BE141030       gb: MR0-HT0067-201099-002-h11 HT0067 Homo   2.63E−03   1.27       438692   AB007950   Hs. 6360   KIAA0481 gene product   5.51E−04   1.27       402320           f-box and leucine-rich repeat protein 7   6.75E−06   1.27       414189   BE378841   Hs. 73452   hypothetical protein MGC10791   3.64E−05   1.26       413961   BE207098       gb: ba10e09.y1 NIH_MGC_7  Homo sapiens  cDN   5.19E−03   1.26       454598   AW809716       gb: MR4-ST0124-241199-026-h09 ST0124 Homo   1.50E−04   1.26       408935   BE539706   Hs. 285363   ESTs   7.92E−04   1.26       450653   AI191771   Hs. 29764   wingless-type MMTV integration site fami   4.58E−03   1.26       403227           Target Exon   1.60E−03   1.26       439471   W69839   Hs. 58033   ESTs   3.83E−03   1.26       433782   AF090945   Hs. 306564     Homo sapiens  clone HQ0670   8.19E−05   1.26       425446   U34802   Hs. 157433   gap junction protein, alpha 8,50 kD (con   6.39E−07   1.26       417313   AA195602       gb: zr32f09.r1 Soares_NhHMPu_S1 Homo sapi   3.92E−05   1.26       437180   BE180234   Hs. 281462     Homo sapiens  cDNA FLJ14793 fis, clone NT   7.39E−04   1.25       436419   AI948626   Hs. 171356   ESTs   1.91E−03   1.25       424713   AI660243   Hs. 318545   transmembrane protease, serine 2   7.11E−03   1.25       401265           C18000090*: gi|6678656|ref|NP_032506.1|1   3.20E−03   1.25       426212   S71824   Hs. 167988   neural cell adhesion molecule 1   5.71E−05   1.25       410285   AA083609       gb: zm63d05.r1 Stratagene fibroblast (937   7.72E−04   1.25       408432   AW195262       gb: xn67b05.x1 NCI_CGAP_CML1  Homo sapiens     6.30E−04   1.25       449405   AA001350       gb: zh83h05.r1 Soares_fetal_liver_spleen —     6.58E−03   1.25       431357   T81154       gb: yd24f01.r1 Soares fetal liver spleen   4.61E−03   1.24       459012   AA047221   Hs. 59752   ESTs   7.13E−03   1.24       408725   AA131539   Hs. 15669   ESTs   4.13E−04   1.24       428568   AC004755         Homo sapiens  chromosome 19, fosmid 37502   2.08E−04   1.24       453492   AA235214   Hs. 184793   DKFZP434F195 protein   2.09E−03   1.24       404247           NM_000500*:  Homo sapiens  cytochrome P450,   3.47E−03   1.24       427595   NM_016153   Hs. 179756   LW-1   2.01E−03   1.24       408038   AW138673   Hs. 252928   ESTs   1.35E−05   1.24       440353   AI366674   Hs. 286194   hypothetical protein FLJ22233   8.84E−03   1.24       438649   AA813136   Hs. 143014   ESTs   1.75E−03   1.24       406370           interleukin 11   1.24E−04   1.24       415037   AA159478       ESTs   2.21E−04   1.24       451005   AI751946   Hs. 20017   chromosome 22 open reading frame 4   3.85E−03   1.24       404075           Target Exon   3.41E−03   1.24       401703           NM_001053:  Homo sapiens  somatostatin rece   1.24E−04   1.23       402252           Target Exon   4.93E−06   1.23       412538   T31119   Hs. 7177   ESTs   7.66E−04   1.23       440190   AW752597       gb: IL3-CT0214-161299-045-B06 CT0214 Homo   3.52E−03   1.23       402316           NM_013447:  Homo sapiens  egf-like module c   3.46E−03   1.23       437913   AI140825   Hs. 121623   ESTs   9.11E−04   1.23       458146   AI286094       ESTs   9.62E−05   1.23       452218   AI936010   Hs. 17649   ESTs   3.58E−04   1.23       437057   BE548498   Hs. 84529   ESTs, Weakly similar to Z202_HUMAN ZINC   3.02E−03   1.22       400818           Target Exon   1.76E−05   1.22       409749   AW977045   Hs. 185981   ESTs, Weakly similar to gag [ H. sapiens ]   1.55E−05   1.22       422626   AA344932   Hs. 118786   metallothionein 2A   4.89E−04   1.22       416666   H73028   Hs. 268992   ESTs   1.34E−05   1.21       409975   AW839324       gb: CM0-LT0069-210100-157-h04 LT0069 Homo   1.78E−03   1.21       404900           NM_025213:  Homo sapiens  spectrin, beta, n   8.14E−03   1.21       416369   AW160617   Hs. 24884   hypothetical protein FLJ13390 similar to   1.83E−04   1.21       417761   R13727   Hs. 21435   ESTs   2.43E−04   1.21       419299   AI311085       hypothetical protein FLJ22573   2.01E−04   1.21       400877           cofilin 1 (non-muscle)   8.03E−03   1.21       437032   AW867372   Hs. 153261   immunoglobulin heavy constant mu   1.61E−03   1.21       423358   AI815474   Hs. 343866   gb: au47f10.y1 Schneider fetal brain 0000   1.38E−04   1.21       400111           Eos Control   3.47E−03   1.21       402610           Target Exon   4.97E−04   1.21       404769           NM_007037*:  Homo sapiens  a disintegrin-li   8.45E−05   1.20       416694   AW161284   Hs. 79564   neuronal PAS domain protein 1   4.72E−03   1.20       433182   AB039920   Hs. 127821   BWRT protein   5.55E−07   1.20       453899   AW134536   Hs. 243994   ESTs   2.91E−03   1.20       447563   BE536115   Hs. 160983   EST   1.53E−04   1.20       423966   AF233523   Hs. 136506   spectrin, beta, non-erythrocytic 5   2.87E−05   1.20       447224   BE617125   Hs. 142076   gb: 601441664F1 NIH_MGC_65  Homo sapiens  c   4.73E−05   1.20       456618   BE245649   Hs. 345728   STAT induced STAT inhibitor 3   3.29E−05   1.20       432345   AW780191   Hs. 6523   chromosome 1 open reading frame 12   6.34E−03   1.20       458281   AW661820   Hs. 44131   ESTs   1.36E−06   1.19       409280   AW372614   Hs. 82962   rTS beta protein   1.51E−04   1.19       436375   AJ227870       gb:  Homo sapiens  partial mRNA; ID YG81-1   6.60E−03   1.19       423308   AI365680   Hs. 114085     Homo sapiens  mRNA for KIAA1755 protein.   6.34E−05   1.19       417213   BE257508   Hs. 24719   modulator of apoptosis 1   7.70E−05   1.19       427983   M17706   Hs. 2233   colony stimulating factor 3 (granulocyte   5.82E−06   1.18       409818   AW500969       gb: UI-HF-BP0p-aiy-c-07-0-Ul.r1 NIH_MGC_5   7.58E−03   1.18       453741   AW855522       gb: CM4-CT0275-040500-521-c06 CT0275 Homo   1.98E−04   1.18       447455   H38335   Hs. 6750     Homo sapiens  mRNA for FLJ00058 protein,   1.35E−03   1.18       402863           C1000493*: gi|9506977|ref|NP_062075.1| ph   3.85E−03   1.18       439665   W93979       gb: zd97h10.r1 Soares_fetal_heart_NbHH19W   2.71E−03   1.18       453198   AI470361   Hs. 61684   ESTs, Weakly similar to T17307 hypotheti   4.42E−06   1.18       458025   AI275406   Hs. 32450   gb: ql63c10.x1 Soares_NhHMPu_S1 Homo sapi   1.60E−05   1.18       439547   BE000242   Hs. 192068   ESTs   5.54E−03   1.17       429947   AA461163   Hs. 270391   ESTs, Moderately similar to ALU1_HUMAN A   3.37E−03   1.17       455977   BE176477       gb: RC3-HT0585-160300-022-b01 HT0585 Homo   2.00E−04   1.17       457424   AW876082       gb: CM4-PT0015-071299-057-e05 PT0015 Homo   8.04E−04   1.17       430204   AA618335       ESTs, Weakly similar to YKQ3_CAEEL HYPOT   2.57E−03   1.17       450335   BE218355   Hs. 201781   ESTs, Weakly similar to B34087 hypotheti   1.65E−04   1.17       458237   AI741225   Hs. 20924   ESTs, Weakly similar to neogenin [H.sapi   5.20E−08   1.17       444295   AI201301   Hs. 143837   ESTs   5.95E−03   1.17       441860   AW451330   Hs. 348198   hypothetical protein FLJ20262   6.20E−07   1.17       435218   T84045   Hs. 119321   ESTs   2.19E−03   1.17       430885   U60181   Hs. 248115   growth hormone secretagogue receptor   6.04E−07   1.17       402012           ubiquitin specific protease 15   2.10E−04   1.17       457204   BE264152   Hs. 221994   ESTs   4.15E−04   1.17       458095   AI375740   Hs. 54580   ring finger protein 27   5.49E−03   1.17       455638   BE063665       gb: RC0-BT0291-031199-031-d08 BT0291 Homo   9.13E−05   1.16       450799   AW407504       gb: UI-HF-BM0-adk-g-12-0-Ul.r1 NIH_MGC_38   2.38E−04   1.16       430326   BE251590   Hs. 239370   DKFZP727I051 protein   2.52E−03   1.16       431256   NM_006093   Hs. 251386   proteoglycan 3   2.66E−05   1.16       458857   AI627342   Hs. 224601   ESTs   3.20E−03   1.16       412944   AA384110   Hs. 197143   ESTs   4.33E−03   1.16       449721   AW073727   Hs. 210265   ESTs   1.02E−04   1.16       452773   AW138920   Hs. 342009   ESTs   8.96E−03   1.16       431972   AI805145   Hs. 191711   ESTs, Weakly similar to T2D3_HUMAN TRANS   1.12E−04   1.16       402411           C1002484*: gi|12052832|emb|CAB66589.1| (A   2.35E−03   1.16       421432   AL049553   Hs. 104311   novel protein with MAM domain   1.40E−03   1.15       444207   AI565004       cathepsin D (lysosomal aspartyl protease   2.97E−07   1.15       423266   AA323875   Hs. 193574   ESTs   5.04E−03   1.15       455194   AW947513       gb: RC0-MT0002-140300-011-e04 MT0002 Homo   3.49E−05   1.15       440054   AW661947   Hs. 6891   splicing factor, arginine/serine-rich 6   4.89E−05   1.15       403567           Target Exon   7.42E−03   1.15       413309   BE312608       gb: 601151425F1 NIH_MGC_19  Homo sapiens  c   1.75E−06   1.15       457140   AI279960   Hs. 178140   ESTs   7.01E−04   1.15       458526   AI202885   Hs. 148611   ESTs   1.35E−03   1.15       430991   AW968826   Hs. 106432     Homo sapiens  cDNA FLJ13410 fis, clone PL   3.98E−06   1.15       401831           C17000644*: gi|631600|pir||S47094 hypothe   5.23E−03   1.15       403248           ESTs, Weakly similar to I78885 serine/th   5.87E−04   1.15       419909   AL136653   Hs. 93675   decidual protein induced by progesterone   8.17E−05   1.14       444552   AW295211   Hs. 230777   ESTs   2.00E−03   1.14       441580   AA938999   Hs. 271414   ESTs, Moderately similar to ALU7_HUMAN A   2.38E−05   1.14       402190           C19000835*: gi|10946730|ref|NP_067362.1|   6.88E−06   1.14       414156   BE392588   Hs. 75777   transgelin   5.43E−03   1.14       416007   N68218   Hs. 105998   ESTs   1.13E−03   1.14       455291   S72043   Hs. 73133   metallothionein 3 (growth inhibitory fac   5.19E−05   1.14       456523   AI083668   Hs. 50601   hypothetical protein MGC10986   4.77E−04   1.14       414314   BE312991   Hs. 50535   gb: 601150275F1 NIH_MGC_19  Homo sapiens  c   4.85E−03   1.14       433091   Y12642   Hs. 3185   lymphocyte antigen 6 complex, locus D   3.42E−03   1.14       402878           ENSP00000217420*: BA122O1.1 (A novel prot   2.18E−05   1.14       417721   R11266   Hs. 20755   ESTs   1.24E−03   1.14       416115   BE147652       gb: RC1-HT0229-030500-111-a05 HT0229 Homo   2.60E−05   1.14       401008           Target Exon   4.08E−04   1.14       442040   AW294162   Hs. 301062   UDP-N-acetyl-alpha-D-galactosamine: polyp   3.70E−03   1.14       437216   H13364       gb: yl71b11.r1 Soares infant brain 1NIB H   1.48E−03   1.14       401037           C11000425: gi|4507721|ref|NP_003310.1| ti   2.01E−10   1.14       441813   BE564575   Hs. 151093   hypothetical protein DKFZp434G1415   5.42E−04   1.14       404187           NM_019602:  Homo sapiens  butyrophilin-like   1.28E−03   1.14       445071   AI280246   Hs. 149504   ESTs   2.53E−03   1.14       444903   AW103062   Hs. 160391   ESTs   6.10E−03   1.13       458863   BE281219   Hs. 179260   chromosome 14 open reading frame 4   3.83E−03   1.13       438327   H87407       chorionic gonadotropin, beta polypeptide   2.14E−05   1.13       407404   AF040257       gb:  Homo sapiens  TNF receptor homolog mRN   5.77E−03   1.13       459014   AW292935   Hs. 100057   Human DNA sequence from clone RP11-550O8   7.10E−03   1.13       414182   AA136301       KIAA1105 protein   7.83E−04   1.13       402869           Target Exon   6.45E−05   1.13       420772   AW752656   Hs. 222707   KIAA1718 protein   4.72E−04   1.13       404504           Target Exon   1.50E−03   1.13       456825   H67220   Hs. 169681   death effector domain-containing   4.95E−03   1.13       405593           Target Exon   4.73E−04   1.13       420167   AA256113   Hs. 60659   ESTs, Weakly similar to T46471 hypotheti   8.70E−04   1.13       454077   AC005952   Hs. 37062   insulin-like 3 (Leydig cell)   2.15E−03   1.13       412755   BE144306   Hs. 179891   ESTs, Weakly similar to P4HA_HUMAN PROLY   1.78E−03   1.13       417639   R10467   Hs. 339793   ESTs, Weakly similar to ALU1_HUMAN ALU S   6.58E−03   1.13       449684   AI659166   Hs. 207144   ESTs   8.20E−03   1.12       442770   AI017267   Hs. 203763   ESTs   6.56E−03   1.12       402255           NM_031417*:  Homo sapiens  MAP/microtubule   4.32E−04   1.12       448943   AI608810   Hs. 193288   ESTs   1.93E−04   1.12       438254   AW269804   Hs. 153019   ESTs   8.64E−03   1.12       428653   AA135370   Hs. 188536     Homo sapiens  cDNA: FLJ21635 fis, clone C   1.94E−03   1.12       406146           NM_003319*:  Homo sapiens  titin (TTN), mRN   8.57E−03   1.12       446947   AF146747   Hs. 232165   polycythemia rubra vera 1; cell surface   5.74E−04   1.12       435264   AI247780   Hs. 117036   ESTs   2.54E−03   1.12       444459   AI680624   Hs. 148676   ESTs   8.40E−04   1.12       444279   U62432   Hs. 89605   cholinergic receptor, nicotinic, alpha p   4.90E−05   1.12       403722           C4001282: gi|7662006|ref|NP_055550.1| KIA   3.96E−03   1.12       452316   AA298484   Hs. 61265   ESTs, Moderately similar to G786_HUMAN P   2.13E−04   1.12       409382   AA071244       gb: zm73g03.r1 Stratagene neuroepithelium   4.57E−03   1.12       452947   AW130413       gb: xf50f04.x1 NCI_CGAP_Gas4  Homo sapiens     1.01E−04   1.12       446900   AV660909   Hs. 282705   ESTs   3.36E−03   1.12       447955   BE544271   Hs. 288390   hypothetical protein FLJ22795   2.44E−07   1.12       451383   AW239364   Hs. 20242   hypothetical protein FLJ12788   6.26E−03   1.12       408112   AW451982   Hs. 248613   ESTs   1.07E−03   1.12       404805           ENSP00000252109*: KIAA1043 PROTEIN (FRAGM   2.50E−04   1.12       403830           NM_001328*:  Homo sapiens  C-terminal bindi   1.78E−03   1.11       411507   AW850140       gb: IL3-CT0219-261099-023-D11 CT0219 Homo   6.34E−03   1.11       448169   BE252749   Hs. 20558   hypothetical protein FLJ20345   4.28E−03   1.11       414125   BE253197   Hs. 334520   hypothetical protein MGC15613   1.73E−03   1.11       442522   AI087038   Hs. 146592   ESTs, Weakly similar to ALU7_HUMAN ALU S   6.74E−04   1.11       447468   AL109959   Hs. 18632     Homo sapiens  mRNA full length insert cDN   5.61E−05   1.11       418028   R36212   Hs. 235534   ESTs, Weakly similar to ALU5_HUMAN ALU S   8.67E−03   1.11       419274   U09877   Hs. 89864   superkiller viralicidic activity 2 (S. c   1.52E−03   1.11       450545   AW135582   Hs. 201767   ESTs   2.51E−06   1.11       457840   AJ245874   Hs. 4245   chromosome 11 hypothetical protein ORF3   2.53E−03   1.11       404909           NM_025213:  Homo sapiens  spectrin, beta, n   5.66E−04   1.11       412419   AW948630       gb: QV0-FT0001-050500-226-g05 FT0001 Homo   4.87E−03   1.11       456126   AA164743   Hs. 187617   hypothetical protein FLJ13941   6.48E−04   1.10       401450           NM_031464*:  Homo sapiens  hypothetical pro   5.69E−03   1.10       428680   U69199       ESTs, Weakly similar to CGHU1S collagen   7.32E−04   1.10       423499   AW608884   Hs. 28068   ESTs   5.44E−05   1.10       447755   AI802667   Hs. 161348   ESTs   6.52E−04   1.10       426070   AF111170   Hs. 306165     Homo sapiens  14q32 Jagged2 gene, complet   7.77E−05   1.10       407631   AW574891   Hs. 55067   hypothetical protein MGC15437   2.49E−03   1.10       441548   AW394255   Hs. 127143   ESTs   2.03E−04   1.10       430820   AF194815       immunoglobulin lambda variable 4-3   2.28E−03   1.10       456469   NM_005109   Hs. 95220   oxidative-stress responsive 1   4.60E−05   1.10       420239   NM_005544   Hs. 96063   insulin receptor substrate 1   8.63E−03   1.10       446541   N73773   Hs. 282950   ESTs   2.36E−03   1.10       417469   AW189533   Hs. 252748     Homo sapiens  cDNA FLJ20394 fis, clone KA   8.97E−04   1.10       458126   AW979136   Hs. 124629   ESTs   1.82E−04   1.10       442364   AA993149   Hs. 129895   ESTs, Moderately similar to TBX3_HUMAN T   2.74E−04   1.10       420958   AA309431   Hs. 66   interleukin 1 receptor-like 1   1.93E−04   1.10       431111   AB033072   Hs. 250015   KIAA1246 protein   3.00E−05   1.09       435773   AW022047   Hs. 41119   otoraplin   2.74E−04   1.09       431365   AA504080   Hs. 191958   immunoglobulin superfamily receptor tran   1.23E−03   1.09       415016   N62934       ESTs   2.17E−04   1.09       459233   AI939966       gb: MR0-CT0015-160799-002-b06 CT0015 Homo   9.36E−03   1.09       454063   AF171928   Hs. 37055   fibroblast growth factor 5   5.43E−03   1.09       412518   BE047637   Hs. 334859   hypothetical protein FLJ10297   3.60E−06   1.09       424324   AA346316       gb: EST52440 Greater omentum tumor Homo s   1.61E−03   1.09       412202   AW900890   Hs. 21782   ESTs, Weakly similar to ALU7_HUMAN ALU S   1.69E−03   1.09       453573   AL042961   Hs. 95111     Homo sapiens  cDNA: FLJ23080 fis, clone L   2.27E−04   1.09       420599   AW294971   Hs. 172084     Homo sapiens , clone IMAGE: 3627860, mRNA,   4.38E−04   1.09       416416   H73127   Hs. 141269   ESTs, Moderately similar to ZN91_HUMAN Z   7.56E−03   1.09       405316           C7002129*: gi|3638957|gb|AAC36301.1|(AC0   3.56E−05   1.09       404364           Target Exon   4.89E−03   1.09       445097   W26975   Hs. 46736   hypothetical protein FLJ23476   3.64E−04   1.09       431807   AW970894   Hs. 324430   ESTs, Moderately similar to 1207289A rev   1.66E−04   1.09       439760   AL355741   Hs. 21641     Homo sapiens  mRNA full length insert cDN   1.36E−04   1.09       425952   BE336863   Hs. 184456   hypothetical protein   6.92E−05   1.08       406138           NM_000179*:  Homo sapiens  mutS ( E. coli ) h   5.55E−03   1.08       452155   AA812225   Hs. 45719   KIAA0823 protein   4.47E−04   1.08       422388   AA310006       gb: EST181073 Jurkat T-cells V Homo sapie   6.14E−03   1.08       459285   BE407166   Hs. 334812   hypothetical protein DKFZp586K0717   4.84E−04   1.08       424397   AI950320       gb: wp08d10.x1 NCI_CGAP_Kid12 Homo sapien   7.44E−03   1.08       451285   AW137912   Hs. 227583     Homo sapiens  chromosome X map Xp11.23 L-   8.92E−05   1.08       441395   AI681412   Hs. 176655   ESTs   3.36E−04   1.08       452703   AW299887   Hs. 213402   ESTs   2.32E−03   1.08       402338           Target Exon   4.16E−05   1.08       420988   AW006352   Hs. 159643   ESTs, Weakly similar to T32554 hypotheti   3.36E−03   1.08       409510   AW877400   Hs. 191782   ESTs, Weakly similar to ALU1_HUMAN ALU S   6.11E−04   1.08       449236   AJ403126   Hs. 26373     Homo sapiens  cDNA: FLJ23449 fis. clone H   2.62E−03   1.08       420243   AA256874   Hs. 187631   ESTs, Weakly similar to Y076_HUMAN HYPOT   6.50E−03   1.08       404244           Target Exon   3.53E−03   1.08       423546   AW341131   Hs. 146345   ESTs   1.20E−04   1.08       417967   BE244373   Hs. 1119   nuclear receptor subfamily 4, group A, m   9.37E−05   1.07       418784   T41418       gb: ph1h3_19/1TV Outward Alu-primed hncDN   1.50E−03   1.07       412682   AW983772       gb: RC3-HN0002-060400-012-h09 HN0002 Homo   2.24E−03   1.07       417408   F17211   Hs. 86092     Homo sapiens  skeletal myosin light chain   2.00E−04   1.07       452104   NM_000197   Hs. 477   hydroxysteroid (17-beta) dehydrogenase 3   9.02E−04   1.07       408710   Y10256   Hs. 47007   mitogen-activated protein kinase kinase   3.05E−05   1.07       402124           NM_031891:  Homo sapiens  cadherin 20, type   3.36E−03   1.07       400470           Target Exon   5.96E−03   1.07       420357   U94333   Hs. 97199   complement component C1q receptor   3.40E−03   1.07       424173   AW138201   Hs. 101064     Homo sapiens  cDNA FLJ12777 fis. clone NT   1.18E−03   1.07       440517   AW139632   Hs. 132246   ESTs   1.93E−04   1.07       438357   AI042101   Hs. 294107   ESTs   8.89E−03   1.07       428813   AA436063   Hs. 25734   ESTs   5.80E−03   1.07       406279           C18000033*: gi|5901944|ref|NP_008977.1|e   9.43E−03   1.07       402635           KIAA0408 gene product   9.81E−04   1.06       417329   AI190413   Hs. 8373   ESTs   9.11E−10   1.06       456059   BE543127   Hs. 336948     Homo sapiens , clone IMAGE: 3530891, mRNA,   1.83E−04   1.06       401532           C15001264*: gi|12737280|ref|XP_006682.2|   5.46E−04   1.06       403358           NM_006898*:  Homo sapiens  homeo box D3 (HO   1.30E−04   1.06       441250   AA926736   Hs. 131338   ESTs   6.75E−03   1.06       413772   BE163499       gb: QV3-HT0460-160200-092-d02 HT0460 Homo   1.16E−03   1.06       458522   AW452054   Hs. 161139   ESTs   2.12E−04   1.06       406755   N80129   Hs. 199263   metallothionein 1L   2.56E−06   1.06       438540   AA810021   Hs. 136906   ESTs   8.27E−05   1.06       402517           Target Exon   8.49E−05   1.06       422867   L32137   Hs. 1584   cartilage oligomeric matrix protein (pse   8.26E−03   1.06       433299   AA582324       ESTs   1.19E−04   1.06       457165   AL353972   Hs. 202613   ESTs   5.47E−04   1.06       440371   BE268550   Hs. 80449     Homo sapiens , clone IMAGE: 3535294, mRNA,   4.10E−03   1.06       414205   BE382438         Homo sapiens , clone IMAGE: 3690478, mRNA,   1.89E−03   1.06       421453   AA234652   Hs. 104555   neuropeptide FF-amide peptide precursor   3.52E−04   1.06       415515   F11327   Hs. 167406   gb: HSC2VD101 normalized infant brain cDN   1.44E−07   1.06       441638   AW293202   Hs. 133451   ESTs   6.88E−03   1.06       400576           Target Exon   1.45E−04   1.06       422221   AA306649   Hs. 169370   FYN oncogene related to SRC, FGR, YES   8.73E−03   1.05       440187   AI814224   Hs. 148565   ESTs   8.70E−03   1.05       410137   AI244459   Hs. 110826   trinucleotide repeat containing 9   5.49E−03   1.05       436537   AI201305   Hs. 335027   ESTs   5.64E−03   1.05       454397   AW974648       gb: EST386752 MAGE resequences, MAGM Homo   3.26E−03   1.05       432767   NM_014114   Hs. 278928   PRO0097 protein   7.72E−03   1.05       456013   T92048   Hs. 324531   gb: yd54g12.s1 Soares fetal liver spleen   1.08E−04   1.05       438233   W52448   Hs. 56147   ESTs   9.94E−03   1.05       442400   AW381148   Hs. 169407   2,3-bisphosphoglycerate mutase   6.12E−03   1.05       424648   AA344576   Hs. 17253   gb: EST50478 Gall bladder I  Homo sapiens     2.96E−03   1.05       404907           NM_025213:  Homo sapiens  spectrin, beta, n   9.51E−06   1.05       409487   H19886       gb: yn57a05.r1 Soares adult brain N2b5HB5   1.22E−04   1.05       422311   AF073515   Hs. 114948   cytokine receptor-like factor 1   4.30E−04   1.05       431151   BE207083       gb: ba10d10.y1 NIH_MGC_7  Homo sapiens  cDN   4.15E−03   1.05       458891   AI659166   Hs. 207144   ESTs   1.35E−05   1.05       452972   M31732   Hs. 31210   B-cell CLL/lymphoma 3   5.22E−05   1.05       456767   AI086412   Hs. 129064     Homo sapiens  chromosome 19, cosmid F2216   1.04E−04   1.05       419017   T83961       gb: yd76c08.s1 Soares fetal liver spleen   4.83E−05   1.05       426738   AA421097   Hs. 291902   ESTs   7.01E−06   1.04       414386   X00442   Hs. 75990   haptoglobin   1.19E−06   1.04       436234   AI809027       ESTs   1.15E−04   1.04       437343   AI521190   Hs. 165983   hypothetical C2H2 zinc finger protein FL   1.58E−03   1.04       413042   BE061618       gb: RC6-BT0252-151099-011-c05 BT0252 Homo   4.40E−03   1.04       400765           Target Exon   2.94E−05   1.04       453989   M63962   Hs. 36992   ATPase, H? exchanging, alpha polypeptide   1.57E−03   1.04       422743   BE304678   Hs. 119598   ribosomal protein L3   5.39E−04   1.04       454065   BE394588       gb: 601311808F1 NIH_MGC_44  Homo sapiens  c   5.26E−05   1.04       405201           Target Exon   6.03E−03   1.04       436221   AK001781   Hs. 296543     Homo sapiens  cDNA FLJ10919 fis, clone OV   4.68E−03   1.04       414376   BE393856   Hs. 66915   ESTs, Weakly similar to 16.7 Kd protein [   1.13E−03   1.04       428633   AW450428   Hs. 112050   ESTs   1.15E−05   1.04       433821   AW182416       ESTs   1.96E−04   1.04       448401   AI498509       ESTs   3.15E−03   1.04       408278   AW876813       phosphoglycerate dehydrogenase   4.02E−05   1.04       405282           Target Exon   2.01E−03   1.04       439548   AA086045   Hs. 137313   ESTs   6.15E−04   1.03       444788   AI871122   Hs. 202821   ESTs   3.94E−04   1.03       430842   AC002511   Hs. 272485   G protein-coupled receptor 41   8.52E−03   1.03       434179   AI743448   Hs. 116177   ESTs   3.72E−03   1.03       427827   AA416577   Hs. 189105   ESTs, Weakly similar to NBR13 [ H. sapiens     8.89E−03   1.03       412139   BE044976       gb: hn25b10.x1 NCI_CGAP_Thy7  Homo sapiens     5.90E−03   1.03       445500   AW451938   Hs. 257512   ESTs   4.34E−03   1.03       452151   AI190405   Hs. 143127   ESTs   8.32E−03   1.03       412474   AI791451       gb: ni50c09.y5 NCI_CGAP_Ov2  Homo sapiens     1.42E−03   1.03       407382   AA503620       gb: ne49b08.s1 NCI_CGAP_Co3  Homo sapiens     5.88E−06   1.03       413805   AW945740   Hs. 289293   ESTs   1.11E−03   1.03       448020   H06022   Hs. 334916     Homo sapiens , clone MGC: 17331, mRNA, com   9.93E−03   1.03       407586   Z37544   Hs. 37121   phospholipase C, beta 3 (phosphatidylino   1.14E−04   1.03       438998   AF075064       gb:  Homo sapiens  full length insert cDNA   2.30E−03   1.03       402022           Target Exon   8.26E−04   1.03       442321   AF207664   Hs. 8230   a disintegrin-like and metalloprotease (   1.86E−06   1.03       459375   BE251770       gb: 601112470F1 NIH_MGC_16  Homo sapiens  c   3.01E−04   1.03       418003   AA976107   Hs. 128691     Homo sapiens  mRNA for KIAA1762 protein,   1.54E−03   1.03       439694   AA843915   Hs. 54707   ESTs   3.55E−04   1.02       458318   BE177830       gb: RC1-HT0598-120400-022-b08 HT0598 Homo   7.76E−04   1.02       435680   H50946   Hs. 284183     Homo sapiens  galectin-related inhibitor   1.38E−05   1.02       445179   AI949743   Hs. 224768   ESTs   4.44E−03   1.02       455932   BE158451       gb: CM1-HT0390-301199-052-b01 HT0390 Homo   2.79E−04   1.02       420429   AW293291   Hs. 182382   ESTs   7.07E−03   1.02       446185   AI279191   Hs. 149454   ESTs, Weakly similar to DSR6_HUMAN DOWN   3.70E−03   1.02       410628   AI131408   Hs. 68756   ESTs, Moderately similar to similar to s   1.52E−05   1.02       428739   AA700158   Hs. 301755     Homo sapiens  cDNA FLJ11465 fis, clone HE   9.54E−03   1.02       409651   H96643   Hs. 283565   FOS-like antigen-1   4.45E−09   1.02       445311   AW027556   Hs. 345522   ESTs   9.11E−03   1.02       403579           Target Exon   4.78E−04   1.02       403957           Target Exon   1.30E−04   1.02       415471   F09747   Hs. 268707   ESTs   6.85E−04   1.02       440763   AB028988   Hs. 7407   KIAA1065 protein   8.27E−04   1.01       445474   AI240014   Hs. 259558   ESTs   5.32E−04   1.01       408690   AW864542       gb: PM4-SN0016-120500-003-h02 SN0016 Homo   1.89E−03   1.01       442574   AI932361   Hs. 238039   hypothetical protein FLJ11090   5.28E−04   1.01       448778   AF074913       gb:  Homo sapiens  transcription factor Pax   8.48E−03   1.01       400425   AY004252   Hs. 287385   PR domain containing 12   3.58E−06   1.01       438326   AW575901   Hs. 123230   ESTs, Weakly similar to Z195_HUMAN ZINC   9.93E−04   1.01       439698   AW779654   Hs. 55876   ESTs   3.98E−03   1.01       419189   T95862   Hs. 112318   6.2 kd protein   5.70E−03   1.01       436407   T88803   Hs. 237517   ESTs, Weakly similar to TIM_HUMAN PROBAB   3.93E−04   1.01       414630   BE410857   Hs. 16064   gb: 601301177F1 NIH_MGC_21  Homo sapiens  c   9.04E−03   1.01       409294   BE546175   Hs. 71746   hypothetical protein FLJ11583   2.83E−03   1.01       450184   W31096   Hs. 237617     Homo sapiens , clone IMAGE: 3447394, mRNA,   8.64E−04   1.01       457771   AI814635   Hs. 187117   ESTs   3.92E−03   1.01       451595   AW965569   Hs. 20996   ESTs   4.46E−04   1.01       416559   AI039195   Hs. 128060   ESTs   6.29E−03   1.01       453680   AL079647   Hs. 14485     Homo sapiens  cDNA: FLJ23220 fis, clone A   5.45E−03   1.01       424365   AI653164   Hs. 128665   ESTs, Moderately similar to I54374 gene   4.16E−03   1.01       419357   AW955121   Hs. 55148   hypothetical protein FLJ14466   6.12E−04   1.00       450991   AI751020   Hs. 313648   gb: cnO7g05.x1 Normal Human Trabecular Bo   5.11E−05   1.00       419861   AW081795   Hs. 233465   ESTs   4.72E−03   1.00                                                                  
 
     [0369]                       TABLE 12B                       Pkey   CAT Number   Accession                  454947   1083824_1   AW846590 AW846615 AW846584 AW846592 AW846621 AW846610       455765   6676_13   BG620787 AV761949 BG980132 AV761951 BE082222 BG979177 BF329571 BF908591 BE082279 BE081722 BG978604       455919   1527074_1   BE157195 BE157345 BE157130 BE157368 BE157136 BE157134 BE157202 BE157305 BE157109 BE157294               BE156971 BE156997 BE157374 BE156970 BE157366 BE157356 BE156973 BE157358 BE157300       412998   1343218_1   BE046254 BE046673 BE046253       417574   2134673_1   R00348 R09593       456636   433615_1   AW954166 AV723710 AW014769 AA916838 AW205448 AA476474 AI214918 BE550871 AI299143 AI685787               AI810480 AA476475 AI681494 AI378542 BF222633 AA769645 AA299751 AA299752       409840   915929_1   AW502122 AW501663 AW501720 AW502125       432745   112643_1   AA658826 AI821926 AI791191 AA635129 AA564492       454810   1073338_1   AW832915 AW832906 AW832788 AW832917 AW832776 AW832913       411772   300555_1   BE154090 AW861539 BF921665 BF350632 BF350631 AW904851 BE170301 BE154336 BE154275       407457   24680_1   AB044546 AJ242724 BF760529 BF946992 BG983676       450703   35938_2   AK056299 AI669104 AI378016 AI420515 AW297177 AI702739 AA889785 AA011202       436871   57685_1   AA070431 AA121992 AA076561 AA080879       459235   26808_3   AW814516 AW815927 AW814504 BF375203 AW814522 AW814521 AW814524 BF375206 AW814518 AW814517               AI940652 BF837881 AW751232 BF374342 AW176453 AW814505 BF886651 AW814525 BG001382 BE933380       426505   1139_4   BG177042 BE185582 BE185655 BE185657 AA380194       423053   367623_1   BE314223 AA320990 BE312679 BI054000 BI324838 AW057717       444163   682245_1   BG403189 AI148521 AI184746 AI126098 R05933 BI057330       440730   1648529_1   BE561722 BE268773 BE268956       447721   1889_2   BC013767 AL572931 BE742185 BI520113 AW959076 AI341487 AI623222 BM091074 AW593800 AI983635 AW275114               AI952164 BM091378 AA977038 AW513859 AI801910 AW273202 AW166266 AW337946 AI086791 BE907359               AW273147 AI453134 AA250733 AW072844 AI818468 AI561259 AW470887 AW300481 AW103087 AW175624               BE048584 BF063936 AI207341 AW193240 AW193322 AW264492               AI682412 AI631778 AI669677 AI128695 AA448630 AA456607 BF313680 BG898294 BI195544 BG421755               BI760100 BE383304 BF329916 BF526599               AA385255 BI520887 AA410939 AA448721 BF525380 BG423666 BI761786 BF944570       455973   1561647_1   BF352282 BE175424 BE175418 BE175383       454707   1067650_1   AW814808 BG999545 AW814989 AW814852       452621   2071061_1   AI910230 AI910262 AL134108 N44030       419555   252042_1   AA244401 AA244416       451402   1958047_1   AI793167 H39479       434646   15463_1   AF147445 AA130804 AA069114 AA069113       409795   MH905_27   AI498073 AI934808 AW374654 BI036066 BE709215 AA077985 BI831355               BF932450 BF770705 BF379220 AA077682               AA076814 AA076875 BI027970 AA077787 AA077311 BF811798 AW393752 BF327269 AA077305 AA078114               BF800885 BF942930 AW903223 BF916052               AW903170 AW903224 BF352664 BF379209       442793   417820_2   BG741247 BG741022 AI017798 AI953594 AW445065 AI245087       413537   1375441_1   BE146866 BE146865 BE146867       455968   1557068_1   BE168828 BE168823 BE168830 BE168820 BE168931 BE168826 BE168928       416648   1982787_1   R97488 H71377 R97368       458867   1246993_1   AW995393 AJ403118       425526   1076747_1   AW962995 AW955306 AA359933 AA358889 AW837746 BG961280               AW837697 AW837755       408099   7104_17   AW151646 AW151645 AW151637 BI562740       434884   10696_1   AF161340 AF150140 AV738842       438687   2575583_1   AI674070 AI239526 AI240515 AA814084       441184   1816784_1   BE715995 BE715973 AI204080 AA954474 AA922009       410312   1001291_1   AW851102 AW851181 AW850953 AW851110 AW629671       423103   879332_1   BE315237 AA322029       447135   579607_1   T58148 AW516579 AW059603       426254   7308_1   BC017081 AL539521 AL524509 AL556058 AL541690               AL543200 BF974751 BE514793 AW247083 BE183238 AA376427               AF202637 NM_022156 BI554151 AL559157 BE909859 AW009244               AW043786 AW273850 AI871111 AI889050 AL045428 AI884485 AI554001               AI375841 AI469097 BF741351 AW188439 AA410448 AW515248 BE301590               AW007777 AI148210 AI805423 BE784190 AV658045 AI093347 AI308976               AI249682 AI206484 AI493895 AA973765 F29582 AA335219 AA379270 F37119               AA026496 BE645159 AA617996 AI886986 BM144558 BC003659               BG739795 BE729530 BG334810 BE746857 BE390302 BM354208 BF757460               AA284639 AW967315 BE769162 W96068 BM477081 BG490980 BM013665               BE735761 BE257483 BE257427 BG255544 AI474585 AL569826 BG337562 BG491737               AL559158 BG822257 AL554642 AL570587 AA588594 AL041071               AA554020 AA287274 AA810799 AA729332 AA659019 BE439973 AA335218 AA639556               AA610680 R16774 H26778 AA026419 AA010840 BF830072               R50167 AL577377 AA622659 F25241 BF880480 AA872445 BE386621 AL571579       415160   1861867_1   T82802 R08505 D78670       416397   1969080_1   T91431 H80874 H53035       412371   1172992_1   AW946709 AW946621 AW946699 AW946695 AW946691               AW946697 AW946666       416323   1964997_1   H47929 N78108 N72630       412433   413465_1   AV698615 AA102400 AA327633 AA102401 AI970895       455663   1490406_1   BE065460 BE065619 BE065633 BE065626 BE065679 BE065617       433010   1234715_1   AW970018 BE843649 BE843644 AA573622 R08736 AA573669       422800   11320_9   BE545343 AW997954       414648   316607_1   BF126232 H54463 BF950132 H54381 BF944624 BE393262       437093   325853_1   BF955573 AA744334 AA745434 AA744302       445481   504944_1   AW003346 AI808038 AI671563 AI240190 AW661846 AI286080       410922   1064329_1   AW810845 AW810831 AW810661 AW810816 AW810772 AW810666               AW810865 AW810859 AW810670 AW810805 AW810856               AW810819 AW810852 AW810722 AW810699       412044   1149589_1   BE086167 AW887835 AW887682 AW887677 BE178621               AW887676 AW887674       448464   661708_1   AW196419 AI522053 AI650395       432909   137712_1   AA702596 AA570111 AI348435 AW192161       415597   1876403_1   T74345 F12588 Z44384       440075   1648556_1   BE559806 R12767 BE268806       441194   138512_1   BE275382 AA703515 BE166690 BG334067       432092   34124_1   AA583908       454537   15351_6   BG421219 BI488939 BE391114 BE391493 BG764533               BE276157 BE388289       446403   488811_1   BE549932 BE467906 BE326357 BG149226 AI298565               AW452904 AW449414 F04362       441662   2674073_1   AI807406 AI798919 AA948548       411154   1071475_1   AW819848 AW819850 AW819863       448544   1139239_1   BM476470 AW902443 AI535819       430725   1597397_1   AI478920 AI478907 AA485056       422579   15032_4   BG035571 BM457635 AA312626       432081   1237080_1   AA525888 AA525391 AA984238 AW972788 BE087083       453196   505145_1   AW003567 AI963955 AI990231       421798   3042_4   BC017829 AW276646 AI984209 AA663933 AA634104 AA551528               AA634041 AA298038 BG483990 T89297 BF853958 H64685               T90329 T60644 T57747 BF852694 T92529 BG482852 BF883064 BF883066 N74880               AA829796 N90716       454803   1072913_1   BI468492 AW862380 AW860148 AW821887 AW821863               AW821894 AW821870 AW862378 AW862351       413619   1524553_1   BE153524 BE153576 BE153583       428177   8737_7   AA779866 AA423967 AA423968       411288   1074988_1   AW835517 AW835513 AW835511       418551   2261897_1   AL564778 R99167 T99393 T75517       415449   1873127_1   H15034 T17195 F09069       457677   1205688_1   AI374612 AA628890       454908   1078884_1   AW840458 AW840400 AW840401 AW840535 AW840539               AW840532 AW840538       413737   1551611_1   BE160704 BE160849 BE160896 BF351011       454186   645362_1   BE141775 BE141030 BE141467 BE141520 BE141028 BE141492               BE141477 BE141460 AW177599 BE141456 BE141753               AW177597 AW177582 AW807582 AW177585 BE141761 AW177598 AW177579 AW177583                AW177587 BE141749 BE141489 BE141474 BE141512 BE141751               BE141024 AW177581 BE141750       413961   566812_1   BG251042 BE266372 BE207098       454598   1063474_1   BF374577 AW809840 AW809996 AW809798 AW809695 AW809646               AW809738 BF374582 AW809716 AW809826 AW809802               AW809747 AW810152       417313   1943_33   W01148 AA195602 N40632       410285   2930719_1   AA083790 AA083609 AA112048       408432   288076_1   AW811262 BF905430 BF908283 BF368183 BF907357 BF908452               BF908282 BG001786 BF908281 BF907042 BF908278 BF908277               BF908451 BF368225 BF379361 BF907348 BF908280 AW195262 R27868       449405   78886_1   AA203114 R00660 H83070 AA001350 H70366 R95157       431357   1235874_1   AW971393 AA503896 T81154 AA507148       428568   738084_1   BE259137 BE251523       415037   980243_1   AA159478 AW901089 AW593155 AA160437       440190   1030220_1   AW848781 AW848490 AW849062 AW752597 AW752699       458146   114488_2   AW589833 AI652176 AI216328 AI286094       409975   926611_1   AW839324 AW516213 BE142635       419299   36328_1   BM477587 BE675426 AA827059 AI597639 AI571409 AI719948               AI311085 AA953361 AI498787 AI364049 AI311084 BF871020               BF549868 AI356384 AA236660       400111   24179_2   NM_006156 D23662 BF038671 BI670321 BI603145 BI666956 BG716628 BG707476               BG768814 BE312007 BF125930               BF037916 BG942671 AI752472 AW009362 BE379126 BI198555 BF126026 N28289 BE388301 BG327102 AI571450               BF038400 AI884649 AI718962 AI742314               AA977058 AI150699 BG944784 AA187402 BG283893 AV712007 W01301 BG774109 W77840 C15672 BI670016               AI752473 AA484409 C14921 N41745 C15220               F30164 AA133181 BF768974 H30334 AA034968 AA384232 AA353297 AW407023 AA337516 F36177 AA374444               AA402758 AI141545 BI021470 AA973914       436375   46760_1   AJ227870 AW798823 AW798704       409818   914614_1   AW502932 AW500969 AW501134 AW501533       453741   1031156_1   AL120304 AW855522 AW753631       439665   24497_1   AF086498 AW955697 W93979 AI936062 AW268568 AA364461 W93980 BI914847 BI523483       455977   1562520_1   BE176686 BE176477 BE176484 BE176679       457424   117833_1   BM041161 BM040921 BM040887 AW876082 AA513157 BM041809 BM041314 AA747408               AA747397 AA736702 AA745146 AA648638       430204   MH1094_26   AI821606 AI826629 AI304327 AI660560 AW050605 AI732165 AW009962 AI262416               AI695625 AA469031 AI791844 AA573825 AA618335       455638   1489140_1   BE142908 BE063665       450799   819959_1   W31274 AW407504 AI738877       444207   9172_3   BE739425 AA514221 AA865491 AI828293 AA470456 AI276739 AA169357 BE932464 AA514889               AW819039 AW819083 BE843048 AI432496               AI470335 AI247243 BG533994 AA513783 AI887309 AA528036 AW972006 AW873028 AI924914 AI818810               AW152378 AW084946 AI521413               AI669583 BE932521 AI581370 BE180238 AW089750 AW771461 AW089714 AI590949 AI819148 AA731056               BF815234 BF911506 AA235803               AA485373 AI735658 AW393133 AW073080 AI707637 BF353320 BE843111 AW819036 AW393135 BG697291               AV648670 AV654332 AV687530               BG566964 AI807430 AI676072 AA837010 AI452482 AI625817 AW241750 BE048616 AI290928 AI680714 AA485530               BE175687 AV648513               AW130312 AI000556 AA632893 BE674169 BF001208 AA948166 BE175650 AA524664 AA490345 AI244948               AA602956 AA483492 AA918178               AW802049 BG675859 AV658871 BG678060 AI565004 AW819026 BE843092 AV686437 AV723049 BG616948               AI911647 AI743490 AI091096               BE857251 AI962074 AA049027 AW769317 AA343477 AA640112 BF876213 R82948 H26425 H82876 BE843095               BE843140 BG536641 BG617830               AA235802 BE774985 BE006682 BF342375 AA903144 BF338083 BF984258 AV657996 AI749532 BE768614               BE857252 BE932516 BE768573               AV657993 AV657777 AV752631 BE774974 T55847 BF095761 BF911511 BE710793 BE180119 BG617338               H45942 T55897 AV657718 BG563497       455194   1107901_1   AW947513 AW864536 AW864318       413309   455217_1   BF315003 BE312608 R10565       416115   863707_2   BE147652 BG990288       437216   645_11   R61679 AA746905 H13364 BF185622 N29108       438327   18001_1   NM_033183 NM_033043 NM_000737 BC006290 J00117               BG479175 AU138071 AI188721 AI188454 AI188947               AI188781 AI188729 AI200658 AI148857 AI188639 AI209155 AI189616 AI189595 AI189275 AI192447 AI188604               AI200457 AI188391 AI184224 AI190013 AI189641               AI207360 AI148695 AI148590 AI149163 BF589174 AI188348 AI189842 AI188498 AI148904 AI138197 AI417614               AI126101 AI160579 AI160936 AI160814               AI123896 AI189442 AI149591 AI131286 AI138448 AI149559 AI128296 AI168482 AA330755 NM_033142               AI192459 AI741512 AI206390 AI186215               AI148647 AI189807 AI183280 AI200559 AI188964 AI188303 AI200022 AI186353 AI219044 AI200270 AI189555               BG200016 BG210411 AI186465               AI186218 AI189968 AI149039 AI273580 AI291937 AI276216 AI188689 AI157454 AI200375 AI184348 AI221605               AI871881 BF432300 AI128424               AI868741 AI219133 H93668 AW451899 H95381 C18834 AA331267 AA330978 AL548158 AI149571 AI149072               AU155932 R68113 R26086 AA330414               AL551303 AI188830 AI188824 AI206355 AI453626 AI189364 AI160692 AI189068 AI219266 T49171 AA330939               AI130720 AI151301 AI199943               AI221019 AI186330 AI149467 AI198460 AI220923 AI161082 AI654493 AI184784 AI219589 AA232905 AI160705               AI189453 T47334 N30758 K03181               AL551349 BG434672 N40745 N41758 T83001 R71610 AA331230 N39958 AA330844 BE901661 AU135260               H86992 H87407 AA330968 AA330717               AA330761 AU139360 N42631 AA333923 AA330974 BG435249 AA331021 AA331049 N41851 AA330831 R23289               H87658 AA331043 AA330803               AL548120 BG479085 AA330609 AA331023 AA331039 BE733206 BE732062 W76381 R63351 BF060995 N56715               N56709 N40038 T52077 N41710               H94535 BI088367 N41834 H94543 AA330643 N47829 R23494 BG434117 N42013 R68922 AA331012 N40479               D78974 R67480 H56737 N40793               N41357 N41591 N41596 H93655 R68162 H87630 T85052 R01541 AI219422 AI221014 AI219055 AI221580 AI220780               T28278 AI219166 AI220865               N27381 N27073 N41361 N42190 N57328 AI149426 N57248 H86986 W71989 N30684 N30822 T85053 AI188728               AI168533 H95374 H94451 T49170               BF369834 N29831 N31955 N30313 N32233 AI221552 AI126906 AA400910 T90191 R23214 AI138431 AI128407               AI188492 AI186418 BF109879               N26397 AI188872 AI149447 N30216 AI431595 AI219009 N30817 N30833 AI148774 AI188715 AI149156 BG774563               H95176 H94991 H94347               N32759 N32604 H12587 H93656 H94015 N29701 N30276 N27302 BF999045 N29730 R68815 H87631 H86993               R63352 H95135 H94446 H87464               H95207 N31616 NM_000894 AV751658 AV752236 AI051683 AV748886 T29543 AA371971 AA371978               AA371346 AV753384 AA372026 AA371909               AV745740 AV746068 AV751144 AV747923 AV745447 AV748231 AV745712 AA063496 N56646 H87574 AW951441       414182   2917943_1   AA136321 AA136301 AI381776       409382   110743_1   AA071477 AA071244       452947   625171_1   AI932362 AW130413       411507   1088866_1   AW850140 AW850195 AW850192       412419   1175957_1   AW948630 AW948616 AW948604 AW948623 AW948627 AW948611 AW948605               AW948610 AW948626 AW948634               AW948631 AW948615 AW948607 AW948602 AW948633 AW948628       428680   41659_1   AB075857 U69199 AL554057 BE550443 AI125387 AI125388 AI372992 AI686618 AA583075               AW079720 AI948894 AI342763               AI982591 AW779115 AI560632 BF001153 AI623930 AA447536 BG911172 AA480680 BI197703 BE294318 AL530842               AL562327 AA448518               AA432018 BE264771 BE259722 BF930927       430820   32425_1   AF194815 AF194816       415016   1806690_1   N62934 BE858324 N46417 N46363 N46427 N46358 D19793 H99021       459233   3170768_1   AI939966 AI939976 AI939951 AI939981 AI939959 AI939988       424324   808543_1   AW954536 AA338802 BE160193 AA346316       422388   870372_−1   BE061034       424397   893246_1   AI950320 AA340023       418784   2306231_1   T41418 T41379 T41320       412682   1242945_1   AW983772 AW983837 AW983730 AW983769 AW983836 AW983835       413772   1553630_1   BE163499 BE163572 BE163580 BE163565 BE163503 BE163510       433299   1752_1   AK056027 AL120636 AA582324 AA582305 AI459497 BI047007 AL589306 AI688987               AI922469 AA350721 AI085972               AF131844 AW954598 AW957578 AA350710 AI884831 R37119 AA666294 AA350709 BF724097 AA203665               AI089250 AA708285 BF831652               AW104744 AW104745 AW129091 AV724110 AW805934 AV682207 AA563965 W93840 AW104743 AW009432               AI085993 BF839379 T79879                BC019656 AA975816 AI953836 BE350274 AW840298 BI043880 BG913327 AW839960 T07306 R53951               AI299256 AI961918 AI190874 AA724491               F04512 BG997879 R08567 BE810546       414205   1266364_1   BF306238 BE295439 BE382708 BE383262 BF315437 BI199567 BE382438       454397   118552_1   AW974648 AA649671 AA652153 BF875948 AA078582       409487   815197_1   H19886 T10231 AW402806       431151   1570517_2   BE207083       419017   2348209_1   T83961 T79425 T85415 T79511       436234   141336_1   AW269942 AI809027 AI799097 AA707010       413042   1487648_1   BE061618 BE061640 BE061619       454065   517162_1   BE394588 AW024754 BE183167 BE183166 BE378353       433821   72553_2   AK054648 AW182416 AA609856 AA918195 AA634398 AA927922 AA868718               AI290470 AI338870 Z25302 T30841               T30825 F29302 AA436128 BF095986 BI829584 AA853991 AA778707       448401   507788_1   AW007014 AI498509 AW156947 AI933042 AW370727 AW370779 AW370731               AW370726 AW370764       408278   MH337_68   BG422281 BG422108 AW177973 BG750536 AW876813 AW876814       412139   1154826_1   AW895327 AW895462 BE044976       412474   1022404_1   BE296601 BG829182 AI791451 BE019234 AI791288 AA111939 BG954837       438998   52228_1   AF075064 R89255 R89256       459375   619648_−3   BE251770       458318   1561764_1   BE177830 AF114068 BE175531 BE175603 BE175601 BE177658       455932   1528183_1   BE158451 BE158453 BE158585 BE158584 BE158454 BE158465 BE158464       408690   105725_1   BG563152 BF846777 BF849354 BF849359 BF846636 BF849201 BF849356               C16931 AA056717 AW864542 AW882724               AA056567       448778   7800_1   AW505435 U62539                                            
     [0370]                           TABLE 12C                       Pkey   Ref   Strand   Nt_position                  404473   8079921   Plus   22639-22773       402845   9369286   Plus   160451-160617, 160788-161009       400692   8118799   Plus   37906-38256       404224   6002294   Minus   80109-80957       405800   2791346   Plus   19271-19813       401149   7229925   Plus   73117-74019       405334   3135285   Plus   139386-139856       404958   7407941   Minus   2731-4531       405058   7655685   Plus   150740-151556       400663   8118474   Plus   88985-89281       403686   7387348   Minus   66625-68364       402399   1905915   Minus   24502-24666, 24986-25102       401624   8575907   Plus   168318-168444, 172964-173647       401706   4826475   Minus   14767-15317       405263   7329364   Minus   104082-104796       403796   8099896   Minus   75073-77664       405639   5091650   Plus   211184-211350       403794   8096910   Plus   163292-163884       403772   7770492   Plus   117668-117899       405126   8316124   Plus   45650-45911       400729   6705887   Plus   117048-118826       403243   7637828   Minus   76343-76585       402690   8348058   Plus   13368-13998       405677   4567140   Plus   31045-31445, 31688-31885       400522   9796828   Plus   40475-40792, 41517-41813,                   42598-42894, 4325       406140   9168231   Minus   49887-50219       401371   9650602   Plus   80901-81283       406357   9256093   Minus   77181-77415       401554   8099284   Minus   153483-153612       405137   8570507   Plus   158969-159423       404843   7940338   Plus   22556-23222       403613   8493504   Plus   81290-81465       402534   9801061   Plus   58989-59457       401629   8575965   Minus   169336-169788       404731   7230299   Minus   168609-168781, 182951-183081       404219   1841541   Plus   50866-51013, 51517-51614,                   51788-52030       405913   7712139   Minus   7484-7678       403180   7523976   Minus   63603-63759       401595   3293210   Plus   58192-58362       406089   9123919   Plus   73784-74296       401899   7230209   Minus   155620-155815       402137   7704985   Plus   11434-11799       404701   9800167   Minus   60061-60180       403474   9957921   Plus   55961-56511       405762   5931935   Plus   160502-161110       405590   6960456   Plus   90492-90818       404825   6478944   Plus   210382-210494       402638   9958128   Minus   82748-83226       406458   9756020   Plus   145874-146911       404923   7341893   Plus   98418-100223       403209   7630841   Minus   60664-60810, 85748-85939       400635   8567750   Minus   102800-102932, 107482-107689       402349   8191067   Minus   6817-6994, 7340-7680       402951   9408717   Plus   73252-73329, 73718-73877,                   76217-76299, 7819       402447   9796640   Plus   47605-47729, 51696-51821,                   52070-52257, 5330       403545   8078400   Plus   25293-25640       402561   9864675   Plus   72967-73163       401516   7637251   Plus   62335-62502       405691   4508112   Plus   171350-171739       404126   9796876   Plus   48919-49155       404046   3688074   Minus   2-773       402991   7631064   Minus   161294-161579       402320   7630359   Minus   46058-46153, 46446-46572       403227   7637789   Plus   24457-24771       401265   9797154   Plus   135413-135573       404247   7406725   Minus   83949-84214, 84312-84415,                   84499-84677, 8487       404247   7406725   Minus   83949-84214, 84312-84415,                   84499-84677, 8487       406370   9256130   Plus   125320-125482       404075   7652011   Plus   53692-53938       401703   4826475   Plus   135-1229       402252   3548788   Plus   6848-7049       402316   7527774   Minus   10751-10919, 18817-19052,                   22131-22328       400818   8569994   Plus   172644-172765, 173085-173200       404900   7331453   Plus   22032-22219       400877   9857603   Minus   156938-157254       402610   9926549   Minus   22955-23124       404769   8099713   Minus   175801-176823       402863   2956660   Minus   29506-29693       402012   7407997   Minus   111771-111909, 112107-112226,                   112519-11269       402411   9796294   Minus   109449-109598, 111328-111478       403567   8101141   Plus   35349-35614       401831   6850361   Minus   107181-108077       403248   7656833   Minus   167439-167606       402190   8576067   Minus   76488-76959       402878   9908870   Minus   56133-56522       401008   8117391   Minus   81421-81551, 82364-82512,                   82862-82938       401037   7232177   Minus   3364-3686       404187   4481839   Plus   7644-7991       402869   6434643   Minus   138639-139335       404504   8151759   Plus   83050-83765       405593   6960456   Plus   157746-158046, 160760-160939       402255   3510233   Plus   9421-9621       406146   8746393   Minus   28514-29086       403722   7528070   Minus   117448-117615, 120977-121188       404805   4165236   Minus   37584-38304       403830   9887814   Minus   20687-20893       404909   7331453   Minus   123713-123909, 124327-124411,                   124511-12462       401450   4680764   Minus   59252-59334, 59945-60427       405316   3638954   Plus   76171-76417, 76692-76844       404364   9964977   Minus   32986-33202       406138   9166422   Plus   42227-42753       402338   6957691   Minus   36915-37250       404244   5672609   Minus   98173-98517       402124   4033680   Plus   164206-164459       400470   9930824   Minus   156245-157227       406279   7547249   Plus   203752-204426       402635   9958100   Minus   167621-168379       401532   7798785   Plus   124414-124950, 125050-125418       403358   8570101   Minus   106778-107580       402517   9798106   Plus   17569-17721       400576   7923997   Minus   91711-91954       404907   7331453   Minus   102880-103828       400765   8131622   Plus   35000-35306       405201   7230116   Plus   36934-37314       405282   3810573   Minus   10482-10689       402022   7139714   Plus   165595-165748       403579   8101179   Minus   36167-36365       403957   8076835   Minus   81649-81754                                                    
     [0371] Table 13A lists about 102 genes up-regulated in Hepatitis C positive liver tissues from patients that are non-responsive to pegylated-interferon-alpha plus ribavirin treatment (non-responders) compared to Hepatitis C positive liver tissues from patients that are responsive to the treatment (responders). In both cases, the liver biopsies were obtained prior to treatment. These 102 genes have potential to be diagnostics and/or prognostic markers for determining the responsiveness of Hepatitis C infected liver tissues to pegylated-interferon-alpha plus ribavirin treatment. They may also provide clinical information on Hepatitis C infection and pathology. They may also be potential targets for therapeutic drugs and/or treatments. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the t-test p-value between the non-responders liver tissues group and the responders liver tissues group was less or equal to 0.01, and that the differences between the average “standardized values” of the different non-responders liver tissues was equal to or above 1.0 more than the average standardized values of the different responders liver tissues. The “standardized values” of the Hepatitis C liver tissues were derived by subtracting the median of the several different Hepatitis C negative liver tissue values from each probeset value, then divided by the interquantile range (IQR) of the same several Hepatitis C negative liver tissue values.  
                                   TABLE 13A                       Pkey   ExAccn   UniGene   Unigene Title   R1   R2                                                        440495   AA887212   Hs. 14161   hypothetical protein DKFZp434l1930   4.81E−03   4.71       439242   BE167324   Hs. 53996   ESTs, Weakly similar to ZN42_HUMAN ZINC   1.71E−03   4.63       437855   AA776740       ESTs   2.88E−03   4.12       413321   BE082938       gb: RC2-BT0642-290200-016-b02 BT0642 Homo   9.87E−03   3.29       453696   AI989482   Hs. 146286   kinesin family member 13A   7.86E−03   3.05       452455   N25153       ESTs, Weakly similar to AF174605 1 F-box   5.32E−03   3.04       455348   AW901517       gb: RC5-NN1013-310300-021-C03 NN1013 Homo   3.47E−03   3.00       459577   AA019148       gb: ze56e02.r1 Soares retina N2b4HR Homo   5.46E−04   2.90       446633   U85996   Hs. 157142   ESTs, Weakly similar to I38022 hypotheti   6.87E−03   2.90       434848   BE256304   Hs. 32148   AD-015 protein   2.06E−04   2.78       452941   AL110347   Hs. 31074   N-sulfoglucosamine sulfohydrolase (sulfa   2.47E−03   2.76       407544   Y10206       gb:  H. sapiens  mRNA for CD64 protein.   2.28E−03   2.70       450578   AI971773   Hs. 232268   ESTs   3.64E−03   2.68       439774   AL360257   Hs. 213493     Homo sapiens  mRNA full length insert cDN   4.81E−03   2.66       436427   AI344378   Hs. 143399   ESTs   4.46E−03   2.60       413348   BE086846       gb: QV1-BT0678-300400-182-b06 BT0678 Homo   2.15E−03   2.58       415210   Z25274   Hs. 154706   hypothetical protein FLJ14917   8.96E−03   2.49       403512           C3000579*: gi|12643308|sp|Q9Y4K1|AIM1_HUM   8.08E−03   2.49       425225   NM_003450   Hs. 155204   zinc finger protein 174   6.11E−03   2.49       422258   AI910976       gb: wd22a06.x1 Soares_NFL_T_GBC_S1 Homo s   5.28E−03   2.46       420400   AI337097   Hs. 156902   ESTs   5.73E−03   2.37       411729   AW861879       gb: CM0-CT0341-260100-160-h12 CT0341 Homo   2.55E−03   2.35       443933   AI091631   Hs. 203845   two pore potassium channel KT3.3   2.27E−03   2.30       449137   AW134478   Hs. 196033   ESTs   8.66E−04   2.28       431498   AK001777   Hs. 258551   aspartyl aminopeptidase   4.39E−03   2.28       444811   AW137791   Hs. 148419   ESTs   1.97E−03   2.28       457365   AA577297   Hs. 303249   EST   4.58E−03   2.27       409198   L19778   Hs. 51011   H2A histone family, member P   1.64E−03   2.19       430144   AI732722   Hs. 187694   ERGL protein; ERGIC-53-like protein   3.29E−03   2.16       420803   M91556   Hs. 99945   sodium channel, voltage-gated, type VI,   6.76E−03   2.16       411504   R90961   Hs. 164584   ESTs   9.64E−03   2.07       428291   AA534009   Hs. 183487   interferon stimulated gene (20 kD)   2.28E−03   2.02       422211   R84341   Hs. 293845     Homo sapiens , clone IMAGE: 3502329, mRNA,   6.74E−03   2.00       453746   AL120611   Hs. 107924   gb: DKFZp761H119_r1 761 (synonym: hamy2)   1.78E−03   1.99       454278   AF217525   Hs. 49002   Down syndrome cell adhesion molecule   1.53E−03   1.96       447281   AA017018   Hs. 18021   hypothetical protein FLJ20446   1.41E−03   1.94       452399   BE513301   Hs. 29344   hypothetical protein, clone 24751   1.86E−03   1.94       426150   NM_003658   Hs. 167218   BarH-like homeobox 2   6.19E−03   1.93       406773   AA812424   Hs. 76067   heat shock 27 kD protein 1   1.01E−03   1.93       430259   BE550182   Hs. 127826   RalGEF-like protein 3, mouse homolog   4.72E−04   1.92       431368   AA760776       ESTs   1.90E−03   1.91       413201   BE275378   Hs. 13972   hypothetical protein MGC12972   6.19E−03   1.91       408893   AW605335   Hs. 288826     Homo sapiens  cDNA FLJ12263 fis, clone MA   8.42E−03   1.90       454521   AW803516       gb: IL2-UM0081-230300-053-B12 UM0081 Homo   6.83E−03   1.89       405419           CX001144*: gi|7242973|dbj|BAA92547.1|(AB   5.89E−03   1.88       403005           C21000027*: gi|1817556|dbj|BAA13672.1|(D   3.44E−03   1.84       454282   AW296422       gb: UI-H-BW0-aio-h-05-0-UI.s1 NCI_CGAP_Su   7.45E−03   1.84       449381   AW388688   Hs. 288217   hypothetical protein MGC2941   7.54E−03   1.83       443305   AI050693   Hs. 133318   ESTs   9.26E−03   1.81       455154   AW859359       gb: MR1-CT0353-150300-102-c02 CT0353 Homo   8.62E−03   1.79       408172   W02488   Hs. 46039   phosphoglycerate mutase 2 (muscle)   9.27E−03   1.78       452711   AW967047   Hs. 293224   ESTs, Weakly similar to T00375 hypotheti   1.61E−03   1.70       448279   BE250564   Hs. 283655   lysophospholipase II   9.00E−03   1.67       408771   AW732573   Hs. 47584   potassium voltage-gated channel, delayed   3.00E−03   1.62       445909   BE262656   Hs. 32603   hypothetical protein MGC3279 similar to   6.81E−03   1.61       445058   AA234031   Hs. 326104   putative mitochondrial solute carrier   8.61E−03   1.60       442620   C00138   Hs. 8535     Homo sapiens  mRNA for KIAA1668 protein,   8.16E−03   1.59       431369   BE184455   Hs. 251754   secretory leukocyte protease inhibitor (   1.85E−03   1.58       441307   AW071696   Hs. 209065   hypothetical protein FLJ14225   1.73E−04   1.56       435012   AA768359   Hs. 149452   ESTs   7.59E−03   1.55       447606   AI588954   Hs. 170995   ESTs   7.61E−03   1.55       432911   AW807634   Hs. 279799   putative zinc finger protein NY-REN-34 a   9.38E−03   1.54       450812   AB002360   Hs. 25515   MCF.2 cell line derived transforming seq   2.25E−03   1.52       441164   AB023180   Hs. 7724   KIAA0963 protein   7.60E−03   1.52       455749   BE075035       gb: PM3-BT0584-260300-002-g05 BT0584 Homo   2.33E−03   1.51       412732   AW993300       gb: RC2-BN0033-180200-015-g06 BN0033 Homo   4.33E−03   1.49       414056   AI187349   Hs. 17681   ESTs   6.51E−03   1.49       458765   AI419235   Hs. 344456   gb: tf21d02.x1 NCI_CGAP_Brn23 Homo sapien   2.19E−03   1.44       407496   U20648       gb: Human zinc finger protein (ZNF154) mR   6.69E−03   1.42       434415   BE177494       gb: RC6-HT0596-270300-011-C05 HT0596 Homo   6.67E−03   1.39       407233   X16354   Hs. 50964   carcinoembryonic antigen-related cell ad   8.97E−03   1.38       410020   T86315   Hs. 728   ribonuclease, RNase A family, 2 (liver,   4.92E−03   1.37       454303   AW857169       gb: RC1-CT0302-110500-018-f10 CT0302 Homo   3.89E−03   1.34       401411           ENSP00000247172*: HYPOTHETICAL 126.2 kDa   5.91E−03   1.33       444754   T83911       transmembrane 4 superfamily member 4   6.61E−04   1.32       446411   AI298828   Hs. 153439   ESTs   1.63E−03   1.30       428407   NM_003963   Hs. 184194   Transmembrane 4 superfamily member 5   5.64E−04   1.30       452910   AI927371   Hs. 288839   hypothetical protein FLJ12178   9.89E−03   1.29       435791   AA243086   Hs. 25204   chondroitin 4-O-sulfotransferase 2   4.10E−03   1.29       441504   BE159181   Hs. 168232   hypothetical protein FLJ13855   5.78E−03   1.29       456477   BE550252   Hs. 1295   calcium channel, voltage-dependent, alph   9.15E−03   1.28       446388   AA292979   Hs. 7788   NPD007 protein   4.50E−03   1.27       418863   AL135743   Hs. 25566   ESTs, Weakly similar to 2004399A chromos   8.80E−03   1.24       406684   X16354   Hs. 50964   carcinoembryonic antigen-related cell ad   9.58E−04   1.24       414784   NM_000344   Hs. 288986   survival of motor neuron 1, telomeric   7.19E−03   1.24       425429   U18009   Hs. 157236   membrane protein of cholinergic synaptic   8.57E−03   1.22       441252   AW360901       hypothetical protein MGC4399   6.93E−03   1.21       448222   AI648587   Hs. 20725   Mov10 (Moloney leukemia virus 10, mouse)   4.64E−03   1.21       414395   BE304888   Hs. 279834   EST   6.16E−03   1.20       441244   BE612935   Hs. 184052   PP1201 protein   2.70E−03   1.19       420886   AA805453       ESTs, Weakly similar to T29012 hypotheti   9.38E−03   1.18       444972   AW195642   Hs. 148901   ESTs   7.68E−03   1.18       417418   NM_002468   Hs. 82116   myeloid differentiation primary response   9.64E−03   1.18       427672   AA356615   Hs. 336916   death-associated protein 6   1.92E−04   1.17       451025   AW028689   Hs. 301985   ESTs   9.53E−03   1.16       407195   C21124       gb: HUMGS0002072 Human adult (K. Okubo) Ho   1.84E−03   1.14       437226   AA432308         Homo sapiens  mRNA; cDNA DKFZp434M0420 (f   5.73E−03   1.13       407465   AJ401466       gb:  Homo sapiens  mRNA for high affinity c   2.51E−03   1.12       444751   AI207406   Hs. 11866   translocase of inner mitochondrial membr   8.36E−03   1.12       429396   AW954598         Homo sapiens  clone 25015 mRNA sequence   5.46E−03   1.06       457097   AB037727   Hs. 334479   hypothetical protein DKFZp586I021   9.69E−03   1.05       440464   AI917706   Hs. 129997   ESTs   7.61E−03   1.02                                                                  
 
     [0372]                       TABLE 13B                       Pkey   CAT Number   Accession                  437855   36765_2   AK056396 AI800037 AA777098 BF939153 AI621113 AA776740               BF446127 AW295790 AA769865 AI690256 N32072 H55081 AL044298 AI286018               BI044678 N45384       413321   1501922_1   BE083171 BE082893 BE082938       452455   928588_1   BE877195 BG988071 AI902576 N25153 AW518714 N25154       455348   1159211_1   AW901523 AW901517 BF363877 BF363878 AW901521 AW901547       459577   86256_1   W31316 AA019148 BF921026 BF921163       413348   1508017_1   BE086846 BE086726 BE086733 BE086849 BE086683       422258   868626_1   AW957794 AW957873 AA307574 AI910976 AA481204       411729   1099453_1   AW861879 AW861948 AW858447 AW861873 AW858418 AW861871       431368   331947_1   AW969020 AA760776 AA504117 AA731957 AA504375 BF962819       454521   1058686_1   BE154783 AW803516 AW803639       454282   725499 _1   H72616 H63825 AW296422       455154   1100782_1   AW859359 AW859373 AW859358 AW859368 AW859363 AW859370 AW859347       455749   1497012_1   BE075035 BE074999 BE075006 BE075008 BE075005 BE075032 BE075037       412732   1245294_1   AW993300 R22345 N23107       434415   110905_1   BE177494 AW276909 AA632849       454303   306545_1   AW857169 BF929104 AW857162 BE153976 BE141977 AW352163 BE141954       444754   2600_1   AK055577 U31449 NM_004617 BC001386 BE617218 BE868856 BM264336               BG385990 BM353313 BI439041 BM272005 BM314705 BG616897               AA345452 BM314731 AA345379 AA344984 BG191629 BF002707 BE138874 AI676255 AI675920 BM264034               BI438713 BM314426 AW471424               BF063338 BM311530 AW518986 BM314400 AI572072 AI337361 AW013983 AI569109 AW338459               AA452917 AI572053 AI886493 R07511               AA506545 AA480323 AA908761 AI921215 R11516 AI583063 AI584071 AW339205 AI640782 R85697               AI784149 AI584060 AI566443 AI982840               BI439748 H78445 H94341 BG210200 BI466960 BG197730 H59265 BG821834 AW951290 R96709 H90091               T83911 T68523 R07564       441252   122_1   NM_032315 BC004991 BM468629 AL583162 BE741793 BE303031 BE244077               BE302759 AL583161 AL572691 AI804708 AI129827 AW872388               AI653103 AI151487 BE504355 AI671476 AW770976 AI206149 AI678224 BE468167 AI201164 AI200893               AA574128 AI991968 AW194793               AA426113 AI220474 AI201028 AA757281 AA844723 AA398466 AA484977 BF059403 AI470557 AA435830               AW016602 AI915990 BF356355               AL569855 AW978643 AW242882 AI823516 AW235374 BF059684 C20622 T66303 AI912746 AW339765               AA968541 AL526958 BF433829               AA628313 AW578403 AI909734 N75265 AW274422 W02124 BG474952       420886   56595_1   AK057268 AA281379 BI856491 AA805453 AA281414 BF373287       407195   1786254_1   AA569403 C21124       437226   2332_1   AL117642 BF056754 AI952151 AI953773 AL045835 AI041069 BF765693 BF765688               BF763048 BG682692 AW967083 BM271900 AV704704               AL040396 AI627368 AW514803 AI761270 AI015622 AI862541 AW197157 AI697779 AI568646 AI200936               BE695042 AI366513 BE711314               BE711324 BE047438 AW474529 AI421029 AL046814 AA400447 BF941647 AI143869 AW591727 BE695050               BF887502 AW963918 BF001425               AI340187 AW006934 AW468251 AW467398 AW516879 BF871799 AI816703 AI223153 BM264535               AI624845 BE711307 AW514703 AW264118               AW474488 BM263438 AW204628 BE711312 BE711330 AI718586 AI247201 BE711341 BF593534 AA626326               AA747785 AA782029 AI341349               AI921814 AW613873 BF332890 BE244575 BE694998 BF197632 AA609664 AW235441 BE042387               AA704683 AA758933 AI970214 BI025187               AA432308 BF871801 AW008470 BF765466 BE711329 BE711328 BF765463 BF765739 AW129408               BF765015 BF764200 AL042362 H58451               T86447 AA873427 AA570077 AW771950 AA400603 N69252 H16763 T65234 AA992089 AA836232                AA813701 AA026623 W80716 AA861629               N54181 N54185 AI015075 AA236563 R54957       407465   303_1   AB043997 NM_021815 AJ401466 AF276871 AV709773 AA364959               AA363955 AA364965       429396   1752_1   AK056027 AL120636 AA582324 AA582305 AI459497 BI047007 AL589306 AI688987               AI922469 AA350721 AI085972 AF131844 AW954598               AW957578 AA350710 AI884831 R37119 AA666294 AA350709 BF724097 AA203665 AI089250 AA708285               BF831652 AW104744 AW104745               AW129091 AV724110 AW805934 AV682207 AA563965 W93840 AW104743 AW009432 AI085993 BF839379               T79879 BC019656 AA975816               AI953836 BE350274 AW840298 BI043880 BG913327 AW839960 T07306 R53951 AI299256 AI961918               AI190874 AA724491 F04512 BG997879               R08567 BE810546                                            
     [0373]                           TABLE 13C                       Pkey   Ref   Strand   Nt_position                  403512   7656757   Minus   114487-114610       405419   4753290   Minus   60924-61120, 61641-61773       403005   5791501   Minus   16945-17053, 20018-20403       401411   7799787   Minus   144144-144329                                                    
     [0374] Table 14A lists about 147 genes up-regulated in Hepatitis C positive liver tissues from patients that are responsive to pegylated-interferon-alpha plus ribavirin treatment (responders) compared to Hepatitis C positive liver tissues from patients that are not responsive to the treatment (non-responders). In both cases, the liver biopsies were obtained prior to treatment. These 147 genes have the potential to be diagnostics and/or prognostic markers for determining the responsiveness of Hepatitis C infected liver tissues to pegylated-interferon-alpha plus ribavirin treatment They may also provide clinical information on Hepatitis C infection and pathology. These were selected from 59680 probesets on the Affymetrix/Eos Hu03 GeneChip array such that the t-test p-value between the non-responders liver tissues group and the responders liver tissues group was less or equal to 0.01, and that the differences between the average “standardized values” of the several different responders liver tissues was equal to or above 1.0 more than the average standardized values of the several different non-responders liver tissues. The “standardized values” of the Hepatitis C liver tissues were derived by subtracting the median of the several different Hepatitis C negative liver tissue values from each probeset value, then divided by the interquantile range (IQR) of the same several Hepatitis C negative liver tissue values.  
                                   TABLE 14A                       Pkey   ExAccn   UnigeneID   Unigene Title   R1   R2                                                        413278   BE563085   Hs. 833   interferon-stimulated protein, 15 kDa   2.39E−04   8.04       402399           C19001025*: gi|11275298|dbj|BAB18302.1|(   9.60E−03   4.25       446783   AW138343   Hs. 141867   ESTs   2.95E−03   4.19       422596   AF063611   Hs. 118633   2′-5′-oligoadenylate synthetase-like   5.19E−03   4.03       433364   AI075407   Hs. 296083   ESTs, Moderately similar to I54374 gene   6.90E−03   3.97       447567   AW474513   Hs. 224397   ESTs, Weakly similar to I38931 Wiskott-A   6.87E−03   3.89       432680   T47364   Hs. 278613   interferon, alpha-inducible protein 27   4.46E−03   3.28       457974   AW842353   Hs. 321717   ESTs, Weakly similar to S22765 heterogen   9.02E−03   2.76       448436   AI520706   Hs. 171012   hypothetical protein FLJ22349   3.22E−03   2.71       405481           Target Exon   7.36E−03   2.65       415682   AI347128   Hs. 191870   ESTs   6.94E−03   2.64       444534   AW271626   Hs. 42294   ESTs   3.28E−03   2.62       417199   H48304       gb: yq77c01.r1 Soares fetal liver spleen   2.23E−03   2.50       440798   AB020648   Hs. 7426   KIAA0841 protein   1.00E−03   2.40       458492   AI143655       ESTs   8.29E−03   2.27       453989   M63962   Hs. 36992   ATPase, H? exchanging, alpha polypeptide   1.16E−03   2.25       409703   NM_006187   Hs. 56009   2′-5′-oligoadenylate synthetase 3 (100 k   5.99E−03   2.22       412003   R11775       ESTs, Weakly similar to Z195_HUMAN ZINC   7.01E−03   2.20       400423   AF264765       Target   7.03E−03   2.16       409665   NM_006731   Hs. 55777   Fukuyama type congenital muscular dystro   8.24E−03   2.12       438146   Z36842   Hs. 57548   ESTs   9.92E−03   2.10       401191           crystallin, beta A1   6.98E−03   2.06       420875   AA782222   Hs. 293224   ESTs, Weakly similar to ALU1_HUMAN ALU S   5.64E−03   2.06       423729   R01566   Hs. 5461   ESTs   1.99E−03   2.04       400301   X03635   Hs. 1657   estrogen receptor 1   2.35E−03   2.03       402885           Target Exon   4.26E−03   2.00       431620   AA126109   Hs. 264981   2′-5′-oligoadenylate synthetase 2 (69-71   4.05E−03   1.96       414915   NM_002462   Hs. 76391   myxovirus (influenza) resistance 1, homo   2.34E−03   1.94       435956   AF269255   Hs. 22604   lysosomal apyrase-like protein 1   1.31E−03   1.90       418165   R45959   Hs. 6637   ESTs   3.05E−03   1.89       449261   AI637592       ESTs   3.00E−03   1.89       458833   AW236702   Hs. 171431   ESTs, Weakly similar to A46010 X-linked   6.83E−03   1.87       433156   R59206   Hs. 17519     Homo sapiens  cDNA: FLJ22539 fis, clone H   4.62E−04   1.86       405468           NM_022820*:  Homo sapiens  cytochrome P450   1.23E−03   1.85       420772   AW752656   Hs. 222707   KIAA1718 protein   3.77E−04   1.85       451505   AI290219   Hs. 25223   ESTs, Highly similar to YSHUT threonine-   7.46E−03   1.84       423955   AI420582   Hs. 136164   cutaneous T-cell lymphoma-associated tum   7.60E−04   1.83       433207   AB040903   Hs. 284146   hypothetical protein DKFZp762N0610   9.89E−03   1.83       402605           Target Exon   3.64E−03   1.82       427958   AA418000   Hs. 98280   potassium intermediate/small conductance   5.64E−03   1.82       416879   H98899   Hs. 42599   ESTs   8.76E−03   1.81       458891   AI659166   Hs. 207144   ESTs   8.31E−03   1.78       432384   AW006770   Hs. 162193   ESTs   4.60E−03   1.78       424049   A8014524   Hs. 138380   KIAA0624 protein   3.61E−04   1.77       415723   AA330633   Hs. 23450   mitochondrial ribosomal protein S25   2.35E−03   1.76       437556   AI223078   Hs. 136776   ESTs   4.24E−03   1.75       436869   NM_014867   Hs. 5333   KIAA0711 gene product   6.34E−03   1.75       417054   AF017060       aldehyde oxidase 1   3.52E−03   1.75       411194   AW821559       gb: IL2-ST0311-271299-030-D03 ST0311 Homo   4.86E−03   1.74       421822   AV650066   Hs. 1430   coagulation factor XI (plasma thrombopla   9.90E−04   1.71       453866   AW291498   Hs. 250557   ESTs   6.34E−03   1.70       414812   X72755   Hs. 77367   monokine induced by gamma interferon   2.10E−03   1.68       457247   AA458605       KIAA1681 protein   9.08E−03   1.66       426315   AA854219   Hs. 348137     Homo sapiens , clone IMAGE: 3542716, mRNA,   1.33E−03   1.66       449774   R06076       gb: ye94c02.s1 Soares fetal liver spleen   1.81E−03   1.66       439281   AA100768   Hs. 48485   ESTs, Weakly similar to I38022 hypotheti   9.06E−03   1.65       435545   AA687415   Hs. 28107   ESTs   5.39E−03   1.65       453336   AW139766   Hs. 233431   ESTs   5.32E−04   1.64       403640           ENSP00000233023*: CDNA FLJ12662 fis, clon   8.54E−04   1.63       436790   AI498610       ESTs   5.14E−03   1.62       400552           Target Exon   9.71E−04   1.62       427185   AA398930       ESTs   3.78E−03   1.61       403609           C3001199: gi|7494834|pir||T15308 hypothet   1.26E−03   1.60       425468   BE141170       gb: MR0-HT0077-011099-001-a05 HT0077 Homo   5.35E−03   1.59       415374   F06904   Hs. 8346   ESTs   8.79E−03   1.59       440700   AW952281   Hs. 296184   guanine nucleotide binding protein (G pr   9.04E−03   1.59       424465   AI216391   Hs. 169939   heparan sulfate 2-O-sulfotransferase   3.85E−03   1.56       430374   AF064104   Hs. 22116   CDC14 (cell division cycle 14, S. cerevi   1.66E−03   1.56       418129   X52997   Hs. 1144   glycoprotein IX (platelet)   8.20E−03   1.55       421497   BE145334       BANP homolog, SMAR1 homolog   8.31E−04   1.54       440083   AI433721   Hs. 164153   ESTs   4.34E−03   1.53       401740           ENSP00000005503*: SA (rat hypertension-as   8.69E−03   1.53       447083   AI472124   Hs. 157757   ESTs   7.48E−03   1.52       411183   BE141178       gb: MR0-HT0077-011099-002-b06 HT0077 Homo   6.03E−03   1.52       426912   AL043054   Hs. 256657   ESTs, Weakly similar to A46302 PTB-assoc   2.41E−03   1.51       405720           Target Exon   5.64E−03   1.51       442068   BE312873   Hs. 314932   ESTs   5.81E−03   1.50       400279           NM_004581*:  Homo sapiens  Rab geranylgeran   9.72E−03   1.49       428138   AA773842   Hs. 293799   ESTs   2.77E−03   1.49       451792   AA019795   Hs. 200235   ESTs   1.40E−03   1.49       400846           sortilin-related receptor, L(DLR class)   7.96E−04   1.48       438683   AA813982       ESTs   7.91E−03   1.48       425304   AA463844   Hs. 31339   fibroblast growth factor 11   9.32E−03   1.42       433785   BE044593   Hs. 112704   ESTs   3.60E−03   1.42       421488   F13451   Hs. 77515   gb: HSC37A091 normalized infant brain cDN   4.59E−03   1.41       443150   AI034467   Hs. 34650   ESTs   4.28E−04   1.39       401439           NM_022495*:  Homo sapiens  hypothetical pro   9.26E−04   1.38       429443   AB028967   Hs. 202687   potassium voltage-gated channel, Shal-re   3.53E−03   1.36       408299   AW886716   Hs. 154396   hypothetical protein FLJ22282   3.26E−03   1.35       427009   AA394290   Hs. 97353   ESTs   5.89E−03   1.34       415770   M79237       gb: EST01385 Subtracted Hippocampus, Stra   3.83E−03   1.34       431718   AI337294       GaINAc alpha-2, 6-sialyltransferase I, I   8.31E−04   1.33       443765   AI084960   Hs. 334589   ESTs   1.23E−03   1.33       436945   AA918210   Hs. 121116   ESTs   6.32E−03   1.33       429018   AW892660   Hs. 146286   kinesin family member 13A   8.65E−04   1.33       428207   BE263644   Hs. 169119   gb: 601192069F1 NIH_MGC_7  Homo sapiens  cD   3.47E−03   1.30       433611   AW327692   Hs. 3446   mitogen-activated protein kinase kinase   5.80E−03   1.29       438900   AA827856   Hs. 124299   ESTs   9.32E−03   1.29       444131   AI806600   Hs. 328579   EST, Weakly similar to A55362 procollage   6.31E−03   1.28       458153   AI792267   Hs. 125363   ESTs   2.19E−03   1.28       425326   AW501870       gb: UI-HF-BR0p-ajo-g-06-0-UI.r1 NIH_MGC_5   4.51E−03   1.28       428803   AA913233   Hs. 153179   ESTs, Highly similar to Human Recombinan   7.01E−03   1.28       409570   AW418720   Hs. 167583   ESTs   7.21E−03   1.26       415835   Z45365       gb: HSC2NF061 normalized infant brain cDN   5.71E−03   1.26       403740           NM_001076*:  Homo sapiens  UDP glycosyltran   4.08E−03   1.24       446780   R31107       gb: yh61g01.s1 Soares placenta Nb2HP Homo   2.41E−03   1.24       443773   AV646452   Hs. 30941   calcium channel, voltage-dependent, beta   4.95E−03   1.24       409008   AA059392   Hs. 66791   ESTs   6.61E−03   1.23       426426   AI569804   Hs. 42792   ESTs, Weakly similar to I78885 serine/th   6.82E−03   1.23       436752   AW298529       ESTs   2.55E−03   1.23       455202   AW865320       gb: PM4-SN0020-300300-007-a11 SN0020 Homo   8.34E−03   1.21       445613   BE550889   Hs. 158491   ESTs   7.33E−03   1.20       442387   AI239835   Hs. 341782   ESTs   2.43E−03   1.19       444521   H58280   Hs. 8366   ESTs   4.22E−04   1.19       458273   AW770493   Hs. 182874   guanine nucleotide binding protein (G pr   9.33E−03   1.19       419662   W87674       gb: zh66a01.r1 Soares_fetal_liver_spleen —     6.47E−04   1.18       402842           ENSP00000241325*: DJ947L8.1.3 (novel CUB   7.14E−03   1.18       417715   AW969587   Hs. 86366   ESTs   9.63E−03   1.15       410209   AI583661   Hs. 60548   hypothetical protein PRO1635   3.03E−03   1.15       414832   W27128   Hs. 100057     Homo sapiens  cDNA: FLJ22902 fis, clone K   1.12E−03   1.14       425851   NM_001490   Hs. 159642   glucosaminyl (N-acetyl) transferase 1, c   7.36E−03   1.14       408906   AW294539   Hs. 255323   ESTs   7.49E−03   1.13       444211   AW390415   Hs. 79013   ESTs, Moderately similar to 1207289A rev   5.07E−03   1.13       444362   AW892056   Hs. 110853   ESTs   2.18E−03   1.12       418453   T93674   Hs. 268815   ESTs   8.59E−03   1.11       427761   AA412205   Hs. 140996   ESTs   8.41E−03   1.11       402149           Target Exon   6.08E−03   1.10       412150   AW895719       gb: QV4-NN0039-290300-154-f06 NN0039 Homo   2.46E−03   1.10       446250   AI283067   Hs. 320873   EST   9.30E−03   1.10       427201   AB037860   Hs. 173933   nuclear factor I/A   2.60E−03   1.10       439620   AA838727   Hs. 124405   ESTs, Weakly similar to A46010 X-linked   6.98E−03   1.10       401929           C17001690: gi|6005701|ref|NP_009099.1|AT   8.77E−03   1.08       406466           Target Exon   4.76E−04   1.07       446266   AI417271   Hs. 163949   ESTs, Weakly similar to I38022 hypotheti   5.84E−03   1.06       424579   BE614288   Hs. 285391   DKFZP564P1916 protein   4.35E−03   1.06       453585   AL043430   Hs. 325309   hypothetical protein FLJ14596   3.07E−03   1.06       420399   AA743258   Hs. 291545   ESTs   6.92E−03   1.05       435147   AL133731   Hs. 4774     Homo sapiens  mRNA; cDNA DKFZp761C1712 (f   6.17E−03   1.04       400636           C10001873: gi|11056014|ref|NP_067651.1|a   8.97E−03   1.03       436737   AI052229   Hs. 25373   ESTs, Weakly similar to T20410 hypotheti   8.30E−03   1.03       414278   AA330116       Human glucose transporter pseudogene   2.95E−03   1.02       457599   AW997833   Hs. 257267   FYVE and coiled-coil domain containing 1   5.05E−03   1.01       431006   BE152871       gb: CM1-HT0333-101299-064-d12 HT0333 Homo   5.72E−03   1.01       421932   W51778   Hs. 323949   kangai 1 (suppression of tumorigenicity   2.60E−03   1.01       405761           ENSP00000203606: CDNA FLJ14191 fis, clone   6.05E−03   1.01       450078   AI681743       gb: tx38g10.x1 NCI_CGAP_Lu24  Homo sapiens     3.38E−03   1.01       402942           Target Exon   5.84E−03   1.00                                                                  
 
     [0375]                       TABLE 14B                       Pkey   CAT Number   Accession                  417199   1965264_1   AA194635 H48304 R22482 R99998       458492   2797412_1   AI869287 AI143655       412003   1146633_1   R11775 F05441 F07670 AW883427 T26374       449261   3029652_1   AI923721 AI860294 AI637592       417054   12405_2   BG533564 BG618564 AW296119 AI269233 BF508328 AW364777 AW292258               AA371049 AI452471 AI092522 BG618376 AL049080 AA631068               BG564643 T53833 AV702544 BG533452 AV705004 AA588281 T28665 BG569026 AV646874 AV647253               AV647455 AV647749 BI759444               AV652457 AV695354 AV696010 AV697248 BG617586 AV722549 AI435836 AI590676 AI245019 AW338243               AA530898 D52191 AI435352               D57473 BG566952 AI420505 AA035245 AV704972 BG564113 AI439237 AI287456 AV695686 AA349017       411194   1072676_1   AW821558 AW821559 AW821557 AW821643 AW821560 AW821497 AW821639               AW821498 AW821496 AW821499       457247   22785_1   AB051468 AW977252 AI261627 AW665579 AW274550 AI418272 AW293861               AA731376 BF798878 BF445807 AB053320 AK022729 AW959911               AV658411 H10450 AI073358 AA889598 BF445392 AI368772 AA421057 AA702576 F09058 AA327610               AL135425 AU135871 AU125838               BE467087 BG661269 AI697843 BF111090 AI814556 AI689772 BE348775 AI689791 BF475299 AA987614               AI802005 N79670 BG564339               AW172331 AW592078 AA487432 AI270312 BF062573 AI755254 AI655337 AI753287 AI753432 N63992               AA758915 AA903180 AA126824               AI202889 AA778528 H99263 BF435656 BI755650 AW806648 BE547432 AA872493 H49166 AI167329               BG222086 AW751006 AW751005               BE827287 BI521573 BE737978 AA194149 W74616 AW138578 AI128240 AI498242 BM314911               AA642425 AW583264 AI332987 AW241875               N62879 AI362749 AI761951 AI370777 AI332423 AA903009 AI207967 AI435328 BG222922 BG222858               AW262522 AA758655 AA649251               AA235233 N77786 H30532 H30545 T94316 AW855131 AW992588 BG998544 BE076575 BG958225               AW772819 T83121 T80942 BF088923       449774   79702_1   AA007258 R06179 AA004224 R06076       436790   647116_1   AI936636 AI498610 AI589571 AA731428 AW182143       427185   1312946_1   AI204518 AA398930 AA402069       425468   1280868_1   BE141170 BE141413 BE141342 AA357975       421497   MH1660_34   BM012343 BG990287 BI054221 AA292029 BE090740 BE147105 BF945352               BE147159 AW837076 BE702303 BE166423 BF833717 BF898447               BF945348 AW085137 N58701 T81141 BG977546 BE160737 R81151 BF833715 R76844 BE145334               AA292072 BF747231       411183   1072365_1   BE141178 AW821110 BI048110       400279   2140_1   Y08200 NM_004581 BC003093 BE733834 BI753321 BG773890 BF091906               BI917541 AI023762 AA587230 BF435086 AI264262 AI687392               AI810536 AW589886 AI244419 AA749261 AA535435 AW205689 AI765770 AI765431 C02465 AW305347               AI818456 AA322111 AW381845               AW381829 AV749407 AA811636 AU159893 AA603065 AA652542 AI468678 R49616 AW381863 BE389867               BE182387 BF087771 AA527551               AA134051 AA831504 AA134052 AI871759 AW089048 BI913532 AA367709 BG828155 BF093014       438683   1241644_1   AA813982 AW978060 AA825734       415770   2051914_1   AA169260 AI267298 M79237       431718   3517_3   AW970730 AA524205 AW293340 AI337294 AA514491 AI858216 AA552097 AI857575       425326   916327_1   BE886799 AW846391 AW501870 AW502583 AW503003 AA355226 AW751981               AW846539 R11565 AA378251 AW846548 AW846136               AW846484       415835   1894612_1   T77496 Z45365 H05203 R25905       446780   1290689_1   AL568290 AI653198 AA371134 BE005364 AI341136 BI493548 H04953 R31107       436752   727461_1   AW977246 AW298529 AA972071 AA730213       455202   1108949_1   AW865320 AW865316 AW865249 AW865381 AW865379 BF373916 AW865250               AW865118 AW865123 AW865391 AW865043 BF373931               BF373934 AW865448       419662   2431548_1   W87872 W87674 W87774       412150   1155126_1   AW895719 N31451 N41451       414278   2649_1   BG564077 AA928199 BI491412 AI913576 AI769974 AA805536 AI978876 AI879646               AI640283 BM153392 AA137260 AI151263 AI474103               AW078667 AW079202 AA150376 BE048238 AI218961 AA631892 AI350813 AI758351 AI458422 AA150275               AI038862 AW183342 AA912346               AW468933 AI003046 AI208534 H60032 T34660 Z40410 AA621093 BE245388 N66384 AW118966 T17277               AW020353 BE467084 AI268780               BE003683 AA330116 R77760 AI473113 AI985726 BE813657 BE813503 BF326782 AI690850 N52225               AW994769 BI036529 R40472 BE813513       431006   1524128_1   AA490552 BE152870 BE152871       450078   1156200_1   AI681743 AW897284 AW897205 AW897287                                            
     [0376]                           TABLE 14C                       Pkey   Ref   Strand   Nt_position                  402399   1905915   Minus   24502-24666, 24986-25102       405481   3688109   Plus   5718-5837, 8719-8818       401191   9716907   Plus   22341-22636       402885   9926751   Plus   71919-72049       405468   8051573   Minus   69367-69529, 71227-71453,                   73076-73236       402605   9909420   Minus   47680-47973       403640   8671948   Minus   161756-161859, 164798-164914       400552   9801071   Plus   93101-93276       403609   8308266   Minus   125974-126320       401740   2982169   Plus   148357-148484, 148591-148690       405720   9797144   Plus   13409-13861       400846   9188605   Plus   39310-39474       401439   8246737   Plus   92993-94026       403740   7630882   Plus   86504-87227       402842   9369121   Minus   76355-76479       402149   8079589   Minus   86399-86618       401929   3810670   Minus   3167-3286, 4216-4310       406466   9795550   Plus   115511-115658, 118766-118915,                   121699-12177       400636   3818355   Minus   102143-102322       405761   1332524   Minus   22866-23294       402942   9368398   Plus   102152-102386                                                    
     [0377]               TABLE 15                          Pkey: 444342       UnigeneID: Hs.10887       Unigene Title: similar to lysosome-associated membrane glycoprotein       DNA Sequence       Nucleic Acid Accession #: NM_014398.1       Coding sequence: 64..1314                     1          11         21         31         41         51           |          |          |          |          |          |       GGCACCGATT CGGGGCCTGC CCGGACTTCG CCGCACGCTG CAGAACCTCG CCCAGCGCCC   60               ACCATGCCCC GGCAGCTCAG CGCGGCGGCC GCGCTCTTCG CGTCCCTGGC CGTAATTTTG   120               CACGATGGCA GTCAAATGAG AGCAAAAGCA TTTCCAGAAA CCAGAGATTA TTCTCAACCT   180               ACTGCAGCAG CAACAGTACA GGACATAAAA AAACCTGTCC AGCAACCAGC TAAGCAAGCA   240               CCTCACCAAA CTTTAGCAGC AAGATTCATG GATGGTCATA TCACCTTTCA AACAGCGGCC   300               ACAGTAAAAA TTCCAACAAC TACCCCAGCA ACTACAAAAA ACACTGCAAC CACCAGCCCA   360               ATTACCTACA CCCTGGTCAC AACCCAGGCC ACACCCAACA ACTCACACAC AGCTCCTCCA   420               GTTACTGAAG TTACAGTCGG CCCTAGCTTA GCCCCTTATT CACTGCCACC CACCATCACC   480               CCACCAGCTC ATACAGCTGG AACCAGTTCA TCAACCGTCA GCCACACAAC TGGGAACACC   540               ACTCAACCCA GTAACCAGAC CACCCTTCCA GCAACTTTAT CGATAGCACT GCACAAAAGC   600               ACAACCGGTC AGAAGCCTGA TCAACCCACC CATGCCCCAG GAACAACGGC AGCTGCCCAC   660               AATACCACCC GCACAGCTGC ACCTGCCTCC ACGGTTCCTG GGCCCACCCT TGCACCTCAG   720               CCATCGTCAG TCAAGACTGG AATTTATCAG GTTCTAAACG GAAGCAGACT CTGTATAAAA   780               GCAGAGATGG GGATACAGCT GATTGTTCAA GACAAGGAGT CGGTTTTTTC ACCTCGGAGA   840               TACTTCAACA TCGACCCCAA CGCAACGCAA GCCTCTGGGA ACTGTGGCAC CCGAAAATCC   900               AACCTTCTGT TGAATTTTCA GGGCGGATTT GTGAATCTCA CATTTACCAA GGATGAAGAA   960               TCATATTATA TCAGTGAAGT GGGAGCCTAT TTGACCGTCT CAGATCCAGA GACAGTTTAC   1020               CAAGGAATCA AACATGCGGT GGTGATGTTC CAGACAGCAG TCGGGCATTC CTTCAAGTGC   1080               GTGAGTGAAC AGAGCCTCCA GTTGTCAGCC CACCTGCAGG TGAAAACAAC CGATGTCCAA   1140               CTTCAAGCCT TTGATTTTGA AGATGACCAC TTTGGAAATG TGGATGAGTG CTCGTCTGAC   1200               TACACAATTG TGCTTCCTGT GATTGGGGCC ATCGTGGTTG GTCTCTGCCT TATGGGTATG   1260               GGTGTCTATA AAATCCGCCT AAGGTGTCAA TCATCTGGAT ACCAGAGAAT CTAATTGTTG   1320               CCCGGGGGGA ATGAAAATAA TGGAATTTAG AGAACTCTTT CATCCCTTCC AGGATGGATG   1380               TTGGGAAATT CCCTCAGAGT GTGGGTCCTT CAAACAATGT AAACCACCAT CTTCTATTCA   1440               AATGAAGTGA GTCATGTGTG ATTTAAGTTC AGGCAGCACA TCAATTTCTA AATACTTTTT   1500               GTTTATTTTA TGAAAGATAT AGTGAGCTGT TTATTTTCTA GTTTCCTTTA GAATATTTTA   1560               GCCACTCAAA GTCAACATTT GAGATATGTT GAATTAACAT AATATATGTA AAGTAGAATA   1620               AGCCTTCAAA TTATAAACCA AGGGTCAATT GTAACTAATA CTACTGTGTG TGCATTGAAG   1680               ATTTTATTTT ACCCTTGATC TTAACAAAGC CTTTGCTTTG TTATCAAATG GACTTTCAGT   1740               GCTTTTACTA TCTGTGTTTT ATGGTTTCAT GTAACATACA TATTCCTGGT GTAGCACTTA   1800               ACTCCTTTTC CACTTTAAAT TTGTTTTTGT TTTTTGAGAC GGAGTTTCAC TCTTGTCACC   1860               CAGGCTGGAG TACAGTGGCA CGATCTCGGC TTATGGCAAC CTCCGCCTCC CGGGTTCAAG   1920               TGATTCTCCT GCTTCAGCTT CCCGAGTAGC TGGGATTACA GGCACACACT ACCACGCCTG   1980               GCTAATTTTT GTATTTTTAT TATAGACGGG TTTCACCATG TTGGCCAGAC TGGTCTTGAA   2040               CTCTTGACCT CAGGTGATCC ACCCACCTCA GCCTCCCAAA GTGCTGGGAT TACAGGCATG   2100               AGCCATTGCG CCCGGCCTTA AATGTTTTTT TTAATCATCA AAAAGAACAA CATATCTCAG   2160               GTTGTCTAAG TGTTTTTATG TAAAACCAAC AAAAAGAACA AATCAGCTTA TATTTTTTAT   2220               CTTGATGACT CCTGCTCCAG AATTGCTAGA CTAAGAATTA GGTGGCTACA GATGGTAGAA   2280               CTAAACAATA AGCAAGAGAC AATAATAATG GCCCTTAATT ATTAACAAAG TGCCAGAGTC   2340               TAGGCTAAGC ACTTTATCTA TATCTCATTT CATTCTCACA ACTTATAAGT GAATGAGTAA   2400               ACTGAGACTT AAGGGAACTG AATCACTTAA ATGTCACCTG GCTAACTGAT GGCAGAGCCA   2460               GAGCTTGAAT TCATGTTGGT CTGACATCAA GGTCTTTGGT CTTCTCCCTA CACCAAGTTA   2520               CCTACAAGAA CAATGACACC ACACTCTGCC TGAAGGCTCA CACCTCATAC CAGCATACGC   2580               TCACCTTACA GGGAAATGGG TTTATCCAGG ATCATGAGAC ATTAGGGTAG ATGAAAGGAG   2640               AGCTTTGCAG ATAACAAAAT AGCCTATCCT TAATAAATCC TCCACTCTCT GGAAGGAGAC   2700               TGAGGGGCTT TGTAAAACAT TAGTCAGTTG CTCATTTTTA TGGGATTGCT TAGCTGGGCT   2760               GTAAAGATGA AGGCATCAAA TAAACTCAAA GTATTTTTAA ATTTTTTTGA TAATAGAGAA   2820               ACTTCGCTAA CCAACTGTTC TTTCTTGAGT GTATAGCCCC ATCTTGTGGT AACTTGCTGC   2880               TTCTGCACTT CATATCCATA TTTCCTATTG TTCACTTTAT TCTGTAGAGC AGCCTGCCAA   2940               GAATTTTATT TCTGCTGTTT TTTTTGCTGC TAAAGAAAGG AACTAAGTCA GGATGTTAAC   3000               AGAAAAGTCC ACATAACCCT AGAATTCTTA GTCAAGGAAT AATTCAAGTC AGCCTAGAGA   3060               CCATGTTGAC TTTCCTCATG TGTTTCCTTA TGACTCAGTA AGTTGGCAAG GTCCTGACTT   3120               TAGTCTTAAT AAAACATTGA ATTGTAGTAA AGGTTTTTGC AATAAAAACT TACTTTGG   3178               Protein Sequence       Protein Accession #: NP_055213.1       1          11         21         31         41         51       |          |          |          |          |          |       MPRQLSAAAA LFASLAVILH DGSQMRAKAF PETRDYSQPT AAATVQDIKK PVQQPAKQAP   60               HQTLAARFMD GHITFQTAAT VKIPTTTPAT TKNTATTSPI TYTLVTTQAT PNNSHTAPPV   120               TEVTVGPSLA PYSLPPTITP PAHTAGTSSS TVSHTTGNTT QPSNQTTLPA TLSIALHKST   180               TGQKPDQPTH APGTTAAAHN TTRTAAPAST VPGPTLAPQP SSVKTGIYQV LNGSRLCIKA   240               EMGIQLIVQD KESVFSPRRY FNIDPNATQA SGNCGTRKSN LLLNFQGGFV NLTFTKDEES   300               YYISEVGAYL TVSDPETVYQ GIKHAVVMFQ TAVGHSFKCV SEQSLQLSAH LQVKTTDVQL   360               QAFDFEDDHF GNVDECSSDY TIVLPVIGAI VVGLCLMGMG VYKIRLRCQS SGYQRI   416                    
     [0378] It is understood that the examples described above in no way serve to limit the true scope of this invention, but rather are presented for illustrative purposes. All publications, sequences of accession numbers, and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference.